Citrus Sinensis ID: 022444
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | 2.2.26 [Sep-21-2011] | |||||||
| Q9STV4 | 445 | CBL-interacting serine/th | no | no | 0.976 | 0.651 | 0.865 | 1e-151 | |
| Q5JLD8 | 446 | CBL-interacting protein k | yes | no | 0.973 | 0.647 | 0.840 | 1e-146 | |
| Q9LDI3 | 446 | CBL-interacting serine/th | no | no | 0.969 | 0.645 | 0.708 | 1e-126 | |
| Q69Q47 | 453 | CBL-interacting protein k | no | no | 0.966 | 0.633 | 0.724 | 1e-125 | |
| Q2V452 | 441 | CBL-interacting serine/th | no | no | 0.973 | 0.655 | 0.676 | 1e-120 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.956 | 0.631 | 0.675 | 1e-120 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.952 | 0.587 | 0.681 | 1e-118 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.973 | 0.658 | 0.680 | 1e-117 | |
| Q2QY53 | 438 | CBL-interacting protein k | no | no | 0.973 | 0.659 | 0.676 | 1e-117 | |
| Q2RAX3 | 454 | CBL-interacting protein k | no | no | 0.973 | 0.636 | 0.676 | 1e-117 |
| >sp|Q9STV4|CIPK8_ARATH CBL-interacting serine/threonine-protein kinase 8 OS=Arabidopsis thaliana GN=CIPK8 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 532 bits (1371), Expect = e-151, Method: Compositional matrix adjust.
Identities = 251/290 (86%), Positives = 274/290 (94%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMK++DRS IIK KM DQIKREISI
Sbjct: 1 MVVRKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHPCVVRL+EVLASRTKIYIILE+ITGGELFDKIV +GRLSESEAR+YF QLIDGV
Sbjct: 61 MKLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDSQG+LKISDFGLSALPEQGV++L+TTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGYNGA AD+WSCGVILYVL+AGYLPFDE+DL TLYSK++KA+FSCP++F +GAKSLI+
Sbjct: 181 HKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLIN 240
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
RILDPNPETRITI EIR DEWF K Y PV+LI+YE VNLDDV AAFDD E
Sbjct: 241 RILDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPE 290
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5JLD8|CIPK8_ORYSJ CBL-interacting protein kinase 8 OS=Oryza sativa subsp. japonica GN=CIPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 518 bits (1333), Expect = e-146, Method: Compositional matrix adjust.
Identities = 243/289 (84%), Positives = 267/289 (92%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+R+VGKYEVGRTIGEGTFAKVKFAQNTE+GESVAMKV+DRS+I+KHKMADQIKREISIM
Sbjct: 6 ALRRVGKYEVGRTIGEGTFAKVKFAQNTESGESVAMKVVDRSSILKHKMADQIKREISIM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KLVRHP VVRLHEVLASR KI+IILEFITGGELFDKI+ HGRL+E++ARRYFQQLIDGVD
Sbjct: 66 KLVRHPNVVRLHEVLASRKKIFIILEFITGGELFDKIIRHGRLNEADARRYFQQLIDGVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
+CHSKGVYHRDLKPENLLLDSQG+LKISDFGLSA P QG +LLRTTCGTPNYVAPEVLSH
Sbjct: 126 FCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSAWPAQGGALLRTTCGTPNYVAPEVLSH 185
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHR 241
KGY+GA AD WSCGVILYVL+AGYLPFDE+DLTTLY K+E A++S P WFP GAKSLIHR
Sbjct: 186 KGYDGALADTWSCGVILYVLLAGYLPFDEVDLTTLYGKIESAEYSFPAWFPNGAKSLIHR 245
Query: 242 ILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
ILDPNP+ RI IEEIRNDEWF+K Y P + IE E+VNLDDVNAAFDD E
Sbjct: 246 ILDPNPDKRIRIEEIRNDEWFKKNYEPTREIESEEVNLDDVNAAFDDPE 294
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LDI3|CIPKO_ARATH CBL-interacting serine/threonine-protein kinase 24 OS=Arabidopsis thaliana GN=CIPK24 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-126, Method: Compositional matrix adjust.
Identities = 204/288 (70%), Positives = 249/288 (86%)
Query: 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+R+VGKYEVGRTIGEGTFAKVKFA+NT+TG++VA+K++ +S I+K++M DQIKREISIMK
Sbjct: 5 MRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMK 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+VRHP +VRL+EVLAS +KIYI+LEF+TGGELFD+IVH GRL ESE+R+YFQQL+D V +
Sbjct: 65 IVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAH 124
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
CH KGVYHRDLKPENLLLD+ G+LK+SDFGLSALP++GV LLRTTCGTPNYVAPEVLS +
Sbjct: 125 CHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVELLRTTCGTPNYVAPEVLSGQ 184
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
GY+G+AAD+WSCGVIL+V++AGYLPF E DL LY K+ A+FSCP WF K LIHRI
Sbjct: 185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRI 244
Query: 243 LDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
LDPNP+TRI I+ I+ D WFR YVP++ E E+VNLDD+ A FD E
Sbjct: 245 LDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIE 292
|
Involved in the regulatory pathway for the control of intracellular Na(+) and K(+) homeostasis and salt tolerance. Activates the vacuolar H(+)/Ca(2+) antiporter CAX1 and operates in synergy with CBL4/SOS3 to activate the plasma membrane Na(+)/H(+) antiporter SOS1. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q69Q47|CIPKO_ORYSJ CBL-interacting protein kinase 24 OS=Oryza sativa subsp. japonica GN=CIPK24 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1153), Expect = e-125, Method: Compositional matrix adjust.
Identities = 208/287 (72%), Positives = 245/287 (85%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
++VG+YEVGRTIG+GTFAKVKFA + +TG +VAMKVLD+ I+ H+M QIKREISIMK+
Sbjct: 13 KRVGRYEVGRTIGQGTFAKVKFAVDADTGAAVAMKVLDKDTILNHRMLHQIKREISIMKI 72
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
VRHP +VRL+EVLA +TKIYIILE ITGGELFDKI G+L E+EAR+YFQQLID ++YC
Sbjct: 73 VRHPNIVRLNEVLAGKTKIYIILELITGGELFDKIARQGKLRENEARKYFQQLIDAINYC 132
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
HSKGVYHRDLKPENLLLDS+G+LK+SDFGLS L ++GV LL TTCGTPNYVAPEVLS+ G
Sbjct: 133 HSKGVYHRDLKPENLLLDSRGNLKVSDFGLSTLAQKGVGLLHTTCGTPNYVAPEVLSNNG 192
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
Y+G+AADVWSCGVILYVL+AGYLPF+E DL TLY K+ FSCP WF GA SLIHRIL
Sbjct: 193 YDGSAADVWSCGVILYVLMAGYLPFEEDDLPTLYDKITAGQFSCPYWFSPGATSLIHRIL 252
Query: 244 DPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
DPNP+TRITIE+IR D WF+K YV +K E E+V+LDDV A FD+ E
Sbjct: 253 DPNPKTRITIEQIREDTWFKKTYVAIKRGEDENVDLDDVQAVFDNIE 299
|
Involved in the regulatory pathway for the control of intracellular Na(+) and K(+) homeostasis and salt tolerance. Operates in synergy with CBL4 to activate the plasma membrane Na(+)/H(+) antiporter SOS1. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 431 bits (1107), Expect = e-120, Method: Compositional matrix adjust.
Identities = 197/291 (67%), Positives = 243/291 (83%), Gaps = 2/291 (0%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYEVGRTIGEGTFAKVKFA+N+ETGE VA+K+LD+ ++KHKMA+QI+REI+ M
Sbjct: 7 VKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATM 66
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL++HP VV+L+EV+AS+TKI+IILE++TGGELFDKIV+ GR+ E EARRYFQQLI VD
Sbjct: 67 KLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVD 126
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLDS G+LKISDFGLSAL +Q LL T+CGTPNYVAPEVL
Sbjct: 127 YCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVL 186
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
+ +GY+GA AD+WSCGV+LYVL+AGYLPFD+ +L LY K+ +F+CP W +GA LI
Sbjct: 187 NDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLI 246
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
RILDPNP TR+T +E+ DEWF+K Y P E +D N+DD++A F DSE
Sbjct: 247 TRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSE 297
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 430 bits (1106), Expect = e-120, Method: Compositional matrix adjust.
Identities = 194/287 (67%), Positives = 244/287 (85%), Gaps = 3/287 (1%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+VG+YE+GRT+GEGTFAKVKFA+N ++GE+VA+K+LD+ ++KHKM QIKREIS MKL+
Sbjct: 9 RVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKREISTMKLI 68
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
RHP V+R+HEV+AS+TKIYI++E +TGGELFDKI GRL E +AR+YFQQLI+ VDYCH
Sbjct: 69 RHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCH 128
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVLSHK 182
S+GVYHRDLKPENLLLD+ G LK+SDFGLSAL +Q LL TTCGTPNYVAPEV+++K
Sbjct: 129 SRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNK 188
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
GY+GA AD+WSCGVIL+VL+AGYLPF++ +L +LY K+ KADFSCP+WF AK LI +I
Sbjct: 189 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKI 248
Query: 243 LDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDS 289
LDPNP TRITI E+ N+EWF+KGY P + E DVNLDD+N+ F++S
Sbjct: 249 LDPNPSTRITIAELINNEWFKKGYQPPRF-ETADVNLDDINSIFNES 294
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 425 bits (1092), Expect = e-118, Method: Compositional matrix adjust.
Identities = 195/286 (68%), Positives = 240/286 (83%), Gaps = 3/286 (1%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
VGKYE+GRT+GEGTFAKVKFA+N E G++VA+KV+D+ ++K+KM QIKREIS MKL++
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
HP V+R+ EV+AS+TKIY +LEF+TGGELFDKI +GRL E EAR+YFQQLI+ VDYCHS
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVLSHKG 183
+GVYHRDLKPENLLLD+ G LK+SDFGLSALP+Q LL TTCGTPNYVAPEV+++KG
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
Y+GA AD+WSCGVIL+VL+AGYLPF++ +LT+LY K+ KA+F+CP WF AK LI RIL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267
Query: 244 DPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDS 289
DPNP TRIT E+ +EWF+KGY K E DV+LDDV+A FDDS
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKF-ENADVSLDDVDAIFDDS 312
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 422 bits (1086), Expect = e-117, Method: Compositional matrix adjust.
Identities = 198/291 (68%), Positives = 237/291 (81%), Gaps = 2/291 (0%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYEVG+T+G+GTFAKV+ A NTETGE VA+K+LD+ ++KHKMA+QI+REI M
Sbjct: 6 VQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL+ HP VVRL+EVLAS+TKIYI+LEF TGGELFDKIVH GRL E AR+YFQQLI+ VD
Sbjct: 66 KLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLD+QG+LK+SDFGLSAL Q G LL T CGTPNY APEVL
Sbjct: 126 YCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVL 185
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
+ +GY+GA AD+WSCGVIL+VL+AGYLPF++ +L TLY K+ ++ CP W GAK+LI
Sbjct: 186 NDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLI 245
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
RILDPNP TRITI E+ D WF+K Y P E E+ NLDDV+A F DSE
Sbjct: 246 VRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSE 296
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-117, Method: Compositional matrix adjust.
Identities = 197/291 (67%), Positives = 240/291 (82%), Gaps = 2/291 (0%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYE+GRTIGEGTFAKVKFA++TETG+ VA+K+LD+ ++KHKM +QIKREIS M
Sbjct: 6 VKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL++HP VVR++EV+ S+TKIYI+LE++TGGELFD IV+HGR+ E EARRYFQQLI+ VD
Sbjct: 66 KLIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLDS G+LK+SDFGLSAL +Q LL TTCGTPNYVAPEVL
Sbjct: 126 YCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVL 185
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
+GY+GA AD+WSCGVIL+VL+AGYLPF++ +L TLY K+ A+F+ P W AK L+
Sbjct: 186 EDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLL 245
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
RILDPNP TR+TI EI DEWF+KGY + E D LDDV A F+DSE
Sbjct: 246 TRILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSE 296
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1080), Expect = e-117, Method: Compositional matrix adjust.
Identities = 197/291 (67%), Positives = 240/291 (82%), Gaps = 2/291 (0%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYE+GRTIGEGTFAKVKFA++TETG+ VA+K+LD+ ++KHKM +QIKREIS M
Sbjct: 6 VKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL++HP VVR++EV+ S+T IYI+LE++TGGELFD IV+HGR+ E EARRYFQQLI+ VD
Sbjct: 66 KLIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLDS G+LK+SDFGLSAL +Q LL TTCGTPNYVAPEVL
Sbjct: 126 YCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVL 185
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
+GY+GA AD+WSCGVIL+VL+AGYLPF++ +L TLY K+ A+F+ P W AK L+
Sbjct: 186 EDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLL 245
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
RILDPNP TRITI EI DEWF+KGY + E D LDDV+A F+DSE
Sbjct: 246 TRILDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSE 296
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | ||||||
| 255572824 | 446 | CBL-interacting serine/threonine-protein | 0.989 | 0.659 | 0.911 | 1e-158 | |
| 397133613 | 449 | CIPK [Gossypium aridum] | 0.986 | 0.652 | 0.901 | 1e-158 | |
| 356507985 | 446 | PREDICTED: CBL-interacting serine/threon | 0.989 | 0.659 | 0.901 | 1e-158 | |
| 356515679 | 446 | PREDICTED: CBL-interacting serine/threon | 0.989 | 0.659 | 0.891 | 1e-157 | |
| 356500781 | 444 | PREDICTED: CBL-interacting serine/threon | 0.976 | 0.653 | 0.903 | 1e-155 | |
| 62857010 | 448 | Ser/Thr protein kinase [Lotus japonicus] | 0.989 | 0.656 | 0.874 | 1e-154 | |
| 357490169 | 475 | CBL-interacting protein kinase [Medicago | 0.976 | 0.610 | 0.827 | 1e-153 | |
| 302142105 | 453 | unnamed protein product [Vitis vinifera] | 0.976 | 0.640 | 0.885 | 1e-153 | |
| 449461361 | 446 | PREDICTED: CBL-interacting serine/threon | 0.976 | 0.650 | 0.886 | 1e-152 | |
| 359492978 | 442 | PREDICTED: CBL-interacting serine/threon | 0.959 | 0.644 | 0.893 | 1e-151 |
| >gi|255572824|ref|XP_002527344.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223533263|gb|EEF35016.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 563 bits (1452), Expect = e-158, Method: Compositional matrix adjust.
Identities = 268/294 (91%), Positives = 282/294 (95%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR+ IIKHKM DQIKREISI
Sbjct: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRTTIIKHKMIDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSE+EARRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSEAEARRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGV+HRDLKPENLLLDSQG+LKISDFGLSA PE GVSLLRTTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVFHRDLKPENLLLDSQGNLKISDFGLSASPEDGVSLLRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGY+GA ADVWSCGVILYVL+AGYLPFDELDLTTLYSK+E+A+FSCP+WFPVGAKSLIH
Sbjct: 181 HKGYDGAVADVWSCGVILYVLMAGYLPFDELDLTTLYSKIERAEFSCPSWFPVGAKSLIH 240
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVGKA 294
RILDPNPETRITIE+IRNDEWF+KGY P +LIEYEDVNLDDV+AAF D E KA
Sbjct: 241 RILDPNPETRITIEQIRNDEWFKKGYAPARLIEYEDVNLDDVDAAFYDPEEQKA 294
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|397133613|gb|AFO10125.1| CIPK [Gossypium aridum] | Back alignment and taxonomy information |
|---|
Score = 562 bits (1449), Expect = e-158, Method: Compositional matrix adjust.
Identities = 264/293 (90%), Positives = 282/293 (96%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKM DQIKREISI
Sbjct: 1 MVVRKVGKYEIGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEV+ASRTKIYIILEFITGGELFDKIVH GRLSE+EARR+FQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVIASRTKIYIILEFITGGELFDKIVHKGRLSEAEARRFFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
+YCHSKGVYHRDLKPENLLLDS G+LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS
Sbjct: 121 EYCHSKGVYHRDLKPENLLLDSLGNLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGY+GA ADVWSCGVILYVL+AGYLPFDELDLTTLYSK+E+ADFSCP+WFPVGAKSLIH
Sbjct: 181 HKGYDGAVADVWSCGVILYVLMAGYLPFDELDLTTLYSKIERADFSCPSWFPVGAKSLIH 240
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVGK 293
RILDPNP+TRITIE+IR+DEWF+K YVP +LIEYED+NLDDVNA FDD E+ K
Sbjct: 241 RILDPNPQTRITIEQIRSDEWFKKSYVPARLIEYEDINLDDVNAVFDDPEIDK 293
|
Source: Gossypium aridum Species: Gossypium aridum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507985|ref|XP_003522743.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 562 bits (1449), Expect = e-158, Method: Compositional matrix adjust.
Identities = 265/294 (90%), Positives = 282/294 (95%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKMADQIKREISI
Sbjct: 1 MVVRKVGKYEIGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMADQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKI+HHGRLSE+++RRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIIHHGRLSETDSRRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDS G++KISDFGLSA PEQGVS+LRTTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSLGNIKISDFGLSAFPEQGVSILRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGYNGA ADVWSCGVILYVL+AGYLPFDELDLTTLYSK+E+A+FSCP WFPVGAK LIH
Sbjct: 181 HKGYNGAVADVWSCGVILYVLLAGYLPFDELDLTTLYSKIERAEFSCPPWFPVGAKLLIH 240
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVGKA 294
RILDPNPETRITIE IRNDEWF++ YVPV L+EYEDVNLDDVNAAFDD+E +A
Sbjct: 241 RILDPNPETRITIEHIRNDEWFQRSYVPVSLLEYEDVNLDDVNAAFDDAEELRA 294
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515679|ref|XP_003526526.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 262/294 (89%), Positives = 283/294 (96%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKM DQIKREISI
Sbjct: 1 MVVRKVGKYEIGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKI+HHGRLSE+++RRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIIHHGRLSEADSRRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLL+S G++KISDFGLSA PEQGVS+LRTTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLNSLGNIKISDFGLSAFPEQGVSILRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGYNGA ADVWSCGVIL+VL+AGYLPFDELDLTTLYSK+E+A+FSCP+WFPVGAK LIH
Sbjct: 181 HKGYNGAVADVWSCGVILFVLLAGYLPFDELDLTTLYSKIERAEFSCPSWFPVGAKMLIH 240
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVGKA 294
RILDPNPETRITIE+IRNDEWF++ YVPV L+EYEDVNLDDVNAAFDD+E +A
Sbjct: 241 RILDPNPETRITIEQIRNDEWFQRSYVPVSLLEYEDVNLDDVNAAFDDAEEPRA 294
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500781|ref|XP_003519209.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 554 bits (1427), Expect = e-155, Method: Compositional matrix adjust.
Identities = 262/290 (90%), Positives = 277/290 (95%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MV+RKVGKYE+GRT+GEGTFAKVKFAQNTE+GESVAMKVLDRSAIIKHKM DQIKREISI
Sbjct: 1 MVLRKVGKYEIGRTVGEGTFAKVKFAQNTESGESVAMKVLDRSAIIKHKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKIV HGRLSE+E+RRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIVSHGRLSEAESRRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
D+CHSKGVYHRDLKPENLLLDSQG++KISDFGLSA PEQGVSLLRTTCGTPNYVAPEVLS
Sbjct: 121 DFCHSKGVYHRDLKPENLLLDSQGNIKISDFGLSAFPEQGVSLLRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGYNGA ADVWSCGVILYVL+AGYLPFDELDLTTLYSK+EKA FSCP FPVGAKSLIH
Sbjct: 181 HKGYNGAPADVWSCGVILYVLLAGYLPFDELDLTTLYSKIEKAQFSCPPSFPVGAKSLIH 240
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
+LDPNPE RITIE+IRNDEWF+K YVPV LIEYEDVNLDDVNAAFD+ E
Sbjct: 241 TMLDPNPERRITIEQIRNDEWFQKEYVPVSLIEYEDVNLDDVNAAFDNDE 290
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857010|dbj|BAD95890.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1413), Expect = e-154, Method: Compositional matrix adjust.
Identities = 257/294 (87%), Positives = 280/294 (95%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MV+RKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMKVLDR+ IIKH M DQIKREISI
Sbjct: 1 MVLRKVGKYEIGRTIGEGTFAKVKFAQNTETGESVAMKVLDRNTIIKHNMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRL+EVLASRTKIYIILEFITGGELFDKI+ HGRLSE+E+RRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLYEVLASRTKIYIILEFITGGELFDKIIRHGRLSEAESRRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDS G++KISDFGLSALPEQGVS+LRTTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSLGNIKISDFGLSALPEQGVSILRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGYNGA ADVWSCGVILYVL+ GYLPFDELDLT+LYSK+EKA++SCP FPVGAK+LIH
Sbjct: 181 HKGYNGAVADVWSCGVILYVLLVGYLPFDELDLTSLYSKIEKAEYSCPPGFPVGAKTLIH 240
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVGKA 294
+ILDPNPETRITIE+IRNDEWF++GYVPV L+EYEDVNLDDVNA FDD+E +A
Sbjct: 241 KILDPNPETRITIEQIRNDEWFQRGYVPVSLLEYEDVNLDDVNAVFDDAEEQRA 294
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357490169|ref|XP_003615372.1| CBL-interacting protein kinase [Medicago truncatula] gi|355516707|gb|AES98330.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1409), Expect = e-153, Method: Compositional matrix adjust.
Identities = 264/319 (82%), Positives = 280/319 (87%), Gaps = 29/319 (9%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MV+RKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMK+LDRS IIKHKMADQIKREISI
Sbjct: 1 MVLRKVGKYEIGRTIGEGTFAKVKFAQNTETGESVAMKILDRSTIIKHKMADQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSE+EARRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSEAEARRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDS G++KISDFGLSALPEQGVS+LRTTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSLGNMKISDFGLSALPEQGVSMLRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGYNGA ADVWSCGVILYVL+AGYLPFDELDLTTLYSK++KADFSCP WFPVGAKSLI
Sbjct: 181 HKGYNGAPADVWSCGVILYVLMAGYLPFDELDLTTLYSKIDKADFSCPAWFPVGAKSLIQ 240
Query: 241 RILDPNPE-----------------------------TRITIEEIRNDEWFRKGYVPVKL 271
RILDPNPE RITIE+IRNDEWF+K YVPV L
Sbjct: 241 RILDPNPEHILYRATHSCLVLQTSHARYLHAWARAACRRITIEQIRNDEWFQKSYVPVHL 300
Query: 272 IEYEDVNLDDVNAAFDDSE 290
+EYEDVNLD++NAAFD +E
Sbjct: 301 LEYEDVNLDEINAAFDSAE 319
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142105|emb|CBI19308.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1409), Expect = e-153, Method: Compositional matrix adjust.
Identities = 262/296 (88%), Positives = 278/296 (93%), Gaps = 6/296 (2%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
+ VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKM DQIKREISI
Sbjct: 2 VAVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMTDQIKREISI 61
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSE+E+R YFQQLIDGV
Sbjct: 62 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSENESRSYFQQLIDGV 121
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDSQG+LKISDFGLSALP GVSLL+TTCGTPNYVAPEVLS
Sbjct: 122 DYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPAPGVSLLKTTCGTPNYVAPEVLS 181
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS------KVEKADFSCPTWFPVG 234
HKGY+GA ADVWSCGVILYVL+AGYLPFDELDLTTLY+ +E+A+FSCP+WFPVG
Sbjct: 182 HKGYDGAVADVWSCGVILYVLMAGYLPFDELDLTTLYNIIFRYGLIERAEFSCPSWFPVG 241
Query: 235 AKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
AKSLIHRILDPNPETRI IE+IR+DEWFRKGYVPV+L+EYEDVNLDDVNA FDD E
Sbjct: 242 AKSLIHRILDPNPETRIRIEQIRSDEWFRKGYVPVRLLEYEDVNLDDVNAVFDDPE 297
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449461361|ref|XP_004148410.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like [Cucumis sativus] gi|449523217|ref|XP_004168620.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1397), Expect = e-152, Method: Compositional matrix adjust.
Identities = 257/290 (88%), Positives = 275/290 (94%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKM +QIK+EISI
Sbjct: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMVEQIKKEISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILE+ITGGELFDKIV HGRLSE+E+R+YFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEYITGGELFDKIVRHGRLSEAESRKYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHS+GVYHRDLKPENLLLDS G+LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL+
Sbjct: 121 DYCHSRGVYHRDLKPENLLLDSLGNLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLN 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGY+GA ADVWSCGVILYVL+AGYLPFDELDLTTLYSK+E+ADFSCP+WFPVGAK+LI
Sbjct: 181 HKGYDGAMADVWSCGVILYVLMAGYLPFDELDLTTLYSKIERADFSCPSWFPVGAKALIC 240
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
RI DPNP TRITIE+IR DEWF+K YV VKL+E EDVNLDDVNA FDD E
Sbjct: 241 RIFDPNPSTRITIEQIREDEWFKKNYVSVKLVEDEDVNLDDVNAVFDDPE 290
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492978|ref|XP_002285603.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 541 bits (1395), Expect = e-151, Method: Compositional matrix adjust.
Identities = 259/290 (89%), Positives = 274/290 (94%), Gaps = 5/290 (1%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
+ VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKM DQIKREISI
Sbjct: 2 VAVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMTDQIKREISI 61
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VV LASRTKIYIILEFITGGELFDKIVHHGRLSE+E+R YFQQLIDGV
Sbjct: 62 MKLVRHPYVV-----LASRTKIYIILEFITGGELFDKIVHHGRLSENESRSYFQQLIDGV 116
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDSQG+LKISDFGLSALP GVSLL+TTCGTPNYVAPEVLS
Sbjct: 117 DYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPAPGVSLLKTTCGTPNYVAPEVLS 176
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGY+GA ADVWSCGVILYVL+AGYLPFDELDLTTLYSK+E+A+FSCP+WFPVGAKSLIH
Sbjct: 177 HKGYDGAVADVWSCGVILYVLMAGYLPFDELDLTTLYSKIERAEFSCPSWFPVGAKSLIH 236
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
RILDPNPETRI IE+IR+DEWFRKGYVPV+L+EYEDVNLDDVNA FDD E
Sbjct: 237 RILDPNPETRIRIEQIRSDEWFRKGYVPVRLLEYEDVNLDDVNAVFDDPE 286
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | ||||||
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.976 | 0.651 | 0.865 | 6.7e-136 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.969 | 0.645 | 0.708 | 2.8e-114 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.973 | 0.640 | 0.676 | 9e-109 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.973 | 0.658 | 0.680 | 2.7e-107 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.969 | 0.597 | 0.673 | 7.2e-107 | |
| TAIR|locus:1005716169 | 831 | AT5G21222 [Arabidopsis thalian | 0.983 | 0.351 | 0.639 | 4.4e-100 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.936 | 0.633 | 0.615 | 1.3e-91 | |
| TAIR|locus:2090537 | 444 | CIPK1 "CBL-interacting protein | 0.969 | 0.648 | 0.558 | 4.6e-89 | |
| TAIR|locus:2007685 | 432 | CIPK17 "CBL-interacting protei | 0.949 | 0.652 | 0.572 | 4.1e-88 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.865 | 0.582 | 0.596 | 1e-84 |
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1331 (473.6 bits), Expect = 6.7e-136, P = 6.7e-136
Identities = 251/290 (86%), Positives = 274/290 (94%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMK++DRS IIK KM DQIKREISI
Sbjct: 1 MVVRKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHPCVVRL+EVLASRTKIYIILE+ITGGELFDKIV +GRLSESEAR+YF QLIDGV
Sbjct: 61 MKLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDSQG+LKISDFGLSALPEQGV++L+TTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240
HKGYNGA AD+WSCGVILYVL+AGYLPFDE+DL TLYSK++KA+FSCP++F +GAKSLI+
Sbjct: 181 HKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLIN 240
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
RILDPNPETRITI EIR DEWF K Y PV+LI+YE VNLDDV AAFDD E
Sbjct: 241 RILDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPE 290
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1127 (401.8 bits), Expect = 2.8e-114, P = 2.8e-114
Identities = 204/288 (70%), Positives = 249/288 (86%)
Query: 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+R+VGKYEVGRTIGEGTFAKVKFA+NT+TG++VA+K++ +S I+K++M DQIKREISIMK
Sbjct: 5 MRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMK 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+VRHP +VRL+EVLAS +KIYI+LEF+TGGELFD+IVH GRL ESE+R+YFQQL+D V +
Sbjct: 65 IVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAH 124
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
CH KGVYHRDLKPENLLLD+ G+LK+SDFGLSALP++GV LLRTTCGTPNYVAPEVLS +
Sbjct: 125 CHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVELLRTTCGTPNYVAPEVLSGQ 184
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
GY+G+AAD+WSCGVIL+V++AGYLPF E DL LY K+ A+FSCP WF K LIHRI
Sbjct: 185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRI 244
Query: 243 LDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
LDPNP+TRI I+ I+ D WFR YVP++ E E+VNLDD+ A FD E
Sbjct: 245 LDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIE 292
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1075 (383.5 bits), Expect = 9.0e-109, P = 9.0e-109
Identities = 197/291 (67%), Positives = 243/291 (83%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYEVGRTIGEGTFAKVKFA+N+ETGE VA+K+LD+ ++KHKMA+QI+REI+ M
Sbjct: 17 VKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATM 76
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL++HP VV+L+EV+AS+TKI+IILE++TGGELFDKIV+ GR+ E EARRYFQQLI VD
Sbjct: 77 KLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVD 136
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLDS G+LKISDFGLSAL +Q LL T+CGTPNYVAPEVL
Sbjct: 137 YCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVL 196
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
+ +GY+GA AD+WSCGV+LYVL+AGYLPFD+ +L LY K+ +F+CP W +GA LI
Sbjct: 197 NDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLI 256
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
RILDPNP TR+T +E+ DEWF+K Y P E +D N+DD++A F DSE
Sbjct: 257 TRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSE 307
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
Identities = 198/291 (68%), Positives = 237/291 (81%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYEVG+T+G+GTFAKV+ A NTETGE VA+K+LD+ ++KHKMA+QI+REI M
Sbjct: 6 VQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL+ HP VVRL+EVLAS+TKIYI+LEF TGGELFDKIVH GRL E AR+YFQQLI+ VD
Sbjct: 66 KLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLD+QG+LK+SDFGLSAL Q G LL T CGTPNY APEVL
Sbjct: 126 YCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVL 185
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
+ +GY+GA AD+WSCGVIL+VL+AGYLPF++ +L TLY K+ ++ CP W GAK+LI
Sbjct: 186 NDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLI 245
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSE 290
RILDPNP TRITI E+ D WF+K Y P E E+ NLDDV+A F DSE
Sbjct: 246 VRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSE 296
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1057 (377.1 bits), Expect = 7.2e-107, P = 7.2e-107
Identities = 196/291 (67%), Positives = 242/291 (83%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+VGKYE+GRT+GEGTFAKVKFA+N E G++VA+KV+D+ ++K+KM QIKREIS MKL+
Sbjct: 27 RVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLI 86
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+HP V+R+ EV+AS+TKIY +LEF+TGGELFDKI +GRL E EAR+YFQQLI+ VDYCH
Sbjct: 87 KHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCH 146
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVLSHK 182
S+GVYHRDLKPENLLLD+ G LK+SDFGLSALP+Q LL TTCGTPNYVAPEV+++K
Sbjct: 147 SRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNK 206
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
GY+GA AD+WSCGVIL+VL+AGYLPF++ +LT+LY K+ KA+F+CP WF AK LI RI
Sbjct: 207 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRI 266
Query: 243 LDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVGK 293
LDPNP TRIT E+ +EWF+KGY K E DV+LDDV+A FDDS K
Sbjct: 267 LDPNPATRITFAEVIENEWFKKGYKAPKF-ENADVSLDDVDAIFDDSGESK 316
|
|
| TAIR|locus:1005716169 AT5G21222 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 993 (354.6 bits), Expect = 4.4e-100, P = 4.4e-100
Identities = 188/294 (63%), Positives = 232/294 (78%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R VGKYEVGR IGE F K++ A +TETG+ VA+ +LD+ ++KHKMA+QIKREISIM
Sbjct: 6 VRRWVGKYEVGRLIGECNFGKLRSAVDTETGDPVALMILDKDKVLKHKMAEQIKREISIM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL+ HP VV+L+EVLAS+ KIYI+LEFI+GG+LFDKI + GR++E EA+RYFQQLI+ VD
Sbjct: 66 KLINHPNVVQLYEVLASKAKIYIVLEFISGGKLFDKIKNDGRMNEDEAQRYFQQLINAVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLD+Q +LK+++FGL AL +Q G L T CG P+Y APEVL
Sbjct: 126 YCHSRGVYHRDLKPENLLLDAQENLKVAEFGLIALSQQAGGDGLRHTACGNPDYAAPEVL 185
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
+ +GY+GA AD+WSCGVIL+VL+AGYLPF++ LTTLY K+ ADFSCP W G K+LI
Sbjct: 186 NDQGYDGAKADLWSCGVILFVLLAGYLPFEDSSLTTLYKKISSADFSCPPWLSSGVKNLI 245
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVGK 293
RILDPNP TRITI EI D WF+K Y P E ++ NL DV A F DSE G+
Sbjct: 246 VRILDPNPMTRITIPEILEDVWFKKDYKPAVFEEKKEANLADVEAVFKDSEEGR 299
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 913 (326.5 bits), Expect = 1.3e-91, P = 1.3e-91
Identities = 176/286 (61%), Positives = 218/286 (76%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KYE+GR +G+GTFAKV A+N +TGESVA+KV+D+ + K + DQIKREIS+M+LVRHP
Sbjct: 11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
VV LHEV+AS+TKIY +E++ GGELFDK V G+L E+ AR+YFQQLI +DYCHS+G
Sbjct: 71 HVVFLHEVMASKTKIYFAMEYVKGGELFDK-VSKGKLKENIARKYFQQLIGAIDYCHSRG 129
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPE--QGVSLLRTTCGTPNYVAPEVLSHKGYN 185
VYHRDLKPENLLLD G LKISDFGLSAL E Q LL TTCGTP YVAPEV+ KGY+
Sbjct: 130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDP 245
GA ADVWSCGV+LYVL+AG+LPF E +L +Y K+ K +F CP WFP K L+ RILDP
Sbjct: 190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249
Query: 246 NPETRITIEEIRNDEWFRKGYVPV---KLIEYEDVN--LDDVNAAF 286
NP +RI IE+I + WF+KG+ + K E ++ + DV+AAF
Sbjct: 250 NPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAF 295
|
|
| TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 889 (318.0 bits), Expect = 4.6e-89, P = 4.6e-89
Identities = 162/290 (55%), Positives = 226/290 (77%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
++GKYE+GRT+GEG F KVKFA++T +G S A+K++D+S I + QIKREI +K++
Sbjct: 16 RLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKREIRTLKML 75
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+HP +VRLHEVLAS+TKI +++E +TGGELFD+IV +G+L+E++ R+ FQQLIDG+ YCH
Sbjct: 76 KHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLIDGISYCH 135
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE--QGVSLLRTTCGTPNYVAPEVLSHK 182
SKGV+HRDLK EN+LLD++GH+KI+DFGLSALP+ + LL TTCG+PNYVAPEVL+++
Sbjct: 136 SKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 195
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
GY+GAA+D+WSCGVILYV++ G LPFD+ +L LY K+ K D P W GA+++I R+
Sbjct: 196 GYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGARTMIKRM 255
Query: 243 LDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVG 292
LDPNP TRIT+ I+ EWF+ Y+P + ++ +D + AF E+G
Sbjct: 256 LDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELG 305
|
|
| TAIR|locus:2007685 CIPK17 "CBL-interacting protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
Identities = 165/288 (57%), Positives = 227/288 (78%)
Query: 1 MVVR--KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI 58
MV++ +VGKYE+GRT+GEG AKVKFA +T TGES A+K++++S I + ++ QIKREI
Sbjct: 1 MVIKGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREI 60
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID 118
+K+++HP +VRLHEVLAS+TKIY++LE +TGG+LFD+IV G+LSE++ R+ FQQLID
Sbjct: 61 RTLKVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLID 120
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE--QGVSLLRTTCGTPNYVAP 176
GV YCH+KGV+HRDLK EN+LLD++GH+KI+DFGLSAL + + LL TTCG+PNYVAP
Sbjct: 121 GVSYCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAP 180
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAK 236
EVL+++GY+GAA+D+WSCGVILYV++ G LPFD+ +L + K+ K D P W +GAK
Sbjct: 181 EVLANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAK 240
Query: 237 SLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNL--DDV 282
++I R+LDPNP TR+TI I+ +WF+ Y P + +DV L +DV
Sbjct: 241 TMIKRMLDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDV 288
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 848 (303.6 bits), Expect = 1.0e-84, P = 1.0e-84
Identities = 155/260 (59%), Positives = 201/260 (77%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
G+YE+GR +G GTFAKV A+N +TG+SVAMKV+ + ++K M DQIKREIS+M++V+H
Sbjct: 22 GRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKH 81
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P +V LHEV+AS++KIY +E + GGELF K+ GRL E AR YFQQLI VD+CHS+
Sbjct: 82 PNIVELHEVMASKSKIYFAMELVRGGELFAKVAK-GRLREDVARVYFQQLISAVDFCHSR 140
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPE--QGVSLLRTTCGTPNYVAPEVLSHKGY 184
GVYHRDLKPENLLLD +G+LK++DFGLSA E + LL TTCGTP YVAPEV+ KGY
Sbjct: 141 GVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGY 200
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244
+GA AD+WSCGVIL+VL+AGYLPF + +L +Y K+ + DF CP W A+ L+ ++LD
Sbjct: 201 DGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLLD 260
Query: 245 PNPETRITIEEIRNDEWFRK 264
PNP TRITIE++ + WF+K
Sbjct: 261 PNPNTRITIEKVMDSPWFKK 280
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5JLD8 | CIPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8408 | 0.9730 | 0.6479 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 297 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-108 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-95 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-83 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-78 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-75 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-71 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-65 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-65 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-65 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-62 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-62 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-58 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-56 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-55 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-54 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-53 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-52 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-51 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-50 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-50 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-49 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-49 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-49 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-49 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-48 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-48 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-47 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-47 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-47 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-47 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-47 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-47 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-46 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-46 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-46 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-45 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-44 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-44 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-44 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-44 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-44 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-44 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-43 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-43 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-42 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-42 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-42 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-42 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-42 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-41 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-41 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-41 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-41 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-41 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-41 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-41 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-40 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-40 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-40 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-40 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-40 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-40 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-39 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-39 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-39 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-39 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-39 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-38 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-37 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-37 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-37 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-36 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-36 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-36 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-35 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-35 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-35 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-35 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-35 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-35 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-34 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-34 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-33 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-33 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-33 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-32 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-32 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-32 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-32 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-32 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-32 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-31 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-31 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-31 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-31 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-31 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-31 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-31 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-30 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-30 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-30 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-30 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-30 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-29 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-29 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-29 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-29 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-29 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-29 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-28 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-28 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-28 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-28 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-27 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-27 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-27 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-27 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-27 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-27 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-27 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-26 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-25 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-24 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-23 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-23 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-22 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-22 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-22 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-22 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-21 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-21 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-21 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-20 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-20 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-19 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-18 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-17 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-10 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-04 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 314 bits (807), Expect = e-108
Identities = 115/258 (44%), Positives = 163/258 (63%), Gaps = 8/258 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
YE+ +GEG+F KV A++ +TG+ VA+KV+ + I K + ++I REI I+K ++HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+VRL++V K+Y+++E+ GG+LFD + GRLSE EAR Y +Q++ ++Y HSKG+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRDLKPEN+LLD GH+K++DFGL+ L T GTP Y+APEVL KGY G A
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFVGTPEYMAPEVLLGKGY-GKA 176
Query: 189 ADVWSCGVILYVLIAGYLPF-DELDLTTLYSKVEKADFSCPTW---FPVGAKSLIHRILD 244
D+WS GVILY L+ G PF + L L+ K+ K P AK LI ++L
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 245 PNPETRITIEEIRNDEWF 262
+PE R+T EE +F
Sbjct: 237 KDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 280 bits (718), Expect = 8e-95
Identities = 104/261 (39%), Positives = 150/261 (57%), Gaps = 8/261 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
YE+ R +G G+F V A++ TG+ VA+K+L + + K K +REI I++ + HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+VRL + + +Y+++E+ GG+LFD + G LSE EA++ Q++ G++Y HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRDLKPEN+LLD G +KI+DFGL+ + S L T GTP Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-----DFSCPTWFPVG--AKSLIHR 241
DVWS GVILY L+ G PF ++ + + +F P W AK LI +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 242 ILDPNPETRITIEEIRNDEWF 262
L+ +P R T EEI WF
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 251 bits (644), Expect = 1e-83
Identities = 102/251 (40%), Positives = 147/251 (58%), Gaps = 4/251 (1%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G+F KV + +TG+ AMKVL + IIK K + E +I+ + HP +V+LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
+ K+Y++LE+ GGELF + GR SE AR Y +++ ++Y HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
PEN+LLD+ GH+K++DFGL+ S T CGTP Y+APEVL KGY G A D WS
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSL 179
Query: 195 GVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRIT-- 252
GV+LY ++ G PF D +Y K+ K P + A+ LI +L +P R+
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239
Query: 253 -IEEIRNDEWF 262
EEI+ +F
Sbjct: 240 GAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 2e-78
Identities = 92/260 (35%), Positives = 154/260 (59%), Gaps = 9/260 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E +T+G G+F +V ++ +G+ A+K+L ++ I+K K + + E I++ +RHP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V L+ + +Y+++E++ GGELF + GR E AR Y Q++ ++Y HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPENLLLDS G++KI+DFG + + T CGTP Y+APE++ KGY G A
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY---TLCGTPEYLAPEIILSKGY-GKA 178
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248
D W+ G+++Y ++AGY PF + + +Y K+ + P++F AK LI +L +
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT 238
Query: 249 TRI-----TIEEIRNDEWFR 263
R+ + +I+N WF
Sbjct: 239 KRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 9e-75
Identities = 95/247 (38%), Positives = 140/247 (56%), Gaps = 35/247 (14%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+GEG F V A++ +TG+ VA+K++ + + +++ REI I+K + HP +V+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 75 VLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
V +Y+++E+ GG L D + + G+LSE E R Q+++G++Y HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 134 KPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
KPEN+LLDS G +K++DFGLS L SLL+T GTP Y+APEVL KGY +D+W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 193 SCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRIT 252
S GVILY L EL K LI ++L +PE R +
Sbjct: 179 SLGVILYEL-------PEL------------------------KDLIRKMLQKDPEKRPS 207
Query: 253 IEEIRND 259
+EI
Sbjct: 208 AKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 4e-71
Identities = 91/279 (32%), Positives = 150/279 (53%), Gaps = 26/279 (9%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKRE-ISIMKLVRHP 67
++ G+ IGEG+F+ V A+ ET + A+K+LD+ +IK K +K E + +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L+ +Y +LE+ GEL I +G L E R Y +++ ++Y HSKG
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 128 VYHRDLKPENLLLDSQGHLKISDFG--------LSALPEQGVSLLRTT------------ 167
+ HRDLKPEN+LLD H+KI+DFG S +G + +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC 227
GT YV+PE+L+ K G ++D+W+ G I+Y ++ G PF + + K+ K ++S
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 228 PTWFPVGAKSLIHRILDPNPETRITI----EEIRNDEWF 262
P FP AK LI ++L +P+ R+ + +E++ +F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 2e-65
Identities = 87/261 (33%), Positives = 143/261 (54%), Gaps = 14/261 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
I +G + +V A+ TG+ A+KV+ ++ +I+ DQ+ E I+ + P VV+L+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
+ +Y+++E++ GG+L + + G L E AR Y +++ ++Y HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLL--------RTTCGTPNYVAPEVLSHKGYNG 186
P+N+L+DS GHLK++DFGLS + + + GTP+Y+APEV+ +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVG--AKSLIHRILD 244
D WS G ILY + G PF ++ + P V A LI ++L
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 245 PNPETRI---TIEEIRNDEWF 262
P+PE R+ +IEEI+N +F
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 2e-65
Identities = 82/258 (31%), Positives = 141/258 (54%), Gaps = 15/258 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKR----EISIMKL 63
KYE+ + IG+G+F KV + G+ +K +D S M+++ + E+ I+K
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS-----NMSEKEREDALNEVKILKK 55
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDG 119
+ HP +++ +E + K+ I++E+ GG+L KI + E + +F QL
Sbjct: 56 LNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
+ Y HS+ + HRD+KP+N+ L S G +K+ DFG+S + V L +T GTP Y++PE+
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CPTWFPVGAKSL 238
+K YN +D+WS G +LY L PF+ +L L K+ K + P+ + ++L
Sbjct: 176 QNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL 234
Query: 239 IHRILDPNPETRITIEEI 256
+ +L +PE R +I +I
Sbjct: 235 VSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 6e-65
Identities = 89/259 (34%), Positives = 143/259 (55%), Gaps = 15/259 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G G F +V+ + + A+K + + I++ + I E I++ HP +V+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
+ IY+++E+ GGEL+ + G E AR Y ++ +Y H++G+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
PENLLLDS G++K+ DFG A + T CGTP YVAPE++ +KGY+ + D WS
Sbjct: 121 PENLLLDSNGYVKLVDFG-FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWSL 178
Query: 195 GVILYVLIAGYLPF--DELDLTTLYSK----VEKADFSCPTWFPVGAKSLIHRILDPNPE 248
G++LY L+ G PF D+ D +Y+ K +F P + AK LI ++L NPE
Sbjct: 179 GILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRNPE 236
Query: 249 TRI-----TIEEIRNDEWF 262
R+ I++I+ +WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 1e-62
Identities = 79/264 (29%), Positives = 137/264 (51%), Gaps = 13/264 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ G +G G+F V A + +TGE +A+K + + + + ++REI I+ ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHP 59
Query: 68 CVVRL--HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+VR E + + I LE+++GG L + G+L E R+Y +Q+++G+ Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKG 183
G+ HRD+K N+L+DS G +K++DFG + + + GTP ++APEV+ +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC-----PTWFPVGAKSL 238
Y G AAD+WS G + + G P+ EL + + K S P AK
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 239 IHRILDPNPETRITIEEIRNDEWF 262
+ + L +P+ R T +E+ +
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 7e-62
Identities = 98/266 (36%), Positives = 154/266 (57%), Gaps = 13/266 (4%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K+ +E+G T+G G+F +V+ A++ TGE A+K L + I+K K + +E SI+ +
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
HP +V + ++Y +LEF+ GGELF + GR A+ Y +L+ +Y H
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
SK + +RDLKPENLLLD++GH+K++DFG + +P++ +L CGTP Y+APEV+ KG
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL----CGTPEYLAPEVIQSKG 191
Query: 184 YNGAAADVWSCGVILYVLIAGYLPF-DELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
+ G A D W+ GV+LY IAGY PF D+ Y K+ P WF A+ L+ +
Sbjct: 192 H-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-YEKILAGRLKFPNWFDGRARDLVKGL 249
Query: 243 LDPNPETRI-----TIEEIRNDEWFR 263
L + R+ + +++N +F
Sbjct: 250 LQTDHTKRLGTLKGGVADVKNHPYFH 275
|
Length = 329 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 9e-58
Identities = 77/260 (29%), Positives = 137/260 (52%), Gaps = 9/260 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ R IG+G F KV Q +T + AMK +++ ++ + E I++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V L +Y++++ + GG+L + + SE + + + +++ ++Y HSKG+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRD+KP+N+LLD QGH+ I+DF ++ +L +T GTP Y+APEVL +GY A
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEVLCRQGY-SVA 179
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTT----LYSKVEKADFSCPTWFPVGAKSLIHRILD 244
D WS GV Y + G P+ T + TW A I+++L+
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW-STEAIDAINKLLE 238
Query: 245 PNPETRI--TIEEIRNDEWF 262
+P+ R+ +++++N +F
Sbjct: 239 RDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 4e-56
Identities = 87/274 (31%), Positives = 153/274 (55%), Gaps = 16/274 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
E +T+G GTF +V ++ + A+KV+ +I+ K + E ++K V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++RL + +Y+++E++ GGELF + + GR S S Y +++ ++Y HSK +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPEN+LLD +GH+K++DFG + ++ T CGTP Y+APEV+ KG+N A
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFA---KKLRDRTWTLCGTPEYLAPEVIQSKGHN-KA 178
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248
D W+ G+++Y ++ GY PF + + +Y K+ P + AK LI ++L +
Sbjct: 179 VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRT 238
Query: 249 TRI-----TIEEIRNDEWFRKGYVPVKLIEYEDV 277
R+ ++++N WF+ ++++DV
Sbjct: 239 RRLGNMKNGADDVKNHRWFKS-------VDWDDV 265
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 183 bits (464), Expect = 3e-55
Identities = 91/282 (32%), Positives = 147/282 (52%), Gaps = 29/282 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y + R +GEG+F +V A++ + VA+KVL + K K ++ REI I+ + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 68 -CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR---LSESEARRYFQQLIDGVDYC 123
+V+L++ +Y+++E++ GG L D + GR LSESEA Q++ ++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 124 HSKGVYHRDLKPENLLLDSQGH-LKISDFGLSAL------PEQGVSLLRTTCGTPNYVAP 176
HSKG+ HRD+KPEN+LLD G +K+ DFGL+ L +L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 177 EVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA----------- 223
EVL Y +++D+WS G+ LY L+ G PF+ ++ S+ K
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 224 --DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFR 263
S P A L+ ++L +P+ R++ + +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-54
Identities = 89/257 (34%), Positives = 149/257 (57%), Gaps = 7/257 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+ +G+G+F KV A+ T E A+KVL + I++ + E ++ L +HP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH ++ +++ ++E++ GG+L I GR E AR Y +++ G+ + H +G+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLDS+GH+KI+DFG+ G T CGTP+Y+APE+LS++ Y G A D
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W+ GV+LY ++AG PF+ D L+ + + + P W AKS++ L NPE R+
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239
Query: 252 TI-----EEIRNDEWFR 263
++I+ +FR
Sbjct: 240 GCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-53
Identities = 89/256 (34%), Positives = 135/256 (52%), Gaps = 6/256 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
+ IG+G+F KV A++ G+ A+KVL + AI+K K I E +++ K V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + K+Y +L+++ GGELF + E AR Y ++ + Y HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKPEN+LLDSQGH+ ++DFGL + T CGTP Y+APEVL + Y+ D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W G +LY ++ G PF D +Y + V A+ L+ +L + R+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239
Query: 252 ----TIEEIRNDEWFR 263
EI+N +F
Sbjct: 240 GAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-52
Identities = 88/261 (33%), Positives = 138/261 (52%), Gaps = 13/261 (4%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
G IG GTF KV A N +TGE +A+K + R K +I E+ +++L++HP +V+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYH 130
+ V R K+YI +E+ +GG L + ++ HGR L E R Y QL++G+ Y HS G+ H
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 131 RDLKPENLLLDSQGHLKISDFGLSA-LPEQG---VSLLRTTCGTPNYVAPEVLSHKGYNG 186
RD+KP N+ LD G +K+ DFG + L +++ GTP Y+APEV++ G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 187 --AAADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVEKADFSCPTWFPVG--AKSLIH 240
AAD+WS G ++ + G P+ ELD ++ P + K +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLD 242
Query: 241 RILDPNPETRITIEEIRNDEW 261
R L+ +P+ R T E+ +
Sbjct: 243 RCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 3e-51
Identities = 89/258 (34%), Positives = 146/258 (56%), Gaps = 10/258 (3%)
Query: 13 RTIGEGTFAKVKFAQN---TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G+G+F KV + + G+ AMKVL + A +K + + K E I+ V HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
V+LH + K+Y+IL+F+ GG+LF ++ +E + + Y +L +D+ HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAA 189
+RDLKPEN+LLD +GH+K++DFGLS + CGT Y+APEV++ +G+ +A
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSA 179
Query: 190 DVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPET 249
D WS GV+++ ++ G LPF D + + KA P + A+SL+ + NP
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239
Query: 250 RI-----TIEEIRNDEWF 262
R+ +EEI+ +F
Sbjct: 240 RLGAGPDGVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 3e-50
Identities = 89/253 (35%), Positives = 135/253 (53%), Gaps = 4/253 (1%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG+G+F KV + +T A+K + ++ I+ E +++ V P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
S K+Y++L FI GGELF + GR S AR Y +L+ ++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
PEN+LLD QGH+ + DFGL L + T CGTP Y+APE+L GY A D W+
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTL 179
Query: 195 GVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITI- 253
GV+LY ++ G PF + ++ +Y K+ + P F AK L+ +L +P R+
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239
Query: 254 --EEIRNDEWFRK 264
+EI+N +F +
Sbjct: 240 GAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 7e-50
Identities = 91/306 (29%), Positives = 138/306 (45%), Gaps = 76/306 (24%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ-IK----REISIMKL 63
YE +GEGT+ V A++ +TGE VA+K I+ ++ I REIS++K
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK------IRLDNEEEGIPSTALREISLLKE 54
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGE-----LFDKIVHHGRLSESEARRYFQQLID 118
++HP +V+L +V+ + K+Y++ E+ + DK G LS + + QL+
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDK--RPGPLSPNLIKSIMYQLLR 109
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN------ 172
G+ YCHS + HRDLKP+N+L++ G LK++DFGL+ G P
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-----------RAFGIPLRTYTHE 158
Query: 173 -----YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAGYLPF------DEL--------- 211
Y APE+L K Y A D+WS G I +I G F D+L
Sbjct: 159 VVTLWYRAPEILLGSKHY-STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGT 217
Query: 212 -------DLTTL------YSKVEKADFS--CPTWFPVGAKSLIHRILDPNPETRITIEEI 256
+T L + K D P P G L+ ++L NP RI+ +E
Sbjct: 218 PTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGID-LLSKMLQYNPAKRISAKEA 276
Query: 257 RNDEWF 262
+F
Sbjct: 277 LKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-49
Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 13/257 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLH 73
I +G F V A+ TG+ A+KVL +S +I +K E +IM + P V +L+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 74 EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
S+ +Y+++E++ GG+ I G L E A++Y +++ GV+ H +G+ HRD+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193
KPENLL+D GHLK++DFGLS + + GTP+Y+APE + G + +D WS
Sbjct: 124 KPENLLIDQTGHLKLTDFGLS----RNGLENKKFVGTPDYLAPETILGVGDD-KMSDWWS 178
Query: 194 CGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVG----AKSLIHRILDPNPET 249
G +++ + GY PF ++ + + P A LI+R+L +P
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238
Query: 250 RI---TIEEIRNDEWFR 263
R+ +EI++ +F+
Sbjct: 239 RLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-49
Identities = 87/260 (33%), Positives = 147/260 (56%), Gaps = 10/260 (3%)
Query: 13 RTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKH-KMADQIKREISIMKLVRHPC 68
+ +G+G + KV + +TG+ AMKVL ++ I+++ K K E +I++ V+HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V L + K+Y+ILE+++GGELF + G E A Y ++ +++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPEN+LLD+QGH+K++DFGL ++ T CGT Y+APE+L G+ G A
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKA 180
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248
D WS G ++Y ++ G PF + K+ K + P + A+ L+ ++L NP
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS 240
Query: 249 TRI-----TIEEIRNDEWFR 263
+R+ E+++ +FR
Sbjct: 241 SRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-49
Identities = 80/261 (30%), Positives = 135/261 (51%), Gaps = 14/261 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
YEV TIG+G+F V+ + G+ + K +D + K Q+ E++I++ ++HP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHP 59
Query: 68 CVVRL--HEVLASRTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVD 121
+VR + S +YI++E+ GG+L I + E R QL+ +
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 122 YCHSKG-----VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
CH++ V HRDLKP N+ LD+ ++K+ DFGL+ + S +T GTP Y++P
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC-PTWFPVGA 235
E L+H Y+ +D+WS G ++Y L A PF + L SK+++ F P +
Sbjct: 180 EQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238
Query: 236 KSLIHRILDPNPETRITIEEI 256
+I +L+ +P+ R + EE+
Sbjct: 239 NEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-49
Identities = 91/258 (35%), Positives = 138/258 (53%), Gaps = 12/258 (4%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
+ IG+G+F KV A+ G A+KVL + I+K K + I E +++ K ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + K+Y +L+++ GGELF + E AR Y ++ + Y HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGL---SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
DLKPEN+LLDSQGH+ ++DFGL PE+ S T CGTP Y+APEVL + Y+
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS---TFCGTPEYLAPEVLRKEPYD-RT 176
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248
D W G +LY ++ G PF D++ +Y + P V A L+ +L +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQR 236
Query: 249 TRI----TIEEIRNDEWF 262
R+ EI+N +F
Sbjct: 237 RRLGAKADFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 3e-49
Identities = 91/290 (31%), Positives = 143/290 (49%), Gaps = 36/290 (12%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+EV + IG G F +V ++ +TG+ AMKVL +S +IK ++ E I+ P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V+L+ +Y+++E++ GG+L + ++ E AR Y +L+ +D H G
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLL----------------------- 164
HRD+KP+N+L+D+ GH+K++DFGL + +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 165 -----RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSK 219
+T GTP+Y+APEVL Y D WS GVILY ++ G+ PF L Y+K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241
Query: 220 V--EKADFSCPTWFPVG--AKSLIHRILDPNPETRIT-IEEIRNDEWFRK 264
+ K P PV A LI R+L PE R+ EEI++ +F+
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 1e-48
Identities = 83/258 (32%), Positives = 138/258 (53%), Gaps = 9/258 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+E+ IG+G F +V A++ TG+ VA+KV+ + + ++I EI I+K +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSK 126
+V+ + + +++I++EF +GG L D + + L+ES+ ++L+ G++Y HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
G+ HRD+K N+LL S G +K+ DFGLSA + T GTP ++APEV++ K Y+
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDY 176
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSCPTWFPVGAKSLIHRIL 243
AD+WS G+ L G P+ EL K+ P + K + + L
Sbjct: 177 -KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235
Query: 244 DPNPETRITIEEIRNDEW 261
NPE R T E++ +
Sbjct: 236 QKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-48
Identities = 79/257 (30%), Positives = 128/257 (49%), Gaps = 5/257 (1%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y++G IG G F V N ETG+ VA+K + I + + I +EI ++K ++HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+ + + +YIILE+ G L I G ES Y Q++ G+ Y H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC-GTPNYVAPEVLSHKGYNG 186
V HRD+K N+L G +K++DFG+ A VS + GTP ++APEV+ G +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGV-ATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS- 177
Query: 187 AAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEKADFSCPTWFPVGAKSLIHRILDP 245
A+D+WS G + L+ G P+ +L+ + L+ V+ P K + +
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQK 237
Query: 246 NPETRITIEEIRNDEWF 262
+P R T +++ W
Sbjct: 238 DPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-47
Identities = 86/242 (35%), Positives = 128/242 (52%), Gaps = 7/242 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + TG+ AMK+L + II E +++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ ++ ++E+ GGELF + SE AR Y +++ + Y HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGAAA 189
LK ENL+LD GH+KI+DFGL ++G+S T CGTP Y+APEVL Y G A
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 176
Query: 190 DVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPET 249
D W GV++Y ++ G LPF D L+ + + P AKSL+ +L +P+
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236
Query: 250 RI 251
R+
Sbjct: 237 RL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 2e-47
Identities = 84/239 (35%), Positives = 127/239 (53%), Gaps = 1/239 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + +G+ AMK+L + II E ++K RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
++ ++ ++E++ GGELF + SE R Y +++ +DY HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
LK ENL+LD GH+KI+DFGL + ++T CGTP Y+APEVL Y G A D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 193 SCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
GV++Y ++ G LPF D L+ + D P AKSL+ +L +P R+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-47
Identities = 83/259 (32%), Positives = 141/259 (54%), Gaps = 14/259 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G + +V A+ +TGE VA+K + +S + K + E I+ + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
+Y+ +E++ GG+ + + G LSE AR Y ++ + VD H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
PEN L+D+ GH+K++DFGLS V+ + G+P+Y+APEVL KGY+ D WS
Sbjct: 129 PENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGYD-FTVDYWSL 184
Query: 195 GVILYVLIAGYLPF-----DELDLTTLYSK--VEKADFSCPTW-FPVGAKSLIHRILDPN 246
G +LY + G+ PF +E Y K +++ + P + A LI ++++ +
Sbjct: 185 GCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN-D 243
Query: 247 PETRI-TIEEIRNDEWFRK 264
P R ++E+I+N +F++
Sbjct: 244 PSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 3e-47
Identities = 92/300 (30%), Positives = 143/300 (47%), Gaps = 47/300 (15%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E + IG G F +V+ Q +TG AMK L +S +++ + ++ E I+ +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV+L+ +Y+I+E++ GG++ ++ +E E R Y + I +D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLS-----------------ALPEQGVSLLRT----- 166
HRD+KP+NLLLD++GH+K+SDFGL ALP + +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 167 ----------------TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
T GTP+Y+APEV GYN D WS GVI+Y ++ GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPFCS 241
Query: 211 LDLTTLYSKVE--KADFSCPTWFPVG--AKSLIHRILDPNPETRI---TIEEIRNDEWFR 263
+ Y K+ K P P+ AK LI R+ E R+ + EI++ +F+
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-47
Identities = 89/277 (32%), Positives = 151/277 (54%), Gaps = 28/277 (10%)
Query: 9 YEVGRTIGEGTFAKVKFAQ---NTETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV 64
+E+ R +G G + KV + + G+ AMKVL ++ I+ K K A+ + E +++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 65 RH-PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
R P +V LH + TK+++IL+++ GGELF + +ESE R Y +++ +D+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSA--LPEQGVSLLRTTCGTPNYVAPEVLSH 181
H G+ +RD+K EN+LLDS+GH+ ++DFGLS L E+ + CGT Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRG 180
Query: 182 K--GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS---------CPTW 230
G++ A D WS GV+ + L+ G PF T + +++ S P
Sbjct: 181 GSGGHD-KAVDWWSLGVLTFELLTGASPF-----TVDGEQNSQSEISRRILKSKPPFPKT 234
Query: 231 FPVGAKSLIHRILDPNPETRI---TIEEIRNDEWFRK 264
A+ I ++L+ +P+ R+ +EI+N +F+
Sbjct: 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 6e-47
Identities = 84/242 (34%), Positives = 131/242 (54%), Gaps = 7/242 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + TG AMK+L + II E +++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ ++ ++E+ GGELF + +E AR Y +++ ++Y HS+ V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAA 189
+K ENL+LD GH+KI+DFGL ++G+S ++T CGTP Y+APEVL Y G A
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 176
Query: 190 DVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPET 249
D W GV++Y ++ G LPF D L+ + + P AKSL+ +L +P+
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236
Query: 250 RI 251
R+
Sbjct: 237 RL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 3e-46
Identities = 93/293 (31%), Positives = 162/293 (55%), Gaps = 22/293 (7%)
Query: 9 YEVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV 64
+E+ + +G G + KV + +TG+ AMKVL ++A++ K K + + E ++++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 65 RH-PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
R P +V LH + K+++IL++++GGE+F + SE E R Y ++I +++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLSHK 182
H G+ +RD+K EN+LLDS+GH+ ++DFGLS + + CGT Y+APE++ K
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFP--VG--AKSL 238
G +G A D WS G++++ L+ G PF S+V + C FP +G A+ L
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDL 241
Query: 239 IHRILDPNPETRI-----TIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAF 286
+H++L +P+ R+ EI+ +F K +++E + L VN F
Sbjct: 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFF-------KGLDWEALALRKVNPPF 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-46
Identities = 86/258 (33%), Positives = 139/258 (53%), Gaps = 12/258 (4%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
+ IG+G+F KV A+ G+ A+KVL + ++ K I E +++ K V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + K+Y +L+F+ GGELF + E AR Y ++ + Y HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGAA 188
DLKPEN+LLDSQGH+ ++DFGL ++G++ TT CGTP Y+APEV+ + Y+
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-T 176
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248
D W G +LY ++ G PF D+ +Y + + A S++ +L+ + +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQ 236
Query: 249 TRI----TIEEIRNDEWF 262
R+ EI+ +F
Sbjct: 237 RRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 5e-46
Identities = 88/301 (29%), Positives = 139/301 (46%), Gaps = 61/301 (20%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD----QIKREISIMKLV 64
YE IGEGT+ +V A+N +TGE VA+K I + REI +++ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55
Query: 65 RHPCVVRLHEVLASRTK--IYIILEFI----TGGELFDKIVHHG--RLSESEARRYFQQL 116
RHP +VRL E++ S+ K IY++ E++ TG ++ + +ES+ + Y +QL
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG------LLDSPEVKFTESQIKCYMKQL 109
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG--TPNYV 174
++G+ Y HS G+ HRD+K N+L+++ G LK++DFGL A P + T T Y
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYR 168
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAG------------------------------ 204
PE+L G D+WS G IL L G
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228
Query: 205 --YLP-FDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEW 261
LP F+ L Y + + F A L+ ++L +P+ RI+ ++ E+
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFK--HLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
Query: 262 F 262
F
Sbjct: 287 F 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 5e-45
Identities = 88/279 (31%), Positives = 138/279 (49%), Gaps = 28/279 (10%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVR 71
+G G F KV A+ +TGE A+K L + II + + E I + RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L + + ++E+ GG+L I H SE A Y ++ G+ Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGAA 188
DLK +NLLLD++G +KI+DFGL ++G+ T CGTP ++APEVL+ Y A
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRA 181
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248
D W GV++Y ++ G PF D ++ + + P + A S++ R+L NPE
Sbjct: 182 VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPE 241
Query: 249 TRI-----TIEEIRNDEWFRKGYVPVKLIEYEDVNLDDV 282
R+ E+++ +FR D+N DD+
Sbjct: 242 RRLGSGEKDAEDVKKQPFFR------------DINWDDL 268
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-44
Identities = 78/260 (30%), Positives = 136/260 (52%), Gaps = 9/260 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVR 71
+ +G+G+F KV A+ T E A+KVL + I++ D E I+ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH ++ +++ ++E++ GG+L +I + E +R Y ++ + + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD++GH K++DFG+ T CGTP+Y+APE+L Y G + D
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W+ GV++Y ++AG PF+ + L+ + D P W A S++ + NP R+
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239
Query: 252 -------TIEEIRNDEWFRK 264
+ I+ +F++
Sbjct: 240 GCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 154 bits (389), Expect = 1e-44
Identities = 89/281 (31%), Positives = 143/281 (50%), Gaps = 5/281 (1%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
+ IG+G+F KV A++ + A+KVL + AI+K K I E +++ K V+HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + K+Y +L++I GGELF + E AR Y ++ + Y HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKPEN+LLDSQGH+ ++DFGL + T CGTP Y+APEVL + Y+ D
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W G +LY ++ G PF + +Y + A+ L+ +L + R+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239
Query: 252 TIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVG 292
++D K ++ I ++D+ + F+ + G
Sbjct: 240 G---AKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSG 277
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-44
Identities = 85/240 (35%), Positives = 128/240 (53%), Gaps = 2/240 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + TG AMK+L + I+ E +++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHR 131
+ ++ ++E+ GGELF + SE AR Y +++ +DY HS K V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK ENL+LD GH+KI+DFGL + + ++T CGTP Y+APEVL Y G A D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W GV++Y ++ G LPF D L+ + + P AKSL+ +L +P+ R+
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 84/255 (32%), Positives = 143/255 (56%), Gaps = 7/255 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLH 73
+G+G+F KV A+ T E A+K+L + II+ + E ++ L + P + +LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 74 EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
+ ++Y ++E++ GG+L I G+ E A Y ++ G+ + HSKG+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193
K +N++LD++GH+KI+DFG+ G RT CGTP+Y+APE+++++ Y G + D W+
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186
Query: 194 CGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITI 253
GV+LY ++AG PFD D L+ + + + S P A S+ +L +P R+
Sbjct: 187 FGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246
Query: 254 -----EEIRNDEWFR 263
+IR +FR
Sbjct: 247 GPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-44
Identities = 78/240 (32%), Positives = 131/240 (54%), Gaps = 2/240 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVR 71
R +G+G+F KV A+ E+G A+KVL + I++ + E I+ L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L+ + +++ ++EF+ GG+L I R E+ AR Y ++ + + H KG+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD +GH K++DFG+ T CGTP+Y+APE+L Y G + D
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W+ GV+LY ++ G+ PF+ + L+ + + PTW A ++ + NP R+
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-44
Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 4/199 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y++ IGEG V A++ ETGE+VA+K + ++ + +Q REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHP 59
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSK 126
VV+L +V + +++E++ L + + R L E++ + Y + L+ GV Y H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT-TCGTPNYVAPEVLSHKGYN 185
G+ HRDLKP NLL+ + G LKI+DFGL+ L + L + T Y APE+L
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 186 GAAADVWSCGVILYVLIAG 204
D+W+ G I L+ G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 8e-44
Identities = 82/253 (32%), Positives = 137/253 (54%), Gaps = 3/253 (1%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+ +G+G+F KV A+ T E A+K L + +++ + E ++ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L ++ ++ ++E++ GG+L I GR E+ AR Y ++I G+ + H KG+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD GH+KI+DFG+ G T CGTP+Y+APE+L + YN + D
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
WS GV+LY ++ G PF D L+ + P W AK + ++ + +P R+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL 239
Query: 252 TIE-EIRNDEWFR 263
++ +IR +FR
Sbjct: 240 GVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-43
Identities = 75/264 (28%), Positives = 127/264 (48%), Gaps = 15/264 (5%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMK---VLDRSAIIKHKMADQIKREISIMKLVRH 66
E + +G+G+ V ++ TG+ A+K V K Q+ RE+ ++
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRSCES 58
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P VV+ + +I I+LE++ GG L D + G++ E +Q++ G+DY H+K
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 127 -GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ HRD+KP NLL++S+G +KI+DFG+S + E + T GT Y++PE + + Y
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY- 177
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKS-----LIH 240
AAD+WS G+ L G PF + + ++ P P S I
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237
Query: 241 RILDPNPETRITIEEIRNDEWFRK 264
L +P+ R + E+ + +K
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 6e-43
Identities = 82/288 (28%), Positives = 138/288 (47%), Gaps = 38/288 (13%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+G +V + TG+ A+KVLD+ +IK ++ E I+ + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 73 HEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
+ + T + +++++ GGELF + LSE AR Y +++ ++Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 131 RDLKPENLLLDSQGHLKISDFGLS-------ALPEQGVSLLRTTC--------------- 168
RDLKPEN+LL GH+ +SDF LS + +
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 169 -------GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVE 221
GT Y+APEV+S G+ G+A D W+ G++LY ++ G PF + +S +
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 222 KADFSCPTWFPVG--AKSLIHRILDPNPETRI----TIEEIRNDEWFR 263
K + + P PV A+ LI ++L +P R+ EI+ +FR
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-42
Identities = 84/286 (29%), Positives = 153/286 (53%), Gaps = 14/286 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLH 73
+G+G+F KV A+ T E A+K+L + +I+ + E ++ L + P + +LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 74 EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
+ ++Y ++E++ GG+L I G+ E +A Y ++ G+ + H +G+ +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193
K +N++LDS+GH+KI+DFG+ RT CGTP+Y+APE+++++ Y G + D W+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186
Query: 194 CGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITI 253
GV+LY ++AG PFD D L+ + + + S P A S+ ++ +P R+
Sbjct: 187 YGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246
Query: 254 -----EEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVGKA 294
+IR +FR+ I+++ + ++ F GK
Sbjct: 247 GPEGERDIREHAFFRR-------IDWDKLENREIQPPFKPKVCGKG 285
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 79/269 (29%), Positives = 130/269 (48%), Gaps = 16/269 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++V +G G F +V+ + TG+ AMKV+ +S ++ + + E I+ + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ +L + +Y+++E+ GG+L + + + E A+ Y +L+ + H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVL-----SH 181
HRD+KPEN+L+D GH+K++DFG +A L + + GTP+Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFP------VGA 235
KG G D WS GVI Y +I G PF E Y+ + +F FP
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI--MNFQRFLKFPEDPKVSSDF 240
Query: 236 KSLIHRILDPNPETRITIEEIRNDEWFRK 264
LI +L + R+ E + +F K
Sbjct: 241 LDLIQSLL-CGQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 87/286 (30%), Positives = 150/286 (52%), Gaps = 4/286 (1%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+ +G+G+F KV A+ T + A+K L + ++ + E ++ L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L+ ++ ++ ++E++ GG+L I + A Y ++I G+ + HSKG+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD+ GH+KI+DFG+ G + T CGTP+Y+APE+L + YN + D
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN-TSVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
WS GV+LY ++ G PF D L+ + + P W AK ++ ++ PE R+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239
Query: 252 TIE-EIRNDEWFRK-GYVPVKLIEYEDVNLDDVNAAFDDSEVGKAF 295
++ +IR +FR+ + ++ E E V +A D S K F
Sbjct: 240 GVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-42
Identities = 86/316 (27%), Positives = 140/316 (44%), Gaps = 90/316 (28%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKV------------LDRSAIIKHKMADQIK 55
+YE G+ +GEGT+A V A++ ETG VA+K ++ +A+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL---------- 50
Query: 56 REISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG---GELFDKIVHHGRLSESEARRY 112
REI +++ ++HP ++ L +V ++ I ++ EF+ + DK + L+ ++ + Y
Sbjct: 51 REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSY 107
Query: 113 FQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172
+ G++Y HS + HRDLKP NLL+ S G LK++DFGL+ + G+PN
Sbjct: 108 MLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-----------RSFGSPN 156
Query: 173 -----------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAG--YLPFD-ELD-LTTLY 217
Y APE+L + G D+WS G I L+ +LP D ++D L ++
Sbjct: 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF 216
Query: 218 SKVEKADFSCPT--WFPVGAKS----------------------------LIHRILDPNP 247
PT +P G S L+ R+L NP
Sbjct: 217 EA-----LGTPTEENWP-GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
Query: 248 ETRITIEEIRNDEWFR 263
RIT + +F
Sbjct: 271 NKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 5e-42
Identities = 74/259 (28%), Positives = 141/259 (54%), Gaps = 10/259 (3%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVL--DRSAIIKHKMADQIKREISIMKLVRHPCV 69
G+ +G+G F +V + +TG +A+K + D + K + ++ EI ++K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
V+ + L + I +E++ GG + D++ +G L+E+ R+Y +Q+++GV+Y HS +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 130 HRDLKPENLLLDSQGHLKISDFG----LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
HRD+K N+L DS G++K+ DFG L + G + +++ GTP +++PEV+S +GY
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSPEVISGEGY- 184
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK--ADFSCPTWFPVGAKSLIHRIL 243
G ADVWS G + ++ P+ E + K+ + P+ A++ + R
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTF 244
Query: 244 DPNPETRITIEEIRNDEWF 262
N + R + EE+ +
Sbjct: 245 VENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 7e-42
Identities = 76/261 (29%), Positives = 135/261 (51%), Gaps = 9/261 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y+ IGEG +V A + TG+ VA+K + ++ + + I EI IMK +HP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHP 75
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSK 126
+V ++ ++++++E++ GG L D I + R++E + ++++ G++Y HS+
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
V HRD+K +N+LL G +K++DFG +A + S + GTP ++APEV+ K Y
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG- 194
Query: 187 AAADVWSCGVILYVLIAGYLP-FDELDLTTLYSKVEKA--DFSCPTWFPVGAKSLIHRIL 243
D+WS G++ + G P E L L+ K P + K +++ L
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCL 254
Query: 244 DPNPETRITIEEIRNDEWFRK 264
+PE R + EE+ + +K
Sbjct: 255 VKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 7e-42
Identities = 90/294 (30%), Positives = 158/294 (53%), Gaps = 23/294 (7%)
Query: 9 YEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV 64
+E+ + +G G + KV + ++G+ AMKVL ++ I+ K K + + E +++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 65 RH-PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
R P +V LH + TK+++IL++I GGELF + R E E + Y +++ +++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLS-H 181
H G+ +RD+K EN+LLDS GH+ ++DFGLS E V + CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF----DELDLTTLYSKVEKADFSCPTWFPVGAKS 237
G + A D WS GV++Y L+ G PF ++ + ++ K++ P AK
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 241
Query: 238 LIHRILDPNPETRI-----TIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAF 286
+I R+L +P+ R+ +EI+ +F+K I ++D+ V A F
Sbjct: 242 IIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK-------INWDDLAAKKVPAPF 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 82/256 (32%), Positives = 132/256 (51%), Gaps = 10/256 (3%)
Query: 13 RTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
RT+G G+F +V A E VA+K ++S IIK K D + E I+ + HP V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L+ + +Y++LEF+ GGE F + + R Y Q++ +Y S + +R
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKPENLLLD G +K++DFG + + + + T CGTP Y+APE+L + G+ G AAD
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGFAKVVD---TRTYTLCGTPEYIAPEILLNVGH-GKAADW 211
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W+ G+ +Y ++ G PF + +Y K+ + P + K L+ ++L + R
Sbjct: 212 WTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRY 271
Query: 252 -----TIEEIRNDEWF 262
+ ++ WF
Sbjct: 272 GNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 81/269 (30%), Positives = 151/269 (56%), Gaps = 9/269 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLH 73
+G+G+F KV A+ T E A+K+L + +I+ + E ++ L + P + +LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 74 EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
+ ++Y ++E++ GG+L +I GR E A Y ++ G+ + HSKG+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193
K +N++LDS+GH+KI+DFG+ +T CGTP+Y+APE+++++ Y G + D W+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186
Query: 194 CGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITI 253
GV+LY ++AG PF+ D L+ + + + + P A ++ ++ +P R+
Sbjct: 187 FGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246
Query: 254 -----EEIRNDEWFRKGYVPVKLIEYEDV 277
+I+ +FR Y+ + +E ++V
Sbjct: 247 GPEGERDIKEHAFFR--YIDWEKLERKEV 273
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 3e-41
Identities = 88/281 (31%), Positives = 131/281 (46%), Gaps = 39/281 (13%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR---SAIIKHKMADQIKREISIMKLVR 65
Y+ IGEGT+ V A++ TGE VA+K + S I K A REI ++K +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP-KTA---LREIKLLKELN 56
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
HP +++L +V + +Y++ EF+ +L+ I R L ES + Y QL+ G+ +CH
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
S G+ HRDLKPENLL++++G LK++DFGL+ V T Y APE+L
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 185 NGAAADVWSCGVILYVLIAGYLPF------DEL-------------DLTTLYSKVEKADF 225
D+WS G I L++ F D+L S F
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 226 SCPTWFPVG-----------AKSLIHRILDPNPETRITIEE 255
S P + A L+ ++L +P RIT E+
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 3e-41
Identities = 80/246 (32%), Positives = 125/246 (50%), Gaps = 14/246 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK---LVRHPCVVR 71
IG+GTF +V + +T AMKVL + I+ K E +I+ L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L + + +Y++ ++++GGELF + GR SE A+ Y +L+ +++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV-LSHKGYNGAAAD 190
DLKPEN+LLD+ GH+ + DFGLS T CGT Y+APEV L KGY D
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKHVD 179
Query: 191 VWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVG-----AKSLIHRILDP 245
WS GV+++ + G+ PF D +Y + FP + + +L+
Sbjct: 180 FWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR----FPKNVLSDEGRQFVKGLLNR 235
Query: 246 NPETRI 251
NP+ R+
Sbjct: 236 NPQHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 8e-41
Identities = 100/336 (29%), Positives = 158/336 (47%), Gaps = 59/336 (17%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E + IG G F +V+ Q +TG AMK+L ++ +++ + I+ E I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV++ + +Y+I+EF+ GG++ ++ LSE + Y + + +D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGL---------------------SALPEQGVS----- 162
HRD+KP+NLLLD++GH+K+SDFGL S Q ++
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 163 ---------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213
L +T GTP+Y+APEV GYN D WS GVI+Y ++ GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 214 TTLYSKVE--KADFSCPTWFPVG--AKSLIHRILDPNPETRI---TIEEIRNDEWF---- 262
Y KV K P P+ AK LI R + E RI +EEI++ +F
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD 300
Query: 263 ------RKGYVPVKLIEYEDV-NLDDVNAAFDDSEV 291
R +P+++ +D N D+ F +S++
Sbjct: 301 WGHIRERPAAIPIEIKSIDDTSNFDE----FPESDI 332
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 9e-41
Identities = 96/306 (31%), Positives = 151/306 (49%), Gaps = 25/306 (8%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K ++V + IG G F +V+ ++ + + AMK+L + +IK + E IM
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+V+LH +Y+++E++ GG+L + + ++ + E AR Y +++ +D H
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH 159
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVL---S 180
S G HRD+KP+N+LLD GHLK++DFG + G+ T GTP+Y++PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV--EKADFSCPTWFPVG--AK 236
GY G D WS GV LY ++ G PF L YSK+ K + P + AK
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279
Query: 237 SLIHRILDPNPET--RITIEEIR------NDEW----FRKGYVPVKLIEYEDVNLDDVNA 284
LI L R ++EI+ ND+W R+ PV +++ D +
Sbjct: 280 DLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPV----VPELSSDIDTS 335
Query: 285 AFDDSE 290
FDD E
Sbjct: 336 NFDDIE 341
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 9e-41
Identities = 69/253 (27%), Positives = 128/253 (50%), Gaps = 9/253 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++V + +G+G++ V + + A+K +D ++ + + D + EI I+ V HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVDYCH 124
++ E K+ I++E+ G+L I + + E E R F QL+ G+ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ + HRDLK N+LL + +KI D G+S + ++ + +T GTP+Y+APEV + Y
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPY 178
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CPTWFPVGAKSLIHRIL 243
+ +D+WS G +LY + PF+ + L KV++ + P + ++ I +L
Sbjct: 179 S-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237
Query: 244 DPNPETRITIEEI 256
P+ R ++I
Sbjct: 238 QVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-40
Identities = 103/341 (30%), Positives = 160/341 (46%), Gaps = 69/341 (20%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E + IG G F +V+ Q +TG AMK+L ++ +++ + I+ E I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV++ + +Y+I+EF+ GG++ ++ L+E E + Y + + +D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLS-----------------ALPE----QGVSLLR-- 165
HRD+KP+NLLLDS+GH+K+SDFGL +LP Q ++ R
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 166 ------------TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213
+T GTP+Y+APEV GYN D WS GVI+Y ++ GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 214 TTLYSKVE--KADFSCPTWFPVG--AKSLI--------HRILDPNPETRITIEEIRNDEW 261
Y KV K P P+ AK LI HRI P +EEI+ + +
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPG------VEEIKTNPF 295
Query: 262 F----------RKGYVPVKLIEYEDV-NLDDVNAAFDDSEV 291
F R +P+++ +D N D+ F DS++
Sbjct: 296 FEGVDWEHIRERPAAIPIEIKSIDDTSNFDE----FPDSDI 332
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 4e-40
Identities = 103/307 (33%), Positives = 157/307 (51%), Gaps = 27/307 (8%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K YEV + IG G F +V+ ++ T + AMK+L + +IK + E IM
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
P VV+L +Y+++E++ GG+L + + ++ + E AR Y +++ +D H
Sbjct: 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIH 159
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSHK- 182
S G HRD+KP+N+LLD GHLK++DFG + ++G+ T GTP+Y++PEVL +
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 183 --GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV--EKADFSCPTWFPVG--AK 236
GY G D WS GV LY ++ G PF L YSK+ K + P + AK
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279
Query: 237 SLIHRILDPNPETRI---TIEEI------RNDEW----FRKGYVPVKLIEYEDVNLDDVN 283
+LI L + E R+ +EEI +ND+W R PV D++ D
Sbjct: 280 NLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPV----VPDLSSDIDT 334
Query: 284 AAFDDSE 290
+ FDD E
Sbjct: 335 SNFDDIE 341
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 5e-40
Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 28/279 (10%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E + I G + V ++ ET + AMK +++ +I Q+ E I+ +P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV + ++ + +++E++ GG+ + + G L AR YF + + ++Y H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT------------------TCGT 170
HRDLKP+NLL+ S GH+K++DFGLS + G+ L T CGT
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW 230
P Y+APEV+ +GY G D W+ G+ILY + G +PF L+ +V D P
Sbjct: 180 PEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG 238
Query: 231 ---FPVGAKSLIHRILDPNPETRI---TIEEIRNDEWFR 263
P A+ LI R+L NP R+ E++ +F
Sbjct: 239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 5e-40
Identities = 79/252 (31%), Positives = 142/252 (56%), Gaps = 17/252 (6%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
R IG G++AKV + +T AMKV+ + + + D ++ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++++ ++E++ GG+L + +L E AR Y ++ ++Y H +G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGAA 188
DLK +N+LLDS+GH+K++D+G+ ++G+ TT CGTPNY+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFS 176
Query: 189 ADVWSCGVILYVLIAGYLPFDEL------DLTT---LYSKVEKADFSCPTWFPVGAKSLI 239
D W+ GV+++ ++AG PFD + D T L+ + + P V A S++
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236
Query: 240 HRILDPNPETRI 251
L+ +P+ R+
Sbjct: 237 KSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 6e-40
Identities = 80/266 (30%), Positives = 134/266 (50%), Gaps = 19/266 (7%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+G +++ + IG+G F+ V A G VA+K + ++ K +EI ++K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH---HGRL-SESEARRYFQQLIDGVD 121
HP V++ ++ I+LE G+L I H RL E +YF QL ++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
+ HSK + HRD+KP N+ + + G +K+ D GL + + GTP Y++PE +
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF--DELDLTTLYSKVEKADFSCPTWFPVGA---- 235
GYN +D+WS G +LY + A PF D+++L +L K+EK D+ P+ A
Sbjct: 181 NGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-----PLPADHYS 234
Query: 236 ---KSLIHRILDPNPETRITIEEIRN 258
+ L+ R ++P+PE R I +
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 76/249 (30%), Positives = 138/249 (55%), Gaps = 11/249 (4%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
R IG G++AKV + +T AMKV+ + + + D ++ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++++ ++EF++GG+L + +L E AR Y ++ +++ H +G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD++GH+K++D+G+ + T CGTPNY+APE+L + Y G + D
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179
Query: 192 WSCGVILYVLIAGYLPFD------ELDLTT---LYSKVEKADFSCPTWFPVGAKSLIHRI 242
W+ GV+++ ++AG PFD D T L+ + + P V A S++
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239
Query: 243 LDPNPETRI 251
L+ +P+ R+
Sbjct: 240 LNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 8e-40
Identities = 104/320 (32%), Positives = 160/320 (50%), Gaps = 33/320 (10%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K Y+V + IG G F +V+ ++ + + AMK+L + +IK + E IM
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
P VV+L +Y+++E++ GG+L + + ++ + E A+ Y +++ +D H
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIH 159
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSHK- 182
S G+ HRD+KP+N+LLD GHLK++DFG + E G+ T GTP+Y++PEVL +
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 183 --GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFP------VG 234
GY G D WS GV L+ ++ G PF L YSK+ D FP
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI--MDHKNSLNFPEDVEISKH 277
Query: 235 AKSLIHRILDPNPETRI---TIEEI------RNDEW----FRKGYVPVKLIEYEDV---N 278
AK+LI L + E R+ +EEI +ND+W R+ PV D+ N
Sbjct: 278 AKNLICAFLT-DREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSN 336
Query: 279 LDDVNAAFDDSE---VGKAF 295
DD+ D E + KAF
Sbjct: 337 FDDIEDDKGDVETFPIPKAF 356
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-39
Identities = 78/267 (29%), Positives = 121/267 (45%), Gaps = 28/267 (10%)
Query: 10 EVGRTIGEGTFAKVK----FAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
E+G+ +GEG F +V T VA+K L A + + E SIMK +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE--FLEEASIMKKLS 59
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
HP +VRL V +YI+ E++ GG+L D + HG L+ + + Q+ G++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTP-NYVAPEVLSHK 182
SK HRDL N L+ +KISDFGLS + E R P ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 183 GYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEK-----ADFSCPTWFPVGAK 236
+ + +DVWS GV+L+ + G P+ + + +E +CP
Sbjct: 180 KFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDE------ 232
Query: 237 SLIHRIL----DPNPETRITIEEIRND 259
++ ++ +PE R T E+ D
Sbjct: 233 --LYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-REI-SIMKLVRH 66
Y+V + +G+GTF V A+N ETGE VA+K + + + + + RE+ S+ KL H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEH 57
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCH 124
P +V+L EV ++Y + E++ G L+ + SES R Q++ G+ + H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP---NYV------A 175
G +HRDLKPENLL+ +KI+DFGL+ R P +YV A
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLA----------REIRSRPPYTDYVSTRWYRA 166
Query: 176 PEVLSHKGYNGAAADVWSCGVI---LYVL 201
PE+L + D+W+ G I LY L
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-39
Identities = 85/280 (30%), Positives = 132/280 (47%), Gaps = 35/280 (12%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+GEGT+A V +N TGE VA+K + A + REIS+MK ++H +VRLH+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 75 VLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
V+ + K+ ++ E++ + D G L + + + QL+ G+ +CH V HRD
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
LKP+NLL++ +G LK++DFGL+ V+ T Y AP+VL + D+W
Sbjct: 126 LKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIW 185
Query: 193 SCGVILYVLIAGYLPF------DEL----------------------DLTTLYSKVEKAD 224
S G I+ +I G F D+L + + + D
Sbjct: 186 SVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQD 245
Query: 225 FSC--PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262
P P+G L+HR+L NPE RI+ + WF
Sbjct: 246 LQQLFPHADPLGI-DLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-39
Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVA---MKVLDRSAIIKHKMADQIKREISIMKL 63
KYEV +GEG + V +N TGE VA K + +K RE+ +++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT----ALREVKVLRQ 56
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH------GRLSESEARRYFQQLI 117
+RH +V L E + ++Y++ E+ ++ + G L R Y QL+
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEY------VERTLLELLEASPGGLPPDAVRSYIWQLL 110
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAP 176
+ YCHS + HRD+KPEN+L+ G LK+ DFG + AL + S L T Y AP
Sbjct: 111 QAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAG 204
E+L G DVW+ G I+ L+ G
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 6e-39
Identities = 72/253 (28%), Positives = 128/253 (50%), Gaps = 5/253 (1%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKV--LDRSAIIKHKMADQIKREISIMKLVR 65
++ G +G G+F V N + G+ A+K L + Q+++EI+++ ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
HP +V+ +YI LE + GG L + +G E R Y +Q++ G++Y H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ HRD+K N+L+D+ G +K++DFG++ + S ++ G+P ++APEV++ +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV--EKADFSCPTWFPVGAKSLIHRIL 243
G AAD+WS G + + G P+ +L+ K+ K P AK I + L
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239
Query: 244 DPNPETRITIEEI 256
+P R T E+
Sbjct: 240 QRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 9e-39
Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 25/267 (9%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V Q TG+ A K LD+ + K K E I++ V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRD 132
++ + +++ + GG+L I + G E+ A Y Q+I G+++ H + + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 133 LKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
LKPEN+LLD G+++ISD GL+ L ++ GTP Y+APEVL + Y+ + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGTPGYMAPEVLQGEVYD-FSVDW 177
Query: 192 WSCGVILYVLIAGYLPF---------DELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
++ G LY +IAG PF +EL TL VE D P AK L +
Sbjct: 178 FALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPE-----AKDLCEAL 232
Query: 243 LDPNPETRI-----TIEEIRNDEWFRK 264
L +PE R+ + +E+R F+
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-38
Identities = 76/253 (30%), Positives = 133/253 (52%), Gaps = 3/253 (1%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+ +G+G+F KV A+ GE A+K L + ++ + E ++ L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L+ ++ ++ ++EF+ GG+L I GR A Y +++ G+ + HSKG+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N++LD GH+KI+DFG+ G + T CGTP+Y+APE+L Y + D
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT-FSVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
WS GV+LY ++ G PF D L+ + P W +K ++ ++ + +P R+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239
Query: 252 TIE-EIRNDEWFR 263
+ IR +F+
Sbjct: 240 GVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 27/262 (10%)
Query: 12 GRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
G+ +GEG F +V + + VA+K L A + + RE IM+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE--EFLREARIMRKLDHP 61
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSK 126
VV+L V +YI++E++ GG+L + + +LS S+ + Q+ G++Y SK
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYN 185
HRDL N L+ +KISDFGLS + P ++APE L +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 186 GAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADF-----SCPTWFPVGAKSLI 239
+ +DVWS GV+L+ + G P+ + + ++ +CP +
Sbjct: 182 -SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCP--------PEL 232
Query: 240 HRIL----DPNPETRITIEEIR 257
+ ++ +PE R T E+
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 75/265 (28%), Positives = 146/265 (55%), Gaps = 15/265 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVR 71
R IG G++AKV + + + AMKV+ + + + D ++ E + + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + +++++++E++ GG+L + +L E AR Y ++ +++ H +G+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD+ GH+K++D+G+ T CGTPNY+APE+L + Y G + D
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179
Query: 192 WSCGVILYVLIAGYLPFDEL----DLTT---LYSKVEKADFSCPTWFPVGAKSLIHRILD 244
W+ GV+++ ++AG PFD + D+ T L+ + + P + V A ++ L+
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239
Query: 245 PNPETRITIE------EIRNDEWFR 263
+P+ R+ + +I++ +FR
Sbjct: 240 KDPKERLGCQPQTGFSDIKSHTFFR 264
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-37
Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 12/212 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKV--LDRSAIIKHK-----MADQIKREISIMKLV 64
G IG+GT+ +V A N TGE +A+K L + +H M ++ EI +K +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
H +V+ + + I LE++ GG + + +GR E R + +Q+++G+ Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC--GTPNYVAPEV--LS 180
SKG+ HRDLK +NLL+D+ G KISDFG+S + + G+ ++APEV
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+GY+ A D+WS G ++ + AG P+ + +
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 90/303 (29%), Positives = 138/303 (45%), Gaps = 55/303 (18%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-------R 56
R V +YE I EGT+ V A++ +TGE VA+K K KM + + R
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLR 53
Query: 57 EISIMKLVRHPCVVRLHEVLASRT--KIYIILEFITGGELFDKI-VHHGRLSESEARRYF 113
EI+I+ ++HP +V + EV+ KIY+++E++ +L + +SE +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG--TP 171
QL+ GV + H + HRDLK NLLL+++G LKI DFGL+ E G L T T
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTL 170
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLI------AGYLPFDELDLT----------- 214
Y APE+L A D+WS G I L+ G D+L+
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230
Query: 215 ----TLYSKVEKADFSCPTW------FPVGAKS-----LIHRILDPNPETRITIEEIRND 259
+ +K F+ + FP + S L++R+L +P RI+ E+
Sbjct: 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290
Query: 260 EWF 262
+F
Sbjct: 291 PYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 86/307 (28%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +TIG G F +V + +T AMK L ++ ++ A +K E I+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV+L+ + +Y ++++I GG++ ++ G E AR Y +L ++ H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGL----------------------SALPEQGVS---- 162
HRD+KP+N+L+D GH+K++DFGL S P + S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 163 -----------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY 205
L + GTPNY+APEVL GY D WS GVILY ++ G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 241
Query: 206 LPFDELDLTTLYSKVEKADFSCPTWFPVGAK------SLIHRILDPNPETRI---TIEEI 256
PF L T ++++ ++ P AK LI R L E R+ +EI
Sbjct: 242 PPF--LADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEI 298
Query: 257 RNDEWFR 263
+ +F+
Sbjct: 299 KAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-37
Identities = 69/264 (26%), Positives = 114/264 (43%), Gaps = 28/264 (10%)
Query: 12 GRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
G+ +GEG F +V VA+K L A + RE IM+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE--FLREARIMRKLDHP 61
Query: 68 CVVRLHEVLASRTKIYIILEFITGGEL--FDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+V+L V + I++E++ GG+L + + LS S+ + Q+ G++Y S
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGY 184
K HRDL N L+ +KISDFGLS P ++APE L +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADF-----SCPTWFPVGAKSL 238
+ +DVWS GV+L+ + G P+ + + ++K +CP
Sbjct: 182 T-SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP--------PE 232
Query: 239 IHRIL----DPNPETRITIEEIRN 258
+++++ +PE R T E+
Sbjct: 233 LYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 77/256 (30%), Positives = 133/256 (51%), Gaps = 11/256 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F KV AQ+ ETG A K++ + + ++ D + EI I+ +HP +V L+E
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMV-EIDILSECKHPNIVGLYE 69
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
K++I++EF GG L ++ R L+E + R +Q+++ +++ HS V HRDL
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA----A 189
K N+LL G +K++DFG+SA + + T GTP ++APEV++ + + A
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189
Query: 190 DVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSCPTWFPVGAKSLIHRILDPN 246
D+WS G+ L L P EL+ + K+ K++ P+ + + L +
Sbjct: 190 DIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKD 249
Query: 247 PETRITIEEIRNDEWF 262
P+ R T E+ +
Sbjct: 250 PDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-36
Identities = 79/246 (32%), Positives = 124/246 (50%), Gaps = 6/246 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y V R +GEG+F + Q+ + + AMK + R + D K + + K+ +HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKM-KHP 58
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRL-SESEARRYFQQLIDGVDYCHS 125
+V E + +YI++E+ GG+L KI + G+L E ++F Q+ GV + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
K V HRD+K +N+ L G +K+ DFG + L + T GTP YV PE+ + YN
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CPTWFPVGAKSLIHRILD 244
+D+WS G ILY L PF L KV + + P+ + +SLI ++
Sbjct: 179 N-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237
Query: 245 PNPETR 250
NP +R
Sbjct: 238 RNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-36
Identities = 75/200 (37%), Positives = 105/200 (52%), Gaps = 34/200 (17%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKV--LDR-------SAIIKHKMADQIKREISIMKLVR 65
IGEGT+ V A++ TGE VA+K L+ +AI REIS++K +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI----------REISLLKELN 56
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
HP +VRL +V+ S K+Y++ EF+ + D G L + Y QL+ G+ YC
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYC 115
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSLLRTTCG---TPNYVAPE 177
HS V HRDLKP+NLL+D +G LK++DFGL+ +P +RT T Y APE
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------VRTYTHEVVTLWYRAPE 169
Query: 178 VLSHKGYNGAAADVWSCGVI 197
+L D+WS G I
Sbjct: 170 ILLGSRQYSTPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 9e-36
Identities = 62/189 (32%), Positives = 106/189 (56%), Gaps = 7/189 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+++ +GEG++ V A + ETG+ VA+KV+ ++ +I +EISI+K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKG 127
+V+ + T ++I++E+ G + D + + L+E E Q + G++Y HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
HRD+K N+LL+ +G K++DFG+S ++ T GTP ++APEV+ GYN
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-N 178
Query: 188 AADVWSCGV 196
AD+WS G+
Sbjct: 179 KADIWSLGI 187
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 9e-36
Identities = 73/250 (29%), Positives = 121/250 (48%), Gaps = 15/250 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ IG+G+F V AMK +D S + + ++ E ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSY 60
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGR-LSESEARRYFQQLIDGVDYCHSK 126
++R +E + K+ I++E+ G+L + + GR L E + R+F Q++ G+ + HSK
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
+ HRD+K NL LD+ ++KI D G++ L + T GTP Y++PE+ K YN
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN- 179
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAK------SLIH 240
+DVW+ GV+LY G PFD + L K+ + F PV LI
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-----PVSQMYSQQLAQLID 234
Query: 241 RILDPNPETR 250
+ L + R
Sbjct: 235 QCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 76/254 (29%), Positives = 134/254 (52%), Gaps = 8/254 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-IKHKMADQIKREISIMKLVRH 66
+YE+ + IGEG+F K+ A+ E +K +D + + +K K A K+E+ ++ ++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAKMKH 58
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRL-SESEARRYFQQLIDGVDYCH 124
P +V +++I++E+ GG+L +I G L SE + +F Q+ G+ + H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 125 SKGVYHRDLKPENLLLDSQGHL-KISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
+ + HRD+K +N+ L G + K+ DFG++ + L T GTP Y++PE+ ++
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CPTWFPVGAKSLIHRI 242
YN D+WS G +LY L PF+ +L L K+ + F+ F +SLI ++
Sbjct: 179 YNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQL 237
Query: 243 LDPNPETRITIEEI 256
+P R +I I
Sbjct: 238 FKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-35
Identities = 67/252 (26%), Positives = 135/252 (53%), Gaps = 5/252 (1%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + IGEG+F K ++ E G+ +K ++ S + K ++ ++E++++ ++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHP 59
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRL-SESEARRYFQQLIDGVDYCHS 125
+V+ E +YI++++ GG+L+ KI G L E + +F Q+ + + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ + HRD+K +N+ L G +K+ DFG++ + V L RT GTP Y++PE+ ++ YN
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHRILD 244
+D+W+ G +LY + F+ ++ L K+ + + + + ++L+ ++
Sbjct: 180 N-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238
Query: 245 PNPETRITIEEI 256
NP R ++ I
Sbjct: 239 RNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 86/280 (30%), Positives = 135/280 (48%), Gaps = 35/280 (12%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEGT+ V A+N TGE VA+K + + + I REIS++K + HP +V+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66
Query: 75 VLASRTKIYIILEFITGG-ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
V+ + K+Y++ EF+ + F + + Y QL+ G+ +CHS V HRDL
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGTPNYVAPEVLSHKGYNGAAADV 191
KP+NLL++++G +K++DFGL+ GV + T T Y APE+L Y A D+
Sbjct: 127 KPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 184
Query: 192 WSCGVILYVLIA--GYLPFD-ELD-----LTTLYSKVEKA--------DF--SCPTWFPV 233
WS G I ++ P D E+D TL + E D+ S P W
Sbjct: 185 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQ 244
Query: 234 G-----------AKSLIHRILDPNPETRITIEEIRNDEWF 262
+ L+ ++L +P RI+ + +F
Sbjct: 245 DFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 76/253 (30%), Positives = 131/253 (51%), Gaps = 8/253 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEG+ V A + TG VA+K +D + K + + + E+ IM+ +HP +V ++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++++++EF+ GG L D IV H R++E + ++ + + H++GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
+++LL S G +K+SDFG A + V ++ GTP ++APEV+S Y G D+WS
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSL 201
Query: 195 GVILYVLIAGYLP-FDE--LDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
G+++ ++ G P F+E L +S + R+L +P R
Sbjct: 202 GIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA 261
Query: 252 TIEEIRNDEWFRK 264
T E+ N + K
Sbjct: 262 TAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-35
Identities = 69/199 (34%), Positives = 110/199 (55%), Gaps = 20/199 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ-----IKREISIMK 62
YE+ + IG GT+ V A++ TGE VA+KV+ K+ I++EIS++K
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI--------KLEPGDDFEIIQQEISMLK 55
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGV 120
RHP +V R K++I++E+ GG L D I R LSE + ++ + G+
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGL 114
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
Y H G HRD+K N+LL G +K++DFG+SA ++ ++ GTP ++APEV +
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 181 HK---GYNGAAADVWSCGV 196
+ GY+G D+W+ G+
Sbjct: 175 VERKGGYDG-KCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-35
Identities = 79/261 (30%), Positives = 131/261 (50%), Gaps = 9/261 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--IKHKMADQIKREISIMKLVR 65
+Y + + +G+G+F V ++ + +KVL + + Q +E ++ +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKI---VHHGR-LSESEARRYFQQLIDGVD 121
HP +V+ H R II E+ G +L K+ H G+ LSE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
Y H + + HRDLK +N+ L LKI DFG+S L L T GTP Y++PE L H
Sbjct: 121 YMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEKADFSCPTWFPVGAKSLIH 240
+GY+ + +D+WS G ILY + F+ + L+ + VE S P + S++
Sbjct: 180 QGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238
Query: 241 RILDPNPETRITIEEIRNDEW 261
+L+ +P R + EI + +
Sbjct: 239 SMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 54/305 (17%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
R V K+++ IGEGT+ +V A++ +TGE VA+K + R K REI I++
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQ 62
Query: 64 VRHPCVVRLHEVLASRTK----------IYIILEFITG---GELFDKIVHHGRLSESEAR 110
+ H +V L E++ + Y++ E++ G L +VH SE +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIK 119
Query: 111 RYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CG 169
+ +QL++G++YCH K HRD+K N+LL+++G +K++DFGL+ L S T
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVL---------------------IAGY--- 205
T Y PE+L + G A DVWSCG IL L + G
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 206 --------LP-FDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEI 256
LP F+ + Y + + +FS + P A L+ +L +P R T EE
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFS---FIPTPALDLLDHMLTLDPSKRCTAEEA 296
Query: 257 RNDEW 261
N W
Sbjct: 297 LNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 5e-35
Identities = 72/258 (27%), Positives = 131/258 (50%), Gaps = 14/258 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII------KHKMADQIKREISIMKLVR 65
G IG G+F V N +GE +A+K ++ ++ K M D + REI+++K ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
H +V+ + I LE++ GG + + ++G E+ R + +Q++ G++Y H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN------YVAPEVL 179
+G+ HRD+K N+L+D++G +KISDFG+S E +T P+ ++APEV+
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEKADFSCPTWFPVGAKSL 238
Y AD+WS G ++ ++ G PF + L ++ E A P+ A
Sbjct: 185 KQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDF 243
Query: 239 IHRILDPNPETRITIEEI 256
+ + + + R T E+
Sbjct: 244 LEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-35
Identities = 79/299 (26%), Positives = 134/299 (44%), Gaps = 62/299 (20%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK--REISIMKLVR- 65
Y++ IGEGTF++V AQ+ +TG+ A+K + + K +Q+ REI ++ +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 66 HPCVVRLHEVLASRT--KIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVD 121
HP ++RL EVL R ++ ++ E + EL L E + Y QL+ +D
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP--LPEKRVKSYMYQLLKSLD 114
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV------- 174
+ H G++HRD+KPEN+L+ LK++DFG S R P Y
Sbjct: 115 HMHRNGIFHRDIKPENILIK-DDILKLADFG-SC---------RGIYSKPPYTEYISTRW 163
Query: 175 --APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELD---------------LT 214
APE L GY G D+W+ G + + +++ + F +ELD +
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223
Query: 215 TLYSKVEKADFSCP----TWF-------PVGAKSLIHRILDPNPETRITIEEIRNDEWF 262
+ K +++ P T L+ ++L +P+ RIT ++ +F
Sbjct: 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 8e-35
Identities = 73/262 (27%), Positives = 111/262 (42%), Gaps = 19/262 (7%)
Query: 13 RTIGEGTFAKVKFA---QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +GEG F +V VA+K L A + + +E +MK + HP V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58
Query: 70 VRLHEVLASRTKIYIILEFITGGEL---------FDKIVHHGRLSESEARRYFQQLIDGV 120
VRL V +Y++LE++ GG+L LS + + Q+ G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TPN-YVAPEV 178
+Y SK HRDL N L+ +KISDFGLS + T G P ++APE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 179 LSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAK 236
L + + +DVWS GV+L+ + G P+ L + + K P + P
Sbjct: 179 LKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237
Query: 237 SLIHRILDPNPETRITIEEIRN 258
L+ +PE R T E+
Sbjct: 238 ELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA---DQIKREISIMKLVR 65
YE+ IG G A V A E VA+K +D K D++++E+ M
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLE-----KCQTSVDELRKEVQAMSQCN 57
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH---HGRLSESEARRYFQQLIDGVDY 122
HP VV+ + ++++++ +++GG L D + G L E+ ++++ G++Y
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR----TTCGTPNYVAPEV 178
HS G HRD+K N+LL G +KI+DFG+SA G R T GTP ++APEV
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 179 LS-HKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211
+ GY+ AD+WS G+ L G P+ +
Sbjct: 178 MEQVHGYD-FKADIWSFGITAIELATGAAPYSKY 210
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 74/251 (29%), Positives = 122/251 (48%), Gaps = 5/251 (1%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
Y R +G+G F + + TE V K ++ + + + + D + EI I+ L++HP
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPN 60
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSK 126
++ + + I +E+ GG L+DKIV E Y Q++ V Y H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
G+ HRD+K N+ L G +K+ DFG+S + S+ T GTP Y++PE+ YN
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN- 179
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSK-VEKADFSCPTWFPVGAKSLIHRILDP 245
+D+W+ G +LY L+ FD + L K V+ + + SL+H +L
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239
Query: 246 NPETRITIEEI 256
+PE R T +E+
Sbjct: 240 DPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 3e-34
Identities = 73/253 (28%), Positives = 131/253 (51%), Gaps = 9/253 (3%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+ + + + IG G F++V A G VA+K + ++ K +EI ++K +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVD 121
HP V++ + ++ I+LE G+L I H + + E +YF QL ++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
+ HS+ V HRD+KP N+ + + G +K+ D GL + + GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF--DELDLTTLYSKVEKADF-SCPT-WFPVGAKS 237
GYN +D+WS G +LY + A PF D+++L +L K+E+ D+ P+ + +
Sbjct: 181 NGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239
Query: 238 LIHRILDPNPETR 250
L++ ++P+PE R
Sbjct: 240 LVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 76/271 (28%), Positives = 139/271 (51%), Gaps = 12/271 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLD-RSAIIKHKMADQIKREISIMKLVRH 66
+ + IG+G+F +V A + T + VA+KV+D A + ++ D I++EI + R
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIED-IQQEIQFLSQCRS 58
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P + + + +K++II+E+ GG D ++ G+L E+ ++++ G++Y H +
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
G HRD+K N+LL +G +K++DFG+S +S T GTP ++APEV+ GY+
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT----WFPVGAKSLIHRI 242
AD+WS G+ L G P +L + + K + P+ F K +
Sbjct: 178 -KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PPSLEGNKFSKPFKDFVSLC 234
Query: 243 LDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273
L+ +P+ R + +E+ ++ +K L
Sbjct: 235 LNKDPKERPSAKELLKHKFIKKAKKTSYLTL 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 76/250 (30%), Positives = 133/250 (53%), Gaps = 11/250 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ +G+G F KV A+N ETG A KV++ + + ++ D + EI I+ HP
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMV-EIEILATCNHPY 70
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKG 127
+V+L K++I++EF GG + ++ R L+E + + +Q+++ + Y HS
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ HRDLK N+LL G +K++DFG+SA + + + GTP ++APEV+ +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 188 ----AADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSCPTWFPVGAKSLIH 240
AD+WS G+ L + P EL+ + K+ K++ S P+ + + + +
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLK 250
Query: 241 RILDPNPETR 250
LD +PETR
Sbjct: 251 TALDKHPETR 260
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-33
Identities = 72/206 (34%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA--DQIKREISIMKLVRHP 67
E IG G V + TG A+KV+ + H+ QI REI I++ V HP
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHP 132
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFD-KIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
VV+ H++ +I ++LEF+ GG L I L++ AR Q++ G+ Y H +
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV-AR----QILSGIAYLHRR 187
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV----LSHK 182
+ HRD+KP NLL++S ++KI+DFG+S + Q + ++ GT Y++PE L+H
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPF 208
Y+G A D+WS GV + G PF
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-33
Identities = 68/209 (32%), Positives = 121/209 (57%), Gaps = 10/209 (4%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVL--DRSAIIKHKMADQIKREISIMKLVRHPCV 69
G+ +G+G F +V + +TG +A K + D + K ++ EI ++K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 70 VRLHEVLASRTK--IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
V+ + L R + + I +E++ GG + D++ +G L+ES R+Y +Q+++G+ Y HS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 128 VYHRDLKPENLLLDSQGHLKISDFG----LSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
+ HRD+K N+L DS G++K+ DFG L + G +R+ GTP +++PEV+S +G
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG-IRSVTGTPYWMSPEVISGEG 185
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELD 212
Y G ADVWS G + ++ P+ E +
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 91/341 (26%), Positives = 139/341 (40%), Gaps = 90/341 (26%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
+YE+ + IG G + V A + TG VA+K + + + A +I REI +++ +RH
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDLIDAKRILREIKLLRHLRH 58
Query: 67 PCVVRLHEVLASRTK-----IYIILEFITGGELFD----KIVHHGRLSESEARRYFQ-QL 116
++ L ++L + +YI+ E L + K++ + + +YF Q+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN---- 172
+ G+ Y HS V HRDLKP N+L++S LKI DFGL+ R +
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA----------RGVDPDEDEKGF 162
Query: 173 ---YV------APEV-LSHKGYNGAAADVWSCGVILYVLIAG--YLP----FDELDLTT- 215
YV APE+ LS Y A D+WS G I L+ P D+L+L
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE 221
Query: 216 ---------------------LYS--KVEKADFS--CPTWFPVGAKSLIHRILDPNPETR 250
L S K K S P P A L+ ++L +P+ R
Sbjct: 222 VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPE-AIDLLEKMLVFDPKKR 280
Query: 251 ITIEE-----------IRNDEWFRKGYVPVKLIEYEDVNLD 280
IT +E DE K P ++D L
Sbjct: 281 ITADEALAHPYLAQLHDPEDEPVAKP--PFDFDFFDDDELT 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 73/256 (28%), Positives = 131/256 (51%), Gaps = 9/256 (3%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+ +++ + IG G F++V A + VA+K + ++ K +EI ++K +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVD 121
HP V++ + ++ I+LE G+L I + + + E +YF QL V+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
+ HS+ V HRD+KP N+ + + G +K+ D GL + + GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF--DELDLTTLYSKVEKADF-SCPT-WFPVGAKS 237
GYN +D+WS G +LY + A PF D+++L +L K+E+ D+ PT + +
Sbjct: 181 NGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239
Query: 238 LIHRILDPNPETRITI 253
L+ + P+P+ R I
Sbjct: 240 LVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 81/261 (31%), Positives = 130/261 (49%), Gaps = 15/261 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRH---PCVV 70
IG G F +V + +TG+ AMK LD+ I K K + + IM LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
+ + K+ IL+ + GG+L + HG SE+E R Y ++I G+++ H++ V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKP N+LLD GH++ISD GL+ + + GT Y+APEVL ++AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 178
Query: 191 VWSCGVILYVLIAGYLPFDEL---DLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247
+S G +L+ L+ G+ PF + D + P F +SL+ +L +
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238
Query: 248 ETRITI-----EEIRNDEWFR 263
R+ +E++ +FR
Sbjct: 239 NRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--- 65
YE IGEG + V A++ TG VA+K + R + + + REI+++K +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 66 HPCVVRLHEVLA-----SRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQLID 118
HP +VRL +V K+ ++ E + K G L + +QL+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLR 118
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC-GTPNYVAPE 177
GVD+ HS + HRDLKP+N+L+ S G +KI+DFGL+ + ++L T+ T Y APE
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVVTLWYRAPE 176
Query: 178 VLSHKGYNGAAADVWSCGVILYVL 201
VL Y D+WS G I L
Sbjct: 177 VLLQSSYA-TPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 85/307 (27%), Positives = 134/307 (43%), Gaps = 60/307 (19%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+T+G G F +V A+ +T AMK L + ++ +K E I+ + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ + +Y ++++I GG++ ++ G E AR Y +L V+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 133 LKPENLLLDSQGHLKISDFGL--------------------------------------- 153
+KP+N+L+D GH+K++DFGL
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 154 --------SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY 205
A + L + GTPNY+APEVL GY D WS GVILY ++ G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 206 LPFDELDLTTLYSKVEKADFSCPTWFPVGAK------SLIHRILDPNPETRI---TIEEI 256
PF L T L ++++ ++ P AK LI ++ PE R+ +EI
Sbjct: 246 PPF--LAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEI 302
Query: 257 RNDEWFR 263
+ +F+
Sbjct: 303 KAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 67/211 (31%), Positives = 121/211 (57%), Gaps = 8/211 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVL--DRSAIIKHKMADQIKREISIMKLVRH 66
+ +G+ +G G F +V + +TG +A+K + D + K + ++ EI ++K +RH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 67 PCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+V+ + L K+ I +E++ GG + D++ +G L+E+ RRY +Q++ GV Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE---QGVSLLRTTCGTPNYVAPEVLSH 181
S + HRD+K N+L DS G++K+ DFG S + + +++ GTP +++PEV+S
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+GY G ADVWS + ++ P+ E +
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 73/261 (27%), Positives = 123/261 (47%), Gaps = 17/261 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KYE R +G G F V + + V +K + + K + E ++KL+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHS 125
++ +E + I++E+ GG L + I L E +F Q++ + + H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 126 KGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
K + HRDLK +N+LLD + +KI DFG+S + S T GTP Y++PE+ K Y
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVVGTPCYISPELCEGKPY 178
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVG------AKSL 238
N +D+W+ G +LY L + F+ +L L K+ F+ P+ + L
Sbjct: 179 N-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-----PISDRYSPDLRQL 232
Query: 239 IHRILDPNPETRITIEEIRND 259
I +L+ +P R + +I
Sbjct: 233 ILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 84/271 (30%), Positives = 135/271 (49%), Gaps = 21/271 (7%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG G F +V + TG+ AMK+L++ ++K + E + LV
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDR 60
Query: 69 --VVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHS 125
+ LH +Y+++++ GG+L + RL E AR Y +++ +D H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFG--LSALPEQGVSLLRTTCGTPNYVAPEVLSH-- 181
G HRD+KP+N+LLD GH++++DFG L L + V GTP+Y++PE+L
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN-VAVGTPDYISPEILQAME 179
Query: 182 --KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV--EKADFSCP---TWFPVG 234
KG G D WS GV +Y ++ G PF L Y K+ K F P T
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239
Query: 235 AKSLIHRILDPNPETRI---TIEEIRNDEWF 262
AK LI R++ PETR+ +++ ++ +F
Sbjct: 240 AKDLIRRLICS-PETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 73/246 (29%), Positives = 119/246 (48%), Gaps = 11/246 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG G F +V + + AMK+L++ ++K + E ++ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKG 127
+ LH +Y+++++ GG+L + RL E AR Y +++ +D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSH----K 182
HRD+KP+N+L+D GH++++DFG L E G GTP+Y++PE+L K
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV--EKADFSCP---TWFPVGAKS 237
G G D WS GV +Y ++ G PF L Y K+ K F P T AK
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242
Query: 238 LIHRIL 243
LI R++
Sbjct: 243 LIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 66/185 (35%), Positives = 104/185 (56%), Gaps = 3/185 (1%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEGT+ V +N +TG+ VAMK + R + + REIS++K ++HP +V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 75 VLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
VL +++Y+I EF++ + D + + + Y Q++ G+ +CHS+ V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
LKP+NLL+D++G +K++DFGL+ V + T Y APEVL D+W
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIW 186
Query: 193 SCGVI 197
S G I
Sbjct: 187 SIGTI 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 70/221 (31%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK----REISI 60
K+ YE+ +GEGTF +V A+ +TG VA+K I+ H D REI I
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKI 60
Query: 61 MKLVRHPCVVRLHEVLASRTK--------IYIILEFIT---GGELFDKIVHHGRLSESEA 109
+K ++HP VV L ++ R +Y++ ++ G L + V L+ES+
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQI 117
Query: 110 RRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ Y QL++G++Y H + HRD+K N+L+D+QG LKI+DFGL A P G G
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL-ARPYDGPPPNPKGGG 176
Query: 170 TPN------------YVAPEVLSHKGYNGAAADVWSCGVIL 198
Y PE+L + A D+W G +
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 71/196 (36%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMK--VLDRSAIIKHKMADQIKREISIMKLVR 65
KYE IGEGT+ V A+N ET E VA+K LD + REI ++K ++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELK 57
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
H +VRL++VL S K+ ++ E+ + FD +G + + + QL+ G+ +C
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFC 115
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL-SHK 182
HS V HRDLKP+NLL++ G LK++DFGL+ V T Y P+VL K
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 183 GYNGAAADVWSCGVIL 198
Y+ + D+WS G I
Sbjct: 176 LYS-TSIDMWSAGCIF 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-31
Identities = 76/249 (30%), Positives = 126/249 (50%), Gaps = 8/249 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R +G+G F +V Q TG+ A K L++ I K K E I++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYH 130
++ + ++L + GG+L I + G E A Y +++ G++ H + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKPEN+LLD GH++ISD GL+ +G +R GT Y+APEVL+++ Y + D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRY-TLSPD 183
Query: 191 VWSCGVILYVLIAGYLPF----DELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246
W G ++Y +I G PF +++ + +V + + F AKS+ +L +
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKD 243
Query: 247 PETRITIEE 255
P+ R+ +E
Sbjct: 244 PKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-31
Identities = 84/249 (33%), Positives = 126/249 (50%), Gaps = 20/249 (8%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRH---PCVV 70
IG G F +V + +TG+ AMK LD+ I K K + + IM LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
+ + K+ IL+ + GG+L + HG SE E R Y ++I G+++ H++ V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKP N+LLD GH++ISD GL+ + + GT Y+APEVL ++AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGTAYDSSAD 178
Query: 191 VWSCGVILYVLIAGYLPF--------DELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
+S G +L+ L+ G+ PF E+D TL VE D P KSL+ +
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPE-----LKSLLEGL 233
Query: 243 LDPNPETRI 251
L + R+
Sbjct: 234 LQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 6e-31
Identities = 66/194 (34%), Positives = 111/194 (57%), Gaps = 5/194 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEG+ V A TG+ VA+K +D + K + + + E+ IM+ H VV ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++++++EF+ GG L D IV H R++E + ++ + Y H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
+++LL S G +K+SDFG A + V ++ GTP ++APEV+S Y G D+WS
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSL 204
Query: 195 GVILYVLIAGYLPF 208
G+++ +I G P+
Sbjct: 205 GIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 68/243 (27%), Positives = 106/243 (43%), Gaps = 48/243 (19%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+T+G G F +V A +T AMK L + ++ +K E I+ + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ + +Y ++++I GG++ ++ E AR Y +L ++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 133 LKPENLLLDSQGHLKISDFGL--------------------------------------- 153
+KP+N+L+D GH+K++DFGL
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 154 --------SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY 205
A + L + GTPNY+APEVL KGY D WS GVIL+ ++ G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 206 LPF 208
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-31
Identities = 89/313 (28%), Positives = 137/313 (43%), Gaps = 59/313 (18%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK------ 55
R V ++E IGEGT+ V A++T +GE VA+K K +M D +
Sbjct: 2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALK--------KVRM-DNERDGIPIS 52
Query: 56 --REISIMKLVRHPCVVRLHEVLASR--TKIYIILEFITG--GELFDKIVHHGRLSESEA 109
REI+++ +RHP +V L EV+ + I++++E+ L D + SES+
Sbjct: 53 SLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQV 110
Query: 110 RRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ QL+ G+ Y H + HRDLK NLLL +G LKI+DFGL+ +
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV 170
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG--YLP-------------------- 207
T Y APE+L A D+W+ G IL L+A LP
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230
Query: 208 -----FDELDLTTLYSKVE------KADFSCPTWFPVGAKSLIHRILDPNPETRITIEEI 256
F +L L ++ + K F W L++ +L +P+ R T EE
Sbjct: 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKF---PWLSEAGLRLLNFLLMYDPKKRATAEEA 287
Query: 257 RNDEWFRKGYVPV 269
+F++ +P
Sbjct: 288 LESSYFKEKPLPC 300
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-31
Identities = 78/263 (29%), Positives = 127/263 (48%), Gaps = 13/263 (4%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R +G+G F +V Q TG+ A K L++ I K K E I++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYH 130
++ + ++L + GG+L I + G E A Y ++ G++ H + + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKPEN+LLD GH++ISD GL+ +G +R GT Y+APEV+ ++ Y + D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERY-TFSPD 183
Query: 191 VWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSLIHRILDPN 246
W G ++Y +I G PF + +VE+ F A+S+ ++L +
Sbjct: 184 WWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKD 243
Query: 247 PETRI-----TIEEIRNDEWFRK 264
P R+ EE++ +FR
Sbjct: 244 PGFRLGCRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 82/259 (31%), Positives = 130/259 (50%), Gaps = 18/259 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG GT+ V A+N TGE A+KV+ + + +++EI +MK +H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V R K++I +EF GG L D G LSES+ ++ + G+ Y HSKG
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV--LSHKGYNG 186
HRD+K N+LL GH+K++DFG+SA ++ ++ GTP ++APEV + KG
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP------TWFPVGAKSLIH 240
D+W+ G+ L P +L + K++F P W + S H
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW----SNSFHH 243
Query: 241 RI---LDPNPETRITIEEI 256
+ L NP+ R T E++
Sbjct: 244 FVKMALTKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 64/194 (32%), Positives = 113/194 (58%), Gaps = 5/194 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEG+ V A+ +G VA+K++D + K + + + E+ IM+ +H VV +++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++++++EF+ GG L D IV RL+E + + ++ + Y HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
+++LL G +K+SDFG A + V ++ GTP ++APEV+S Y G D+WS
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSL 203
Query: 195 GVILYVLIAGYLPF 208
G+++ ++ G P+
Sbjct: 204 GIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-30
Identities = 66/212 (31%), Positives = 120/212 (56%), Gaps = 10/212 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVL--DRSAIIKHKMADQIKREISIMKLVRH 66
+ +G+ +G+G F +V + +TG +A+K + D + K + ++ EI ++K + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 67 PCVVRLHEVL--ASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+V+ + L + I +E + GG + D++ +G L+E+ R+Y +Q+++GV Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFG----LSALPEQGVSLLRTTCGTPNYVAPEVLS 180
S + HRD+K N+L DS G++K+ DFG L + G + T GTP +++PEV+S
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSPEVIS 182
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+GY G AD+WS G + ++ P+ E +
Sbjct: 183 GEGY-GRKADIWSVGCTVVEMLTEKPPWAEFE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-30
Identities = 76/262 (29%), Positives = 133/262 (50%), Gaps = 14/262 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V Q TG+ A K L++ + K K + E I+ V +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
++T + +++ + GG+L I + + E A Y Q+I G+++ H + + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKPEN+LLD+ G+++ISD GL+ + G S + GTP ++APE+L + Y+ + D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD-FSVD 179
Query: 191 VWSCGVILYVLIAGYLPF----DELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246
++ GV LY +IA PF ++++ L ++ + P F +KS +L +
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239
Query: 247 PETRI-----TIEEIRNDEWFR 263
PE R+ + +R FR
Sbjct: 240 PEKRLGFRDGNCDGLRTHPLFR 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-30
Identities = 72/213 (33%), Positives = 113/213 (53%), Gaps = 6/213 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-REISIMKLVRH 66
KYE +GEG++ V ++ ETG+ VA+K S KM +I REI ++K +RH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE--DDKMVKKIAMREIRMLKQLRH 59
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+V L EV + ++Y++ EF+ L D + L ES R+Y Q++ G+++CHS
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
+ HRD+KPEN+L+ G +K+ DFG + + T Y APE+L G
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 187 AAADVWSCGVILYVLIAG--YLPFDELDLTTLY 217
A D+W+ G ++ ++ G P D D+ LY
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDS-DIDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 81/310 (26%), Positives = 136/310 (43%), Gaps = 55/310 (17%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK--REIS 59
+V KYE IG+GTF +V A++ +T + VA+K + + K I REI
Sbjct: 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITALREIK 63
Query: 60 IMKLVRHPCVVRLHEVLAS--------RTKIYIILEFIT---GGELFDKIVHHGRLSESE 108
I++L++H VV L E+ + + Y++ EF G L +K V + + SE
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSE 120
Query: 109 ARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSLLR 165
++ + L++G+ Y H + HRD+K N+L+ G LK++DFGL+ +L +
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 166 TT-CGTPNYVAPEVLSHKGYNGAAADVWSCGVIL------YVLIAGYLPFDELDLTT--- 215
T T Y PE+L + G D+W G I+ ++ G +L L +
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240
Query: 216 ------LYSKVEKADFSCPTWFPVGAK-----------------SLIHRILDPNPETRIT 252
++ V+K + P G K LI ++L +P RI
Sbjct: 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID 300
Query: 253 IEEIRNDEWF 262
+ N ++F
Sbjct: 301 ADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-29
Identities = 76/258 (29%), Positives = 125/258 (48%), Gaps = 21/258 (8%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V Q TG+ A K LD+ + K E I++ V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRD 132
S+T + +++ + GG+L I + G L Y Q+ G+ + HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
+KPEN+LLD QG+ ++SD GL+ + G ++ + GT Y+APE+L + Y+ D +
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILKEEPYS-YPVDWF 178
Query: 193 SCGVILYVLIAGYLPF---------DELDLTTLYSKV--EKADFSCPTWFPVGAKSLIHR 241
+ G +Y ++AG PF +EL TL +V E +F+ + K +
Sbjct: 179 AMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEES------KDICRL 232
Query: 242 ILDPNPETRITIEEIRND 259
L PE R+ E +D
Sbjct: 233 FLAKKPEDRLGSREKNDD 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 72/265 (27%), Positives = 131/265 (49%), Gaps = 14/265 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLD---RSAIIKHKMADQIKREISIMKLVRHPC 68
G+ +G G F+ A++ +TG +A+K + ++ + ++ + +++EI +M + HP
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++R+ + + +E++ GG + + +G E+ Y +QL+ G+ Y H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 129 YHRDLKPENLLLDSQGH-LKISDFGLSA-LPEQ--GVSLLR-TTCGTPNYVAPEVLSHKG 183
HRD+K NLL+DS G L+I+DFG +A L + G + GT ++APEVL +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS---KVEKADF--SCPTWFPVGAKSL 238
Y G + DVWS G ++ + P++ + + K+ A S P G + +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 239 IHRILDPNPETRITIEEIRNDEWFR 263
R L+ PE R E+ FR
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-29
Identities = 77/245 (31%), Positives = 123/245 (50%), Gaps = 8/245 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R +G+G F +V Q TG+ A K L++ I K K E I++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYF--QQLIDGVDYCHSKGVYH 130
++ + ++L + GG+L I H G E R F ++ G++ H + + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKPEN+LLD GH++ISD GL+ +G + ++ GT Y+APEV+ ++ Y + D
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRVGTVGYMAPEVVKNERYT-FSPD 183
Query: 191 VWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSLIHRILDPN 246
W+ G +LY +IAG PF + +VE+ F A+SL +L +
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKD 243
Query: 247 PETRI 251
P+ R+
Sbjct: 244 PKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 83/307 (27%), Positives = 134/307 (43%), Gaps = 60/307 (19%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ IG+G F +V+ Q +TG+ AMK L +S + K +K E ++ P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ +Y+I+EF+ GG+L ++ + SE R Y + + ++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 133 LKPENLLLDSQGHL------------KISDFGLSALPEQGVS------------------ 162
+KP+N+L+D GH+ K D QG S
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 163 -----------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY 205
+ +T GTP+Y+APE+ +GY G D WS G I++ + G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 206 LPFDELDLTTLYSKVEKADFSCPTWFP------VGAKSLIHRILDPNPETRI---TIEEI 256
PF + Y K+ ++ +FP V A+ LI R++ N E R+ EI
Sbjct: 246 PPFCSENSHETYRKI--INWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302
Query: 257 RNDEWFR 263
++ +FR
Sbjct: 303 KSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 69/262 (26%), Positives = 135/262 (51%), Gaps = 13/262 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH- 66
+ E+ IG G + V ++ TG VA+K+++ ++D I+RE++++ +R
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSD-IQREVALLSQLRQS 59
Query: 67 --PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
P + + + +++II+E+ GG + ++ G ++E ++++ + Y H
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIH 118
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
GV HRD+K N+L+ + G++K+ DFG++AL Q S T GTP ++APEV++ Y
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDL---TTLYSKVEKADFSCPTWFPVGAKSLIHR 241
AD+WS G+ +Y + G P+ ++D L K + + + + +
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKL-LREFVAA 237
Query: 242 ILDPNPETRITIEEIRNDEWFR 263
LD P+ R++ EE+ +W +
Sbjct: 238 CLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 76/257 (29%), Positives = 134/257 (52%), Gaps = 13/257 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ +G+G F KV AQN ETG A KV+D + + ++ D + EI I+ HP
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMV-EIDILASCDHPN 63
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKG 127
+V+L + ++I++EF GG + ++ R L+E + R +Q ++ ++Y H
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL-----SHK 182
+ HRDLK N+L G +K++DFG+SA + + + GTP ++APEV+ +
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSCPTWFPVGAKSLI 239
Y+ ADVWS G+ L + P EL+ + K+ K++ + P+ + K +
Sbjct: 184 PYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242
Query: 240 HRILDPNPETRITIEEI 256
+ L+ N + R T ++
Sbjct: 243 KKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMK-VLDRSAIIKHKMADQIKREISIMKLVR 65
K +GEG V + TG A+K + K QI RE+ I K +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK---QILRELEINKSCK 57
Query: 66 HPCVVRLHE--VLASRTKIYIILEFITGGELFDKIVHH-----GRLSESEARRYFQQLID 118
P +V+ + + S + I I +E+ GG L D I GR+ E + + ++
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
G+ Y HS+ + HRD+KP N+LL +G +K+ DFG+S E SL T GT Y+APE
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYMAPER 174
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
+ K Y+ +DVWS G+ L + PF
Sbjct: 175 IQGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 5e-29
Identities = 76/266 (28%), Positives = 135/266 (50%), Gaps = 18/266 (6%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEG+ V A +G+ VA+K +D + K + + + E+ IM+ +H VV ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++++++EF+ GG L D IV H R++E + ++ + H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
+++LL G +K+SDFG A + V ++ GTP ++APE++S Y G D+WS
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSL 202
Query: 195 GVILYVLIAGYLP-FDELDLT-------TLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246
G+++ ++ G P F+E L L K++ P+ K + R+L +
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPS-----LKGFLDRLLVRD 257
Query: 247 PETRITIEEIRNDEWFRKGYVPVKLI 272
P R T E+ + K P ++
Sbjct: 258 PAQRATAAELLKHPFLAKAGPPSCIV 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 74/266 (27%), Positives = 121/266 (45%), Gaps = 24/266 (9%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+G G V + TG+ +A+K + I + QI RE+ I+ P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 73 HEVLASRTKIYIILEFITGGELFDKI--VHHGRLSESEARRYFQQLIDGVDYCHSK-GVY 129
+ + I I +E++ GG L DKI GR+ E + ++ G+ Y H K +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRD+KP N+L++S+G +K+ DFG+S Q V SL +T GT +Y+APE + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGNDY-SVK 179
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTT-----LYSKVEKADFSCPTWFPVG--AKSLIHR 241
+D+WS G+ L L G P+ + L + P P G +
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFSPDFQDF 236
Query: 242 I---LDPNPETRITIEEIRNDEWFRK 264
+ L +P R + +E+ + +K
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-29
Identities = 74/248 (29%), Positives = 120/248 (48%), Gaps = 15/248 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG G F +V + T AMK+L++ ++K + E ++ LV C
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV--LVNGDC 60
Query: 69 --VVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHS 125
+ LH +Y+++++ GG+L + RL E AR Y +++ + H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSH--- 181
HRD+KP+N+LLD GH++++DFG + + G GTP+Y++PE+L
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 182 -KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV----EKADF-SCPTWFPVGA 235
G G D WS GV +Y ++ G PF L Y K+ E+ F S T A
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240
Query: 236 KSLIHRIL 243
K LI R++
Sbjct: 241 KDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 88/324 (27%), Positives = 139/324 (42%), Gaps = 62/324 (19%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR---SAIIKHKMADQIKREISIMKLV 64
+Y+ +G G + +V A +T+TG VA+K L R SAI H A + RE+ ++K +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI--H--AKRTYRELRLLKHM 71
Query: 65 RHPCVVRLHEV------LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID 118
H V+ L +V L +Y++ + G +L + IV +LS+ + Q++
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILR 129
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
G+ Y HS G+ HRDLKP N+ ++ LKI DFGL+ + + T Y APE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEI 186
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPF------DELDL---------TTLYSKVE-- 221
+ + + D+WS G I+ L+ G F D+L L K+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246
Query: 222 -------------KADFSCPTWFPVG---AKSLIHRILDPNPETRITIEEIRNDEWFRKG 265
K DF F A L+ ++L +P+ RIT E +
Sbjct: 247 SARNYIQSLPQMPKKDFK--EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA-- 302
Query: 266 YVPVKLIEYEDVNLDDVNAAFDDS 289
EY D + V +D S
Sbjct: 303 -------EYHDPEDEPVAPPYDQS 319
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 74/258 (28%), Positives = 134/258 (51%), Gaps = 15/258 (5%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+K ++E IG+G V A + TG+ VA+K ++ K ++ I EI +M+
Sbjct: 19 KKYTRFE---KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL---IINEILVMRE 72
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+HP +V + ++++++E++ GG L D +V + E + ++ + +++
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFL 131
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSA--LPEQGVSLLRTTCGTPNYVAPEVLSH 181
HS V HRD+K +N+LL G +K++DFG A PEQ S T GTP ++APEV++
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTR 189
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF-DELDLTTLY--SKVEKADFSCPTWFPVGAKSL 238
K Y G D+WS G++ ++ G P+ +E L LY + + P +
Sbjct: 190 KAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248
Query: 239 IHRILDPNPETRITIEEI 256
++R L+ + E R + +E+
Sbjct: 249 LNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 13/199 (6%)
Query: 13 RTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +GEG F KV+ TGE VA+K L+ S +H +D +REI I++ + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH-RSD-FEREIEILRTLDHEN 67
Query: 69 VVRLHEVL--ASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHS 125
+V+ V + +I+E++ G L D + H +++ + Q+ G+DY S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTP-NYVAPEVLSHK 182
+ HRDL N+L++S+ +KISDFGL+ + + ++ +P + APE L
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187
Query: 183 GYNGAAADVWSCGVILYVL 201
++ +A+DVWS GV LY L
Sbjct: 188 KFS-SASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-28
Identities = 70/243 (28%), Positives = 124/243 (51%), Gaps = 5/243 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG+G+F +V + T E VA+K++D + I++EI+++ P + R +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
TK++II+E++ GG D ++ G L E+ ++++ G+DY HS+ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
N+LL QG +K++DFG++ T GTP ++APEV+ Y+ AD+WS
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSL 187
Query: 195 GVILYVLIAGYLPFDELD-LTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITI 253
G+ L G P +L + L+ + + + + K + L+ +P R T
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTA 247
Query: 254 EEI 256
+E+
Sbjct: 248 KEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-28
Identities = 82/262 (31%), Positives = 132/262 (50%), Gaps = 24/262 (9%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ---IKREISIMKLVR 65
YE+ + +G GT+ V A+N TGE A+K IIK + D I++EI ++K +
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVK------IIKLEPGDDFSLIQQEIFMVKECK 64
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYC 123
H +V SR K++I +E+ GG L D ++H G LSE + ++ + G+ Y
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLSELQIAYVCRETLQGLAYL 122
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS--- 180
HSKG HRD+K N+LL G +K++DFG++A ++ ++ GTP ++APEV +
Sbjct: 123 HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP------TWFPVG 234
+ GYN D+W+ G+ L P +L + K++F P W
Sbjct: 183 NGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS-T 240
Query: 235 AKSLIHRILDPNPETRITIEEI 256
+ + L NP+ R T E +
Sbjct: 241 FHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 46/140 (32%), Positives = 82/140 (58%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
I G F KV + + A+KV+ ++ +I M Q++ E + L + P +V L+
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
L S +Y+++E++ GG++ + +G E A +Y ++ +DY H G+ HRDLK
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 135 PENLLLDSQGHLKISDFGLS 154
P+N+L+ ++GH+K++DFGLS
Sbjct: 132 PDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 24/267 (8%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGES-VAMK-------VLDRSAIIKHKMADQIKREISI 60
Y V +G G F V + G++ +A+K + + K I E++I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 61 MK-LVRHPCVVRLHEVLASRTKIYIILEFITG---GELFDKIVH-HGRLSESEARRYFQQ 115
+K +RHP +VR ++ ++YI+++ I G GE F+ + R +E F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 116 LIDGVDYCH-SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
++ + Y H K + HRDL P N++L + I+DFGL A +Q S L + GT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQPESKLTSVVGTILYS 180
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVG 234
PE++ ++ Y G ADVW+ G ILY + PF ++ +L +K+ +A + P P G
Sbjct: 181 CPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-P--LPEG 236
Query: 235 AKS-----LIHRILDPNPETRITIEEI 256
S +I L P+ E R I ++
Sbjct: 237 MYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-27
Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 10/213 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY IG+G V A + TG+ VA+K ++ + K + I EI +MK +++P
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNP 76
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V + ++++++E++ GG L D +V + E++ ++ + +++ H+
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA--LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
V HRD+K +N+LL G +K++DFG A PEQ S T GTP ++APEV++ K Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 186 GAAADVWSCGVILYVLIAGYLPF-DELDLTTLY 217
G D+WS G++ ++ G P+ +E L LY
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 77/250 (30%), Positives = 125/250 (50%), Gaps = 18/250 (7%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R +G+G F +V Q TG+ A K L++ I K K E I++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYH 130
++ + ++L + GG+L I + G E A Y +L G++ + + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKPEN+LLD +GH++ISD GL+ +G + +R GT Y+APEV++++ Y + D
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRVGTVGYMAPEVINNEKYT-FSPD 183
Query: 191 VWSCGVILYVLIAGYLPF---------DELDLTTLYSKVEKADFSCPTWFPVGAKSLIHR 241
W G ++Y +I G PF +E+D + E ++ F AKS+
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE-----KFSEDAKSICRM 238
Query: 242 ILDPNPETRI 251
+L NP+ R+
Sbjct: 239 LLTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 74/261 (28%), Positives = 134/261 (51%), Gaps = 12/261 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY IG+G V A + TG+ VA++ ++ K ++ I EI +M+ ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V + ++++++E++ GG L D +V + E + ++ + +++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA--LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
V HRD+K +N+LL G +K++DFG A PEQ S T GTP ++APEV++ K Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 186 GAAADVWSCGVILYVLIAGYLPF-DELDLTTLY--SKVEKADFSCPTWFPVGAKSLIHRI 242
G D+WS G++ +I G P+ +E L LY + + P + ++R
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 243 LDPNPETRITIEEIRNDEWFR 263
LD + E R + +E+ ++ +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 68/213 (31%), Positives = 115/213 (53%), Gaps = 10/213 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY IG+G V A + TG+ VA+K ++ K ++ I EI +M+ ++P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNP 76
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V + ++++++E++ GG L D +V + E + ++ + +D+ HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA--LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
V HRD+K +N+LL G +K++DFG A PEQ S T GTP ++APEV++ K Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 186 GAAADVWSCGVILYVLIAGYLPF-DELDLTTLY 217
G D+WS G++ ++ G P+ +E L LY
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 9/245 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG+G+F +V + T + VA+K++D + I++EI+++ P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
TK++II+E++ GG D ++ G E + ++++ G+DY HS+ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
N+LL QG +K++DFG++ T GTP ++APEV+ Y+ + AD+WS
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSL 187
Query: 195 GVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW---FPVGAKSLIHRILDPNPETRI 251
G+ L G P ++ + + K + PT F K I L+ +P R
Sbjct: 188 GITAIELAKGEPPNSDMHPMRVLFLIPK--NNPPTLTGEFSKPFKEFIDACLNKDPSFRP 245
Query: 252 TIEEI 256
T +E+
Sbjct: 246 TAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ IG G + V A +T +G+ VA+K + A +A + RE+ I++ +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH-AFDVPTLAKRTLRELKILRHFKHD 64
Query: 68 CVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGV 120
++ + ++L R +Y++++ + +L I+H + L+E R + QL+ G+
Sbjct: 65 NIIAIRDIL--RPPGADFKDVYVVMDLM-ESDL-HHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFG----LSALPEQGVSLLRTTCGTPNYVAP 176
Y HS V HRDLKP NLL++ L+I DFG LS+ P + + T Y AP
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 177 EVL-SHKGYNGAAADVWSCGVIL 198
E+L S Y A D+WS G I
Sbjct: 181 ELLLSLPEYT-TAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH- 66
YE IGEGT+ KV A++ TG+ VA+K R + + + REIS+++++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSES 60
Query: 67 PCVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGR-----LSESEARRYFQQL 116
+VRL +V K +Y++ E++ +L + +GR L + + QL
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQGVSLLRTTCGTPNYVA 175
+ GV +CH GV HRDLKP+NLL+D Q G LKI+D GL V T Y A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179
Query: 176 PEVLSHKGYNGAAADVWSCGVI 197
PEVL + D+WS G I
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCI 201
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 71/249 (28%), Positives = 124/249 (49%), Gaps = 17/249 (6%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG+G+F +V + T + VA+K++D + I++EI+++ P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
TK++II+E++ GG D ++ G L E++ ++++ G+DY HS+ HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
N+LL G +K++DFG++ T GTP ++APEV+ Y+ + AD+WS
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 187
Query: 195 GVILYVLIAGYLPFDELDLTTLYSKVEK-------ADFSCPTWFPVGAKSLIHRILDPNP 247
G+ L G P EL + + K ++S P K + L+ P
Sbjct: 188 GITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL------KEFVEACLNKEP 241
Query: 248 ETRITIEEI 256
R T +E+
Sbjct: 242 SFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 74/226 (32%), Positives = 114/226 (50%), Gaps = 16/226 (7%)
Query: 49 KMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH----HGRL 104
+ A + E+ + H +V+ + S K+ +I+E+ +GG+L +I H
Sbjct: 107 RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF 166
Query: 105 SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL- 163
E E F Q++ +D HS+ + HRDLK N+ L G +K+ DFG S VSL
Sbjct: 167 QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD-----ELDLTTLY 217
+ CGTP Y+APE+ K Y+ AD+WS GVILY L+ + PF E+ LY
Sbjct: 227 VASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285
Query: 218 SKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFR 263
K + F CP G K+L+ +L NP R T +++ + E+ +
Sbjct: 286 GKYDP--FPCPV--SSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLV 64
G +E+ IGEGT+ KV A++ +TG+ VA+K++D I ++IK E +I+ K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 65 RHPCVVRLHEV------LASRTKIYIILEFITGG---ELFDKIVHHGRLSESEARRYF-Q 114
HP + + + ++++++E GG +L + G+ + E Y +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
+ + G+ Y H V HRD+K +N+LL +K+ DFG+SA + + T GTP ++
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 175 APEVLSHKGYNGAA----ADVWSCGV 196
APEV++ A+ +DVWS G+
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-27
Identities = 63/210 (30%), Positives = 112/210 (53%), Gaps = 11/210 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMK--VLDRSAIIK-HKMADQIKREISIMKLVRHPC 68
G +G+G + V + T G+ +A+K LD S ++ K ++++ E+ ++K ++H
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V+ I I +EF+ GG + + G L E +Y +Q++DGV Y H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLS------ALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
HRD+K N++L G +K+ DFG + L ++L++ GTP ++APEV++
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELD 212
GY G +D+WS G ++ + G P +D
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-27
Identities = 72/260 (27%), Positives = 132/260 (50%), Gaps = 13/260 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLD-RSAIIKHKMADQIKREISIMKLVRHPCVVR 71
R +G+G++ +V ++ G+ +K L+ R+A + + A + +E ++ ++HP +V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIVA 63
Query: 72 LHEVLASRT-KIYIILEFITGGELFDKIVHH-GRL-SESEARRYFQQLIDGVDYCHSKGV 128
E +YI++ F GG+L+ K+ G+L E++ +F Q+ + Y H K +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRDLK +N+ L +K+ D G++ + E + T GTP Y++PE+ S+K YN
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN-YK 182
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTL-YSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247
+DVW+ G +Y + F+ D+ +L Y +E P + LI +L P
Sbjct: 183 SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRP 242
Query: 248 ETRITIEEIRNDEWFRKGYV 267
E R +++ I R+ Y+
Sbjct: 243 EKRPSVKSI-----LRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 80/320 (25%), Positives = 135/320 (42%), Gaps = 62/320 (19%)
Query: 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-----------REIS 59
G +GEGT+ KV+ A +T TG+ VA+K + I D+ RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 60 IMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQLI 117
IM ++H ++ L +V I ++++ + ++ D+ + RL+ES+ + Q++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTESQVKCILLQIL 129
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-----ALPEQGVSLLRTTCGTPN 172
+G++ H HRDL P N+ ++S+G KI+DFGL+ +S T
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 173 ---------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELD-------- 212
Y APE+L A D+WS G I L+ G F +E+D
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249
Query: 213 ----------------LTTLYSKVEKADFSCPTWFPVGAKS---LIHRILDPNPETRITI 253
L T ++ + D T FP + L+ +L NP RI+
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLK--TIFPNASDDAIDLLQSLLKLNPLERISA 307
Query: 254 EEIRNDEWFRKGYVPVKLIE 273
+E E+F+ +P +
Sbjct: 308 KEALKHEYFKSDPLPCDPSQ 327
|
Length = 335 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA---IIKHKMADQIKREISIMKLV 64
KYE IGEG++ V +N ETG+ VA+K S +IK K+A REI ++K +
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIA---LREIRMLKQL 57
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+HP +V L EV + K++++ E+ L + + + E ++ Q + V++CH
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
HRD+KPEN+L+ QG +K+ DFG + + T Y APE+L
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 185 NGAAADVWSCGVILYVLIAG 204
G DVW+ G + L+ G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 73/259 (28%), Positives = 117/259 (45%), Gaps = 26/259 (10%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++G TIG+G F V G+ VA+K L + A E S+M +RHP +
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID-------GVDY 122
V+L V+ +YI+ E++ G L D + GR A Q + G++Y
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEY 117
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSH 181
K HRDL N+L+ K+SDFGL+ QG + P + APE L
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAPEALRE 173
Query: 182 KGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLI 239
K ++ +DVWS G++L+ + + G +P+ + L + VEK P P ++
Sbjct: 174 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232
Query: 240 HRILDPNPETRITIEEIRN 258
+ +P R T +++R
Sbjct: 233 KDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 76/230 (33%), Positives = 118/230 (51%), Gaps = 24/230 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + R +G G V A+ GE A+KV+D + + AD+ + + + L+
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE---ADKNRAQAEVCCLLN-- 87
Query: 68 C----VVRLHEVLASRTK--------IYIILEFITGGELFDKIVHHGRLS----ESEARR 111
C +V+ HE A + I ++L++ G+L +I + + E EA
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCG 169
F Q++ V + HSK + HRD+K N+LL S G +K+ DFG S + VS + RT CG
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSK 219
TP YVAPE+ K Y+ AD++S GV+LY L+ PFD ++ + K
Sbjct: 208 TPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ-----IKREISIMK 62
+YE IGEGT+ V A++ T E++A+K I+ + D+ REIS++K
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKK------IRLEQEDEGVPSTAIREISLLK 56
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESE-----ARRYFQQLI 117
++H +VRL +V+ S ++Y++ E++ D H + + Y Q++
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 118 DGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
G+ YCHS V HRDLKP+NLL+D LK++DFGL+ V T Y AP
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172
Query: 177 EVLSHKGYNGAAADVWSCGVI 197
E+L + D+WS G I
Sbjct: 173 EILLGSRHYSTPVDIWSVGCI 193
|
Length = 294 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
Y+ IGEG + V A + TG VA+K + S + REI I++ +H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 69 VVRLHEVLASRT-----KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
++ + +++ + +YI+ E + +L+ K++ LS + + Q++ G+ Y
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTT-CGTPNYVAPEV-L 179
HS V HRDLKP NLLL++ LKI DFGL A PE + T T Y APE+ L
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182
Query: 180 SHKGYNGAAADVWSCGVILYVLIAG 204
+ KGY A D+WS G IL +++
Sbjct: 183 NSKGYT-KAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 70/224 (31%), Positives = 118/224 (52%), Gaps = 19/224 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH-KMADQIKREISIMKLVRH 66
+Y++ IG+G++ V A +T TGE VA+K ++ + +H A +I REI +++L+RH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND--VFEHVSDATRILREIKLLRLLRH 58
Query: 67 PCVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
P +V + ++ ++ IY++ E + +L I + L+ + + QL+ +
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTT-CGTPNYVAPEV 178
Y H+ V+HRDLKP+N+L ++ LKI DFGL+ A + ++ T T Y APE+
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 179 L-SHKGYNGAAADVWSCGVILYVLIAGYLPF------DELDLTT 215
S A D+WS G I ++ G F +LDL T
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLIT 221
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 86/302 (28%), Positives = 129/302 (42%), Gaps = 74/302 (24%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + IG G + V A+N+ET E VA+K + +A A + REI +++ + H
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 68 CVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHH-----GRLSESEARRYFQQLI 117
V+ + +++ + +YI+ E L D +H LS+ + + QL+
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN----- 172
G+ Y HS V HRDLKP NLLL++ LKI DFGL+ RTT +
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----------RTTSEKGDFMTEY 168
Query: 173 -----YVAPEV-LSHKGYNGAAADVWSCGVILYVLIAGYLPF------------------ 208
Y APE+ L+ Y A DVWS G I L+ F
Sbjct: 169 VVTRWYRAPELLLNCSEY-TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227
Query: 209 -DELDLTTLYSK-----------VEKADFSCPTWFP---VGAKSLIHRILDPNPETRITI 253
E DL + ++ + F+ FP A L+ ++L +P RIT+
Sbjct: 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITV 285
Query: 254 EE 255
EE
Sbjct: 286 EE 287
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 5e-24
Identities = 67/228 (29%), Positives = 113/228 (49%), Gaps = 33/228 (14%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR--------SAIIKHKMADQIKR 56
K+ Y+ +GEG++A V ++ TG+ VA+K + +AI R
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----------R 52
Query: 57 EISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQ 115
E S++K ++H +V LH+++ ++ + ++ E++ +L + G LS R + Q
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 116 LIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSLLRTTCGTPN 172
L+ G+ YCH + V HRDLKP+NLL+ +G LK++DFGL+ ++P + S T
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS---NEVVTLW 168
Query: 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF-------DELDL 213
Y P+VL + D+W G I Y + G F D+L
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 7e-24
Identities = 71/219 (32%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ-IKREISIMKLVRH 66
K +G IGEG F V Q TG+ VA+K IK + Q E ++M + H
Sbjct: 7 KLTLGEIIGEGEFGAV--LQGEYTGQKVAVK------NIKCDVTAQAFLEETAVMTKLHH 58
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEAR--RYFQQLIDGVDYCH 124
+VRL V+ +YI++E ++ G L + + GR S + ++ + +G++Y
Sbjct: 59 KNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
SK + HRDL N+L+ G K+SDFGL+ + GV + + APE L HK +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKLPVKWTAPEALKHKKF 174
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK 222
+ + +DVWS GV+L+ V G P+ ++ L + VEK
Sbjct: 175 S-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK 212
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-23
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 27/222 (12%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMK--VLDRSAIIKHKMADQIKREISIMKLV 64
+Y R +G G+ V A +++ + VA+K VL +KH + REI I++ +
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-----REIKIIRRL 59
Query: 65 RHPCVVRLHEVLASRTK--------------IYIILEFITGGELFDKIVHHGRLSESEAR 110
H +V+++EVL +YI+ E++ ++ G LSE AR
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHAR 117
Query: 111 RYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH-LKISDFGLSALPEQGVS---LLRT 166
+ QL+ G+ Y HS V HRDLKP N+ ++++ LKI DFGL+ + + S L
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
T Y +P +L A D+W+ G I ++ G F
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-23
Identities = 62/194 (31%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
K+EV +GEG + V ++ ET E VA+K S ++ + RE+ +++ ++
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQE 60
Query: 68 CVVRLHEVLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+V L E R K+Y++ E++ EL ++ + + R Y QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHKGY 184
+ HRD+KPENLL+ LK+ DFG + +G + T T Y +PE+L Y
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 185 NGAAADVWSCGVIL 198
G A D+WS G IL
Sbjct: 179 -GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-23
Identities = 86/321 (26%), Positives = 142/321 (44%), Gaps = 47/321 (14%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y + +G G + V A + TG VA+K L R A + RE+ ++K ++H
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHE 74
Query: 68 CVVRLHEVLASRTKI------YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
V+ L +V + Y+++ F+ G K++ H +LSE + Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
Y H+ G+ HRDLKP NL ++ LKI DFGL+ Q S + T Y APEV+ +
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYRAPEVILN 189
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF---DELDLTTLYSKV------------------ 220
+ D+WS G I+ ++ G F D LD KV
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249
Query: 221 ---------EKADFSC--PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269
K DF P P+ A +++ ++L + E+RIT E +F + + P
Sbjct: 250 NYVKKLPRFRKKDFRSLLPNANPL-AVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
Query: 270 KLIEYE--DVNLDDVNAAFDD 288
E D + D+V+ + ++
Sbjct: 309 DETEAPPYDDSFDEVDQSLEE 329
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-23
Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 9/199 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y + +G G F V A++ TG++VA+K + +A + RE+ ++K +RH
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 68 CVVRLHEVLAS-RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
++ L ++ S IY + E + G +++ L + + + Q++ G+ Y HS
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV-LSHKGYN 185
GV HRDLKP N+L++ LKI DFGL+ + + + T Y APE+ L+ + Y+
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQD---PQMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 186 GAAADVWSCGVILYVLIAG 204
D+WS G I ++ G
Sbjct: 185 -VEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-23
Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 8/203 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ + R +G G F +V + + VA+K+L ++K + ++E+ +K +RH
Sbjct: 8 FTLERKLGSGYFGEV-WEGLWKNRVRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQ-QLIDGVDYCHSK 126
++ L V + +YII E + G L + G++ + Q+ +G+ Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
HRDL N+L+ K++DFGL+ L ++ V L + APE SH ++
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS- 182
Query: 187 AAADVWSCGVILY-VLIAGYLPF 208
+DVWS G++LY + G +P+
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-23
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 10/188 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R IG G+F V FA++ T E VA+K + S ++ I +E+ ++ +RHP +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 73 HEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
++++E+ G ++ + VH L E E + G+ Y HS H
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYNGAA 188
RD+K N+LL G +K++DFG ++L VS + GTP ++APEV+ +G
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASL----VSPANSFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 189 ADVWSCGV 196
DVWS G+
Sbjct: 195 VDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 18/236 (7%)
Query: 30 ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL-HEVLASRTKIYIILEF 88
TG VA+K+L A + + +RE ++ + HP +V L A ++ + E+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---H 145
+ G L + + G L E R Q++D + H++G+ HRDLKP+N+++ G H
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 146 LKISDFGLSAL-PEQG----VSLLRTT--CGTPNYVAPEVLSHKGYNGAAADVWSCGVIL 198
K+ DFG+ L P +L RTT GTP Y APE L + +D+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179
Query: 199 YVLIAGYLPFDELDLT-TLYSKVEKADFSCPTWF---PVGAKSLIHRILDPNPETR 250
+ G + LY ++ D S P W P+G ++ + L+ +P R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQ--VLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-23
Identities = 67/218 (30%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRHP 67
+E+ TIG+GT+ KV N + G A+K+LD H + ++I+ E +I+K L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHP 75
Query: 68 CVVRLHEVLASRT-----KIYIILEFITGGELFDKI---VHHG-RLSESEARRYFQQLID 118
VV+ + + + +++++LE GG + D + + G R+ E + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
G+ + H HRD+K N+LL ++G +K+ DFG+SA T+ GTP ++APEV
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 179 LS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211
++ Y+ A DVWS G+ L G P +L
Sbjct: 196 IACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 9e-23
Identities = 72/252 (28%), Positives = 116/252 (46%), Gaps = 12/252 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG G F +V + VA+K + + + + +E I+K HP +VRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
V + IYI++E + GG+ + G RL E + + G++Y SK HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN----YVAPEVLSHKGYNGAAA 189
N L+ + LKISDFG+S E GV +T G + APE L++ Y+ + +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTAPEALNYGRYS-SES 177
Query: 190 DVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILDPNP 247
DVWS G++L+ + G +P+ L +E+ CP P L+ R + +P
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237
Query: 248 ETRITIEEIRND 259
R + + +
Sbjct: 238 GQRPSFSTVHQE 249
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 71/226 (31%), Positives = 118/226 (52%), Gaps = 19/226 (8%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVR 65
+E+ TIG+GT+ KV N + G A+K+LD + + ++I+ E +I++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 66 HPCVVRLHEVLASRTK-----IYIILEFITGG---ELFDKIVHHG-RLSESEARRYFQQL 116
HP VV+ + + K ++++LE GG EL ++ G RL E+
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+ G+ + H+ + HRD+K N+LL ++G +K+ DFG+SA T+ GTP ++AP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197
Query: 177 EVLS-HKGYN---GAAADVWSCGVILYVLIAGYLP-FDELDLTTLY 217
EV++ + Y+ A DVWS G+ L G P FD + TL+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 1e-22
Identities = 78/274 (28%), Positives = 122/274 (44%), Gaps = 26/274 (9%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K YE +GEG++A V ++ G+ VA+KV+ + RE S++K +
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGL 60
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+H +V LH+++ ++ + ++ E++ + DK H G L + + QL+ G+ Y
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSY 118
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
H + + HRDLKP+NLL+ G LK++DFGL+ T Y P+VL
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPF-------DELDLTTLYSKVEKADFSCPTWFPVGA 235
D+W G I +I G F D+L+ L D TW G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED----TW--PGV 232
Query: 236 KSLIHRILDPNPETRITIEEIRN--DEWFRKGYV 267
SL H PE R T+ +N W + YV
Sbjct: 233 HSLPHF----KPE-RFTLYSPKNLRQAWNKLSYV 261
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-22
Identities = 70/249 (28%), Positives = 113/249 (45%), Gaps = 8/249 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V F + VA+K + ++ + E I+K HP +V+L
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 75 VLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
V R IYI++E + GG+ + L + ++ G+ Y SK HRDL
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAAADVW 192
N L+ LKISDFG+S + G+ P + APE L++ Y+ + +DVW
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS-SESDVW 178
Query: 193 SCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILDPNPETR 250
S G++L+ + G P+ + +VEK SCP P ++ R D PE R
Sbjct: 179 SYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238
Query: 251 ITIEEIRND 259
E++ +
Sbjct: 239 PKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 58/193 (30%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK--REISIMKLVRHPCVVRL 72
+GEGT+A V ++ T VA+K + ++H+ RE+S++K ++H +V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRL-SESEARRYFQQLIDGVDYCHSKGVYHR 131
H+++ + + ++ E++ +L + + G L S + + QL+ G+ YCH + + HR
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKP+NLL++ +G LK++DFGL+ T Y P+VL D+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187
Query: 192 WSCGVILYVLIAG 204
W G ILY + G
Sbjct: 188 WGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-22
Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 16/252 (6%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R IG G+F V FA++ T E VA+K + S ++ I +E+ ++ ++HP +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
++++E+ G VH L E E + G+ Y HS + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYNGAAAD 190
+K N+LL G +K++DFG +++ S + GTP ++APEV+ +G D
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASI----ASPANSFVGTPYWMAPEVILAMDEGQYDGKVD 206
Query: 191 VWSCGVILYVLIAGYLP-FDELDLTTLY--SKVEKADFSCPTW---FPVGAKSLIHRILD 244
VWS G+ L P F+ ++ LY ++ E W F S + +I
Sbjct: 207 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI-- 264
Query: 245 PNPETRITIEEI 256
P+ R T EE+
Sbjct: 265 --PQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-22
Identities = 59/193 (30%), Positives = 100/193 (51%), Gaps = 8/193 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+GEG++A V + G+ VA+KV+ + + RE S++K ++H +V LH+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++ ++ + + E++ I H G L R + QL+ G+ Y H + + HRDLK
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK 130
Query: 135 PENLLLDSQGHLKISDFGLS---ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
P+NLL+ G LK++DFGL+ ++P Q S + T Y P+VL +A D+
Sbjct: 131 PQNLLISYLGELKLADFGLARAKSIPSQTYS---SEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 192 WSCGVILYVLIAG 204
W G I ++ G
Sbjct: 188 WGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 4e-22
Identities = 72/261 (27%), Positives = 113/261 (43%), Gaps = 29/261 (11%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKR----EISIMKLVRHPC 68
IG+G F V + + VA+K + + +KR E I+K HP
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKT------CRSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID-------GVD 121
+V+L V + IYI++E + GG L L + + R ++L+ G++
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLT------FLRKKKNRLTVKKLLQMSLDAAAGME 107
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVL 179
Y SK HRDL N L+ LKISDFG+S E G+ + P + APE L
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 180 SHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKS 237
++ Y + +DVWS G++L+ G P+ + ++E P P
Sbjct: 168 NYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYR 226
Query: 238 LIHRILDPNPETRITIEEIRN 258
L+ + +PE R + EI N
Sbjct: 227 LMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTET--GESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
YE+ + +G+G + V A+N ET E+VA+K + K +A + RE+ +++ R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITN-VFSKKILAKRALRELKLLRHFRG 60
Query: 66 HPCVVRLHEV----LASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGV 120
H + L+++ + ++Y+ E + +I+ G L+++ + + Q++ G+
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL----SALPEQGVSLLRTTCGTPNYVAP 176
Y HS V HRDLKP NLL+++ LKI DFGL S P + + T Y AP
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 177 EV-LSHKGYNGAAADVWSCGVILYVLIAG 204
E+ LS + Y A DVWS G IL L+
Sbjct: 179 EIMLSFQSYT-KAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (238), Expect = 5e-22
Identities = 73/238 (30%), Positives = 119/238 (50%), Gaps = 39/238 (16%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
++ +YEV + IG G F +V ++ T E K + + K + Q+ E+++M+ +
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMREL 69
Query: 65 RHPCVVRLHEVLASRT--KIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLID 118
+H +VR + ++ K+YI++EF G+L I G++ E +QL+
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 119 GVDYCHS-------KGVYHRDLKPENLLLDSQG--HL----------------KISDFGL 153
+ YCH+ + V HRDLKP+N+ L S G H+ KI DFGL
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFL-STGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 154 SALPEQGVSLLRTTC-GTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPF 208
S G+ + +C GTP Y +PE+L H K Y+ +D+W+ G I+Y L +G PF
Sbjct: 189 SK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-22
Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 25/272 (9%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMK----VLDRSAIIKHKMADQIKREISIMKLVR 65
EV +G+G + V + TG ++AMK LD S +QI E+ I+
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF------NQIIMELDILHKAV 57
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGG---ELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
P +V + +Y+ +E++ G +L+ V + E RR ++ G+ +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 123 CHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
+ + HRD+KP N+L++ G +K+ DFG+S SL +T G +Y+APE +
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--SLAKTNIGCQSYMAPERIKS 175
Query: 182 KGYNGAA-----ADVWSCGVILYVLIAGYLPFDELDLTTLYSK----VEKADFSCPTWFP 232
G N +DVWS G+ + + G P+ ++++ V+ + P+ +
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235
Query: 233 VGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
A+ + + L+ P R T ++ W K
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-22
Identities = 73/256 (28%), Positives = 123/256 (48%), Gaps = 13/256 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+GT+ V A++ T +A+K + + + EI++ ++H +V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP---ERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 75 VLASRTKIYIILEFITGGELFDKIVHH-GRLSESEA--RRYFQQLIDGVDYCHSKGVYHR 131
+ I +E + GG L + G L ++E Y +Q+++G+ Y H + HR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 132 DLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH--KGYNGAA 188
D+K +N+L+++ G +KISDFG S T GT Y+APEV+ +GY GA
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAP 191
Query: 189 ADVWSCGVILYVLIAGYLPFDEL-DLTTLYSKVE--KADFSCPTWFPVGAKSLIHRILDP 245
AD+WS G + + G PF EL + KV K P AK+ I R +P
Sbjct: 192 ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEP 251
Query: 246 NPETRITIEEIRNDEW 261
+P+ R + ++ D +
Sbjct: 252 DPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-21
Identities = 74/270 (27%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
E +G G V ++ TG +A KV+ A K + QI RE+ IM R P +
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYI 65
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSK-G 127
V + + I + +EF+ G L D+I G + + +++G+ Y ++
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ HRD+KP N+L++S+G +K+ DFG+S E S+ T GT Y++PE + Y
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADTFVGTSTYMSPERIQGGKYT-V 181
Query: 188 AADVWSCGVILYVLIAGYLPFDE--------------LDLTTLYSKVEKADFSCPT-WFP 232
+DVWS G+ + L G PF LDL L V++ P+ FP
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL--LQQIVQEPPPRLPSSDFP 239
Query: 233 VGAKSLIHRILDPNPETRITIEEI-RNDEW 261
+ + L +P R T +++ +
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 70/260 (26%), Positives = 121/260 (46%), Gaps = 23/260 (8%)
Query: 13 RTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ IG G F +V + G+ VA+K L + K E SIM HP +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNI 67
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHSKG 127
+RL V+ + II E++ G L DK + + G+ + + + + G+ Y
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGYN 185
HRDL N+L++S K+SDFGLS E + T G P + APE ++++ +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 186 GAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL- 243
+A+DVWS G++++ V+ G P+ ++ + VE + P P+ S +++++
Sbjct: 187 -SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPP--PMDCPSALYQLML 242
Query: 244 -----DPNPETRITIEEIRN 258
D N R T +I +
Sbjct: 243 DCWQKDRN--ERPTFSQIVS 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMK----VLDRSAIIKHKMADQIKREISIMKLVRHPC 68
R IG G F V + G+ VA+K V K ++ RE+ ++ +H
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK-----RVFRELKMLCFFKHDN 60
Query: 69 VVRLHEVLASR-----TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
V+ ++L +IY++ E + +L IV LS + + Q++ G+ Y
Sbjct: 61 VLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHK 182
HS G+ HRD+KP NLL++S LKI DFGL+ + E S T T Y APE+L
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179
Query: 183 GYNGAAADVWSCGVILYVLIAGYL------PFDELDLTT 215
+ +A D+WS G I L+ + P +LDL T
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-21
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 6/184 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG G+F V FA N+ T E VA+K + S ++ I +E+ ++ ++HP +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++++E+ G VH L E E + G+ Y HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYNGAAADVW 192
N+LL G +K++DFG ++ S + GTP ++APEV+ +G DVW
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPANSFV----GTPYWMAPEVILAMDEGQYDGKVDVW 204
Query: 193 SCGV 196
S G+
Sbjct: 205 SLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-21
Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 15/200 (7%)
Query: 13 RTIGEGTFAKVKF----AQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
R +GEG F KV N TGE VA+K L R ++ K+EI+I+K + H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67
Query: 69 VVRLHEVLASRTK--IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+V+ + + + +I+E++ G L D + H +L+ ++ + QQ+ +G+ Y HS+
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYV---APEVLSHK 182
HRDL N+LLD+ +KI DFGL+ A+PE G R + V A E L
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAVECLKEN 185
Query: 183 GYNGAAADVWSCGVILYVLI 202
++ A+DVWS GV LY L+
Sbjct: 186 KFS-YASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 25/219 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRS-AIIKHKMADQIKREISIMKLVRH 66
+Y+ + IG G V A +T TG++VA+K L R + H A + RE+ +MKLV H
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH--AKRAYRELVLMKLVNH 74
Query: 67 PCVVRLHEVLASRTK------IYIILEFITGG--ELFDKIVHHGRLSESEARRYF-QQLI 117
++ L V + +Y+++E + ++ + H R+S Y Q++
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS------YLLYQML 128
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAP 176
G+ + HS G+ HRDLKP N+++ S LKI DFGL+ G S + T T Y AP
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 186
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELD 212
EV+ GY D+WS G I+ +I G + F D +D
Sbjct: 187 EVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHID 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 4e-21
Identities = 75/217 (34%), Positives = 107/217 (49%), Gaps = 35/217 (16%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMK-VLDRSAIIKHKMADQIKREISIMK-LVR 65
KYE+ + +G+G + V A + T E VA+K + D A A + REI ++ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD--AFRNATDAQRTFREIMFLQELGD 65
Query: 66 HPCVVRLHEVL-ASRTK-IYIILEF--------ITGGELFDKIVHHGRLSESEARRY-FQ 114
HP +V+L V+ A K IY++ E+ I L + VH +RY
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL--EDVH---------KRYIMY 114
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL----SALPE-QGVSLLRTTCG 169
QL+ + Y HS V HRDLKP N+LL+S +K++DFGL S L E +L
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 170 TPNYVAPEVL--SHKGYNGAAADVWSCGVILYVLIAG 204
T Y APE+L S + Y D+WS G IL ++ G
Sbjct: 175 TRWYRAPEILLGSTR-YT-KGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-21
Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 15 IGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70
+G+G F V+ + TGE VA+K L S + D +REI I+K ++H +V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRD-FEREIEILKSLQHDNIV 68
Query: 71 RLHEVL--ASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ V A R + +++E++ G L D + H RL + Y Q+ G++Y SK
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN-----YVAPEVLSHK 182
HRDL N+L++S+ +KI DFGL+ + Q + P + APE L+
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR--EPGESPIFWYAPESLTES 186
Query: 183 GYNGAAADVWSCGVILYVL 201
++ A+DVWS GV+LY L
Sbjct: 187 KFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 6e-21
Identities = 69/260 (26%), Positives = 120/260 (46%), Gaps = 41/260 (15%)
Query: 18 GTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA 77
G KV +T T ++ +K L +S+ + + I I V P +V LH+ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTI-IPHCV--PNMVCLHKYIV 55
Query: 78 SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPEN 137
S ++++L+ GG+L+ I + E +R+ +++ +D H +G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 138 LLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP---NYVAPEV--LSHKGYNGAAADVW 192
+LLD +GH++++ F + + + G Y APEV +S + A D W
Sbjct: 116 ILLDDRGHIQLTYFS------RWSEVEDSCDGEAVENMYCAPEVGGISEE---TEACDWW 166
Query: 193 SCGVILYVLIAGYL-----PFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247
S G IL+ L+ G P TTL + P W A+SL+ ++L NP
Sbjct: 167 SLGAILFELLTGKTLVECHPSGINTHTTL---------NIPEWVSEEARSLLQQLLQFNP 217
Query: 248 ETRI-----TIEEIRNDEWF 262
R+ +E+I++ +F
Sbjct: 218 TERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-21
Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 6/186 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R IG G+F V FA++ E VA+K + S ++ I +E+ ++ +RHP ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
++++E+ G VH L E E + G+ Y HS + HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYNGAAAD 190
+K N+LL G +K+ DFG +++ ++ GTP ++APEV+ +G D
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQYDGKVD 196
Query: 191 VWSCGV 196
VWS G+
Sbjct: 197 VWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 73/260 (28%), Positives = 117/260 (45%), Gaps = 29/260 (11%)
Query: 12 GRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
R +G G F +V + T+ VA+K L + +E IMK +RH
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK----VAVKTLKPGTMSPEAFL----QEAQIMKKLRHDK 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARR-YFQQLID-------GV 120
+V+L+ V + IYI+ E+++ G L D L E ++ QL+D G+
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVL 179
Y S+ HRDL N+L+ KI+DFGL+ L E R P + APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 180 SHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKS 237
++ G +DVWS G++L ++ G +P+ + + +VE+ P P
Sbjct: 177 NY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235
Query: 238 LIHRILDPNPETRITIEEIR 257
L+ + D +PE R T E ++
Sbjct: 236 LMLQCWDKDPEERPTFEYLQ 255
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-20
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-- 65
+YE IG G + V A++ +G VA+K + R + + RE++++K +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 66 -HPCVVRLHEVLAS-----RTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLI 117
HP +VRL +V A+ TK+ ++ E + DK+ G L + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFL 118
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177
G+D+ H+ + HRDLKPEN+L+ S G +K++DFGL+ + ++L T Y APE
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYRAPE 177
Query: 178 VLSHKGYNGAAADVWSCGVIL 198
VL Y D+WS G I
Sbjct: 178 VLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK--REISIMKLVRHPCVVRL 72
+GEGT+A V ++ T VA+K + ++H+ RE+S++K ++H +V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHR 131
H+++ + + ++ E++ +L + G +S + + Q++ G+ YCH + V HR
Sbjct: 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKP+NLL++ +G LK++DFGL+ T Y P+VL D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188
Query: 192 WSCGVILYVLIAGYLPF------DELDL 213
W G I + + +G F DEL L
Sbjct: 189 WGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-20
Identities = 74/226 (32%), Positives = 111/226 (49%), Gaps = 24/226 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR---SAIIKHKMADQIKREISIMKLV 64
+Y + +G G + V A + TGE VA+K L R S I A + RE++++K +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FAKRAYRELTLLKHM 71
Query: 65 RHPCVVRLHEVLASRT------KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID 118
+H V+ L +V S Y+++ ++ KI+ H LSE + + Q++
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLC 128
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
G+ Y HS G+ HRDLKP NL ++ LKI DFGL+ + + T Y APEV
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEV 185
Query: 179 -LSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDLTTLYSKV 220
L+ YN D+WS G I+ ++ G F D LD T KV
Sbjct: 186 ILNWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 32/203 (15%)
Query: 15 IGEGTFAKVKFAQ-NTETGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+G+G+F V+ + +T G+ VA+K L +S + M D + +E +IM + H ++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFL-KEAAIMHSLDHENLIR 60
Query: 72 LHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
L+ V+ + + ++ E G L D + G S Y Q+ +G+ Y SK
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 130 HRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYV------------AP 176
HRDL N+LL S +KI DFGL ALP+ +YV AP
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQ----------NEDHYVMEEHLKVPFAWCAP 169
Query: 177 EVLSHKGYNGAAADVWSCGVILY 199
E L + ++ A+DVW GV L+
Sbjct: 170 ESLRTRTFS-HASDVWMFGVTLW 191
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-20
Identities = 55/193 (28%), Positives = 99/193 (51%), Gaps = 8/193 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK--REISIMKLVRHPCVVRL 72
+GEGT+A V ++ T VA+K + ++H+ RE+S++K ++H +V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRL-SESEARRYFQQLIDGVDYCHSKGVYHR 131
H+++ + + ++ E++ +L + G + + + QL+ G++YCH + V HR
Sbjct: 70 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKP+NLL++ +G LK++DFGL+ T Y P++L D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188
Query: 192 WSCGVILYVLIAG 204
W G I Y + G
Sbjct: 189 WGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-20
Identities = 72/261 (27%), Positives = 116/261 (44%), Gaps = 19/261 (7%)
Query: 9 YEVGRT-------IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+E+ RT +G G + +V + +VA+K L + ++ +E ++M
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVM 56
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQ---QLID 118
K ++HP +V+L V YII EF+T G L D + R E A Q+
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISS 115
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPE 177
++Y K HRDL N L+ +K++DFGLS L P + APE
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 178 VLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGA 235
L++ ++ +DVW+ GV+L+ + G P+ +DL+ +Y +EK P P
Sbjct: 176 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKV 234
Query: 236 KSLIHRILDPNPETRITIEEI 256
L+ NP R + EI
Sbjct: 235 YELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-20
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR--SAIIKHKMADQIKREISIMKLVR 65
+Y+ +G G + V A +T + VA+K L R ++I A + RE+ ++K ++
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH---ARRTYRELRLLKHMK 72
Query: 66 HPCVVRLHEVLASRT------KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDG 119
H V+ L +V T ++Y++ + G + IV +LS+ + QL+ G
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
+ Y HS G+ HRDLKP N+ ++ L+I DFGL+ Q + T Y APE++
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEIM 187
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPF 208
+ + D+WS G I+ L+ G F
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-20
Identities = 74/270 (27%), Positives = 126/270 (46%), Gaps = 29/270 (10%)
Query: 13 RTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
R +GEG F KV+ + TGE VA+K L + H +AD +K+EI I++ + H
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-IAD-LKKEIEILRNLYHEN 67
Query: 69 VVRLHEVLASR--TKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHS 125
+V+ + I +I+EF+ G L + + + +++ + +Y Q+ G+DY S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPE--QGVSLLRTTCGTPNY-VAPEVLSHK 182
+ HRDL N+L++S+ +KI DFGL+ E + ++ +P + APE L
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 183 GYNGAAADVWSCGVILYVLI----AGYLPFDE-----------LDLTTLYSKVEKAD-FS 226
+ A+DVWS GV LY L+ + P + +T L +E+
Sbjct: 188 KFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP 246
Query: 227 CPTWFPVGAKSLIHRILDPNPETRITIEEI 256
P P L+ + + P R T + +
Sbjct: 247 RPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-20
Identities = 61/212 (28%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G G F VK+ + VA+K++ ++ + D+ E +M + H +V+L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQL 64
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHR 131
+ V + IYI+ E+++ G L + + HG R S+ + + +G+ Y SK HR
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 132 DLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAA 189
DL N L+D QG +K+SDFGLS L ++ S + + + PEVL + ++ + +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLLYSKFS-SKS 182
Query: 190 DVWSCGVILY-VLIAGYLPFDELDLTTLYSKV 220
DVW+ GV+++ V G +P++ + + KV
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-20
Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
+YE IGEG + KV A++ + G VA+K + R + M RE+++++ +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 66 --HPCVVRLHEVLA-SRT----KIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQL 116
HP VVRL +V SRT K+ ++ E + DK+ G +E+ + QL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKDMMFQL 119
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+ G+D+ HS V HRDLKP+N+L+ S G +K++DFGL+ + L + T Y AP
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRAP 178
Query: 177 EVLSHKGYNGAAADVWSCGVIL 198
EVL Y D+WS G I
Sbjct: 179 EVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-20
Identities = 77/263 (29%), Positives = 125/263 (47%), Gaps = 40/263 (15%)
Query: 14 TIGEGTFAKVKFAQNTETGESVAMKV--LDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+G G V A + T +A+KV LD I ++ QI E+ I+ P ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLD----ITVELQKQIMSELEILYKCDSPYIIG 63
Query: 72 LHEVLASRTKIYIILEFITGGEL--FDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKG 127
+ +I I EF+ GG L + KI H GR++ + ++ G+ Y S
Sbjct: 64 FYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA--------VVKGLTYLWSLK 115
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SLLRTTCGTPNYVAPEVLSHKGYNG 186
+ HRD+KP N+L++++G +K+ DFG+S Q V S+ +T GT Y+APE +S + Y G
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQY-G 171
Query: 187 AAADVWSCGVILYVLIAGYLPFDELD--------LTTLYSKVEKADFSCPTWFPVG--AK 236
+DVWS G+ L G P+ ++ L L V++ P PVG ++
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED----PPVLPVGQFSE 227
Query: 237 SLIHRI---LDPNPETRITIEEI 256
+H I + P+ R E +
Sbjct: 228 KFVHFITQCMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 9e-20
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 16/213 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR--SAIIKHKMADQIKREISIMKLVR 65
+Y+ +G G + V A +T+TG VA+K L R +II A + RE+ ++K ++
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMK 74
Query: 66 HPCVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDG 119
H V+ L +V +Y++ + G + IV +L++ + Q++ G
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
+ Y HS + HRDLKP NL ++ LKI DFGL+ + ++ T Y APE++
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---GYVATRWYRAPEIM 189
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+ + D+WS G I+ L+ G F D
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 9e-20
Identities = 80/333 (24%), Positives = 131/333 (39%), Gaps = 95/333 (28%)
Query: 8 KYEVGRTIGEGTFAKV-----------------KFAQNTETGESVAMKVLDRSAIIKHKM 50
KYE+ IG GT+ +V KF + E ++ SA
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ-----SAC----- 50
Query: 51 ADQIKREISIMKLVRHPCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHGR----- 103
REI++++ ++H VV L EV +Y++ ++ +L+ I H +
Sbjct: 51 -----REIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVS 104
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSAL--- 156
+ S + Q+++GV Y HS V HRDLKP N+L+ +G +KI D GL+ L
Sbjct: 105 IPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
Query: 157 PEQGVSLLRTTCGTPNYVAPEV-LSHKGYNGAAADVWSCGVILYVLIAGYLPF----DEL 211
P + ++ L T Y APE+ L + Y A D+W+ G I L+ F ++
Sbjct: 165 PLKPLADLDPVVVTIWYRAPELLLGARHYT-KAIDIWAIGCIFAELLTLEPIFKGREAKI 223
Query: 212 DLTTLYSK--VEK--------------------------ADFSCPT-WFPVGAK------ 236
+ + + +E+ DF T AK
Sbjct: 224 KKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHK 283
Query: 237 -------SLIHRILDPNPETRITIEEIRNDEWF 262
L+ ++L+ +P RIT EE +F
Sbjct: 284 KPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-19
Identities = 68/257 (26%), Positives = 119/257 (46%), Gaps = 20/257 (7%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+TIG+G F V G VA+K + A + +A E S+M +RH +V+L
Sbjct: 12 QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 64
Query: 73 HEVLAS-RTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVY 129
V+ + +YI+ E++ G L D + GR L ++ + + ++Y +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAA 188
HRDL N+L+ K+SDFGL+ + S + T P + APE L K ++
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALREKKFS-TK 179
Query: 189 ADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILDPN 246
+DVWS G++L+ + + G +P+ + L + +VEK P P ++ + +
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLD 239
Query: 247 PETRITIEEIRNDEWFR 263
TR + ++R E
Sbjct: 240 AATRPSFLQLR--EQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-19
Identities = 72/257 (28%), Positives = 106/257 (41%), Gaps = 22/257 (8%)
Query: 13 RTIGEGTFAKVKFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G G F V VA+K L + I K + RE S+M + HPC+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
VRL V + +++E G L + + S+ + Q+ G+ Y SK
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT--P-NYVAPEVL-----SH 181
HRDL N+LL ++ KISDFG+S G R T P + APE + S
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 182 KGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLI 239
K DVWS GV L+ G P+ E+ + + +E + P P S++
Sbjct: 178 KS------DVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIM 231
Query: 240 HRILDPNPETRITIEEI 256
PE R T E+
Sbjct: 232 LSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 12/228 (5%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISI 60
K + E + +G G F V GE VA+KVL K +I E +
Sbjct: 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYV 62
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDG 119
M V HP VVRL + S + +I + + G L D + +H + + Q+ G
Sbjct: 63 MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPE 177
+ Y K + HRDL N+L+ + H+KI+DFGL+ L + G P ++A E
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 178 VLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD 224
+ H+ Y +DVWS GV ++ L+ G P++ + + +EK +
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-19
Identities = 68/253 (26%), Positives = 119/253 (47%), Gaps = 16/253 (6%)
Query: 13 RTIGEGTFAKV--KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70
+ +G G F +V + VA+K L + ++ + E ++MK ++HP +V
Sbjct: 12 KKLGAGQFGEVWMGYYNGHT---KVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLV 64
Query: 71 RLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
RL+ V+ ++ IYII E++ G L D K +L+ ++ Q+ +G+ + K
Sbjct: 65 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGA 187
HRDL+ N+L+ KI+DFGL+ L E R P + APE +++ G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTI 182
Query: 188 AADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILDP 245
+DVWS G++L ++ G +P+ + + +E+ P P L+
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKE 242
Query: 246 NPETRITIEEIRN 258
PE R T E +R+
Sbjct: 243 KPEERPTFEYLRS 255
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-19
Identities = 60/224 (26%), Positives = 113/224 (50%), Gaps = 29/224 (12%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
G +E+ +G GT+ +V ++ +TG+ A+KV+D + ++IK+EI+++K H
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 67 PCVVRLHEVLAS-------------RTKIYIILEFITGGELFDKIVH-HGRLSESEARRY 112
H +A+ ++++++EF G + D I + G + E Y
Sbjct: 62 ------HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 115
Query: 113 F-QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
++++ G+ + H V HRD+K +N+LL +K+ DFG+SA ++ V T GTP
Sbjct: 116 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 175
Query: 172 NYVAPEVLSHKGYNGAA----ADVWSCGVILYVLIAGYLPFDEL 211
++APEV++ A +D+WS G+ + G P ++
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-19
Identities = 57/215 (26%), Positives = 108/215 (50%), Gaps = 17/215 (7%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVR 65
G +E+ +G GT+ +V ++ +TG+ A+KV+D + ++IK EI+++K
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 66 HPCVVRLHEVLASRT------KIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLI 117
H + + ++ ++++++EF G + D K L E ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177
G+ + H+ V HRD+K +N+LL +K+ DFG+SA ++ V T GTP ++APE
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191
Query: 178 VLSHKGYNGAA----ADVWSCGVILYVLIAGYLPF 208
V++ A +D+WS G+ + G P
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 84/324 (25%), Positives = 134/324 (41%), Gaps = 80/324 (24%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ + IG G V A +T G +VA+K L R A + RE+ ++K V H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHK 80
Query: 68 CVVRLHEVLASRTK------IYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLI 117
++ L V + +Y+++E + +++H H R+S Q++
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMS-----YLLYQML 133
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-------- 169
G+ + HS G+ HRDLKP N+++ S LKI DFGL+ RT C
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----------RTACTNFMMTPYV 183
Query: 170 -TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV------EK 222
T Y APEV+ GY D+WS G I+ L+ G + F D ++KV
Sbjct: 184 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242
Query: 223 ADFSC-------------------------PTW-FPVG----------AKSLIHRILDPN 246
A+F P W FP A+ L+ ++L +
Sbjct: 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID 302
Query: 247 PETRITIEEIRNDEWFRKGYVPVK 270
P+ RI+++E + Y P +
Sbjct: 303 PDKRISVDEALRHPYITVWYDPAE 326
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 4e-19
Identities = 54/179 (30%), Positives = 97/179 (54%), Gaps = 14/179 (7%)
Query: 45 IIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR 103
IIK K + I E + +L++ +P ++L+ + + +I+++I G+LFD + G+
Sbjct: 48 IIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK 105
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVS 162
LSE+E ++ +QL++ ++ H + H D+K EN+L D ++ + + D+GL S
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTPS 164
Query: 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD-----ELDLTTL 216
GT +Y +PE + Y+ + D W+ GV+ Y L+ G PF ELDL +L
Sbjct: 165 CYD---GTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219
|
Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-19
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G G F V + VA+K ++ A+ + + E +M + HP +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQL 64
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
+ V + +YI+ EF+ G L + + G+LS+ Q + +G++Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 132 DLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTP---NYVAPEVLSHKGYNG 186
DL N L+ S G +K+SDFG++ L ++ S + G + PEV + Y+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS----SSGAKFPVKWSPPEVFNFSKYS- 179
Query: 187 AAADVWSCGVILY-VLIAGYLPFD 209
+ +DVWS GV+++ V G +PF+
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-18
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 13 RTIGEGTFAKVKFA-QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+ +G G F +V N T VA+K L + E ++MK ++H +VR
Sbjct: 12 KKLGAGQFGEVWMGYYNNST--KVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVR 65
Query: 72 LHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
L+ V+ IYII E++ G L D K G++ + + Q+ +G+ Y K
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAA 188
HRDL+ N+L+ KI+DFGL+ + E R P + APE ++ +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IK 184
Query: 189 ADVWSCGVILYVLIA-GYLPF 208
+DVWS G++LY ++ G +P+
Sbjct: 185 SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-18
Identities = 71/231 (30%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ + IG G V A + +VA+K L R A + RE+ +MK V H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHK 83
Query: 68 CVVRLHEVLASRTK------IYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDG 119
++ L V + +YI++E + ++ + H R+S Q++ G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 138
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEV 178
+ + HS G+ HRDLKP N+++ S LKI DFGL+ G S + T T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV-EKADFSCP 228
+ GY D+WS G I+ +I G + F D ++KV E+ CP
Sbjct: 197 ILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 74/258 (28%), Positives = 118/258 (45%), Gaps = 26/258 (10%)
Query: 13 RTIGEGTFAKVKFAQNTETGES-VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+ +G G F +V T G + VA+K L + + E IMK +RH +V+
Sbjct: 12 KKLGNGQFGEV--WMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQ 65
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRY-FQQLID-------GVDYC 123
L+ V+ S IYI+ E+++ G L D L + E R L+D G+ Y
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHK 182
HRDL+ N+L+ KI+DFGL+ L E R P + APE +
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 177
Query: 183 GYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240
G +DVWS G++L L+ G +P+ ++ + +VE+ CP P+ L+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237
Query: 241 RILDPNPETRITIEEIRN 258
+ +PE R T E +++
Sbjct: 238 QCWKKDPEERPTFEYLQS 255
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 8 KYEVGRTIGEGTFAKV--KFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMK 62
K + R +G+G+F V A+ GE VA+K ++ +A ++ ++ + E S+MK
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFD-------KIVHHGRLSESEARRYFQ- 114
VVRL V+++ +++E + G+L + ++ L +++ Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 115 --QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ-------GVSLLR 165
++ DG+ Y +K HRDL N ++ +KI DFG++ + G LL
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL- 183
Query: 166 TTCGTP-NYVAPEVLSHKGYNGAAADVWSCGVILY 199
P ++APE L G +DVWS GV+L+
Sbjct: 184 -----PVRWMAPESLK-DGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-18
Identities = 68/234 (29%), Positives = 109/234 (46%), Gaps = 19/234 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ + IG G V A + +VA+K L R A + RE+ +MK V H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHK 76
Query: 68 CVVRLHEVLASRTK------IYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDG 119
++ L V + +Y+++E + ++ + H R+S Q++ G
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 131
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEV 178
+ + HS G+ HRDLKP N+++ S LKI DFGL+ G S + T T Y APEV
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV-EKADFSCPTWF 231
+ GY D+WS G I+ ++ + F D ++KV E+ CP +
Sbjct: 190 ILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-17
Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 16/240 (6%)
Query: 13 RTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ IG G F +V + G+ VA+K L A K E SIM HP +
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ L V+ + I+ E++ G L D + H G+ + + + + G+ Y G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP---NYVAPEVLSHKGY 184
HRDL N+L++S K+SDFGLS + E TT G + APE ++++ +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
+A+DVWS G++++ V+ G P+ E+ + +E+ + P P+ + +H+++
Sbjct: 187 T-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPA--PMDCPAALHQLM 242
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-17
Identities = 74/249 (29%), Positives = 113/249 (45%), Gaps = 12/249 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V T + VA+K L + M + +E IMK +RH +V L+
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 75 VLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
V+ S IYI+ EF+ G L D K L + Q+ DG+ Y HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAAADV 191
L+ N+L+ KI+DFGL+ L E R P + APE + G +DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDV 186
Query: 192 WSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILDPNPET 249
WS G++L L+ G +P+ + + +VE+ CP P L+ +P+
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDE 246
Query: 250 RITIEEIRN 258
R T E I++
Sbjct: 247 RPTFEYIQS 255
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 4/172 (2%)
Query: 46 IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLS 105
IK + +QI RE+ ++ P +V + S +I I +E + GG L + GR+
Sbjct: 42 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 101
Query: 106 ESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164
E + +I G+ Y K + HRD+KP N+L++S+G +K+ DFG+S + S+
Sbjct: 102 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMA 159
Query: 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
+ GT +Y++PE L Y+ +D+WS G+ L + G P D L
Sbjct: 160 NSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+ +G G F V + VA+K++ A+ + D E +M + HP +V+
Sbjct: 9 LKELGSGQFGVVHLGK-WRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQ 63
Query: 72 LHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
L+ V + I+I+ E++ G L + + G+L + + ++Y S G H
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123
Query: 131 RDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTP---NYVAPEVLSHKGYN 185
RDL N L+ +K+SDFGL+ L +Q S + GT + PEV + ++
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS----SQGTKFPVKWAPPEVFDYSRFS 179
Query: 186 GAAADVWSCGVILY-VLIAGYLPFD 209
+ +DVWS GV+++ V G +P++
Sbjct: 180 -SKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
Y V +T+ G+ +V A + V +K+ + + M +++ V HP
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM---------LLQNVNHPS 118
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKG 127
V+R+ + L S ++L + +L+ + L +A +Q+++G+ Y H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ HRD+K EN+ ++ + I D G + P + L GT APEVL+ YN +
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-GLAGTVETNAPEVLARDKYN-S 235
Query: 188 AADVWSCGVILYVLIA 203
AD+WS G++L+ ++A
Sbjct: 236 KADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-17
Identities = 67/252 (26%), Positives = 116/252 (46%), Gaps = 7/252 (2%)
Query: 10 EVGRTIGEGTFAKV-KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+GR IGEG F V + + E +A+ V + ++ +E IM+ HP
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L V+ + ++I++E GEL + V+ L + Y QL + Y SK
Sbjct: 69 IVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNG 186
HRD+ N+L+ S +K+ DFGLS E + P ++APE ++ + +
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT- 186
Query: 187 AAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILD 244
+A+DVW GV ++ +L+ G PF + + ++E + P P SL+ +
Sbjct: 187 SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 246
Query: 245 PNPETRITIEEI 256
+P R E+
Sbjct: 247 YDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 6/203 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G G V Q+ +G +A K++ IK + +QI RE+ ++ P +V +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDL 133
S +I I +E + GG L + R+ E + ++ G+ Y K + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193
KP N+L++S+G +K+ DFG+S + S+ + GT +Y++PE L Y+ +D+WS
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWS 187
Query: 194 CGVILYVLIAGYLPFDELDLTTL 216
G+ L L G P D L
Sbjct: 188 MGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 66/256 (25%), Positives = 119/256 (46%), Gaps = 22/256 (8%)
Query: 13 RTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+ +G G F +V A N T VA+K + ++ E ++MK ++H +V+
Sbjct: 12 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKLVK 65
Query: 72 LHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
LH V+ ++ IYII EF+ G L D K + + + Q+ +G+ + +
Sbjct: 66 LHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAA 188
HRDL+ N+L+ + KI+DFGL+ + E R P + APE ++ +
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IK 183
Query: 189 ADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-----DFSCPTWFPVGAKSLIHRI 242
+DVWS G++L ++ G +P+ + + +E+ +CP +++ R
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL----YNIMMRC 239
Query: 243 LDPNPETRITIEEIRN 258
PE R T E I++
Sbjct: 240 WKNRPEERPTFEYIQS 255
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-17
Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 25/270 (9%)
Query: 9 YEVGRTIGEGTFAKVKFAQ---NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+ +GR +G+G F V+ AQ + + VA+K+L ++ I ++ RE + MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 66 HPCVVRLHEV-LASRTK-----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID- 118
HP V++L V L SR K +IL F+ G+L ++ R+ E Q L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM-SRIGEEPFTLPLQTLVRF 118
Query: 119 ------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP- 171
G++Y SK HRDL N +L+ + ++DFGLS G R C +
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-DYYRQGCASKL 177
Query: 172 --NYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSC 227
++A E L+ Y +DVW+ GV ++ ++ G P+ ++ + +Y+ + K +
Sbjct: 178 PVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236
Query: 228 PTWFPVGAKSLIHRILDPNPETRITIEEIR 257
P L+ + P P+ R + + +R
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLR 266
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-17
Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 20/242 (8%)
Query: 13 RTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ IG G F +V K E +VA+K L K E SIM H
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEV--AVAIKTL--KPGYTEKQRQDFLSEASIMGQFSHH 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHS 125
++RL V+ II E++ G L DK + H G S + + + G+ Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP---NYVAPEVLSHK 182
HRDL N+L++S K+SDFGLS + E TT G + APE ++++
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 183 GYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHR 241
+ +A+DVWS G++++ V+ G P+ ++ + + F P P+ S +++
Sbjct: 186 KFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPA--PMDCPSAVYQ 241
Query: 242 IL 243
++
Sbjct: 242 LM 243
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 38/236 (16%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+ +Y++ R IG+G +V A + VA+K + + + RE I +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGEL--FDKIV---------HHGRLSESEARRYFQ 114
HP +V ++ + + +Y + +I G L K V + S F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL-------------SALPEQGV 161
++ ++Y HSKGV HRDLKP+N+LL G + I D+G + E+ +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 162 SLLRTT-----CGTPNYVAPEVLSHKGYNGAAA----DVWSCGVILYVLIAGYLPF 208
T GTP+Y+APE L G A D+++ GVILY ++ P+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLL-----GVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-16
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG G F V E + VA+K + A+ + + E +M + HP +V+L+
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 75 VLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
V R+ I ++ EF+ G L D + G+ S+ + +G+ Y S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 134 KPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTP---NYVAPEVLSHKGYNGAA 188
N L+ +K+SDFG++ L +Q S + GT + +PEV S Y+ +
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTS----STGTKFPVKWSSPEVFSFSKYS-SK 181
Query: 189 ADVWSCGVILY-VLIAGYLPFD 209
+DVWS GV+++ V G P++
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-16
Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 46 IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRL 104
IK + +QI RE+ ++ P +V + S +I I +E + GG L D+++ GR+
Sbjct: 38 IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 96
Query: 105 SESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
E+ + ++ G+ Y K + HRD+KP N+L++S+G +K+ DFG+S + S+
Sbjct: 97 PENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSM 154
Query: 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDLTTLYSKV 220
+ GT +Y++PE L Y +D+WS G+ L + G P D +L ++ +
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP 213
Query: 221 EKADFSCPTWFPVG 234
+ + PV
Sbjct: 214 VSEGEAKESHRPVS 227
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-16
Identities = 66/258 (25%), Positives = 113/258 (43%), Gaps = 25/258 (9%)
Query: 13 RTIGEGTFAKV-KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
R +G G F +V + N T VA+K L + E IMK +RHP +++
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQ 65
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARR-YFQQLID-------GVDYC 123
L+ V IYI+ E + G L + L R QLID G+ Y
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLE------YLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHK 182
++ HRDL N+L+ K++DFGL+ + ++ + R P + APE +
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 183 GYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240
++ +DVWS G++L ++ G +P+ + + +V++ CP P ++
Sbjct: 180 RFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238
Query: 241 RILDPNPETRITIEEIRN 258
+P+ R T E ++
Sbjct: 239 DCWKEDPDDRPTFETLQW 256
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-16
Identities = 69/248 (27%), Positives = 110/248 (44%), Gaps = 12/248 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V T VA+K L + + +E +MK +RH +V+L+
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 75 VLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
V+ S IYI+ E+++ G L D K L + Q+ G+ Y HRD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAAADV 191
L+ N+L+ K++DFGL+ L E R P + APE + G +DV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDV 186
Query: 192 WSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILDPNPET 249
WS G++L L G +P+ + + +VE+ CP P L+ + PE
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 246
Query: 250 RITIEEIR 257
R T E ++
Sbjct: 247 RPTFEYLQ 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
Y++G IG G+F V A +T E VA+K + + K+ RE+ IMK + H
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-------RELLIMKNLNHIN 120
Query: 69 VVRLHE------VLASRTKIY--IILEFITGGELFDKIVHHGRLSESE----ARRYFQQL 116
++ L + + I+ +++EFI + + H+ R + + + Y QL
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGH-LKISDFGLSALPEQGVSLLRTTCGTPNYVA 175
+ Y HSK + HRDLKP+NLL+D H LK+ DFG + G + C + Y A
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC-SRFYRA 238
Query: 176 PEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
PE++ D+WS G I+ +I GY F
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 15 IGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+GEG F KV + + SVA+K L +A K + + ++E +M ++HP +
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQ--------------- 114
V L V ++ E++ G+L + +V + S+ A +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 115 -QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL-------PEQGVSLLRT 166
Q+ G++Y S HRDL N L+ +KISDFGLS Q SLL
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
++ PE + + G +D+WS GV+L+
Sbjct: 191 -----RWMPPEAILY-GKFTTESDIWSFGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-15
Identities = 65/240 (27%), Positives = 117/240 (48%), Gaps = 18/240 (7%)
Query: 15 IGEGTFAKVKFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
IG G F +V + G+ VA+K L +S + + D + E SIM HP ++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLS-EASIMGQFDHPNIIH 69
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
L V+ + II EF+ G L D + + G+ + + + + G+ Y
Sbjct: 70 LEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT----CGTP-NYVAPEVLSHKGY 184
HRDL N+L++S K+SDFGLS E S T P + APE ++++ +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
+A+DVWS G++++ V+ G P+ ++ + + +E+ D+ P P+ + +H+++
Sbjct: 189 T-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPP--PMDCPTALHQLM 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+ +G+ +GEG F +V A+ N +VA+K+L A + ++D + E+ +MK
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVS-EMEMMK 70
Query: 63 LV-RHPCVVRLHEVLASRTKIYIILEFITGGELFD----------------KIVHHGRLS 105
++ +H ++ L V +Y+++E+ G L D L+
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 106 ESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165
+ + + Q+ G+++ SK HRDL N+L+ +KI+DFGL+ +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 166 TTCG-TP-NYVAPEVLSHKGYNGAAADVWSCGVILY 199
TT G P ++APE L + Y +DVWS GV+L+
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGES--VAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+YE G +G GT+ V A+ + + A+K ++ + I + REI++++ ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELK 56
Query: 66 HPCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHG---------RLSESEARRYFQ 114
HP V+ L +V S + K++++ ++ +L+ I H +L S +
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLY 115
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSAL---PEQGVSLLRTT 167
Q++DG+ Y H+ V HRDLKP N+L+ +G +KI+D G + L P + ++ L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLI 202
T Y APE+L + A D+W+ G I L+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 30/235 (12%)
Query: 11 VGRTIGEGTFAKVKFA-------QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+G+ +GEG F +V A + +VA+K+L +A K +AD I E+ +MKL
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-DLADLIS-EMELMKL 73
Query: 64 V-RHPCVVRLHEVLASRTKIYIILEFITGGEL---------------FDKI-VHHGRLSE 106
+ +H ++ L V +Y+I+E+ G L FD V +LS
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 107 SEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166
+ Q+ G++Y S+ HRDL N+L+ +KI+DFGL+ +T
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 167 TCG--TPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYS 218
+ G ++APE L + Y +DVWS G++++ + G P+ + + L+
Sbjct: 194 SNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 61/246 (24%), Positives = 117/246 (47%), Gaps = 16/246 (6%)
Query: 15 IGEGTFAKVK--FAQNTETGESVAMKVL---DRSAIIKHKMADQIKREISIMKLVRHPCV 69
+G G F VK + ++ ++VA+K+L + +K D++ RE ++M+ + +P +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALK----DELLREANVMQQLDNPYI 58
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
VR+ + + + + +++E G L + + ++E Q+ G+ Y
Sbjct: 59 VRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 130 HRDLKPENLLLDSQGHLKISDFGLS-ALPE-QGVSLLRTTCGTP-NYVAPEVLSHKGYNG 186
HRDL N+LL +Q + KISDFGLS AL + +T P + APE +++ ++
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS- 176
Query: 187 AAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILD 244
+ +DVWS GV+++ + G P+ + + +E + CP P L+
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236
Query: 245 PNPETR 250
+ R
Sbjct: 237 YGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 8 KYEVGRTIGEGTFAKV---------------KFAQNTETGESVAMKVLDRSAIIKHKMAD 52
+ V + G F K+ + +T G+ +++ + + A
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAI 208
Query: 53 QIKREISIMKLVRHPCVVRLHEVLASRTKIYII---LEFITGGELFDKIVH-HGRLSESE 108
Q++ EI + + H ++++ E+L S Y+I +F ++D+ R +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 109 ARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT- 167
R +QL+ V+Y H K + HRD+K EN+ L+ G + + DFG +A+P +
Sbjct: 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKEREAFDYG 327
Query: 168 -CGTPNYVAPEVLSHKGYNGAAADVWSCGVIL 198
GT +PE+L+ GY D+WSCG+IL
Sbjct: 328 WVGTVATNSPEILAGDGY-CEITDIWSCGLIL 358
|
Length = 501 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 74/275 (26%), Positives = 121/275 (44%), Gaps = 46/275 (16%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGES-----VAMKVLDRSAIIKHKMADQIKREISIM-KL 63
G+T+G G F KV A +S VA+K+L +A + A + E+ IM L
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA--LMSELKIMSHL 95
Query: 64 VRHPCVVRLHEVLASRTK---IYIILEFITGGELFDKIVHHGR---LSESEARRYFQQLI 117
H +V L L + T I +I E+ G+L + + R L+ + + Q+
Sbjct: 96 GNHENIVNL---LGACTIGGPILVITEYCCYGDLLN-FLRRKRESFLTLEDLLSFSYQVA 151
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHL-KISDFGLSALPEQGVSLLRTTCGTPNYV-- 174
G+ + SK HRDL N+LL + G + KI DFGL+ R NYV
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLL-THGKIVKICDFGLA----------RDIMNDSNYVVK 200
Query: 175 ----------APEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA 223
APE + + Y +DVWS G++L+ + + G P+ + + + + K+ K
Sbjct: 201 GNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 224 DF--SCPTWFPVGAKSLIHRILDPNPETRITIEEI 256
+ + P P ++ D +P R T ++I
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-14
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ--NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+YE G +G GT+ V A+ + + A+K ++ + I + REI++++ ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELK 56
Query: 66 HPCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHG---------RLSESEARRYFQ 114
HP V+ L +V S K++++ ++ +L+ I H +L +
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 115
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSAL---PEQGVSLLRTT 167
Q++DG+ Y H+ V HRDLKP N+L+ +G +KI+D G + L P + ++ L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLI 202
T Y APE+L + A D+W+ G I L+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-14
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKR---EISIMKLVRHPC--V 69
IG GT +V + +TG +A+K + R+ ++ KR ++ ++ L H C +
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-----NKEENKRILMDLDVV-LKSHDCPYI 76
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSK- 126
V+ + + + ++I +E + DK++ G + E + ++ + Y K
Sbjct: 77 VKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRT-TCGTPNYVAPEVLSHKGY 184
GV HRD+KP N+LLD+ G++K+ DFG+S L + S +T + G Y+APE +
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYMAPERIDPPDP 191
Query: 185 NGA---AADVWSCGVILYVLIAGYLPFDELD 212
N ADVWS G+ L L G P+
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-14
Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 22/268 (8%)
Query: 11 VGRTIGEGTFAKVKFAQNTETGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+G+T+GEG F V Q + VA+K + + + +M D + E MK HP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHPN 61
Query: 69 VVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI----- 117
V+RL V + +IL F+ G+L +++ RL + Q L+
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLY-SRLGDCPQYLPTQMLVKFMTD 120
Query: 118 --DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VSLLRTTCGTPNY 173
G++Y SK HRDL N +L+ ++ ++DFGLS G R +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWF 231
+A E L+ + Y +DVWS GV ++ + G P+ ++ + +Y + + + P
Sbjct: 181 IAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239
Query: 232 PVGAKSLIHRILDPNPETRITIEEIRND 259
G SL+ NP+ R + E +R +
Sbjct: 240 LDGLYSLMSSCWLLNPKDRPSFETLRCE 267
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F V GE VA+K L R A K +I E +M V +P
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REAT-SPKANKEILDEAYVMASVDNPH 70
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKG 127
V RL + + T + +I + + G L D + H + + Q+ G++Y +
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGYN 185
+ HRDL N+L+ + H+KI+DFGL+ L G P ++A E + H+ Y
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 186 GAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD 224
+DVWS GV ++ L+ G P+D + + + S +EK +
Sbjct: 190 -HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI-SIMKLVRHPCVVRLH 73
IG G F V + +G +A+K + RS + + + ++ ++ +M+ P +V+ +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQK-RLLMDLDVVMRSSDCPYIVKFY 69
Query: 74 EVLASRTKIYIILEFI-TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG----- 127
L +I +E + + F K V+ E ++++ + K
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 128 ----VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL---S 180
+ HRD+KP N+LLD G++K+ DFG+S ++ R P Y+APE + +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPERIDPSA 183
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
GY+ +DVWS G+ LY + G P+ + +
Sbjct: 184 RDGYD-VRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 50/228 (21%), Positives = 99/228 (43%), Gaps = 31/228 (13%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+G+ + V A++ T VA+K ++ + + +++EI + ++HP
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPN 60
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHS 125
++ +++Y++ + G D + H G L E + +++ +DY HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSA--------------LPEQGVSLLRTTCGTP 171
KG HR +K ++LL G + +S S P+ V L
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL------- 172
Query: 172 NYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+++PEVL +GYN +D++S G+ L G++PF ++ T +
Sbjct: 173 PWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 34/226 (15%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETG-----ESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+G+T+GEG F KV A +VA+K+L +A + E +++K
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD--LLSEFNLLK 58
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGEL-----FDKIVHHGRLSESEARR------ 111
V HP V++L+ + + +I+E+ G L + V L R
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 112 -------------YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA-LP 157
+ Q+ G+ Y + HRDL N+L+ +KISDFGLS +
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 158 EQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAAADVWSCGVILYVLI 202
E+ + R+ P ++A E L Y +DVWS GV+L+ ++
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 26/230 (11%)
Query: 15 IGEGTFAKVKFAQNTETGE--SVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
IGEG F +V A + G + A+K+L A E+ ++ KL HP ++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 72 LHEVLASRTKIYIILEFITGGELFDKI-------------VHHGRLSESEARRYFQQLID 118
L +R +YI +E+ G L D + HG S +++ Q D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 119 ---GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYV 174
G+ Y K HRDL N+L+ KI+DFGLS E V + +T P ++
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE--VYVKKTMGRLPVRWM 185
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA 223
A E L++ Y +DVWS GV+L+ +++ G P+ + LY K+ +
Sbjct: 186 AIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-13
Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS-----IMKLVRHPCV 69
IGEG F +V A+ + G +++ +K + R+ + + KL HP +
Sbjct: 3 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIV-------------HHGRLSESEAR---RYF 113
+ L R +Y+ +E+ G L D + + S ++ +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-N 172
+ G+DY K HRDL N+L+ KI+DFGLS E V + +T P
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--VYVKKTMGRLPVR 176
Query: 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA 223
++A E L++ Y +DVWS GV+L+ +++ G P+ + LY K+ +
Sbjct: 177 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-13
Identities = 60/242 (24%), Positives = 102/242 (42%), Gaps = 22/242 (9%)
Query: 13 RTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +G G F ++ K E VA+ L K + E + H
Sbjct: 11 RILGTGRFGELCRGCLKLPSKREL--PVAIHTLRAGCSDKQRRG--FLAEALTLGQFDHS 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHS 125
+VRL V+ + I+ E+++ G L D + H G+L + L G+ Y
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHK 182
G H+ L +L++S KIS F L E + TT + V APE + +
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY- 182
Query: 183 GYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHR 241
+ +A+DVWS G++++ V+ G P+ ++ + VE F P P +L+H+
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPA--PRNCPNLLHQ 239
Query: 242 IL 243
++
Sbjct: 240 LM 241
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-13
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 12/205 (5%)
Query: 35 VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94
VA+KVL + + D++ RE IM + +P +VR+ V + + +++E +GG L
Sbjct: 25 VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPL 81
Query: 95 FDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152
+K + + ++ S Q+ G+ Y K HRDL N+LL +Q + KISDFG
Sbjct: 82 -NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFG 140
Query: 153 LS-AL-PEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPF 208
LS AL + R+ P + APE ++ + ++ + +DVWS G+ ++ G P+
Sbjct: 141 LSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPY 199
Query: 209 DELDLTTLYSKVEKAD-FSCPTWFP 232
++ + S +E+ CP P
Sbjct: 200 KKMKGPEVMSFIEQGKRLDCPAECP 224
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 25/263 (9%)
Query: 14 TIGEGTFAKVKFAQNTETGES-----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
T+G G F +V A+ E V +K L ++ + + +RE+ + + + H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKN 69
Query: 69 VVRLHEVLASRTKIYIILEFITGGEL---------FDKIVHHGRLSESEARRYFQQLIDG 119
VVRL + Y+ILE+ G+L D+ + LS + Q+ G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP-EQGVSLLRTTCGTPNYVAPEV 178
+D+ + HRDL N L+ SQ +K+S LS LR ++APE
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 179 LSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKS 237
+ ++ +DVWS GV+++ V G LPF L + ++++ P P G S
Sbjct: 190 VQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV--PEGCPS 246
Query: 238 LIHRIL----DPNPETRITIEEI 256
+++++ NP+ R + E+
Sbjct: 247 RLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 30/234 (12%)
Query: 11 VGRTIGEGTFAKVKFAQNTETGES-------VAMKVLDRSAIIKHKMADQIKREISIMKL 63
+G+ +GEG F +V A+ + VA+K+L A K ++D I E+ +MK+
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDLIS-EMEMMKM 79
Query: 64 V-RHPCVVRLHEVLASRTKIYIILEFITGGELFDKI----------------VHHGRLSE 106
+ +H ++ L +Y+I+E+ + G L + + V +LS
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 107 SEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166
+ Q+ G++Y SK HRDL N+L+ +KI+DFGL+ +T
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 167 TCG--TPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
T G ++APE L + Y +DVWS GV+L+ + G P+ + + L+
Sbjct: 200 TNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHPC 68
EV +G G + V ++ TG +A+K + A + + ++ ++ I M+ V P
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPY 61
Query: 69 VVRLHEVLASRTKIYIILEFITGG--ELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHS 125
V + L ++I +E + + + K+ G + E + ++ ++Y HS
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 126 K-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SLLRTT-CGTPNYVAPE----V 178
K V HRD+KP N+L++ G +K+ DFG+S V S+ +T G Y+APE
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
L+ KGY+ +DVWS G+ + L G P+D
Sbjct: 179 LNQKGYD-VKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGESV----AMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F V GE+V A+K+L+ + K + + E IM + HP
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+VRL V S T I ++ + + G L D + H + + Q+ G+ Y +
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP--NYVAPEVLSHKGYN 185
+ HRDL N+L+ S H+KI+DFGL+ L E G ++A E + ++ +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 186 GAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD 224
+DVWS GV ++ L+ G P+D + + +EK +
Sbjct: 190 -HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 59/237 (24%), Positives = 111/237 (46%), Gaps = 30/237 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ-------NTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
K +G+ +GEG F +V A+ + +VA+K+L A K ++D + E+ +
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVS-EMEM 73
Query: 61 MKLV-RHPCVVRLHEVLASRTKIYIILEFITGGELFDKI----------------VHHGR 103
MK++ +H ++ L +Y+I+E+ + G L + + V +
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
++ + Q+ G++Y S+ HRDL N+L+ +KI+DFGL+
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193
Query: 164 LRTTCG--TPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
+TT G ++APE L + Y +DVWS GV+++ + G P+ + + L+
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-12
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F V GE+ VA+KVL + K +I E +M V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPY 70
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKG 127
V RL + + T + ++ + + G L D + + R+ + + Q+ G+ Y
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGYN 185
+ HRDL N+L+ S H+KI+DFGL+ L + + G P ++A E + H+ +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 186 GAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD 224
+DVWS GV ++ L+ G P+D + + +EK +
Sbjct: 190 -HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 67/285 (23%), Positives = 105/285 (36%), Gaps = 51/285 (17%)
Query: 10 EVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIK--REISIMK 62
+ R +G G F +V VA+K L S D+ E IM
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMS 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--------LSESEARRYFQ 114
H +VRL V R +I+LE + GG+L + R L+ + +
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGL-------SALPEQGVSLL 164
+ G Y HRD+ N LL +G KI+DFG+ S + G ++L
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPF------DELDLTTLY 217
++ PE G + DVWS GV+L+ + GY+P+ + ++ T
Sbjct: 184 PI-----KWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237
Query: 218 SKVEKADFSCPTWFPVGAKSLIHRILDPNPETR---ITIEEIRND 259
+++ P P ++ PE R TI E
Sbjct: 238 GRLDP-----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 30/237 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ-------NTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
+ +G+ +GEG F +V A+ +VA+K+L A K ++D + E+ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-DLSDLVS-EMEM 70
Query: 61 MKLV-RHPCVVRLHEVLASRTKIYIILEFITGGEL---------------FDKI-VHHGR 103
MK++ +H ++ L +Y+++E+ + G L FD + +
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
L+ + Q+ G++Y S+ HRDL N+L+ +KI+DFGL+
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 164 LRTTCG--TPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
+TT G ++APE L + Y +DVWS GV+L+ + G P+ + + L+
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 28/228 (12%)
Query: 15 IGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVV 70
IGEG F +V A+ + G ++ ++ + ++ H+ E+ ++ KL HP ++
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 71
Query: 71 RLHEVLASRTKIYIILEFITGGELFD--------------KIVHH--GRLSESEARRYFQ 114
L R +Y+ +E+ G L D I + LS + +
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NY 173
+ G+DY K HRDL N+L+ KI+DFGLS Q V + +T P +
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRW 189
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKV 220
+A E L++ Y +DVWS GV+L+ +++ G P+ + LY K+
Sbjct: 190 MAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 11 VGRTIGEGTFAKVKFAQ-NTETGES--VAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+G+ +GEG F V Q + + G VA+K + + I + ++ E + MK HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 68 CVVRLHEV---LASRTKI---YIILEFITGGELFDKIVHHGRLSESEARRYFQQLID--- 118
V++L V +S KI +IL F+ G+L +++ RL + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY-SRLGGLPEKLPLQTLLKFMV 120
Query: 119 ----GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP--- 171
G++Y ++ HRDL N +L + ++DFGLS G R
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPV 179
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPF 208
++A E L+ + Y + +DVW+ GV ++ + G P+
Sbjct: 180 KWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 46/278 (16%)
Query: 13 RTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +GEG F KV + E VA+K L +A + +RE ++ +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHE 68
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG--------------RLSESEARRYF 113
+V+ + V ++ E++ G+L + HG L+ S+ +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY 173
Q+ G+ Y S+ HRDL N L+ +KI DFG+S R T Y
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS----------RDVYTTDYY 178
Query: 174 ------------VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKV 220
+ PE + ++ + +DVWS GV+L+ + G P+ L + +
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
Query: 221 EKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIR 257
+ P P ++ +P+ RI I++I
Sbjct: 238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 17 EGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKR---EISIMKLVRHPCVVR-L 72
EGTF ++ + + +V + + H Q+ E ++ + H ++ L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVK-TVKDHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 73 HEVLASRTKIYIILEFITGGEL--FDKIVHHGRLSESEARRYFQ------QLIDGVDYCH 124
H + +++ ++ G L F + G + +A Q Q+ G+ Y H
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
+GV H+D+ N ++D + +KI+D LS P L ++A E L +K
Sbjct: 135 KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK 194
Query: 183 GYNGAAADVWSCGVILYVLIA-GYLPFDELD 212
Y+ +A+DVWS GV+L+ L+ G P+ E+D
Sbjct: 195 EYS-SASDVWSFGVLLWELMTLGQTPYVEID 224
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-11
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 15 IGEG--TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
IG G V A+ TGE V ++ ++ A ++M ++ E+ + KL HP +V
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYH 130
+ +++++ F+ G D I H +SE Q ++ +DY H G H
Sbjct: 65 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH 124
Query: 131 RDLKPENLLLDSQGHLKISDF-GLSALPEQGVSLLRTTCGTPNY-------VAPEVLSH- 181
R +K ++L+ G + +S ++ G LR P Y ++PEVL
Sbjct: 125 RSVKASHILISVDGKVYLSGLRSNLSMINHG-QRLRVVHDFPKYSVKVLPWLSPEVLQQN 183
Query: 182 -KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
+GY+ A +D++S G+ L G++PF ++ T +
Sbjct: 184 LQGYD-AKSDIYSVGITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 63/272 (23%), Positives = 112/272 (41%), Gaps = 38/272 (13%)
Query: 15 IGEGTFAKVK----FAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70
+GE F K+ + + + VA+K L + + ++E S+M + HP +V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQEASLMAELHHPNIV 70
Query: 71 RLHEVLASRTKIYIILEFITGGELFDKIV-------------HHGRLSESEARRYFQ--- 114
L V+ + ++ E++ G+L + ++ G + S F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 115 -QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA-------LPEQGVSLLRT 166
Q+ G++Y S H+DL N+L+ Q H+KISD GLS Q SLL
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD- 224
++ PE + + ++ + +D+WS GV+L+ + + G P+ + V K
Sbjct: 191 -----RWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244
Query: 225 FSCPTWFPVGAKSLIHRILDPNPETRITIEEI 256
C P SL+ P R ++I
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 13 RTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +GEG F KV A+ + VA+K L ++ K RE ++ ++H
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK---DFHREAELLTNLQHE 67
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-------------RLSESEARRYFQ 114
+V+ + V + ++ E++ G+L + HG L++S+ Q
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTPN 172
Q+ G+ Y S+ HRDL N L+ +KI DFG+S + T
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 173 YVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDEL 211
++ PE + ++ + +DVWS GV+L+ + G P+ +L
Sbjct: 188 WMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 13 RTIGEGTFAKVKFAQNTE-----TGES-VAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+G G F +V T+ +G VA+K L + A + K + +E +M H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID-------G 119
P +V+L V YII+E + GG+L + ++L+D G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGH-----LKISDFGLSA-------LPEQGVSLLRTT 167
Y HRDL N L+ +G+ +KI DFGL+ ++G LL
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV- 177
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPF 208
++APE L + +DVWS GV+++ +L G P+
Sbjct: 178 ----RWMAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 8 KYEVGRTIGEGTFAKV--KFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMK 62
K + R +G+G+F V A++ GE+ VA+K ++ SA ++ ++ + E S+MK
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELF--------DKIVHHGRLSES--EARRY 112
VVRL V++ +++E + G+L + + GR + E +
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 113 FQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA-------LPEQGVSLLR 165
++ DG+ Y ++K HRDL N ++ +KI DFG++ + G LL
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
++APE L G ++D+WS GV+L+
Sbjct: 185 V-----RWMAPESLK-DGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 68/285 (23%), Positives = 114/285 (40%), Gaps = 42/285 (14%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
E R IG+G F +V A+ E VA+K+L A M +RE ++M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 62
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFD-------KIVHHGRLSESEARRYFQ 114
HP +V+L V A + ++ E++ G+L + + S S AR+
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 115 ---------------QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159
Q+ G+ Y + HRDL N L+ +KI+DFGLS +
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS----R 178
Query: 160 GVSLLRTTCGTPN------YVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELD 212
+ + N ++ PE + + Y +DVW+ GV+L+ + + G P+ +
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMA 237
Query: 213 LTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEI 256
+ V + SCP P+ +L+ P R + I
Sbjct: 238 HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 8/157 (5%)
Query: 56 REISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQ 115
REI I+K + H ++ L ++ + +++ +LF + G L +A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 116 LIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC----GTP 171
L++ + Y H +G+ HRD+K EN+ LD + + DFG A + C GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG--AACKLDAHPDTPQCYGWSGTL 251
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
+PE+L+ Y A D+WS G++L+ + +
Sbjct: 252 ETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 43/187 (22%), Positives = 82/187 (43%), Gaps = 14/187 (7%)
Query: 28 NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL- 86
+ +T E V +K R E I++ + HP +++L +IL
Sbjct: 113 DNKTCEHVVIKAGQRGGTAT---------EAHILRAINHPSIIQLKGTFTYNKFTCLILP 163
Query: 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHL 146
+ T +L+ + ++ + + ++ + Y H + HRD+K EN+ ++ G +
Sbjct: 164 RYKT--DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDV 221
Query: 147 KISDFGLSALP-EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY 205
+ DFG + P + + GT APE+L+ Y G A D+WS G++L+ + +
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
Query: 206 LPFDELD 212
E D
Sbjct: 281 DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-10
Identities = 64/269 (23%), Positives = 112/269 (41%), Gaps = 29/269 (10%)
Query: 13 RTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +GEG F KV A+ T+ VA+K L + K +RE ++ ++H
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQHE 67
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG----------------RLSESEARR 111
+V+ + V + ++ E++ G+L + HG L S+
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCG 169
Q+ G+ Y S+ HRDL N L+ + +KI DFG+S + T
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSC 227
++ PE + ++ + +DVWS GVIL+ + G P+ +L T + + +
Sbjct: 188 PIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 246
Query: 228 PTWFPVGAKSLIHRILDPNPETRITIEEI 256
P P ++ P+ R+ I+EI
Sbjct: 247 PRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 8e-10
Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 35/231 (15%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
++++ +GEGTF KV A + + E A+K++ K K EI M+ VR
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQ 184
Query: 67 P------CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI--- 117
++++ + T I+ G L D I+ HG S R+ Q+I
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH----RHLAQIIFQT 240
Query: 118 -DGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL----LRTTC--- 168
+DY H++ + H DLKPEN+L+++ + ALP + L C
Sbjct: 241 GVALDYFHTELHLMHTDLKPENILMET-SDTVVDPVTNRALPPDPCRVRICDLGGCCDER 299
Query: 169 -------GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
T +Y +PEV+ G+ + D+WS G I+Y L G L +D D
Sbjct: 300 HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHD 349
|
Length = 467 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 8 KYEVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
K + R +G+G+F V K E VA+K ++ +A ++ ++ + E S+MK
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFD-------KIVHHGRLSESEARRYFQ- 114
VVRL V++ +I+E +T G+L ++ ++ + ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 115 --QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-------ALPEQGVSLLR 165
++ DG+ Y ++ HRDL N ++ +KI DFG++ + G LL
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
+++PE L G +DVWS GV+L+
Sbjct: 185 V-----RWMSPESLK-DGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 60/246 (24%), Positives = 108/246 (43%), Gaps = 40/246 (16%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
E+GR G V A++T TG V +++ D + + ++ E+ + RHP +
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 70 VRLHEVLASRTKIYIILEFITGG---ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+ V + + +++I F+ G L G +SE+ + G++Y H
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR--------------TTCGTPN 172
G HR++K ++L+ G + +S GLS L SL+R +T P
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHL----YSLVRNGQKAKVVYDFPQFSTSVLP- 173
Query: 173 YVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL---------YSKVE 221
+++PE+L GYN +D++S G+ L G +PF ++ T + YS ++
Sbjct: 174 WLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232
Query: 222 KADFSC 227
F C
Sbjct: 233 ITTFPC 238
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 41/175 (23%), Positives = 67/175 (38%), Gaps = 29/175 (16%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGES----------------VAMKVLDRSAIIKHKM 50
+GEG F +V + + VA+KVL R +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAR 63
Query: 51 ADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL---------FDKIVHH 101
D +K E+ I+ + P + RL V + +I+E++ G+L +
Sbjct: 64 EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 102 GRLSESEARRYFQ--QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154
S S + + Q+ G+ Y S HRDL N L+ +KI+DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 40/172 (23%)
Query: 15 IGEGTFAKVKFAQ------------NTETGES--VAMKVLDRSAIIKHKMADQIKREISI 60
+GEG F +V + G+ VA+K+L R+ + K D +K EI I
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARNDFLK-EIKI 70
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQ------ 114
M +++P ++RL V S + +I E++ G+L + LS+ E F
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL------NQFLSQREIESTFTHANNIP 124
Query: 115 ------------QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154
Q+ G+ Y S HRDL N L+ + +KI+DFG+S
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 29/88 (32%), Positives = 49/88 (55%), Gaps = 3/88 (3%)
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTP 171
+QL+ +DY H +G+ HRD+K EN+L++ + + DFG + S GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILY 199
+ APEVL+ Y + D+WS G++++
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 51/221 (23%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS----IMKLVRHP 67
+ +G G F V G+S+ + V + I+ + Q +EI+ M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIK--TIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSK 126
+VRL + + ++ + G L D + H L + Q+ G+ Y
Sbjct: 70 YIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTP-NYVAPEVLSHKGY 184
+ HR+L N+LL S ++I+DFG++ L + TP ++A E + G
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI-LFGR 187
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD 224
+DVWS GV ++ +++ G P+ + + +EK +
Sbjct: 188 YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 72/264 (27%), Positives = 115/264 (43%), Gaps = 32/264 (12%)
Query: 13 RTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
R IG+G F V + A+K L+R I + +Q +E IMK HP V
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 70 VRLHEV-LASRTKIYIILEFITGGELFDKIVHHGRLSESEARR--------YFQQLIDGV 120
+ L + L S ++L ++ G+L + I SE + Q+ G+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFI-------RSETHNPTVKDLIGFGLQVAKGM 111
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGT-P-NYVAP 176
+Y SK HRDL N +LD +K++DFGL+ ++ S+ T P ++A
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIA-GYLPF---DELDLTTLYSKVEKADFSCPTWFP 232
E L + + +DVWS GV+L+ L+ G P+ D D+T + + P + P
Sbjct: 172 ESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR--LLQPEYCP 228
Query: 233 VGAKSLIHRILDPNPETRITIEEI 256
++ P PE R T E+
Sbjct: 229 DPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 54/242 (22%)
Query: 15 IGEGTFAKV--------------KFAQNTETGES--VAMKVLDRSAIIKHKMADQIKREI 58
+GEG F +V +F N G VA+K+L R K+ D +K E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLK-EV 70
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEAR-------- 110
I+ ++ P ++RL V + +I E++ G+L + H L + E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH-HLDDKEENGNDAVPPA 129
Query: 111 ------------RYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA--- 155
Q+ G+ Y S HRDL N L+ +KI+DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 156 ----LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY--VLIAGYLPFD 209
QG ++L ++A E + G A+DVW+ GV L+ +++ P+
Sbjct: 190 AGDYYRIQGRAVLPI-----RWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYG 243
Query: 210 EL 211
EL
Sbjct: 244 EL 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-08
Identities = 67/271 (24%), Positives = 105/271 (38%), Gaps = 39/271 (14%)
Query: 15 IGEGTFAKVKFAQNTETGESVA---MKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
IG G F KV G S A +K L SA ++ +E+ + + HP V++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVLQ 59
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEA------RRYFQQLIDGVDYCHS 125
++LEF G+L + R ++ +R ++ G+ + H
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDL-KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H DL N L + +KI D+GL PE ++APE++ +G
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 184 YNGAAAD------VWSCGVILYVLI-AGYLPFDEL-DLTTLYSKVEKADFSCPT------ 229
+ D +WS GV ++ L A P+ +L D L V + D P
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238
Query: 230 ----WFPVGAKSLIHRILDPNPETRITIEEI 256
W+ V + LD PETR T EE+
Sbjct: 239 YSDRWYEV----MQFCWLD--PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 15 IGEGTFAKV---------KFAQNTETGES-------VAMKVLDRSAIIKHKMADQIKREI 58
+GEG F +V KF + + VA+K+L R K+ D +K EI
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARNDFLK-EI 70
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-----------GRLSES 107
IM ++ P ++RL V + + +I E++ G+L + H +S S
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 108 EARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154
Q+ G+ Y S HRDL N L+ +KI+DFG+S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 56/246 (22%), Positives = 107/246 (43%), Gaps = 34/246 (13%)
Query: 15 IGEGTFAKVKFAQ--NTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+GE F KV T GE +VA+K L A + + ++ K E + ++HP +
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNI 70
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVH---HGRLSESEARRYFQ------------ 114
V L V+ + +I + + +L + +V H + ++ + +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 115 -QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTTCGTP 171
Q+ G+++ S V H+DL N+L+ + ++KISD GL L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-------GYLPFDELDLTTLYSKVEKAD 224
+++PE + + G +D+WS GV+L+ + + GY D +++ + D
Sbjct: 191 RWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD 249
Query: 225 FSCPTW 230
CP W
Sbjct: 250 -DCPAW 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 23/100 (23%)
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
Y Q+ G+++ S+ HRDL N+LL +KI DFGL+ R P
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDP 227
Query: 172 NYV------------APEVLSHKGYNGAAADVWSCGVILY 199
+YV APE + K Y +DVWS GV+L+
Sbjct: 228 DYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-07
Identities = 60/276 (21%), Positives = 110/276 (39%), Gaps = 48/276 (17%)
Query: 15 IGEGTFAKVKFAQNTETGES-----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+GEG F KV A+ VA+K L ++ +RE ++ +++H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHI 69
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHG---------------RLSESEARRYFQ 114
VR + V + ++ E++ G+L + HG +L+ +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY- 173
Q+ G+ Y S HRDL N L+ +KI DFG+S R T Y
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS----------RDIYSTDYYR 179
Query: 174 -----------VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVE 221
+ PE + ++ + +D+WS GV+L+ + G P+ +L T +
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 222 KA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEI 256
+ + P P +++ P+ R+ I++I
Sbjct: 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 26/161 (16%)
Query: 111 RYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170
R+ Q+ G+D+ SK HRD+ N+LL KI DFGL+ R
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA----------RDIMND 265
Query: 171 PNYV------------APEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
NYV APE + Y +DVWS G++L+ + + G P+ + + + +
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324
Query: 218 SKVEKADF--SCPTWFPVGAKSLIHRILDPNPETRITIEEI 256
K+ K + S P + P S++ + P R T +I
Sbjct: 325 YKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 23/100 (23%)
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
Y Q+ G+++ S+ HRDL N+LL +KI DFGL+ R P
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDP 228
Query: 172 NYV------------APEVLSHKGYNGAAADVWSCGVILY 199
+YV APE + K Y +DVWS GV+L+
Sbjct: 229 DYVRKGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 28/158 (17%)
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHL-KISDFGLSALPEQGVSLLRTTCGTPNY 173
Q+ G+ + SK HRDL N+LL + G + KI DFGL+ R NY
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILL-THGRITKICDFGLA----------RDIRNDSNY 270
Query: 174 V------------APEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKV 220
V APE + + Y +DVWS G++L+ + + G P+ + + + + K+
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329
Query: 221 EKADFS--CPTWFPVGAKSLIHRILDPNPETRITIEEI 256
K + P P ++ D +P R T ++I
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 14/111 (12%)
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL-------SALPEQGVSLLRTT 167
Q+ +G+++ SK HRDL N+L+ +KI DFGL S +G + L
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL- 305
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
++APE + + Y +DVWS G++L+ + G P+ EL + +
Sbjct: 306 ----KWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 19/39 (48%), Positives = 27/39 (69%)
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152
+Q++ G+ H G+ HRD+KPENLL+ G +KI DFG
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 32/100 (32%), Positives = 46/100 (46%), Gaps = 23/100 (23%)
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
Y Q+ G+++ S+ HRDL N+LL +KI DFGL+ R P
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDP 233
Query: 172 NYV------------APEVLSHKGYNGAAADVWSCGVILY 199
+YV APE + + Y +DVWS GV+L+
Sbjct: 234 DYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 49/251 (19%), Positives = 102/251 (40%), Gaps = 45/251 (17%)
Query: 32 GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLH----EVLASRTKIYIILE 87
+ V ++ + + D + EI ++ + +++++ +++ ++ +ILE
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY---------HRDLKPENL 138
+ T G L + + LS + +L +D C KG+Y +++L +
Sbjct: 103 YCTRGYLREVLDKEKDLS------FKTKLDMAIDCC--KGLYNLYKYTNKPYKNLTSVSF 154
Query: 139 LLDSQGHLKISDFGL----SALPEQGVSLLRTTCGTPNYVAPEVLSH--KGYNGAAADVW 192
L+ LKI GL S+ P + V+ + Y + ++L+ Y D++
Sbjct: 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMV-------YFSYKMLNDIFSEYT-IKDDIY 206
Query: 193 SCGVILYVLIAGYLPFDELDLTTLYSKV------EKADFSCPTWFPVGAKSLIHRILDPN 246
S GV+L+ + G +PF+ L +Y + K CP K ++ +
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEI----KCIVEACTSHD 262
Query: 247 PETRITIEEIR 257
R I+EI
Sbjct: 263 SIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 25/75 (33%), Positives = 38/75 (50%), Gaps = 12/75 (16%)
Query: 110 RRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVS------ 162
+ +Q++ +D HS G+ HRD+KP+N++ G KI D G +A G++
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEF 317
Query: 163 LLRTTCGTPNYVAPE 177
LL P Y APE
Sbjct: 318 LL-----DPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL-------SALPEQGVSLLRTT 167
Q+ G+++ SK HRDL N+LL +KI DFGL S +G + L
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV- 303
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL-TTLYSKVEKA-D 224
++APE + Y +DVWS G++L+ + + G P+ + + +T Y+K++
Sbjct: 304 ----KWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358
Query: 225 FSCPTWFPVGAKSLIHRILDPNPETR 250
+ P ++ + + PE R
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 33/212 (15%)
Query: 13 RTIGEGTFAKVKFAQ-NTE-TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70
+ IG G F KV + N+ T V +K L SA ++ +M + E + ++H ++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLL 58
Query: 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEA------RRYFQQLIDGVDYCH 124
+ T +++EF G+L + R +E +R ++ G+ + H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDL-KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSAL---------PEQGVSLLRTTCGTPNYVA 175
H DL N LL + +KI D+GLS P+Q LR ++A
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR-------WIA 170
Query: 176 PEVLSHKGYNGAAAD------VWSCGVILYVL 201
PE++ N D VWS GV ++ L
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 2/43 (4%)
Query: 169 GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF-DE 210
GTP+Y+APE+L K + G A D W+ GV L+ + G PF DE
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDE 583
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 36/168 (21%)
Query: 57 EISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSE-----SEARR 111
EI+ M ++HP +V+L + S Y+I E+I G LSE S RR
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG----------KNLSEVLRNLSWERR 782
Query: 112 YFQQLIDGVD------YCH-SKGVYHRDLKPENLLLDSQG--HLKISDFGLSALPEQGVS 162
+++ G+ +C S V +L PE +++D + HL++S LP G+
Sbjct: 783 --RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLS------LP--GLL 832
Query: 163 LLRTTCGTPN-YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
T C + YVAPE K +D++ G+IL L+ G P D
Sbjct: 833 CTDTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 52/245 (21%), Positives = 92/245 (37%), Gaps = 38/245 (15%)
Query: 34 SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGE 93
SV +KVL H+ + S+M + H +V+L+ V I ++ E++ G
Sbjct: 32 SVVLKVLGS----DHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGP 86
Query: 94 LFDKIVHHGRLSESEARRYF--QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH------ 145
L D +H + + S + +QL + Y K + H ++ +N+L+ G
Sbjct: 87 L-DVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVP 145
Query: 146 -LKISDFGLSALPEQGVSLLRTTCGTPNY-------VAPEVLSHKGYN-GAAADVWSCGV 196
+K+SD G + T + +APE + + + AAD WS G
Sbjct: 146 FIKLSDPG-----------IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGT 194
Query: 197 ILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIE 254
L + G P L + + P + LI++ +P R +
Sbjct: 195 TLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELAN--LINQCWTYDPTKRPSFR 252
Query: 255 EIRND 259
I D
Sbjct: 253 AILRD 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 35/124 (28%), Positives = 52/124 (41%), Gaps = 16/124 (12%)
Query: 92 GELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150
L D + GR L+E E Q + + H + K N+LL G LK+
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKLDG 54
Query: 151 FGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLP-FD 209
PEQ P ++APEV+ + Y AD++S G+ LY + LP +
Sbjct: 55 SVAFKTPEQSR-------PDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNE 106
Query: 210 ELDL 213
E +L
Sbjct: 107 EREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 65/268 (24%), Positives = 117/268 (43%), Gaps = 35/268 (13%)
Query: 14 TIGEGTFAKVKFAQNTETGE-------SVAMKVLDRSAIIKHK-MADQIKREISIMKLVR 65
++G+GTF K+ E G+ V +KVLD+S H+ ++ S+M +
Sbjct: 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLS 57
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYC 123
H +V + V + ++ E++ G L D + + ++ S +QL + +
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFL 116
Query: 124 HSKGVYHRDLKPENLLLDSQGH--------LKISDFGLS--ALPEQGVSLLRTTCGTPNY 173
KG+ H ++ +N+LL + +K+SD G+S LP++ + L R +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-ILLERIP-----W 170
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLT-TLYSKVEKADFSCPTWF 231
V PE + + AAD WS G L+ + G P LD L ++ P W
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWT 230
Query: 232 PVGAKSLIHRILDPNPETRITIEEIRND 259
+ +LI++ +D P+ R + I D
Sbjct: 231 ELA--NLINQCMDYEPDFRPSFRAIIRD 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 18/152 (11%)
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQL 116
S+M+ V H +V L+ V + ++ EF+ G L D +H L+ + +QL
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQL 114
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQG-------HLKISDFGLSALPEQGVSLLRTTC- 168
+ Y K + H ++ +N+LL +G +K+SD G+ L R C
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI-----TVLSRQECV 169
Query: 169 -GTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
P ++APE + AAD WS G L+
Sbjct: 170 ERIP-WIAPECVEDSKNLSIAADKWSFGTTLW 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 9e-04
Identities = 63/248 (25%), Positives = 97/248 (39%), Gaps = 45/248 (18%)
Query: 35 VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94
V +KVLD S +A S+M V H + +H V ++ ++ EF+ G L
Sbjct: 47 VVLKVLDPS---HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 95 FDKIVHHGRLSESEARRYF--QQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-------H 145
D + + A + QQL + Y K + H ++ +N+LL G
Sbjct: 104 -DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 146 LKISDFGLS--ALP-EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCG-VILYVL 201
+K+SD G+S AL E+ V + ++APE + AAD WS G +L +
Sbjct: 163 IKLSDPGVSFTALSREERVERI-------PWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215
Query: 202 IAGYLPFDELDLTTLYSKVEKADF----------SCPTWFPVGAKSLIHRILDPNPETRI 251
G +P E + EK F SC +LI + L P R
Sbjct: 216 FDGEVPLKE------RTPSEKERFYEKKHRLPEPSCKE-----LATLISQCLTYEPTQRP 264
Query: 252 TIEEIRND 259
+ I D
Sbjct: 265 SFRTILRD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.43 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.41 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.32 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.96 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.92 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.89 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.86 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.7 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.68 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.31 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.21 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.18 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.16 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.14 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.13 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.01 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.96 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.9 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.88 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.82 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.62 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.6 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.59 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.57 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.47 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.39 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.3 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.25 | |
| PLN02236 | 344 | choline kinase | 97.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.12 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.1 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.93 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.87 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.61 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.6 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.9 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.89 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.75 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.52 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.46 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.88 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.84 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.72 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-57 Score=396.33 Aligned_cols=266 Identities=36% Similarity=0.701 Sum_probs=254.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+|...+.||.|+|..||.+++..+|+.||+|++...........+.+.+|+++.+.++|||||+++++|++.++.|++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 67999999999999999999999999999999999988888888899999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|.|..++|..++++.++++|.+++.+++||+.||.|||+++|+|+|||..|+|++++.++|++|||++............
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999877777778
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
.+|+|.|+|||++...+.. ..+||||+||+||.|+.|++||+..+..+.+++|+..++.+|..++.++.+||.+||+++
T Consensus 178 lCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~ 256 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPN 256 (592)
T ss_pred ecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCC
Confidence 8999999999999988877 999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCcccccCcccccccc
Q 022444 247 PETRITIEEIRNDEWFRKGYVPVKLIE 273 (297)
Q Consensus 247 p~~Rps~~~il~~p~~~~~~~~~~~~~ 273 (297)
|.+|||++++|.|+||.+++.+.-...
T Consensus 257 P~~Rpsl~~vL~h~Ff~~g~~p~~lp~ 283 (592)
T KOG0575|consen 257 PSERPSLDEVLDHPFFKSGFTPARLPS 283 (592)
T ss_pred cccCCCHHHHhcCHhhhCCCcCCCCCc
Confidence 999999999999999988877665544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-57 Score=377.88 Aligned_cols=264 Identities=37% Similarity=0.684 Sum_probs=234.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH----HHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH----KMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||.++....... .-.....+|+++|++++||||++++++|+....
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4568899999999999999999999999999999976543321 122346799999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC---CCEEEcccCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPE 158 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~---~~~~l~df~~~~~~~ 158 (297)
.|+|+||+.||+|.+.+..++.+.+..-+.+++|++.|+.|||++||+|+||||+||+++.+ ..+|++|||++...+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 99999999999999999999999999999999999999999999999999999999999766 579999999999887
Q ss_pred CCccccccccCCccccCCccccccCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhhhccccCCCC----C
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYN--GAAADVWSCGVILYVLIAGYLPFDELDLTT-LYSKVEKADFSCPTW----F 231 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~----~ 231 (297)
. .......+|++.|.|||++.+.+.. +.+.|+|||||++|-+++|.+||.+..... +.+.|..+++.+.+. +
T Consensus 331 ~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I 409 (475)
T KOG0615|consen 331 E-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI 409 (475)
T ss_pred c-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence 4 4667788999999999999766554 357899999999999999999998776555 888999998876543 7
Q ss_pred ChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 232 PVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
+++..+||++||..||++|||+.|+|+||||+...+..+
T Consensus 410 seea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s~ 448 (475)
T KOG0615|consen 410 SEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLSK 448 (475)
T ss_pred hHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccch
Confidence 899999999999999999999999999999999876654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=367.59 Aligned_cols=258 Identities=28% Similarity=0.485 Sum_probs=234.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-eEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-KIYI 84 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 84 (297)
.++.+.++.||+|..|+||+++++.+++.+|+|++.... +++..+++.+|+++++.++|||||++|+.|.... ..++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 346778899999999999999999999999999995443 5666788999999999999999999999998888 5999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||++|||..++.+.+++++..+-.++.+++++|.|||. .+|+||||||+||+++..|.+||||||.+.....+ .
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~ 233 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I 233 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h
Confidence 99999999999999999999999999999999999999995 89999999999999999999999999999877665 5
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHhhhcc-ccCCCC-CChhHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-----DLTTLYSKVEKAD-FSCPTW-FPVGAK 236 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-----~~~~~~~~i~~~~-~~~~~~-~~~~l~ 236 (297)
....+|+..|||||.+.+..|+ .++||||||+.++|+++|+.||... ...++...|..+. +..|.. ++++++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~ 312 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFR 312 (364)
T ss_pred cccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence 5678899999999999999887 9999999999999999999999774 6778888888754 456665 999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 237 SLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
+||+.||++||++|||+.++++|||+++....
T Consensus 313 ~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 313 SFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 99999999999999999999999999987543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-54 Score=358.61 Aligned_cols=262 Identities=38% Similarity=0.707 Sum_probs=245.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..+.|+++++||.|+||.||+++.+.+++-+|+|++++.........+....|..+|.+++||.|++++-.|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 45789999999999999999999999999999999998877777778889999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|++|++||.|+..+++.+.+++..++-++..|+.||.|||+.||+|||+||+||+++.+|+++|+|||++..........
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998776666666
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCC-CChhHHHHHHHhc
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW-FPVGAKSLIHRIL 243 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~l~~li~~~L 243 (297)
...+|++.|+|||++.+.+++ .++|.||||+++|+|++|.+||...+...+++++..++.+.++. ++.+++++++++|
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLL 261 (357)
T ss_pred ccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHh
Confidence 778999999999999999988 99999999999999999999999999999999999999555444 9999999999999
Q ss_pred CCCcCCCC----CHHHHhcCcccccCcc
Q 022444 244 DPNPETRI----TIEEIRNDEWFRKGYV 267 (297)
Q Consensus 244 ~~~p~~Rp----s~~~il~~p~~~~~~~ 267 (297)
+.+|++|. ++.+|-+||||....=
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 99999994 8999999999987643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=368.55 Aligned_cols=261 Identities=34% Similarity=0.665 Sum_probs=243.1
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 82 (297)
+...+|...+.||.|+||+|++|+++.+++.+|||++.+..+..+.-++.+..|-..|..+ .||+|++++-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 4567899999999999999999999999999999999988888887788888999999999 699999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
|+|+||+++|+|.+++.+.+.|++...+.++.+|+.||+|||++||||+||||+|||+|.+++++++|||.+..+.....
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876543211
Q ss_pred c---------c----ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC
Q 022444 163 L---------L----RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT 229 (297)
Q Consensus 163 ~---------~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 229 (297)
. . ...+|+-.|.+||.+.....+ +.+|||+|||++|+|+.|.+||.+.+..-+.++|....+.+++
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~ 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence 1 1 235788899999999887766 9999999999999999999999999999999999999999999
Q ss_pred CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 230 WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 230 ~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
..|+.+.+||.++|-.||++|+|+.+|-+||||...
T Consensus 309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 999999999999999999999999999999999876
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=365.35 Aligned_cols=261 Identities=56% Similarity=1.014 Sum_probs=242.0
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh--HHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK--HKMADQIKREISIMKLVR-HPCVVRLHEVLASRT 80 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (297)
...++|.+.+.||+|.||.|+.+.+..++..||+|++....... ....+.+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45789999999999999999999999999999999776542221 134566778999999999 999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC-CCEEEcccCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQ 159 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~-~~~~l~df~~~~~~~~ 159 (297)
.+++||||+.||+|.+++.+.+++++..+..+++|+++|++|+|+.||+|+||||+||+++.+ +++||+|||++.....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999998999999999999999999999999999999999999999999 9999999999988753
Q ss_pred CccccccccCCccccCCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCC-ChhHHH
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWF-PVGAKS 237 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~l~~ 237 (297)
........+|++.|+|||++.+.. +++.++||||+|+++|.|++|..||...+...++.++..+.+.+|..+ +.++..
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~ 253 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARS 253 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHH
Confidence 445667889999999999999988 889999999999999999999999999999999999999999999999 999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
++++||..+|.+|+|+.+|++||||+.
T Consensus 254 Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 254 LIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-52 Score=334.56 Aligned_cols=258 Identities=37% Similarity=0.734 Sum_probs=245.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
.+++|+.++.||.|+||.|.+++.+.+|..+|+|++...........+...+|..+|+.+.||.++++++.+.+.+++|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 46789999999999999999999999999999999998888888888899999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||++||.|++++.+.++++++.++.++.+|+.||+|||+++|+++|+||+||++|.+|.+|++|||.+...... .
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---T 198 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---T 198 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---E
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999877654 3
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
-..+|+|.|+|||++...++. .+.|.||||+++|+|+.|.+||...++..++++|..++..+|+.++.++++|++.+|+
T Consensus 199 ~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQ 277 (355)
T ss_pred EEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHh
Confidence 467899999999999999987 9999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCC-----CCHHHHhcCcccccCc
Q 022444 245 PNPETR-----ITIEEIRNDEWFRKGY 266 (297)
Q Consensus 245 ~~p~~R-----ps~~~il~~p~~~~~~ 266 (297)
.|-.+| .-.++|-.||||+...
T Consensus 278 vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 278 VDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred hhhHhhhcCcCCCccccccCccccccc
Confidence 999999 4678999999999754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=346.06 Aligned_cols=262 Identities=36% Similarity=0.670 Sum_probs=238.8
Q ss_pred ccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..+..++|.+.+.||+|+|++||+|+++.++..||||.+....+ .....+.+..|+.+|+.++|+||+.+++++..++.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 45678999999999999999999999999999999999987653 34456778999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC------CCEEEcccCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ------GHLKISDFGLSA 155 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~------~~~~l~df~~~~ 155 (297)
+|+|||||+||+|.+++.+.+.+++..++.++.||+.||++||+++|+|+||||.||+++.. -.+|++|||+++
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999865 358999999999
Q ss_pred CCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc---cCCCCCC
Q 022444 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---SCPTWFP 232 (297)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~ 232 (297)
....+ ......+|++.|||||++....|+ .++|+||+|+++|++++|+.||...++.++...++.+.. ..+..++
T Consensus 164 ~L~~~-~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 164 FLQPG-SMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred hCCch-hHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 88854 555677899999999999988888 999999999999999999999999999999888777754 3344477
Q ss_pred hhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 233 VGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 233 ~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
..+.+++...|+.+|.+|.++.+.+.|+++....
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8888999999999999999999999999999886
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=342.78 Aligned_cols=257 Identities=30% Similarity=0.541 Sum_probs=229.8
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEE-EE-EcCCe
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE-VL-ASRTK 81 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~-~~~~~ 81 (297)
.++..|+|.++||.|.||+||++++..+|+.+|.|.+.... -+....+....|+.+|++++||||+++++ .+ ++.+-
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 34567999999999999999999999999999999998433 45556788999999999999999999987 33 44455
Q ss_pred EEEEEcccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CC--CEEecCCCCCeeecCCCCEEEcccCC
Q 022444 82 IYIILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHS--KG--VYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~--~~--i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
++++||+|.+|+|.++++.. ..+++..+|+++.|++.||+++|+ -. ++|+||||.|||++.+|.+||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 89999999999999999754 358999999999999999999999 34 99999999999999999999999999
Q ss_pred CCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-CC-CCC
Q 022444 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CP-TWF 231 (297)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~-~~~ 231 (297)
++............+|+|.|++||.+.+.+++ .+||||||||++|+|+.-++||.+.+...+.++|.++..+ .| ..+
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~Y 253 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHY 253 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHh
Confidence 99999888888889999999999999999998 9999999999999999999999999999999999999875 55 558
Q ss_pred ChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 232 PVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
+.+++.+|..|+..||..||+. +|++++.-.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 9999999999999999999996 555555433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-51 Score=360.26 Aligned_cols=271 Identities=42% Similarity=0.810 Sum_probs=251.6
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
.+.|-|++.+.||.|+-|.|-+|++..+|+.+|||++.............+.+|+-+++.++|||++.+++++++..++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 35678999999999999999999999999999999998764344444567899999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
++.||+++|.|++++.+.+++++.++..+++||+.|+.|.|..+|+|+|+||+|+++|..+++|++|||-+.....+ ..
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999988765554 55
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
....+|++.|.+||++.|..|++.++||||.|+++|.|++|+.||++.+...++.+++.+.+.+|..+|.++++|+++||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 66789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCcccccccccc
Q 022444 244 DPNPETRITIEEIRNDEWFRKGYVPVKLIEYE 275 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~ 275 (297)
..||.+|.|.+||++|||+..........+.+
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~ 279 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGYTSLPSSKSLR 279 (786)
T ss_pred ccCccccccHHHHhhCchhhcCCCCChhhhcC
Confidence 99999999999999999999987666653333
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-50 Score=343.78 Aligned_cols=256 Identities=33% Similarity=0.652 Sum_probs=231.8
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||++.++.+++.+++|.+...........+.+.+|+.+++.+.||||+++++++.+....+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997655444444567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++.+.+.+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---WT 157 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---cc
Confidence 999999999999988889999999999999999999999999999999999999999999999999987654321 23
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
..+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+......++..++..+.+++++||+.|
T Consensus 158 ~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d 236 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236 (291)
T ss_pred ccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCC
Confidence 4578899999999877766 899999999999999999999999998888999888888888889999999999999999
Q ss_pred cCCCCC-----HHHHhcCcccccCc
Q 022444 247 PETRIT-----IEEIRNDEWFRKGY 266 (297)
Q Consensus 247 p~~Rps-----~~~il~~p~~~~~~ 266 (297)
|.+||+ ++++++||||+...
T Consensus 237 p~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 237 RTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred HHHccCCccCCHHHHhcCccccCCC
Confidence 999995 99999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=348.16 Aligned_cols=257 Identities=37% Similarity=0.729 Sum_probs=234.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++++|++.+.||+|++|.||+++++.+++.+++|.+...........+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 46789999999999999999999999999999999986654444556778899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+|||+.+++|.+.+.+.+.+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987554322
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+......++..++..+.+|+.+||+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 251 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQ 251 (329)
T ss_pred ceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhh
Confidence 234678899999999877765 9999999999999999999999998888888888888888888899999999999999
Q ss_pred CCcCCCCC-----HHHHhcCcccccC
Q 022444 245 PNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 245 ~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
.||++|++ ++++++||||++.
T Consensus 252 ~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 252 TDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred cCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999997 7999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=344.76 Aligned_cols=260 Identities=35% Similarity=0.648 Sum_probs=234.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
.+++|++++.||+|+||.||+|+.+.+|+.+|+|+++++.......+..++.|=.+|.....+++|+++-.|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 46789999999999999999999999999999999998888887778889999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC-----
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ----- 159 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~----- 159 (297)
||||++||++..++.+.+.+++..++.++.+++-||.-||+.|++|+||||+|+|||..|++||+|||+|.-...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999999999999842110
Q ss_pred ------------------Ccc-------c-----------------cccccCCccccCCccccccCCCCCchhHHHHHHH
Q 022444 160 ------------------GVS-------L-----------------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVI 197 (297)
Q Consensus 160 ------------------~~~-------~-----------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~l 197 (297)
... . ....+|+|.|+|||++.+.++. ..+|.|||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHHH
Confidence 000 0 1123589999999999999987 99999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHhhhcc--ccC--CCCCChhHHHHHHHhcCCCcCCCCC---HHHHhcCcccccCc
Q 022444 198 LYVLIAGYLPFDELDLTTLYSKVEKAD--FSC--PTWFPVGAKSLIHRILDPNPETRIT---IEEIRNDEWFRKGY 266 (297)
Q Consensus 198 l~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~--~~~~~~~l~~li~~~L~~~p~~Rps---~~~il~~p~~~~~~ 266 (297)
||+|+.|.+||.+.++.+.+.+|.+-+ +.+ ...+++++.+||.+||. ||.+|.- ++||-+||||+...
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 999999999999999999999997765 333 44478999999999999 9999985 99999999999764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=345.42 Aligned_cols=253 Identities=34% Similarity=0.607 Sum_probs=227.9
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (297)
+.||+|+||.||+++++.+|+.+++|++.............+.+|+.+++.+.|+||+++++.+......|++|||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998655444445566788999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCcc
Q 022444 93 ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (297)
Q Consensus 93 ~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 172 (297)
+|.+.+.....+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..............|++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 99999988888999999999999999999999999999999999999999999999999988754333333345568999
Q ss_pred ccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC-
Q 022444 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI- 251 (297)
Q Consensus 173 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp- 251 (297)
|+|||.+.+..++ .++|||||||++|+|++|..||...+.......+......++..+++++.+++.+||..||++||
T Consensus 161 y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 161 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred ccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999877776 89999999999999999999999888888888888888888888999999999999999999999
Q ss_pred ----CHHHHhcCcccccCc
Q 022444 252 ----TIEEIRNDEWFRKGY 266 (297)
Q Consensus 252 ----s~~~il~~p~~~~~~ 266 (297)
++.++++||||+...
T Consensus 240 ~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 240 GGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 899999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=347.31 Aligned_cols=262 Identities=31% Similarity=0.503 Sum_probs=225.3
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC-
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRT- 80 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 80 (297)
+..++||.++++||.|.||.||+|+.+.+|+.||||.++..... .+..- -.+|++.|++++ ||||+++.+++.+..
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 44578999999999999999999999999999999988765433 22122 358999999998 999999999998877
Q ss_pred eEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
++|+|||+|+. .|.++++.. ..|+++.++.++.||+++|+|+|++|++|+|+||+||+++....+|++|||+++...+
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999965 999999754 4699999999999999999999999999999999999999899999999999997766
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc----------------
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---------------- 223 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---------------- 223 (297)
. ......+.+.+|+|||++....+.+.+.|+|++||+++++.+-++.|.+.+..+.+.+|..-
T Consensus 163 k-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 K-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred C-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 4 45567788999999999988877789999999999999999999999998877776666221
Q ss_pred ---cccCC-----------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 224 ---DFSCP-----------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 224 ---~~~~~-----------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+.+| +.++.++.+++.+||+|||++|||+.++|+|||||.+..-
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 11111 1256889999999999999999999999999999987654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=331.80 Aligned_cols=275 Identities=29% Similarity=0.474 Sum_probs=235.1
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.|++...||.|..++||+|+....++.|+||.+......+. .+.+++|+..++.+.||||++++..|..+..+|+||
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 579999999999999999999999999999999987664333 789999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 87 EFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
.+|.+||+.+.++... .+++..+..+++++++||.|||.+|.||||||+.||+|+.+|.++|+|||.+..+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 9999999999998654 59999999999999999999999999999999999999999999999999876554433332
Q ss_pred ----ccccCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC---------
Q 022444 165 ----RTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT--------- 229 (297)
Q Consensus 165 ----~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--------- 229 (297)
....++++|+|||++.. .+|+ .++||||||++..+|.+|..||....+...+-.-.++.++.+.
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~ 262 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDED 262 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHh
Confidence 34489999999999543 4555 9999999999999999999999988877654444444443221
Q ss_pred -CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCcccccc
Q 022444 230 -WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNA 284 (297)
Q Consensus 230 -~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (297)
.++..++.++..||.+||++|||++++|+|+||++...+.-+..+.-..+.++..
T Consensus 263 k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~l~~l~~l~~ 318 (516)
T KOG0582|consen 263 KKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKLLQSLPPLGT 318 (516)
T ss_pred hhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhhhccCCcHHH
Confidence 2567899999999999999999999999999999998777666665555555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=327.47 Aligned_cols=261 Identities=24% Similarity=0.417 Sum_probs=224.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|+.+.++|.|++|+||+++++.+|+-||||++..+. .++...+-..+|+++|++++|+|+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 468999999999999999999999999999999997654 2344456679999999999999999999999999999999
Q ss_pred EcccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+|||+. ++.+.++ ....++...+..++.|++.|+.|+|+++++|+||||+||+++.+|.+||||||+++....+....
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 999987 5555555 45579999999999999999999999999999999999999999999999999999988777788
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--------------------
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-------------------- 224 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-------------------- 224 (297)
...+.+.+|+|||.+.+....+...||||+||++.+|++|.+.|++...-++...|...-
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 888999999999999885445599999999999999999999999887776666553221
Q ss_pred -ccCC----------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 225 -FSCP----------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 225 -~~~~----------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+.+ +.++.-+.+|+..||..||.+|+|.+++|.||||+..-.+
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence 1100 0134567799999999999999999999999999655444
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=342.26 Aligned_cols=257 Identities=32% Similarity=0.600 Sum_probs=231.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCC-cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
..++|++.+.||.|++|.||+|.++.++ ..+++|.+...........+.+.+|+.+++.+.||||+++++++.+....|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4568999999999999999999976554 689999997655444555677889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
++|||+.+++|.+++.+...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--- 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--- 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC---
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....|++.|+|||++.+..++ .++|+||||+++|+|++|..||...+.....+.+......++..+++++.+++++||
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l 263 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLL 263 (340)
T ss_pred cceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence 2244688899999999877665 899999999999999999999999888888888888888888889999999999999
Q ss_pred CCCcCCCC-----CHHHHhcCcccccC
Q 022444 244 DPNPETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rp-----s~~~il~~p~~~~~ 265 (297)
+.+|.+|+ |++++++||||++.
T Consensus 264 ~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 264 SHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred ccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999995 99999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=335.31 Aligned_cols=258 Identities=31% Similarity=0.569 Sum_probs=219.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--eEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--KIYI 84 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 84 (297)
.++...+.||+|+||.||++.++.+|...+||.+....... .+.+.+|+.+|++++|||||++++.....+ .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 45788899999999999999999999999999987653222 677999999999999999999999744433 6999
Q ss_pred EEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-CCCEEEcccCCCCCCCC---
Q 022444 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQ--- 159 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-~~~~~l~df~~~~~~~~--- 159 (297)
.|||+++|+|.+++.+.+ .++++.++.+.++++++|.|||++|++|+||||+||+++. ++.+||+|||.+.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999999999887 7999999999999999999999999999999999999999 79999999998876653
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhhhc--cccCCCCCChhHH
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE-LDLTTLYSKVEKA--DFSCPTWFPVGAK 236 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~l~ 236 (297)
.........|++.|+|||++........++|||||||++.+|+||+.||.. .......-.+-.. .+.+|..+|++++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK 253 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence 112233567899999999998532223699999999999999999999987 3333333333222 3567888999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 237 SLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
+|+.+|+..+|++|||++++|+|||+++...
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999999999999999999998765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=349.21 Aligned_cols=264 Identities=30% Similarity=0.557 Sum_probs=246.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+.+|.+.+.||+|.||.||+++.+.+.+.||+|.+.+.. ........+.+|+++++.++||||+.+++.|+...++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 468999999999999999999999999999999997655 2334578899999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
.||+.| +|..++...+.++++.+..++.++..||.|||+++|.|+|+||.||++++.|.+|++|||+++..........
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 999987 9999999999999999999999999999999999999999999999999999999999999999888777777
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCC
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~ 245 (297)
...|+|.|+|||.+.+..++ ..+|+|||||++|+++.|++||-......+.+.|.....+.|...+..+.+|+..+|.+
T Consensus 159 sikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred eccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence 78899999999999999988 99999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCHHHHhcCcccccCccccccc
Q 022444 246 NPETRITIEEIRNDEWFRKGYVPVKLI 272 (297)
Q Consensus 246 ~p~~Rps~~~il~~p~~~~~~~~~~~~ 272 (297)
||.+|.|..+++.|||......-....
T Consensus 238 dP~~RltW~~Ll~HpF~k~~~~~~~~~ 264 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGHPFWKGKINIAELP 264 (808)
T ss_pred ChhhcccHHHHhcChHHhhhhhhhccc
Confidence 999999999999999998775444433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=337.27 Aligned_cols=253 Identities=33% Similarity=0.611 Sum_probs=226.8
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (297)
+.||+|+||.||+++++.+|+.|++|.+.............+.+|+.+++.+.||||+++++.+......|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998655444445566778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCcc
Q 022444 93 ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (297)
Q Consensus 93 ~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 172 (297)
+|...+.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............+++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 99999988888999999999999999999999999999999999999999999999999988754333333334568899
Q ss_pred ccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC-
Q 022444 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI- 251 (297)
Q Consensus 173 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp- 251 (297)
|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+.......+..+++++.+++.+||..||++|+
T Consensus 161 y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 161 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence 9999999877776 89999999999999999999999888888888887777788888999999999999999999998
Q ss_pred ----CHHHHhcCcccccCc
Q 022444 252 ----TIEEIRNDEWFRKGY 266 (297)
Q Consensus 252 ----s~~~il~~p~~~~~~ 266 (297)
++.++++||||.+..
T Consensus 240 ~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 240 GGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=337.21 Aligned_cols=250 Identities=36% Similarity=0.637 Sum_probs=225.4
Q ss_pred eccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCCh
Q 022444 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (297)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (297)
||+|+||.||+++++.+++.+++|.+.............+.+|+.+++.+.||||+++++.+......+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999765444445566778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCcccc
Q 022444 95 FDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174 (297)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 174 (297)
.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............|++.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99998888899999999999999999999999999999999999999999999999999875443333334456889999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC---
Q 022444 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI--- 251 (297)
Q Consensus 175 aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp--- 251 (297)
|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+......++..+++++.+++.+||+.||++||
T Consensus 161 aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 161 APELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred CHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 99999887776 89999999999999999999999888888888888888888888999999999999999999997
Q ss_pred CHHHHhcCcccccC
Q 022444 252 TIEEIRNDEWFRKG 265 (297)
Q Consensus 252 s~~~il~~p~~~~~ 265 (297)
++.++++||||.+.
T Consensus 240 ~~~e~l~hp~~~~~ 253 (312)
T cd05585 240 GAQEIKNHPFFSQL 253 (312)
T ss_pred CHHHHHcCCCcCCC
Confidence 57999999999985
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=337.49 Aligned_cols=252 Identities=34% Similarity=0.630 Sum_probs=225.9
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (297)
+.||+|+||.||++.++.+++.+|+|++.............+.+|+.+++.+.|+||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998655444445567788999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCcc
Q 022444 93 ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (297)
Q Consensus 93 ~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 172 (297)
+|...+.....+++..++.++.+|+.||.|||+.|++|+||||+||+++.++.++|+|||++..............+++.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 99999988888999999999999999999999999999999999999999999999999998754333233334568899
Q ss_pred ccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC-
Q 022444 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI- 251 (297)
Q Consensus 173 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp- 251 (297)
|+|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+......++..++.++.+++++||.+||++|+
T Consensus 161 y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 161 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred ccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999877766 99999999999999999999999888888888887777888888999999999999999999997
Q ss_pred ----CHHHHhcCcccccC
Q 022444 252 ----TIEEIRNDEWFRKG 265 (297)
Q Consensus 252 ----s~~~il~~p~~~~~ 265 (297)
++.++++||||...
T Consensus 240 ~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 240 GGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=335.90 Aligned_cols=252 Identities=31% Similarity=0.614 Sum_probs=224.3
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|++|.||+++++.+++.|++|++................|...++.. .|+||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999765443444455666777778766 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|.+.+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............|++
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 99999998888999999999999999999999999999999999999999999999999998875433333334456889
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+.......+..++.++.+++++||+.||++||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 161 DYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred cccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 99999999877666 89999999999999999999999999988888888888888888999999999999999999999
Q ss_pred CH------HHHhcCcccccC
Q 022444 252 TI------EEIRNDEWFRKG 265 (297)
Q Consensus 252 s~------~~il~~p~~~~~ 265 (297)
++ +++++||||+..
T Consensus 240 ~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 240 GSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 98 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=334.23 Aligned_cols=257 Identities=32% Similarity=0.618 Sum_probs=228.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCeEEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 86 (297)
+|++.+.||+|++|.||+|+++.+++.+++|++.............+..|..++..+.| ++++++++.+...+..|++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999976554444445667788888888876 56888999999899999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 99999999999988888999999999999999999999999999999999999999999999999988654333233344
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
..|++.|+|||.+.+..++ .++||||||+++|+|++|+.||...+..+....+.......+..++.++.+++.+||.++
T Consensus 161 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239 (324)
T ss_pred ecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 5688999999999887776 899999999999999999999999998889999888888888889999999999999999
Q ss_pred cCCCCCH-----HHHhcCcccccC
Q 022444 247 PETRITI-----EEIRNDEWFRKG 265 (297)
Q Consensus 247 p~~Rps~-----~~il~~p~~~~~ 265 (297)
|++|++. +++++||||+..
T Consensus 240 P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 240 PAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999987 899999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=328.47 Aligned_cols=260 Identities=29% Similarity=0.463 Sum_probs=221.3
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|++.+.||+|+||.||++.+..+|+.+++|.+.............+.+|+.+++.+.|++++++++.+...+..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999876554444444567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+++++|.+.+... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR 159 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence 99999998877543 36899999999999999999999999999999999999999999999999998764332 1223
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhhhccccCCCCCChhHHHHHHH
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT----TLYSKVEKADFSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~l~~li~~ 241 (297)
...++..|+|||.+.+..++ .++||||||+++|+|++|+.||...+.. .....+.......+..+++++.+|+++
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 45688999999999887776 8999999999999999999999875432 233334444455667789999999999
Q ss_pred hcCCCcCCCCC-----HHHHhcCcccccCcccc
Q 022444 242 ILDPNPETRIT-----IEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 242 ~L~~~p~~Rps-----~~~il~~p~~~~~~~~~ 269 (297)
||+.||++||+ ++++++||||++.....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR 271 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence 99999999997 89999999998875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=328.89 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=212.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++++|++.+.||.|++|.||++.++.++..|++|.+..... ......+.+|+.+++.++|+||+++++++......++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 46889999999999999999999999999999999865431 1223456789999999999999999999998899999
Q ss_pred EEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||++.+ +|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 9999986 8988887544 4789999999999999999999999999999999999999999999999998765443333
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-------------------
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD------------------- 224 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~------------------- 224 (297)
.....++..|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 3455678899999998764433489999999999999999999998776555443332110
Q ss_pred c-----------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 225 F-----------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 225 ~-----------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
. .....++.++.+|+++||++||++|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0 0112357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=333.25 Aligned_cols=256 Identities=32% Similarity=0.576 Sum_probs=224.4
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHH---HhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM---KLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
|++.+.||+|++|.||++.++.+++.+++|++...........+.+.+|...+ +.+.|+||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999765433344445566665554 566799999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|||+++++|...+.. ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 999999999887754 5799999999999999999999999999999999999999999999999998875443333334
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCC
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~ 245 (297)
...+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+.......+..++.++.+++.+||+.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 238 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR 238 (324)
T ss_pred ccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence 55688999999999877765 89999999999999999999999988888888888888888888999999999999999
Q ss_pred CcCCCC-----CHHHHhcCcccccCc
Q 022444 246 NPETRI-----TIEEIRNDEWFRKGY 266 (297)
Q Consensus 246 ~p~~Rp-----s~~~il~~p~~~~~~ 266 (297)
||++|| ++.++++||||++..
T Consensus 239 dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 239 NPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred CHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 999999 799999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=335.75 Aligned_cols=256 Identities=30% Similarity=0.564 Sum_probs=225.8
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||+|++..+++.|++|++.............+.+|+.+++.++|+||+++++++......|++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445667888999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++.+...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS 157 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCC
Confidence 9999999999998888899999999999999999999999999999999999999999999999998875543 2234
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc--cCCC------CCChhHHHH
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF--SCPT------WFPVGAKSL 238 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~------~~~~~l~~l 238 (297)
..+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+..... ..+. .+++++.++
T Consensus 158 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred cccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence 5688999999999887766 999999999999999999999998888777666654321 1111 358999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+.+||+.+|++|||++++++||||.+..
T Consensus 237 i~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 237 ITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 9999999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=340.35 Aligned_cols=260 Identities=34% Similarity=0.628 Sum_probs=228.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|+||++++..+++.||+|++.............+.+|+.+++.+.|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998665444455667889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-----
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV----- 161 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~----- 161 (297)
||+.+++|.+++.+...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987654432
Q ss_pred ------------------------cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022444 162 ------------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (297)
Q Consensus 162 ------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~ 217 (297)
.......+++.|+|||.+.+..++ .++|||||||++|+|++|..||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 122345688999999999887766 9999999999999999999999998887777
Q ss_pred HHhhh--ccccCC--CCCChhHHHHHHHhcCCCcCCCCC-HHHHhcCcccccCccc
Q 022444 218 SKVEK--ADFSCP--TWFPVGAKSLIHRILDPNPETRIT-IEEIRNDEWFRKGYVP 268 (297)
Q Consensus 218 ~~i~~--~~~~~~--~~~~~~l~~li~~~L~~~p~~Rps-~~~il~~p~~~~~~~~ 268 (297)
.++.. .....+ ..+++++.++|.+||. +|.+||+ ++++++||||++....
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence 77766 333333 3369999999999997 9999999 9999999999876443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=308.71 Aligned_cols=258 Identities=37% Similarity=0.695 Sum_probs=243.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++++|.+.+.||.|.||.||+|+.+.++--|++|++-++.........++.+|+++-..++||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 45789999999999999999999999999999999988887777778889999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
++||...|++...+. ...++++.....++.|++.|+.|+|..+++|+||+|+|++++-++.++++|||-+.... ..
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~ 177 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SN 177 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--CC
Confidence 999999999999998 66789999999999999999999999999999999999999999999999999876555 34
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHh
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~ 242 (297)
.....+|+..|.|||...+...+ ...|+|++|++.|+++.|..||......+.+++|...+..+|+.++.++.++|++|
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRL 256 (281)
T ss_pred CceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHH
Confidence 55677899999999999999888 99999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccC
Q 022444 243 LDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
|.++|.+|.+..+++.|||+...
T Consensus 257 l~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred hccCccccccHHHHhhhHHHHhc
Confidence 99999999999999999999764
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=335.63 Aligned_cols=253 Identities=34% Similarity=0.619 Sum_probs=225.9
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (297)
+.||+|+||.||++.+..+|+.+++|++.............+.+|+.+++.+.|+||+++++.+......|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998655444444566778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 93 ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 93 ~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
+|...+.....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++..............+++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999999888889999999999999999999997 7999999999999999999999999998865433333333456889
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||++.+..++ .++||||||+++|+|++|..||...+.....+.+......++..+++++.+++.+||+.||++|+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 161 EYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred ccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence 99999999877776 89999999999999999999999988888888888888888888999999999999999999997
Q ss_pred -----CHHHHhcCcccccCc
Q 022444 252 -----TIEEIRNDEWFRKGY 266 (297)
Q Consensus 252 -----s~~~il~~p~~~~~~ 266 (297)
++.++++||||.+..
T Consensus 240 ~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 240 GGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=331.13 Aligned_cols=252 Identities=35% Similarity=0.695 Sum_probs=224.8
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|+||.||++.++.+++.+++|.+.............+..|..+++.+ .|+||+++++++......|++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876544444456677888888877 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|...+.+...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 99999998888899999999999999999999999999999999999999999999999998865433323333456888
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+.......+..++.++.+++.+||..||++||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 161 DYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred cccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence 99999999887776 89999999999999999999999988888888888877778888999999999999999999999
Q ss_pred CH-----HHHhcCcccccC
Q 022444 252 TI-----EEIRNDEWFRKG 265 (297)
Q Consensus 252 s~-----~~il~~p~~~~~ 265 (297)
|+ .++++||||+..
T Consensus 240 s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 240 GCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 99 999999999885
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=332.86 Aligned_cols=252 Identities=31% Similarity=0.616 Sum_probs=224.5
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|+||.||+++++.+++.+++|++................|..+++.+ .|++|+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999765444444455666788888765 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|...+.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..............++.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 99999998888899999999999999999999999999999999999999999999999998875433333334456888
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+.......+..++.++.+++.+||+.+|++|+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 161 DYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred cccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 99999999877776 89999999999999999999999999999999988888888888999999999999999999999
Q ss_pred -------CHHHHhcCcccccC
Q 022444 252 -------TIEEIRNDEWFRKG 265 (297)
Q Consensus 252 -------s~~~il~~p~~~~~ 265 (297)
+++++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 240 GCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CCCCCCCCHHHHhcCCccCCC
Confidence 99999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=328.57 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=209.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+.++|++.+.||.|++|.||+++++.+++.+++|++..... ........+|+..++.++|+||+++++++......++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 45789999999999999999999999999999999865431 1123346689999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+|||+.+ +|.+.+... +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 81 VFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred EEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9999964 777777653 56899999999999999999999999999999999999999999999999988755443333
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhhhc-------------------
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL-TTLYSKVEKA------------------- 223 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~~~i~~~------------------- 223 (297)
.....+++.|+|||++.+....+.++||||||+++|+|++|..||..... ....+.+...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 34556788999999987654334899999999999999999999976532 2222222100
Q ss_pred --ccc--CC---------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 224 --DFS--CP---------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 224 --~~~--~~---------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
... .+ ..++.++.+|+++||+.||++|||++++|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000 00 0134678899999999999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=330.23 Aligned_cols=257 Identities=30% Similarity=0.598 Sum_probs=227.6
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.|++.+.||+|+||.||+++++.+++.+++|.+................+..++..+ .|++++++++.+...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 489999999999999999999999999999999865443344445566677777776 4799999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+.+.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999988754433333345
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
..|++.|+|||.+.+..++ .++|||||||++|+|++|..||...+.....+.+......++..++.++.+++.+||+.+
T Consensus 161 ~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~ 239 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239 (323)
T ss_pred CCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccC
Confidence 5688999999999887776 999999999999999999999999999889888888888888889999999999999999
Q ss_pred cCCCCCH-----HHHhcCcccccC
Q 022444 247 PETRITI-----EEIRNDEWFRKG 265 (297)
Q Consensus 247 p~~Rps~-----~~il~~p~~~~~ 265 (297)
|++|+++ .++++||||+..
T Consensus 240 p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 240 PGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999984 899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=334.40 Aligned_cols=258 Identities=34% Similarity=0.599 Sum_probs=222.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++++.||+|++|+||+++++.+++.+++|++.............+.+|+.+++.+.|++|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765445555677889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc----
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---- 162 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~---- 162 (297)
||+++++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864322100
Q ss_pred -------------------------------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022444 163 -------------------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (297)
Q Consensus 163 -------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~ 211 (297)
......|++.|+|||++.+..++ .++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 01234688999999999887776 8999999999999999999999988
Q ss_pred CHHHHHHHhhhcc--ccCC--CCCChhHHHHHHHhcCCCcC---CCCCHHHHhcCcccccCc
Q 022444 212 DLTTLYSKVEKAD--FSCP--TWFPVGAKSLIHRILDPNPE---TRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 212 ~~~~~~~~i~~~~--~~~~--~~~~~~l~~li~~~L~~~p~---~Rps~~~il~~p~~~~~~ 266 (297)
+..+...++.... ..++ ..+++++.+++.+|+. +|. .||+++++++||||+...
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 8888887776532 3333 3478999999999876 344 468999999999998763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=331.99 Aligned_cols=253 Identities=35% Similarity=0.627 Sum_probs=221.4
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS-IMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|++|+||+++++.+|+.+++|++.............+..+.. +++.++|+||+++++.+...+..+++|||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433333344444444 56788999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|..++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............|++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 99999998888899999999999999999999999999999999999999999999999998875443333344556889
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+..+.+.......+..++.++.+++.+||+.||++||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 161 EYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred hhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence 99999999887766 89999999999999999999999988888888888777777778999999999999999999999
Q ss_pred CH----HHHhcCcccccCc
Q 022444 252 TI----EEIRNDEWFRKGY 266 (297)
Q Consensus 252 s~----~~il~~p~~~~~~ 266 (297)
++ +++++||||....
T Consensus 240 ~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 240 GAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 98 6999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=341.37 Aligned_cols=259 Identities=32% Similarity=0.630 Sum_probs=241.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 83 (297)
.+++|.+.++||+|.||.|+++..+.+++.+|||++++......+.++.+..|-.++.... ||.++.++..|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 5678999999999999999999999999999999999888877778888888888887775 999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||++||++ ..+...+.+++..+.-++..++.||.|||++||||+|+|.+||++|.+|.+||+|||+++........
T Consensus 446 fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 446 FVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred EEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCc
Confidence 99999999995 44555678999999999999999999999999999999999999999999999999999877756567
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
...-+|++.|+|||++.+..|+ .+.|.||||++||+|+.|..||.+.+-+++.+.|...+..+|..++.+..++++++|
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll 603 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLL 603 (694)
T ss_pred cccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHh
Confidence 7788999999999999999987 999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCH-----HHHhcCcccccC
Q 022444 244 DPNPETRITI-----EEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps~-----~~il~~p~~~~~ 265 (297)
.++|.+|.-+ ++|..||||+..
T Consensus 604 ~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 604 RKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ccCcccccCCCCCCchhhhhCCccccC
Confidence 9999999875 889999999875
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=330.12 Aligned_cols=253 Identities=34% Similarity=0.634 Sum_probs=223.8
Q ss_pred eEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 12 GRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
++.||+|+||.||++++. .+++.+++|++...... .......+.+|+.+++.++||||+++++.+..+...|++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 47889999999764432 22334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
|+++++|.+.+.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999886543333333345
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCc
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p 247 (297)
.+++.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+.......+..+++++.+++.+||+++|
T Consensus 161 ~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 161 CGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239 (323)
T ss_pred CCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 688999999999877765 8999999999999999999999998888888888888888888899999999999999999
Q ss_pred CCCC-----CHHHHhcCcccccC
Q 022444 248 ETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 248 ~~Rp-----s~~~il~~p~~~~~ 265 (297)
++|| +++++++||||+..
T Consensus 240 ~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 240 SSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred hHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999 89999999999875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=329.14 Aligned_cols=253 Identities=30% Similarity=0.607 Sum_probs=221.4
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh-cCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL-VRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|+||.||+++++.+|+.+++|.+................|...+.. ..|++|+++++.+....+.|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999976543333334555667777765 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|...+.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..............|+.
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999998888899999999999999999999999999999999999999999999999998865433333334556889
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+.......+..++.++.+++.+||..||++||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (316)
T cd05620 161 DYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239 (316)
T ss_pred CccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 99999999887776 89999999999999999999999888888888888777777888999999999999999999999
Q ss_pred CH-HHHhcCcccccCc
Q 022444 252 TI-EEIRNDEWFRKGY 266 (297)
Q Consensus 252 s~-~~il~~p~~~~~~ 266 (297)
++ .++++||||+...
T Consensus 240 ~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 240 GVVGNIRGHPFFKTIN 255 (316)
T ss_pred CChHHHHcCCCcCCCC
Confidence 98 5899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=306.01 Aligned_cols=270 Identities=30% Similarity=0.462 Sum_probs=231.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.||...++||+|.+|.||+|++..+|+.||||++......+. ....+.+|++.|+.++|+||+.++++|...+++.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 689999999999999999999999999999999987654332 2345679999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
||++. +|...++.. ..++...+..++.+++.+++|+|++.|+|+||||+|++++.+|.+|++|||+++..........
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99976 898888754 4689999999999999999999999999999999999999999999999999998887766666
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------------
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--------------------- 224 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--------------------- 224 (297)
..+-+.+|+|||.+.|....+...||||.||++.||+-|.+.|.+.+.-++...+-..-
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 66788899999999988777799999999999999999999998887666666552210
Q ss_pred -ccCC------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCC
Q 022444 225 -FSCP------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVN 278 (297)
Q Consensus 225 -~~~~------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~ 278 (297)
.+.+ +.+++++.+|+..|+..||.+|+|+.|+|+|+||.+.+.+..-...+-.+
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~ 300 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPS 300 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCc
Confidence 1111 11467789999999999999999999999999999988777665555433
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=328.82 Aligned_cols=252 Identities=33% Similarity=0.652 Sum_probs=220.6
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh-cCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL-VRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|+||.||++++..+++.||+|++................+...+.. ..|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999986543333334445556666654 4799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............|++
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999875543333344556899
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+.......+..++.++.+++.+||+.+|++||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 161 DYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred cccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 99999999877766 89999999999999999999999998888888888877778888999999999999999999999
Q ss_pred CH-HHHhcCcccccC
Q 022444 252 TI-EEIRNDEWFRKG 265 (297)
Q Consensus 252 s~-~~il~~p~~~~~ 265 (297)
++ .++++||||+..
T Consensus 240 ~~~~~l~~h~~~~~~ 254 (316)
T cd05592 240 GVDGDIRQHPFFRGI 254 (316)
T ss_pred CChHHHHcCcccCCC
Confidence 86 488999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=338.48 Aligned_cols=254 Identities=26% Similarity=0.499 Sum_probs=227.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|...++||+|+-|.||.|....+++.|+||.+..... ...+-+.+|+.+++..+|+|||++++.+...+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 468899999999999999999999999999999986652 22455789999999999999999999988889999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||++||+|.+.+... .+++.++..+++.+++||.|||.+||+|+|||.+||+++.+|.+||+|||+|............
T Consensus 350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 999999998877654 6999999999999999999999999999999999999999999999999999988877777788
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc---cccCCCCCChhHHHHHHHhc
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---DFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~l~~li~~~L 243 (297)
-+|+++|+|||+.....|. ++.||||||+++++|+.|.+||-.-++..-...|... +...+..++..+++|+.+||
T Consensus 429 mVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL 507 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCL 507 (550)
T ss_pred ccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHh
Confidence 8999999999999988887 9999999999999999999999766655544444333 45667789999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccC
Q 022444 244 DPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~ 265 (297)
..|+.+|+|+.|+|+||||+..
T Consensus 508 ~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 508 VVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred hcchhcCCCHHHHhcChhhhhc
Confidence 9999999999999999999554
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=330.70 Aligned_cols=252 Identities=30% Similarity=0.614 Sum_probs=219.2
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|++|.||+++++.+++.+|+|++...........+.+..|..+++.+ .||||+++++++......|++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544555566788899999888 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|.+++.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............|+.
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999998865333333334456889
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHhhhccccCCCCCChhHHHHHHHh
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL---------DLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~ 242 (297)
.|+|||.+.+..++ .++|+||||+++|+|++|+.||... ......+.+.......+..++.++.+++.+|
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 161 NYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239 (329)
T ss_pred cccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 99999999887776 8999999999999999999999632 1223455566666777888999999999999
Q ss_pred cCCCcCCCCC------HHHHhcCcccccC
Q 022444 243 LDPNPETRIT------IEEIRNDEWFRKG 265 (297)
Q Consensus 243 L~~~p~~Rps------~~~il~~p~~~~~ 265 (297)
|+.||++|+| ++++++||||...
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999997 7899999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=327.08 Aligned_cols=257 Identities=31% Similarity=0.604 Sum_probs=227.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+|+..+.||+|++|.||+++++.+|+.||+|++................|..+++.+. |++++++++.+...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999998654444444556777888888876 577888999999989999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 99999999999988888999999999999999999999999999999999999999999999999988754433333334
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
..|+..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.....+.+.......+..++.++.+++.+||+.+
T Consensus 161 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 239 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 239 (323)
T ss_pred ccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccC
Confidence 5688999999999877766 899999999999999999999999988888888888888888889999999999999999
Q ss_pred cCCCCC-----HHHHhcCcccccC
Q 022444 247 PETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 247 p~~Rps-----~~~il~~p~~~~~ 265 (297)
|++|++ .+++++||||+..
T Consensus 240 p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 240 PSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HhhCCCCCCCCHHHHhcCcccCCC
Confidence 999998 5799999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=313.81 Aligned_cols=262 Identities=36% Similarity=0.687 Sum_probs=237.1
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
++..++|++.+.||+|+||.|+++.+..+|+.+++|.++....... ..+++.+|+.+-+.++||||+++++.+.+....
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 4567889999999999999999999999999999999876554444 468899999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec---CCCCEEEcccCCCCCCCC
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~---~~~~~~l~df~~~~~~~~ 159 (297)
|+|+|.+.|++|..-+-..-.+++..+-.+++||++||.|.|.+||+|+|++|.|+++- ...-+||+|||++....
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999999999977776656788999999999999999999999999999999999993 34469999999998887
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC----CCChhH
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT----WFPVGA 235 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~l 235 (297)
+.....+..|+|.|+|||++...++. ..+|||+-|+++|-|+.|.+||.+-+...+++.|..+...+++ .+++++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 55777889999999999999877776 8999999999999999999999999999999999999887765 378999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
++++++||..||++|.|+.|.|+|||+.+..+
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 99999999999999999999999999987643
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=333.89 Aligned_cols=257 Identities=34% Similarity=0.641 Sum_probs=222.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+|++++.||.|+||.||+++++.+++.||+|++.............+.+|+.+++.+.|+||+++++.+.+....|++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998655444445567888999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc----
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---- 162 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~---- 162 (297)
||+.+++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998764322110
Q ss_pred ----------------------------------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022444 163 ----------------------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208 (297)
Q Consensus 163 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf 208 (297)
......|++.|+|||++....++ .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 00123588999999999877776 9999999999999999999999
Q ss_pred CCCCHHHHHHHhhhcc--ccCC--CCCChhHHHHHHHhcCCCcCCCCC---HHHHhcCcccccC
Q 022444 209 DELDLTTLYSKVEKAD--FSCP--TWFPVGAKSLIHRILDPNPETRIT---IEEIRNDEWFRKG 265 (297)
Q Consensus 209 ~~~~~~~~~~~i~~~~--~~~~--~~~~~~l~~li~~~L~~~p~~Rps---~~~il~~p~~~~~ 265 (297)
...+.......+.... ...+ ..+++++.++|.+||. +|.+|++ ++++++||||...
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9888777766665433 2222 2468999999999997 8999998 9999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=326.25 Aligned_cols=252 Identities=31% Similarity=0.619 Sum_probs=220.1
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh-cCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL-VRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|+||.||+++++.+++.+|+|.+................|...++. +.||||+++++++.+....+++|||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999976543323334445566666765 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..............++.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 99999998878899999999999999999999999999999999999999999999999998865433323333456888
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+.......+..++.++.+++.+||+.+|++||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 161 DYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred cccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC
Confidence 99999999877766 89999999999999999999999988888888887777777778999999999999999999999
Q ss_pred CHH-HHhcCcccccC
Q 022444 252 TIE-EIRNDEWFRKG 265 (297)
Q Consensus 252 s~~-~il~~p~~~~~ 265 (297)
++. ++++||||+..
T Consensus 240 ~~~~~l~~h~~~~~~ 254 (316)
T cd05619 240 GVKGDIRQHPFFREI 254 (316)
T ss_pred CChHHHHcCcccCCC
Confidence 997 89999999885
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=332.43 Aligned_cols=261 Identities=32% Similarity=0.569 Sum_probs=223.7
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
...++|++.+.||+|++|.||+++++.+++.+|+|.+.............+.+|+.+++.+.|+||+++++.+.+....|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999999999999999997654444444556778999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
+||||+++++|.+++.+ ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999999999998865 4689999999999999999999999999999999999999999999999999875543221
Q ss_pred ccccccCCccccCCccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--ccCCC--CCChhH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKG---YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSCPT--WFPVGA 235 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~l 235 (297)
......|++.|+|||.+.+.. ..+.++|||||||++|+|++|..||...+....+.++.... ...+. .++.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 223456889999999986532 23489999999999999999999999888877777776543 33333 479999
Q ss_pred HHHHHHhcCCCcCC--CCCHHHHhcCcccccC
Q 022444 236 KSLIHRILDPNPET--RITIEEIRNDEWFRKG 265 (297)
Q Consensus 236 ~~li~~~L~~~p~~--Rps~~~il~~p~~~~~ 265 (297)
.+++++||+.+|++ |+|+.++++||||++.
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999988 9999999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=333.12 Aligned_cols=259 Identities=29% Similarity=0.492 Sum_probs=219.8
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|++++.||+|+||+||+|+++.+++.+|+|++.............+.+|+.+++.+.|+||+++++.+.+....+++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999998765555555677899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-----
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV----- 161 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~----- 161 (297)
||+++++|.+++.+...+++..+..++.+++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999864321000
Q ss_pred ------------------------------------------cccccccCCccccCCccccccCCCCCchhHHHHHHHHH
Q 022444 162 ------------------------------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199 (297)
Q Consensus 162 ------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~ 199 (297)
.......|+..|+|||.+.+..++ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHH
Confidence 001123588899999999877776 8999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHhhhc--cccC--CCCCChhHHHHHHHhcC--CCcCCCCCHHHHhcCcccccCc
Q 022444 200 VLIAGYLPFDELDLTTLYSKVEKA--DFSC--PTWFPVGAKSLIHRILD--PNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 200 ~ll~g~~pf~~~~~~~~~~~i~~~--~~~~--~~~~~~~l~~li~~~L~--~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+|++|..||...+.......+... .... ...+++++.+++.+|+. .++..|++++++++||||++..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 999999999887776655555432 2222 33578999999999665 4555699999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=322.58 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=211.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||+++++.+++.+++|++..... .......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999875432 2233456778999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-ccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~~ 165 (297)
||+.++++..+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9999877765555556799999999999999999999999999999999999999999999999999876543222 223
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------------
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--------------------- 224 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--------------------- 224 (297)
...++..|+|||.+.+..++ .++|+||||+++|+|++|+.||...+..+....+....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 34678899999999877765 89999999999999999999998765443322221110
Q ss_pred c-----------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 225 F-----------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 225 ~-----------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
. .....++.++.+|+++||++||++|||++++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0011267789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=325.02 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=220.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++++.||.|++|.||+++++.++..+++|.+.... .......+.+|++.+++++|+||+++++++...+..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999987543 233456788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|||+++++|.+++.+...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 159 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA 159 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--cc
Confidence 99999999999999888899999999999999999999986 6999999999999999999999999988755432 22
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh----------------------
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK---------------------- 222 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~---------------------- 222 (297)
....++..|+|||.+.+..++ .++||||||+++|+|++|+.||...+..++...+..
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence 344678899999999877766 899999999999999999999977665444322111
Q ss_pred ------------------------cc-ccC-CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 223 ------------------------AD-FSC-PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 223 ------------------------~~-~~~-~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
.. ... ...+++++.+|+.+||++||++|||++++++||||+......
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~ 311 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEE 311 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccccc
Confidence 00 011 123678999999999999999999999999999999876543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=328.19 Aligned_cols=252 Identities=31% Similarity=0.613 Sum_probs=217.9
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|+||.||+++++.+++.+++|++.............+..|+.++..+ .|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544445566677888888776 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|...+.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............|+.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999998875433333334456889
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHhhhccccCCCCCChhHHHHHHHh
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL---------DLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~ 242 (297)
.|+|||.+.+..++ .++|+||||+++|+|++|..||... ......+.+.......|..++.++.+++++|
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 161 NYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239 (329)
T ss_pred cccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 99999999887776 8999999999999999999999521 1233455556666777888999999999999
Q ss_pred cCCCcCCCCC------HHHHhcCcccccC
Q 022444 243 LDPNPETRIT------IEEIRNDEWFRKG 265 (297)
Q Consensus 243 L~~~p~~Rps------~~~il~~p~~~~~ 265 (297)
|+.||++||| +.++++||||++.
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999998 5799999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=324.88 Aligned_cols=265 Identities=37% Similarity=0.648 Sum_probs=228.9
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHH-----------HHHHHHHHHHHHHhcCCCCeeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-----------MADQIKREISIMKLVRHPCVVRL 72 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~ 72 (297)
+.+.+|++.+.||+|.+|.|-+|++..+++.||||++.+....... ..+..++|+.+++++.|+|||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4567999999999999999999999999999999999754433211 13578999999999999999999
Q ss_pred EEEEEc--CCeEEEEEcccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEc
Q 022444 73 HEVLAS--RTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKIS 149 (297)
Q Consensus 73 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~ 149 (297)
+++..+ .+.+|+|+|||..|.+.+. -...+ +++.+++.+++++..+|+|||.+||+|+||||+|+|++.+|++|+.
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 999854 4589999999998877443 33334 8999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCC-----CccccccccCCccccCCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh
Q 022444 150 DFGLSALPEQ-----GVSLLRTTCGTPNYVAPEVLSH---KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVE 221 (297)
Q Consensus 150 df~~~~~~~~-----~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~ 221 (297)
|||.+..... .........|+|.|+|||.+.+ ..+++.+.||||||+++|.|+.|+.||.+....+++.+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 9999875522 2223445789999999999876 3455789999999999999999999999999999999999
Q ss_pred hccccCCCC--CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 222 KADFSCPTW--FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 222 ~~~~~~~~~--~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
+..+.+|.. +.+.++++|.+||.+||.+|.+..+|-.|||........
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 998877766 789999999999999999999999999999998774433
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=326.37 Aligned_cols=257 Identities=37% Similarity=0.694 Sum_probs=235.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 85 (297)
+.|++.+.||+|.||.||.++.+.+|+.+|+|.+.+...........+.+|+.++++++ ||||+.+++++++....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 47999999999999999999999999999999998877665556678999999999999 99999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC----CCEEEcccCCCCCCCCCc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGV 161 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~----~~~~l~df~~~~~~~~~~ 161 (297)
||++.||.|.+.+.+. .+++..+..+++++++++.|+|+.|++|+|+||+|+++... +.++++|||++..... .
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~ 192 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-G 192 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-C
Confidence 9999999999999876 49999999999999999999999999999999999999533 4799999999998877 5
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCC----CChhHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW----FPVGAKS 237 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~~l~~ 237 (297)
......+|++.|+|||++....+. ...||||+|+++|.|++|..||...+.......+..+.+.++.. +++.+.+
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd 271 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKD 271 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHH
Confidence 667788999999999999887877 99999999999999999999999999888888888887755433 6899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
||+.||..||.+|+|+.++|+|||++...
T Consensus 272 ~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 272 FIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 99999999999999999999999998763
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=331.61 Aligned_cols=257 Identities=32% Similarity=0.548 Sum_probs=219.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+|++++.||+|+||.||++++..+++.+++|.+.............+.+|+.+++.+.|+||+++++.+.+....|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999997655444455677889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-----
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV----- 161 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~----- 161 (297)
||+++++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999864221000
Q ss_pred ------------------------------------------cccccccCCccccCCccccccCCCCCchhHHHHHHHHH
Q 022444 162 ------------------------------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199 (297)
Q Consensus 162 ------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~ 199 (297)
.......|++.|+|||++.+..++ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 001123578899999999888776 9999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHhhhcc--c--cCCCCCChhHHHHHHHhcCCCcCCCCC---HHHHhcCcccccC
Q 022444 200 VLIAGYLPFDELDLTTLYSKVEKAD--F--SCPTWFPVGAKSLIHRILDPNPETRIT---IEEIRNDEWFRKG 265 (297)
Q Consensus 200 ~ll~g~~pf~~~~~~~~~~~i~~~~--~--~~~~~~~~~l~~li~~~L~~~p~~Rps---~~~il~~p~~~~~ 265 (297)
+|++|..||...+.......+.... . +....+++++.++|.+|+ .+|.+|++ +.++++||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999998887766655554322 2 223457899999999987 59999997 9999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=315.92 Aligned_cols=275 Identities=27% Similarity=0.439 Sum_probs=239.8
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.|++++.||.|.-|+||+++.++++..+|+|++.+.......-..++..|-++|+.+.||.++.+|..|+.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 46889999999999999999999999999999999888777777788889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC-----
Q 022444 87 EFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ----- 159 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~----- 159 (297)
|||+||+|..+++++. .+++..++.++..++-||+|||..|||++|+||+||+|.++|++.|+||+++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 9999999999988754 599999999999999999999999999999999999999999999999998643211
Q ss_pred ----------------------------Ccc-----------------------ccccccCCccccCCccccccCCCCCc
Q 022444 160 ----------------------------GVS-----------------------LLRTTCGTPNYVAPEVLSHKGYNGAA 188 (297)
Q Consensus 160 ----------------------------~~~-----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~ 188 (297)
... .....+|+..|.|||++.|.+.. .+
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg-sA 315 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG-SA 315 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC-ch
Confidence 000 00112467789999999999987 99
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC--CCChhHHHHHHHhcCCCcCCCCC----HHHHhcCccc
Q 022444 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT--WFPVGAKSLIHRILDPNPETRIT----IEEIRNDEWF 262 (297)
Q Consensus 189 ~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~l~~li~~~L~~~p~~Rps----~~~il~~p~~ 262 (297)
.|.|+||+++|+|+.|+.||.+.+..+...++......+|. .++..+++||+++|.+||++|.- +.||-+||||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccc
Confidence 99999999999999999999999999888888777666654 47799999999999999999999 9999999999
Q ss_pred ccCccccccccccCCCcccc
Q 022444 263 RKGYVPVKLIEYEDVNLDDV 282 (297)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~ 282 (297)
+...=...-...|+.-..+.
T Consensus 396 ~gVnWaLir~~~PP~iP~~~ 415 (459)
T KOG0610|consen 396 EGVNWALIRCARPPEIPKPV 415 (459)
T ss_pred cCCChhheeccCCCcCCCcc
Confidence 98765555555555544443
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=327.84 Aligned_cols=252 Identities=35% Similarity=0.646 Sum_probs=223.0
Q ss_pred eEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 12 GRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
++.||+|++|.||++++. .+|+.+++|++....... .....+.+|+.++++++|+||+++++++......|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999863 578999999997654322 2234567889999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccccc
Q 022444 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC 168 (297)
Q Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~ 168 (297)
+.+++|.+.+.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..............
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 159 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 159 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence 99999999998888899999999999999999999999999999999999999999999999999876544433334456
Q ss_pred CCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcC
Q 022444 169 GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248 (297)
Q Consensus 169 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~ 248 (297)
+++.|+|||.+.+..++ .++||||||+++|+|++|+.||...+.......+.......+..+++++.+++++||+.||+
T Consensus 160 g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 160 GTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred CChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 88899999999877765 89999999999999999999999988888888888888888888999999999999999999
Q ss_pred CCCC-----HHHHhcCcccccC
Q 022444 249 TRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 249 ~Rps-----~~~il~~p~~~~~ 265 (297)
+||| .++++.||||+..
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCCC
Confidence 9999 7889999999875
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=331.84 Aligned_cols=257 Identities=33% Similarity=0.602 Sum_probs=219.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+|++++.||+|+||.||++.++.+++.+++|++...........+.+.+|+.+++.+.|+||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444555677889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-----
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV----- 161 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~----- 161 (297)
||+++++|.+++.+...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999885321100
Q ss_pred -------c-----------------------------------ccccccCCccccCCccccccCCCCCchhHHHHHHHHH
Q 022444 162 -------S-----------------------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199 (297)
Q Consensus 162 -------~-----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~ 199 (297)
. ......|++.|+|||.+.+..++ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 0 00013588899999999877776 8999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHhhhc--cccCCC--CCChhHHHHHHHhcCCCcCCC---CCHHHHhcCcccccC
Q 022444 200 VLIAGYLPFDELDLTTLYSKVEKA--DFSCPT--WFPVGAKSLIHRILDPNPETR---ITIEEIRNDEWFRKG 265 (297)
Q Consensus 200 ~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~l~~li~~~L~~~p~~R---ps~~~il~~p~~~~~ 265 (297)
+|++|..||...+..+....+... ....+. .++.++.+|+++||. +|.+| +|+.++++||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999999999888877766666542 223333 478899999999998 67665 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=327.58 Aligned_cols=258 Identities=29% Similarity=0.541 Sum_probs=222.8
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||++.++.+++.+++|++.............+.+|+.+++.+.|++|+++++.+.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544555677889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-cc
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~ 164 (297)
||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999876 6799999999999999999999999999999999999999999999999999876543322 22
Q ss_pred ccccCCccccCCccccc------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----ccCCCCCChh
Q 022444 165 RTTCGTPNYVAPEVLSH------KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD----FSCPTWFPVG 234 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~ 234 (297)
....+++.|+|||.+.. ..+ +.++||||||+++|+|++|..||...+......++.... .+....++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTY-GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred ecccCCccccCHHHhccccccccCCC-CCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 33468889999999863 233 489999999999999999999998887777766665432 2233457899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+.+++..||+ +|++|||++++++||||++..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 9999999998 999999999999999998743
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=317.76 Aligned_cols=250 Identities=30% Similarity=0.507 Sum_probs=213.5
Q ss_pred eccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCCh
Q 022444 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (297)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (297)
||+|+||+||++.++.+++.+++|.+.............+..|+.+++.+.|+||+++.+++......+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998765544444456677899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCC
Q 022444 95 FDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170 (297)
Q Consensus 95 ~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 170 (297)
...+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..............++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 877642 3468999999999999999999999999999999999999999999999999987655443333445678
Q ss_pred ccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhhhccccCCCCCChhHHHHHHHhcCCC
Q 022444 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL----TTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 171 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
+.|+|||.+.+..++ .++|+||||+++|+|++|+.||..... ......+.......+..+|.++.+++.+||+.|
T Consensus 161 ~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 161 PGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred cCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence 899999999887776 899999999999999999999976432 233334444444556678999999999999999
Q ss_pred cCCCC-----CHHHHhcCcccccC
Q 022444 247 PETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 247 p~~Rp-----s~~~il~~p~~~~~ 265 (297)
|++|| +++++++||||+..
T Consensus 240 P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 240 PEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999 88999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=321.09 Aligned_cols=265 Identities=41% Similarity=0.751 Sum_probs=248.3
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.||++.+.||.|.+|.|.+|....+|..|+||.+++....+.+..-.+++|++++..++||||+.++++|++.+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 58999999999999999999999999999999999999888888889999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||..+|.|.+++...+.+++.+++.+++||.+|+.|.|+++++|+|+|.+||++|.++++|+.|||++...... .....
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kfLqT 211 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KFLQT 211 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999998766554 44567
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
.+|++.|.+||++.|.+|.++..|-||||+++|.|..|..||++.+...+...|..+.+..|. -|..+.-||+.||-.+
T Consensus 212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLmVN 290 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWMLMVN 290 (668)
T ss_pred hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHHhcC
Confidence 899999999999999999999999999999999999999999999999999999999887665 5788899999999999
Q ss_pred cCCCCCHHHHhcCcccccCcccccccc
Q 022444 247 PETRITIEEIRNDEWFRKGYVPVKLIE 273 (297)
Q Consensus 247 p~~Rps~~~il~~p~~~~~~~~~~~~~ 273 (297)
|.+|.|.++|-+|=|++=+|.-..+..
T Consensus 291 P~RRATieDiAsHWWvNwgy~~~V~~~ 317 (668)
T KOG0611|consen 291 PERRATIEDIASHWWVNWGYNMPVIQE 317 (668)
T ss_pred cccchhHHHHhhhheeecccccccccc
Confidence 999999999999999988776554443
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=324.37 Aligned_cols=253 Identities=35% Similarity=0.612 Sum_probs=220.0
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHH-HHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI-SIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||.|++|.||++++..+++.+++|++.............+..+. .+++.+.|+||+++++.+...+..+++|||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999765443333344444444 467888999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|...+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999998875433333334456888
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+.......+...+.++.+++.+||+.+|++|+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 161 EYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred ccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence 99999999877766 89999999999999999999999988888888888777777788899999999999999999999
Q ss_pred CH----HHHhcCcccccCc
Q 022444 252 TI----EEIRNDEWFRKGY 266 (297)
Q Consensus 252 s~----~~il~~p~~~~~~ 266 (297)
++ .++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 240 GAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCCCHHHHhCCCCcCCCC
Confidence 76 4999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=325.31 Aligned_cols=263 Identities=28% Similarity=0.460 Sum_probs=211.3
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CeE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----TKI 82 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 82 (297)
+|++.+.||+|++|.||+++++.+++.|++|.+..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999864321 122235677899999999999999999987432 358
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
|++|||+. ++|.+.+.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 58999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred ---ccccccCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh---------------
Q 022444 163 ---LLRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK--------------- 222 (297)
Q Consensus 163 ---~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~--------------- 222 (297)
......++..|+|||.+.+ ..+ +.++||||||+++|+|++|+.||...+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1234568889999999865 344 4899999999999999999999976654332211100
Q ss_pred c-----------ccc-----CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccccc
Q 022444 223 A-----------DFS-----CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273 (297)
Q Consensus 223 ~-----------~~~-----~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~ 273 (297)
. ..+ ....+++.+.+++.+||+.+|++|||++++|+||||++........+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~ 304 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPS 304 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccc
Confidence 0 000 01236788999999999999999999999999999987655443333
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=326.61 Aligned_cols=252 Identities=33% Similarity=0.607 Sum_probs=219.7
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS-IMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||.|+||+||+++++.+|+.+++|++.............+..+.. +++.+.|+||+++++.+...+..+++|||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333333344444444 56778999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|...+.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333334556889
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+.......+...+..+.+++.+||..+|.+||
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 161 EYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred hhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence 99999999887776 89999999999999999999999988888888887777777777899999999999999999999
Q ss_pred CH----HHHhcCcccccC
Q 022444 252 TI----EEIRNDEWFRKG 265 (297)
Q Consensus 252 s~----~~il~~p~~~~~ 265 (297)
++ .++++||||...
T Consensus 240 ~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 240 GAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 87 589999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=324.95 Aligned_cols=273 Identities=32% Similarity=0.516 Sum_probs=231.5
Q ss_pred ccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--
Q 022444 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-- 79 (297)
Q Consensus 2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 79 (297)
+.++.+.|+.+++||+|.||.||+|++..+|+.||+|+++.... .+.......+||.+|+++.||||+++.++..+.
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 35667789999999999999999999999999999999986552 233455677999999999999999999988665
Q ss_pred CeEEEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
..+|+|+|||+. +|.-++.+.+ .|++.++.-+++||+++|.|+|++|++|+|||.+|||||.+|.+|++|||++++..
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 689999999975 8888877643 69999999999999999999999999999999999999999999999999999765
Q ss_pred CCcc-ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc----------cC
Q 022444 159 QGVS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF----------SC 227 (297)
Q Consensus 159 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~----------~~ 227 (297)
.... .....+-+.+|+|||.+.|....+.+.|+||.||+|.+|++|++.|.+.+..+++.+|..... .+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 5443 356677888999999998876667999999999999999999999999988877777743311 01
Q ss_pred C-------------------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccC
Q 022444 228 P-------------------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYED 276 (297)
Q Consensus 228 ~-------------------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~ 276 (297)
| ..+|....+|+..||+.||++|.|+.++|+++||...+..-+-.+.+.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPK 417 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCC
Confidence 1 114678889999999999999999999999999976665555555555
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=323.77 Aligned_cols=258 Identities=33% Similarity=0.618 Sum_probs=219.6
Q ss_pred ceEEeEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKI 82 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 82 (297)
.|++.+.||+|++|.||++++. .+++.+++|++...... .....+....|+.+++.+. |++|+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 47899999999754332 2233456778999999995 89999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+++|||+.+++|.+++.....+++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875433222
Q ss_pred -ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHhhhccccCCCCCChhHHH
Q 022444 163 -LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL----DLTTLYSKVEKADFSCPTWFPVGAKS 237 (297)
Q Consensus 163 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~l~~ 237 (297)
......|+..|+|||.+.+....+.++||||||+++|+|++|..||... ........+.....+.+..++..+.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 2224468899999999976543448999999999999999999999642 33445555666666777789999999
Q ss_pred HHHHhcCCCcCCCC-----CHHHHhcCcccccC
Q 022444 238 LIHRILDPNPETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 238 li~~~L~~~p~~Rp-----s~~~il~~p~~~~~ 265 (297)
++.+||+.||++|| +++++++||||++.
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 88899999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=330.17 Aligned_cols=259 Identities=26% Similarity=0.491 Sum_probs=240.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe-EE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK-IY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~ 83 (297)
.++.|..++++|.|+||.+++++++.+++.+++|.+......... .....+|..+++++.||||+.+.+.|..+++ .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 468899999999999999999999999999999999876544333 4578899999999999999999999988887 99
Q ss_pred EEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 84 IILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
++|+||+||++.+.+.+.+ -++++.+..|+.|++.|+.|||+++|+|+|+|+.|||+++++.++|+|||+++......
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999999998765 48999999999999999999999999999999999999999999999999999998887
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIH 240 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~ 240 (297)
.......|++.|++||.+.+.++. .++|||||||++|+|++-+.+|...+...+..++.... .+.+..++.+++.+|.
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence 677788999999999999999998 99999999999999999999999999999999999888 6788889999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccC
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.||..+|..|||+.++|.+|.++.-
T Consensus 240 ~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHhhcCCccCCCHHHHhhChhhhhH
Confidence 9999999999999999999988743
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=327.69 Aligned_cols=260 Identities=33% Similarity=0.585 Sum_probs=221.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||+++++.+++.+++|++.............+.+|+.+++.+.||||+++++.+.+....|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 45689999999999999999999999999999999976444344445667889999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-c
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~ 163 (297)
||||+++++|.+++... .+++..+..++.+++.||.|||+.||+|+||||+||+++.++.++|+|||.+........ .
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 99999999999988654 689999999999999999999999999999999999999999999999999876543222 2
Q ss_pred cccccCCccccCCccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--ccCCC--CCChhHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKG---YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSCPT--WFPVGAK 236 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~l~ 236 (297)
.....|++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||...+.......+.... ...+. .++..+.
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 23556899999999986543 23489999999999999999999999888777777776533 33333 4689999
Q ss_pred HHHHHhcCCCcCC--CCCHHHHhcCcccccC
Q 022444 237 SLIHRILDPNPET--RITIEEIRNDEWFRKG 265 (297)
Q Consensus 237 ~li~~~L~~~p~~--Rps~~~il~~p~~~~~ 265 (297)
+++..||..++.+ |+|+.++++||||+..
T Consensus 280 ~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 280 NLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999999866554 8999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=329.67 Aligned_cols=257 Identities=35% Similarity=0.633 Sum_probs=222.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.|++++.||+|++|.||+++++.+++.+++|++.............+.+|+.++..++|++|+++++.+.+....|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998655444555677888999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc----
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---- 162 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~---- 162 (297)
||+++++|.+++.+...+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998764322100
Q ss_pred -------------------------------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022444 163 -------------------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (297)
Q Consensus 163 -------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~ 211 (297)
......|++.|+|||++.+..++ .++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 01124688999999999888776 8999999999999999999999988
Q ss_pred CHHHHHHHhhhcc--ccCCC--CCChhHHHHHHHhcCCCcCCCC---CHHHHhcCcccccC
Q 022444 212 DLTTLYSKVEKAD--FSCPT--WFPVGAKSLIHRILDPNPETRI---TIEEIRNDEWFRKG 265 (297)
Q Consensus 212 ~~~~~~~~i~~~~--~~~~~--~~~~~l~~li~~~L~~~p~~Rp---s~~~il~~p~~~~~ 265 (297)
+......++.... ..++. .+++++.+++.+|+. +|.+|+ +++++++||||++.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 8888777766432 23333 378899999999874 999998 48999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=315.65 Aligned_cols=256 Identities=36% Similarity=0.708 Sum_probs=230.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+|++.+.||.|++|.||++.+..+++.+++|.+.............+.+|++.++++.|+||+++++++......+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997655444455677889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++.+...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYT 157 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCC
Confidence 99999999999988889999999999999999999999999999999999999999999999999988765543 223
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
..+++.|+|||.+.+...+ .++|+||||+++|+|++|..||...+.....+.+..+....+..++..+.+++.+||..+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 236 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236 (290)
T ss_pred CCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCC
Confidence 4577899999998776655 899999999999999999999988887777777777777888889999999999999999
Q ss_pred cCCCC-----CHHHHhcCcccccCc
Q 022444 247 PETRI-----TIEEIRNDEWFRKGY 266 (297)
Q Consensus 247 p~~Rp-----s~~~il~~p~~~~~~ 266 (297)
|.+|+ +++++++||||+...
T Consensus 237 p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 237 LTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHHccCcccCCHHHHHcCcccccCC
Confidence 99999 999999999997754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=322.53 Aligned_cols=247 Identities=30% Similarity=0.501 Sum_probs=216.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcE-EEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-eEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGES-VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-KIYII 85 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~-~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 85 (297)
...+.+.||+|+||+||.+.+. |+. +++|.+......... .+.+.+|+.++.+++||||+++++++.+.. .+++|
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 4456677999999999999987 445 999999876655544 788999999999999999999999998877 79999
Q ss_pred EcccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CEEecCCCCCeeecCCC-CEEEcccCCCCCCCCCc
Q 022444 86 LEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKG-VYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGV 161 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~-i~h~di~~~nIli~~~~-~~~l~df~~~~~~~~~~ 161 (297)
|||+++|+|.+++.+ ...++...++.++.+|+.|+.|||+++ |||+|+||+||+++.++ ++|++|||+++......
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999999987 578999999999999999999999999 99999999999999997 99999999998776543
Q ss_pred cccccccCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh--hccccCCCCCChhHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVE--KADFSCPTWFPVGAKS 237 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~l~~ 237 (297)
.......|+..|+|||++.+ ..++ .++||||+|+++|+|+||..||...........+. ..++..+..+|+.+..
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~ 277 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSS 277 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 33444678999999999984 4665 99999999999999999999999998866655553 3345667779999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 022444 238 LIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+|+..||++||++.+|+.
T Consensus 278 l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 278 LMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999999999976
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=331.27 Aligned_cols=257 Identities=31% Similarity=0.543 Sum_probs=219.8
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.|++++.||+|++|.||+++++.+++.+|+|++.............+.+|+.+++.+.|+||+++++.+.+.+.+|++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997655444444567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC------
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG------ 160 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~------ 160 (297)
||+++++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999986422100
Q ss_pred -------------------------------------ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh
Q 022444 161 -------------------------------------VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA 203 (297)
Q Consensus 161 -------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~ 203 (297)
........|++.|+|||++.+..++ .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 0001123588899999999887776 89999999999999999
Q ss_pred CCCCCCCCCHHHHHHHhhhcc--cc--CCCCCChhHHHHHHHhcCCCcCCCC---CHHHHhcCcccccC
Q 022444 204 GYLPFDELDLTTLYSKVEKAD--FS--CPTWFPVGAKSLIHRILDPNPETRI---TIEEIRNDEWFRKG 265 (297)
Q Consensus 204 g~~pf~~~~~~~~~~~i~~~~--~~--~~~~~~~~l~~li~~~L~~~p~~Rp---s~~~il~~p~~~~~ 265 (297)
|..||...+..+....+.... .. ....++.++.+++.+|+ .+|.+|+ |+.++++||||+..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999888776655554332 22 22357899999999987 5999999 99999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=315.48 Aligned_cols=256 Identities=30% Similarity=0.491 Sum_probs=218.5
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|++.+.||.|++|.||++.+..+++.+++|.+.............+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999976544444444556789999999999999999999998899999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+.+++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIR 159 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-ccc
Confidence 99999998887543 358999999999999999999999999999999999999999999999999887643321 223
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHhhhccccCCCCCChhHHHHHHH
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL----YSKVEKADFSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~l~~li~~ 241 (297)
...++..|+|||.+.+..++ .++||||+|+++|++++|..||.+.+.... ...+.......+..++..+.+++.+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred cccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence 44678899999999877665 889999999999999999999987655333 3333344445566689999999999
Q ss_pred hcCCCcCCCC-----CHHHHhcCcccccC
Q 022444 242 ILDPNPETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 242 ~L~~~p~~Rp-----s~~~il~~p~~~~~ 265 (297)
||..||++|| ++.++++||||++.
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 9999999999 89999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=309.05 Aligned_cols=272 Identities=29% Similarity=0.392 Sum_probs=229.5
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCe
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTK 81 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 81 (297)
+.++.|+.++.|++|.||.||+|+++.+++-||+|.++...-... .-=...+|+.+|.++.|||||.+-++... -+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G-FPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG-FPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC-CcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 456789999999999999999999999999999999976541111 11124589999999999999999998754 357
Q ss_pred EEEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
+|+|||||.. +|.+++.+-+ +|...++.-++.|++.|+.|||.+.|+|+|+||+|++++..|.+|++|||+++..+++
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999999975 9999998765 7999999999999999999999999999999999999999999999999999998888
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----------------
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---------------- 224 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---------------- 224 (297)
.......+-+.+|+|||.+.+....+.+.|+||+||++.+|+++++.|.+..-.+..++|-..-
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 7777777888999999999988777799999999999999999999998887666666552210
Q ss_pred ---------------ccCCCC-CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCC
Q 022444 225 ---------------FSCPTW-FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDV 277 (297)
Q Consensus 225 ---------------~~~~~~-~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~ 277 (297)
..++.. +++...+|++.+|..||.+|.|+++.|.|+||...+.+.+=.-.|.+
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~ 379 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTW 379 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCC
Confidence 011111 45778899999999999999999999999999997666554444433
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=323.81 Aligned_cols=252 Identities=35% Similarity=0.608 Sum_probs=218.9
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHH-HHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKRE-ISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|+||.||+++++.+++.+++|++.............+..+ ..+++.+.|+||+++++.+...+..+++|||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999976543333333333333 3456788999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|.+.+.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..............|++
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999875433333334556889
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
.|+|||++.+..++ .++||||||+++|+|++|..||...+..+..+.+.......+..++..+.+++.+||+.+|.+|+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 161 EYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred cccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 99999999887776 89999999999999999999999988888888887777777778999999999999999999999
Q ss_pred CHH----HHhcCcccccC
Q 022444 252 TIE----EIRNDEWFRKG 265 (297)
Q Consensus 252 s~~----~il~~p~~~~~ 265 (297)
++. ++++|+||...
T Consensus 240 ~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 240 GAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CCCCCHHHHhcCcccCCC
Confidence 876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=322.34 Aligned_cols=252 Identities=29% Similarity=0.605 Sum_probs=219.1
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||+|++|.||++.++.+++.+++|++...........+.+.+|..+++++ .|++|+++++.+......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555555567788899988888 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|...+.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..............|++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999998875433323334556889
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-------DLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
.|+|||.+.+..++ .++||||||+++|+|++|..||... ......+.+.....+.+..++..+.+++.+||+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 161 NYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred ccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999877776 8999999999999999999999532 223445555555667778899999999999999
Q ss_pred CCcCCCCC------HHHHhcCcccccC
Q 022444 245 PNPETRIT------IEEIRNDEWFRKG 265 (297)
Q Consensus 245 ~~p~~Rps------~~~il~~p~~~~~ 265 (297)
.||++|++ ++++++||||+..
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999998 5799999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=313.65 Aligned_cols=252 Identities=37% Similarity=0.671 Sum_probs=213.9
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
|++++.||+|++|+||++.+..+++.+|+|.+......... .....+|+..++.++|+||+++++++......+++|++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999887644433 23345699999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccccc
Q 022444 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC 168 (297)
Q Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~ 168 (297)
+.+++|.+++.+...++...++.++.++++||.+||+.|++|+||+|+||+++.++.++|+|||.+..............
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999888999999999999999999999999999999999999999999999999999875433334445667
Q ss_pred CCccccCCcccc-ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhhhccccCCC----CCChhHHHHHH
Q 022444 169 GTPNYVAPEVLS-HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT---TLYSKVEKADFSCPT----WFPVGAKSLIH 240 (297)
Q Consensus 169 ~~~~~~aPE~~~-~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~----~~~~~l~~li~ 240 (297)
++..|.|||.+. +... +.++|+||||+++++|++|..||...... ............... ..+.++.+++.
T Consensus 160 ~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 238 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK 238 (260)
T ss_dssp SSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred ccccccccccccccccc-cccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence 888999999987 4444 49999999999999999999999887322 233322222221111 12489999999
Q ss_pred HhcCCCcCCCCCHHHHhcCccc
Q 022444 241 RILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~ 262 (297)
+||+.||++|||+.++++||||
T Consensus 239 ~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 239 KMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=319.13 Aligned_cols=259 Identities=25% Similarity=0.442 Sum_probs=214.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++++|.+.+.||+|++|.||+++++.+++.+++|.+..... ......+.+|+..+++++|+||+++++++......++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 46789999999999999999999999999999999875432 1223346689999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+|||+.+ +|.+++.... .++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9999976 8888776543 5889999999999999999999999999999999999999999999999998765443333
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--------------------
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-------------------- 223 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~-------------------- 223 (297)
.....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+..+....+...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 344567889999999876543448999999999999999999999877654443322110
Q ss_pred -cc---------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 224 -DF---------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 224 -~~---------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
.. .....++.++.+++.+||+.||.+|||++|+++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00 01123678899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=325.56 Aligned_cols=251 Identities=31% Similarity=0.564 Sum_probs=216.4
Q ss_pred eccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc---CCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
||+|+||+||+++++.+++.+++|++................+..++... .||+|+++++.+......|++|||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443333344445566666555 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|.+.+.+...+++..++.++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++..............|+.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999875443333344556889
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC-CCChhHHHHHHHhcCCCcCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT-WFPVGAKSLIHRILDPNPETR 250 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~l~~li~~~L~~~p~~R 250 (297)
.|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.......+. .+++++.+++.+||+.||++|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 9999999876543348999999999999999999999998888888888777666654 378999999999999999999
Q ss_pred C----CHHHHhcCcccccC
Q 022444 251 I----TIEEIRNDEWFRKG 265 (297)
Q Consensus 251 p----s~~~il~~p~~~~~ 265 (297)
| ++.++++||||...
T Consensus 241 ~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 241 LGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCCHHHHhcCccccCC
Confidence 8 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=328.41 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=231.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|...+.||+|.||.||+|.+..+++-||+|++....... ....+.+|+.++..++++||.++|+.+-.+..+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 35888899999999999999999999999999998766333 3677889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|||.||++.+.++....+.+..+.-+++.++.|+.|||..+.+|+||++.||+++.+|.++|+|||.+............
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999887776666678
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-CCCCCChhHHHHHHHhcCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~l~~li~~~L~~ 245 (297)
.+|++.|||||++.+..|+ .++||||||++.++|++|.+|+...++.....-|....+| ....+++.+++|+..||++
T Consensus 171 fvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k 249 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDK 249 (467)
T ss_pred ccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhc
Confidence 8999999999999988888 9999999999999999999999988875544444444333 2334788999999999999
Q ss_pred CcCCCCCHHHHhcCcccccCccc
Q 022444 246 NPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 246 ~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
||+.|||+.++|+|+|+++....
T Consensus 250 ~P~~RpsA~~LLKh~FIk~a~k~ 272 (467)
T KOG0201|consen 250 NPEFRPSAKELLKHKFIKRAKKT 272 (467)
T ss_pred CcccCcCHHHHhhhHHHHhcCCc
Confidence 99999999999999999996533
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=325.16 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=214.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|+.++.||.|++|.||++++..+++.|++|++.... .......+.+|+.+++.++|+||+++++++......++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3567999999999999999999999999999999986543 23345678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+|||+.+++|.+. ...++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 9999999988643 245678889999999999999999999999999999999999999999999987655433333
Q ss_pred ccccCCccccCCccccc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhh-hccccCCCCCChhHH
Q 022444 165 RTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT---LYSKVE-KADFSCPTWFPVGAK 236 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~---~~~~i~-~~~~~~~~~~~~~l~ 236 (297)
....++..|+|||.+.. ..+.+.++||||||+++|+|++|+.||......+ ....+. ......+..++.++.
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 305 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR 305 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence 44568899999998743 2233468999999999999999999997433222 222222 222344556889999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 237 SLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
+||.+||+.||++|||+.|+++||||.+...+..
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~~ 339 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQHPFILRAQPGQG 339 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccccCCcccc
Confidence 9999999999999999999999999999866543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=322.64 Aligned_cols=260 Identities=34% Similarity=0.583 Sum_probs=221.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||+++++.+++.+++|++.............+.+|..+++.+.||||+++++.+......++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999999976544444445667889999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-c
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~ 163 (297)
+|||+++++|.+++.. ..+++..+..++.+++.||.|||+.||+|+||||+||+++.++.++|+|||.+........ .
T Consensus 121 v~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 121 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence 9999999999998865 4689999999999999999999999999999999999999999999999999876543222 2
Q ss_pred cccccCCccccCCccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--ccCC--CCCChhHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKG---YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSCP--TWFPVGAK 236 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~l~ 236 (297)
.....|++.|+|||.+.+.. ..+.++||||||+++|+|++|..||...+......++.... ..++ ..++..+.
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHH
Confidence 23456899999999986543 23489999999999999999999999888877777776543 2233 35889999
Q ss_pred HHHHHhcCCCcCC--CCCHHHHhcCcccccC
Q 022444 237 SLIHRILDPNPET--RITIEEIRNDEWFRKG 265 (297)
Q Consensus 237 ~li~~~L~~~p~~--Rps~~~il~~p~~~~~ 265 (297)
+++.+||..++.+ |++++++++||||++.
T Consensus 280 ~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 280 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999999854543 8899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=314.74 Aligned_cols=259 Identities=24% Similarity=0.429 Sum_probs=215.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++++|++.+.||.|++|.||++.++.+++.|++|.+..... ......+.+|+..++.++|+||+++++++......++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 57889999999999999999999999999999999865431 1223446689999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
++||+.+ +|.+++... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9999975 888887653 46899999999999999999999999999999999999999999999999998765443333
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-------------------c
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-------------------D 224 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~-------------------~ 224 (297)
.....+++.|+|||.+.+....+.++||||||+++|+|++|+.||...+..+....+... .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 344556889999999876543458999999999999999999999877765444332111 0
Q ss_pred cc-----------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 225 FS-----------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 225 ~~-----------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
.. ....++..+.++|.+||+.||.+|||+.++|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 1123678899999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=321.86 Aligned_cols=263 Identities=39% Similarity=0.733 Sum_probs=242.3
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+=|.+.+.||+|.|.+|.+|++..+|+.|+||++.+....+.. ...+.+|+..++.++|||||++|++...+..+|+|.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3588999999999999999999999999999999887654433 466789999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec-CCCCEEEcccCCCCCCCCCcccc
Q 022444 87 EFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~-~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|.-++|+|++++.++. .+++....+++.||+.|+.|.|+..+||+|+||+||.+. +-|-+||+|||++.....+ ...
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL 175 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKL 175 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-chh
Confidence 9999999999998654 699999999999999999999999999999999998775 5788999999998776665 455
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
...+|+..|-|||++.|..|+.++.||||||+++|.|..|+.||...+..+.+..|...++..|+.++.++++||..||.
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLV 255 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHh
Confidence 67789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCcccccc
Q 022444 245 PNPETRITIEEIRNDEWFRKGYVPVKL 271 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~~~~~~ 271 (297)
.||++|.|.++|..++|+|.+-+...-
T Consensus 256 RdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 256 RDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred cCchhhccHHHHhccccccCCCCCccc
Confidence 999999999999999999998776543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=308.18 Aligned_cols=269 Identities=27% Similarity=0.406 Sum_probs=223.3
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-----CCe
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-----RTK 81 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 81 (297)
.+|..++.||.|++|.|..+.++.+|+.||||++.... ......++..+|+++++.++|+||+.+.+++.. -..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 35667899999999999999999999999999986433 344557788899999999999999999998854 346
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC-
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG- 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~- 160 (297)
.|+|+|.|. .+|.+.++.++.+++..+..++.|++.||.|+|+.|++|+|+||+|++++.+..+|++|||+++.....
T Consensus 101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 899999995 599999998878999999999999999999999999999999999999999999999999999877542
Q ss_pred -ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc----------------
Q 022444 161 -VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---------------- 223 (297)
Q Consensus 161 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---------------- 223 (297)
.......+.+.+|+|||.+....-.+.+.||||+||++.+|++|++.|.+.+...+++.+...
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 233456778899999999865444459999999999999999999999887644444333111
Q ss_pred ------------ccc---CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCC
Q 022444 224 ------------DFS---CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDV 277 (297)
Q Consensus 224 ------------~~~---~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~ 277 (297)
..+ .-+..++.+.+|+.+||..||.+|+|++|+|+|||+.....+.+=..-+..
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~ 328 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPI 328 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCC
Confidence 000 012356889999999999999999999999999999999777665544433
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=305.88 Aligned_cols=255 Identities=28% Similarity=0.521 Sum_probs=218.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh--hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+.|++.+.||.|++|.||.+.+..+++++++|.+...... .....+.+.+|+..+++++|+||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999999999999998754322 22235678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
++|++++++|.+.+...+.+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999886543321111
Q ss_pred ---ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cccCCCCCChhHHHHH
Q 022444 165 ---RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPVGAKSLI 239 (297)
Q Consensus 165 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~l~~li 239 (297)
....++..|+|||.+.+...+ .++||||||+++|++++|+.||...+........... ....+..++..+.+++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 234567789999999877655 9999999999999999999999876655544443332 3345667899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCccc
Q 022444 240 HRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
.+||..+|++|||++++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=323.71 Aligned_cols=257 Identities=27% Similarity=0.449 Sum_probs=213.9
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----eE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-----KI 82 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 82 (297)
.|++.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47899999999999999999999999999998864321 2223456789999999999999999999987665 78
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV- 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~- 161 (297)
|+++||+. ++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 5888888887889999999999999999999999999999999999999999999999999987544322
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc------------------
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA------------------ 223 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~------------------ 223 (297)
.......++..|+|||.+.+....+.++|||||||++|+|++|+.||...+..+....+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 12233456789999999877554458999999999999999999999887765554443211
Q ss_pred -----c---------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 224 -----D---------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 224 -----~---------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
. .......++++.+|+.+||+.||++|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0 012233578899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=317.12 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=216.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.++||.|++|.||++.++.++..+++|.+.... .......+.+|++.++.++|+||+++++++...+..+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 468999999999999999999999999999999886542 223356688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|||+++++|.+++.+.+.+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 159 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA 159 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--cc
Confidence 99999999999999888899999999999999999999975 7999999999999999999999999988654332 12
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh------------------------
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV------------------------ 220 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i------------------------ 220 (297)
....++..|+|||.+.+..++ .++|+||||+++|++++|..||...........+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred ccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 234578899999999877665 8999999999999999999999765543332111
Q ss_pred --------------------hhcc-ccCC-CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 221 --------------------EKAD-FSCP-TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 221 --------------------~~~~-~~~~-~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.... ...+ ..++.++.+|+.+||++||++|||+.+++.||||+....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~ 308 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAE 308 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccc
Confidence 0000 1111 1257889999999999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=303.01 Aligned_cols=253 Identities=26% Similarity=0.520 Sum_probs=217.0
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-CCeEEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-RTKIYIIL 86 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 86 (297)
.|++.+.||.|++|.||++.++.+++.+++|.+...... ....+.+.+|+..+++++|+|++++++.+.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 589999999999999999999999999999998654322 2234567889999999999999999988764 44689999
Q ss_pred cccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 87 EFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|++++++|.+++.. ...+++.+++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 99999999998875 3458999999999999999999999999999999999999999999999999987654433333
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHHhc
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~L 243 (297)
....+++.|+|||.+.+..++ .++|+||||++++++++|..||...+.......+..+.. ..+..+++++.+++.+|+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML 238 (257)
T ss_pred ccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence 445678899999999877766 899999999999999999999988777666665555443 445668899999999999
Q ss_pred CCCcCCCCCHHHHhcCccc
Q 022444 244 DPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~ 262 (297)
+.+|.+|||+.++++||||
T Consensus 239 ~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 239 SKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=303.14 Aligned_cols=253 Identities=27% Similarity=0.468 Sum_probs=221.1
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|.+.+.||+|++|.||++.++.+++.+++|.+...... ......+.+|+..++.++|+|++++++.+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999998754332 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+++++|.+++... ..++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999998764 5689999999999999999999999999999999999999999999999998876554433334
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHHhcC
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~L~ 244 (297)
...++..|+|||.+.+..++ .++|+||||+++++|++|..||...+.......+..... +.+..++.++.+++.+|++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 45678899999999877766 899999999999999999999988887776666655543 3445789999999999999
Q ss_pred CCcCCCCCHHHHhcCccc
Q 022444 245 PNPETRITIEEIRNDEWF 262 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~ 262 (297)
.+|++||++.++++|||+
T Consensus 239 ~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 239 KDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCcccCcCHHHHhhCCCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=318.94 Aligned_cols=259 Identities=29% Similarity=0.456 Sum_probs=209.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (297)
..++|++.+.||+|+||.||++.+..+|+.+++|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 46799999999999999999999999999999999865432 223345677899999999999999999988543
Q ss_pred -CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
...|++|||+.+ +|.+.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 357999999976 5666654 358899999999999999999999999999999999999999999999999987543
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh----------------
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK---------------- 222 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~---------------- 222 (297)
.. .......++..|+|||.+.+..++ .++||||||+++|+|++|..||.+.+..+....+..
T Consensus 175 ~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 175 TN-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cC-ccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 32 222345678899999999887776 899999999999999999999987664432221110
Q ss_pred ------cccc--------------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 223 ------ADFS--------------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 223 ------~~~~--------------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
.... .....++++.+|+.+||..||++|||+.|+|+||||+....+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 0000 0112357789999999999999999999999999998755443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=322.32 Aligned_cols=250 Identities=20% Similarity=0.312 Sum_probs=205.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
..+|++++.||.|++|.||++.+..+++.|++|... ...+.+|+.+++.++||||+++++++......+++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 357999999999999999999999999999999643 23356899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC-cccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG-VSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~-~~~~ 164 (297)
+|++. ++|..++.....+++..++.++.+++.||.|||+.||+|+||||+||+++.++.++|+|||.+...... ....
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 99996 589888888788999999999999999999999999999999999999999999999999998653322 1223
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHh-----------------
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD-------LTTLYSKV----------------- 220 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-------~~~~~~~i----------------- 220 (297)
....|++.|+|||++.+..++ .++||||||+++|+|++|..||.... .......+
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred ccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 345789999999999877766 99999999999999999998764321 00000000
Q ss_pred ---------hhccccC---------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 221 ---------EKADFSC---------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 221 ---------~~~~~~~---------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
....... ...+|.++.+++.+||++||.+|||++|+|+||||+..+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0000000 012567899999999999999999999999999998854
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=315.23 Aligned_cols=259 Identities=29% Similarity=0.561 Sum_probs=217.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||+++++.+++.+|+|++...........+.+.+|..+++.+.|+||+++++.+....+.|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997644444444566888999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-cc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~ 164 (297)
||+.+++|.+++.+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999976 45789999999999999999999999999999999999999999999999998865443222 22
Q ss_pred ccccCCccccCCccccc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--ccCC---CCCChhH
Q 022444 165 RTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSCP---TWFPVGA 235 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~l 235 (297)
....+++.|+|||++.. ....+.++||||||+++|+|++|+.||...+..+....+.... ...+ ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23468899999999863 2223478999999999999999999998887777666664432 2222 3478999
Q ss_pred HHHHHHhcCCCcCC--CCCHHHHhcCcccccC
Q 022444 236 KSLIHRILDPNPET--RITIEEIRNDEWFRKG 265 (297)
Q Consensus 236 ~~li~~~L~~~p~~--Rps~~~il~~p~~~~~ 265 (297)
.+++++||..++++ |++++++++||||...
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 99999999764444 8899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=308.98 Aligned_cols=256 Identities=30% Similarity=0.495 Sum_probs=215.0
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||.|++|.||++.+..+++.+++|.+.............+.+|+.+++.++|++++++++.+...+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999876544444444556789999999999999999999999899999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+.+++|.+.+... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIK 159 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-ccc
Confidence 99999999888543 358999999999999999999999999999999999999999999999999886543321 223
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhhhccccCCCCCChhHHHHHHH
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT----TLYSKVEKADFSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~l~~li~~ 241 (297)
...++..|+|||.+.+..++ .++|+||+|+++|+|++|..||...... .............+..+++++.+|+.+
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred CCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence 44688899999999877766 8999999999999999999999765321 111111222233455688999999999
Q ss_pred hcCCCcCCCCC-----HHHHhcCcccccC
Q 022444 242 ILDPNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 242 ~L~~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
||+.||.+||| ++++++||||++.
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999 8999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=307.25 Aligned_cols=253 Identities=31% Similarity=0.614 Sum_probs=224.0
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||.|++|.||++.+..+++.+++|.+...........+.+.+|+..+++++||||+++++.+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999986554444556788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
|+.+++|.+.+....++++..+..++.+++++|.|||++|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTST 159 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccccc
Confidence 99999999999887789999999999999999999999999999999999999999999999999887654432 22345
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD---LTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
.++..|+|||.+.+...+ .++|+||||+++|++++|..||...+ ...+.+.........+..+|.++.+++++||+
T Consensus 160 ~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (258)
T cd05578 160 SGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLE 238 (258)
T ss_pred CCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHcc
Confidence 577889999999877655 89999999999999999999998776 44455444445566777899999999999999
Q ss_pred CCcCCCCCH--HHHhcCccc
Q 022444 245 PNPETRITI--EEIRNDEWF 262 (297)
Q Consensus 245 ~~p~~Rps~--~~il~~p~~ 262 (297)
.+|.+||++ .++++||||
T Consensus 239 ~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 239 RDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CChhHcCCccHHHHhcCCCC
Confidence 999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=311.50 Aligned_cols=259 Identities=31% Similarity=0.550 Sum_probs=223.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+|++.+.||+|++|.||++.+..+++.+++|.+.............+.+|++.++.+.|+||+++++.+......++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--
Q 022444 87 EFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-- 162 (297)
Q Consensus 87 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-- 162 (297)
|++.+++|.+++... ..+++..++.++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 4689999999999999999999999999999999999999999999999998764432111
Q ss_pred ---------------------------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022444 163 ---------------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (297)
Q Consensus 163 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~ 215 (297)
......++..|+|||.+.+...+ .++||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 11123567789999999877665 89999999999999999999998888777
Q ss_pred HHHHhhhccccCCCC--CChhHHHHHHHhcCCCcCCCCC----HHHHhcCcccccCc
Q 022444 216 LYSKVEKADFSCPTW--FPVGAKSLIHRILDPNPETRIT----IEEIRNDEWFRKGY 266 (297)
Q Consensus 216 ~~~~i~~~~~~~~~~--~~~~l~~li~~~L~~~p~~Rps----~~~il~~p~~~~~~ 266 (297)
...++.......+.. ++..+.+++.+||..+|++||| ++++|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 766666555444443 6899999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=298.86 Aligned_cols=257 Identities=37% Similarity=0.677 Sum_probs=227.8
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh-----hHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMKLVR-HPCVVRLHEVLASRT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (297)
..|...+.||.|..++|-++.++.+|+.+++|++...... ..+..+.-.+|+.+|+++. ||+|.++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4677888999999999999999999999999998532211 3344566788999999996 999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..++|+|.|+.|.|++++...-.+++++.+.++++++++++|||..+|+|+|+||+||+++++.+++++|||+++....+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999988776
Q ss_pred ccccccccCCccccCCccccc------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCC----
Q 022444 161 VSLLRTTCGTPNYVAPEVLSH------KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW---- 230 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---- 230 (297)
......+|+|+|.|||.+.. .+| +...|+|++|++||.|+.|.+||-.....-+...|..+++.+.+.
T Consensus 177 -ekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad 254 (411)
T KOG0599|consen 177 -EKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD 254 (411)
T ss_pred -hhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence 44557899999999999843 333 478999999999999999999998777777888999998766443
Q ss_pred CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 231 FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 231 ~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
++....++|++||+.||.+|.|++|+|+||||++-
T Consensus 255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 67889999999999999999999999999999654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=309.73 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=215.3
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||++.+..++..+++|.+.... .......+.+|++.+++++|+||+++++.+...+..++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999886543 2334566888999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
||+++++|.+++.+...+++..+..++.++++||.|||+ ++++|+||+|+||+++.++.++++|||.+...... ...
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~ 156 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN 156 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccc
Confidence 999999999999888889999999999999999999997 69999999999999999999999999987654332 123
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc----------------------
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---------------------- 223 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---------------------- 223 (297)
...++..|+|||.+.+..++ .++|+||||+++|++++|..||...+.......+...
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred cCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 44678899999998776665 8999999999999999999999765543332222111
Q ss_pred --------------c-ccCC-CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 224 --------------D-FSCP-TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 224 --------------~-~~~~-~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
. ...+ ..++.++.+|+.+||+.+|++|||++++++||||++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 0 0011 1257789999999999999999999999999999886443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=309.68 Aligned_cols=252 Identities=29% Similarity=0.423 Sum_probs=202.3
Q ss_pred cceEEeEEeccCCceeEEEEEeCC-CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc---CCCCeeEEEEEEE-----
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE-TGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLA----- 77 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~----- 77 (297)
.+|++.+.||+|++|.||++++.. ++..+++|.+....... .......+|+..++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 46889999886543222 1123344555555554 6999999999874
Q ss_pred cCCeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 78 SRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
.....++++|++. ++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999997 4898888653 358999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc----------
Q 022444 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---------- 225 (297)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---------- 225 (297)
..... .......++..|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+.....
T Consensus 159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCC-cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 55433 223345678899999999877666 899999999999999999999988776665555432110
Q ss_pred -----------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 226 -----------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 226 -----------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
.....+++.+.+++.+||+.||++|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112367788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=306.68 Aligned_cols=258 Identities=28% Similarity=0.497 Sum_probs=224.0
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .......+.+|+.+++.+.|+|++++++.+.+....++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47999999999999999999999999999999987543 2233466788999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|++++++|.+++... ++++..++.++.+++.|+.+||+.|++|+||+|+||+++.++.++++|||.+............
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 999999999998765 8899999999999999999999999999999999999999999999999998776654344445
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCC-CChhHHHHHHHhcC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTW-FPVGAKSLIHRILD 244 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~-~~~~l~~li~~~L~ 244 (297)
..++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+..... ..+.. ++.++.+++.+||.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred ccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence 5677889999999877765 999999999999999999999988776665555544433 22333 78899999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCccc
Q 022444 245 PNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+|++|||++++++||||++..+.
T Consensus 237 ~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 237 KDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred CChhhCcCHHHHhhChhhcCCCcc
Confidence 999999999999999999987554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=318.28 Aligned_cols=244 Identities=29% Similarity=0.480 Sum_probs=216.4
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
++.++.||+|.||.||.+.++.+ ..|++|.+....... +.+.+|++++++++|++|+++++++..++.++|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 45678999999999999999744 369999987643222 3456999999999999999999999988889999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc-cc
Q 022444 89 ITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL-LR 165 (297)
Q Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~-~~ 165 (297)
++.|+|.+++.. ...+...+++.++.|||++++||+++++||+||-+.||||+.+..+|++|||+++........ ..
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999999987 456899999999999999999999999999999999999999999999999999965544332 33
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHHhc
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~L 243 (297)
+..-+..|.|||++....++ .+|||||+|++||+++| |+.||.+.+..+..+.+..+ +.+.|..+|+++.+++..|+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW 441 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCW 441 (468)
T ss_pred CCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHh
Confidence 44456799999999988887 99999999999999999 99999999999999999887 57889999999999999999
Q ss_pred CCCcCCCCCHHHHhc
Q 022444 244 DPNPETRITIEEIRN 258 (297)
Q Consensus 244 ~~~p~~Rps~~~il~ 258 (297)
..+|++|||++.+..
T Consensus 442 ~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 442 HEDPEDRPTFETLRE 456 (468)
T ss_pred hCCcccCCCHHHHHH
Confidence 999999999997754
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=308.34 Aligned_cols=261 Identities=30% Similarity=0.465 Sum_probs=223.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||.|++|.||++.+..+++.+++|.+.... ....+.+.+|+.++++++|+|++++++.+......+++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 357999999999999999999999899999999986543 23345677899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|||+++++|.+++.+. ..+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++.++++|||.+..........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999999988764 468999999999999999999999999999999999999999999999999877655443434
Q ss_pred ccccCCccccCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc---cCCCCCChhHH
Q 022444 165 RTTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---SCPTWFPVGAK 236 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~l~ 236 (297)
....++..|+|||.+.. ..+ +.++|+||||+++|+|++|..||...+......++..... ..+..++.++.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~-~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPY-DYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCC-CccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 45567889999999752 223 3789999999999999999999988877766666655432 23456889999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 237 SLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
+++.+||+.+|++|||++++++||||.+...+.+
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 273 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKA 273 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhcccchhHH
Confidence 9999999999999999999999999998754433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=309.44 Aligned_cols=264 Identities=30% Similarity=0.436 Sum_probs=219.6
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh--hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+|++.+.||.|++|.||++.+..+++.+++|.+...... .......+..|+..++.++|+|++++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765432 122345567899999999999999999999998999999
Q ss_pred EcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|||+ +++|.+++.... .+++..++.++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999998766 79999999999999999999999999999999999999999999999999987665543333
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--------------------
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-------------------- 224 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-------------------- 224 (297)
....++..|.|||.+.+....+.++|+||||++++++++|..+|...+..+...++....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 344567789999998654444589999999999999999988887766544443332110
Q ss_pred ---c-----cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccc
Q 022444 225 ---F-----SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLI 272 (297)
Q Consensus 225 ---~-----~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~ 272 (297)
. ......+..+.+++.+||+++|++|||+.++++||||++.+.+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~ 295 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS 295 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCC
Confidence 0 00122467889999999999999999999999999999998877543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=303.76 Aligned_cols=263 Identities=28% Similarity=0.442 Sum_probs=222.8
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEEcCC-----
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRT----- 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 80 (297)
..|+.+++||.|.+|+||.|+.+.+|+.||+|++...... +..-....+|+.+++.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4578888999999999999999999999999999765421 122344679999999999999 999999997766
Q ss_pred -eEEEEEcccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 81 -KIYIILEFITGGELFDKIVHHG----RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 81 -~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
.+++|+|+++. +|..++.... .++...++.++.||+.||+|||++||+|+|+||.||+|+.+|.+||+|||+++
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 78999999975 9999998755 57788999999999999999999999999999999999999999999999999
Q ss_pred CCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc------------
Q 022444 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA------------ 223 (297)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~------------ 223 (297)
....+.......+.+..|+|||++.+....+...||||+||++++|+++...|.+....++..+|-..
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 77766666677788889999999998866669999999999999999999999888776666655221
Q ss_pred ------cccCCCC------------CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccc
Q 022444 224 ------DFSCPTW------------FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKL 271 (297)
Q Consensus 224 ------~~~~~~~------------~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~ 271 (297)
+..++.. ...+..+++.+||+.+|.+|.|++.+|.||||+....+...
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~ 314 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ 314 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence 1111111 12478899999999999999999999999999998665544
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=302.95 Aligned_cols=254 Identities=28% Similarity=0.517 Sum_probs=217.2
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh------hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII------KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
+|.+...||.|++|.||.|.+..+++.+++|.+...... .....+.+.+|+.+++++.|+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578889999999999999999989999999988643221 22344668899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
.++++||+++++|.+++...+.+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999887654321
Q ss_pred cc------cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-cccCCCCCChh
Q 022444 162 SL------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-DFSCPTWFPVG 234 (297)
Q Consensus 162 ~~------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 234 (297)
.. .....++..|+|||.+.+..++ .++|+||||+++|+|++|+.||...+.......+... ....+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 11 1123467789999999877665 8999999999999999999999877655544444333 34556678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
+.+++.+||+.+|++||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=302.76 Aligned_cols=249 Identities=35% Similarity=0.685 Sum_probs=219.3
Q ss_pred eccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCCh
Q 022444 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (297)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (297)
||.|++|.||++++..+++.+++|.+...........+.+.+|+.+++.+.|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999999999999999876555455567789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCcccc
Q 022444 95 FDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174 (297)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 174 (297)
.+++.+...++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence 9999888789999999999999999999999999999999999999999999999999987665432 222345778999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhh--hccccCCCCCChhHHHHHHHhcCCCcCCC
Q 022444 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVE--KADFSCPTWFPVGAKSLIHRILDPNPETR 250 (297)
Q Consensus 175 aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~--~~~~~~~i~--~~~~~~~~~~~~~l~~li~~~L~~~p~~R 250 (297)
|||.+.+..++ .++|+||||+++|++++|..||.... .......+. ......+...++++.+++.+||+.+|++|
T Consensus 160 ~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 160 APEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred ChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence 99998776665 89999999999999999999998776 556666655 34556666678999999999999999999
Q ss_pred CC-----HHHHhcCcccccC
Q 022444 251 IT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 251 ps-----~~~il~~p~~~~~ 265 (297)
|+ ++++++||||.+.
T Consensus 239 ~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 239 LGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred cCCcccCHHHHhcChhhhCC
Confidence 99 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=325.66 Aligned_cols=253 Identities=28% Similarity=0.380 Sum_probs=204.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-------
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------- 78 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 78 (297)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999999999999999885432 223468999999999999999887632
Q ss_pred -CCeEEEEEcccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccC
Q 022444 79 -RTKIYIILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFG 152 (297)
Q Consensus 79 -~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~ 152 (297)
...++++|||+++ +|.+++. ....+++..++.++.|++.||.|||+.||+|+||||+||+++.++ .++|+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 1246799999975 6766654 345789999999999999999999999999999999999998665 69999999
Q ss_pred CCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc---------
Q 022444 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--------- 223 (297)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--------- 223 (297)
++........ .....+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 217 la~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 217 SAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred cchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 9876543322 224567889999999876543348999999999999999999999887655444333211
Q ss_pred --------c------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 224 --------D------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 224 --------~------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
. ..++...|+++.+|+.+||++||.+|||+.++|+||||+....
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0 0123346789999999999999999999999999999987543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=305.09 Aligned_cols=249 Identities=29% Similarity=0.479 Sum_probs=207.0
Q ss_pred eccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCCh
Q 022444 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (297)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (297)
||+|+||.||+++++.+|+.+++|.+.............+..|+++++.++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998754433333344556789999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCcc
Q 022444 95 FDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (297)
Q Consensus 95 ~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 172 (297)
.+.+.... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence 88875433 58899999999999999999999999999999999999999999999999887654332 2234567889
Q ss_pred ccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhhhccccC-CCCCChhHHHHHHHhcCCCc
Q 022444 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL----TTLYSKVEKADFSC-PTWFPVGAKSLIHRILDPNP 247 (297)
Q Consensus 173 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~-~~~~~~~l~~li~~~L~~~p 247 (297)
|+|||++.+..++ .++|+||||+++|+|++|..||..... .............. ...+++++.+++++||+.||
T Consensus 160 y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 160 YMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred ccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence 9999999877765 999999999999999999999976432 23333333333222 23578999999999999999
Q ss_pred CCCCCH----HHHhcCcccccC
Q 022444 248 ETRITI----EEIRNDEWFRKG 265 (297)
Q Consensus 248 ~~Rps~----~~il~~p~~~~~ 265 (297)
.+||++ ++++.||||+..
T Consensus 239 ~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 239 EDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hhCCCCccchhhhhcChhhcCC
Confidence 999999 678899999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=315.31 Aligned_cols=266 Identities=26% Similarity=0.386 Sum_probs=212.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (297)
-.++|++.+.||.|+||.||++.+..+++.||+|.+..... .......+.+|+..++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34689999999999999999999999999999999875432 222345577899999999999999999877432
Q ss_pred -CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
...+++++++ +++|.+++. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3578999988 668877665 4579999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-------------
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------------- 225 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------------- 225 (297)
.. .....++..|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+.....
T Consensus 170 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred CC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 32 22446788999999987644345899999999999999999999987665444333221100
Q ss_pred ----------c--------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccC
Q 022444 226 ----------S--------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYED 276 (297)
Q Consensus 226 ----------~--------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~ 276 (297)
. .....++.+.+|+.+||..||++|||+.++|+||||.+...+......+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~ 315 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEP 315 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCc
Confidence 0 01124567889999999999999999999999999998755543333333
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=312.44 Aligned_cols=259 Identities=27% Similarity=0.527 Sum_probs=218.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|+||.||+++++.+++.+++|++.............+.++..++..+.|++|+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997644334444556788899999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-cc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~ 164 (297)
||+.+++|.+++.+ ...+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||.+........ ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999976 45789999999999999999999999999999999999999999999999998865433222 22
Q ss_pred ccccCCccccCCccccc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc--cCC---CCCChhH
Q 022444 165 RTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF--SCP---TWFPVGA 235 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~---~~~~~~l 235 (297)
....|++.|+|||++.. ....+.++||||||+++|+|++|+.||...+.......+..... +.+ ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 34568899999999853 22234899999999999999999999998888777777755432 222 3478999
Q ss_pred HHHHHHhcCCCcCC--CCCHHHHhcCcccccC
Q 022444 236 KSLIHRILDPNPET--RITIEEIRNDEWFRKG 265 (297)
Q Consensus 236 ~~li~~~L~~~p~~--Rps~~~il~~p~~~~~ 265 (297)
.+++++||..++++ |++++++++||||+..
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 99999999765544 7899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=304.87 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=212.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||++.++.+++.+++|.+..... .....+.+.+|+.+++.++|+|++++++++......++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999998864331 1222345678999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|..+..+...+++..++.++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 99999888887777778999999999999999999999999999999999999999999999999998766544333334
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------------c
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---------------------F 225 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---------------------~ 225 (297)
..++..|+|||.+.+....+.++|+||||+++|+|++|..||.+.+..+....+.... .
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 4567889999998764434489999999999999999999998766544333221100 0
Q ss_pred c----------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 226 S----------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 226 ~----------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
+ ....++..+.+|+.+||+.+|++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 012357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=316.10 Aligned_cols=260 Identities=27% Similarity=0.451 Sum_probs=210.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (297)
..++|++.+.||+|+||.||++.+..+++.+++|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 46899999999999999999999999999999999865432 223345677899999999999999999988543
Q ss_pred -CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
...+++|||+++ ++.+.+.. .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 67666653 58899999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc---------------
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--------------- 223 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--------------- 223 (297)
... ......++..|+|||.+.+..++ .++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 171 ~~~-~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 171 TSF-MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred Ccc-ccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 432 22345678899999999887776 8999999999999999999999876644332221110
Q ss_pred -------c--------------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 224 -------D--------------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 224 -------~--------------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
. ...+...+.++.+|+.+||..||++|||+.++|+||||+..+.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~ 322 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAE 322 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhh
Confidence 0 0011123567899999999999999999999999999987765433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=300.08 Aligned_cols=253 Identities=26% Similarity=0.581 Sum_probs=219.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||+|++|.+|.+.+..+|+.+++|.+....... .....+.+|+..+++++|+|++++.+.+......++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 6999999999999999999999999999999987543222 234567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+.+++|.+.+.... .+++..++.++.+++.++.+||++|++|+||+|+||+++.++.++++|||.+...........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 999999999887543 578999999999999999999999999999999999999999999999998876544333333
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHHhcC
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~L~ 244 (297)
...++..|+|||.+.+...+ .++|+||||++++++++|..||...+..+....+..+.. +.+..++.++.+++.+||+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence 44577889999998776655 899999999999999999999988877777666554443 4566689999999999999
Q ss_pred CCcCCCCCHHHHhcCccc
Q 022444 245 PNPETRITIEEIRNDEWF 262 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~ 262 (297)
.+|++||++.++++||||
T Consensus 239 ~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 239 RNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CChhhCcCHHHHhhCcCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=325.22 Aligned_cols=253 Identities=29% Similarity=0.480 Sum_probs=219.0
Q ss_pred ceEEeEEeccCCceeEEEEEeCCC-CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTET-GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.|.+.+.||+|++|.||.|.+..+ +..+++|.+.... ......+.+|+..++.++||||+++++.+...+..|+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 499999999999999999998877 7888888765432 233456778999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 87 EFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 87 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
||+++++|.+.+.. ..++++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999887643 34689999999999999999999999999999999999999999999999999876543222
Q ss_pred --ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHH
Q 022444 163 --LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLI 239 (297)
Q Consensus 163 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li 239 (297)
......|++.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..+.. +.+..++.++.+++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence 22344688999999999877766 899999999999999999999998888777777665544 45667899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCccccc
Q 022444 240 HRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
.+||..+|++|||+++++.|||++.
T Consensus 304 ~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHhccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999999864
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=305.55 Aligned_cols=267 Identities=31% Similarity=0.586 Sum_probs=226.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|++.+.||+|++|.||++.++.+++.|++|.+.............+.+|+..++.+.|+||+++++.+......+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999987665444445567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc----
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---- 162 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~---- 162 (297)
|++++++|.+++.+...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998753211100
Q ss_pred -----------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC---
Q 022444 163 -----------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP--- 228 (297)
Q Consensus 163 -----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 228 (297)
......++..|+|||.+.+..++ .++|+||||+++|++++|..||.+.+..+............+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 01123456789999998776665 999999999999999999999998888877777666543332
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCC---HHHHhcCcccccCccccccccc
Q 022444 229 TWFPVGAKSLIHRILDPNPETRIT---IEEIRNDEWFRKGYVPVKLIEY 274 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps---~~~il~~p~~~~~~~~~~~~~~ 274 (297)
..+|.++.+++.+||+.+|++||| +.++++||||...........+
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~ 288 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQK 288 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcC
Confidence 247899999999999999999998 7999999999776555544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=312.42 Aligned_cols=259 Identities=28% Similarity=0.527 Sum_probs=218.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|+||.||+++++.+++.+++|.+.............+.++..++..+.|++|+++++.+.+.+..|++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997644334444566788899999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-cc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~ 164 (297)
||+.+++|.+++.+ ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999986 46789999999999999999999999999999999999999999999999999865543222 22
Q ss_pred ccccCCccccCCcccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--ccCCC---CCChhH
Q 022444 165 RTTCGTPNYVAPEVLSHK----GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSCPT---WFPVGA 235 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~---~~~~~l 235 (297)
....|++.|+|||++.+. ...+.++|+||||+++|+|++|+.||...+..+....+.... .+.+. .+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 234688999999998652 222489999999999999999999998888777777665543 22332 368999
Q ss_pred HHHHHHhcCCCcCC--CCCHHHHhcCcccccC
Q 022444 236 KSLIHRILDPNPET--RITIEEIRNDEWFRKG 265 (297)
Q Consensus 236 ~~li~~~L~~~p~~--Rps~~~il~~p~~~~~ 265 (297)
.+++.+||...+++ |++++++++||||+..
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 99999999876655 5799999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=316.88 Aligned_cols=262 Identities=28% Similarity=0.431 Sum_probs=213.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (297)
..++|++.+.||+|++|.||.+.+..+++.+++|.+..... .......+.+|+.+++.+.|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 46799999999999999999999999999999999865432 223345677899999999999999999887433
Q ss_pred -CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
...|+||||+.+ +|.+.+.. .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999975 77776653 58889999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--------------
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-------------- 224 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-------------- 224 (297)
... ......++..|+|||++.+..++ .++||||||+++|+|++|+.||...+..+...++....
T Consensus 178 ~~~-~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 178 TSF-MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCC-cccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 432 22345678899999999887776 89999999999999999999998776555444332110
Q ss_pred --------cc--------------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccc
Q 022444 225 --------FS--------------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLI 272 (297)
Q Consensus 225 --------~~--------------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~ 272 (297)
.. .....+.++.++|.+||+.||++|||+.++|+||||+..+.+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 00 0011245789999999999999999999999999999766655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=303.39 Aligned_cols=259 Identities=30% Similarity=0.479 Sum_probs=219.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|+..+.||.|+||+||.+.+..+++.+++|.+.............+.+|+.+++.+.|++++++.+.+..++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999876544444444567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+.+++|.+.+... .++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-ccc
Confidence 99999998877543 369999999999999999999999999999999999999999999999999886543321 223
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHhhhccccCCCCCChhHHHHHHH
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL----YSKVEKADFSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~l~~li~~ 241 (297)
...++..|+|||.+.+..++ .++|+||||+++|++++|..||........ ...+.......+..++.++.+|+..
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred CCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 44678999999999877766 899999999999999999999987655433 3333333445556688999999999
Q ss_pred hcCCCcCCCCC-----HHHHhcCcccccCccc
Q 022444 242 ILDPNPETRIT-----IEEIRNDEWFRKGYVP 268 (297)
Q Consensus 242 ~L~~~p~~Rps-----~~~il~~p~~~~~~~~ 268 (297)
||+.+|++||+ +.+++.||||+.....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 99999999999 8899999999987443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=304.06 Aligned_cols=253 Identities=30% Similarity=0.473 Sum_probs=207.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|++++.||+|++|.||++.++.+++.+++|.+..... .......+.+|+..++.++|+|++++++++..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 48999999999999999999999999999999865432 22234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 88 FITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|+. ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 997 4888877543 458999999999999999999999999999999999999999999999999987554433333
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc------------------c--
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA------------------D-- 224 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~------------------~-- 224 (297)
....+++.|+|||.+.+....+.++|+||||+++++|++|+.||...+........... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 34456789999999866543348999999999999999999999765433221111000 0
Q ss_pred ---------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 225 ---------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 225 ---------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
......+++++.+++.+||+.||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123378899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=304.68 Aligned_cols=257 Identities=25% Similarity=0.452 Sum_probs=218.2
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
....+|++.+.||+|++|.||++.+..++..+++|.+...... ....+.+|+..++.+.|+|++++++.+......+
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 3456899999999999999999999999999999998754422 2355778999999999999999999999889999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+|+||+++++|.+++.. ..++..++..++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999999998864 46899999999999999999999999999999999999999999999999988765443333
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh-cc--ccCCCCCChhHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK-AD--FSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~-~~--~~~~~~~~~~l~~li~ 240 (297)
.....+++.|+|||.+.+...+ .++|+||||+++|+|++|..||...+.......+.. .. .+.+..++..+.+++.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred cCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 3345678899999999876665 899999999999999999999987665443322222 21 2234557889999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccC
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+||..+|.+|||+.++++||||...
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=304.71 Aligned_cols=255 Identities=25% Similarity=0.463 Sum_probs=218.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
..+|++.+.||.|++|.||++.+..+++.+++|.+..... .....+.+|+..++.++|+|++++++.+......+++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 3579999999999999999999999999999999865432 2245678899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
+||+++++|..++.. ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+...........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 999999999988865 4689999999999999999999999999999999999999999999999998776544333333
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc---cccCCCCCChhHHHHHHHh
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---DFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~l~~li~~~ 242 (297)
...++..|+|||.+.+..++ .++|+||||+++|++++|..||...+.......+... ....+..++..+.+++.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252 (296)
T ss_pred CcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence 44677899999999877665 8999999999999999999999887665444333322 2234556889999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccC
Q 022444 243 LDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
|..+|++|||+.+++.||||+..
T Consensus 253 l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 253 LEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred hhcChhhCCCHHHHhhChHhhhc
Confidence 99999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=324.56 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=201.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC------CCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR------HPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 79 (297)
.++|++.+.||.|+||.||++.+..+++.||||++..... .......|+.+++.+. |.+++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 4689999999999999999999999999999999864321 1223344555555554 45688899988654
Q ss_pred -CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCC-------------
Q 022444 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQG------------- 144 (297)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~------------- 144 (297)
.+.|++|+++ +++|.+++.+.+.+++..+..++.|++.||.|||+ .||+|+||||+||+++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999988 66899999888889999999999999999999998 5999999999999998765
Q ss_pred ---CEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh
Q 022444 145 ---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVE 221 (297)
Q Consensus 145 ---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~ 221 (297)
.++|+|||.+...... .....++..|+|||++.+..++ .++|||||||++|+|++|+.||...+..+....+.
T Consensus 283 ~~~~vkl~DfG~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERHS---RTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCceEEECCCCccccCccc---cccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 4999999987643322 2345688999999999888776 89999999999999999999998776554433322
Q ss_pred hccccCC------------------------------------------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 222 KADFSCP------------------------------------------TWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 222 ~~~~~~~------------------------------------------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
......+ ....+.+.+||.+||.+||.+|||++|+|+|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 1110000 0013456799999999999999999999999
Q ss_pred cccccCcc
Q 022444 260 EWFRKGYV 267 (297)
Q Consensus 260 p~~~~~~~ 267 (297)
|||++.+.
T Consensus 439 p~~~~~~~ 446 (467)
T PTZ00284 439 PYVLKYYP 446 (467)
T ss_pred ccccccCC
Confidence 99998654
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=298.62 Aligned_cols=251 Identities=30% Similarity=0.497 Sum_probs=216.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||.|++|.||.+.+..+++.+++|.+..... ...+.+.+|+..++.++|+|++++++.+......+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 689999999999999999999998999999999976532 24577889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
||+.+++|.+++... ..+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++.++++|||.+...........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 999999999988765 6899999999999999999999999999999999999999999999999998876554333333
Q ss_pred cccCCccccCCcccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-----cCCCCCChhHHH
Q 022444 166 TTCGTPNYVAPEVLSHK---GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-----SCPTWFPVGAKS 237 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~l~~ 237 (297)
...++..|+|||.+.+. ..+ .++|+||||+++|+|++|..||...+.......+..... ..+..++.++.+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238 (262)
T ss_pred cccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence 45677789999998765 555 899999999999999999999988766555444443322 123346788999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEW 261 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~ 261 (297)
++.+||+.+|.+|||+.+++.|||
T Consensus 239 li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=325.31 Aligned_cols=260 Identities=30% Similarity=0.476 Sum_probs=221.4
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--- 80 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 80 (297)
...++|++.+.||+|+||+||++++..+|+.||+|.+...... ......+.+|+..+..++|+|++++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3457899999999999999999999999999999998765432 233556788999999999999999988764321
Q ss_pred -----eEEEEEcccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEccc
Q 022444 81 -----KIYIILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (297)
Q Consensus 81 -----~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df 151 (297)
.++++|||+++++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 368999999999999988642 46899999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCc--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCC
Q 022444 152 GLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCP 228 (297)
Q Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~ 228 (297)
|++....... .......|++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+..... +.+
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 9987544321 122345688999999999877766 999999999999999999999998888777776655543 466
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
..+++++.+++.+||+.+|.+|||+.++++|||++..
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 7789999999999999999999999999999998754
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=318.73 Aligned_cols=251 Identities=29% Similarity=0.458 Sum_probs=213.2
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-C-----CCeeEEEEEEEcCCe
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-H-----PCVVRLHEVLASRTK 81 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~ 81 (297)
||.|.+.||+|.||+|-+|.+..+++.||||+++... ....+...|+.+|..++ | -|+++++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 7999999999999999999999999999999997654 44566778899999887 3 489999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC--CEEEcccCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG--HLKISDFGLSALP 157 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~--~~~l~df~~~~~~ 157 (297)
+|+|+|... .+|.++++.+. +++.+.++.++.||+.+|..||+.||||+||||+|||+...+ .+|++|||+++..
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999996 49999998754 689999999999999999999999999999999999996543 6999999999987
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--------------
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-------------- 223 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~-------------- 223 (297)
..... ..+.+..|+|||++.|..++ .+.|||||||+++||++|.+.|.+.+..++...|...
T Consensus 342 ~q~vy---tYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 342 SQRVY---TYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred CCcce---eeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 76543 66788899999999999998 9999999999999999999999877755554444100
Q ss_pred --------------------------------------cccCCCC-----------CChhHHHHHHHhcCCCcCCCCCHH
Q 022444 224 --------------------------------------DFSCPTW-----------FPVGAKSLIHRILDPNPETRITIE 254 (297)
Q Consensus 224 --------------------------------------~~~~~~~-----------~~~~l~~li~~~L~~~p~~Rps~~ 254 (297)
....|.. ....+.+|+.+||.+||.+|+|+.
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 0001100 124568999999999999999999
Q ss_pred HHhcCcccccCcc
Q 022444 255 EIRNDEWFRKGYV 267 (297)
Q Consensus 255 ~il~~p~~~~~~~ 267 (297)
++|+||||.....
T Consensus 498 qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 498 QALNHPFLTGTSL 510 (586)
T ss_pred HHhcCcccccccc
Confidence 9999999995433
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=305.45 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=200.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh---cCCCCeeEEEEEEEc-----C
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL---VRHPCVVRLHEVLAS-----R 79 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~~i~~~~~~~~~-----~ 79 (297)
+|++.+.||+|++|.||+++++.+++.+++|.+........ ......+|+..++. +.|+||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 69999999999999999999999999999998865322111 11223345555554 479999999998753 3
Q ss_pred CeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~ 157 (297)
...++++|++.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999975 888888654 34899999999999999999999999999999999999999999999999988755
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-------------
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD------------- 224 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~------------- 224 (297)
.... ......++..|+|||.+.+..++ .++||||||+++|+|++|..||......+...++....
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 159 SCQM-ALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cCcc-cCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 4321 22234567889999999877665 89999999999999999999998776655444432210
Q ss_pred -----c---------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 225 -----F---------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 225 -----~---------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
. .....+++.+.+++.+||++||++|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112367888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=301.90 Aligned_cols=255 Identities=29% Similarity=0.448 Sum_probs=213.4
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
....++|++.+.||+|++|.||+++++.+++.+++|++..... .....+.+|+..+++++|+|++++++.+......
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 3445679999999999999999999999999999999865431 2234577899999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
++++||+++++|.+++....++++..+..++.+++.||.|||+.|++|+|++|+||+++.++.++++|||.+........
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999999999998778899999999999999999999999999999999999999999999999999876544333
Q ss_pred ccccccCCccccCCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-----CCCCCChh
Q 022444 163 LLRTTCGTPNYVAPEVLSH---KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-----CPTWFPVG 234 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~ 234 (297)
......++..|+|||.+.. ..+ +.++|+||+|+++|+|++|..||...........+...... ....++..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred ccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 3334567789999999853 223 37899999999999999999999765544333322222221 12346889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEW 261 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~ 261 (297)
+.+++++||+.+|.+|||++++|+|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=307.11 Aligned_cols=253 Identities=31% Similarity=0.475 Sum_probs=207.7
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||.|++|.||+++++.+|+.+++|.+..... .......+.+|+..++.++|+|++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999865432 22233456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 88 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|+.+ +|.+++.+ ...+++..++.++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 9975 78777764 457899999999999999999999999999999999999999999999999998765544333344
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHhhhcc---------------------
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF-DELDLTTLYSKVEKAD--------------------- 224 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf-~~~~~~~~~~~i~~~~--------------------- 224 (297)
..++..|+|||.+.+....+.++||||||+++|+|++|..|+ ...+.....+.+....
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 566789999999876554458999999999999999998885 4444333333221100
Q ss_pred --------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 225 --------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 225 --------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
......+++++.+++.+||+.||.+|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=295.78 Aligned_cols=253 Identities=29% Similarity=0.536 Sum_probs=221.6
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||.|++|.||.+++..+++.+++|.+....... .....+.+|+..+++++|+||+++++++.+....++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987554323 335667899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+++++|.+++... ..+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++.++++|||.+...........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999999764 4589999999999999999999999999999999999999999999999998876554433344
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-CCCCCChhHHHHHHHhcC
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~l~~li~~~L~ 244 (297)
...+++.|.|||.+.+..++ .++|+||||+++++|++|..||...+..+....+..+... .+..++.++.+++.+||.
T Consensus 160 ~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred ccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 55678899999999877665 8999999999999999999999888877777766655443 335578999999999999
Q ss_pred CCcCCCCCHHHHhcCccc
Q 022444 245 PNPETRITIEEIRNDEWF 262 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~ 262 (297)
.+|++|||+.++++|||+
T Consensus 239 ~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 239 QDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCcccCCCHHHHhhCcCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=304.48 Aligned_cols=255 Identities=35% Similarity=0.667 Sum_probs=225.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 85 (297)
.+|++.+.||+|++|.||++.+..+++.+++|++.............+.+|..+++.+. |+||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999997654444444567788999999998 99999999999888999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc---
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--- 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~--- 162 (297)
||++.+++|.+++.+...+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999998875543221
Q ss_pred -----------------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc
Q 022444 163 -----------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF 225 (297)
Q Consensus 163 -----------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~ 225 (297)
......++..|+|||...+...+ .++|+||||++++++++|..||.........+.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG-KSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 11223467789999998776655 899999999999999999999998887777777777777
Q ss_pred cCCCCCChhHHHHHHHhcCCCcCCCCCH----HHHhcCccc
Q 022444 226 SCPTWFPVGAKSLIHRILDPNPETRITI----EEIRNDEWF 262 (297)
Q Consensus 226 ~~~~~~~~~l~~li~~~L~~~p~~Rps~----~~il~~p~~ 262 (297)
..+..+|+.+.+++.+||+.+|++|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 7888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=305.13 Aligned_cols=262 Identities=24% Similarity=0.431 Sum_probs=219.9
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
...++|++++.||+|++|.||++.+..+++.+++|.+...... ....+.+|+..++.+.|+|++++++.+......+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 3457899999999999999999999999999999998654322 2355778899999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
++|||+++++|.+++.+ ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999999998865 46889999999999999999999999999999999999999999999999988765443333
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-c--ccCCCCCChhHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-D--FSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~-~--~~~~~~~~~~l~~li~ 240 (297)
.....+++.|+|||.+.+..++ .++|+||||+++|++++|..||...+.......+... . ...+..++..+.+++.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred cCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 3345678899999999877765 8999999999999999999999766543322222211 1 1234557889999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
+||..+|++|||++++++||||+.......
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhcccccccc
Confidence 999999999999999999999997754443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=302.41 Aligned_cols=256 Identities=29% Similarity=0.489 Sum_probs=216.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.|++++.||.|++|.||++.+..+++.+++|.+.... ......+.+|+..++.+.|+|++++++.+..+...+++|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 67999999999999999999999999999999986543 333566788999999999999999999999889999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
||+++++|...+.+ ...+++..++.++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 99999999887654 45689999999999999999999999999999999999999999999999998765443333334
Q ss_pred cccCCccccCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc---cCCCCCChhHHH
Q 022444 166 TTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---SCPTWFPVGAKS 237 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~l~~ 237 (297)
...++..|+|||.+.+ ..+ +.++|+||||+++|+|++|..||...+......++..... ..+..++.++.+
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247 (292)
T ss_pred eecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence 4567789999999853 223 3789999999999999999999987766555544443322 234557889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
++.+||+.+|++||+++++++||||+...
T Consensus 248 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 248 FLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 99999999999999999999999998653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=297.08 Aligned_cols=253 Identities=32% Similarity=0.582 Sum_probs=220.0
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE--cCCeEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA--SRTKIYII 85 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 85 (297)
+|++.+.||.|++|.||++.+..++..+++|.+...... ....+.+.+|+..++.++|+|++++++.+. .....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998754432 233566888999999999999999999774 34568999
Q ss_pred EcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCEEecCCCCCeeecCCCCEEEcccCCCCC
Q 022444 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCH-----SKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh-----~~~i~h~di~~~nIli~~~~~~~l~df~~~~~ 156 (297)
+||+++++|.+++.+ ..++++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++++|||.+..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998865 357899999999999999999999 89999999999999999999999999999887
Q ss_pred CCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhH
Q 022444 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGA 235 (297)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l 235 (297)
............++..|+|||.+.+...+ .++|+||||+++++|++|..||...+.....+.+..... ..+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence 66544434455688899999999876655 899999999999999999999998887777777766654 3556688999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
.+++.+||+.+|++|||+.++++|||+
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=305.32 Aligned_cols=265 Identities=30% Similarity=0.435 Sum_probs=216.2
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--Ce
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TK 81 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (297)
+.+++|++.+.||.|++|.||++.++.+|+.|++|.+....... .......+|+.++++++|+|++++++++... +.
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 35788999999999999999999999999999999986543211 1123455789999999999999999998654 56
Q ss_pred EEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.++++|++.+ +|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 8999999975 88888775 356899999999999999999999999999999999999999999999999998766543
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----------------
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---------------- 224 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---------------- 224 (297)
........++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 3333334456789999998764444589999999999999999999998887766655443310
Q ss_pred ---ccC-----------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 225 ---FSC-----------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 225 ---~~~-----------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
... ....++++.++|++||++||++|||+.++++||||++...+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 000 0125788899999999999999999999999999998866643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=305.32 Aligned_cols=255 Identities=29% Similarity=0.448 Sum_probs=212.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||++.++.+++.+++|.+....... ...+.+.+|+..++.++|+|++++++++......++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999899999999886543222 23456778999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|..+......+++..++.++.+++.+|.|||+.|++|+|++|+||+++.++.++|+|||.+............
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 99999888887776667999999999999999999999999999999999999999999999999988765544333344
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----------------------
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---------------------- 224 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---------------------- 224 (297)
..++..|+|||.+.+....+.++||||||+++++|++|+.||......+...++....
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 5677899999998765444588999999999999999999997655433322221100
Q ss_pred --c-------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 225 --F-------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 225 --~-------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
. .....++..+.+++.+||..+|.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 0123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=300.66 Aligned_cols=257 Identities=29% Similarity=0.495 Sum_probs=217.1
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
-|++.+.||.|++|.||++.+..++..+++|.+.... ......+.+|+..++.+.|+|++++++.+......++++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 4788999999999999999999999999999886543 2234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 88 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|+++++|...+.+ ..++++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+............
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 9999999887754 457899999999999999999999999999999999999999999999999988655433333334
Q ss_pred ccCCccccCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---ccCCCCCChhHHHH
Q 022444 167 TCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSCPTWFPVGAKSL 238 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~l~~l 238 (297)
..++..|+|||.+.. ..+ +.++|+||+|+++|+|++|..||...+.......+.... ...+..++.++.++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred ccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 567889999999742 233 378999999999999999999998877666555544332 23345688999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
+.+||+.+|.+|||+.++++||||+.....
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence 999999999999999999999999987443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=297.10 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=216.0
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||++.+..++..+++|.+..... .+.+.+|++.++.++|+|++++++.+......|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 579999999999999999999998899999999865432 567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|++++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 99999999999875 45689999999999999999999999999999999999999999999999999876655443334
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc---cccCCCCCChhHHHHHHHh
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---DFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~l~~li~~~ 242 (297)
...++..|+|||.+.+...+ .++||||||+++|+|++|..||...........+... ....+..++.++.+++.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred cccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 45577899999999877665 8999999999999999999999876655443333222 1223345778999999999
Q ss_pred cCCCcCCCCCHHHHhcCccc
Q 022444 243 LDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~p~~ 262 (297)
|+.+|++|||+.++|+||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=301.14 Aligned_cols=251 Identities=31% Similarity=0.482 Sum_probs=210.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||.+.+..+++.+++|.+..... .....+.+|+..++.++|+||+++++.+......++++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 579999999999999999999999999999999875432 22345678899999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++...+.+++..++.++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999988655443333345
Q ss_pred ccCCccccCCcccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-----CCCCCChhHHHH
Q 022444 167 TCGTPNYVAPEVLS---HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-----CPTWFPVGAKSL 238 (297)
Q Consensus 167 ~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~l~~l 238 (297)
..++..|+|||.+. ...+ +.++|+||||+++|+|++|..||.................. ....+++.+.++
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF 244 (267)
T ss_pred ccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence 56888999999874 2334 48999999999999999999998665433322222222111 112467899999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcc
Q 022444 239 IHRILDPNPETRITIEEIRNDEW 261 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~ 261 (297)
+.+||+.+|++|||++++++|||
T Consensus 245 i~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 245 VKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=296.33 Aligned_cols=253 Identities=25% Similarity=0.478 Sum_probs=213.7
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchh---hhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI---IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+|++.+.||.|++|.||++.+ .+++.+++|.+..... ........+.+|+..++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 4788899998864321 123334668899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC----
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG---- 160 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~---- 160 (297)
++||+++++|.+++.+..++++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999988788999999999999999999999999999999999999999999999999987654221
Q ss_pred --ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc---cccCCCCCChhH
Q 022444 161 --VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---DFSCPTWFPVGA 235 (297)
Q Consensus 161 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~l 235 (297)
........++..|+|||.+.+..++ .++|+||||++++++++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1112234577889999999877665 8999999999999999999999876654433333322 234556689999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
.+++.+||+.+|++||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=301.17 Aligned_cols=260 Identities=27% Similarity=0.464 Sum_probs=222.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|+..+.||.|++|.||.+.+..+++.+++|.+..... ......+.+|+..++++.|+|++++++.+.+....+++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468889999999999999999999999999999875432 233567888999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++.. .++++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++++|||.+............
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 99999999998865 57899999999999999999999999999999999999999999999999988665443333334
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHHhcCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~L~~ 245 (297)
..++..|+|||.+.+...+ .++|+||||+++|+|++|..||...........+.... ...+..+|..+.+++.+||+.
T Consensus 161 ~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred ccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHccc
Confidence 4567789999999877665 89999999999999999999998777666555543332 233445788999999999999
Q ss_pred CcCCCCCHHHHhcCcccccCccccc
Q 022444 246 NPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 246 ~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
+|++||+++++++||||.+...+.+
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~~~~~~ 264 (277)
T cd06640 240 DPSFRPTAKELLKHKFIVKNAKKTS 264 (277)
T ss_pred CcccCcCHHHHHhChHhhhcchhhh
Confidence 9999999999999999988876643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=295.24 Aligned_cols=254 Identities=27% Similarity=0.505 Sum_probs=216.9
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchh--hhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+|+..+.||+|++|.||++.+..+++.+++|.+..... ...+..+.+.+|+..++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58888999999999999999998999999999865331 1233456788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
+||+++++|.+++.+...+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK 159 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence 9999999999999888789999999999999999999999999999999999999999999999999887654432 223
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh--ccccCCCCCChhHHHHHHHhc
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK--ADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~l~~li~~~L 243 (297)
...++..|+|||.+......+.++|+||||+++|++++|..||...........+.. .....+..+++.+.+++.+||
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 455778899999987665234899999999999999999999987765544444333 223445668899999999999
Q ss_pred CCCcCCCCCHHHHhcCccc
Q 022444 244 DPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~ 262 (297)
+.+|++|||+.+++.|||+
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=299.92 Aligned_cols=252 Identities=31% Similarity=0.487 Sum_probs=212.1
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CeE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----TKI 82 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 82 (297)
+|...+.+|+|+||.||.|....+++++|||.+....- .-.+|+++++.+.||||+++.-+|... -+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 68999999999999999999999999999999865431 233689999999999999998877422 246
Q ss_pred EEEEcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC-CCEEEcccCCCCCC
Q 022444 83 YIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALP 157 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~-~~~~l~df~~~~~~ 157 (297)
.+||||++. +|.+.++. ...++.-.++-+..||++||.|||+.||+|+||||.|+++|.+ |.+|+||||++...
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 789999975 89888874 5679999999999999999999999999999999999999986 89999999999887
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--------------
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-------------- 223 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~-------------- 223 (297)
..+..+ .....+-.|+|||.+.+..-.+.+.||||.||++.||+.|.+.|.+.+..++...|.+.
T Consensus 177 ~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 177 VKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred ccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 766444 45566889999999988665569999999999999999999999988777665554111
Q ss_pred ---ccc------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 224 ---DFS------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 224 ---~~~------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
... +....++++.+|++++|..+|++|.|+.+++.||||+.-..+
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000 223368899999999999999999999999999999987655
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=295.36 Aligned_cols=255 Identities=29% Similarity=0.494 Sum_probs=221.9
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|++.+.||.|++|.||++++..+++.+++|.+...... .....+.+++..++.++|+|++++++++......++++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 689999999999999999999999999999998765422 335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|+++++|.+++.....+++..++.++.++++++.+||+ .|++|+||+|+||+++.++.++|+|||.+............
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 99999999999888889999999999999999999999 99999999999999999999999999988766554443334
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHhhhcc-ccCCCC-CChhHHHHHHH
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL---DLTTLYSKVEKAD-FSCPTW-FPVGAKSLIHR 241 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~---~~~~~~~~i~~~~-~~~~~~-~~~~l~~li~~ 241 (297)
..+...|+|||.+.+..++ .++|+||||+++|++++|..||... ...+....+.... ...+.. +|..+.+++.+
T Consensus 160 ~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (264)
T cd06623 160 FVGTVTYMSPERIQGESYS-YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA 238 (264)
T ss_pred eeecccccCHhhhCCCCCC-chhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHH
Confidence 5677899999998777555 8999999999999999999999777 3444444444332 334444 78999999999
Q ss_pred hcCCCcCCCCCHHHHhcCcccccC
Q 022444 242 ILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
||..+|++|||++++++|||+++.
T Consensus 239 ~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 239 CLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=298.61 Aligned_cols=256 Identities=28% Similarity=0.457 Sum_probs=213.1
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC--
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR-- 79 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-- 79 (297)
++..++|++.+.||.|++|.||++.++.+++.+++|++..... ..+.+.+|+.+++++ .|+|++++++.+...
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 4567899999999999999999999998999999999876542 235678899999998 699999999998653
Q ss_pred ----CeEEEEEcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEccc
Q 022444 80 ----TKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (297)
Q Consensus 80 ----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df 151 (297)
...+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 358999999999999888765 347899999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccccCCccccCCccccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc--
Q 022444 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG----YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-- 225 (297)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-- 225 (297)
|.+..............++..|+|||.+.... ..+.++||||||++++++++|..||...........+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 98876554434444556788999999875422 124789999999999999999999987655444444433322
Q ss_pred -cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 226 -SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 226 -~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
..+..++.++.+++.+||..||++|||+.++++|||+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2223367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=296.16 Aligned_cols=254 Identities=29% Similarity=0.489 Sum_probs=214.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||.|++|+||++....++..+++|++....... ..+.+.+|+..++.+.|+|++++++.+......++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999986543222 4567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 87 EFITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 87 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
|++++++|.+.+.+. ..+++..+..++.+++.||.+||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999988655443222
Q ss_pred ----cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-CC-----CCCCh
Q 022444 164 ----LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CP-----TWFPV 233 (297)
Q Consensus 164 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~-----~~~~~ 233 (297)
.....++..|+|||.+......+.++|+||||+++++|++|..||...+......+......+ .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 123357789999999876633358999999999999999999999877665554444333221 11 24678
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
.+.+++.+||..+|++|||++++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=300.16 Aligned_cols=258 Identities=26% Similarity=0.510 Sum_probs=217.2
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCeEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR---HPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 84 (297)
.|++.+.||.|++|.||++.+..+++.+++|.+.... .......+.+|+.+++.+. |+|++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888999999999999999999999999999986543 2223456778888888886 9999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+|||+++++|.+++.. ..+++..++.++.+++.+|.+||+.|++|+||+|+||+++.++.++++|||.+..........
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 9999999999998865 478999999999999999999999999999999999999999999999999887665443333
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCC-CCChhHHHHHHHh
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPT-WFPVGAKSLIHRI 242 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~-~~~~~l~~li~~~ 242 (297)
....++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+..... ..+. .++.++.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence 4456788999999986544335899999999999999999999987766555444333322 2222 2788999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccCccc
Q 022444 243 LDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
|+.+|++||++.+++.||||++....
T Consensus 239 l~~~p~~R~~~~~il~~~~~~~~~~~ 264 (277)
T cd06917 239 LDEEPKERLSAEELLKSKWIKAHSKT 264 (277)
T ss_pred cCCCcccCcCHHHHhhChHhhccccC
Confidence 99999999999999999999887644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=298.16 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=208.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||++++..+++.+++|.+.... .......+.+|+.+++++.|+|++++++.+......++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36899999999999999999999999999999986543 2233456888999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|..+ ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~ 152 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKT 152 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccC
Confidence 99999988544 35788999999999999999999999999999999999999999999999988754432 2234
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHhhhcccc--CCCCCChhHHH
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL-------TTLYSKVEKADFS--CPTWFPVGAKS 237 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~--~~~~~~~~l~~ 237 (297)
..++..|+|||.+.+..++ .++|+||||+++|+|++|..||..... ....+.+.....+ .....++++.+
T Consensus 153 ~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 153 YVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 5678899999999877765 899999999999999999999965321 1222222222211 12347789999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
++.+||+.+|.+||+++++++||||++.
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=298.00 Aligned_cols=256 Identities=27% Similarity=0.484 Sum_probs=219.3
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|...+.||.|++|.||++.++.+++.+++|.+.... ....+.+.+|+..++.+.|+|++++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 5777889999999999999999899999999886433 2224557789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
++.+++|.+++.. .+++...+..++.+++.+|++||+.|++|+||+|+||+++.++.++++|||.+.............
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 9999999998877 678999999999999999999999999999999999999999999999999876544333333345
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccC---CCCCChhHHHHHHHhcC
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC---PTWFPVGAKSLIHRILD 244 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~l~~li~~~L~ 244 (297)
.++..|+|||.+.+..++ .++|+||||+++++|++|..||...+.......+.....+. +..++..+.+++.+||+
T Consensus 176 ~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (285)
T cd06648 176 VGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV 254 (285)
T ss_pred cCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 678899999998776665 89999999999999999999998877766666665543222 23378899999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCccc
Q 022444 245 PNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+|++|||+.++++||||++....
T Consensus 255 ~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 255 RDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred cChhhCcCHHHHccCcccccCCCc
Confidence 999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=307.16 Aligned_cols=254 Identities=22% Similarity=0.415 Sum_probs=204.2
Q ss_pred EeEEeccC--CceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 11 VGRTIGEG--TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 11 ~~~~lg~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
++++||+| ++++||++.++.+|+.|++|.+...... ......+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 6789999999999999999998765422 23356678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc----
Q 022444 89 ITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---- 162 (297)
Q Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~---- 162 (297)
+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.+++.||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999998653 4589999999999999999999999999999999999999999999999986433221111
Q ss_pred ---ccccccCCccccCCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc------------
Q 022444 163 ---LLRTTCGTPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------------ 225 (297)
Q Consensus 163 ---~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------------ 225 (297)
......++..|+|||.+.+. .++ .++||||||+++|+|++|..||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 11123455679999998753 344 899999999999999999999976554433222211110
Q ss_pred ----------------------------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 226 ----------------------------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 226 ----------------------------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+....+++.+.+|+++||+.||++|||++++++||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 01112467899999999999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=309.00 Aligned_cols=281 Identities=28% Similarity=0.406 Sum_probs=224.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----C
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----T 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 80 (297)
..+|++.+.||.|++|.||.+++..+++.+++|.+..... .......+.+|+..++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4579999999999999999999999999999999865422 222245567899999999999999999877543 3
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..++++||+. ++|.+++.+...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999996 589999988888999999999999999999999999999999999999999999999999998765443
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh------------------
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK------------------ 222 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~------------------ 222 (297)
........++..|+|||.+......+.++|+||||+++|+|++|..||...+.......+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 33333445678899999986533345899999999999999999999976543222211110
Q ss_pred ------c----c---ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCccccccccCCh
Q 022444 223 ------A----D---FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDS 289 (297)
Q Consensus 223 ------~----~---~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (297)
. . ......++.++.+++.+||+++|++|||++++++||||....... ..++...++..+||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~----~~~~~~~~~~~~~~~~ 317 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS----DEPVCQTPFSFDFEED 317 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc----cCccCCCccchhhhhh
Confidence 0 0 011234788999999999999999999999999999999874443 3444556777788887
Q ss_pred hhh
Q 022444 290 EVG 292 (297)
Q Consensus 290 ~~~ 292 (297)
+..
T Consensus 318 ~~~ 320 (337)
T cd07858 318 ALT 320 (337)
T ss_pred hcC
Confidence 754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=300.03 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=216.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||.|++|.||++.++.+++.+++|.+..... ......+.+|++.++.+.|+||+++++.+......++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999876542 234566788999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|++.+++|.+++... ..+++..+..++.+++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999999999999876 789999999999999999999999 99999999999999999999999999987655432221
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHhhhcc-ccCCCC-CChhHHH
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-----DLTTLYSKVEKAD-FSCPTW-FPVGAKS 237 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-----~~~~~~~~i~~~~-~~~~~~-~~~~l~~ 237 (297)
...++..|+|||.+.+..++ .++|+||||++++++++|..||... ...+..+.+.... ...+.. ++.++.+
T Consensus 158 -~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 158 -TFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred -cccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 25677889999999877665 9999999999999999999999654 2333333333322 223333 7889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+|.+||..+|++|||+.+++.||||++-+
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 99999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=297.48 Aligned_cols=250 Identities=34% Similarity=0.646 Sum_probs=219.5
Q ss_pred eccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCCh
Q 022444 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (297)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (297)
||.|++|.||++++..+|+.+++|.+.............+.+|+..++++.|+|++++++.+......|+++|++.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999766544445567788999999999999999999999989999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--------cccc
Q 022444 95 FDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--------LLRT 166 (297)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~--------~~~~ 166 (297)
.+++.+.+.+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998877899999999999999999999999999999999999999999999999998765443311 2233
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCC--ChhHHHHHHHhcC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWF--PVGAKSLIHRILD 244 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~l~~li~~~L~ 244 (297)
..+...|+|||.......+ .++|+||||++++++++|..||...........+.......+... +..+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHS-KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 4567789999998776654 899999999999999999999998888888877776666555555 9999999999999
Q ss_pred CCcCCCCCH---HHHhcCcccccC
Q 022444 245 PNPETRITI---EEIRNDEWFRKG 265 (297)
Q Consensus 245 ~~p~~Rps~---~~il~~p~~~~~ 265 (297)
.+|++|||+ .++|+||||.+.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCC
Confidence 999999999 999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=292.71 Aligned_cols=252 Identities=28% Similarity=0.484 Sum_probs=217.5
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||.|++|.||++.++.+++.+++|.+....... .....+.+|+..++.++|+|++++++.+......++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999997654322 335678899999999999999999999988899999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccCCCCCCCCCcccc
Q 022444 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~~~~~~~~~~~~~ 164 (297)
++++++|.+++... ..+++..+..++.+++.+|.+||++|++|+||+|+||+++.++ .++++|||.+........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~ 158 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-A 158 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-c
Confidence 99999999999763 3589999999999999999999999999999999999998654 579999999876554322 2
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHHhc
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~L 243 (297)
....++..|+|||.+.+...+ .++|+||||+++|+|++|..||...+.......+.... .+.+..++.++.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML 237 (256)
T ss_pred cccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHc
Confidence 234577899999999876655 89999999999999999999998887776666655443 3456668999999999999
Q ss_pred CCCcCCCCCHHHHhcCccc
Q 022444 244 DPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~ 262 (297)
+++|++|||++++++||||
T Consensus 238 ~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 238 NLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred cCChhhCCCHHHHhhCCCC
Confidence 9999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=298.27 Aligned_cols=254 Identities=30% Similarity=0.483 Sum_probs=211.3
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||.|++|.||+|.+..+|+.+++|.+...... ......+.+|+..++.+.|+|++++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999998764422 2334568889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-ccc
Q 022444 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~~ 165 (297)
++ +++|.+++.. ...+++..++.++.+++.+|.|||+.|++|+||+|+||+++.++.++++|||.+........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99 8999998864 45689999999999999999999999999999999999999999999999998876544321 223
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------------
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--------------------- 224 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--------------------- 224 (297)
...++..|+|||.+.+....+.++||||||+++++|++|..+|...........+...-
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 45678899999998765544589999999999999999988887665444333221100
Q ss_pred c---------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 225 F---------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 225 ~---------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
. ......+.++.+++.+||+.+|++|||++++|+||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 01123578899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=298.63 Aligned_cols=249 Identities=32% Similarity=0.528 Sum_probs=210.9
Q ss_pred eccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCCh
Q 022444 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (297)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (297)
||+|++|+||++.+..+|+.+++|.+.............+.+|+.+++.++|+|++++++.+...+..|+++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999999765443334445567899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCcc
Q 022444 95 FDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (297)
Q Consensus 95 ~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 172 (297)
.+++.+.. .+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+...... .......+...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCC
Confidence 99987765 6899999999999999999999999999999999999999999999999988654432 22233456778
Q ss_pred ccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcC
Q 022444 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL----TTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248 (297)
Q Consensus 173 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~ 248 (297)
|+|||.+.+..++ .++|+||||+++++|++|+.||..... ..+...+.......+..+++.+.+++.+||+.+|+
T Consensus 160 y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 160 YMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred cCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence 9999998776655 899999999999999999999976543 23333333334455566899999999999999999
Q ss_pred CCC-----CHHHHhcCcccccC
Q 022444 249 TRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 249 ~Rp-----s~~~il~~p~~~~~ 265 (297)
+|| ++.++++||||.+.
T Consensus 239 ~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 239 KRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred HccCCCcccHHHHHhChhhhcC
Confidence 999 88889999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=297.59 Aligned_cols=255 Identities=26% Similarity=0.487 Sum_probs=213.9
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecch---hhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA---IIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+|+..+.||+|++|.||.+.+..+++.+++|++.... .......+.+.+|+..++.++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4888999999999999999999999999999986432 1223345778899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccCCCCCCCCCcc-
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~~~~~~~~~~~- 162 (297)
++||+.+++|.+++...+++++..++.++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 599999999866543211
Q ss_pred ---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh-----hccccCCCCCChh
Q 022444 163 ---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVE-----KADFSCPTWFPVG 234 (297)
Q Consensus 163 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~-----~~~~~~~~~~~~~ 234 (297)
......++..|+|||.+.+..++ .++|+||||++++++++|..||...........+. ......+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 11234567899999998776665 89999999999999999999996544322222221 1223445567899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
+.+++.+||..+|++|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=297.56 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=210.8
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC---
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR--- 79 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--- 79 (297)
+..++|++.+.||+|++|.||++.++.+++.+++|.+.... .....+.+++..++++ +|+|++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34678999999999999999999999999999999986532 1134466788888888 799999999988543
Q ss_pred --CeEEEEEcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 80 --TKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 80 --~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
...++++||+++++|.+++.. ...+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 368999999999999988753 45689999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCCccccccccCCccccCCccccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---cc
Q 022444 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGY----NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FS 226 (297)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---~~ 226 (297)
+..............++..|+|||.+..... .+.++|+||||+++|+|++|..||...+.......+.... ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 8765443333334567888999999754321 2489999999999999999999998776655444443332 22
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
.+..++..+.+++.+||+.+|.+|||+.++++||||+
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2445778899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=292.97 Aligned_cols=254 Identities=33% Similarity=0.587 Sum_probs=214.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
||++.+.||+|++|.||++.+..++..+++|.+...... ....+.+.+|+..++.+.|+||+++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999989999999998765433 3456788999999999999999999999988999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc----
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL---- 163 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~---- 163 (297)
|+++++|.+++.+...+++..+..++.+++.++.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999988777999999999999999999999999999999999999999999999999988765433222
Q ss_pred cccccCCccccCCccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhhc-cccCCCC--CChhHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKG--YNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEKA-DFSCPTW--FPVGAKS 237 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~i~~~-~~~~~~~--~~~~l~~ 237 (297)
.....+...|+|||.+.+.. ..+.++||||||++++++++|..||...+ .......+... ....+.. ++..+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 12345678999999987654 12489999999999999999999997653 22222222222 2233333 4889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
++.+||+.+|.+|||+++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=294.33 Aligned_cols=254 Identities=28% Similarity=0.506 Sum_probs=211.2
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchh--hhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCeEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--IKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTKIY 83 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 83 (297)
.|++.+.||+|++|.||++.+..++..+++|.+..... ........+.+|+.+++.++|+|++++++++.. ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 58899999999999999999999999999998864321 122345668889999999999999999998865 35788
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc--
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-- 161 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~-- 161 (297)
+++|++++++|.+.+.+...+++...+.++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999999999887889999999999999999999999999999999999999999999999999886543211
Q ss_pred -cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cccCCCCCChhHHHH
Q 022444 162 -SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPVGAKSL 238 (297)
Q Consensus 162 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~l~~l 238 (297)
.......++..|+|||.+.+..++ .++|+||+|+++|++++|..||...+.......+... ....+..+++.+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 111223467789999999877665 8999999999999999999999877655444433222 233455578889999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
+ +|+..+|++|||++++++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 57778999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=297.24 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=210.7
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc----
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS---- 78 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---- 78 (297)
.-.++|++.+.||.|++|.||.+.++.+++.+++|.+.... .....+.+|+.+++.+ .|+|++++++.+..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 44578999999999999999999999999999999986543 1234567888888888 69999999998864
Q ss_pred --CCeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 79 --RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 79 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
....++++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 24689999999999999988763 35899999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCccccccccCCccccCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc--cC
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF--SC 227 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~ 227 (297)
..............++..|+|||.+.+ ..+ +.++|+||+|+++|+|++|..||...........+..... ..
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 765443333344567889999999853 233 3789999999999999999999977665544443332221 22
Q ss_pred CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 228 PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 228 ~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
...++.++.+|+.+||..+|.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 34478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=301.74 Aligned_cols=257 Identities=31% Similarity=0.435 Sum_probs=213.1
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--Ce
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TK 81 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (297)
+..+.|++.+.||.|++|.||+|.++.+++.+++|.+...... ......+.+|+..++.+.|+|++++++++... ..
T Consensus 2 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred cchhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 4567899999999999999999999999999999998754422 22234466899999999999999999998776 78
Q ss_pred EEEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.|+++||+.+ +|.+.+.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999999975 8988887644 5899999999999999999999999999999999999999999999999988766554
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-----------------
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA----------------- 223 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~----------------- 223 (297)
........++..|+|||.+.+....+.++|+||||+++++|++|..||...+..+...++...
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 333344556788999999876554458999999999999999999999877665544433211
Q ss_pred --------------cccCCCC-CChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 224 --------------DFSCPTW-FPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 224 --------------~~~~~~~-~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
...++.. +++.+.+++.+||+.+|++|||+.|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0111222 47889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=298.75 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=205.8
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++++|++.+.||.|++|.||++.++.+++.+++|.+...... .......+|+.+++.++|+||+++++++......++
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 467899999999999999999999989999999998654311 112345679999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
||||+.+ +|.+++... ..+++..++.++.++++||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9999985 898888654 46899999999999999999999999999999999999999999999999988754433222
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhhc-------------------
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEKA------------------- 223 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~i~~~------------------- 223 (297)
.....++..|+|||.+.+....+.++||||+|+++|+|++|..||.... ..+....+...
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2333457789999998764433489999999999999999999997654 22222211100
Q ss_pred --ccc---------CCCCCC--hhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 224 --DFS---------CPTWFP--VGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 224 --~~~---------~~~~~~--~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
... ....++ .++.+++.+||+++|++|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 001233 788899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=297.24 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=220.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.-|++.+.||.|++|.||++.+..+++.+++|.+..... ....+.+.+++..++++.|+|++++++.+..+...++++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 348889999999999999999998999999998765432 233567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++.+ ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+............
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 99999999988865 46899999999999999999999999999999999999999999999999988655443223333
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHHhcCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~L~~ 245 (297)
..++..|+|||.+.+...+ .++|+||||+++|++++|..||...........+..... ..+..++.++.+++.+||+.
T Consensus 161 ~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 4577789999999876665 899999999999999999999988776666655544432 34556889999999999999
Q ss_pred CcCCCCCHHHHhcCcccccCccc
Q 022444 246 NPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 246 ~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
+|++||++.++++||||.+....
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhhhhc
Confidence 99999999999999999987443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=293.00 Aligned_cols=249 Identities=30% Similarity=0.548 Sum_probs=216.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||.|++|.||.+.++.+++.+++|.+..... ....+.+.+|+..++.+.|+|++++++.+......++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2235667789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+++++|.+.+.. ...+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++++|||.+...........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 9999999988764 34589999999999999999999999999999999999999999999999999876554433333
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHHhcC
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~L~ 244 (297)
...++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+..+.. +.+..++..+.+++.+||+
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence 45678889999999877665 899999999999999999999998887777666655543 4566689999999999999
Q ss_pred CCcCCCCCHHHHhcC
Q 022444 245 PNPETRITIEEIRND 259 (297)
Q Consensus 245 ~~p~~Rps~~~il~~ 259 (297)
.||++|||+.++++-
T Consensus 238 ~~P~~Rp~~~~il~~ 252 (255)
T cd08219 238 RNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCCCHHHHhhc
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=297.97 Aligned_cols=260 Identities=32% Similarity=0.603 Sum_probs=245.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++..|+.++.||.|.||.|.+++.+.+++.+|+|++++........++.-..|-.+|+..+||.+..+.-.|+..+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 57789999999999999999999999999999999988877777778888899999999999999888878889999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||.+||.|.-.+.+...+++...+.+...|..||.|||+.+|+++|+|.+|.++|++|++|++|||++..........
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccccee
Confidence 99999999999999998899999999999999999999999999999999999999999999999999998777666777
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
...+|+|.|.|||++....+. .+.|.|.+|++||+|+.|+.||.+.+...+.+-|..+...+|..+++++..++..+|.
T Consensus 326 kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~ 404 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLK 404 (516)
T ss_pred ccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhh
Confidence 788999999999999999887 9999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCC-----CHHHHhcCcccccC
Q 022444 245 PNPETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 245 ~~p~~Rp-----s~~~il~~p~~~~~ 265 (297)
+||++|. .+.||.+|+||...
T Consensus 405 kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 405 KDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred cChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999997 58999999999865
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=299.27 Aligned_cols=253 Identities=29% Similarity=0.479 Sum_probs=208.1
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|++++.||.|++|.||+++++.+++.+++|.+..... .......+.+|+..+++++|+|++++++++.+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999998865432 12223567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+. ++|.+++.. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 996 588888764 34689999999999999999999999999999999999999999999999998876544333333
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-c--------------------
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-D-------------------- 224 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~-~-------------------- 224 (297)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+......++... .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 4456778999999876554458899999999999999999999766543322221110 0
Q ss_pred --------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 225 --------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 225 --------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
......++.++.++|.+||+.||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=306.31 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=203.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 79 (297)
.++|++.+.||.|+||.||+|.+. .++..|++|.+.... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999752 345789999986432 222346688999999999 899999999988654
Q ss_pred -CeEEEEEcccCCCChHHHHHhc---------------------------------------------------------
Q 022444 80 -TKIYIILEFITGGELFDKIVHH--------------------------------------------------------- 101 (297)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------------------- 101 (297)
...+++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999888642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--ccccccCCcccc
Q 022444 102 -----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYV 174 (297)
Q Consensus 102 -----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~ 174 (297)
.+++...+..++.|+++||.|||+.|++|+||||+||+++.++.++|+|||++........ ......++..|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 2377888999999999999999999999999999999999999999999999875432211 112233456899
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHhhhc-cccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 175 APEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT-TLYSKVEKA-DFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 175 aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~-~~~~~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
|||.+.+..++ .++||||||+++|+|++ |..||...... .....+..+ ....+..+++++.+++.+||+.||++||
T Consensus 244 aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999877766 89999999999999997 99999875533 333433333 3345667899999999999999999999
Q ss_pred CHHHHhc
Q 022444 252 TIEEIRN 258 (297)
Q Consensus 252 s~~~il~ 258 (297)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=290.81 Aligned_cols=253 Identities=32% Similarity=0.600 Sum_probs=221.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|++.++.++|+|++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 689999999999999999999999999999998764422 2335668889999999999999999999988899999999
Q ss_pred ccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 88 FITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 88 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
++++++|.+.+.+. ..++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999999988764 67999999999999999999999999999999999999999999999999988766554333
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHHh
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~ 242 (297)
.....+++.|+|||.+.+...+ .++|+||+|++++++++|..||...+............ .+.+..++.++.+++.+|
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred ecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 3445678899999998776665 89999999999999999999998887777666655543 345556889999999999
Q ss_pred cCCCcCCCCCHHHHhcCccc
Q 022444 243 LDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~p~~ 262 (297)
|..+|++|||+.++|+||||
T Consensus 239 l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 239 LQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=297.31 Aligned_cols=240 Identities=18% Similarity=0.244 Sum_probs=207.6
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc----CCeEEEEEcc
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----RTKIYIILEF 88 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~ 88 (297)
..|+.|+++.||.+.. +|+.|++|++...........+.+.+|+..+++++||||+++++++.+ ....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999987 588999999976554444446778899999999999999999998865 3578999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
+++++|.+++.+...++......++.+++.+|.+||+. +++|+||+|+||+++.++.++++|||++....... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~~ 180 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKN 180 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---ccc
Confidence 99999999999888899999999999999999999984 99999999999999999999999999887544321 234
Q ss_pred cCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cccCCCCCChhHHHHHHHhc
Q 022444 168 CGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 168 ~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~l~~li~~~L 243 (297)
.++..|+|||.+.+ ..++ .++||||||+++|+|++|..||...+..+....+... ..+.+..+|+++.+++.+||
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~-~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYT-IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred cCcccccCHHHhhhcccccc-chhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 56789999999875 4454 8999999999999999999999988888777776433 44555568999999999999
Q ss_pred CCCcCCCCCHHHHhc
Q 022444 244 DPNPETRITIEEIRN 258 (297)
Q Consensus 244 ~~~p~~Rps~~~il~ 258 (297)
+.||++|||+.++++
T Consensus 260 ~~dp~~Rps~~ell~ 274 (283)
T PHA02988 260 SHDSIKRPNIKEILY 274 (283)
T ss_pred cCCcccCcCHHHHHH
Confidence 999999999999986
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=295.94 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=204.7
Q ss_pred EeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHH---HHHhcCCCCeeEEEEEEEcCCeEEEEEcccC
Q 022444 14 TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS---IMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
.||+|++|.||++.+..+++.+++|.+...............++.. .+....|++++.+++.+...+..+++|||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999886543222221222233333 3334469999999999988889999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCC
Q 022444 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170 (297)
Q Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 170 (297)
+++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+....... .....++
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGT 158 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcCCC
Confidence 99999999888889999999999999999999999999999999999999999999999999886543321 2234678
Q ss_pred ccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhhhccccCCCCCChhHHHHHHHhcCCCc
Q 022444 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL---TTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247 (297)
Q Consensus 171 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p 247 (297)
..|+|||.+......+.++|+||+|+++|+|++|..||..... ..............+..++.++.+++++||..||
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 8999999986433234899999999999999999999965432 2222222233345566789999999999999999
Q ss_pred CCCC-----CHHHHhcCcccccCcccccc
Q 022444 248 ETRI-----TIEEIRNDEWFRKGYVPVKL 271 (297)
Q Consensus 248 ~~Rp-----s~~~il~~p~~~~~~~~~~~ 271 (297)
++|| |+.++++||||+.....+..
T Consensus 239 ~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 239 SKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267 (279)
T ss_pred HHhcCCCCCCHHHHHhCccccCCCHhHHh
Confidence 9999 69999999999986544443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=293.56 Aligned_cols=252 Identities=28% Similarity=0.520 Sum_probs=212.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++.+.||.|++|.||+++++.+++.+++|.+......+......+.+|+..++.++|+|++++++.+......+++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 46899999999999999999999999999999988654433444456678899999999999999999999988999999
Q ss_pred EcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+|++++++|.+++.. ...+++..++.++.+++.||.|||++|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999888753 3458899999999999999999999999999999999999999999999999887655433
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhhhccccC--CCCCChhHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVEKADFSC--PTWFPVGAKS 237 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~--~~~~~~~l~~ 237 (297)
.......++..|+|||.+.+...+ .++|+||+|+++|+|++|..||.... .....+.+.....+. ...++..+.+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 333345677899999999877766 89999999999999999999996543 344555544433221 2347789999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 022444 238 LIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+||+.+|++|||++++++
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHH
Confidence 999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=291.91 Aligned_cols=255 Identities=27% Similarity=0.514 Sum_probs=211.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchh--hhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CeE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--IKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKI 82 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 82 (297)
..|++.+.||+|++|.||.+.+..++..+++|.+..... ........+.+|+..++++.|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 469999999999999999999999999999998864321 1223456788899999999999999999988653 468
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV- 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~- 161 (297)
++++||+++++|.+++.+...+++..++.++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 8999999999999999887788999999999999999999999999999999999999999999999999887543211
Q ss_pred --cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cccCCCCCChhHHH
Q 022444 162 --SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPVGAKS 237 (297)
Q Consensus 162 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~l~~ 237 (297)
.......++..|+|||.+.+...+ .++|+||||+++|+|++|+.||...+.......+... ....+..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 112233577789999999876665 8999999999999999999999876544444333322 22344557788999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
++++|+. +|++|||++++++|||++
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=296.25 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=204.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+.+.|++.+.||+|++|.||.+.++.+++.+++|.+..... ......+.+|+..++.++|+||+++++++......++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 46789999999999999999999999999999999865432 1222345688999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
++|++. +++.+.+.. ...++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 999996 577666654 356788999999999999999999999999999999999999999999999988755443333
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhh---------------c---c
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEK---------------A---D 224 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~---------------~---~ 224 (297)
.....++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.. +....+.. . .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 344456789999999875432348899999999999999999999765432 11111100 0 0
Q ss_pred -----ccCC---------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 225 -----FSCP---------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 225 -----~~~~---------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
...+ ...+.++.+++.+||..||++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=291.87 Aligned_cols=247 Identities=41% Similarity=0.743 Sum_probs=221.9
Q ss_pred eccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCCh
Q 022444 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (297)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (297)
||.|++|.||.+.+..+++.+++|.+.............+..|+..++.+.|+|++++++.+......+++||++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999989999999998876554444567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCcccc
Q 022444 95 FDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174 (297)
Q Consensus 95 ~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 174 (297)
.+++.+...+++..+..++.++++++.+||+.|++|+||+|+||+++.++.++++|||.+..............++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 99998887899999999999999999999999999999999999999999999999998876554433334456778899
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCH-
Q 022444 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITI- 253 (297)
Q Consensus 175 aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~- 253 (297)
|||...+...+ .++|+||||+++|++++|..||...+.....+.+.....+.+..+|..+.+++.+||..||++|||+
T Consensus 161 ~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 161 APEVLLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred ChHHhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 99998776655 8999999999999999999999888877777777777788888899999999999999999999999
Q ss_pred --HHHhcCccc
Q 022444 254 --EEIRNDEWF 262 (297)
Q Consensus 254 --~~il~~p~~ 262 (297)
+++++||||
T Consensus 240 ~~~~l~~~~~f 250 (250)
T cd05123 240 GAEEIKAHPFF 250 (250)
T ss_pred cHHHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=312.71 Aligned_cols=262 Identities=41% Similarity=0.798 Sum_probs=247.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
.++-|.+.+.||.|.|+.|.++++..++..||||.+.+....... .+.+.+|+++++.++||||++++.+.+....+|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 467899999999999999999999999999999999877654444 4558999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||+.++.+++++.+++.+.+..+..++.|+.+|++|+|+.+|+|+|||++||+++.+.+++++|||++.+...+ ...
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~~l 211 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-LML 211 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-ccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999888743 566
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
...+|++.|.|||.+.+..+++++.|+||||+++|.|+.|..||++.+...+..+...+++..+-.++-++.++|+++|-
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLV 291 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhc
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCccc
Q 022444 245 PNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+|++|++..++..|+|...+...
T Consensus 292 l~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 292 LNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred cCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999988777
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=301.83 Aligned_cols=258 Identities=27% Similarity=0.465 Sum_probs=219.3
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.|++.+.||.|++|.||++.+..++..+++|.+..... ....+.+.+|+..++++.|+|++++++.+......++++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 468888999999999999999998999999998865432 223567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++.. ..+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++.++++|||.+............
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 99999999988764 57899999999999999999999999999999999999999999999999998765543333333
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHHhcCC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~L~~ 245 (297)
..++..|+|||.+.+..++ .++|+||||+++|++++|..||...........+.... ...+..++.++.+++.+||+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred ccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 4577889999999877765 89999999999999999999998766655554443332 233445788999999999999
Q ss_pred CcCCCCCHHHHhcCcccccCccc
Q 022444 246 NPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 246 ~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
+|++|||+.++++||||+.....
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06642 240 DPRFRPTAKELLKHKFITRYTKK 262 (277)
T ss_pred CcccCcCHHHHHHhHHHHHHhhh
Confidence 99999999999999999875433
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=289.07 Aligned_cols=253 Identities=30% Similarity=0.551 Sum_probs=219.2
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CeEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKIYII 85 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 85 (297)
+|++.+.||+|++|.||.+.+..+++.+++|.+...... ....+.+.+++..+++++|+|++++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999998765432 33467788999999999999999999999887 889999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--c
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--L 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~--~ 163 (297)
+|++++++|.+++.+...+++..++.++.+++.+|.|||+.|++|+|++|+||+++.++.++|+|||.+........ .
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998887999999999999999999999999999999999999999999999999998876655432 1
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhh--ccccCCCCCChhHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEK--ADFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~i~~--~~~~~~~~~~~~l~~li~ 240 (297)
.....+...|+|||.+.+...+ .++|+||||++++++++|..||.... .......+.. .....+..++..+.+++.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYG-RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 3345678899999998776655 99999999999999999999998765 3333333332 234556668999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCccc
Q 022444 241 RILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~ 262 (297)
+|++.+|++|||+.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=298.69 Aligned_cols=258 Identities=23% Similarity=0.428 Sum_probs=215.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||++.+..++..+++|.+.... .......+.+|+..++++.|+||+++++.+......++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47899999999999999999999999999999886542 2233466788999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 87 EFITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 87 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
||+++++|.+++... ..+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++++|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999998888763 378999999999999999999997 599999999999999999999999999886543321
Q ss_pred ccccccCCccccCCccccccCC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hhhc-cccCCCCCCh
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGY-----NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSK---VEKA-DFSCPTWFPV 233 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~---i~~~-~~~~~~~~~~ 233 (297)
.....++..|+|||.+.+... .+.++|+||||+++|++++|..||........... +... ....+..++.
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence 223456778999999855432 14789999999999999999999976554443332 2222 2345556889
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
++.+|+.+||..+|++||+++++++||||......
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 99999999999999999999999999999888654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=288.75 Aligned_cols=253 Identities=29% Similarity=0.534 Sum_probs=221.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||+|++|.||.+.+..+++.+++|.+...... ......+.+|++.++++.|+|++++++++.+....+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999765432 2345678999999999999999999999998899999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
++++++|.+++.+...+++..++.++.+++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.............
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999988766554434455
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-hhccccCCCCCChhHHHHHHHhcCCC
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV-EKADFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
.++..|+|||...+...+ .++|+||||++++++++|..||...+........ .......+..++..+.+++.+||..+
T Consensus 160 ~~~~~y~~pe~~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 160 VGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred ccchhhcCHhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 678899999998776644 8999999999999999999999776654433333 34445566778999999999999999
Q ss_pred cCCCCCHHHHhcCccc
Q 022444 247 PETRITIEEIRNDEWF 262 (297)
Q Consensus 247 p~~Rps~~~il~~p~~ 262 (297)
|++|||+.+++.||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=291.48 Aligned_cols=248 Identities=32% Similarity=0.604 Sum_probs=208.1
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHH-HHhcCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
+.||.|++|.||+|.+..+++.+++|++................+... .....|+|++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999876543332223333344333 4455899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..... .....++.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTP 157 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCc
Confidence 99999998888899999999999999999999999999999999999999999999999998765433 12345677
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc----CCCCCChhHHHHHHHhcCCCc
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS----CPTWFPVGAKSLIHRILDPNP 247 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~l~~li~~~L~~~p 247 (297)
.|+|||.+.+..++ .++|+||||+++|++++|..||...+.......+...... ....+|.++.+++.+||+.+|
T Consensus 158 ~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 236 (260)
T cd05611 158 DYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236 (260)
T ss_pred CccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCH
Confidence 89999998876654 8999999999999999999999988887777766554432 223478999999999999999
Q ss_pred CCCC---CHHHHhcCcccccC
Q 022444 248 ETRI---TIEEIRNDEWFRKG 265 (297)
Q Consensus 248 ~~Rp---s~~~il~~p~~~~~ 265 (297)
++|| ++++++.||||++.
T Consensus 237 ~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 237 AKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHccCCCcHHHHHcChHhhcC
Confidence 9999 45799999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=292.51 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=211.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
..+|++.+.||+|+||.||++.++ ..+..+++|.+..... ......+.+|+..++.++||||+++++++......
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 457999999999999999999875 4567899999876532 22345678899999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+++|||+++++|.+++... ..+++..++.++.+++.||+|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999998764 478999999999999999999999999999999999999999999999999766543221
Q ss_pred cc-cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHH
Q 022444 162 SL-LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSL 238 (297)
Q Consensus 162 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~l 238 (297)
.. .....++..|+|||.+.+..++ .++||||||+++|++++ |..||......+..+.+.... .+.+..+|..+.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 11 1122334689999999877766 89999999999999775 999999888887777766543 35566789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 022444 239 IHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~ 258 (297)
+.+|++.+|.+|||+++|++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=295.89 Aligned_cols=253 Identities=24% Similarity=0.411 Sum_probs=208.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEE------
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA------ 77 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------ 77 (297)
..+.|++.+.||.|++|.||++.+..+++.+++|.+.... .....+..++..++++ .|+|++++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4578999999999999999999999999999999986543 2234567888888888 6999999999874
Q ss_pred cCCeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 78 SRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
.....+++|||+.+++|.+++... ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 245789999999999999988653 358888999999999999999999999999999999999999999999999887
Q ss_pred CCCCCccccccccCCccccCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc--CC
Q 022444 156 LPEQGVSLLRTTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS--CP 228 (297)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~ 228 (297)
.............++..|+|||.+.. ..+ +.++|+||||+++|+|++|..||...........+.....+ ..
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence 55433333334567889999999752 233 37899999999999999999999766554433333322221 12
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
..+|.++.+++.+||+.||.+|||+.++|+||||
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 3478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=296.87 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=212.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|++|.||++.++.+++.+++|.+..... .....+.+.+|+..++.++|+|++++++++...+..++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999998865332 2334567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-ccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~~ 165 (297)
||++++.+.....+...+++..+..++.+++.+|.|||+.|++|+|++|+||+++.++.++|+|||.+........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9999877766666667799999999999999999999999999999999999999999999999999876654432 333
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc----------------------
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---------------------- 223 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---------------------- 223 (297)
...++..|+|||.+.+....+.++|+||||+++|++++|..||......+....+...
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 4556788999999987633449999999999999999999999766544332222110
Q ss_pred ----------cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 224 ----------DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 224 ----------~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
....+..+|.++.+|+.+||..+|++|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 001233358899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=291.53 Aligned_cols=253 Identities=28% Similarity=0.565 Sum_probs=216.7
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||+|++|.||++.++.+|..+++|.+....... ...+.+.+|+..++.++|+|++++++.+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5899999999999999999999999999999987643222 234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC-EEEcccCCCCCCCCCcccc
Q 022444 88 FITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH-LKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~-~~l~df~~~~~~~~~~~~~ 164 (297)
|+++++|.+++.... .+++..+..++.++++||.|||+.+++|+||+|+||+++.++. ++++|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999887543 4789999999999999999999999999999999999988764 6999999887665443333
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHHhc
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~L 243 (297)
....++..|+|||.+.+...+ .++|+||||++++++++|..||...+.......+..... +.+..++.++.+++.+||
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred cccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence 345678899999998766655 899999999999999999999988776666555544433 344557899999999999
Q ss_pred CCCcCCCCCHHHHhcCccc
Q 022444 244 DPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~ 262 (297)
..+|++|||+.+++.||||
T Consensus 239 ~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 239 KVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccChhhCcCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=304.30 Aligned_cols=262 Identities=29% Similarity=0.475 Sum_probs=212.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC------
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR------ 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 79 (297)
.++|++.+.||+|++|.||++.+..+++.+++|.+..... .......+.+|+.+++.++|+|++++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 5689999999999999999999999999999999864322 223345677899999999999999999987533
Q ss_pred CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
...|+++|++.+ +|.+.+... ++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 357999999965 888877653 89999999999999999999999999999999999999999999999999876544
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc----------------
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---------------- 223 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---------------- 223 (297)
... .....++..|+|||.+.+..++ .++||||||+++|+|++|+.||...+......++...
T Consensus 171 ~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 171 SFM-MTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCC-CCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 322 2234567889999999887776 9999999999999999999999876644433332110
Q ss_pred ------cc-----cC----------------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccccc
Q 022444 224 ------DF-----SC----------------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273 (297)
Q Consensus 224 ------~~-----~~----------------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~ 273 (297)
.. ++ +...++++.+++.+||+.||++|||+.++|+||||++++....+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~ 325 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEA 325 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCC
Confidence 00 00 1124567899999999999999999999999999997766555433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=309.06 Aligned_cols=251 Identities=22% Similarity=0.374 Sum_probs=205.4
Q ss_pred cceEEeEEeccCCceeEEEEEeC--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
.+|++++.||.|++|.||++... .++..+++|.+... ....+|+.+++.++|+||+++++.+......|+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 47999999999999999999864 35678999987542 224578999999999999999999998899999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-- 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-- 162 (297)
+|+++. ++|.+++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 999996 58888887778899999999999999999999999999999999999999999999999999875543322
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhhh-----------------
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT---TLYSKVEK----------------- 222 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---~~~~~i~~----------------- 222 (297)
......++..|+|||.+.+..++ .++|||||||++|+|++|..||.+.... .....+..
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 12345688999999999877776 8999999999999999999999654311 11111100
Q ss_pred ------c----c--ccCC-----CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 223 ------A----D--FSCP-----TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 223 ------~----~--~~~~-----~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
. + ...+ ..++.++.++|++||..||.+|||+.++|.||||++.+.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 0 0 0011 124668889999999999999999999999999988644
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=295.52 Aligned_cols=252 Identities=32% Similarity=0.527 Sum_probs=208.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++++.||.|++|.||+++++.+|+.+++|.+..... ......+.+|+..++.++|+|++++++.+...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999875432 1223456689999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 88 FITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|+.+ +|.+++... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9985 888877654 358999999999999999999999999999999999999999999999999887554433333
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc------------------cc
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD------------------FS 226 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~------------------~~ 226 (297)
....++..|+|||.+.+....+.++|+||||+++|++++|..||...+..+....+.... ..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 344567789999998665444589999999999999999999998776554433322110 00
Q ss_pred -----------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 227 -----------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 227 -----------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
..+.++..+.+++.+||+.+|.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112357888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=293.72 Aligned_cols=260 Identities=30% Similarity=0.480 Sum_probs=211.6
Q ss_pred EeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHH---HHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccC
Q 022444 14 TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
.||+|++|.||++.+..+++.+++|.+............... .....++...|++++++++.+...+..++++||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998754322211111122 23344555679999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCC
Q 022444 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170 (297)
Q Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 170 (297)
+++|..++.+.+.+++..+..++.+++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+....... .....++
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGT 158 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCcCCC
Confidence 99999999888889999999999999999999999999999999999999999999999999886543322 2244678
Q ss_pred ccccCCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCC
Q 022444 171 PNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIAGYLPFDEL---DLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 171 ~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
..|+|||.+.+. .++ .++||||+|+++|+|++|..||... ................+..++.++.+++.+||..+
T Consensus 159 ~~y~aPE~~~~~~~~~-~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~ 237 (278)
T cd05606 159 HGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 237 (278)
T ss_pred cCCcCcHHhcCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcC
Confidence 899999998754 344 8999999999999999999999766 33344444444455666678999999999999999
Q ss_pred cCCCC-----CHHHHhcCcccccCccccccccccC
Q 022444 247 PETRI-----TIEEIRNDEWFRKGYVPVKLIEYED 276 (297)
Q Consensus 247 p~~Rp-----s~~~il~~p~~~~~~~~~~~~~~~~ 276 (297)
|++|| ++.++++||||+..........+.+
T Consensus 238 p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~ 272 (278)
T cd05606 238 VNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYP 272 (278)
T ss_pred HHhccCCCCCCHHHHHhCccccCCCchHhhhcccC
Confidence 99999 9999999999998765555544443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=294.37 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=208.1
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEE-----
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA----- 77 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~----- 77 (297)
+..++|++.+.||+|++|.||++.++.+++.+++|....... ....+.+|+.+++.+ +|+|++++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 356789999999999999999999999999999998754321 124466788889998 6999999999873
Q ss_pred cCCeEEEEEcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 78 SRTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
.+...+++|||+++++|.+++.+ ...+++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 44578999999999999887653 34688999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccccccCCccccCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---c
Q 022444 154 SALPEQGVSLLRTTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---F 225 (297)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---~ 225 (297)
+..............++..|+|||.+.. ..+ +.++|+||||+++|+|++|..||...........+.... .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred eeecccCCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 8765443333334567889999999753 223 489999999999999999999998766544433332221 1
Q ss_pred cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 226 SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 226 ~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
..+..++.++.+++.+||+.+|++|||+.++++|+||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2234467899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=302.27 Aligned_cols=269 Identities=27% Similarity=0.378 Sum_probs=219.0
Q ss_pred CccccccceEE-eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHH-----------HHHHHHHHHHHHHhcCCCC
Q 022444 1 MVVRKVGKYEV-GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-----------MADQIKREISIMKLVRHPC 68 (297)
Q Consensus 1 ~~~~~~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~ 68 (297)
|.....+||.. .+.||.|++|+||++.++.+++.+++|.+......... ....+.+|+.+++.++|+|
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 81 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN 81 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence 45566778875 46799999999999999999999999998654322110 1124678999999999999
Q ss_pred eeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEE
Q 022444 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKI 148 (297)
Q Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l 148 (297)
|+++++++...+..+++||++. ++|.+++.+...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence 9999999999999999999997 589999988788999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCC--------------CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022444 149 SDFGLSALPEQ--------------GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (297)
Q Consensus 149 ~df~~~~~~~~--------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~ 214 (297)
+|||.+..... .........++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99998865441 1111223345678999999876554458999999999999999999999887766
Q ss_pred HHHHHhhhccc----------------------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 215 TLYSKVEKADF----------------------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 215 ~~~~~i~~~~~----------------------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+....+..... ......+.++.+++.+||+.+|++|||++++|.||||+...
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 55444322100 00123578899999999999999999999999999999887
Q ss_pred cccc
Q 022444 267 VPVK 270 (297)
Q Consensus 267 ~~~~ 270 (297)
.+.+
T Consensus 321 ~~~~ 324 (335)
T PTZ00024 321 LPCD 324 (335)
T ss_pred CCCC
Confidence 7755
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=295.83 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=213.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCC-----cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
..+|++.+.||.|++|.||++.+...+ ..+++|.+.... .......+.+|+..++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 568999999999999999999976554 679999886543 2333566889999999999999999999998888
Q ss_pred eEEEEEcccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC
Q 022444 81 KIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG 144 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~ 144 (297)
..++++||+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 999999999999999998764 3578899999999999999999999999999999999999999
Q ss_pred CEEEcccCCCCCCCCCc--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhh
Q 022444 145 HLKISDFGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVE 221 (297)
Q Consensus 145 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~ 221 (297)
.++|+|||.+....... .......++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+....+..+.+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999886543221 112234456789999998777665 89999999999999998 999999888888887776
Q ss_pred hcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 222 KAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 222 ~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
... ...+..+|.++.+++.+||+.+|++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 554 34566799999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=291.34 Aligned_cols=255 Identities=30% Similarity=0.487 Sum_probs=210.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh-------HHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-------HKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
+|.+.+.||.|++|.||++.+..+|+.+++|.+....... ....+.+.+|+..++.+.|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5889999999999999999999899999999886432211 123456788999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..++++||+++++|.+.+.+...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999988754332
Q ss_pred cc--ccccccCCccccCCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cccCC----CCC
Q 022444 161 VS--LLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCP----TWF 231 (297)
Q Consensus 161 ~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~----~~~ 231 (297)
.. ......++..|+|||.+.... ..+.++|+||||++++++++|..||...+.......+... ....+ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 11 122334677899999987654 2248999999999999999999999765544333322211 11222 236
Q ss_pred ChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 232 PVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
+.++.+++.+||.++|++|||++++++|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=306.69 Aligned_cols=246 Identities=25% Similarity=0.431 Sum_probs=198.0
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|++++.||+|++|.||++.+..+++.+++|...... ...|+.+++.++|+||+++++++......++++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 46999999999999999999999999999999754322 235788999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
+++.+ +|.+++.+ ..++++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+...... ....
T Consensus 137 e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 214 (357)
T PHA03209 137 PHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFL 214 (357)
T ss_pred EccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-cccc
Confidence 99965 78887764 457899999999999999999999999999999999999999999999999988754332 1223
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCH----------HHHHHHhhhcc---ccC----
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF-DELDL----------TTLYSKVEKAD---FSC---- 227 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf-~~~~~----------~~~~~~i~~~~---~~~---- 227 (297)
...++..|+|||.+.+..++ .++||||||+++|+|+++..++ ..... ..+...+.... ..+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred cccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 45678899999999877776 8999999999999999855443 32211 11111111000 000
Q ss_pred --------------------------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 228 --------------------------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 228 --------------------------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
...++.++.++|.+||+.||++|||+.|+|+||||++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0135677788999999999999999999999999986
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=295.66 Aligned_cols=252 Identities=31% Similarity=0.474 Sum_probs=208.4
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
|++.+.||.|++|.||++.++.+|+.+++|++..... .......+.+|+..++.++|+|++++++++.+....++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6789999999999999999999999999999875432 222335577899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 89 ITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 89 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
++ ++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 95 58999887765 6899999999999999999999999999999999999999999999999998765443333333
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-----------------------
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA----------------------- 223 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~----------------------- 223 (297)
..++..|+|||.+.+....+.++|+||||+++|+|++|..||...+......++...
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 456788999998866543348999999999999999999999776554332222110
Q ss_pred --c----ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 224 --D----FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 224 --~----~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
. ......++..+.+++.+||+.+|.+|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 01123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=296.49 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=216.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
..+|++.+.||+|++|+||++.+..+++.+++|++.... .......+.+|+++++.++|+||+++++.+......+++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 467999999999999999999999999999999886543 233456788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+||+++++|.+++.+.+.++...+..++.+++.+|.|||+ .|++|+||+|+||+++.++.++++|||.+....... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--~ 159 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--A 159 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--c
Confidence 9999999999999887889999999999999999999997 699999999999999999999999999876443221 1
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHhhhcc-ccCCCC-C
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-----------TLYSKVEKAD-FSCPTW-F 231 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-----------~~~~~i~~~~-~~~~~~-~ 231 (297)
....++..|+|||.+.+..++ .++|+||||+++|++++|..||...... +....+.... ...+.. +
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238 (284)
T ss_pred CccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence 234678899999998776655 8999999999999999999999764431 2222222221 222222 7
Q ss_pred ChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 232 PVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
|.++.+|+.+||+.||.+|||+.++++||||.+..+.
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~ 275 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 8899999999999999999999999999999876433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.84 Aligned_cols=258 Identities=28% Similarity=0.413 Sum_probs=216.0
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----eE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-----KI 82 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 82 (297)
+|++.+.||.|++|.||++++..+++.+++|.+.... ......+.+.+|+..++.++|+|++++.+++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999899999999887543 12334567888999999999999999999887664 78
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV- 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~- 161 (297)
|++|+|+.+ +|.+.+.+..++++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999974 899998887789999999999999999999999999999999999999999999999999987665443
Q ss_pred --cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc--------------
Q 022444 162 --SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-------------- 225 (297)
Q Consensus 162 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-------------- 225 (297)
.......++..|+|||.+.+....+.++|+||||+++++|++|..||...+..+....+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 1223445677899999998773334899999999999999999999987776555444332110
Q ss_pred -----------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 226 -----------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 226 -----------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
.....++.++.+++.+||+++|++|||++++++||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 011236788999999999999999999999999999998744
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=295.35 Aligned_cols=255 Identities=29% Similarity=0.432 Sum_probs=205.3
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCe----
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTK---- 81 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~---- 81 (297)
++|++.+.||+|++|.||++.+..+++.+++|.+..... .......+.+|+..++.+. |+|++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999998865432 1222355778999999996 6999999998876555
Q ss_pred -EEEEEcccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-CCCEEEcccCCC
Q 022444 82 -IYIILEFITGGELFDKIVHH-----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLS 154 (297)
Q Consensus 82 -~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-~~~~~l~df~~~ 154 (297)
.|++|||+++ +|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 788877542 35799999999999999999999999999999999999998 889999999988
Q ss_pred CCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----------
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---------- 224 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---------- 224 (297)
..............+.+.|+|||.+.+....+.++|+||||+++|+|++|..||...+......++....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 7554332322334567789999998654444589999999999999999999997765444333221110
Q ss_pred ---------c---------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 225 ---------F---------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 225 ---------~---------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
. .....++.++.+||.+||.++|.+|||+.+++.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 00123788899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=289.93 Aligned_cols=254 Identities=27% Similarity=0.443 Sum_probs=209.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.+.+.....||+|++|.||++.+..++..+++|.+..... ...+.+.+|+.+++.++|+||+++++++...+..+++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3445556789999999999999999999999998865432 2345678999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-CCCEEEcccCCCCCCCCCc
Q 022444 86 LEFITGGELFDKIVHH-GRL--SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~-~~~--~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-~~~~~l~df~~~~~~~~~~ 161 (297)
+|++++++|.+.+... ..+ ++..+..++.+++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999988764 445 88889999999999999999999999999999999976 6789999999887654433
Q ss_pred cccccccCCccccCCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HhhhccccCCCCCChhHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELDLTTL--YS-KVEKADFSCPTWFPVGAKS 237 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~--~~-~i~~~~~~~~~~~~~~l~~ 237 (297)
.......++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||........ .. .........+..+++++.+
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence 3333445788999999986543 134899999999999999999999976543221 11 1122234456668899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
++.+||+.+|++|||+.+++.||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=298.68 Aligned_cols=258 Identities=26% Similarity=0.461 Sum_probs=218.1
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.|.....||.|++|.||++.+..++..+++|.+.... ......+.+|+..++.+.|+|++++++.+...+..+++|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34566778999999999999999899999999986543 233456788999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++.. ..+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 99999999888754 46899999999999999999999999999999999999999999999999988655433333334
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---ccCCCCCChhHHHHHHHhc
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~l~~li~~~L 243 (297)
..++..|+|||.+.+..++ .++|+||||+++|++++|+.||...+.......+.... .+....++..+.+++.+||
T Consensus 178 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 256 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256 (292)
T ss_pred eecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence 5678899999999776665 89999999999999999999998777665555444322 2223347889999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCcccc
Q 022444 244 DPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
..+|++|||++++++||||+....+.
T Consensus 257 ~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 257 VREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred cCChhHCcCHHHHhhChhhhccCCcc
Confidence 99999999999999999999876554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=318.17 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=231.0
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
-|.|+..||.|+||.||.|+++.++-..+.|++... ..+....+.-||++|..+.||+|+++++.|...+.+|++.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 467899999999999999999988888888888643 34557778899999999999999999998888899999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 88 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
+|.||-+...+.. ..++++.++..+++++++||.|||+++|||+|+++.||+++.+|.++|.|||.+............
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 9999998777654 447999999999999999999999999999999999999999999999999998877776667778
Q ss_pred ccCCccccCCcccc-----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccC---CCCCChhHHHH
Q 022444 167 TCGTPNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC---PTWFPVGAKSL 238 (297)
Q Consensus 167 ~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~l~~l 238 (297)
.+|+|+|+|||+.. ..+|+ +++||||||+++.+|..+.+|-...++...+-++....++. |+.++..+.+|
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df 268 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF 268 (1187)
T ss_pred ccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence 89999999999974 35666 99999999999999999999999999999888887776653 56688999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
+.+||.+||+.||++.++|+|||+++...+.
T Consensus 269 Lk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 269 LKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred HHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence 9999999999999999999999999887653
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=325.97 Aligned_cols=262 Identities=27% Similarity=0.456 Sum_probs=213.4
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCe
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTK 81 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 81 (297)
..+++|++++.||.|+||+||++.++.++..+++|.+....... .....+..|+.+++.+.||||++++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 35679999999999999999999999999999999987654322 335668889999999999999999998843 457
Q ss_pred EEEEEcccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-------CCEEecCCCCCeeecCC-------
Q 022444 82 IYIILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSK-------GVYHRDLKPENLLLDSQ------- 143 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~~-------~i~h~di~~~nIli~~~------- 143 (297)
+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+. +|+|+||+|+|||++.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999988652 5699999999999999999999985 49999999999999642
Q ss_pred ----------CCEEEcccCCCCCCCCCccccccccCCccccCCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022444 144 ----------GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELD 212 (297)
Q Consensus 144 ----------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~~ 212 (297)
+.++|+|||++....... ......+++.|+|||++.+.. ..+.++|||||||++|+|++|..||...+
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999987654321 223446889999999986432 22489999999999999999999997654
Q ss_pred H-HHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 213 L-TTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 213 ~-~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
. ..+...+...........+.++.+||..||+.+|.+|||+.++|.|||+.....
T Consensus 248 ~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 248 NFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred cHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 3 334444433322223447899999999999999999999999999999986643
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=296.13 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=213.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+|++.+.||+|++|.||.+.+..+++.+++|.+...........+.+.+|+..++.++|+|++++.+++......++++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999999999999999986544334444567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
||+.+ ++.+.+.. ...+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----~ 169 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----N 169 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----C
Confidence 99975 77676653 456899999999999999999999999999999999999999999999999988655432 2
Q ss_pred cccCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-C-CCCCChhHHHHHHH
Q 022444 166 TTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-C-PTWFPVGAKSLIHR 241 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~-~~~~~~~l~~li~~ 241 (297)
...++..|+|||.+.+ ....+.++||||||+++|+|++|..||...+.......+.....+ . +..++.++.+++.+
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence 3356778999998742 222348999999999999999999999887766554444433221 1 23368899999999
Q ss_pred hcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 242 ILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
||+.+|++|||+.+++.||||+....
T Consensus 250 ~l~~~p~~Rp~~~~il~~~~~~~~~~ 275 (307)
T cd06607 250 CLQKIPQDRPSSEELLKHRFVLRERP 275 (307)
T ss_pred HhcCChhhCcCHHHHhcChhhcccCC
Confidence 99999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=296.23 Aligned_cols=258 Identities=25% Similarity=0.453 Sum_probs=216.8
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
+..++|++.+.||+|++|.||++.+..++..+++|.+.... ....+.+.+|+..++.+.|+|++++++.+...+..+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 34578999999999999999999998899999999986432 222455778899999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+++||+++++|.+++.+ ..++...+..++.+++.||.+||+.|++|+|++|+||+++.++.++|+|||.+.........
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred EEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999999998865 36789999999999999999999999999999999999999999999999987655443333
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-c--ccCCCCCChhHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-D--FSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~-~--~~~~~~~~~~l~~li~ 240 (297)
.....++..|+|||.+.+..++ .++|+||||+++|++++|..||...+.......+... . ...+..++..+.++++
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred cccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 3344677889999998777665 8999999999999999999999876554432222211 1 2223446788999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+||..+|.+||++++++.||||++..
T Consensus 251 ~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999998874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=294.29 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=209.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++.+.||.|++|.||++.++.+++.+++|.+..... .......+.+|+..++.+.|+|++++++++......++|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999998865432 122345677899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-CCCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-~~~~~l~df~~~~~~~~~~~ 162 (297)
|||+++ +|.+.+..... +++..++.++.+++.||.|||+.|++|+||+|+||+++. ++.++++|||.+........
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 999964 78777765443 578889999999999999999999999999999999985 45799999999876544333
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-------------------
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA------------------- 223 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~------------------- 223 (297)
......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+...++...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 3334456789999999876544448999999999999999999999776544333322110
Q ss_pred ----ccc------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 224 ----DFS------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 224 ----~~~------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
..+ ....+++++.+++.+||+.+|.+||++.++++||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 000 1134678899999999999999999999999999998763
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=293.66 Aligned_cols=257 Identities=28% Similarity=0.486 Sum_probs=220.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
...|++.+.||+|++|.||.+.+..++..+++|++..... ....+.+|+..++.++|+|++++++.+......+++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3568899999999999999999998899999999875442 345677899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+||+++++|.+++.... .++...+..++.+++.+|.+||+.|++|+|++|+||+++.++.++|+|||.+..........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence 99999999999998876 89999999999999999999999999999999999999999999999999876554433333
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-c--CCCCCChhHHHHHHH
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-S--CPTWFPVGAKSLIHR 241 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~--~~~~~~~~l~~li~~ 241 (297)
....+...|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+..... . .+..+|.++.+++++
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252 (286)
T ss_pred ccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence 344567889999998877665 899999999999999999999987766555444433322 2 223378999999999
Q ss_pred hcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 242 ILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
||+.+|.+|||+.++++||||.+.-.
T Consensus 253 ~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 253 CLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HhccChhhCcCHHHHhhChHhhccCc
Confidence 99999999999999999999999433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.19 Aligned_cols=265 Identities=25% Similarity=0.407 Sum_probs=214.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE----cCCeE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA----SRTKI 82 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~ 82 (297)
++|++.+.||.|++|.||++.++.+|+.|++|.+..... .......+.+|+.+++.++|+||+++++++. .....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999865332 2233566778999999999999999998775 33578
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
++++||+. ++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 58999988777899999999999999999999999999999999999999999999999998865432211
Q ss_pred ----ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh----------------
Q 022444 163 ----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK---------------- 222 (297)
Q Consensus 163 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~---------------- 222 (297)
......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 122346778999999986543345899999999999999999999976654332221111
Q ss_pred --------cc--cc-----CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccccc
Q 022444 223 --------AD--FS-----CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273 (297)
Q Consensus 223 --------~~--~~-----~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~ 273 (297)
.. .. ....+++++.++|.+||+.+|++|||+++++.||||++...+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~ 308 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT 308 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc
Confidence 00 00 11336889999999999999999999999999999998877666443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=288.73 Aligned_cols=251 Identities=27% Similarity=0.508 Sum_probs=219.1
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++.+.||.|++|.||++.++.+++.+++|.+....... .....+.+|+..++.++|+||+++++.+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999987654333 234567789999999999999999999988899999999
Q ss_pred ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 88 FITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 88 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
++++++|.+++.. ...+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~ 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence 9999999988866 346899999999999999999999999999999999999999999999999988766544 2
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHHh
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~ 242 (297)
.....++..|+|||.+.+...+ .++|+||||++++++++|+.||...+...+...+..... ..+..++.++.+++.+|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM 236 (256)
T ss_pred cccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHH
Confidence 2345678899999999877665 899999999999999999999998888777666655543 34456889999999999
Q ss_pred cCCCcCCCCCHHHHhcCccc
Q 022444 243 LDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~p~~ 262 (297)
|+.+|++|||+.++++||++
T Consensus 237 l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 237 LQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred cCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=295.32 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=203.3
Q ss_pred cceEEeEEeccCCceeEEEEEeC----------------CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCee
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNT----------------ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~----------------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 70 (297)
++|++.++||+|+||.||++.+. .++..+++|.+.... .......+.+|+..+++++|+||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 58999999999999999999853 234579999887543 223356688999999999999999
Q ss_pred EEEEEEEcCCeEEEEEcccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEe
Q 022444 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHG-------------------RLSESEARRYFQQLIDGVDYCHSKGVYHR 131 (297)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~ 131 (297)
++++++......+++|||+.+++|.+++.... .++...++.++.+++.||.|||+.|++|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999998889999999999999999886431 36778899999999999999999999999
Q ss_pred cCCCCCeeecCCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh--CCCC
Q 022444 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA--GYLP 207 (297)
Q Consensus 132 di~~~nIli~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~--g~~p 207 (297)
||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++ .++||||||+++|+|++ +..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999875433221 11223346789999998776665 89999999999999987 5678
Q ss_pred CCCCCHHHHHHHhhhc--------cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 208 FDELDLTTLYSKVEKA--------DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 208 f~~~~~~~~~~~i~~~--------~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
|...+..+....+... ....+..+|..+.+++.+||+.+|++|||+.+|.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 8877766655443221 12234568899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=292.93 Aligned_cols=249 Identities=28% Similarity=0.500 Sum_probs=202.5
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcC--CeEEEE
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASR--TKIYII 85 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv 85 (297)
|++++.||+|++|.||++.+..+++.+++|.+........ .....+|+..++++. |+|++++++++.+. +..+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999998865321111 123346788888885 99999999999877 889999
Q ss_pred EcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+||+.+ ++.+.+.+ ...+++..++.++.+++.||.|||+.|++|+||+|+||+++. +.++|+|||.+........ .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~ 155 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-Y 155 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-c
Confidence 999975 77777765 356899999999999999999999999999999999999999 9999999999876543322 2
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc------------------ccc
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA------------------DFS 226 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~------------------~~~ 226 (297)
....++..|+|||.+......+.++|+||||+++|+|++|..||...+..+....+... ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccccc
Confidence 23456788999998765554458999999999999999999999877655543333211 001
Q ss_pred C-----------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 227 C-----------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 227 ~-----------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
. ...+|.++.+++.+||+++|++|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1 12467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=309.40 Aligned_cols=247 Identities=21% Similarity=0.328 Sum_probs=200.8
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|.+.+.||+|++|.||++.+..+++.|++|.... ....+|+.++++++|+||+++++++......++++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 479999999999999999999999999999996432 23457999999999999999999998889999999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--c
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--L 163 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~--~ 163 (297)
+++. ++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........ .
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 9996 5888887653 4699999999999999999999999999999999999999999999999999875433211 1
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHhhhcccc---CC----
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL--------DLTTLYSKVEKADFS---CP---- 228 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~---~~---- 228 (297)
.....|+..|+|||++.+..++ .++|||||||++|+|++|..++... ....+.+.+...... ++
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2234588999999999887776 8999999999999999987654221 122232222221110 00
Q ss_pred ---------------------------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 229 ---------------------------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 229 ---------------------------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
..++.++.+||++||+.||++|||+.|+|+||||++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 023457899999999999999999999999999975
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=287.85 Aligned_cols=252 Identities=30% Similarity=0.561 Sum_probs=213.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||.|++|.||++.+..+|+.+++|.+...........+.+.+|++.+++++|++++++++.+......+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36899999999999999999999999999999998754433444456788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
|||+++++|.+++.+ ...+++..++.++.+++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999988864 2358999999999999999999999999999999999999999999999999887655443
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhhhccc-cCCC-CCChhHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVEKADF-SCPT-WFPVGAKS 237 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~--~~~~~~~i~~~~~-~~~~-~~~~~l~~ 237 (297)
.......++..|+|||.+.+..++ .++|+||||+++|++++|..||.... .....+.+..... +.+. .++..+.+
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred cccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 333445678889999999877766 89999999999999999999995443 3344444443322 2333 57889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 022444 238 LIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+||..+|++|||+.++++
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=295.15 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=204.7
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-- 80 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 80 (297)
.+-.++|++.+.||+|++|.||++.++.+++.+++|.+...... ........+|+..++++.|+||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 34578899999999999999999999999999999988654321 122234567899999999999999999875443
Q ss_pred ------eEEEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 81 ------KIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 81 ------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
..++++||+.+ +|.+.+.+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 46999999975 7877776543 689999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCCcc----ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc----
Q 022444 154 SALPEQGVS----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---- 225 (297)
Q Consensus 154 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---- 225 (297)
+........ ......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 875533221 122345677899999986654334899999999999999999999987665443332222110
Q ss_pred ---------------cCC-------------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 226 ---------------SCP-------------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 226 ---------------~~~-------------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
..+ ...+..+.++|.+||..||.+|||++++|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 0124667899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=292.25 Aligned_cols=246 Identities=31% Similarity=0.540 Sum_probs=205.3
Q ss_pred EEeEEeccCCceeEEEEEeC----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 10 EVGRTIGEGTFAKVKFAQNT----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.+.+.||.|.||.||+|..+ ..+..|+||.+.... ..+..+.+.++++.+++++|+||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 57889999999999999987 456889999995532 333467788999999999999999999999988889999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC--c
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--V 161 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~--~ 161 (297)
+||+++++|.+++... ..++...+..++.+++.||.|||+.+++|++|+++||+++.++.+||+|||.+...... .
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 67999999999999999999999999999999999999999999999999988765221 1
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLI 239 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li 239 (297)
...........|+|||.+.+..++ .++||||||+++|++++ |+.||...+..+....+.... .+.+..+|..+.+++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 223344567789999998776655 99999999999999999 789999998888888875554 345667899999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 022444 240 HRILDPNPETRITIEEIRN 258 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~ 258 (297)
.+||+.+|++|||+.++++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=287.27 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=212.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|.+.+.||+|++|.||++.++.+++.+++|.+.... .....+.+|+..++.++|+|++++++++......+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 46999999999999999999999999999999886432 22456778999999999999999999999889999999
Q ss_pred cccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 87 EFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||+++++|.+++... ..++...++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999998653 358899999999999999999999999999999999999999999999999987655432221
Q ss_pred -ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHH
Q 022444 165 -RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 165 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~ 241 (297)
.....+..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+... ....+..+|.++.+++.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240 (263)
T ss_pred cCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 122234579999998877766 89999999999999998 99999888887777776654 345567789999999999
Q ss_pred hcCCCcCCCCCHHHHhc
Q 022444 242 ILDPNPETRITIEEIRN 258 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~ 258 (297)
||+.+|++|||+.++++
T Consensus 241 cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=283.37 Aligned_cols=249 Identities=33% Similarity=0.566 Sum_probs=214.1
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|.+.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+..++.+.|++++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998999999999976542 345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 88 FITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 88 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|+++++|.+++... ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNT 156 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccc
Confidence 99999999998776 5789999999999999999999999999999999999999999999999998876655432 334
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-cccC--CCCCChhHHHHHHHhc
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-DFSC--PTWFPVGAKSLIHRIL 243 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~--~~~~~~~l~~li~~~L 243 (297)
..+...|+|||.+.+...+ .++|+||||++++++++|..||...+........... .... ...++..+.+++.+||
T Consensus 157 ~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 235 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYD-YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235 (253)
T ss_pred eecCCcccCHHHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHc
Confidence 5677899999998766654 8999999999999999999999887554443333322 1222 2224899999999999
Q ss_pred CCCcCCCCCHHHHhcCcc
Q 022444 244 DPNPETRITIEEIRNDEW 261 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~ 261 (297)
+.||++|||+.++++|||
T Consensus 236 ~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 236 QKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cCChhhCCCHHHHhcCCC
Confidence 999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=300.23 Aligned_cols=258 Identities=28% Similarity=0.398 Sum_probs=205.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC------
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR------ 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 79 (297)
-++|++.+.||.|++|.||++.++.+|+.+++|.+..... ...+.+.+|+.+++.++|+|++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 4789999999999999999999999999999999865442 3346677899999999999999998766433
Q ss_pred --------CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-CCCEEEcc
Q 022444 80 --------TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISD 150 (297)
Q Consensus 80 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-~~~~~l~d 150 (297)
...++++||+.+ +|.+.+.. ..+++..++.++.|+++||.|||+.|++|+||+|+||+++. ++.++++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 357999999974 88887754 47899999999999999999999999999999999999975 55789999
Q ss_pred cCCCCCCCCCcc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---
Q 022444 151 FGLSALPEQGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--- 224 (297)
Q Consensus 151 f~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--- 224 (297)
||.+........ ......++..|+|||.+......+.++||||||+++|+|++|..||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 998865432211 11223567789999987554334489999999999999999999997765443332221100
Q ss_pred ---------------------c------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 225 ---------------------F------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 225 ---------------------~------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
. .....++.++.+|+.+||++||.+|||+.++++||||+....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 0 0122467889999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=301.09 Aligned_cols=267 Identities=26% Similarity=0.390 Sum_probs=215.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe----
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK---- 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 81 (297)
-++|++.+.||+|++|.||++++..+++.+++|.+...... ......+.+|+..++.+.|+|++++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 45799999999999999999999999999999988654322 2234567789999999999999999887755443
Q ss_pred --EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 82 --IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 82 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
.+++++++ +++|.+++.. ..+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999999 5689888875 5799999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc--------------
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-------------- 225 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-------------- 225 (297)
. .....++..|+|||.+.+....+.++||||||+++|++++|+.||...+.......+.....
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 171 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred c---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 2 22345677899999986543345899999999999999999999987765544443322110
Q ss_pred -----------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCC
Q 022444 226 -----------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVN 278 (297)
Q Consensus 226 -----------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~ 278 (297)
.....++..+.+++.+||+.+|++|||+.++++||||++......-...+..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPPYD 317 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccccccC
Confidence 00123578999999999999999999999999999999987776544433333
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=296.34 Aligned_cols=258 Identities=26% Similarity=0.472 Sum_probs=217.6
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
-|+....||.|++|.||.+.+..+++.+++|.+..... .....+.+|+..++.+.|+|++++++.+......++++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 35667789999999999999999999999999865432 224557789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
|+++++|.+++.. ..+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.............
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 9999999887654 578999999999999999999999999999999999999999999999999886544333333345
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc---cCCCCCChhHHHHHHHhcC
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---SCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~l~~li~~~L~ 244 (297)
.++..|+|||.+.+..++ .++|+||||+++++|++|..||...+.......+..... .....++..+.+++.+||+
T Consensus 178 ~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 178 VGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred ecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 678899999999877665 899999999999999999999987776665555443322 2233478899999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCccccc
Q 022444 245 PNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
.+|++|||++++++||||.+...+..
T Consensus 257 ~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 257 REPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred CCcccCcCHHHHhhChhhccCCCccc
Confidence 99999999999999999998855433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=290.19 Aligned_cols=252 Identities=28% Similarity=0.537 Sum_probs=212.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++.+.||.|++|.||+++++.+++.+++|.+......+......+.+|+.+++.+.|+|++++++.+......+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 46899999999999999999999999999999988765444444556788999999999999999999999988999999
Q ss_pred EcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+|++++++|.+++.. ...+++..++.++.+++.+|.|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999988863 3458999999999999999999999999999999999999999999999999887654433
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhhhcccc-C-CCCCChhHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL--TTLYSKVEKADFS-C-PTWFPVGAKS 237 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~--~~~~~~i~~~~~~-~-~~~~~~~l~~ 237 (297)
.......++..|+|||.+.+...+ .++|+||||+++|+|++|..||..... ......+.....+ . +..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred cccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 333345678899999999877765 899999999999999999999965432 3344444333222 2 2347889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 022444 238 LIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+||..+|++|||+.+|++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=289.69 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=204.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS-IMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
++|++.+.||+|+||.||+++++.+|+.|++|.+........ ...+..++. .++...|+|++++++++......+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 469999999999999999999999999999999876432222 223333444 46677899999999999988999999
Q ss_pred EcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
+||++ ++|.+++.. ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++++|||.+......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 477776643 34689999999999999999999997 9999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCccccccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhhhccccCC-CCCChh
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGY---NGAAADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVEKADFSCP-TWFPVG 234 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~ll~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~-~~~~~~ 234 (297)
. ......++..|+|||.+.+... .+.++|+||||+++|+|++|..||.... .......+.......+ ..+|.+
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd06617 158 V-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236 (283)
T ss_pred c-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence 1 1223456778999998864211 2488999999999999999999997532 2233333332223332 347899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+.+++.+||..+|++|||++++++||||++..
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 99999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.86 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=210.3
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCeEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTKIYI 84 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 84 (297)
++|...+.||.|++|.||++.+..+++.+++|.+..... ......+.+|++.++.+.|+||+++++++.. ....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999875432 2335667889999999999999999998854 347899
Q ss_pred EEcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 85 ILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
+|||+++++|.+++.. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887643 345899999999999999999999999999999999999999999999999987654432
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHhhhccc-cCC------
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-----DLTTLYSKVEKADF-SCP------ 228 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-----~~~~~~~~i~~~~~-~~~------ 228 (297)
.. ....++..|+|||.+.+..++ .++|+||||+++|+|++|..||... ...+....+..... ..+
T Consensus 159 ~~--~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd06621 159 LA--GTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235 (287)
T ss_pred cc--ccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence 22 133467789999999877766 8999999999999999999999765 22333333333211 111
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
..+++.+.+++.+||..+|++|||+.|++.||||++.-..
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 1245789999999999999999999999999999776544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=286.65 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=211.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
++|++.+.||+|+||.||+|.++.+ ...+++|.+.... .......+.+|+..++.++|+||+++++.+......+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 5799999999999999999998744 4578999886543 2233456778999999999999999999999889999
Q ss_pred EEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 84 IILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
++||++++++|.+++... +.++...++.++.+++.|+.|||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999999998764 4689999999999999999999999999999999999999999999999999886642211
Q ss_pred c--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHH
Q 022444 163 L--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSL 238 (297)
Q Consensus 163 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~l 238 (297)
. .....++..|+|||.+.+..++ .++||||||+++|++++ |..||...........+... ..+.+..+|+.+.++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 1122345689999999877665 89999999999999998 99999888877777776654 335556689999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcC
Q 022444 239 IHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~ 259 (297)
+.+|++.+|++|||+.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=297.53 Aligned_cols=261 Identities=28% Similarity=0.447 Sum_probs=208.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----C
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----T 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 80 (297)
.++|++.+.||+|++|.||++.++.+|+.|++|.+.... .......+.+|+..++.++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 478999999999999999999999999999999986422 223345677899999999999999999876543 3
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..++++|++.+ +|.+.+.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 57999999975 88777653 57999999999999999999999999999999999999999999999999988654332
Q ss_pred cc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh---------------
Q 022444 161 VS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK--------------- 222 (297)
Q Consensus 161 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~--------------- 222 (297)
.. ......++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 112345678899999876543334899999999999999999999976553322211100
Q ss_pred cc-------c---------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 223 AD-------F---------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 223 ~~-------~---------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
.. . ...+.++.++.+++.+||+.+|.+|||+.++++||||++...+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 00 0 011235788999999999999999999999999999998876533
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=297.91 Aligned_cols=261 Identities=28% Similarity=0.414 Sum_probs=211.5
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--- 80 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 80 (297)
...++|++++.||.|++|.||++.+..++..|++|.+.... ........+.+|+.+++.++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34578999999999999999999999999999999886432 12233456778999999999999999999886543
Q ss_pred ---eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCC
Q 022444 81 ---KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 81 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~ 157 (297)
..+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+...
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 6688877764 57999999999999999999999999999999999999999999999999988755
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc------------
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------------ 225 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------------ 225 (297)
.... ....++..|+|||.+.+....+.++|+||||+++|++++|..||...+.......+.....
T Consensus 169 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSEM---TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccCc---cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 4321 2335677899999987643345899999999999999999999987654433332211100
Q ss_pred -------------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 226 -------------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 226 -------------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
.....++..+.+++.+||..||++|||+.+++.||||+.......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~ 309 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED 309 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence 112346788999999999999999999999999999998855433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=284.26 Aligned_cols=243 Identities=29% Similarity=0.505 Sum_probs=204.1
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (297)
+.||+|++|.||+++++.+++.+++|.+.... .......+.+|+.+++.++|+||+++++++......++++||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999999999999876433 2333466888999999999999999999999999999999999999
Q ss_pred ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc--ccccC
Q 022444 93 ELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL--RTTCG 169 (297)
Q Consensus 93 ~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~--~~~~~ 169 (297)
+|.+++.+.. .+++..++.++.++++||.|||+.|++|+||+|+||+++.++.++|+|||.+.......... .....
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999987543 58999999999999999999999999999999999999999999999999887544321111 11122
Q ss_pred CccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHHhcCCCc
Q 022444 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILDPNP 247 (297)
Q Consensus 170 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~L~~~p 247 (297)
+..|+|||.+.+..++ .++|+||||+++|++++ |..||...........+... ....+..+|..+.+++.+||+.+|
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 4569999998776665 89999999999999997 99999877766655555443 345566789999999999999999
Q ss_pred CCCCCHHHHhc
Q 022444 248 ETRITIEEIRN 258 (297)
Q Consensus 248 ~~Rps~~~il~ 258 (297)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=288.72 Aligned_cols=246 Identities=24% Similarity=0.446 Sum_probs=203.3
Q ss_pred cccceEEeEEe--ccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh-cCCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTI--GEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL-VRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~l--g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~ 81 (297)
..+.|++.+.+ |+|++|.||++.++.++..+++|.+........ +...... ..|+|++++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34567777777 999999999999999999999999865432111 1111111 269999999999998899
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~~~~~~~~~ 160 (297)
.+++|||+++++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++++|||.+......
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999999998877999999999999999999999999999999999999999988 9999999988655432
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhhhccccCCCCCChhH
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-----TLYSKVEKADFSCPTWFPVGA 235 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~l 235 (297)
....++..|+|||.+.+..++ .++|+||+|+++|+|++|..||...... ...... ....+.+..++..+
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNA 237 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHH
Confidence 123567889999999877766 8999999999999999999999754332 222222 33344555689999
Q ss_pred HHHHHHhcCCCcCCCCC-HHHHhcCccccc
Q 022444 236 KSLIHRILDPNPETRIT-IEEIRNDEWFRK 264 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps-~~~il~~p~~~~ 264 (297)
.+|+.+||+.+|.+||+ ++++|+||||++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999999996 699999999974
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=288.15 Aligned_cols=250 Identities=25% Similarity=0.458 Sum_probs=214.3
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
+.-..|++.++||.|++|.||.+.++. +..+++|.+..... .....+.+|+..++.++|+|++++++++......+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 344679999999999999999999987 88899999876542 22456788999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 84 IILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
++|||+++++|.+++... ..++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999999753 358999999999999999999999999999999999999999999999999987654433
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLI 239 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li 239 (297)
.......++..|+|||.+....++ .++|+||||+++|+|++ |..||...+..+....+... ..+.+..+|+.+.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 323334456689999998776665 89999999999999998 89999888777666666544 3455677899999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 022444 240 HRILDPNPETRITIEEIRN 258 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~ 258 (297)
.+||+.+|++|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=288.07 Aligned_cols=257 Identities=24% Similarity=0.327 Sum_probs=211.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|++|.||++..+. .+..+++|.+..... ......+.+++..++.+.|+|++++++++....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4689999999999999999987642 355799998764431 222345678999999999999999999998888
Q ss_pred eEEEEEcccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcc
Q 022444 81 KIYIILEFITGGELFDKIVHHG----------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~d 150 (297)
..+++|||+++++|.+++.+.. ..+...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999999996532 346678899999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-cc
Q 022444 151 FGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FS 226 (297)
Q Consensus 151 f~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~ 226 (297)
||.+......... .....++..|+|||.+.+..++ .++|+||||+++|++++ |..||......+....+.... ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9988754332211 1122345679999998876665 89999999999999998 789998888777766665443 34
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc------CcccccC
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRITIEEIRN------DEWFRKG 265 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~------~p~~~~~ 265 (297)
.+..+++.+.+++.+||+.+|++|||+.++++ ||||+..
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 55667899999999999999999999999987 7777653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=284.85 Aligned_cols=244 Identities=29% Similarity=0.449 Sum_probs=213.3
Q ss_pred EEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEccc
Q 022444 13 RTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (297)
+.||.|++|.||.+.+... +..+++|.+....... ..+.+.+|+..++.+.|+|++++++++......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8999999997654322 4577889999999999999999999999989999999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 90 TGGELFDKIVHH---------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 90 ~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
++++|.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 67999999999999999999999999999999999999999999999999998766543
Q ss_pred c--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHH
Q 022444 161 V--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAK 236 (297)
Q Consensus 161 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~ 236 (297)
. .......++..|+|||.+....++ .++||||||+++|+|++ |..||...+..+..+.+... ....+..+|.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 2 223344567789999998776655 99999999999999999 69999999888888877754 3455677899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 022444 237 SLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~ 259 (297)
+++.+||+.+|++|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=288.89 Aligned_cols=252 Identities=32% Similarity=0.501 Sum_probs=209.1
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CeEEEEE
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKIYIIL 86 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 86 (297)
|++.+.||+|++|.||++.+..+++.+++|.+.... ........+.+|+..++.+.|+|++++++++... ...++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998654 2233345677899999999999999999999877 7899999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-cc
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~ 164 (297)
||+++ +|.+++.+. ..+++..++.++.++++||.+||+.|++|+||+|+||+++.++.++++|||.+........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 99975 888888765 5799999999999999999999999999999999999999999999999998876554321 12
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-------------------
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------------------- 225 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------------------- 225 (297)
....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.....
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 2345677899999876544345899999999999999999999987766554444322100
Q ss_pred ------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 226 ------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 226 ------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
.....++..+.+++.+||+.+|.+|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0011137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.78 Aligned_cols=245 Identities=27% Similarity=0.466 Sum_probs=190.1
Q ss_pred eEEeccCCceeEEEEEeC--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCeEEEEEc
Q 022444 12 GRTIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTKIYIILE 87 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 87 (297)
.++||+|+||.||+|+++ .+++.+++|.+..... ...+.+|+.++++++||||+++++.+.. ....++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999976 4678999998865421 2346689999999999999999998853 457899999
Q ss_pred ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee----cCCCCEEEcccCCC
Q 022444 88 FITGGELFDKIVHH---------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLS 154 (297)
Q Consensus 88 ~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli----~~~~~~~l~df~~~ 154 (297)
++.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||.+
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 887776532 258999999999999999999999999999999999999 45678999999998
Q ss_pred CCCCCCcc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHhhh
Q 022444 155 ALPEQGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL---------TTLYSKVEK 222 (297)
Q Consensus 155 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---------~~~~~~i~~ 222 (297)
........ ......+++.|+|||.+.+....+.++||||+||++|+|++|..||..... .+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 76543221 223456788999999987755445899999999999999999999964321 011111100
Q ss_pred c----------------------------cc----------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 223 A----------------------------DF----------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 223 ~----------------------------~~----------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
. .. ......+.++.+++.+||++||++|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 00 0001124568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=292.37 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=207.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEE--EEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESV--AMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~--~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 81 (297)
....|++.+.||.|+||.||+|.++.++..+ ++|...... .......+.+|+..+.++ +|+|++++++++...+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 4568999999999999999999998777654 666554322 233346677899999999 89999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~ 145 (297)
.++++||+++++|.+++.+.. .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999986542 4789999999999999999999999999999999999999999
Q ss_pred EEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-
Q 022444 146 LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA- 223 (297)
Q Consensus 146 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~- 223 (297)
++|+|||++....... .......+..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+..+.+...
T Consensus 163 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred EEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9999999876432211 11122335679999998776655 89999999999999998 99999887777766666544
Q ss_pred cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 224 DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
....+..+++++.+++.+||+.+|++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 233455578999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.76 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=203.4
Q ss_pred cceEEeEEeccCCceeEEEEEe-----CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQN-----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (297)
++|++.+.||+|+||.||++++ ..++..|++|++..... ....+.+.+|+.+++.+ .||||+++++++....
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 3799999999999999999974 34577899999865431 22345678899999999 7999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcC----------------------------------------------------------
Q 022444 81 KIYIILEFITGGELFDKIVHHG---------------------------------------------------------- 102 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------- 102 (297)
..+++|||+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999998886421
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc--
Q 022444 103 -----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL-- 163 (297)
Q Consensus 103 -----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~-- 163 (297)
.+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 3678889999999999999999999999999999999999999999999998755432211
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHhhhcc-ccCCCCCChhHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT-TLYSKVEKAD-FSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~l~~li~ 240 (297)
.....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...... ...+.+.... ...+...|.++.+++.
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 351 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK 351 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHH
Confidence 1122345679999999877766 89999999999999998 89999776533 3344444332 2334557899999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+||+.||++|||+.++++
T Consensus 352 ~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 352 SCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHccCChhHCcCHHHHHH
Confidence 999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=286.90 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=208.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|++|.||.+.++. ++..+++|++.... .......+.+|+..++.+.|+||+++++++....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4679999999999999999998652 35679999875432 1223456778999999999999999999998888
Q ss_pred eEEEEEcccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcc
Q 022444 81 KIYIILEFITGGELFDKIVHHG----------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~d 150 (297)
..+++|||+++++|.+++.+.. .++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 9999999999999999886532 356788999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-cc
Q 022444 151 FGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FS 226 (297)
Q Consensus 151 f~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~ 226 (297)
||.+......... .....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+.... ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9988654332221 1123346689999999876665 89999999999999998 789998888777666555443 34
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.+..++..+.+++.+||+.+|++|||+.+++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.95 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=203.1
Q ss_pred cceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (297)
++|++.+.||+|+||.||.+++.. ++..|++|.+..... ......+.+|+.+++.+ .|+||+++++.+....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 469999999999999999998643 345799999875432 22346688899999999 7999999999999989
Q ss_pred eEEEEEcccCCCChHHHHHhc-----------------------------------------------------------
Q 022444 81 KIYIILEFITGGELFDKIVHH----------------------------------------------------------- 101 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------- 101 (297)
..+++|||+++++|.+++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999999999888542
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc--ccccc
Q 022444 102 -----------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL--LRTTC 168 (297)
Q Consensus 102 -----------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~--~~~~~ 168 (297)
.++++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 24678889999999999999999999999999999999999999999999998754332211 11222
Q ss_pred CCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc--cccCCCCCChhHHHHHHHhcCC
Q 022444 169 GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA--DFSCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 169 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~l~~li~~~L~~ 245 (297)
++..|+|||++.+..++ .++||||||+++|+|++ |..||............... ....+..+|+++.+++.+||+.
T Consensus 276 ~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 354 (374)
T cd05106 276 LPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNL 354 (374)
T ss_pred CccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCC
Confidence 44579999999776665 89999999999999997 99999776544333232222 2344556799999999999999
Q ss_pred CcCCCCCHHHHhc
Q 022444 246 NPETRITIEEIRN 258 (297)
Q Consensus 246 ~p~~Rps~~~il~ 258 (297)
+|++|||+.++++
T Consensus 355 dp~~RPs~~~l~~ 367 (374)
T cd05106 355 EPTERPTFSQISQ 367 (374)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=289.25 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=212.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|.+.+.||.|++|.||++.+.. ++..+++|.+..... .+..+.+.+|+++++.+.|+|++++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4579999999999999999998753 467899999865432 223567889999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCE
Q 022444 81 KIYIILEFITGGELFDKIVHHG--------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHL 146 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~ 146 (297)
..+++|||+++++|.+++...+ .+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999987542 37888999999999999999999999999999999999999999
Q ss_pred EEcccCCCCCCCCCc--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc
Q 022444 147 KISDFGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA 223 (297)
Q Consensus 147 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~ 223 (297)
+|+|||.+....... .......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999886543221 112233446789999999877766 89999999999999998 99999888888877777766
Q ss_pred ccc-CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 224 DFS-CPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 224 ~~~-~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
... .+..+|..+.+++.+||+.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 543 35568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=282.76 Aligned_cols=253 Identities=28% Similarity=0.505 Sum_probs=212.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecch--hhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CeEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA--IIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKIY 83 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 83 (297)
.|++.+.||+|++|.||++.+..+++.+++|.+.... .........+.+|+..++.++|+||+++++.+.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 6999999999999999999999999999999875421 12233456788999999999999999999988654 4688
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc--
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-- 161 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~-- 161 (297)
+++|++++++|.+.+.+.+.+++..++.++.+++.||.+||++|++|+||+|+||+++.++.++++|||.+.......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence 999999999999999887789999999999999999999999999999999999999999999999999987543211
Q ss_pred -cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cccCCCCCChhHHHH
Q 022444 162 -SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPVGAKSL 238 (297)
Q Consensus 162 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~l~~l 238 (297)
.......++..|+|||.+.+...+ .++|+||||++++++++|+.||...........+... ....+..+++++.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 241 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241 (264)
T ss_pred CccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence 111234577889999999877665 8999999999999999999999877655544443322 234566788999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCccc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
+.+||.. |.+|||+.+++.|||.
T Consensus 242 i~~~l~~-~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 242 LKQIFVE-EKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHhcC-cccCccHHHHhcCCCC
Confidence 9999995 7999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=293.52 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=202.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCC--CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CeEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTE--TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKIY 83 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 83 (297)
+|++.+.||+|++|.||+|.++. +++.+++|.+.............+.+|+.+++.++|||++++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999998764322233345567899999999999999999999877 7899
Q ss_pred EEEcccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC----CCCEEEcccCCC
Q 022444 84 IILEFITGGELFDKIVHH-----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS----QGHLKISDFGLS 154 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~----~~~~~l~df~~~ 154 (297)
+|+|++.+ ++.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++++|||.+
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 676666432 26899999999999999999999999999999999999999 899999999998
Q ss_pred CCCCCCcc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHh--
Q 022444 155 ALPEQGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT---------LYSKV-- 220 (297)
Q Consensus 155 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~---------~~~~i-- 220 (297)
........ ......++..|+|||.+.+....+.++|+||||+++++|++|..||...+... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76543322 12233567789999988765433489999999999999999999997543221 00000
Q ss_pred ------------------------hhccccCC-----------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 221 ------------------------EKADFSCP-----------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 221 ------------------------~~~~~~~~-----------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
.......+ ...+.++.+++.+||++||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000111 1356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=282.32 Aligned_cols=247 Identities=24% Similarity=0.425 Sum_probs=209.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|++|.||++..+ ++..+++|.+...... ...+.+|+..++.+.|+||+++++++......+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 357999999999999999999876 4567999987643311 34577899999999999999999999998999999
Q ss_pred EcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-c
Q 022444 86 LEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~ 163 (297)
|||+++++|.+++.. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999999998865 34689999999999999999999999999999999999999999999999998875533222 1
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHR 241 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~ 241 (297)
.....++..|+|||.+.+..++ .++|+||||+++|++++ |+.||...+..+....+..+.. ..+...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1223345689999999877766 89999999999999999 8999998888877777766543 3455578899999999
Q ss_pred hcCCCcCCCCCHHHHhc
Q 022444 242 ILDPNPETRITIEEIRN 258 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~ 258 (297)
|++.+|++|||+.++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=286.29 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=209.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (297)
....|++.+.||+|++|.||++.+.. ++..+++|.+..... ......+.+|+..++.+.|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45679999999999999999999987 678899998864432 22235577899999999999999999999888
Q ss_pred CeEEEEEcccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC---CEEEc
Q 022444 80 TKIYIILEFITGGELFDKIVHHG-------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKIS 149 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~---~~~l~ 149 (297)
...+++||++.+++|.+++.... .+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++ .++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 88999999999999999987653 488999999999999999999999999999999999998654 58999
Q ss_pred ccCCCCCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cc
Q 022444 150 DFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DF 225 (297)
Q Consensus 150 df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~ 225 (297)
|||.+......... ......+..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998765322111 1122334679999999877766 99999999999999997 99999888777766655443 34
Q ss_pred cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 226 SCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 226 ~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
..+..+|..+.+++.+||+.+|++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5566789999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=294.52 Aligned_cols=280 Identities=24% Similarity=0.344 Sum_probs=219.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (297)
..++|++.+.||+|++|.||++.+..+++.|++|.+...... ......+.+|+..+++++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 347899999999999999999999999999999998754322 22245577899999999999999999987532
Q ss_pred -CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
...+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478888887 6688877754 468999999999999999999999999999999999999999999999999887543
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--------------
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-------------- 224 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-------------- 224 (297)
.. .....++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+....
T Consensus 172 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 172 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred cc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 32 2234567789999998663333489999999999999999999997665443322221100
Q ss_pred ---------ccC--------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCccccccccC
Q 022444 225 ---------FSC--------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFD 287 (297)
Q Consensus 225 ---------~~~--------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (297)
... ....++++.+++.+||+.||.+|||+.++++||||++...+..-..-.+++.........
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLL 328 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCCccCcchhcccC
Confidence 000 112577899999999999999999999999999999887766555555555555554444
Q ss_pred Chh
Q 022444 288 DSE 290 (297)
Q Consensus 288 ~~~ 290 (297)
.+|
T Consensus 329 ~~~ 331 (345)
T cd07877 329 IDE 331 (345)
T ss_pred HHH
Confidence 443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=290.65 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=214.4
Q ss_pred EEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEccc
Q 022444 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (297)
+...+||.|++|.||.+..+.+++.+++|.+.... ......+.+|+..++.+.|+|++++++.+...+..+++|||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33467999999999999999999999999885432 223456888999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccC
Q 022444 90 TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169 (297)
Q Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 169 (297)
++++|.+++.. ..+++..+..++.+++.++.|||+.|++|+||+|+||+++.++.++++|||.+..............+
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 99999887654 47899999999999999999999999999999999999999999999999987655433323334457
Q ss_pred CccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---ccCCCCCChhHHHHHHHhcCCC
Q 022444 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 170 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~l~~li~~~L~~~ 246 (297)
+..|+|||.+.+..++ .++|+||+|+++|+|++|..||...........+.... ......++..+.+++.+||+.+
T Consensus 179 ~~~y~~pE~~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 179 TPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred CccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 7889999998766665 89999999999999999999998776665555443332 2233457899999999999999
Q ss_pred cCCCCCHHHHhcCcccccCccc
Q 022444 247 PETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 247 p~~Rps~~~il~~p~~~~~~~~ 268 (297)
|.+||++.++++||||.+...+
T Consensus 258 P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 258 PAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred cccCcCHHHHhcChHHhccCCC
Confidence 9999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=287.01 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=212.3
Q ss_pred cceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..|.+.+.||.|++|.||.+.+. .++..+++|.+.... ......+.+|+..++++.|+|++++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 46999999999999999999853 345668888876432 2335668899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEE
Q 022444 82 IYIILEFITGGELFDKIVHHG-------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKI 148 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l 148 (297)
.++++||+++++|.+++...+ .+++..++.++.+++.||+|||+.|++|+||+|+||+++.++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999987543 3899999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccc
Q 022444 149 SDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADF 225 (297)
Q Consensus 149 ~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 225 (297)
+|||.+........ ......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||......+....+..+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999875533211 11223345689999999877665 89999999999999998 9999988888777777766653
Q ss_pred -cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 226 -SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 226 -~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
..+..++.++.+++.+||+.+|.+|||+.+++. .+++.
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~ 279 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNL 279 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHH
Confidence 445568899999999999999999999999966 44443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=318.04 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=207.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++.++||+|++|.||+|.+..+|+.|++|.+...........+.+.+|+.+++.+.|||++++++++.+.+..+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 57999999999999999999999999999999999765444444556788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 86 LEFITGGELFDKIVHH-----------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
|||++|++|.+++.+. .+.+...++.++.++++||.|||+.|++|+||||+||+++.++.++++|||.+
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988642 23556778999999999999999999999999999999999999999999998
Q ss_pred CCCCCCc------------------cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022444 155 ALPEQGV------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (297)
Q Consensus 155 ~~~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~ 216 (297)
....... .......|++.|+|||.+.+..++ .++||||||+++|+|++|..||...+....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 7552110 011123588999999999877765 999999999999999999999987654433
Q ss_pred HHHhhhcc---ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 217 YSKVEKAD---FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 217 ~~~i~~~~---~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
........ ......+|+.+.+++.+||..||++|++..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 32211111 1112357899999999999999999987666554
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=282.77 Aligned_cols=247 Identities=24% Similarity=0.431 Sum_probs=209.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.++||+|++|.||++.+. ++..+++|.+..... ..+.+.+|+.+++.++|+||+++++.+......+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 467999999999999999999975 556799998765331 245678899999999999999999999888999999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+|++++++|.+++... ..++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999998653 45888999999999999999999999999999999999999999999999998765432221
Q ss_pred -cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
.....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...........+... ..+....+|.++.+++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred ccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1223345679999998776665 89999999999999998 99999888777776666544 23444568999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+||+.+|++|||++++++
T Consensus 239 ~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 239 TCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=286.11 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=210.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeC----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNT----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++.|++.+.||+|+||.||++.+. .++..+++|.+.... .......+.+|+..++++.|+|++++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3578999999999999999999853 456789999886533 2233466888999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC
Q 022444 81 KIYIILEFITGGELFDKIVHH-----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~ 143 (297)
..|++|||+++++|.+++... ..+++..++.++.+++.||.|||++|++|+||+|+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999988532 237888899999999999999999999999999999999999
Q ss_pred CCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q 022444 144 GHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKV 220 (297)
Q Consensus 144 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i 220 (297)
+.++|+|||.+........ ......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||.+.......+.+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999876543221 11223345679999999776665 89999999999999998 99999887776666665
Q ss_pred hhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 221 EKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 221 ~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.... .+.+..+|+.+.+++.+||+.+|.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5443 45566789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=290.71 Aligned_cols=257 Identities=31% Similarity=0.520 Sum_probs=208.2
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--- 80 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 80 (297)
...++|++.+.||.|++|.||++.++.+|+.+++|.+...... ......+.+|+.++++++|+|++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 3567899999999999999999999999999999998754321 122345678999999999999999999886544
Q ss_pred -------eEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccC
Q 022444 81 -------KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (297)
Q Consensus 81 -------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~ 152 (297)
..++++||+++ ++...+.+. ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999986 676766653 468999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcc-ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc------
Q 022444 153 LSALPEQGVS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------ 225 (297)
Q Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------ 225 (297)
.+........ ......++..|+|||.+.+....+.++||||||+++++|++|+.||...+..+....+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 8876543321 122234567899999886544345899999999999999999999987665544433322100
Q ss_pred ------------------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 226 ------------------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 226 ------------------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
.....+|..+.+++.+||+.+|++|||++++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0112368999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.89 Aligned_cols=256 Identities=24% Similarity=0.414 Sum_probs=212.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|...+.||+|++|.||++.+..+++.+++|.+.............+.+|+..++.++|+|++++++++.+....|++||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 47778899999999999999999999999999876543344445667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 88 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|+.+ ++.+.+.. ..++++..+..++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+..... ...
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~ 176 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANS 176 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CCC
Confidence 9965 77777654 45689999999999999999999999999999999999999999999999998764322 123
Q ss_pred ccCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccC--CCCCChhHHHHHHHh
Q 022444 167 TCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC--PTWFPVGAKSLIHRI 242 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~l~~li~~~ 242 (297)
..++..|+|||.+.. ....+.++|+||||+++|+|++|..||...+.......+.....+. ...++..+.+|+.+|
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC 256 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 457788999999842 2223489999999999999999999998877665555544333221 234678899999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccCccc
Q 022444 243 LDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
|+.+|.+||++.+++.||||+.....
T Consensus 257 l~~~P~~Rp~~~~~l~~~~~~~~~~~ 282 (313)
T cd06633 257 LQKIPQERPASAELLRHDFVRRDRPA 282 (313)
T ss_pred ccCChhhCcCHHHHhcCcccCCCchh
Confidence 99999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=325.72 Aligned_cols=261 Identities=33% Similarity=0.579 Sum_probs=231.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
-++|.|++.||+|+||.|.+++++.+++-+|.|++++-........+-+..|-.++.....+-|+.++-.|.+..++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 45799999999999999999999999999999998764444444456788888888888899999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC-CCcccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE-QGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~-~~~~~~ 164 (297)
|||++||+|..++.+..++++..++.++..|.-||.-||+.|+||+||||+||++|..|+++|.|||.|-.+. .+.-..
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 9999999999999999899999999999999999999999999999999999999999999999999987766 444466
Q ss_pred ccccCCccccCCccccc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cccCC--CCCChhHH
Q 022444 165 RTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCP--TWFPVGAK 236 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~l~ 236 (297)
...+|+|.|++||++.. .+..+..+|.||||+++|+|+.|..||......+.+.+|.+- .+.+| ..+|+++.
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeak 313 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAK 313 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHH
Confidence 78899999999999843 233468999999999999999999999998888888888665 45566 55999999
Q ss_pred HHHHHhcCCCcCCCCC---HHHHhcCcccccCcc
Q 022444 237 SLIHRILDPNPETRIT---IEEIRNDEWFRKGYV 267 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps---~~~il~~p~~~~~~~ 267 (297)
+||++++.. |..|.. ++++-.||||.+..=
T Consensus 314 dLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 314 DLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHhcC-hhhhcccccHHHHHhCccccCCCh
Confidence 999999965 888888 999999999998643
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=294.20 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=208.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC------
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR------ 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 79 (297)
..+|.+.+.||.|++|.||+|++..+|+.+++|.+..... .......+.+|+.+++.+.|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4789999999999999999999999999999999865432 222345577899999999999999999988643
Q ss_pred CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
..++++++++.. +|.+.. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 346999999964 666554 24689999999999999999999999999999999999999999999999998875432
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--------------- 224 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--------------- 224 (297)
. .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+....
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 E---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred C---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 2 1234567789999998764333489999999999999999999998766444333222100
Q ss_pred --------ccC--------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccccc
Q 022444 225 --------FSC--------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273 (297)
Q Consensus 225 --------~~~--------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~ 273 (297)
... ....+..+.+++.+||+.||.+|||+.+++.||||+..........
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~ 311 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETE 311 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCC
Confidence 000 1235678999999999999999999999999999999865444443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=293.97 Aligned_cols=257 Identities=25% Similarity=0.450 Sum_probs=227.8
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
|.++++||.|++|.||+|.++.+|+-++||.++... ..+++.+|+.+++++..+++|++++.+.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 788999999999999999999999999999987643 367788999999999999999999988888889999999
Q ss_pred cCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 89 ITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 89 ~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
|..|++.+.+. +++++++.++..+++..+.+|+|||...-+|+|||..||++..+|..||.|||.+-.+.......+.-
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence 99999999886 45689999999999999999999999999999999999999999999999999998877766666778
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc---cccCCCCCChhHHHHHHHhcC
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---DFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~l~~li~~~L~ 244 (297)
.|++.|+|||++..-+|+ ..+||||||++..+|..|++||....+..-+-.+... .++.|+.++.++.+|+++||-
T Consensus 190 IGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred ccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 899999999999988888 8999999999999999999999876654433222222 233455688999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCcccccc
Q 022444 245 PNPETRITIEEIRNDEWFRKGYVPVKL 271 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~~~~~~ 271 (297)
++|.+|.|+-++++|||+++...+.++
T Consensus 269 K~PE~R~TA~~L~~H~FiknA~g~~I~ 295 (502)
T KOG0574|consen 269 KKPEERKTALRLCEHTFIKNAPGCDIM 295 (502)
T ss_pred CCHHHHHHHHHHhhhhhhcCCCcccHH
Confidence 999999999999999999999776554
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.10 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=210.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCC-----CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTET-----GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||.|++|.||++.++.. +..+++|...... .......+.+++..++.++|+|++++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 46899999999999999999998643 3789999986443 2222456778999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcc
Q 022444 81 KIYIILEFITGGELFDKIVHHG----------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~d 150 (297)
..+++|||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999999986432 367789999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-ccc
Q 022444 151 FGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFS 226 (297)
Q Consensus 151 f~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~ 226 (297)
||.+........ ......++..|+|||.+.+...+ .++||||||+++|++++ |..||...+.....+.+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 998875443221 12233456789999998776665 89999999999999998 99999888877777666644 345
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+..+|.++.+++.+||+.+|++|||+.++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 66778999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=281.50 Aligned_cols=246 Identities=28% Similarity=0.452 Sum_probs=206.3
Q ss_pred EEeccCCceeEEEEEeCCCC---cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEccc
Q 022444 13 RTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (297)
++||+|++|.||+|....++ ..+++|.+...... ...+.+.+|+..++.+.|+|++++++++. ....+++||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876544 78999998765432 33566888999999999999999999875 45689999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc---
Q 022444 90 TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT--- 166 (297)
Q Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~--- 166 (297)
.+++|.+++.....+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999988778999999999999999999999999999999999999999999999999998765443322111
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHHhcC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~L~ 244 (297)
..++..|+|||.+.+..++ .++||||||+++|++++ |..||...+..+....+.... ...+..++..+.+++.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1123579999999777665 89999999999999998 999998888777766665553 34556688999999999999
Q ss_pred CCcCCCCCHHHHhcCccccc
Q 022444 245 PNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~ 264 (297)
.+|++|||+.++++ .|++
T Consensus 237 ~~p~~Rp~~~~l~~--~l~~ 254 (257)
T cd05060 237 YRPEDRPTFSELES--TFRR 254 (257)
T ss_pred CChhhCcCHHHHHH--HHHh
Confidence 99999999999987 4443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=287.33 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=209.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCC----------------cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETG----------------ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~----------------~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 68 (297)
..++|++++.||+|+||.||++.+...+ ..+++|.+..... ....+.+.+|+..++.++|+|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999876533 5678998875432 234567889999999999999
Q ss_pred eeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCC
Q 022444 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-----------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPEN 137 (297)
Q Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~n 137 (297)
++++++++..+...++++|++.+++|.+++.+.. .+++..++.++.+++.||.|||+.|++|+||+|+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999998899999999999999999987765 68999999999999999999999999999999999
Q ss_pred eeecCCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCH
Q 022444 138 LLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA--GYLPFDELDL 213 (297)
Q Consensus 138 Ili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~--g~~pf~~~~~ 213 (297)
|+++.++.++|+|||.+........ ......++..|+|||.+.+..++ .++||||||+++|++++ +..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999998875433211 12233456689999998776655 99999999999999998 7889988776
Q ss_pred HHHHHHhhhc--------cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 214 TTLYSKVEKA--------DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 214 ~~~~~~i~~~--------~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+....+... ..+.+..+|+++.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6665554432 12334557899999999999999999999999966
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=288.39 Aligned_cols=252 Identities=31% Similarity=0.504 Sum_probs=210.0
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
|++.+.||+|++|.||.+++..+++.+++|.+.... ......+.+.+|+..++.++|+|++++++++.+....++++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999987654 2233345677899999999999999999999888999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 89 ITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
+.+ +|.+++.+. ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.............
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 985 899999876 579999999999999999999999999999999999999999999999999987665543333344
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc------------------c--c--
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA------------------D--F-- 225 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~------------------~--~-- 225 (297)
.....|+|||.+.+....+.++|+||||++++++++|..||...+......++... . .
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 55678999999876633458999999999999999999999876654443332210 0 0
Q ss_pred -------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 226 -------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 226 -------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
.....++..+.+++.+||..+|++||++++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0011247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=293.44 Aligned_cols=259 Identities=33% Similarity=0.532 Sum_probs=232.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+...|+.-++||.|+||.|+.++.+.+|+-+|.|.+.+..........-..+|-.+|.+++.+.||.+--.|+..+.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 45679999999999999999999999999999998877766666666668899999999999999999888999999999
Q ss_pred EEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
|+..|+||+|.-.+.+.+ .++++.++.++.+|+-+|++||+.+||++|+||+||++|+.|++++.|+|++.....+ .
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-~ 341 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-K 341 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC-C
Confidence 999999999988887766 7999999999999999999999999999999999999999999999999999877665 3
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHhhhccccCCCCCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL----DLTTLYSKVEKADFSCPTWFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~l~~l 238 (297)
.....+|+.+|+|||++.+..|+ ...|.|||||++|+|+.|+.||... ...++.+++......++...+++++++
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred ccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 34466999999999999988876 9999999999999999999999654 344666777777788889999999999
Q ss_pred HHHhcCCCcCCCCC-----HHHHhcCcccccC
Q 022444 239 IHRILDPNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 239 i~~~L~~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
.+.+|++||++|.- +.++-+||||+..
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 99999999999875 4599999999983
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=288.65 Aligned_cols=252 Identities=32% Similarity=0.500 Sum_probs=209.9
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
|++.+.||+|++|.||++.+..+++.+++|.+...... ......+.+|+..++.++|+|++++++++......++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998654422 23346677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 89 ITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 89 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
+.+ ++.+.+.. ...+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.............
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 976 88777765 4578999999999999999999999999999999999999999999999999887665543223334
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-------------------c---
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-------------------F--- 225 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-------------------~--- 225 (297)
.+...|+|||.+.+....+.++|+||||+++|++++|+.||...+..+...++.... .
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 577789999998766334599999999999999999999998776655443332110 0
Q ss_pred --------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 226 --------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 226 --------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
...+.++.++.+++.+||++||.+||++++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.03 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=206.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCc--EEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 83 (297)
++|++.+.||.|++|.||+++++.++. .+++|.+.... .....+.+.+|+..+.++ .||||+++++++......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999887765 46777765322 222345678899999999 6999999999998888999
Q ss_pred EEEcccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEE
Q 022444 84 IILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~ 147 (297)
+++||+++++|.+++.+.. .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999986532 478899999999999999999999999999999999999999999
Q ss_pred EcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-c
Q 022444 148 ISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-F 225 (297)
Q Consensus 148 l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~ 225 (297)
|+|||++........ ......+..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.....+.+.... .
T Consensus 160 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~ 237 (297)
T cd05089 160 IADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM 237 (297)
T ss_pred ECCcCCCccccceec-cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 999998764332111 1112234579999998777665 89999999999999997 999998888877777665543 3
Q ss_pred cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 226 SCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 226 ~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
..+..++.++.+|+.+||+.+|.+|||++++++.
T Consensus 238 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4456689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=285.16 Aligned_cols=259 Identities=31% Similarity=0.583 Sum_probs=216.3
Q ss_pred ceEEeEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 82 (297)
.|++.+.||.|++|.||.+.+. .+|..+++|.+...... .....+.+.+|+.+++.+ .|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999975 47899999998754322 222345677899999999 489999999999988899
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
++++||+++++|.+++....++++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999998875443221
Q ss_pred -ccccccCCccccCCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHhhhccccCCCCCChhHH
Q 022444 163 -LLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDEL----DLTTLYSKVEKADFSCPTWFPVGAK 236 (297)
Q Consensus 163 -~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~l~ 236 (297)
......++..|+|||.+.+.. ..+.++||||||+++|++++|..||... ........+.....+.+..++..+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 122345778899999986532 2248899999999999999999999643 2344455555555666777899999
Q ss_pred HHHHHhcCCCcCCCC-----CHHHHhcCcccccCc
Q 022444 237 SLIHRILDPNPETRI-----TIEEIRNDEWFRKGY 266 (297)
Q Consensus 237 ~li~~~L~~~p~~Rp-----s~~~il~~p~~~~~~ 266 (297)
+++.+||+.+|++|| ++++++.||||++..
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999999999997 899999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=282.45 Aligned_cols=255 Identities=29% Similarity=0.571 Sum_probs=222.0
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEEEcccC
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
.+.||+|+++.|-.++.-.+|..++||++.+.. ...+.++.+|++++++++ |+||+.++++|++++.+|+|||.+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 357999999999999999999999999998764 344677889999999996 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC---CEEEcccCCCCCCCCC-------
Q 022444 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPEQG------- 160 (297)
Q Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~---~~~l~df~~~~~~~~~------- 160 (297)
||+|.+.+.+..-|++.++.++.++|+.||.+||..||.|+|+||+||+-.... -+|++||++..-....
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 999999999999999999999999999999999999999999999999996544 4899999987543221
Q ss_pred ccccccccCCccccCCcccc----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------------HHHHHHHhh
Q 022444 161 VSLLRTTCGTPNYVAPEVLS----HKGYNGAAADVWSCGVILYVLIAGYLPFDELD---------------LTTLYSKVE 221 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---------------~~~~~~~i~ 221 (297)
......++|+..|||||+.. ...+.+.++|.||||+++|-|+.|.+||.+.- -..+.+.|.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 22334567888999999862 22333489999999999999999999996542 567889999
Q ss_pred hccccCCCC----CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 222 KADFSCPTW----FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 222 ~~~~~~~~~----~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
.+++.+|.. ++.+..++++.+|..|+.+|.++.++++|||++......
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 999999876 789999999999999999999999999999999886553
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=280.26 Aligned_cols=247 Identities=23% Similarity=0.407 Sum_probs=208.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|++|.||++.+. +++.+++|.+..... ..+.+.+|+..+++++|+|++++++++......+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999975 457899999865431 135577899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 86 LEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
||++.+++|.+++.... .++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999987644 6899999999999999999999999999999999999999999999999988765432211
Q ss_pred -cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
......+..|+|||.+.+..++ .++|+||||+++++|++ |+.||...+.......+... ..+.+..++..+.+++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238 (261)
T ss_pred ccCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 1122234579999998876665 89999999999999999 99999888777766665444 33456668999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+|++.+|++||++.++++
T Consensus 239 ~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 239 DCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHhhcCcccCCCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=279.20 Aligned_cols=243 Identities=28% Similarity=0.531 Sum_probs=210.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
...|++.+.||.|++|.||.+... |+.+++|.+..... ..+.+.+|+.+++.+.|+|++++++++......+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 457999999999999999999875 78899999976542 356788899999999999999999999888899999
Q ss_pred EcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 86 LEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
||++++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999999997665 689999999999999999999999999999999999999999999999998876633222
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~ 241 (297)
....+..|.|||.+.+..++ .++|+||||++++++++ |..||...+..+..+.+... ....+..+|+++.+++.+
T Consensus 158 --~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD 234 (256)
T ss_pred --cCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence 23345679999998766665 89999999999999997 99999888877777666544 334456689999999999
Q ss_pred hcCCCcCCCCCHHHHhc
Q 022444 242 ILDPNPETRITIEEIRN 258 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~ 258 (297)
||..+|++|||++++++
T Consensus 235 ~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 235 CWELDPAKRPTFKQLRE 251 (256)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=294.43 Aligned_cols=258 Identities=29% Similarity=0.403 Sum_probs=208.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC--Ce
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR--TK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~ 81 (297)
-.++|++.+.||+|++|.||++.+..+++.+++|.+..... .......+.+|+..++++ +|+||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35689999999999999999999998999999998854321 122234566899999999 999999999988543 46
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
.++++|++.+ +|.+++.+. .+++..++.++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 8999999975 998888765 78899999999999999999999999999999999999999999999999887554322
Q ss_pred c-----ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc------------
Q 022444 162 S-----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD------------ 224 (297)
Q Consensus 162 ~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~------------ 224 (297)
. ......++..|+|||.+.+....+.++|+||||+++|+|++|+.||..........++....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1 22234567889999988665444589999999999999999999997665443332221110
Q ss_pred -------------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 225 -------------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 225 -------------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
......++.++.+++.+||+.+|++|||+.++++|||+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 01112268899999999999999999999999999999887
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=288.29 Aligned_cols=277 Identities=25% Similarity=0.409 Sum_probs=215.9
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-CCeE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-RTKI 82 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 82 (297)
...++|++.+.||.|++|.||++.++.+++.+++|.+..... .......+.+|+.+++.+.|||++++.+++.. ....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999999999999998764321 22234567789999999999999999998865 5678
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
++++|++. ++|.+.+.. .++++..+..++.++++||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 86 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 86 YFVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred EEEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 99999994 588777654 46888999999999999999999999999999999999999999999999988754332
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh--------------------
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK-------------------- 222 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~-------------------- 222 (297)
.....++..|+|||.+.+....+.++|+||||+++|++++|..||...........+..
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 12345677899999986533334899999999999999999999976654322111100
Q ss_pred -------c-ccc---CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccc-ccccCCCcccccccc
Q 022444 223 -------A-DFS---CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKL-IEYEDVNLDDVNAAF 286 (297)
Q Consensus 223 -------~-~~~---~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 286 (297)
. ..+ ....++.++.+++.+||+.+|++|||+++++.||||+....+..- ...+.++|++.+.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDADL 316 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhcCCchhcccC
Confidence 0 000 012367899999999999999999999999999999877555222 233355565554443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.83 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=210.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (297)
+.++|.+.+.||+|++|.||++.+. .++..+++|.+.... ....+.+.+|+..++++.|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4567999999999999999999864 345668888876543 22245678899999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~ 143 (297)
...+++|||+++++|.+++.... .+++..++.++.+++.||+|||+.|++|+||+|+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999986542 37889999999999999999999999999999999999999
Q ss_pred CCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q 022444 144 GHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKV 220 (297)
Q Consensus 144 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i 220 (297)
+.++|+|||.+........ ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.....+.+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999875543221 12233456789999998877665 89999999999999999 99999888877777766
Q ss_pred hhccc-cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 221 EKADF-SCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 221 ~~~~~-~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
..... ..+...|..+.+++.+||+.+|++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 66544 334557899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=286.66 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=210.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCC-----CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTET-----GESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 79 (297)
.++|++.+.||+|++|.||++.++.. ...+++|.+.... .......+.+|+..++.+ +|+||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 45799999999999999999997643 3779999887543 222345678899999999 799999999999988
Q ss_pred CeEEEEEcccCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC
Q 022444 80 TKIYIILEFITGGELFDKIVH----------------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~----------------~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~ 143 (297)
...+++|||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 899999999999999999854 2358899999999999999999999999999999999999999
Q ss_pred CCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q 022444 144 GHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKV 220 (297)
Q Consensus 144 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i 220 (297)
+.++|+|||.+........ ......++..|+|||.+.+..++ .++||||||+++|++++ |..||......+..+.+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999876543221 11222345679999998777666 89999999999999997 99999988877777766
Q ss_pred hhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 221 EKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 221 ~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.... ...+..++.++.+++.+||+.+|++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5553 34556688999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=280.29 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=208.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||.|++|.||.+.+.. +..+++|.+...... .+.+.+|+..++.+.||||+++++++......+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 3579999999999999999998764 456999988654321 24577899999999999999999999888889999
Q ss_pred EcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc-
Q 022444 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL- 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~- 163 (297)
|||+.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+.....+...
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999998764 46899999999999999999999999999999999999999999999999988755433221
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHR 241 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~ 241 (297)
.....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+..... ..+...++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1123345679999999876665 89999999999999998 9999988877777666655533 3455578999999999
Q ss_pred hcCCCcCCCCCHHHHhcC
Q 022444 242 ILDPNPETRITIEEIRND 259 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~~ 259 (297)
||+.+|.+|||+.+++.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.86 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=208.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS 78 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 78 (297)
++|.+.+.||+|+||.||.+.+.. +...+++|.+.... .......+.+|+.+++.+ +|+|++++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 689999999999999999998743 23469999887542 222345677899999999 79999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC
Q 022444 79 RTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS 142 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~ 142 (297)
....++++||+++++|.+++.... .++...++.++.+++.||.|||++|++|+||+|+||+++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 999999999999999999997542 3788999999999999999999999999999999999999
Q ss_pred CCCEEEcccCCCCCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022444 143 QGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSK 219 (297)
Q Consensus 143 ~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~ 219 (297)
++.++|+|||.+......... .....++..|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..+....
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999988755432111 1112234679999999877665 89999999999999998 8999988888777777
Q ss_pred hhhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 220 VEKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 220 i~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.... ...+..++.++.+++.+||..+|++|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 66554 3455668999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=289.80 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=207.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcE----EEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..+|++.+.||+|+||.||+|.+..+++. +++|.+.... .....+.+.+|+..++.++|+||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 35799999999999999999998666554 8999886432 223356678899999999999999999998654 5
Q ss_pred EEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.+++++++++++|.+++... ..++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 78999999999999998764 35889999999999999999999999999999999999999999999999999865533
Q ss_pred ccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHH
Q 022444 161 VSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAK 236 (297)
Q Consensus 161 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~ 236 (297)
... ......+..|+|||.+.+..++ .++||||||+++|++++ |..||.+....++.+.+... ..+.+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 221 1122335679999999877766 89999999999999997 99999887777665554443 3355566889999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 022444 237 SLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~ 259 (297)
+++.+||..+|.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=282.42 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=209.5
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCc----EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS 78 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (297)
.-+..+|++.+.||.|++|+||+|.+..+++ +|++|++.... .......+.++...++.+.|+||+++++++..
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 3456789999999999999999999877766 47899886543 22334567889999999999999999998865
Q ss_pred CCeEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCC
Q 022444 79 RTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~ 157 (297)
...+++++++++++|.+.+.. .+.+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 457899999999999999876 346899999999999999999999999999999999999999999999999998765
Q ss_pred CCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCCh
Q 022444 158 EQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPV 233 (297)
Q Consensus 158 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 233 (297)
...... .....++..|+|||.+.+..++ .++||||||+++|++++ |..||...........+.... .+.+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCH
Confidence 432221 1223345689999999877766 89999999999999998 999998877766666555543 344566899
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+++.+||..||++|||+.+++.
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=310.32 Aligned_cols=245 Identities=31% Similarity=0.506 Sum_probs=205.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEE-EE---c---C
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEV-LA---S---R 79 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~---~---~ 79 (297)
+++|.+.|.+|||+.||+|++...|..+|+|.+-.. ++...+.+.+|+++++.|+ |+|||.+++. .. . .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 578999999999999999999988899999988665 4566788999999999998 9999999993 21 1 1
Q ss_pred CeEEEEEcccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
-...++||||.|+.|.+++.. ...|++.++++|+.++++|+.+||.+. |||||||.+||||+.+|..||||||.++
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 246899999999999999974 346999999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCccc---------cccccCCccccCCccc---cccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc
Q 022444 156 LPEQGVSL---------LRTTCGTPNYVAPEVL---SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA 223 (297)
Q Consensus 156 ~~~~~~~~---------~~~~~~~~~~~aPE~~---~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~ 223 (297)
........ .-....++.|++||.+ .+... ++++|||+|||+||-|+..+.||+..... .|..+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEec
Confidence 54433211 1134578999999997 34444 49999999999999999999999875332 34455
Q ss_pred cccCCC--CCChhHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 022444 224 DFSCPT--WFPVGAKSLIHRILDPNPETRITIEEIRNDE 260 (297)
Q Consensus 224 ~~~~~~--~~~~~l~~li~~~L~~~p~~Rps~~~il~~p 260 (297)
.+.+|+ .++..+.+||+.||+.||++||++-+++.+-
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 555554 5899999999999999999999999998843
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=281.03 Aligned_cols=250 Identities=25% Similarity=0.427 Sum_probs=209.5
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCC---cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.++|++.+.||+|++|.||++.++.++ ..+++|.+..... ......+.+|+..++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 357999999999999999999986444 3789998865432 23356788899999999999999999999988999
Q ss_pred EEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+++||++++++|.+++... ..++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999998764 468999999999999999999999999999999999999999999999999987654432
Q ss_pred ccc---ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHH
Q 022444 162 SLL---RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAK 236 (297)
Q Consensus 162 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~ 236 (297)
... .....+..|+|||.+.+..++ .++|+||||+++|++++ |..||......+....+.... .+.+..+|+.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 211 111224579999999877665 89999999999999886 999998887777666665542 344556789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 022444 237 SLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~ 258 (297)
+++.+|++.+|++|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=301.79 Aligned_cols=237 Identities=25% Similarity=0.443 Sum_probs=208.7
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
++=||+|+.|.||+++.. ++.||||+++.. -..+|+-|++++|+||+.+.++|....++|||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 456899999999999976 678999987422 23578999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 171 (297)
|.|...++...+++...+..|..+|+.++.|||.+.|||+|+|.-||+|+.+..+|++|||.+...... ...-...|+.
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTV 275 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTV 275 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhH
Confidence 999999999999999999999999999999999999999999999999999999999999988755443 3334567899
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh--hccccCCCCCChhHHHHHHHhcCCCcCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVE--KADFSCPTWFPVGAKSLIHRILDPNPET 249 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~l~~li~~~L~~~p~~ 249 (297)
.|+|||++.+.+.+ ++.||||+|+++|+|+||..||...+...++=-+- ...++.|+.+|+.+.-|+++||+-.|+.
T Consensus 276 aWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN 354 (904)
T KOG4721|consen 276 AWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN 354 (904)
T ss_pred hhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence 99999999988876 99999999999999999999998877655433332 2357889999999999999999999999
Q ss_pred CCCHHHHhcCccc
Q 022444 250 RITIEEIRNDEWF 262 (297)
Q Consensus 250 Rps~~~il~~p~~ 262 (297)
|||+++||.|-=+
T Consensus 355 RPSFrqil~HldI 367 (904)
T KOG4721|consen 355 RPSFRQILLHLDI 367 (904)
T ss_pred CccHHHHHHHHhh
Confidence 9999999998543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=280.22 Aligned_cols=246 Identities=26% Similarity=0.445 Sum_probs=206.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|+++++||+|++|.||++..+ +++.+++|.+...... ...+.+|+.++++++|+|++++++++. ....+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 467999999999999999999865 5678999998754321 345778999999999999999999874 4568999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-c
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-S 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~-~ 162 (297)
+|++.+++|.+.+... ..++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999999988653 358899999999999999999999999999999999999999999999999886554221 1
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
......++..|+|||.+.+..++ .++||||||+++|++++ |+.||...+..+..+.+... ..+.+..+|.++.+++.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR 237 (260)
T ss_pred cccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 22233456689999998776665 89999999999999998 99999888777776666544 33555668899999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+||+.+|++|||++++++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 238 LCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHccCChhhCCCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=280.47 Aligned_cols=247 Identities=23% Similarity=0.433 Sum_probs=207.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+|++.+.||+|++|.||++.++ ++..+++|.+...... ...+.+|+..++.+.|+||+++++++......++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46889999999999999999886 4667999988643321 234667999999999999999999998888999999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc-c
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL-L 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~-~ 164 (297)
|++++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+......... .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999998753 46899999999999999999999999999999999999999999999999988755432111 1
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHHh
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~ 242 (297)
....++..|+|||.+.+..++ .++|+||||+++|++++ |..||...+..+....+... ....+..+|.++.+++.+|
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 122234579999999877766 89999999999999998 89999887777777666554 3345566899999999999
Q ss_pred cCCCcCCCCCHHHHhcC
Q 022444 243 LDPNPETRITIEEIRND 259 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~ 259 (297)
|+.+|++|||+.++++.
T Consensus 238 l~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=286.84 Aligned_cols=257 Identities=24% Similarity=0.412 Sum_probs=214.3
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|+..+.||+|++|.||++++..++..+++|.+.............+.+|+..++.+.|+|++++++++......+++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 38889999999999999999999999999999875543344445678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 88 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|+.+ ++.+.+.. ..++++..+..++.+++.++.|||+.|++|+||+|+||+++.++.++++|||.+...... ..
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~ 180 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NS 180 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----cc
Confidence 9975 77776654 456899999999999999999999999999999999999999999999999987644332 23
Q ss_pred ccCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cC-CCCCChhHHHHHHHh
Q 022444 167 TCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SC-PTWFPVGAKSLIHRI 242 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~-~~~~~~~l~~li~~~ 242 (297)
..++..|+|||.+.. ....+.++|+||||+++|+|++|..||...+.......+..... .. ...++..+.+++.+|
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence 456778999999742 22234899999999999999999999987766665555544432 22 234788999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 243 LDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
|+.+|.+||++.++++|+|+.....+.
T Consensus 261 l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 261 LQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred ccCCcccCcCHHHHHhChhhhccCccc
Confidence 999999999999999999997764443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=290.76 Aligned_cols=245 Identities=28% Similarity=0.462 Sum_probs=188.7
Q ss_pred eEEeccCCceeEEEEEeCC--CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE--cCCeEEEEEc
Q 022444 12 GRTIGEGTFAKVKFAQNTE--TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA--SRTKIYIILE 87 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 87 (297)
..+||+|+||.||+|+++. ++..+++|.+.... ....+.+|+.+++.++|+|++++++++. .....++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3589999999999999764 56889999886432 1234668999999999999999999884 4567899999
Q ss_pred ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee----cCCCCEEEcccCCC
Q 022444 88 FITGGELFDKIVHH---------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLS 154 (297)
Q Consensus 88 ~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli----~~~~~~~l~df~~~ 154 (297)
|+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9975 777776421 247899999999999999999999999999999999999 45678999999998
Q ss_pred CCCCCCcc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHH---
Q 022444 155 ALPEQGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT----------TLYS--- 218 (297)
Q Consensus 155 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~----------~~~~--- 218 (297)
........ ......++..|+|||.+.+....+.++||||||+++|+|++|..||...... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 76543322 1233457889999999876544458999999999999999999999643211 0000
Q ss_pred -----------Hhhh-------------cc----------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 219 -----------KVEK-------------AD----------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 219 -----------~i~~-------------~~----------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
.+.. .. .......+..+.+++.+||..||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 00 00011134568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=279.35 Aligned_cols=242 Identities=23% Similarity=0.397 Sum_probs=204.6
Q ss_pred EeccCCceeEEEEEe--CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 14 TIGEGTFAKVKFAQN--TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 14 ~lg~g~~~~v~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
.||+|++|.||++.+ +.++..+++|++.... ......+.+.+|+.+++.+.|+||+++++++. .+..+++||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999965 4567899999886443 23344567889999999999999999999875 4567899999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc---ccccc
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL---LRTTC 168 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~---~~~~~ 168 (297)
++|.+++.....+++..+..++.+++.||.+||+.|++|+||+|.||+++.++.++|+|||.+......... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999988888999999999999999999999999999999999999999999999999998765443221 11222
Q ss_pred CCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHHhcCCC
Q 022444 169 GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 169 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~L~~~ 246 (297)
++..|+|||.+....++ .++|+||||+++|++++ |..||...+.......+.... .+.+..+|+++.++|.+|++.|
T Consensus 160 ~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 34689999998766555 89999999999999998 999999888777777776653 4566779999999999999999
Q ss_pred cCCCCCHHHHhc
Q 022444 247 PETRITIEEIRN 258 (297)
Q Consensus 247 p~~Rps~~~il~ 258 (297)
|++|||+.+|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999965
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=289.11 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=202.8
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc------
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------ 78 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 78 (297)
.+++|++.+.||.|++|.||++.++.+++.+++|.+........ ......+|++.++.++|+||+++++++..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 36899999999999999999999999999999999865432221 12345689999999999999999987643
Q ss_pred --CCeEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 79 --RTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 79 --~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
....+++++|+.+ ++...+.. ...+++..+..++.++++||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 2357999999975 67666654 4479999999999999999999999999999999999999999999999999886
Q ss_pred CCCCCcccc-----------ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc
Q 022444 156 LPEQGVSLL-----------RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD 224 (297)
Q Consensus 156 ~~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~ 224 (297)
......... ....+++.|+|||.+.+....+.++||||||+++|+|++|+.||...+.....+.+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 543322111 112346779999988655434589999999999999999999998776655444332110
Q ss_pred c-----------------------cC-------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 225 F-----------------------SC-------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 225 ~-----------------------~~-------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
. .. ...++..+.+++.+||+.+|.+|||+.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 00 01244678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=279.12 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=209.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|.+.+.||.|++|.||++.++ ++..+++|.+..... ..+.+.+|+..++.++|+|++++++++......+++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 468999999999999999999976 457799998875432 235577899999999999999999999888899999
Q ss_pred EcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 86 LEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
||++++++|.+++.... .++...+..++.+++.|+.|||++|++|+||+|+||+++.++.++++|||.+........
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999999997643 689999999999999999999999999999999999999999999999998875543211
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
.......+..|+|||.+.+...+ .++|+||||++++++++ |+.||...+.....+.+... ..+.+...|.++.+++.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML 238 (261)
T ss_pred hhhccCCCccccCHHHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 11122344679999999876665 89999999999999998 99999888877777776554 34556668999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+||+.+|++||+++++++
T Consensus 239 ~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 239 QCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHcccCcccCCCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=303.07 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=220.0
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|.-++.||.|+||.||.|++..+.+.|+||++..+.....+--+.+.+|+..|+++.|||++.+.++|-.....|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46777899999999999999999999999999987765555555778899999999999999999999988889999999
Q ss_pred ccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 88 FITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 88 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||-| |-.+++. ..+++-+.++..++.+.+++|+|||+.+.||+|||..||++++.|.|||+|||.+....+- +.
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----ns 181 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----NS 181 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch----hc
Confidence 9965 6666664 2358999999999999999999999999999999999999999999999999988765543 45
Q ss_pred ccCCccccCCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC-C-CCChhHHHHHHH
Q 022444 167 TCGTPNYVAPEVLSH---KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP-T-WFPVGAKSLIHR 241 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~-~~~~~l~~li~~ 241 (297)
.+|+|+|+|||++.. ..|+ -+.||||||++..+|...++|+.+.+...-+..|.....|.. + .+++.+.+|+..
T Consensus 182 FvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred ccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 689999999999842 3444 899999999999999999999998888777777766655432 2 278899999999
Q ss_pred hcCCCcCCCCCHHHHhcCcccccCc
Q 022444 242 ILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
||++-|.+|||.+++|.|+|+....
T Consensus 261 CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHhhCcccCCcHHHHhhcchhccCC
Confidence 9999999999999999999997653
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=283.18 Aligned_cols=250 Identities=30% Similarity=0.441 Sum_probs=202.4
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc---CCCCeeEEEEEEEcCCe----
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLASRTK---- 81 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~---- 81 (297)
|++.+.||.|++|.||+++++.+++.+++|.+......+ .....+.+|+..++++ .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 789999999999999999999889999999997543221 2223445566666555 59999999999977666
Q ss_pred -EEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 82 -IYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 82 -~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
.++++|++++ +|.+++.+.. .+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8888887643 48999999999999999999999999999999999999999999999999886654
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-------c-----
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-------S----- 226 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-------~----- 226 (297)
.... .....++..|+|||.+.+..++ .++|+||||+++|+|++|..||......+...++..... +
T Consensus 159 ~~~~-~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 159 FEMA-LTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred CCcc-cccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 3322 2233467789999999877665 899999999999999999999987776655554432100 0
Q ss_pred ---------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 227 ---------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 227 ---------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
....++..+.+++.+||+.||++||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 001245778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=279.29 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=205.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.++||.|++|.||++.+..+ ..+++|.+..... ....+.+|+..++.++|+||+++++.+. ....+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 36799999999999999999998755 4599998875332 1245778999999999999999999874 4568999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
||++++++|.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999999753 35789999999999999999999999999999999999999999999999988755433221
Q ss_pred -cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
.....++..|+|||...+..++ .++|+||||+++|++++ |..||...........+... ..+.+..+|..+.+++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 237 (262)
T ss_pred cccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 1233456679999998777665 89999999999999999 88999888777766665443 23445668999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+|++++|++|||+.++++
T Consensus 238 ~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 238 QCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=306.23 Aligned_cols=249 Identities=29% Similarity=0.488 Sum_probs=220.4
Q ss_pred EeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCC
Q 022444 14 TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGE 93 (297)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 93 (297)
+||.|.+|+||.|++..+...++||.++... .+..+.+..|+.+-++++|.|||++.|.+..++.+-+.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 7999999999999999999999999997654 4557889999999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-CCCEEEcccCCCCCCCCCccccccccC
Q 022444 94 LFDKIVHH-GRL--SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCG 169 (297)
Q Consensus 94 L~~~l~~~-~~~--~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-~~~~~l~df~~~~~~~~~~~~~~~~~~ 169 (297)
|.+++... +++ ++..+-.+.+||+++|.|||++.|||+|||-+||+|.. +|.+|+.|||.++....-+.......|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 99999764 456 88899999999999999999999999999999999965 789999999999888776677777789
Q ss_pred CccccCCccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhhhccccCCCCCChhHHHHHHHhcCC
Q 022444 170 TPNYVAPEVLSHKGY-NGAAADVWSCGVILYVLIAGYLPFDELD---LTTLYSKVEKADFSCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 170 ~~~~~aPE~~~~~~~-~~~~~Di~slG~ll~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~ 245 (297)
+..|+|||++..... .+.++|||||||++.+|.||++||-... ...+.--..+..+++|+.++.+++.||.+|..+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP 818 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence 999999999954322 2589999999999999999999996543 333344445567888888999999999999999
Q ss_pred CcCCCCCHHHHhcCcccccC
Q 022444 246 NPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 246 ~p~~Rps~~~il~~p~~~~~ 265 (297)
+|.+|||+.++|++||++..
T Consensus 819 d~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 819 DPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CcccCccHHHhccCcccccC
Confidence 99999999999999999988
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=286.60 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=204.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 85 (297)
+.|+..+.||+|++|.||++.+..+++.+++|.+...... .....+.+|+..+.++. |+||+++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677888999999999999999999999999998754322 33456778899999986 99999999999888889999
Q ss_pred EcccCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 86 LEFITGGELFDKIV-----HHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 86 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
+|++.. ++.++.. ....+++..+..++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 5544322 235789999999999999999999975 999999999999999999999999998865433
Q ss_pred CccccccccCCccccCCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhhhcc-ccC----CCCC
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDL-TTLYSKVEKAD-FSC----PTWF 231 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~~~i~~~~-~~~----~~~~ 231 (297)
.... ....++..|+|||.+.+. ...+.++||||||+++|++++|..||..... ......+.... ... +..+
T Consensus 161 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd06616 161 SIAK-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239 (288)
T ss_pred CCcc-ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence 2211 233567789999998765 2334899999999999999999999976542 11222222111 111 1237
Q ss_pred ChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 232 PVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
+.++.+|+.+||+++|++|||+++++.||||++....
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence 8899999999999999999999999999999875433
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=287.94 Aligned_cols=256 Identities=23% Similarity=0.395 Sum_probs=211.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+|+..+.||.|++|.||+++++.+++.+++|.+.............+.+|+.+++.++|+|++++.+++......++++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 35888899999999999999999999999999986543333344556778999999999999999999999989999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
||+.+ ++.+.+.. ..++++..+..++.+++.++.|||+.|++|+||+|+||+++.++.++++|||.+...... .
T Consensus 95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----~ 169 (308)
T cd06634 95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----N 169 (308)
T ss_pred EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----c
Confidence 99974 77776653 456899999999999999999999999999999999999999999999999987654432 2
Q ss_pred cccCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc--CCCCCChhHHHHHHH
Q 022444 166 TTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS--CPTWFPVGAKSLIHR 241 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~l~~li~~ 241 (297)
...++..|+|||.+.+ ....+.++||||||+++|+|++|..||...+.......+.....+ ....++..+.+++++
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHH
Confidence 3356778999999743 222348999999999999999999999877655544444433322 233578899999999
Q ss_pred hcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 242 ILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
||+.+|++||++.++++|||+.+...
T Consensus 250 cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 250 CLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HhhCCcccCCCHHHHhhCccccccCC
Confidence 99999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=271.52 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=204.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE-----cC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-----SR 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (297)
-..||++.+.||.|||+-||+++...+++.+|+|++.... .+..+...+|++..++++|||+++++++.- ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3579999999999999999999999999999999998765 334677889999999999999999876552 23
Q ss_pred CeEEEEEcccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeecCCCCEEEcccCC
Q 022444 80 TKIYIILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
...|++++|...|+|.+.+... ..+++.+++.++.++++||.+||+.. ++|+||||.||++++++.++++|||+
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 4589999999999999988653 35899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCccc---------cccccCCccccCCccccccCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHh
Q 022444 154 SALPEQGVSL---------LRTTCGTPNYVAPEVLSHKGYN--GAAADVWSCGVILYVLIAGYLPFDELDL--TTLYSKV 220 (297)
Q Consensus 154 ~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~ll~~ll~g~~pf~~~~~--~~~~~~i 220 (297)
++...-.... ......+..|+|||.+.-.... +.+.|||||||++|.|+.|..||+.... ..+.-.+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 8754422111 1123457799999998543222 5999999999999999999999953211 1111122
Q ss_pred hhcc--ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 221 EKAD--FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 221 ~~~~--~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.++. .+-...+|+.+.++|+.||+.||.+||++.+++.+
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2222 33345589999999999999999999999999873
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=279.61 Aligned_cols=246 Identities=26% Similarity=0.444 Sum_probs=206.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||.|++|.||++.+. ++..+++|.+...... ...+.+|+..+++++|++++++++++. ....+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 468999999999999999999876 5566999988654321 245778999999999999999999874 4568999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
||++++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999998753 35899999999999999999999999999999999999999999999999998755432211
Q ss_pred -cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
.....++..|+|||.+.+...+ .++|+||||+++|++++ |..||...+..+....+... ..+.+...|..+.+++.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237 (260)
T ss_pred cccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 1122345679999998766665 89999999999999999 89999888777777766544 34556678999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+||..+|++|||++++++
T Consensus 238 ~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 238 QCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=292.15 Aligned_cols=255 Identities=20% Similarity=0.355 Sum_probs=201.7
Q ss_pred EEeccC--CceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccC
Q 022444 13 RTIGEG--TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 13 ~~lg~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
..||.| ++|+||++.+..+|+.|++|.+....... ...+.+.+|+.+++.++|+||+++++++......++++|++.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 88999999999999999999987543222 335778899999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc-----
Q 022444 91 GGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL----- 163 (297)
Q Consensus 91 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~----- 163 (297)
++++.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999988764 35899999999999999999999999999999999999999999999999754322111110
Q ss_pred --cccccCCccccCCccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----------------
Q 022444 164 --LRTTCGTPNYVAPEVLSHKGY-NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---------------- 224 (297)
Q Consensus 164 --~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---------------- 224 (297)
.....+...|+|||.+.+... .+.++||||||+++|+|++|..||................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011223456999999865321 2489999999999999999999997765433322211110
Q ss_pred -------------------------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 225 -------------------------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 225 -------------------------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+.+..+++.+.+|+++||+.||++|||+.++|+||||++..+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 01112256788999999999999999999999999999988664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=284.82 Aligned_cols=250 Identities=22% Similarity=0.378 Sum_probs=211.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
+.+|++.+.||.|++|.||++.+.. .++.+++|++.... .......+.+|..++..+.|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 4568899999999999999998754 35789999987543 2233466788999999999999999999999888
Q ss_pred eEEEEEcccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC
Q 022444 81 KIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG 144 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~ 144 (297)
..+++++|+.+++|.+++... ..++...++.++.|++.||.|||+.|++|+||+|+||++++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999888532 2478888999999999999999999999999999999999999
Q ss_pred CEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhh
Q 022444 145 HLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVE 221 (297)
Q Consensus 145 ~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~ 221 (297)
.++|+|||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||......+..+.+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999998875533211 12233456789999998776665 89999999999999998 889998888888887776
Q ss_pred hccc-cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 222 KADF-SCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 222 ~~~~-~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.... +.+..+|..+.+++.+||+.+|++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 6643 456779999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=277.68 Aligned_cols=246 Identities=28% Similarity=0.450 Sum_probs=204.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||.|++|.||++.+..+ ..+++|.+..... ..+.+.+|+..++.+.|+|++++++++. ....+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46799999999999999999998755 4589998764331 2345678999999999999999999875 4568999
Q ss_pred EcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 86 LEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
|||+.+++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999999997543 4789999999999999999999999999999999999999999999999998755433221
Q ss_pred -cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
.....++..|+|||...+...+ .++|+||||+++|++++ |..||...........+... ..+.+...|..+.++++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK 237 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 1223345679999998766655 89999999999999999 99999887777766666544 23445668999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+||.++|++|||++++++
T Consensus 238 ~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 238 LCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=278.82 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=209.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
...|++.+.||+|++|.||+|.++.+++ .+++|.+.... .......+..|+..++.+.||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3569999999999999999999887664 59999886532 233456788999999999999999999999988999
Q ss_pred EEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
++++||+++++|.+++.. .+.++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999998875 3568999999999999999999999999999999999999999999999999886544322
Q ss_pred ccc--cccc---CCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChh
Q 022444 162 SLL--RTTC---GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVG 234 (297)
Q Consensus 162 ~~~--~~~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 234 (297)
... .... .+..|+|||.+.+..++ .++||||||+++|++++ |..||...+.....+.+... ..+.+..+|..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 211 1111 23479999999877766 89999999999999886 99999888877777776543 23445668999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.+++.+||+.+|++||++++++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=278.43 Aligned_cols=251 Identities=35% Similarity=0.628 Sum_probs=214.7
Q ss_pred ccceEEe-EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc----C
Q 022444 6 VGKYEVG-RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS----R 79 (297)
Q Consensus 6 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~ 79 (297)
+++|.+. ++||-|-.|.|-.+.++.+++.+|+|++.- ..+.++|+++--.. .|+|||.+++++++ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3456654 589999999999999999999999998743 34466777765555 49999999998854 3
Q ss_pred CeEEEEEcccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---CCCEEEcccCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGLS 154 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~~~~~l~df~~~ 154 (297)
.++.+|||.+.||.|++.++..+. +++.++-.++++|+.|+.|||+.+|.|+|+||+|++.+. +..+||+|||++
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 578899999999999999987665 999999999999999999999999999999999999964 446999999999
Q ss_pred CCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHhhhccccCCCC
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD----LTTLYSKVEKADFSCPTW 230 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~ 230 (297)
.....+ .....++-++.|.|||++....++ ..+|+||||++||-|+.|.+||.... ...+..+|..+.+.+|..
T Consensus 212 K~t~~~-~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 212 KETQEP-GDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred cccCCC-ccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 866643 344567789999999999888877 99999999999999999999996654 446788888887776655
Q ss_pred ----CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 231 ----FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 231 ----~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+++...++|+.+|..+|.+|.|..++++|||+.+-.
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 789999999999999999999999999999998764
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=284.51 Aligned_cols=250 Identities=24% Similarity=0.424 Sum_probs=208.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-------CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-------ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 77 (297)
.++|.+.+.||+|++|.||++++. .....+++|.+.... .......+.+|+..++.+ .|+||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 368999999999999999999863 234568899876432 223355677899999999 5999999999998
Q ss_pred cCCeEEEEEcccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec
Q 022444 78 SRTKIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~ 141 (297)
.....++++||+++++|.+++... ..++...+..++.+++.||.|||++|++|+||+|+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 888899999999999999998653 2478899999999999999999999999999999999999
Q ss_pred CCCCEEEcccCCCCCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022444 142 SQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYS 218 (297)
Q Consensus 142 ~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~ 218 (297)
.++.++|+|||.+......... .....++..|+|||.+.+..++ .++||||||+++|++++ |..||...+..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999998765432111 1112234579999999876665 89999999999999999 899998888887777
Q ss_pred Hhhhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 219 KVEKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 219 ~i~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+.... ...+..++.++.+++.+||+.+|++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 766553 3455668899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=282.17 Aligned_cols=260 Identities=33% Similarity=0.587 Sum_probs=215.5
Q ss_pred ceEEeEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 82 (297)
.|++.+.||.|++|.||++++. .+++.+++|.+...... .......+.+|+.+++++ .|++++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46789999998754322 223345678899999999 499999999999988999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+++|||+.+++|.+.+.....+++..+..++.|++++|.+||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998777899999999999999999999999999999999999999999999999998865443322
Q ss_pred c-cccccCCccccCCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHhhhccccCCCCCChhHH
Q 022444 163 L-LRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDEL----DLTTLYSKVEKADFSCPTWFPVGAK 236 (297)
Q Consensus 163 ~-~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~l~ 236 (297)
. .....++..|++||.+.+.. ..+.++|+||||+++++|++|..||... ......+.+.....+.+..++..+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 1 22345788999999986543 1248999999999999999999999543 2334444555555666777899999
Q ss_pred HHHHHhcCCCcCCCCC---HHHHhcCcccccCcc
Q 022444 237 SLIHRILDPNPETRIT---IEEIRNDEWFRKGYV 267 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps---~~~il~~p~~~~~~~ 267 (297)
+++.+||+.+|++||| +.++|+||||++..-
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 9999999999999998 567799999988743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=281.00 Aligned_cols=249 Identities=23% Similarity=0.393 Sum_probs=208.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
..+|+..++||+|++|.||++... .++..+++|.+.... ......+.+|+..++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 457899999999999999999743 356778888876433 233567889999999999999999999999889
Q ss_pred eEEEEEcccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHG---------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~ 145 (297)
..++++||+++++|.+++.... .+++..++.++.+++.|+.|||+.|++|+||+|+||++++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999987643 4788999999999999999999999999999999999999999
Q ss_pred EEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhh
Q 022444 146 LKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEK 222 (297)
Q Consensus 146 ~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~ 222 (297)
++|+|||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||......+....+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999998864432211 11122345789999998877766 89999999999999998 9999988777666665554
Q ss_pred cc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 223 AD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 223 ~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.. ...+..+|+.+.+++.+||+.||.+||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 43 3455678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=276.48 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=211.0
Q ss_pred eEEeEEeccCCceeEEEEEeCCCC----cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETG----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+++.+.||.|++|.||++.+..++ ..+++|.+...... ...+.+..|+..++.+.|+|++++++.+...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467889999999999999998766 89999998655322 245678899999999999999999999998899999
Q ss_pred EEcccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+||++++++|.+++..... +++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999876554 89999999999999999999999999999999999999999999999999876554322
Q ss_pred ccc-cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHH
Q 022444 163 LLR-TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLI 239 (297)
Q Consensus 163 ~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li 239 (297)
... ...++..|+|||.+.+...+ .++|+||||+++++|++ |..||...+.....+.+..... ..+..+|.++.+++
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM 237 (258)
T ss_pred cccccCCCcccccChHHhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 111 23356789999998666555 99999999999999998 8999988888777777665543 44556899999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 022444 240 HRILDPNPETRITIEEIRN 258 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~ 258 (297)
.+||+.+|++|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHCcCChhhCcCHHHHHh
Confidence 9999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=278.74 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=212.4
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCc----EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS 78 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (297)
+-+.++|++.+.||+|+||.||++.++.+|+ .+++|....... ......+.+|+..++.++|+|++++++++..
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 3456789999999999999999999876654 588888765432 3334667889999999999999999999876
Q ss_pred CCeEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCC
Q 022444 79 RTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~ 157 (297)
...++++|++.+++|.+++... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 7889999999999999998764 46899999999999999999999999999999999999999999999999998765
Q ss_pred CCCcccc--ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCCh
Q 022444 158 EQGVSLL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPV 233 (297)
Q Consensus 158 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 233 (297)
....... ....++..|+|||.+....++ .++|+||||+++|++++ |..||......++.+.+.... .+.+...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCH
Confidence 4332211 112234579999998766665 89999999999999998 999999988888777776553 345566789
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+++.+||..+|++|||+.++++
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=282.21 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=206.7
Q ss_pred ceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
+|++.+.||+|+||.||++.+.. ....+++|.+..... ......+.+|+..++.+.||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 48899999999999999998753 235688888765432 22346688899999999999999999999988999
Q ss_pred EEEEcccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCe
Q 022444 83 YIILEFITGGELFDKIVHH------------------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENL 138 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nI 138 (297)
++++||+.+++|.+++... ..++...++.++.+++.||.|||+.|++|+||+|+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999987642 2478889999999999999999999999999999999
Q ss_pred eecCCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022444 139 LLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (297)
Q Consensus 139 li~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~ 215 (297)
+++.++.++|+|||.+........ ......++..|+|||.+.+..++ .++||||||+++++|++ |..||.......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999875432211 11223345689999998776665 89999999999999998 999999888877
Q ss_pred HHHHhhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 216 LYSKVEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 216 ~~~~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.+.+... ....+..++.++.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 77766543 33456668999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=293.94 Aligned_cols=261 Identities=24% Similarity=0.416 Sum_probs=208.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 84 (297)
-..|+++++||+||.+.||++..-+. .-+++|.+.... .+....+-+.+|+.+|.+++ |.+|++++++-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34699999999999999999987544 446666554332 24556788999999999996 8999999999888999999
Q ss_pred EEcccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 85 ILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
|||+-+ .+|..++..... .+.-.++.+..|++.|+.++|.+||||.|+||.|+++ -.|.+||+|||++........
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccc
Confidence 999985 599999987654 3445899999999999999999999999999999998 778999999999987665433
Q ss_pred -ccccccCCccccCCccccccCCC----------CCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhhccc--cCC
Q 022444 163 -LLRTTCGTPNYVAPEVLSHKGYN----------GAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEKADF--SCP 228 (297)
Q Consensus 163 -~~~~~~~~~~~~aPE~~~~~~~~----------~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~i~~~~~--~~~ 228 (297)
.....+|+..|++||++.....+ +.++|||||||++|+|+.|+.||.... ...-...|..... ++|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 24567899999999998543332 578999999999999999999996543 2222333444322 333
Q ss_pred CCCC-hhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 229 TWFP-VGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 229 ~~~~-~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
..=+ .++.++++.||.+||++|||..++|+|||++-.+.+..
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~ 638 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVE 638 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccch
Confidence 3322 33999999999999999999999999999998665543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=290.96 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=202.1
Q ss_pred cceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc-C
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS-R 79 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~ 79 (297)
++|++.+.||.|+||.||.|.+.. +++.|++|++..... ....+.+.+|+..++++ .|+||+++++++.. +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 589999999999999999997543 457899999865432 22345677899999999 79999999998754 4
Q ss_pred CeEEEEEcccCCCChHHHHHhc----------------------------------------------------------
Q 022444 80 TKIYIILEFITGGELFDKIVHH---------------------------------------------------------- 101 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------- 101 (297)
...++++||+++++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5789999999999999888542
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc--cccccCCccccCC
Q 022444 102 ---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAP 176 (297)
Q Consensus 102 ---~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aP 176 (297)
.+++...+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||.+......... .....++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25788999999999999999999999999999999999999999999999998765332211 1223345679999
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHhhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCH
Q 022444 177 EVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT-LYSKVEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITI 253 (297)
Q Consensus 177 E~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~-~~~~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~ 253 (297)
|.+.+..++ .++|||||||++|+|++ |..||......+ +...+... ....+...++++.+++.+||+.+|.+|||+
T Consensus 245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999887776 89999999999999998 999997654332 33333332 223445678999999999999999999999
Q ss_pred HHHhcC
Q 022444 254 EEIRND 259 (297)
Q Consensus 254 ~~il~~ 259 (297)
.++++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=279.87 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=199.4
Q ss_pred ccce-EEeEEeccCCceeEEEEE----eCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--
Q 022444 6 VGKY-EVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-- 78 (297)
Q Consensus 6 ~~~y-~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 78 (297)
.+|| ++.+.||.|++|+||++. ...++..+++|.+..... ......+.+|+..++.++|+|++++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3566 999999999999998865 335788999999875432 2234567789999999999999999998754
Q ss_pred CCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 79 RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
....+++||++++++|.+++... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 34689999999999999988764 69999999999999999999999999999999999999999999999999987654
Q ss_pred CCccc---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHh
Q 022444 159 QGVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT---------------TLYSKV 220 (297)
Q Consensus 159 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---------------~~~~~i 220 (297)
..... .....++..|+|||.+.+...+ .++||||||+++++|++|..|+...... ...+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 32221 1122345679999998776665 8999999999999999999998543311 011111
Q ss_pred h-hccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 221 E-KADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 221 ~-~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
. ....+.+..+|.++.+++.+||+++|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 1122345567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=272.57 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=210.5
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEEEc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.+++..||+|..|+|+.++.+.+|...|||.+.... +.+..+++...+.+..... .|+||+.+++|..+...+++||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 456778999999999999999999999999998765 4444677777777776654 7999999999999989999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-hCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCH-SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh-~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
.|.. .+..++.+ .+++++..+-.+...+..||.||. ++|++|+|+||+||++|+.|++||||||++-+...+.. ..
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-ht 249 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-HT 249 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc-cc
Confidence 9853 44444443 347899999999999999999996 56999999999999999999999999999977765422 33
Q ss_pred cccCCccccCCcccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhhccccC---CCCCChhHHHH
Q 022444 166 TTCGTPNYVAPEVLSHK---GYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEKADFSC---PTWFPVGAKSL 238 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~---~~~~~~~l~~l 238 (297)
...|.+.|+|||.+.-. .|+ .++||||||+++++|.||..||.+.+ ..+...++.+.+++. ....++.+.+|
T Consensus 250 rsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f 328 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF 328 (391)
T ss_pred cccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH
Confidence 56789999999998543 344 89999999999999999999998854 345566666655433 23378999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
+..||++|+.+||...++|+|||+..-+.-
T Consensus 329 v~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 329 VKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred HHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 999999999999999999999999876443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=281.12 Aligned_cols=253 Identities=29% Similarity=0.534 Sum_probs=208.6
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh--hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
||.+.+.||+|++|.||++.+...+..+++|+....... .......+..|+.+++.++|||++++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999877776766665432211 111233456788899999999999999999888899999
Q ss_pred EcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+||+++++|.+.+.. ...+++..++.++.+++.||.+||+.|++|+|++|+||+++. +.++++|||.+.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999887753 346899999999999999999999999999999999999964 669999999887654433
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIH 240 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~ 240 (297)
.......++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+.... ...+..++.++.+++.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 333344577889999998776665 88999999999999999999998776666555554443 3345568899999999
Q ss_pred HhcCCCcCCCCCHHHHhcCccc
Q 022444 241 RILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~ 262 (297)
+||+.+|++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=283.27 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=203.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCC--------------CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTET--------------GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~--------------~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 71 (297)
..+|++.+.||+|+||.||++++... ...+++|.+.... .......+.+|++.+++++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 35899999999999999999987543 2358899887543 2233566889999999999999999
Q ss_pred EEEEEEcCCeEEEEEcccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCee
Q 022444 72 LHEVLASRTKIYIILEFITGGELFDKIVHHG------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLL 139 (297)
Q Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIl 139 (297)
+++++......+++|||+.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999998899999999999999999886432 3678899999999999999999999999999999999
Q ss_pred ecCCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 022444 140 LDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA--GYLPFDELDLTT 215 (297)
Q Consensus 140 i~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~--g~~pf~~~~~~~ 215 (297)
++.++.++|+|||.+........ ......++..|+|||.+.+..++ .++|+||||+++++|++ +..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999998875433211 11223346689999998776665 99999999999999988 678888776665
Q ss_pred HHHHhhh--------ccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 216 LYSKVEK--------ADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 216 ~~~~i~~--------~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
....+.. .....+..+|+.+.+|+.+|++.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5444321 112234557899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=276.25 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=208.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
..|+..+.||+|++|.||++.++.++. .+++|.+.... .....+.+.+|+..++.++|+|++++.+++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 478999999999999999999876654 68889886542 1223566788999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 84 IILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
++||++++++|.+++... +.+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999999998753 5689999999999999999999999999999999999999999999999998875543222
Q ss_pred ccc---cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHH
Q 022444 163 LLR---TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKS 237 (297)
Q Consensus 163 ~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~ 237 (297)
... ....+..|+|||.+.+..++ .++|+||||+++|++++ |..||...+..+....+.... .+.+..+|.++.+
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 111 11223479999998877665 89999999999999997 999998877777777665542 3444557899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 022444 238 LIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+|++.+|++||++.++++
T Consensus 242 li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 242 LMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=282.33 Aligned_cols=250 Identities=30% Similarity=0.449 Sum_probs=203.4
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEEEc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 87 (297)
|++.+.||+|++|.||+|....+++.+++|.+...... .......+|+..++++. |+|++++++++..+...+++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999989999999988654321 11223446888899998 9999999999988999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 88 FITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+ +++|.+.+.... .+++..+..++.+++.+|.|||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~ 156 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYT 156 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcC
Confidence 99 679988887654 78999999999999999999999999999999999999999999999999887554322 122
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-------------------c-
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-------------------F- 225 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-------------------~- 225 (297)
...++..|+|||.+......+.++|+||||+++++|++|+.||......+...++.... .
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 34567789999988654434589999999999999999999997765544433221100 0
Q ss_pred ----------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 226 ----------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 226 ----------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
......+..+.+++++||+.+|++|||++|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=275.61 Aligned_cols=242 Identities=26% Similarity=0.486 Sum_probs=204.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEE-EcCCeEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVL-ASRTKIYI 84 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~l 84 (297)
..+|++.+.||+|++|.||++... |..+++|...... ..+.+.+|+..++.++|++++++++++ ...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 468999999999999999999765 7789999885432 245678899999999999999999875 45567899
Q ss_pred EEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
++||+++++|.+++.+.. .+++..++.++.+++.+|+|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 999999999999987644 378999999999999999999999999999999999999999999999998875433221
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~ 240 (297)
....+..|+|||.+.+...+ .++||||||+++|+|++ |+.||...+.......+.... ...+..+|+.+.+++.
T Consensus 158 ---~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05082 158 ---TGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233 (256)
T ss_pred ---CCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 22335679999998776665 89999999999999997 999998888777777665542 3445668999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+|++.+|++|||+.++++
T Consensus 234 ~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 234 QCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=278.99 Aligned_cols=249 Identities=20% Similarity=0.360 Sum_probs=204.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCc----EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
.++|++.+.||.|++|.||++.+..++. .+++|.+.... .......+..++..++.+.|+||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 4679999999999999999999877666 46777765332 1233456778888889999999999999875 456
Q ss_pred EEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.++++|++++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7889999999999999975 456899999999999999999999999999999999999999999999999998754332
Q ss_pred cc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHH
Q 022444 161 VS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAK 236 (297)
Q Consensus 161 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~ 236 (297)
.. ......++..|+|||.+.+..++ .++||||||+++|++++ |..||.........+.+.... .+.+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 21 12233456689999999776665 99999999999999998 999998877766655555443 334455788999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 022444 237 SLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~ 258 (297)
.++.+|+..+|++|||+.++++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=274.89 Aligned_cols=242 Identities=28% Similarity=0.459 Sum_probs=205.4
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (297)
++||.|++|.||++.+.. ++.+++|.+...... .....+.+|+++++++.|+||+++++++......++++|+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999887 899999988765432 33567889999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc--cccC
Q 022444 93 ELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR--TTCG 169 (297)
Q Consensus 93 ~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~--~~~~ 169 (297)
+|.+++.. ...++...+..++.+++.+|.+||++|++|+||+|+||+++.++.++|+|||.+........... ....
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999865 34688999999999999999999999999999999999999999999999998875542211111 1223
Q ss_pred CccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHHhcCCCc
Q 022444 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILDPNP 247 (297)
Q Consensus 170 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~L~~~p 247 (297)
+..|+|||.+.+..++ .++|+||||+++|++++ |..||...........+... ..+.+..+|.++.+++.+||+.+|
T Consensus 158 ~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 4569999998776665 89999999999999998 89999888877776666554 344566789999999999999999
Q ss_pred CCCCCHHHHhc
Q 022444 248 ETRITIEEIRN 258 (297)
Q Consensus 248 ~~Rps~~~il~ 258 (297)
++|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999987
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=278.57 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=205.7
Q ss_pred eEEeEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe----
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK---- 81 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 81 (297)
|++.+.||+|++|.||.|....+ +..+++|.+..... .......+.+|+..++.+.|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999997643 47899999875432 22335668889999999999999999998755443
Q ss_pred --EEEEEcccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 82 --IYIILEFITGGELFDKIVHH------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 82 --~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
.++++||+++++|..++... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999998887432 3589999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCC
Q 022444 154 SALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPT 229 (297)
Q Consensus 154 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~ 229 (297)
+......... ......+..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+..+.+.... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 8755433211 1122345679999998766665 89999999999999999 999998888777777666543 44567
Q ss_pred CCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 230 WFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 230 ~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+++++.+++.+||+.||++|||+.+++.
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=281.75 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=204.6
Q ss_pred cceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (297)
++|.+.+.||.|++|.||++.+. .++..+++|.+.... .....+.+.+|+.+++++ .|+||+++++.+....
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 47999999999999999999852 345689999886543 223356788999999999 7999999999999888
Q ss_pred eEEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
..++++||+++++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+....
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999999999987543 38999999999999999999999999999999999999999999999999987554
Q ss_pred CCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHhhhc-cccCCCCCCh
Q 022444 159 QGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY-SKVEKA-DFSCPTWFPV 233 (297)
Q Consensus 159 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~-~~i~~~-~~~~~~~~~~ 233 (297)
.... ......++..|+|||.+.+..++ .++||||||+++|++++ |..||......... ..+..+ ....+...++
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA 271 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCH
Confidence 3221 11122345689999998877665 89999999999999998 99999776654433 333322 2233455789
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+++.+||+++|++|||+.++++
T Consensus 272 ~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 272 EIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=281.12 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=209.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||.|++|.||++.+.. ++..+++|.+.... .......+.+|+..++.+.|+|++++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4679999999999999999999753 67889999886543 2233466888999999999999999999999888
Q ss_pred eEEEEEcccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCe
Q 022444 81 KIYIILEFITGGELFDKIVHHG----------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENL 138 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nI 138 (297)
..++++||+++++|.+++.... .+++..++.++.+++.||.+||+.|++|+||+|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999986432 367888999999999999999999999999999999
Q ss_pred eecCCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022444 139 LLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (297)
Q Consensus 139 li~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~ 215 (297)
+++.++.++++|||.+........ .......+..|+|||.+.+..++ .++|+||||+++|+|++ |..||.+....+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999998765432211 11222345679999998877766 89999999999999997 888998888777
Q ss_pred HHHHhhhccc-cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 216 LYSKVEKADF-SCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 216 ~~~~i~~~~~-~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
....+..... +.+..+|.++.+++.+||+.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777665543 345668899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=304.00 Aligned_cols=260 Identities=22% Similarity=0.340 Sum_probs=194.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCC-cEEEEEE--------------eecchhhhHHHHHHHHHHHHHHHhcCCCCee
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKV--------------LDRSAIIKHKMADQIKREISIMKLVRHPCVV 70 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~iK~--------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 70 (297)
.++|++++.||+|+||.||++..+... ...+.|. +.............+.+|+.+++.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998765322 2222221 1111111222345678999999999999999
Q ss_pred EEEEEEEcCCeEEEEEcccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC
Q 022444 71 RLHEVLASRTKIYIILEFITGGELFDKIVHH-----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (297)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~ 145 (297)
++++++......|++++++.+ +|.+++... .......++.++.|++.||.|||+.||+|+||||+||+++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999864 777766432 12346678889999999999999999999999999999999999
Q ss_pred EEEcccCCCCCCCCCcc-ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCC-CCCCC--H-HHHHHHh
Q 022444 146 LKISDFGLSALPEQGVS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLP-FDELD--L-TTLYSKV 220 (297)
Q Consensus 146 ~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~p-f~~~~--~-~~~~~~i 220 (297)
++|+|||++........ ......|+..|+|||.+.+..++ .++|||||||++|+|++|..+ +.... . ..+.+.+
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 99999999876543322 22345688999999999887776 899999999999999998754 43221 1 1121111
Q ss_pred hhcc---ccC----------------------------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 221 EKAD---FSC----------------------------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 221 ~~~~---~~~----------------------------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
.... ..+ ...++.++.+++.+||++||++|||+.|+|+||||.....
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~ 462 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE 462 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence 1000 000 1124667788899999999999999999999999987643
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=277.61 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=204.1
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCc--EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC------C
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR------T 80 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 80 (297)
|.+.+.||+|++|.||++++..++. .+++|.+..... .....+.+.+|+..++.++|+||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3577899999999999999887665 689998765432 223356778899999999999999999976321 2
Q ss_pred eEEEEEcccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 81 KIYIILEFITGGELFDKIVH------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
..++++||+.+++|.+++.. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 46899999999999888742 234789999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCC
Q 022444 155 ALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTW 230 (297)
Q Consensus 155 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~ 230 (297)
......... .....++..|++||.+.+..++ .++||||||+++|++++ |..||.........+.+.... .+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 765433221 1222356689999999877666 89999999999999999 899998887777777666553 345667
Q ss_pred CChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 231 FPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 231 ~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
++..+.+++.+||+.+|.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=275.15 Aligned_cols=242 Identities=27% Similarity=0.452 Sum_probs=204.8
Q ss_pred EEeccCCceeEEEEEeCC-CC--cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEccc
Q 022444 13 RTIGEGTFAKVKFAQNTE-TG--ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~-~~--~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (297)
+.||+|++|.||++.+.. ++ ..+++|.+...... ...+.+.+|+..+++++|+||+++++.+.. ...++++|++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 33 36899998765533 456778899999999999999999999887 8899999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc---c
Q 022444 90 TGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL---L 164 (297)
Q Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~---~ 164 (297)
++++|.+.+.... .+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999997654 6899999999999999999999999999999999999999999999999998765442221 1
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc--cccCCCCCChhHHHHHHH
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA--DFSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~l~~li~~ 241 (297)
....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+... ....+..+|..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 123456789999998877665 89999999999999998 99999888877776665532 233455688999999999
Q ss_pred hcCCCcCCCCCHHHHhc
Q 022444 242 ILDPNPETRITIEEIRN 258 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~ 258 (297)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=274.61 Aligned_cols=241 Identities=26% Similarity=0.432 Sum_probs=201.2
Q ss_pred EeccCCceeEEEEEeC--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 14 TIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 14 ~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
.||+|++|.||++.+. ..+..+++|+..... .....+.+.+|+.+++++.|+||+++++++. ....+++|||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999875 445678999886543 2333566889999999999999999999875 4578999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc---ccc
Q 022444 92 GELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL---RTT 167 (297)
Q Consensus 92 ~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~---~~~ 167 (297)
++|.+++.. ...+++..++.++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......... ...
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998874 4578999999999999999999999999999999999999999999999999987544332211 112
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHHhcCC
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~L~~ 245 (297)
.++..|+|||.+.+..++ .++||||||+++|++++ |..||......+....+..+. ...+..+++++.+++.+||+.
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 234679999998776665 89999999999999996 999999888877776665543 455677899999999999999
Q ss_pred CcCCCCCHHHHhc
Q 022444 246 NPETRITIEEIRN 258 (297)
Q Consensus 246 ~p~~Rps~~~il~ 258 (297)
+|++||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=278.14 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=210.3
Q ss_pred cceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
++|++.+.||.|++|.||+++.+. +.+.+++|...... .....+.+.+|+.++++++|+|++++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 579999999999999999999753 45678899875433 22345678899999999999999999999988889
Q ss_pred EEEEEcccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccC
Q 022444 82 IYIILEFITGGELFDKIVHHG---------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~ 152 (297)
.+++||++++++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999997655 68999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCc-cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccc--cCC
Q 022444 153 LSALPEQGV-SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADF--SCP 228 (297)
Q Consensus 153 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~~--~~~ 228 (297)
.+....... .......++..|+|||.+.+.... .++||||||+++|++++ |..||...........+..... +.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 876443221 122233456679999998776665 89999999999999998 8889987777776666664443 345
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
..+|..+.+++.+||+.+|++|||+.+++..
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 6689999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=284.16 Aligned_cols=259 Identities=28% Similarity=0.407 Sum_probs=205.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCC--CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc----CC
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTET--GESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS----RT 80 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~ 80 (297)
+|++.+.||+|++|.||++++..+ +..+++|.+.... ......+.+.+|+..++++ .|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999887 8999999886432 1222345567889999998 59999999986532 24
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..+++++++. ++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5788999986 589999988888999999999999999999999999999999999999999999999999998754432
Q ss_pred cc----ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhh--------------
Q 022444 161 VS----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK-------------- 222 (297)
Q Consensus 161 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~-------------- 222 (297)
.. ......++..|+|||.+.+....+.++|+||||+++|++++|..||...+.......+..
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112335778899999876543334899999999999999999999977654332221110
Q ss_pred -c-------------cc---cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 223 -A-------------DF---SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 223 -~-------------~~---~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
. .. .....++..+.+++.+||+.+|++|||+.+++.|||+++...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 0 00 0112357889999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=280.94 Aligned_cols=250 Identities=23% Similarity=0.422 Sum_probs=209.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-------CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-------ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 77 (297)
.++|++.+.||+|++|.||.+++. .++..+++|...... .......+.+|+..++.+ .|+||+++++.+.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 457999999999999999999753 234578999886432 223356788999999999 7999999999999
Q ss_pred cCCeEEEEEcccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec
Q 022444 78 SRTKIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~ 141 (297)
.....+++|||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 989999999999999999998753 2467888999999999999999999999999999999999
Q ss_pred CCCCEEEcccCCCCCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022444 142 SQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYS 218 (297)
Q Consensus 142 ~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~ 218 (297)
.++.++|+|||.+......... .....++..|+|||++.+..++ .++||||||+++|++++ |..||...+..++.+
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999998765432221 1223345679999999877666 89999999999999998 889998888888887
Q ss_pred Hhhhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 219 KVEKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 219 ~i~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+.... ...+..++.++.+++.+||..+|++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 251 LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 776553 2345668899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=272.04 Aligned_cols=242 Identities=28% Similarity=0.487 Sum_probs=202.2
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (297)
+.||+|++|.||++... ++..+++|.+.... .......+.+|+..++.+.|+|++++++++......+++|||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999865 67889999886543 2223446788999999999999999999999888999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc-ccccCC
Q 022444 93 ELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL-RTTCGT 170 (297)
Q Consensus 93 ~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~ 170 (297)
+|.+++... ..+++..+..++.+++.+|.|+|+.|++|+||+|+||+++.++.++|+|||.+.......... ....++
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999988653 457899999999999999999999999999999999999999999999999886543322211 122335
Q ss_pred ccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHHhcCCCcC
Q 022444 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILDPNPE 248 (297)
Q Consensus 171 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~ 248 (297)
..|+|||.+.+..++ .++||||||+++|++++ |..||...........+... ....+..+|..+.+++.+|++.+|.
T Consensus 158 ~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 579999998766655 89999999999999998 99999887777666665544 2345566899999999999999999
Q ss_pred CCCCHHHHhc
Q 022444 249 TRITIEEIRN 258 (297)
Q Consensus 249 ~Rps~~~il~ 258 (297)
+|||+.++++
T Consensus 237 ~Rp~~~~l~~ 246 (250)
T cd05085 237 NRPKFSELQK 246 (250)
T ss_pred cCCCHHHHHH
Confidence 9999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=281.20 Aligned_cols=259 Identities=23% Similarity=0.382 Sum_probs=205.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 83 (297)
..+.|++.+.||+|++|.||++.+..+++.+++|.+...... .....+..++..+... .|+||+++++++......+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 457899999999999999999999988999999998754321 1234445566555555 5999999999999999999
Q ss_pred EEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 84 IILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
++||++.+ ++.+.+.. ...+++..+..++.+++.++.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99999864 67776655 4578999999999999999999997 599999999999999999999999999887554322
Q ss_pred cccccccCCccccCCccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhhhcc-ccC--CCCCChh
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKG---YNGAAADVWSCGVILYVLIAGYLPFDELDL-TTLYSKVEKAD-FSC--PTWFPVG 234 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~~~i~~~~-~~~--~~~~~~~ 234 (297)
. .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|+.||..... .+....+.... ... ...++.+
T Consensus 170 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 170 A-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred c-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 2 22345677899999986543 124899999999999999999999976432 23333333222 222 2237889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
+.+|+.+||+.+|++|||++++++||||+....
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 999999999999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=291.77 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=203.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (297)
.++|++.+.||.|+||.||.+.+.. ++..|++|++.... .....+.+.+|+.+++.+. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 4578899999999999999998743 24579999986543 2233467889999999996 99999999999988
Q ss_pred CeEEEEEcccCCCChHHHHHhc----------------------------------------------------------
Q 022444 80 TKIYIILEFITGGELFDKIVHH---------------------------------------------------------- 101 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------- 101 (297)
...|++|||+++++|.+++...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999998887542
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC
Q 022444 102 --------------------------------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (297)
Q Consensus 102 --------------------------------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~ 143 (297)
..+++..+..++.+++.||.|||+.|++|+||+|+||+++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136778889999999999999999999999999999999999
Q ss_pred CCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHH
Q 022444 144 GHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT-TLYSK 219 (297)
Q Consensus 144 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~-~~~~~ 219 (297)
+.++|+|||.+........ ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...... .....
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 9999999999875433211 12223456789999999877665 89999999999999997 99999765433 33344
Q ss_pred hhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 220 VEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 220 i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+... ..+.+..+|.++.+++.+||+.+|++|||+.++.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 4433 33455668999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=279.92 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=202.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCC----------------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCee
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE----------------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 70 (297)
++|++.+.||+|++|.||++.+.. ++..+++|.+.... .......+.+|+..++.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 479999999999999999986432 34568999886543 233356788999999999999999
Q ss_pred EEEEEEEcCCeEEEEEcccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCee
Q 022444 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHG-----------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLL 139 (297)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIl 139 (297)
++++++......+++|||+++++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999899999999999999999887643 3567789999999999999999999999999999999
Q ss_pred ecCCCCEEEcccCCCCCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 022444 140 LDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA--GYLPFDELDLTT 215 (297)
Q Consensus 140 i~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~--g~~pf~~~~~~~ 215 (297)
++.++.++|+|||.+......... ......+..|++||...+..++ .++|+||||+++|+|++ |..||...+..+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999998754332211 1122345679999988766665 89999999999999998 778997766655
Q ss_pred HHHHhhh--------ccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 216 LYSKVEK--------ADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 216 ~~~~i~~--------~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
....... ...+.+..+|+.+.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4443311 123445568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=276.33 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=208.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCC----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-CC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTE----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-RT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 80 (297)
-++|++.+.||+|++|.||.+.+.. ++..+++|.+.... .......+.+|+..++.++|+|++++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4689999999999999999999875 35788888876432 23335667889999999999999999998765 46
Q ss_pred eEEEEEcccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccC
Q 022444 81 KIYIILEFITGGELFDKIVHH--------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~ 152 (297)
..+++++++++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++++|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 789999999999999988653 358899999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCC
Q 022444 153 LSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCP 228 (297)
Q Consensus 153 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~ 228 (297)
+++........ .....++..|+|||.+.+..++ .++||||||+++|++++ |..||...+..+....+..+. ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 98754332111 1122345679999999777665 89999999999999998 999998888777766655542 2344
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
..+|+++.+++.+|+..+|++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 557899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=296.03 Aligned_cols=257 Identities=25% Similarity=0.472 Sum_probs=222.3
Q ss_pred ccceE-EeEEeccCCceeEEEEEeCCCCcEEEEEEeecch-hhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe--
Q 022444 6 VGKYE-VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA-IIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK-- 81 (297)
Q Consensus 6 ~~~y~-~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 81 (297)
.+||- ...+||+|+|-+||+|.|..+|..||.--+.... ...+...+.+..|+.+|+.++|+||+++++.+.+...
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 34543 5678999999999999999999999886554322 2344557889999999999999999999999976654
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeecC-CCCEEEcccCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDS-QGHLKISDFGLSALPE 158 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~~-~~~~~l~df~~~~~~~ 158 (297)
+.+|.|.+..|+|+.|+++.+.++.+.++.|++||+.+|.|||++. |+|+|||-+||||+. .|.||++|+|++....
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 8899999999999999999999999999999999999999999995 999999999999986 5799999999998877
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhhhccccC--CCCCChhH
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLYSKVEKADFSC--PTWFPVGA 235 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~--~~~~~~~l 235 (297)
.+... .-+|+|.|||||.+. ..|+ +..||||||++|.+|+|+.+||... ++.+++.++..+..|- ..--.+++
T Consensus 198 ~s~ak--svIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPev 273 (632)
T KOG0584|consen 198 KSHAK--SVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEV 273 (632)
T ss_pred ccccc--eeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHH
Confidence 65443 368999999999987 6666 9999999999999999999999775 6788999998886542 22236899
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
++||.+||.. .++|||+.|+|.||||+....
T Consensus 274 r~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 274 REFIEKCLAT-KSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred HHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence 9999999999 999999999999999998644
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=272.49 Aligned_cols=247 Identities=25% Similarity=0.444 Sum_probs=206.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++.+. .+..+++|.+.... ...+.+.+|+.+++.+.|+|++++++.+.. ...++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 3578999999999999999999865 45669999876432 124567789999999999999999999877 77899
Q ss_pred EEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+|||+++++|.+++.+. ..++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999998763 3578889999999999999999999999999999999999999999999998865443221
Q ss_pred -ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHH
Q 022444 163 -LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLI 239 (297)
Q Consensus 163 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li 239 (297)
......++..|+|||.+.....+ .++|+||||+++|++++ |..||...+..+..+.+.... .+.+...|.++.+++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236 (260)
T ss_pred ccccCCcccccccCHhHhccCCcC-ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence 12233445679999999776655 89999999999999998 999999887777776665542 344556889999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 022444 240 HRILDPNPETRITIEEIRN 258 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~ 258 (297)
.+|+..+|++||++.++++
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 237 MRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=275.75 Aligned_cols=242 Identities=26% Similarity=0.402 Sum_probs=199.5
Q ss_pred EEeccCCceeEEEEEeCCCCc--EEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEEccc
Q 022444 13 RTIGEGTFAKVKFAQNTETGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFI 89 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (297)
+.||.|++|.||+++++.++. .+++|...... .......+.+|+..++++ .|+||+++++++...+..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999987775 45777775322 223345678899999999 7999999999999888999999999
Q ss_pred CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 90 TGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 90 ~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
++++|.+++.... .+++..++.++.+++.||+|||+.|++|+||+|+||+++.++.++++|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999986532 478899999999999999999999999999999999999999999999998
Q ss_pred CCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCC
Q 022444 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWF 231 (297)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~ 231 (297)
+....... .......+..|+|||.+.+..++ .++|+||||+++++|++ |..||...+..+..+.+... ....+..+
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 236 (270)
T cd05047 159 SRGQEVYV-KKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 236 (270)
T ss_pred ccccchhh-hccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcC
Confidence 75332211 11122234579999998776665 89999999999999997 99999887777766666544 23445567
Q ss_pred ChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 232 PVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.++.+++.+|++.+|.+|||+.+++.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 237 DDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=274.80 Aligned_cols=249 Identities=26% Similarity=0.420 Sum_probs=207.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
-.+|.+.+.||.|++|.||+|.+... ...+++|....... ....+.+.+|+..++.+.|+|++++++++.. +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 35799999999999999999987543 35688898865432 2335678889999999999999999998865 557
Q ss_pred EEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+++|||+++++|.+++.+.. .++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999999999999997644 58999999999999999999999999999999999999999999999999886554332
Q ss_pred c-ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHH
Q 022444 162 S-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSL 238 (297)
Q Consensus 162 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~l 238 (297)
. ......++..|+|||.+....++ .++||||||++++++++ |..||...+..+....+... ..+.+..+|..+.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240 (270)
T ss_pred ceecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 1 11222344679999998776665 89999999999999886 99999888777666666554 345567789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 022444 239 IHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~ 258 (297)
+.+|+..+|++|||+.+++.
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.92 Aligned_cols=251 Identities=24% Similarity=0.421 Sum_probs=208.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCC-------CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTET-------GESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS 78 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 78 (297)
.+|++.+.||+|+||.||.+.+... +..+++|.+.... .....+.+.+|+.+++++ .|+||+++++.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 4799999999999999999986432 2368999876432 223356788899999999 79999999999988
Q ss_pred CCeEEEEEcccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC
Q 022444 79 RTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS 142 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~ 142 (297)
....++++||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 889999999999999999987532 3677889999999999999999999999999999999999
Q ss_pred CCCEEEcccCCCCCCCCCccc--cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022444 143 QGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSK 219 (297)
Q Consensus 143 ~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~ 219 (297)
++.++|+|||.++........ .....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999988754432111 1122234579999999877766 89999999999999998 8999998888888777
Q ss_pred hhhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 022444 220 VEKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDE 260 (297)
Q Consensus 220 i~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p 260 (297)
+.... ...+..++.++.+++.+||+.+|.+|||+.+++++-
T Consensus 249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 76543 345566889999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=271.68 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=207.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+|++.+.||.|++|.||++.+. ++..+++|.+...... ...+.+|++.++++.|++++++++++......++++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 47899999999999999999886 4678999988654321 245778999999999999999999998888999999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc-c
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL-L 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~-~ 164 (297)
|++++++|.+++... ..++++.++.++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+......... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999999988754 46899999999999999999999999999999999999999999999999987654332211 1
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHHh
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~ 242 (297)
.....+..|+|||.+.+..++ .++|+||||+++|++++ |..||.........+.+..... ..+...+..+.+++.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 223345689999998876665 89999999999999998 9999988887777777665432 33455789999999999
Q ss_pred cCCCcCCCCCHHHHhc
Q 022444 243 LDPNPETRITIEEIRN 258 (297)
Q Consensus 243 L~~~p~~Rps~~~il~ 258 (297)
|+.+|++|||+.++++
T Consensus 238 l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 238 WKERPEDRPSFSLLLH 253 (256)
T ss_pred cccChhhCCCHHHHHH
Confidence 9999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=304.06 Aligned_cols=151 Identities=30% Similarity=0.634 Sum_probs=139.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
.+++|+++++||.|+||.||++.+..+++.|++|++.............+..|+..++.++|+||++++..+......|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 36789999999999999999999999999999999976554445556778899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
||||+.+++|.+++...+.+++..++.++.+|+.||.|||+.||+|+||+|+||+++.++.++|+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.27 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=220.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
....+..+.||.|+||.||+|+-. .....|+||.++... +.+..+++++|++++..++|+|||+++|+|..++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 345678899999999999999864 345779999987665 4445788999999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCE
Q 022444 81 KIYIILEFITGGELFDKIVHHG----------R----LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHL 146 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~----------~----~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~ 146 (297)
-.|+|+|||..|||.+++.... . ++..+.+.++.||+.++.||.++.+||+|+-+.|++|.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 9999999999999999996542 2 7889999999999999999999999999999999999999999
Q ss_pred EEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc
Q 022444 147 KISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA 223 (297)
Q Consensus 147 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~ 223 (297)
|++|||+++....... ......-+.+|||||.+....++ .+|||||+|+++||+++ |..||.+...++.++.+..+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 9999999986543211 22234557799999999988887 99999999999999998 99999999999999999988
Q ss_pred cc-cCCCCCChhHHHHHHHhcCCCcCCCCCHHHH
Q 022444 224 DF-SCPTWFPVGAKSLIHRILDPNPETRITIEEI 256 (297)
Q Consensus 224 ~~-~~~~~~~~~l~~li~~~L~~~p~~Rps~~~i 256 (297)
.. +.|..+|.++.+|+..|++.+|++|||+.||
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 74 7889999999999999999999999999999
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=282.11 Aligned_cols=249 Identities=22% Similarity=0.392 Sum_probs=197.7
Q ss_pred CceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCChHHHH
Q 022444 19 TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKI 98 (297)
Q Consensus 19 ~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 98 (297)
+.+.||.++.+.+++.+++|++..... .......+.+|+..++.++|+||+++++++...+..+++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 456677777778999999999876522 2334577899999999999999999999999999999999999999999998
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-------ccccccC
Q 022444 99 VHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-------LLRTTCG 169 (297)
Q Consensus 99 ~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~ 169 (297)
.+. ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++++||+.+........ ......+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 753 4589999999999999999999999999999999999999999999999998754322111 1122345
Q ss_pred CccccCCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhhhcc----------------------
Q 022444 170 TPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY-SKVEKAD---------------------- 224 (297)
Q Consensus 170 ~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~-~~i~~~~---------------------- 224 (297)
+..|+|||.+... .++ .++|+||+|+++|+|++|..||......... +.+....
T Consensus 171 ~~~y~aPE~~~~~~~~~~-~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred cccccCHHHhcCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 6689999998653 344 8899999999999999999999876544322 2211100
Q ss_pred -----------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 225 -----------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 225 -----------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
......++.++.+|+.+||.++|++|||++++|+||||++...+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~ 305 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN 305 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccc
Confidence 000111346788999999999999999999999999999876443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=275.73 Aligned_cols=248 Identities=28% Similarity=0.447 Sum_probs=199.7
Q ss_pred ceEEeEEeccCCceeEEEEEe----CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--Ce
Q 022444 8 KYEVGRTIGEGTFAKVKFAQN----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TK 81 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (297)
-|++++.||+|++|.||++.. +.++..+++|.+.... .......+.+|+..++.+.|+|++++.+++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 378999999999999999974 4578899999986543 233356788999999999999999999988764 56
Q ss_pred EEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.+++|||+++++|.+++.+. ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999998654 35899999999999999999999999999999999999999999999999998765433
Q ss_pred ccc---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHhhh
Q 022444 161 VSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL---------------DLTTLYSKVEK 222 (297)
Q Consensus 161 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~---------------~~~~~~~~i~~ 222 (297)
... .....++..|+|||.+.+..++ .++||||||+++|+++++..|.... ........+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 221 1223456679999998776665 8999999999999999987654221 11111122222
Q ss_pred c-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 223 A-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 223 ~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
. ..+.+..++..+.+|+.+||+.+|++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2 23445668899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=274.18 Aligned_cols=248 Identities=28% Similarity=0.453 Sum_probs=198.5
Q ss_pred cceEEeEEeccCCceeEEEEE----eCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (297)
.+|++++.||+|++|.||.+. +..++..+++|.+.... ....+.+.+|+..++.++|+|++++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999997 34578899999986543 2334667899999999999999999997643 34
Q ss_pred eEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
..++++||+++++|.+++.+. ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999998754 4689999999999999999999999999999999999999999999999999876543
Q ss_pred Cccc---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHh
Q 022444 160 GVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT----------------TLYSKV 220 (297)
Q Consensus 160 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~----------------~~~~~i 220 (297)
.... .....++..|+|||.+.+..++ .++||||||+++++|++|..++...... .+.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3221 1112234469999999776665 8999999999999999987765432211 111111
Q ss_pred hhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 221 EKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 221 ~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
... ..+.+..+|.++.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 23445568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=289.30 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=219.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCC----cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETG----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
+-.+.++||+|+||.||.+..+..+ ..||+|..............++.+|.++++.++|+||++++|++...+-++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 3445689999999999999987432 238999887644445566788999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 84 IILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+|||+|+||+|.+++++.+. ++..+...++.+.+.+|+|||+.+++|+||-..|++++.++.+|++|||+++.......
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 99999999999999998774 99999999999999999999999999999999999999999999999999887652211
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc--cccCCCCCChhHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA--DFSCPTWFPVGAKSLI 239 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~l~~li 239 (297)
.....--+..|+|||.+....++ .++||||+|+++|++++ |..||.+....+...++... +.+.+...|.++..++
T Consensus 318 ~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~ 396 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVM 396 (474)
T ss_pred ccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHH
Confidence 11122356799999999877665 99999999999999999 88899999999999999443 3456677899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 240 HRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+|+..+|++|||+.++.+ +++.....
T Consensus 397 ~~c~~~~p~~R~tm~~i~~--~l~~~~~~ 423 (474)
T KOG0194|consen 397 KQCWKKDPEDRPTMSTIKK--KLEALEKK 423 (474)
T ss_pred HHhccCChhhccCHHHHHH--HHHHHHhc
Confidence 9999999999999999977 55544433
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=270.75 Aligned_cols=229 Identities=28% Similarity=0.475 Sum_probs=190.7
Q ss_pred CCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCChHHH
Q 022444 18 GTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDK 97 (297)
Q Consensus 18 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 97 (297)
|.++.||+++++.+++.+++|.+..... ..++...+....|+|++++++++......+++|||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8899999999999999999999875431 12233444555799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCccccCCc
Q 022444 98 IVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177 (297)
Q Consensus 98 l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE 177 (297)
+.+..++++..+..++.++++||.|||+.|++|+||+|+||+++.++.++++|||.+....... ....++..|+|||
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE 152 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPE 152 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCc
Confidence 9887789999999999999999999999999999999999999999999999999765544321 2334466799999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCH----
Q 022444 178 VLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITI---- 253 (297)
Q Consensus 178 ~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~---- 253 (297)
.+.+..++ .++|+||+|+++|++++|..|+....... . .......+..+++.+.+++.+||+.||++||++
T Consensus 153 ~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 227 (237)
T cd05576 153 VGGISEET-EACDWWSLGAILFELLTGKTLVECHPSGI--N--THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAG 227 (237)
T ss_pred ccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhc--c--cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccc
Confidence 98776665 89999999999999999998875432211 0 111234556689999999999999999999996
Q ss_pred -HHHhcCccc
Q 022444 254 -EEIRNDEWF 262 (297)
Q Consensus 254 -~~il~~p~~ 262 (297)
+++++||||
T Consensus 228 ~~~~~~h~~~ 237 (237)
T cd05576 228 VEDIKSHPFF 237 (237)
T ss_pred hHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=292.53 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=209.1
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++..+...||+|.||+||+|.+-++ ||||++........ ..+.+++|+.++++-+|.||+-+.|++..... .+|.
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred HHhhccceeccccccceeecccccc---eEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 4567889999999999999999754 99999987665444 68899999999999999999999999988776 9999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCC--CCCccc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP--EQGVSL 163 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~--~~~~~~ 163 (297)
.||.|.+|..++.- ...|.....+.|++|+++|+.|||..+|||+|+|..|||+.++++|+++|||++... ..+...
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence 99999999988853 346888999999999999999999999999999999999999999999999998532 244556
Q ss_pred cccccCCccccCCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-----cCCCCCChhH
Q 022444 164 LRTTCGTPNYVAPEVLSH---KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-----SCPTWFPVGA 235 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~l 235 (297)
.....+...|+|||++.. .++ ++.+||||+|+++|||++|..||......+++=.+-.+.. .....+|.++
T Consensus 547 ~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~m 625 (678)
T KOG0193|consen 547 LEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM 625 (678)
T ss_pred cCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHH
Confidence 667788999999999853 333 5999999999999999999999986555555444444421 2234478899
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 022444 236 KSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~ 258 (297)
..|+..|+++++++||++.+||.
T Consensus 626 k~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 626 KRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHhcCcccCccHHHHHH
Confidence 99999999999999999999987
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=282.40 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=201.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc-
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS- 78 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 78 (297)
-++|++.+.||.|+||.||+|++. .+++.|++|.+.... .......+.+|+..+.++ .|+|++++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 368999999999999999999853 467899999987543 122346678899999999 58999999997754
Q ss_pred CCeEEEEEcccCCCChHHHHHhc---------------------------------------------------------
Q 022444 79 RTKIYIILEFITGGELFDKIVHH--------------------------------------------------------- 101 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------------------- 101 (297)
....+++|||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45679999999999999888642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--ccccccC
Q 022444 102 ----------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCG 169 (297)
Q Consensus 102 ----------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~--~~~~~~~ 169 (297)
..++...+..++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+........ ......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1357788899999999999999999999999999999999999999999998875432211 1112234
Q ss_pred CccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHhhhc-cccCCCCCChhHHHHHHHhcCCC
Q 022444 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT-TLYSKVEKA-DFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 170 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~-~~~~~i~~~-~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
+..|+|||.+.+..++ .++||||||+++|++++ |..||...... .....+..+ ..+.+...++++.+++.+||+.+
T Consensus 244 ~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5679999998777665 89999999999999997 99999765432 333333332 33445567889999999999999
Q ss_pred cCCCCCHHHHhcC
Q 022444 247 PETRITIEEIRND 259 (297)
Q Consensus 247 p~~Rps~~~il~~ 259 (297)
|++|||+.++++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=304.14 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=215.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCC-C----cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTET-G----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~-~----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..-+..+.||+|+||.||.+..... | ..|++|.+.... +.+....+.+|..+++++.||||++++|++.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3466788999999999999997532 2 237777776544 55567889999999999999999999999999889
Q ss_pred EEEEEcccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 82 IYIILEFITGGELFDKIVHH-------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
.++++|||.+|+|.+++++. ..++...++.++.+|+.++.||+++++||+||...|+|++....+|++|||++
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999876 34899999999999999999999999999999999999999999999999999
Q ss_pred CCCCCC-cccccc-ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH-HhhhccccCCCC
Q 022444 155 ALPEQG-VSLLRT-TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYS-KVEKADFSCPTW 230 (297)
Q Consensus 155 ~~~~~~-~~~~~~-~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~-~i~~~~~~~~~~ 230 (297)
+..... ...... ...+..|+|||.+....++ .++||||||+++||+++ |..||.+.+..+... ....++++.|..
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFt-skSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFT-SKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccc-cccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 843221 111222 2456799999999987776 99999999999999999 999999999888877 666678889999
Q ss_pred CChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 231 FPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 231 ~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+|+.+.+++..|++.+|.+||++..|++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999987
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.17 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=204.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCc----EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..+|++.+.||+|++|.||++.+..+|. .+++|.+..... ......+.+|+..++.+.|+||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4679999999999999999999877775 468887764331 22234577899999999999999999988654 4
Q ss_pred EEEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.+++++++++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 678999999999999987644 5899999999999999999999999999999999999999999999999998765432
Q ss_pred cc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHH
Q 022444 161 VS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAK 236 (297)
Q Consensus 161 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~ 236 (297)
.. ......++..|+|||.+.+..++ .++||||||+++|++++ |..||.+.......+.+.... .+.+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 22 12223345689999998877665 89999999999999997 999998776655555444332 344556789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 022444 237 SLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~ 259 (297)
+++.+|+..+|++||+++++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=267.97 Aligned_cols=242 Identities=30% Similarity=0.537 Sum_probs=203.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||.+.. +++.+++|.+.... ....+.+|+..++.++|+|++++++++... ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 346799999999999999998864 67889999886532 134577899999999999999999988654 5799
Q ss_pred EEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+|||+.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999999987643 47899999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~ 240 (297)
.....+..|+|||.+.+..++ .++|+||||+++|+|++ |..||...+.......+.... ...+..+|+.+.+++.
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMT 231 (254)
T ss_pred --CCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHH
Confidence 122335679999998776665 89999999999999997 999999888877776665542 2334568899999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+||+.+|++|||+.+++.
T Consensus 232 ~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 232 SCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=273.13 Aligned_cols=239 Identities=24% Similarity=0.322 Sum_probs=194.8
Q ss_pred EEeccCCceeEEEEEeCCCCc-------EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 13 RTIGEGTFAKVKFAQNTETGE-------SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~-------~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+.||+|+||.||++.++..+. ++++|...... ....+.+.++..+++.+.|+|++++++++......+++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 468999999999999865443 47788765432 23345677899999999999999999999988899999
Q ss_pred EcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC--------EEEcccCCCCC
Q 022444 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH--------LKISDFGLSAL 156 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~--------~~l~df~~~~~ 156 (297)
|||+++++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++++|||.+..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997644 5899999999999999999999999999999999999987764 69999998764
Q ss_pred CCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhccccCCCCCChhH
Q 022444 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLYSKVEKADFSCPTWFPVGA 235 (297)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l 235 (297)
.... ....++..|+|||.+.+....+.++||||||+++|++++| ..||...+...... ........+...+.++
T Consensus 158 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (258)
T cd05078 158 VLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWTEL 232 (258)
T ss_pred cCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcHHH
Confidence 4322 1234667899999997644334899999999999999998 56776665554333 2334455666677899
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 236 KSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.+++.+||+.+|++|||++++++.
T Consensus 233 ~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 233 ANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHhccChhhCCCHHHHHHh
Confidence 999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=285.17 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=203.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (297)
.++|.+.+.||.|+||.||++++. .+++.|++|++..... ....+.+.+|+.++.++. |+||+++++.+...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 346888999999999999999964 3457899999975432 222456789999999997 99999999999888
Q ss_pred CeEEEEEcccCCCChHHHHHhcC---------------------------------------------------------
Q 022444 80 TKIYIILEFITGGELFDKIVHHG--------------------------------------------------------- 102 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------------- 102 (297)
...++++||+++++|.+++.+.+
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 89999999999999999886431
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec
Q 022444 103 -----------------------------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (297)
Q Consensus 103 -----------------------------------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~ 141 (297)
.++...++.++.+++.||.|||+.|++|+||+|+||+++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 256677889999999999999999999999999999999
Q ss_pred CCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-
Q 022444 142 SQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY- 217 (297)
Q Consensus 142 ~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~- 217 (297)
.++.++|+|||.+........ ......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||......+..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999875432211 11223456789999999877665 89999999999999998 88999776544433
Q ss_pred HHhhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 218 SKVEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 218 ~~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
..+..+ ....+..++.++.+++.+|+..+|.+|||+++|++
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 333332 23455668899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.76 Aligned_cols=239 Identities=22% Similarity=0.272 Sum_probs=191.7
Q ss_pred EEeccCCceeEEEEEeCC------------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 13 RTIGEGTFAKVKFAQNTE------------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~------------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
+.||.|++|.||.+.... ....+++|++.... ......+.+++..++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 23358888865432 333456778889999999999999999998888
Q ss_pred eEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC-------EEEcccC
Q 022444 81 KIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH-------LKISDFG 152 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~-------~~l~df~ 152 (297)
..+++|||+++++|..++.. ...+++..++.++.|+++||.|||+.|++|+||+|+||+++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 89999999999999888865 356899999999999999999999999999999999999987664 8999999
Q ss_pred CCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHhhhccccCCCCC
Q 022444 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLI-AGYLPFDELDLTTLYSKVEKADFSCPTWF 231 (297)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 231 (297)
.+...... ....++..|+|||.+......+.++||||||+++|+|+ +|..||......+... ............
T Consensus 158 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~ 232 (262)
T cd05077 158 IPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPS 232 (262)
T ss_pred CCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCCC
Confidence 87654332 23346678999998864433348999999999999997 5888987765544332 223333344446
Q ss_pred ChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 232 PVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
++++.+++.+||+.||.+||++.+|+++
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 7889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=273.38 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=203.6
Q ss_pred cceEEeEEeccCCceeEEEEEeC----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNT----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (297)
+.|++.+.||+|++|.||++... .+++.+++|.+...... .....+.+|++.++.+.|+||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 56889999999999999999864 34889999998765432 345678899999999999999999998876 55
Q ss_pred eEEEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
..++++||+++++|.+++.+.. .++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 7899999999999999997654 589999999999999999999999999999999999999999999999999876653
Q ss_pred Cccc---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHhh
Q 022444 160 GVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT---------------TLYSKVE 221 (297)
Q Consensus 160 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---------------~~~~~i~ 221 (297)
.... ......+..|+|||.+.+..++ .++|+||||+++++|++|..|+...... ...+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 2221 1122345579999998777665 8999999999999999999998653221 1222222
Q ss_pred hc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 222 KA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 222 ~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.. ..+.+..+|.++.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 23445567899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.93 Aligned_cols=248 Identities=32% Similarity=0.634 Sum_probs=218.1
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
.+.||+|.||+||-++++.+|+.||||++.+....... ...+++|+.+|+.+.||+|+.+--.|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 46899999999999999999999999999875544433 37899999999999999999999999999999999999976
Q ss_pred CChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC---CEEEcccCCCCCCCCCcccccc
Q 022444 92 GELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 92 ~~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~---~~~l~df~~~~~~~~~~~~~~~ 166 (297)
++.+++.. .+++++.....++.||+.||.|||-.||+|+|+||+||++.... .+||||||+++..+.. +....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrs 725 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRS 725 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhh
Confidence 77787754 35799999999999999999999999999999999999996543 6999999999988775 44556
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCC----CChhHHHHHHHh
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW----FPVGAKSLIHRI 242 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~~l~~li~~~ 242 (297)
-+|++.|.|||++..+++. ..-|+||.|+++|--+.|..||.. .+++.+.|.+..+-+|.. +++++.+||+.+
T Consensus 726 VVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlIn~L 802 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLINNL 802 (888)
T ss_pred hcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence 7899999999999999998 999999999999999999999964 355666666666655443 789999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccC
Q 022444 243 LDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
|+..-++|.|....|.|||+|+-
T Consensus 803 LqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=267.98 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=196.4
Q ss_pred EEeccCCceeEEEEEeCC---CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE-cCCeEEEEEcc
Q 022444 13 RTIGEGTFAKVKFAQNTE---TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-SRTKIYIILEF 88 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~ 88 (297)
+.||+|++|.||++.+.. .+..+++|.+.... .......+.+|+..++.++|+|++++++++. .+...++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 34678999875422 2233566778999999999999999999765 45568899999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc----c
Q 022444 89 ITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS----L 163 (297)
Q Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~----~ 163 (297)
+.+++|.+++.+. ...+...+..++.++++||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999998754 3467788899999999999999999999999999999999999999999998875432211 1
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~ 241 (297)
.....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+.... ...+..+|+.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1122345689999998777665 89999999999999999 567787777766666655543 33455678999999999
Q ss_pred hcCCCcCCCCCHHHHhc
Q 022444 242 ILDPNPETRITIEEIRN 258 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~ 258 (297)
||+.+|++||++.+++.
T Consensus 238 cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 238 CWHPKPEMRPTFSELVS 254 (262)
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999987
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=289.18 Aligned_cols=244 Identities=36% Similarity=0.641 Sum_probs=210.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh-cCCCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL-VRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~ 83 (297)
....|.+...+|.|+|+.|-.+.+..+++..++|++..... ...+++..+.. -.|+||++.++.+.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 35678999999999999999999999999999999976521 12244533333 36999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee-cCCCCEEEcccCCCCCCCCCcc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL-DSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli-~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+|||.++|+-+.+.+.....+. .++..|+.+|+.|+.|||++|++|||++|+||++ +..++++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999998888887765555 7888999999999999999999999999999999 58899999999998866654
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhhccccCCCCCChhHHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEKADFSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~l~~li~~ 241 (297)
...++-+..|.|||.....+++ +++|+||||+++|+|++|..||...... ++..++..+.+. ..+++.+++|+++
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~ 545 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQ 545 (612)
T ss_pred -hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHH
Confidence 2344567799999999988887 9999999999999999999999876655 666666665444 7799999999999
Q ss_pred hcCCCcCCCCCHHHHhcCccc
Q 022444 242 ILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~~p~~ 262 (297)
||+.||.+||++.+++.||||
T Consensus 546 LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 546 LLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hccCChhhCcChhhhccCcch
Confidence 999999999999999999999
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=271.07 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=200.5
Q ss_pred EEeccCCceeEEEEEeCCCC------cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 13 RTIGEGTFAKVKFAQNTETG------ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.||+|++|.||+++++... ..+++|.+.... .......+.+|+..++.+.|+||+++++++......++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986433 678999875432 1223456778999999999999999999998888999999
Q ss_pred cccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-----CEEEcccCCC
Q 022444 87 EFITGGELFDKIVHH-------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-----HLKISDFGLS 154 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-----~~~l~df~~~ 154 (297)
|++++++|.+++.+. ..+++..++.++.+++.||.|||+.+++|+||+|+||+++.++ .++++|||.+
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 2378899999999999999999999999999999999998877 8999999988
Q ss_pred CCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCC
Q 022444 155 ALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTW 230 (297)
Q Consensus 155 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~ 230 (297)
........ .......+..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+... ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcc-cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 65432211 11223445789999999877665 99999999999999998 99999887776666665443 3455666
Q ss_pred CChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 231 FPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 231 ~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+|..+.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999976
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=270.62 Aligned_cols=238 Identities=24% Similarity=0.292 Sum_probs=190.7
Q ss_pred EeccCCceeEEEEEeCC------------------------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe
Q 022444 14 TIGEGTFAKVKFAQNTE------------------------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69 (297)
Q Consensus 14 ~lg~g~~~~v~~~~~~~------------------------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 69 (297)
.||+|+||.||++.... ....+++|++.... ......+.+++..++.++|+||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 58999999999987421 22457888875432 2334567788899999999999
Q ss_pred eEEEEEEEcCCeEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC----
Q 022444 70 VRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---- 144 (297)
Q Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~---- 144 (297)
+++++++......++||||+++++|..++.+ .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999998999999999999999988865 45689999999999999999999999999999999999997643
Q ss_pred ---CEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHH-HhCCCCCCCCCHHHHHHHh
Q 022444 145 ---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVL-IAGYLPFDELDLTTLYSKV 220 (297)
Q Consensus 145 ---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l-l~g~~pf~~~~~~~~~~~i 220 (297)
.++++|||.+...... ....++..|+|||.+.+....+.++|+||||+++|++ ++|..||...........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~- 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF- 233 (274)
T ss_pred ccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-
Confidence 3799999987543222 1234667899999886543334899999999999998 479999987765554332
Q ss_pred hhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 221 EKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 221 ~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.......+...+..+.+++.+||+.+|++|||+.++|++
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 223344455567789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=268.68 Aligned_cols=249 Identities=28% Similarity=0.510 Sum_probs=206.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCC-CCcEEEEEEeecchh-------hhHHHHHHHHHHHHHHHh-cCCCCeeEEEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTE-TGESVAMKVLDRSAI-------IKHKMADQIKREISIMKL-VRHPCVVRLHEVLAS 78 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 78 (297)
.|++.+.||.|++|.||.+.++. +++.+++|.+..... ........+.+|+.++.+ +.|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 688999998754221 122234556677877765 689999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 79 RTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
....+++|||+.+++|.+.+.. ...+++..++.++.+++.+|.+||+ .|++|+||+|.||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999887743 3468999999999999999999996 6899999999999999999999999999
Q ss_pred CCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-CC-CCC
Q 022444 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CP-TWF 231 (297)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~-~~~ 231 (297)
+....... ......++..|+|||.+.+..++ .++|+||||+++|++++|..||...+.......+...... .+ ..+
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCCCCc-hHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 87654432 33445678899999999876655 8999999999999999999999887776666665554332 22 257
Q ss_pred ChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 232 PVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.++.+++.+||+.||++|||+.++.+
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=277.31 Aligned_cols=260 Identities=32% Similarity=0.597 Sum_probs=236.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 83 (297)
+..+|-.+.+||.|+||.|-++..+.+.+.+|||+++.....+...++--..|-++|.... -|.+++++..|+.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 4567899999999999999999999999999999998766555555554555666666654 578889999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||++||+|--.++.-+.+.++.+..++..|+-+|-+||+.||+++|+|.+||+++.+|.+|++|||.+.....+...
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999877776677
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
....+|++.|+|||++...+|. .+.|.||+|+++|+|+.|..||++-+..++.+.|..-...+|..++.++.++....|
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~l 585 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLL 585 (683)
T ss_pred eeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHh
Confidence 7788999999999999988887 999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCH-----HHHhcCcccccC
Q 022444 244 DPNPETRITI-----EEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps~-----~~il~~p~~~~~ 265 (297)
.+.|.+|..+ ++|-.||||+..
T Consensus 586 tK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 586 TKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred hcCCccccCCCCccccchhhCcchhhc
Confidence 9999999764 689999999864
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=265.88 Aligned_cols=236 Identities=21% Similarity=0.248 Sum_probs=191.0
Q ss_pred EEeccCCceeEEEEEeCCCC----------cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 13 RTIGEGTFAKVKFAQNTETG----------ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~----------~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
+.||+|++|.||++.+..++ ..+++|.+..... ....+.+++.+++.++|+||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998766 3477776654331 14667889999999999999999999877 778
Q ss_pred EEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-------CEEEcccCCC
Q 022444 83 YIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-------HLKISDFGLS 154 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-------~~~l~df~~~ 154 (297)
++++||+++++|.+++.... .++...+..++.+++.||.|||+.|++|+||+|+||+++.++ .++++|||.+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998765 789999999999999999999999999999999999999887 7999999988
Q ss_pred CCCCCCccccccccCCccccCCcccccc-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccccCCCCCC
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADFSCPTWFP 232 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 232 (297)
...... ....+...|+|||.+.+. ...+.++|+||||+++|++++ |..||...+......... .....+....
T Consensus 156 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (259)
T cd05037 156 ITVLSR----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDC 230 (259)
T ss_pred cccccc----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCc
Confidence 765431 233456679999998765 233489999999999999999 588887765433333222 2222223334
Q ss_pred hhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 233 VGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 233 ~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
..+.+++.+||..+|++|||+.++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 231 AELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred hHHHHHHHHHhccChhhCCCHHHHHH
Confidence 88999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=265.35 Aligned_cols=243 Identities=21% Similarity=0.250 Sum_probs=191.0
Q ss_pred EEeccCCceeEEEEEeC--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccC
Q 022444 13 RTIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
+.||+|+||.||++... .++..+++|.+..... ......+.+|+..++.++|+|++++++.+.+....+++|||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999865 3456799998865432 2223467789999999999999999999988888999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--c
Q 022444 91 GGELFDKIVHHG-----RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--L 163 (297)
Q Consensus 91 ~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~--~ 163 (297)
+++|.+++.... ..+...++.++.+++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999986432 356678889999999999999999999999999999999999999999998865432211 1
Q ss_pred cccccCCccccCCccccccCC------CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhh-hccc-----cCCCC
Q 022444 164 LRTTCGTPNYVAPEVLSHKGY------NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVE-KADF-----SCPTW 230 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~------~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~-~~~~-----~~~~~ 230 (297)
.....++..|+|||.+.+... .+.++|+||||+++|+|++ |..||......+...... .... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 123345678999999854221 2479999999999999996 999998776655433222 2111 12224
Q ss_pred CChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 231 FPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 231 ~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.++.+.+++++|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=314.60 Aligned_cols=258 Identities=32% Similarity=0.544 Sum_probs=225.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
|++-...||.|.||.||.+.+..+|+..|+|.+...... ....+...+|..++..++|||+++++++-.+.+..++.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 567778999999999999999999999999998766544 5557788899999999999999999999888889999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc----c
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS----L 163 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~----~ 163 (297)
||.+|+|.+.++...-..+.....+..|++.++.|||++||||+||||.||+++.+|.+|++|||.+........ .
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999999999999877788888899999999999999999999999999999999999999999999987665432 2
Q ss_pred cccccCCccccCCccccccCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhhc-cccCCCCCChhHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYN--GAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEKA-DFSCPTWFPVGAKSLI 239 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~~-~~~~~~~~~~~l~~li 239 (297)
.....|++.|+|||++.+.... .-+.|||||||++.+|+||+.||...+.. .+..++..+ .++.|..++.+-++||
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence 3456799999999999765432 47899999999999999999999887654 344444444 5678888999999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 240 HRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
.+||..||++|-++.++|+|-|-..+.
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred HHHHhcCchhhhHHHHHHHhhcccccc
Confidence 999999999999999999999876653
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=265.16 Aligned_cols=248 Identities=25% Similarity=0.422 Sum_probs=201.5
Q ss_pred eEEeEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----
Q 022444 9 YEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----- 80 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 80 (297)
|.+.+.||+|++|.||++.++ .++..+++|.+........ ..+.+.+|+..++.+.|+|++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS-DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH-HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999865 3578999999865432222 3466788999999999999999999875432
Q ss_pred -eEEEEEcccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 81 -KIYIILEFITGGELFDKIVHH------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 81 -~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
..+++++|+.+++|.+++... ..++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247889999999998776432 2478899999999999999999999999999999999999999999999998
Q ss_pred CCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCC
Q 022444 154 SALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPT 229 (297)
Q Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~ 229 (297)
+........ ......++..|++||.+.....+ .++||||||+++|+|++ |..||...+.......+.... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 876543221 11223345679999998777665 89999999999999999 899998887776666554443 34455
Q ss_pred CCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 230 WFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 230 ~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
..+..+.+++.+||+.+|++|||+.++++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=274.58 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=198.4
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-eE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-KI 82 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 82 (297)
+.+..|.-.+.||+|+||.||++...+ |..||||.+....... ..++.+|+.++.+++|+|+++++|+|.+.+ ..
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 445678888999999999999999764 4889999776544221 345999999999999999999999999888 59
Q ss_pred EEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---CEEecCCCCCeeecCCCCEEEcccCCCCCC
Q 022444 83 YIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKG---VYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~---i~h~di~~~nIli~~~~~~~l~df~~~~~~ 157 (297)
++|+||++.|+|.+.+.... ++++..+.+|+.++|.||+|||+.. |+|+|||++||++|.+.+.|++|||++...
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999999999997655 8899999999999999999999864 999999999999999999999999999655
Q ss_pred CCCccccccc-cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHH-HHhhhcc-----
Q 022444 158 EQGVSLLRTT-CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD------LTTLY-SKVEKAD----- 224 (297)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~------~~~~~-~~i~~~~----- 224 (297)
.......... .|+.+|++||.......+ .++||||+|+++.++++|+.+.+... ..+.. ..+....
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~lt-~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYASTGKLT-EKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred CccccceeeecCCCCccCChhhhccCCcC-cccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 4411111222 789999999999875555 99999999999999999998776432 12211 1111111
Q ss_pred -ccCC-CCCC--hh---HHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 225 -FSCP-TWFP--VG---AKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 225 -~~~~-~~~~--~~---l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
..+. ...+ .+ +..+..+|++.+|++||+..++++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 2223 22 457889999999999999999855
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=264.81 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=189.9
Q ss_pred EEeccCCceeEEEEEeCC--CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccC
Q 022444 13 RTIGEGTFAKVKFAQNTE--TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
+.||+|+||.||++.... ....+++|.+.... .......+.+|+..++.++|+||+++++.+......+++|||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997542 34568888765432 22334567789999999999999999999988889999999999
Q ss_pred CCChHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--c
Q 022444 91 GGELFDKIVHHGR-----LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--L 163 (297)
Q Consensus 91 ~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~--~ 163 (297)
+++|.+++..... .++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999999876432 46778899999999999999999999999999999999999999999998764332211 1
Q ss_pred cccccCCccccCCcccccc------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh-hhccc-----cCCCC
Q 022444 164 LRTTCGTPNYVAPEVLSHK------GYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKV-EKADF-----SCPTW 230 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i-~~~~~-----~~~~~ 230 (297)
.....++..|+|||.+... ...+.++||||||+++|+|++ |..||......+..... ..... ..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233455679999987431 122489999999999999999 78899877655544333 32222 22345
Q ss_pred CChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 231 FPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 231 ~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
++..+.+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=271.75 Aligned_cols=251 Identities=29% Similarity=0.456 Sum_probs=204.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC--C----CeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH--P----CVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----~i~~~~~~~~~~ 79 (297)
..||.++..+|+|.||.|-.+.+..++..+|||+++.-. .+....+-|+++++++.+ | .++.+.++|.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 568999999999999999999999999999999986533 445566778999999842 1 356667788888
Q ss_pred CeEEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec----------------
Q 022444 80 TKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---------------- 141 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~---------------- 141 (297)
++.|+|+|.+ |.|+.+++.+++ +++...++.++.|+++++.+||+.+++|.|+||+||++.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999999 559999998654 689999999999999999999999999999999999992
Q ss_pred ----CCCCEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--
Q 022444 142 ----SQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT-- 215 (297)
Q Consensus 142 ----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-- 215 (297)
++..++++|||.+++..... ..-+.+.-|+|||++.+.+|+ ..+||||+||+++++++|...|...+..+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 12358999999998877654 345667799999999999998 99999999999999999999997665433
Q ss_pred -HHHHhhhccc------------------cCCC---------------C----------CChhHHHHHHHhcCCCcCCCC
Q 022444 216 -LYSKVEKADF------------------SCPT---------------W----------FPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 216 -~~~~i~~~~~------------------~~~~---------------~----------~~~~l~~li~~~L~~~p~~Rp 251 (297)
+.+++....+ .-+. . --.++.+|+++||..||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 3333322110 0000 0 014578999999999999999
Q ss_pred CHHHHhcCcccccC
Q 022444 252 TIEEIRNDEWFRKG 265 (297)
Q Consensus 252 s~~~il~~p~~~~~ 265 (297)
|+.|+|.||||...
T Consensus 399 Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 399 TLREALSHPFFARL 412 (415)
T ss_pred cHHHHhcCHHhhcC
Confidence 99999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=259.58 Aligned_cols=240 Identities=47% Similarity=0.801 Sum_probs=208.5
Q ss_pred CceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCChHHHH
Q 022444 19 TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKI 98 (297)
Q Consensus 19 ~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 98 (297)
++|.||++.+..+++.+++|++........ .+.+.+|+..+++++|+|++++++.+......++++|++.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 578999999998999999999876543221 567889999999999999999999998889999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCccccCCcc
Q 022444 99 VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178 (297)
Q Consensus 99 ~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~ 178 (297)
.....++...++.++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ......+...|+|||.
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEV 157 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHH
Confidence 876668999999999999999999999999999999999999999999999999987665432 2334557778999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhhhccccCCCC---CChhHHHHHHHhcCCCcCCCCCHH
Q 022444 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDE-LDLTTLYSKVEKADFSCPTW---FPVGAKSLIHRILDPNPETRITIE 254 (297)
Q Consensus 179 ~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~---~~~~l~~li~~~L~~~p~~Rps~~ 254 (297)
..+...+ .++|+||||++++++++|..||.. .+.....+.+.......... ++.++.+++.+|+..+|++||++.
T Consensus 158 ~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 236 (244)
T smart00220 158 LLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE 236 (244)
T ss_pred HccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence 9877666 799999999999999999999987 56666666666555543333 889999999999999999999999
Q ss_pred HHhcCccc
Q 022444 255 EIRNDEWF 262 (297)
Q Consensus 255 ~il~~p~~ 262 (297)
++++||||
T Consensus 237 ~~~~~~~~ 244 (244)
T smart00220 237 EALQHPFF 244 (244)
T ss_pred HHhhCCCC
Confidence 99999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=283.91 Aligned_cols=258 Identities=33% Similarity=0.607 Sum_probs=236.5
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+..++.+..||-|+||.|=++..+.....+|+|.+++....+......+..|-.++..+..+.|+++|..|.++.+.|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 45677888999999999999998766666889988877666666667788899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
||-|-||.|+..+...+.|.+...+.++..+++|+.|||+.||+++|+||+|.+++.+|-+||.|||++.....+....
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw- 577 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW- 577 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCcee-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999988875543
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--ccCCCCCChhHHHHHHHhc
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~l~~li~~~L 243 (297)
..+|++.|.|||++.+.+.+ .+.|.||||+++|+|++|.+||.+.++...++-|.++. ..+|..++....+++++++
T Consensus 578 TFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred eecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 56899999999999999988 99999999999999999999999999999999998874 5678889999999999999
Q ss_pred CCCcCCCCC-----HHHHhcCcccccC
Q 022444 244 DPNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
..+|.+|.. ..+|-.|.||...
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcC
Confidence 999999887 8999999999875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=265.55 Aligned_cols=249 Identities=14% Similarity=0.157 Sum_probs=189.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhh--hHH------HHHHHHHHHHHHHhcCCCCeeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAII--KHK------MADQIKREISIMKLVRHPCVVRLHEV 75 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~--~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (297)
.+|++.+.||+|+||.||++.+..+ +..+++|+....... .+. .......++..+..+.|++++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5899999999999999999998877 667777764322110 000 00112233444556789999999987
Q ss_pred EEcCC----eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEccc
Q 022444 76 LASRT----KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (297)
Q Consensus 76 ~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df 151 (297)
+.... ..+++++++.. ++.+.+......++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 64432 34677787643 66677766556788999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCc-------cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-H--------H
Q 022444 152 GLSALPEQGV-------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL-T--------T 215 (297)
Q Consensus 152 ~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~--------~ 215 (297)
|+++...... .......+++.|+|||++.+..++ .++||||||+++++|++|..||..... . +
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~ 249 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD 249 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence 9987543221 111233588999999999887776 999999999999999999999977632 1 2
Q ss_pred HHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 216 LYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 216 ~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
....+....... ...|+.+.+++..|++.+|++||++.++++
T Consensus 250 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 250 FIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 334444433333 346899999999999999999999999975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=297.48 Aligned_cols=254 Identities=31% Similarity=0.514 Sum_probs=205.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEE---------
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVL--------- 76 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--------- 76 (297)
...|+.++.||+||||.||+++++-+|..+|||+++... +......+.+|+..+.+++|||+++++..+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 456888999999999999999999999999999998877 444567888999999999999999998111
Q ss_pred ---------------------------------------------------E------------------c---------
Q 022444 77 ---------------------------------------------------A------------------S--------- 78 (297)
Q Consensus 77 ---------------------------------------------------~------------------~--------- 78 (297)
. +
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0 0
Q ss_pred ------------------------C--------CeEEEEEcccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 022444 79 ------------------------R--------TKIYIILEFITGGELFDKIVHHGRL-SESEARRYFQQLIDGVDYCHS 125 (297)
Q Consensus 79 ------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~al~~Lh~ 125 (297)
. ..+||-||||...++.+++..+... -...+|+++++|++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 2378999999886666666544332 478899999999999999999
Q ss_pred CCCEEecCCCCCeeecCCCCEEEcccCCCCCCC------------------CCccccccccCCccccCCccccccC--CC
Q 022444 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPE------------------QGVSLLRTTCGTPNYVAPEVLSHKG--YN 185 (297)
Q Consensus 126 ~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~------------------~~~~~~~~~~~~~~~~aPE~~~~~~--~~ 185 (297)
.|+||+||||.|||++.++.||++|||+++... .+.......+|+..|.|||.+.+.. ..
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999987611 0111234567899999999997765 23
Q ss_pred CCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHhhhccccCCCCCC----hhHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 022444 186 GAAADVWSCGVILYVLIAGYLPF-DELDLTTLYSKVEKADFSCPTWFP----VGAKSLIHRILDPNPETRITIEEIRNDE 260 (297)
Q Consensus 186 ~~~~Di~slG~ll~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~----~~l~~li~~~L~~~p~~Rps~~~il~~p 260 (297)
+.+.|+||||+++++|+. || +.......+.++..+..+.+..+. +.-..+|+.||+.||++|||+.|+|++.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 499999999999999974 35 445666778888877777763322 3456899999999999999999999999
Q ss_pred cccc
Q 022444 261 WFRK 264 (297)
Q Consensus 261 ~~~~ 264 (297)
||.-
T Consensus 873 llpp 876 (1351)
T KOG1035|consen 873 LLPP 876 (1351)
T ss_pred CCCc
Confidence 9984
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=259.00 Aligned_cols=259 Identities=28% Similarity=0.590 Sum_probs=233.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 84 (297)
+..|+++++||+|++..|-+++.+.+.+-+++|++++....+.+..+....|-.+..+- +||.++.++..|...+.+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 45799999999999999999999999999999999887766667777777777777666 58999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|.||++||+|--.++++..++++.++.+...|+-||.|||+.||+++|+|.+|+++|..|.+||+|+|.+.....+....
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 99999999998888888899999999999999999999999999999999999999999999999999988766666777
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHhhhccccCCCCCChhHH
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL--------DLTTLYSKVEKADFSCPTWFPVGAK 236 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~~~~~~~~~l~ 236 (297)
+..+|++.|+|||++.+..+. ...|.|+||++|++|+.|+.||+.. +...+.+.|.....+.|..++-.+.
T Consensus 409 stfcgtpnyiapeilrgeeyg-fsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas 487 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKAS 487 (593)
T ss_pred ccccCCCcccchhhhcccccC-ceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhH
Confidence 788999999999999999987 9999999999999999999999533 2445677777777888888999999
Q ss_pred HHHHHhcCCCcCCCCC------HHHHhcCcccccC
Q 022444 237 SLIHRILDPNPETRIT------IEEIRNDEWFRKG 265 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps------~~~il~~p~~~~~ 265 (297)
.+++..|++||.+|.. ++++-.|+||+..
T Consensus 488 ~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 488 HVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred HHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 9999999999999864 6899999999853
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.79 Aligned_cols=243 Identities=20% Similarity=0.295 Sum_probs=188.9
Q ss_pred EEeccCCceeEEEEEeCCC--CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccC
Q 022444 13 RTIGEGTFAKVKFAQNTET--GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
+.||+|+||.||++....+ ...+++|.+..... ......+.+++..++.++|||++++++.+......+++|||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 34466776654331 2234667888999999999999999999998889999999999
Q ss_pred CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc--ccc
Q 022444 91 GGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV--SLL 164 (297)
Q Consensus 91 ~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~--~~~ 164 (297)
+++|.+++.+. ...+...++.++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999998753 235677788999999999999999999999999999999999999999999875432211 122
Q ss_pred ccccCCccccCCccccccC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc------ccCCCCC
Q 022444 165 RTTCGTPNYVAPEVLSHKG------YNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD------FSCPTWF 231 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~------~~~~~~~ 231 (297)
....++..|+|||.+.... ..+.++||||||+++|+|++ |..||...+..+....+.... ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 2445678899999975321 11478999999999999997 577887776665555433221 2233447
Q ss_pred ChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 232 PVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+.+++..|+ .+|++|||++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=236.55 Aligned_cols=257 Identities=32% Similarity=0.489 Sum_probs=219.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|+-.++||+|.+|+||++++..+++-|++|.++.....+ ..-....+|+-+++.++|.||++++++..++..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 45777889999999999999999999999999997654222 22344678999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|+|.. +|..+..+ ++.+..+.++.++.|++.+|.+.|++++.|+|+||.|.+|..+|.+||.|||+++..+.+....+
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 99964 88888875 45688899999999999999999999999999999999999999999999999998888777777
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-------ccCCCC-------
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-------FSCPTW------- 230 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-------~~~~~~------- 230 (297)
..+-+..|+||.++.+....+...|+||-||++.++.. |.+.|.+.+..+...+|-..- .+....
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 77888999999999998887789999999999999987 888999999888887773321 111000
Q ss_pred ---------------CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 231 ---------------FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 231 ---------------~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
++..-++++..+|.-+|.+|.|+++.++||||...
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 12344789999999999999999999999999865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=262.66 Aligned_cols=129 Identities=33% Similarity=0.586 Sum_probs=113.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC--------CCCeeEEEEEEE-
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--------HPCVVRLHEVLA- 77 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~- 77 (297)
+||.+.++||.|.||+||++.|..+...||+|+.+... .+.+....||++|+++. ..+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 79999999999999999999999999999999997543 45566789999999884 247899999884
Q ss_pred ---cCCeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeee
Q 022444 78 ---SRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLL 140 (297)
Q Consensus 78 ---~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli 140 (297)
++.+.|+|+|+. |..|..+|.+. +.++...+++|++|++.+|.|||+ +||||.||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 566899999999 56888888754 479999999999999999999996 599999999999999
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=269.96 Aligned_cols=243 Identities=26% Similarity=0.435 Sum_probs=216.1
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
....++||.|.+|.||.+.++.-.-.|+||.++... -.+.++..|..+++.++|||+|+++++|....-+|||.||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 445679999999999999999888899999886543 2356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc-
Q 022444 89 ITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR- 165 (297)
Q Consensus 89 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~- 165 (297)
|..|.|.+++....+ ++...++.++.||.+|++||...++||+|+-..|.++.++-.+|+.|||+++++........
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 999999999987653 77888999999999999999999999999999999999999999999999998876544332
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHHhc
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~L 243 (297)
+..-+.-|.|||.+..+.++ .++|||+||+++|++.| |-.||.+.+..+.+.-+.++ +..-|+.||+.+..|++.|+
T Consensus 425 GAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW 503 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACW 503 (1157)
T ss_pred CccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHh
Confidence 23345689999999888877 99999999999999998 99999999999888887766 45667889999999999999
Q ss_pred CCCcCCCCCHHHH
Q 022444 244 DPNPETRITIEEI 256 (297)
Q Consensus 244 ~~~p~~Rps~~~i 256 (297)
+|+|++||+++|+
T Consensus 504 ~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 504 NWSPSDRPSFAEI 516 (1157)
T ss_pred cCCcccCccHHHH
Confidence 9999999999999
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=256.00 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=207.9
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEEc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.+-...||.|+||+|++..++.+|+..|||.++.... +...++++.|.+...+- +.||||++++.....+-.|++||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 4456789999999999999999999999999988774 33356677788777666 47999999999888888999999
Q ss_pred ccCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 88 FITGGELFDKIV-----HHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 88 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
.|+- ||..+-+ ....++++-+-.+......||.||.+ ..|+|+|+||+||+++..|.+||||||++-.+..+.
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 9964 6643322 23468999999999999999999975 589999999999999999999999999987665543
Q ss_pred cccccccCCccccCCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhhhccccCC---CC---CC
Q 022444 162 SLLRTTCGTPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDL-TTLYSKVEKADFSCP---TW---FP 232 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~---~~---~~ 232 (297)
.. ....|...|+|||.+... +++ .+||+||||++++++.||+.|+.+++. .+....+..+.++.. .. ++
T Consensus 223 Ak-T~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 223 AK-TVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred Hh-hhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 22 345688899999999654 445 999999999999999999999999864 344555555555432 22 67
Q ss_pred hhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 233 VGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 233 ~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
..+..||..||.+|-+.||++.+++.+||.+-...
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 88999999999999999999999999999986643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=276.61 Aligned_cols=260 Identities=25% Similarity=0.418 Sum_probs=223.6
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEE----
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLA---- 77 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---- 77 (297)
+...+.|++.+.||.|.+|.||+++++.+++..++|+...... .-.++..|+++++..+ |||++.+++++.
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3456789999999999999999999999999999999876542 2345667888888886 899999999884
Q ss_pred -cCCeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 78 -SRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 78 -~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
.++.+|+|||+|.+||.-+++++. ..+.++.+..+++.++.++.+||.+.++|+||+=.||+++.++.+||+|||.+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 456899999999999999988764 46899999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccccCCccccCCccccccCCC----CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---ccC
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN----GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSC 227 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~----~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~ 227 (297)
.............+|++.|+|||++...... +.++|+||||++..+|.-|.+|+-...+...+=.|...- +.-
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 9998888888899999999999998542211 478999999999999999999998877665444333221 223
Q ss_pred CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 228 PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 228 ~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
++..+.++.+||+.||.+|..+||+..++|+|||+..+.
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 455788999999999999999999999999999999654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=277.22 Aligned_cols=255 Identities=18% Similarity=0.275 Sum_probs=175.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCC----CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEE-----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTET----GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEV----- 75 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~----~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~----- 75 (297)
..++|++.+.||+|+||.||++++..+ +..+++|.+............ .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-------~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-------RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-------HHHhhchhhHHHHHHhhhccc
Confidence 467899999999999999999999988 899999987543211111111 1111111111111110
Q ss_pred -EEcCCeEEEEEcccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCEEecCC
Q 022444 76 -LASRTKIYIILEFITGGELFDKIVHHGR--------------------LSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134 (297)
Q Consensus 76 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~ 134 (297)
.......++++||+.+++|.+++..... .....+..++.|++.||.|||+.||+|+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2355678999999999999988865321 1233466899999999999999999999999
Q ss_pred CCCeeecC-CCCEEEcccCCCCCCCCCc-cccccccCCccccCCccccccCCC---------------------CCchhH
Q 022444 135 PENLLLDS-QGHLKISDFGLSALPEQGV-SLLRTTCGTPNYVAPEVLSHKGYN---------------------GAAADV 191 (297)
Q Consensus 135 ~~nIli~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~---------------------~~~~Di 191 (297)
|+||+++. ++.++|+|||++....... .......+++.|+|||.+...... +.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 5789999999997553321 222345678899999976432211 245699
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc---------------------cCCCCCChhHHHHHHHhcCCCcCCC
Q 022444 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---------------------SCPTWFPVGAKSLIHRILDPNPETR 250 (297)
Q Consensus 192 ~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------------~~~~~~~~~l~~li~~~L~~~p~~R 250 (297)
|||||++|+|+++..++... ...+...+..... ......+....+||.+||++||++|
T Consensus 363 wSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999999999977665321 1111111111100 0001122345589999999999999
Q ss_pred CCHHHHhcCcccccCcc
Q 022444 251 ITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 251 ps~~~il~~p~~~~~~~ 267 (297)
||+.++|+||||++...
T Consensus 442 ~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 442 ISAKAALAHPYFDREGL 458 (566)
T ss_pred CCHHHHhCCcCcCCCCc
Confidence 99999999999987644
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=267.70 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=215.6
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+..++++||+|.||.|.+++.. .+..||+|+.+.... ......+.+|++.|.+++||||+.++++|..++.+++++|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 4678999999999999999975 378999999987663 3346889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--c
Q 022444 88 FITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--L 163 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~--~ 163 (297)
|+..|+|.+++.++.. ...+....++.||+++++||.+.+++|+|+-+.|++++.++++|++|||.++....+.. .
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999999988743 35667788999999999999999999999999999999999999999999986654322 2
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHhhhc--------cccCCCCCCh
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA--GYLPFDELDLTTLYSKVEKA--------DFSCPTWFPV 233 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~--g~~pf~~~~~~~~~~~i~~~--------~~~~~~~~~~ 233 (297)
-...+.+.+|+|||.+...+++ .++|+|++|+++|++++ ...||...+..+..++.... -+..|.-+|.
T Consensus 696 qgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~ 774 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ 774 (807)
T ss_pred ecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence 2234567899999999888877 99999999999999766 67899988888777765332 2355677999
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
++.+++-+|+..+.++|||++++ |.+|++.
T Consensus 775 ~lyelml~Cw~~es~~RPsFe~l--h~~lq~~ 804 (807)
T KOG1094|consen 775 GLYELMLRCWRRESEQRPSFEQL--HLFLQED 804 (807)
T ss_pred HHHHHHHHHhchhhhcCCCHHHH--HHHHHHh
Confidence 99999999999999999999999 5566653
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=268.40 Aligned_cols=244 Identities=27% Similarity=0.455 Sum_probs=210.7
Q ss_pred EeEEeccCCceeEEEEEeCC----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 11 VGRTIGEGTFAKVKFAQNTE----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.++||.|-||.||.+.... ..-.||||+.+..+ +.+..+.+..|..+++.+.||||++++|++.+ +-.|+||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 44689999999999998642 23457788877655 33446788999999999999999999999854 5689999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-cc
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~ 164 (297)
|.++.|.|+.+++.+ ..++...+..++.||+.||+|||+..++|+||-..||++....-+||+|||+++....... ..
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka 549 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA 549 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc
Confidence 999999999999865 4689999999999999999999999999999999999999888899999999997765422 33
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHHh
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~ 242 (297)
.....+.-|+|||.+....++ .++|||.||++||+++. |..||.+....+.+-++.++ ++++|+.+|+.+..+..+|
T Consensus 550 S~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskc 628 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKC 628 (974)
T ss_pred cccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHH
Confidence 344457789999999888877 99999999999999766 99999999998888888777 5799999999999999999
Q ss_pred cCCCcCCCCCHHHHhc
Q 022444 243 LDPNPETRITIEEIRN 258 (297)
Q Consensus 243 L~~~p~~Rps~~~il~ 258 (297)
+..+|.+||.+.+|..
T Consensus 629 WayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 629 WAYEPSKRPRFTEIKA 644 (974)
T ss_pred hccCcccCCcHHHHHH
Confidence 9999999999988744
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=251.90 Aligned_cols=263 Identities=29% Similarity=0.451 Sum_probs=206.6
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCC----CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTET----GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS- 78 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~----~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 78 (297)
+-+..|++++.||+|.+|.||+|..+.+ .+++|||.+......+ ......-+|+.+++.++|+|++.+..++..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 4456899999999999999999976543 2368999887652211 123445689999999999999999998866
Q ss_pred CCeEEEEEcccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC----CCEEEc
Q 022444 79 RTKIYIILEFITGGELFDKIVHH-----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ----GHLKIS 149 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~----~~~~l~ 149 (297)
+.+.++++||... +|+..+.-+ ..++...+..++.||+.++.|||++=++|+|+||.||++..+ |.+|++
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 7789999999975 999888543 358999999999999999999999999999999999999988 899999
Q ss_pred ccCCCCCCCCCcccc---ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------HHHHH
Q 022444 150 DFGLSALPEQGVSLL---RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD---------LTTLY 217 (297)
Q Consensus 150 df~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---------~~~~~ 217 (297)
|+|+++....+.... ..-+-+.+|+|||.+.|....+.+.|+|+.||++.+|+|..+.|.+.. ..+..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999998776654432 223456799999999988777799999999999999999888884321 11222
Q ss_pred HHhhhc-------cc----cCCCC--------------------------CChhHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 022444 218 SKVEKA-------DF----SCPTW--------------------------FPVGAKSLIHRILDPNPETRITIEEIRNDE 260 (297)
Q Consensus 218 ~~i~~~-------~~----~~~~~--------------------------~~~~l~~li~~~L~~~p~~Rps~~~il~~p 260 (297)
++|... .. .+|+. -++...+|+.+||+.||-+|.|+++.|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 222110 00 00000 134477999999999999999999999999
Q ss_pred ccccCccc
Q 022444 261 WFRKGYVP 268 (297)
Q Consensus 261 ~~~~~~~~ 268 (297)
||.....+
T Consensus 339 yF~~d~lp 346 (438)
T KOG0666|consen 339 YFTEDPLP 346 (438)
T ss_pred ccccCCCC
Confidence 99998665
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=265.97 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=210.8
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC------CCCeeEEEEEEEc
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR------HPCVVRLHEVLAS 78 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 78 (297)
.-++|.+..-.|.|-||+|-.|.+...|..||||++..+. .+.+.-+.|+++|+++. ..++++++..|..
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3468999999999999999999999999999999998654 44455678999999995 3578889999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccCCC
Q 022444 79 RTKIYIILEFITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLS 154 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~~~ 154 (297)
.+++|+|+|... ..|.+++++.+ .+....+..++.|++-||..|..+|++|.||||+|||+.++. .+||||||.+
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 999999999985 58999998876 488899999999999999999999999999999999998755 6899999998
Q ss_pred CCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCC----
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW---- 230 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---- 230 (297)
....... .....-+-.|+|||++.|..|+ +..|+||.||+||+|.||+..|++.+..+++.-....+.++|..
T Consensus 585 ~~~~ene--itPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASENE--ITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccccc--ccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 7766532 2234456689999999999998 99999999999999999999998887666655433222222211
Q ss_pred -------------------------------------------------CC-------hhHHHHHHHhcCCCcCCCCCHH
Q 022444 231 -------------------------------------------------FP-------VGAKSLIHRILDPNPETRITIE 254 (297)
Q Consensus 231 -------------------------------------------------~~-------~~l~~li~~~L~~~p~~Rps~~ 254 (297)
+| ..+.+|+..||..||.+|.|++
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 11 3567899999999999999999
Q ss_pred HHhcCccccc
Q 022444 255 EIRNDEWFRK 264 (297)
Q Consensus 255 ~il~~p~~~~ 264 (297)
+.|.||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=238.83 Aligned_cols=251 Identities=26% Similarity=0.470 Sum_probs=205.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC--eE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRT--KI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~ 82 (297)
.+.|++++++|+|.+|.||.+.+..+.+.++||++++-. .+.+.+|+++|+.+. +|||+++.++..+.. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 568999999999999999999998899999999986543 567889999999998 999999999986543 56
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~~~~~~~~~~ 161 (297)
.+++|+++..+...+- ..++...++.++.+++.||.|.|+.||+|+|+||.|++|+... .++|+|+|++.+...+
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~- 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 186 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC-
Confidence 8999999887665543 4678889999999999999999999999999999999998754 6999999999887765
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHhhh------------------
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD-ELDLTTLYSKVEK------------------ 222 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~-~~~~~~~~~~i~~------------------ 222 (297)
...+.++.+..|.-||.+......++..|+|||||++..|+..+.||- +.+..++.-+|..
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 444566778899999999766555699999999999999999988883 3333333222200
Q ss_pred ---------c-------cccC---CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 223 ---------A-------DFSC---PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 223 ---------~-------~~~~---~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
. ++.. ...+++++.+|+.++|..|-.+|+|+.|.+.||||....
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 0 0000 111568999999999999999999999999999998653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.41 Aligned_cols=201 Identities=31% Similarity=0.550 Sum_probs=174.0
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC------e
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT------K 81 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~ 81 (297)
-+..-+.||.|+||.||+++++.+|+.||||.++... ....++..-+|++++++++|+|||+++++-+... .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4566789999999999999999999999999997654 3344677889999999999999999998764433 4
Q ss_pred EEEEEcccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC--CC--CEEEcccCCC
Q 022444 82 IYIILEFITGGELFDKIVH---HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS--QG--HLKISDFGLS 154 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~--~~--~~~l~df~~~ 154 (297)
..++||||+||||+..+.+ ..++++.+++.++.++..||.|||++||+|+||||.||++.. +| ..||+|||.+
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 6899999999999999965 457999999999999999999999999999999999999943 34 3699999999
Q ss_pred CCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~ 211 (297)
+....+. ....-+|+..|.+||.+..+.+.+...|.||+|+++|+++||..||...
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 8877664 6667889999999999986555569999999999999999999999543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=261.49 Aligned_cols=255 Identities=30% Similarity=0.549 Sum_probs=216.6
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
|..++.||-|+||.|-++....+...++.|.+.+........+.....|-++|..-.++-+|+++-.|.+++++|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 88899999999999999999999999999999877666666677788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC---------C
Q 022444 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE---------Q 159 (297)
Q Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~---------~ 159 (297)
++||++-+++.+-+-|.+..++.++..+..|+++.|+.|+||+||||+|||||.+|.+||+|||+|.-.. .
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999985211 0
Q ss_pred Cccc---------------------------------cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCC
Q 022444 160 GVSL---------------------------------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYL 206 (297)
Q Consensus 160 ~~~~---------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~ 206 (297)
+... ....+|++.|+|||++...+++ ..+|.||.|+++|+|+.|..
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCCC
Confidence 0000 1123578999999999988887 99999999999999999999
Q ss_pred CCCCCCHHHHHHHhhh----ccccCCCCCChhHHHHHHHhcCCCcCCCC---CHHHHhcCcccccC
Q 022444 207 PFDELDLTTLYSKVEK----ADFSCPTWFPVGAKSLIHRILDPNPETRI---TIEEIRNDEWFRKG 265 (297)
Q Consensus 207 pf~~~~~~~~~~~i~~----~~~~~~~~~~~~l~~li~~~L~~~p~~Rp---s~~~il~~p~~~~~ 265 (297)
||-..++.+...++.+ ..++.-..++.++.++|.+++.- ++.|. -+.++-.||||+..
T Consensus 870 pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~s-ad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 870 PFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCS-ADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcC-hhhhhcccchhhhhcCcccccc
Confidence 9977665554444322 23455566899999999887754 66665 35679999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=245.05 Aligned_cols=263 Identities=29% Similarity=0.473 Sum_probs=213.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC------C
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR------T 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 80 (297)
.||..++.+|.|+. .|-.|-|.-.+++|++|+...+ .......+...+|...+..+.|+||++++.+|... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 47899999999999 6778888889999999998766 33455567888999999999999999999998543 2
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..|+|||++.. +|.+.+. -.+.-+.+..++.|++.|+.|||+.||+|+|+||+||++..++.+|+.|||+++.....
T Consensus 95 e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 47999999975 8877776 35677889999999999999999999999999999999999999999999999887765
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-----------------
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA----------------- 223 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~----------------- 223 (297)
......+.+..|+|||++.+..+. +..||||+||++.+|++|+..|.+.+.-+.+.++...
T Consensus 172 -~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred -cccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 455677788899999999988865 9999999999999999999999877644443333111
Q ss_pred ----------cccCCCCC---------------ChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccC
Q 022444 224 ----------DFSCPTWF---------------PVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYED 276 (297)
Q Consensus 224 ----------~~~~~~~~---------------~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~ 276 (297)
...++..+ ...+++++.+||-.+|++|.|++++|+|||++-++........++
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~p 327 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPP 327 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCC
Confidence 01111111 245789999999999999999999999999996655444444333
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=247.80 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=207.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc------
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------ 78 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 78 (297)
-.+.|.-+.+||+|.||.||+|+.+.+|+.|++|++-..+-.. ..--...+++++|+.++|+|++.++++|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 3556777889999999999999999999999998764322111 112335689999999999999999887632
Q ss_pred --CCeEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 79 --RTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 79 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
...+|+|+++|.. +|.-.+.+. .+++...+..++.++..+|+|+|++.|+|+|+||.|++|+.+|.++|.|||+++
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 2358999999975 888888765 579999999999999999999999999999999999999999999999999996
Q ss_pred CCCCCcc----ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc------
Q 022444 156 LPEQGVS----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------ 225 (297)
Q Consensus 156 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------ 225 (297)
....+.. ....++-+..|++||.+.|..-.++..|||+-||+|.+|.++.+.+.+.+....+.-|.....
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 4433211 122344578999999998766666999999999999999999999977665554444322110
Q ss_pred ----------------cCCCC-------------CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 226 ----------------SCPTW-------------FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 226 ----------------~~~~~-------------~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
+.+.. -.++..+++..||..||.+|+++.++|+|.||-+.+.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 01110 12467799999999999999999999999999998776
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=270.10 Aligned_cols=247 Identities=24% Similarity=0.410 Sum_probs=218.9
Q ss_pred eEEeEEeccCCceeEEEEEeCCCC---cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
..|.++||.|.||.|+.++.+-.| ..||||.++.-. .+.....++.|..++-++.||||+++.++.....-..+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 568999999999999999988554 679999987654 334467788999999999999999999999988899999
Q ss_pred EcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
.|||.+|+|..++.. .++|+..++..+++.|+.++.||.+.|+||+||-+.|||++.+...|+.|||+++.........
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 999999999999975 4679999999999999999999999999999999999999999999999999999776554322
Q ss_pred c---cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHH
Q 022444 165 R---TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLI 239 (297)
Q Consensus 165 ~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li 239 (297)
. +..-+.+|.|||++....++ .+|||||+|++||+.++ |..||=++..++.++.|..+ +++.|-.+|..+.+|+
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLM 867 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLM 867 (996)
T ss_pred ccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHH
Confidence 2 22335799999999988887 99999999999999776 99999999999999998877 5677778999999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 022444 240 HRILDPNPETRITIEEIRN 258 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~ 258 (297)
..|+++|-.+||.+.+|++
T Consensus 868 ldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 868 LDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHhhcCCCHHHHHH
Confidence 9999999999999999976
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=255.70 Aligned_cols=272 Identities=26% Similarity=0.389 Sum_probs=223.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh----hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE-cCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII----KHKMADQIKREISIMKLVRHPCVVRLHEVLA-SRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 80 (297)
.+||-++..||+|+|+.||+|.+......|++|+-..+..+ ...+.+..-+|..+-+.+.||.||+++++|. +..
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 46888999999999999999999888899999987654433 2335566788999999999999999999996 445
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCEEecCCCCCeeec---CCCCEEEcccCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK--GVYHRDLKPENLLLD---SQGHLKISDFGLSA 155 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~--~i~h~di~~~nIli~---~~~~~~l~df~~~~ 155 (297)
.+|-|.|||+|.+|.-+++.+..+++.+++.++.||..||.||.+. .|+|.|+||.||++- ..|.+|++|||++.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 7899999999999999999999999999999999999999999876 599999999999994 34679999999998
Q ss_pred CCCCCccc-------cccccCCccccCCcccc-c--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH--h-h
Q 022444 156 LPEQGVSL-------LRTTCGTPNYVAPEVLS-H--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSK--V-E 221 (297)
Q Consensus 156 ~~~~~~~~-------~~~~~~~~~~~aPE~~~-~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~--i-~ 221 (297)
.+...... .....|+-+|.|||.+. + .+..+.+.||||+|+++|+++.|+.||...... ++++. | .
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 76543222 33456888999999974 2 333468999999999999999999999765433 23221 1 1
Q ss_pred hcc--ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCC
Q 022444 222 KAD--FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDV 277 (297)
Q Consensus 222 ~~~--~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~ 277 (297)
..+ ++..+-++.++..||++||++--.+|...-++-.||+|.-+.++....+.+..
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~gs~~~ 759 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTGSPAG 759 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccCCCcc
Confidence 222 33344489999999999999999999999999999999998888776665543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=263.14 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=217.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCC-CC--cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE-TG--ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~-~~--~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
++..+.+.||+|+||.|+++.++. +| -.|+||.+....... ....+.+|...+.+++|+|++++|++..+ ...-
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 455677899999999999999874 33 457888887654332 57889999999999999999999999876 6678
Q ss_pred EEEcccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 84 IILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+|+|.++.|+|.+-+.+ ...|....+..++.||+.|+.||.+.++||+|+-..|+++-....+|++|||+.+.++...
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999998876 3358889999999999999999999999999999999999888899999999998777654
Q ss_pred cccc---cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHH
Q 022444 162 SLLR---TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAK 236 (297)
Q Consensus 162 ~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~ 236 (297)
.... ...-+..|+|||.+....++ .++|+|++|+++|+|++ |..||.+....++++++..+ +++-|..+|+++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 4322 12235589999999988887 99999999999999999 89999999999999999755 3567788999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 237 SLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+++..||..+|.+|||+.+|.+.-+++..
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 99999999999999999999765554443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=258.24 Aligned_cols=261 Identities=18% Similarity=0.263 Sum_probs=185.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeC----------------CCCcEEEEEEeecchhhhH-H----------HHHHHHHH
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNT----------------ETGESVAMKVLDRSAIIKH-K----------MADQIKRE 57 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~----------------~~~~~~~iK~~~~~~~~~~-~----------~~~~~~~e 57 (297)
..++|++.++||+|+||.||++.+. ..+..|+||.+........ + .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4568999999999999999998752 3456799999864321110 0 01122345
Q ss_pred HHHHHhcCCCCe-----eEEEEEEEc--------CCeEEEEEcccCCCChHHHHHhcC----------------------
Q 022444 58 ISIMKLVRHPCV-----VRLHEVLAS--------RTKIYIILEFITGGELFDKIVHHG---------------------- 102 (297)
Q Consensus 58 ~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~---------------------- 102 (297)
+.++.+++|.++ +++++++.. ....++|+||+.+++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666666666544 555665532 346899999999999988886421
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-ccccccCCccccCCccc
Q 022444 103 --RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LLRTTCGTPNYVAPEVL 179 (297)
Q Consensus 103 --~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~ 179 (297)
.++...++.++.+++.+|.|||+.+++|+||||+||+++.++.++++|||++.....+.. ......+++.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 235567888999999999999999999999999999999999999999999865433211 11123346899999997
Q ss_pred cccCCC---------------------CCchhHHHHHHHHHHHHhCCC-CCCCCCHHH-----------HHHHhhhccc-
Q 022444 180 SHKGYN---------------------GAAADVWSCGVILYVLIAGYL-PFDELDLTT-----------LYSKVEKADF- 225 (297)
Q Consensus 180 ~~~~~~---------------------~~~~Di~slG~ll~~ll~g~~-pf~~~~~~~-----------~~~~i~~~~~- 225 (297)
...... ....|+||+||++++|++|.. ||....... ..........
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 543211 134799999999999999876 765422111 1111122222
Q ss_pred -cCCCCCChhHHHHHHHhcCCCc---CCCCCHHHHhcCcccccC
Q 022444 226 -SCPTWFPVGAKSLIHRILDPNP---ETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 226 -~~~~~~~~~l~~li~~~L~~~p---~~Rps~~~il~~p~~~~~ 265 (297)
.....+++...+|+.+||..+| .+|+|+.|+|+||||...
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 2234478899999999999766 789999999999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=266.20 Aligned_cols=250 Identities=30% Similarity=0.447 Sum_probs=198.1
Q ss_pred eEEeEEeccCCcee-EEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEE
Q 022444 9 YEVGRTIGEGTFAK-VKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 9 y~~~~~lg~g~~~~-v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
|...+.+|.|+.|+ ||++.. .|++||||.+-. +..+.+.+|+..++.- .||||+++++.-.+....|+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 34456788999976 888876 478999998743 3356788999999998 4999999999988889999999
Q ss_pred cccCCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---CC--CEEEcccCCCCCC
Q 022444 87 EFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QG--HLKISDFGLSALP 157 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~~--~~~l~df~~~~~~ 157 (297)
|.|.. +|.++++.... ......+.++.|+++||++||+.+|+|+|+||.||+|+. ++ +.++.|||+|+..
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99975 99999987411 122456888999999999999999999999999999976 34 6899999999887
Q ss_pred CCCcc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhccccCCCC---
Q 022444 158 EQGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLYSKVEKADFSCPTW--- 230 (297)
Q Consensus 158 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~--- 230 (297)
..+.. ......|+.+|+|||++...... .+.|||||||++|+.++| .+||... .+...+|..+.......
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEPL 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeeccC
Confidence 65433 34566789999999999876665 799999999999998885 9999753 22233444443322211
Q ss_pred CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 231 FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 231 ~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
...++.+||.+|++++|..|||+.++|.||||=..+.+..
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~ 778 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLS 778 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHH
Confidence 1127899999999999999999999999999977665543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=282.53 Aligned_cols=236 Identities=21% Similarity=0.288 Sum_probs=183.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|...+.||+|++|.||+|+++.++..|++|.+..... ....++..+++++||||+++++++.+....++||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 346667899999999999999998999999998864321 1123577889999999999999999988999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH---SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh---~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
||+++++|.+++. .+++..+..++.++++|++||| +.+++|+|++|+||+++.++..++. ++........
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999999986 4788999999999999999999 6699999999999999988877665 4433222111
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHhh---------hccc----
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD-----LTTLYSKVE---------KADF---- 225 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-----~~~~~~~i~---------~~~~---- 225 (297)
....++..|+|||++.+..++ .++||||+|+++|+|++|+.||.... ......... ....
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 123567899999999877766 89999999999999999999985321 111111100 0000
Q ss_pred cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 226 SCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 226 ~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
..+.....++.+++.+|++.+|++|||++++++
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 000011235678999999999999999999988
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=260.38 Aligned_cols=256 Identities=29% Similarity=0.470 Sum_probs=222.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|..+..+|+|.+|.||+++++.++++.++|+++.... ...+-+.+|+-+++.++|+||+.+++.+.....+|++|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 579999999999999999999999999999999986552 33566889999999999999999999998899999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|||.+|+|.+.-.-.+++++.++..+++..++++.|||+.|-+|+|||-.||++++.|.+++.|||.+............
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 99999999888777889999999999999999999999999999999999999999999999999998877766666677
Q ss_pred ccCCccccCCcccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccC-----CCCCChhHHHH
Q 022444 167 TCGTPNYVAPEVLS---HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC-----PTWFPVGAKSL 238 (297)
Q Consensus 167 ~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~l~~l 238 (297)
..|++.|+|||+-. ..++. ..+|||++|+...++-.-+.|-....+.....-..+..+.. +...++.+.+|
T Consensus 172 fiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f 250 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF 250 (829)
T ss_pred ccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence 88999999999852 23444 89999999999999988888876666555444443333322 23377899999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
++.+|.++|++|||++-+|.|||+.+..
T Consensus 251 vK~altknpKkRptaeklL~h~fvs~~l 278 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTAEKLLQHPFVSQTL 278 (829)
T ss_pred HHHHhcCCCccCCChhhheeceeeccch
Confidence 9999999999999999999999998873
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=234.13 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=209.5
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CeEE
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----TKIY 83 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 83 (297)
.+.-+.||.|+||.||.+.|.++|+.+++|++..-. .+....+.+-+|++++..++|.|++...++.... +.+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455678999999999999999999999999886432 2233356678999999999999999988876433 2467
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
++.|.+.. +|...+-+.+.++...+.-++.||+.+|.|||+.||.|+||||.|.+++.+..+|+||||+++.......
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 88888865 8888888888999999999999999999999999999999999999999999999999999987665322
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc-------------------
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA------------------- 223 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~------------------- 223 (297)
.....+-+..|+|||++.|....+.+.||||.||++.+++..+..|...++-+..+.|...
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 3444556779999999998877779999999999999999999999777665555544211
Q ss_pred ----cccCCC-----------CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 224 ----DFSCPT-----------WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 224 ----~~~~~~-----------~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
..+.|+ ....+...++..||.+||++|.+.++.+.|+++..+..
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 011111 12245678999999999999999999999999987753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=219.09 Aligned_cols=213 Identities=44% Similarity=0.785 Sum_probs=186.8
Q ss_pred eccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCCh
Q 022444 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (297)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (297)
||.|.+|.||++....+++.+++|.+....... ..+.+.+|+..++.+.|++++++++++......++++|++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654322 346788999999999999999999999888899999999998999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-CCCEEEcccCCCCCCCCCccccccccCCcc
Q 022444 95 FDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (297)
Q Consensus 95 ~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 172 (297)
.+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++++||+.+..............+...
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 9998875 57899999999999999999999999999999999999999 899999999988766544322334567789
Q ss_pred ccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCC
Q 022444 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRIT 252 (297)
Q Consensus 173 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps 252 (297)
|.+||........+.+.|+|++|++++++ ..+.+++..|++.+|++||+
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 99999987652334899999999999999 67899999999999999999
Q ss_pred HHHHhcCc
Q 022444 253 IEEIRNDE 260 (297)
Q Consensus 253 ~~~il~~p 260 (297)
++++++++
T Consensus 208 ~~~l~~~~ 215 (215)
T cd00180 208 AKEILEHL 215 (215)
T ss_pred HHHHhhCC
Confidence 99999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=252.84 Aligned_cols=250 Identities=25% Similarity=0.441 Sum_probs=212.0
Q ss_pred EEeEEeccCCceeEEEEEeCC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCe
Q 022444 10 EVGRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTK 81 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 81 (297)
++.+.||+|+||.|+.+.-.. ....||||+....... ...+.+..|+++++.+. |+|++.+.+.+...+.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 566699999999999998431 1456899988765533 44678899999999995 9999999999988889
Q ss_pred EEEEEcccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~ 145 (297)
.+++.||+..|+|.+++.+.. .++...++.++.||+.+++||++.+++|+|+-..||++..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998765 3889999999999999999999999999999999999999999
Q ss_pred EEEcccCCCCCCCCCcccc-cccc--CCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHh
Q 022444 146 LKISDFGLSALPEQGVSLL-RTTC--GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELD-LTTLYSKV 220 (297)
Q Consensus 146 ~~l~df~~~~~~~~~~~~~-~~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~-~~~~~~~i 220 (297)
+|++|||+++......... .... .+..|+|||.+....++ .++||||+|+++|++++ |..||.+.. ..++.+.+
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l 535 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFL 535 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHH
Confidence 9999999998544322211 1111 46679999999986666 99999999999999998 899998866 67777777
Q ss_pred hhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 221 EKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 221 ~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
..+. ...|..+++++.++++.|++.+|.+||++.++.+ +|..
T Consensus 536 ~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~ 578 (609)
T KOG0200|consen 536 KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK 578 (609)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence 7774 4778889999999999999999999999999977 6655
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=246.18 Aligned_cols=206 Identities=31% Similarity=0.588 Sum_probs=182.9
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHH-----HHHHHHHHHHhcC---CCCeeEEEE
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD-----QIKREISIMKLVR---HPCVVRLHE 74 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~-----~~~~e~~~l~~l~---h~~i~~~~~ 74 (297)
.++...|..++.+|.|+||.|++|.++.+...|+||++.+.......+.+ .+-.|+++|..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 46677899999999999999999999999999999999765444333322 3456899999887 999999999
Q ss_pred EEEcCCeEEEEEccc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 75 VLASRTKIYIILEFI-TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 75 ~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
+|++++++|+++|.. +|.+|++++.....+++.++..+++|++.++.+||+.||+|+|||-+|+.++.+|-++|+|||.
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 999999999999976 4689999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022444 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (297)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~ 210 (297)
+.....+ +.....|+..|.|||.+.|..|-+..-|||+||+++|.++....||.+
T Consensus 717 aa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8776653 344667999999999999999988999999999999999999999853
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=247.06 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=212.1
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCC----cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETG----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
...+-.++||+|+||+||++.+-..| -+|++|++..... .....++.+|.-.+.++.|+|++++++++..+. .
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 34566789999999999999986444 4678888876552 233567889999999999999999999997655 7
Q ss_pred EEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
-+|.+|+++|.|.++++.+ ..+-.+..+.|..||++++.|||.++++||||-+.||+|..-..+|++|||+++......
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 7899999999999999764 468889999999999999999999999999999999999999999999999998877654
Q ss_pred ccccc--ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHH
Q 022444 162 SLLRT--TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKS 237 (297)
Q Consensus 162 ~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~ 237 (297)
..... ..-++-|+|-|.+....++ .++||||+|+++|+++| |..|+.+....++-+-+..+ +++-|+.++.++..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYM 931 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHH
Confidence 44332 2345678999988877776 99999999999999998 99999999988888777666 46778889999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 022444 238 LIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+||..|+..||+++++..
T Consensus 932 ~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 932 VMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHhccCcccCccHHHHHH
Confidence 999999999999999998865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=208.69 Aligned_cols=206 Identities=23% Similarity=0.448 Sum_probs=170.1
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEEccc
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFI 89 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (297)
.+..||+|++|.|=..++..+|.-.|+|.+...-. .+..+++.+++++..+. ..|.++.+++........|++||.|
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 45679999999999999999999999999976553 33356677888877766 5899999999888888999999999
Q ss_pred CCCChH----HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 90 TGGELF----DKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 90 ~~~~L~----~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+. ||. +.++..+..++..+-+++..+..||.|||+. .++|+|+||+||+++.+|++|+||||++-.+..+.. .
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-k 205 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-K 205 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-H
Confidence 65 664 3445667799999999999999999999976 899999999999999999999999999877765422 2
Q ss_pred ccccCCccccCCccccc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhh
Q 022444 165 RTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVE 221 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~i~ 221 (297)
....|...|+|||.+.. .+|+ .++||||||+++.+|.+++.||+.+. +.+++..+.
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 34678899999999843 3444 89999999999999999999998763 444444433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=211.54 Aligned_cols=214 Identities=44% Similarity=0.754 Sum_probs=182.6
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
|.+.+.||.|+++.||.+.+..+++.+++|.+...... ...+.+.+|+..++.+.|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999765433 2457788999999999999999999999888899999999
Q ss_pred cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-ccccc
Q 022444 89 ITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SLLRT 166 (297)
Q Consensus 89 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~-~~~~~ 166 (297)
+++++|.+++..... +++..+..++.+++.++.+||+.+++|+|++|.||+++.++.++++|||.+....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999999987766 8999999999999999999999999999999999999999999999999887655432 12223
Q ss_pred ccCCccccCCccc-cccCCCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHhhhccc
Q 022444 167 TCGTPNYVAPEVL-SHKGYNGAAADVWSCGVILYVLIAGYLPFDE--LDLTTLYSKVEKADF 225 (297)
Q Consensus 167 ~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~--~~~~~~~~~i~~~~~ 225 (297)
..+...|++||.+ ....++ .++|+|+||++++++++|+.||.. .+...+.+.+..+..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred eeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 4567789999998 545555 799999999999999999999977 344466666666553
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=222.98 Aligned_cols=242 Identities=23% Similarity=0.411 Sum_probs=187.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh--cCCCCeeEEEEEEEc----CCe
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL--VRHPCVVRLHEVLAS----RTK 81 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~ 81 (297)
+..+.+.||+|.||.||++.+. |+.||||++.... .....+|.++.++ ++|+||+.+++.-.. ...
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 5889999999999999999996 7889999996543 2333455555554 489999999876532 246
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK--------GVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~--------~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
+|+|.+|.+.|||.+++.+ ..++.+..++++..++.+|++||.. .|.|+|||..||+|.+++..-++|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 8999999999999999998 6899999999999999999999963 299999999999999999999999999
Q ss_pred CCCCCCCc----cccccccCCccccCCccccccC----CCC-CchhHHHHHHHHHHHHhC----------CCCCCCC---
Q 022444 154 SALPEQGV----SLLRTTCGTPNYVAPEVLSHKG----YNG-AAADVWSCGVILYVLIAG----------YLPFDEL--- 211 (297)
Q Consensus 154 ~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~----~~~-~~~Di~slG~ll~~ll~g----------~~pf~~~--- 211 (297)
+..-.... -..+..+|+.+|+|||++...- +.+ ..+||||||+++|+++-. ..||...
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 86543331 2345778999999999985421 112 468999999999998763 3677433
Q ss_pred --CHHHHHHHhhhccc--cCCCCCC-----hhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 212 --DLTTLYSKVEKADF--SCPTWFP-----VGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 212 --~~~~~~~~i~~~~~--~~~~~~~-----~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.+++.+.+...+. ..|.... ..+..+++.|+..+|.-|.|+--|-.
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 45555555544433 3333221 34568899999999999999977643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=220.62 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=206.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE-cCC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-SRT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 80 (297)
+|++..-.+-+|.||.||.+.+.. +.+.+.+|.+.... .+-....+..|--++....|+|+..+.++.. +..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 467888889999999999997653 23445666654433 2223566778888889999999999999874 456
Q ss_pred eEEEEEcccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccC
Q 022444 81 KIYIILEFITGGELFDKIVH--------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~ 152 (297)
..++++.++.-+.|..++.- .+.++..++..++.|++.|++|||+.|++|.||-..|.+|++..++||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 77899999988999999872 2347888999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCC--ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCC
Q 022444 153 LSALPEQG--VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCP 228 (297)
Q Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~ 228 (297)
+++..-+. +........+..|++||.+.+..++ .++|+||||+++|+|+| |+.|+...++.++..-++.+. ..-|
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP 520 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence 88754332 1122233456799999999988887 99999999999999998 999999999999988888774 5667
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
-.+|+++..++--|+...|.+|||++++..
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 789999999999999999999999999854
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=224.77 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=201.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCC---CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTE---TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRT 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (297)
....|.++++||.|.|++||++.+.. ....|++|.+..... -..+.+|+++|..+. +.||+++.+.+...+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44568999999999999999999876 788999999865432 345789999999996 899999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-CCCEEEcccCCCCC-CC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSAL-PE 158 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-~~~~~l~df~~~~~-~~ 158 (297)
...+|+||.+..+..++.. .++..++..+++.++.||.++|++||+|+||||+|++.+. .++-.|+|||++.. ..
T Consensus 109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 9999999998877776654 4678999999999999999999999999999999999986 56789999999751 00
Q ss_pred CC-------------------------------------------ccccccccCCccccCCccccccCCCCCchhHHHHH
Q 022444 159 QG-------------------------------------------VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCG 195 (297)
Q Consensus 159 ~~-------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG 195 (297)
.. ........|+++|+|||++...+..+.+.||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 00011234889999999997766667899999999
Q ss_pred HHHHHHHhCCCCCCCCC--------------HHHH---------------------------H-----HHhhhccc----
Q 022444 196 VILYVLIAGYLPFDELD--------------LTTL---------------------------Y-----SKVEKADF---- 225 (297)
Q Consensus 196 ~ll~~ll~g~~pf~~~~--------------~~~~---------------------------~-----~~i~~~~~---- 225 (297)
+++..++++..||-... ...+ + ..+...+.
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999993221 0000 0 00011000
Q ss_pred --cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 226 --SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 226 --~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
...+..|..+.+++.+||..||.+|.|+++.|.||||....+-+.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~ 392 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTER 392 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhh
Confidence 011114557899999999999999999999999999996654443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=219.98 Aligned_cols=241 Identities=24% Similarity=0.291 Sum_probs=184.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHH--HHHhcCCCCeeEEEEEEEcCC----
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS--IMKLVRHPCVVRLHEVLASRT---- 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~--~l~~l~h~~i~~~~~~~~~~~---- 80 (297)
.-.++.+.||+|+||.||+|+.. ++.||||+++... .+.+.+|-+ .+-.++|+||+++++.-+...
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 34567789999999999999875 5899999997544 333334433 344568999999998765444
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCEEecCCCCCeeecCCCCEEEccc
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK---------GVYHRDLKPENLLLDSQGHLKISDF 151 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~---------~i~h~di~~~nIli~~~~~~~l~df 151 (297)
.+++|++|.+.|+|-+++.++ ..++....+++..++++|+|||+. .|+|+|||..||+|..|++..++||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 799999999999999999874 789999999999999999999973 4999999999999999999999999
Q ss_pred CCCCCCCCCcc--ccccccCCccccCCccccccCCC-----CCchhHHHHHHHHHHHHhCCCCCC---------------
Q 022444 152 GLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYN-----GAAADVWSCGVILYVLIAGYLPFD--------------- 209 (297)
Q Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~ll~~ll~g~~pf~--------------- 209 (297)
|++.....+.. ..-..+|+.+|+|||.+.+.--- -.+.||||+|+++|++++....+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99976554322 33457899999999999753211 246899999999999999654441
Q ss_pred --CCCHHHHHHHhhh--ccccCCCC-----CChhHHHHHHHhcCCCcCCCCCHHHH
Q 022444 210 --ELDLTTLYSKVEK--ADFSCPTW-----FPVGAKSLIHRILDPNPETRITIEEI 256 (297)
Q Consensus 210 --~~~~~~~~~~i~~--~~~~~~~~-----~~~~l~~li~~~L~~~p~~Rps~~~i 256 (297)
.....++...+.. .++.++.. ...-+.+.+..|+..||.-|.|+.=+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 1123333333322 23333333 23456789999999999999998744
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=207.85 Aligned_cols=254 Identities=24% Similarity=0.425 Sum_probs=193.3
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEE-EEcCCe
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEV-LASRTK 81 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~~~ 81 (297)
+..+.|.|.+.||.|.||.+-+++++++...+++|.++.+... .+.+.+|...--.+. |.||+.-+++ |+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 4567899999999999999999999999999999999876533 345666665555554 8999987764 566778
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC--CCCEEEcccCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS--QGHLKISDFGLSALPEQ 159 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~--~~~~~l~df~~~~~~~~ 159 (297)
+.+++|+++.|+|.+.+.. .++-+.....++.|+++||.|+|+.++||+|||.+||+|-. ..++||||||.++..+.
T Consensus 97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 8999999999999888765 46788999999999999999999999999999999999954 33799999998876554
Q ss_pred CccccccccCCccccCCcccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HH-HHHHhhhccccCC--
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHK----GYNGAAADVWSCGVILYVLIAGYLPFDELDL----TT-LYSKVEKADFSCP-- 228 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~----~~-~~~~i~~~~~~~~-- 228 (297)
... .......|.+||.+... -...+.+|+|.||+++|.++||+.||..... .. ..+-........|
T Consensus 176 tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 176 TVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred eeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 322 22234468888876432 1125789999999999999999999964321 11 1111111112222
Q ss_pred -CCCChhHHHHHHHhcCCCcCCC---CCHHHHhcCcccccC
Q 022444 229 -TWFPVGAKSLIHRILDPNPETR---ITIEEIRNDEWFRKG 265 (297)
Q Consensus 229 -~~~~~~l~~li~~~L~~~p~~R---ps~~~il~~p~~~~~ 265 (297)
..+++.+..++++-|+++|++| -++.......|.+..
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 2367889999999999999999 666666666666554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=243.34 Aligned_cols=199 Identities=20% Similarity=0.222 Sum_probs=142.5
Q ss_pred hcCC-CCeeEEEEEE-------EcCCeEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecC
Q 022444 63 LVRH-PCVVRLHEVL-------ASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133 (297)
Q Consensus 63 ~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di 133 (297)
.++| .||+++++.+ .....++.++|++ +++|.+++... ..+++..++.++.||++||.|||++||+|+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3344 4666666655 2234677888988 55999999753 45899999999999999999999999999999
Q ss_pred CCCCeeecCCCCEE-------------------EcccCCCCCCCCCc----------------cccccccCCccccCCcc
Q 022444 134 KPENLLLDSQGHLK-------------------ISDFGLSALPEQGV----------------SLLRTTCGTPNYVAPEV 178 (297)
Q Consensus 134 ~~~nIli~~~~~~~-------------------l~df~~~~~~~~~~----------------~~~~~~~~~~~~~aPE~ 178 (297)
||+||+++..+.++ ++|||.++...... .......+++.|+|||.
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996655544 55555443211000 00011346778999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-CCCCCChhHHHHHHHhcCCCcCCCCCHHHHh
Q 022444 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CPTWFPVGAKSLIHRILDPNPETRITIEEIR 257 (297)
Q Consensus 179 ~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~l~~li~~~L~~~p~~Rps~~~il 257 (297)
+.+..++ .++|||||||++|+|++|..|+.... .....+.....+ ...........++.+||.++|.+|||+.++|
T Consensus 187 ~~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSSN-CASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCCC-chhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 9887775 99999999999999999988875422 112222111111 1111245567899999999999999999999
Q ss_pred cCcccccC
Q 022444 258 NDEWFRKG 265 (297)
Q Consensus 258 ~~p~~~~~ 265 (297)
+||||.+.
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=193.65 Aligned_cols=159 Identities=21% Similarity=0.228 Sum_probs=127.6
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCC
Q 022444 92 GELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170 (297)
Q Consensus 92 ~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 170 (297)
|+|.+++.. ..++++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+...... ...++
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence 588888876 446999999999999999999999999 999999999999999 9987755432 22577
Q ss_pred ccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhhhccccC-------CCCCCh--hHHHHHH
Q 022444 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL-TTLYSKVEKADFSC-------PTWFPV--GAKSLIH 240 (297)
Q Consensus 171 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~-------~~~~~~--~l~~li~ 240 (297)
+.|+|||++.+..++ .++||||||+++|+|++|..||..... ......+....... +..++. ++.+++.
T Consensus 68 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 68 PYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred ccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999999888776 899999999999999999999965432 22222222221111 112333 6999999
Q ss_pred HhcCCCcCCCCCHHHHhcCccccc
Q 022444 241 RILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
+||+.+|++|||+.++++|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=228.04 Aligned_cols=261 Identities=32% Similarity=0.505 Sum_probs=207.5
Q ss_pred EEeEEeccCCceeEEEEEeCCCCcEEEEEEeec---chhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR---SAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.-.+.+|.|++|.|+.+......+.+..|.+.. ...........+..|+-+-..++|+|+......+.+.......|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356789999999888888776666666665542 11112222233666777777889999977766655555555559
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc----c
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV----S 162 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~----~ 162 (297)
|||++ +|+..+.+.+.++..++--+++|++.++.|+|+.|+.|+|+|++|++++.+|.++++|||.+....... .
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999 999999988889999999999999999999999999999999999999999999999999886544332 3
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHh-------hhccccCCCCCCh
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY--SKV-------EKADFSCPTWFPV 233 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~--~~i-------~~~~~~~~~~~~~ 233 (297)
...+..|+..|.|||.+.+..|+....||||.|+++..|.+|+.||......+.. +.. ..+..+....+|.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~ 559 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR 559 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence 3557789999999999999999989999999999999999999999665544321 111 1112233344789
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKL 271 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~ 271 (297)
..+.++.+||+++|.+|.|+++|++.+||+...++..-
T Consensus 560 ~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v~ 597 (601)
T KOG0590|consen 560 ETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHVD 597 (601)
T ss_pred hHHHHHHHHccCChhheecHHHHhhChHhhhcceEEec
Confidence 99999999999999999999999999999999888754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=194.68 Aligned_cols=267 Identities=24% Similarity=0.307 Sum_probs=204.3
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCC-cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC----CCCeeEEEEEE-EcCCe
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVR----HPCVVRLHEVL-ASRTK 81 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~ 81 (297)
+|++.+.||+|+||.||.+.+..++ +.+|+|+......... ..+..|..+++.+. ..++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998764 6788888765432111 14566777777775 26899999988 47778
Q ss_pred EEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC-----CCEEEcccCCC
Q 022444 82 IYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-----GHLKISDFGLS 154 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~-----~~~~l~df~~~ 154 (297)
.|+||+.+ |.+|.++.... +.++...+..++.|++.+|.+||+.|++|+||||.|+.+... -.+.+.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 89999998 66999888544 479999999999999999999999999999999999999765 35999999999
Q ss_pred C--CCC-CCcc----c---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc
Q 022444 155 A--LPE-QGVS----L---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD 224 (297)
Q Consensus 155 ~--~~~-~~~~----~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~ 224 (297)
+ ... .... . .....|+..|+++....+.... .+.|+||++.++.++..|..||...........+....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~-r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQG-RRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccC-CchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8 321 1111 1 1234488999999999888877 99999999999999999999997765433233222221
Q ss_pred c----c-CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCccc
Q 022444 225 F----S-CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDD 281 (297)
Q Consensus 225 ~----~-~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~~ 281 (297)
. . .....|.++..+...+-+.+...+|....+.. .+++...+.......+++|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~--~l~~~~~~~~~~~~~~~dw~~ 313 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE--LLKDVFDSEGSKEDSPFDWEV 313 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH--HHHHHHHhcCCCCCCCCcccc
Confidence 1 1 22346788888888888899999999999977 365655555555555666554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-23 Score=181.43 Aligned_cols=263 Identities=33% Similarity=0.576 Sum_probs=214.6
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCC-CeeEEEEEEEcCCeEEEEEc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP-CVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e 87 (297)
|.+.+.||.|+++.||.+.+. ..+++|.+.............+.++...+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 77899998766544443567788899999999988 79999999977777899999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccCCCCCCCCCcc-
Q 022444 88 FITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~~~~~~~~~~~- 162 (297)
++.++++.+.+.... .++......++.+++.++.++|+.|++|+|++|+||+++..+ .++++|||.+........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997777665 799999999999999999999999999999999999999988 799999998874443322
Q ss_pred -----ccccccCCccccCCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhhhcccc-CCCC
Q 022444 163 -----LLRTTCGTPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDL----TTLYSKVEKADFS-CPTW 230 (297)
Q Consensus 163 -----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~----~~~~~~i~~~~~~-~~~~ 230 (297)
......++..|++||.+.+. .......|+|++|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 23566789999999999874 3445999999999999999999999877663 4555555554433 2222
Q ss_pred CC--------hhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccc
Q 022444 231 FP--------VGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEY 274 (297)
Q Consensus 231 ~~--------~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~ 274 (297)
.. ..+.+++.+++..+|..|.+..+...+++.............
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~ 290 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccccccccc
Confidence 22 478999999999999999999999998777666544444333
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=176.49 Aligned_cols=270 Identities=21% Similarity=0.325 Sum_probs=219.9
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.|++.++||.|.||..+.+.+.-++++||||.-+... ...+++.|+...+.+. .++|..++-+...+.+-.+|+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 5999999999999999999999999999999876432 2466888999999886 699999998888888889999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-----CEEEcccCCCCCCCCC
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-----HLKISDFGLSALPEQG 160 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-----~~~l~df~~~~~~~~~ 160 (297)
|.. |.||.++..-+ ..|+...+..++.|++.-++++|+..+|++||||+|++|...+ .+.++|||.+.....+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 998 56888888644 4699999999999999999999999999999999999996544 4899999999754433
Q ss_pred cc-------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhhhccccCC--
Q 022444 161 VS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT---TLYSKVEKADFSCP-- 228 (297)
Q Consensus 161 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~-- 228 (297)
.. ......|+.+|++=.-..+...+ .+.|+-|||-++.+++-|..||.+.... +-+++|-..+...+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 22 12334578889988777777776 8999999999999999999999887544 44555544433222
Q ss_pred ---CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCcccccccc
Q 022444 229 ---TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAF 286 (297)
Q Consensus 229 ---~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (297)
..+|+++..-+.-.-..+-.+-|..+.+.. .|...-.+..-.....++|..++.+.
T Consensus 262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~--Lf~dvldr~g~t~Dg~yDW~~ln~g~ 320 (449)
T KOG1165|consen 262 VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRK--LFDDVLDRLGETDDGEYDWMGLNNGK 320 (449)
T ss_pred HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHH--HHHHHHHhcCCcccccccccccCCCC
Confidence 337899999888888888999999988766 67777777788888889998888443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=178.93 Aligned_cols=235 Identities=29% Similarity=0.365 Sum_probs=153.2
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC----------CCCeeEEEEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR----------HPCVVRLHEVLA 77 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~----------h~~i~~~~~~~~ 77 (297)
.+...+.||.|+++.||.+++..+++++++|++...........+.++++......+. |-+++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4667889999999999999999999999999997655444445666766665555432 223333333321
Q ss_pred ------------cCC-----eEEEEEcccCCCChHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHhCCCEEecC
Q 022444 78 ------------SRT-----KIYIILEFITGGELFDKIV---HHGR----LSESEARRYFQQLIDGVDYCHSKGVYHRDL 133 (297)
Q Consensus 78 ------------~~~-----~~~lv~e~~~~~~L~~~l~---~~~~----~~~~~~~~~~~~i~~al~~Lh~~~i~h~di 133 (297)
... +.+++|+-+. ++|.+++. .... ........+..|+...+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 2467777775 47766643 2222 223334556689999999999999999999
Q ss_pred CCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCccccCCccccccC-------CCCCchhHHHHHHHHHHHHhCCC
Q 022444 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG-------YNGAAADVWSCGVILYVLIAGYL 206 (297)
Q Consensus 134 ~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~~Di~slG~ll~~ll~g~~ 206 (297)
+|+|++++.+|.++|+||+.....+..... ...+..|.|||...... ..+.+.|.|+||+++|.+.++..
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999999876655543221 33446799999764321 12488999999999999999999
Q ss_pred CCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCC
Q 022444 207 PFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETR 250 (297)
Q Consensus 207 pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~R 250 (297)
||+.......... .-..+. .+|+.++.+|..||+++|.+|
T Consensus 249 Pf~~~~~~~~~~~---~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW---DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG---GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc---cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9986644322221 111333 689999999999999999988
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=168.60 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=200.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCeEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 84 (297)
-+.|+++++||+|+||.+|++..-.+|+.||||+-....- -..+..|..+.+.+++ .+|+.+.-++.+..+-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 4689999999999999999999999999999998754331 1335567777777764 788888888888888999
Q ss_pred EEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC---CCEEEcccCCCCCCCCC
Q 022444 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQG 160 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~---~~~~l~df~~~~~~~~~ 160 (297)
||+.. |.||.++..- ...++...++-++-|++.-++|+|..+++|+||||+|+++.-+ ..+.|+|||++......
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99998 5688877763 4579999999999999999999999999999999999999643 46999999999754332
Q ss_pred cc-------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhhhccccCC--
Q 022444 161 VS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT---LYSKVEKADFSCP-- 228 (297)
Q Consensus 161 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~-- 228 (297)
.. ......|+.+|.+-.+..+...+ .+.|+-|+|.++.++--|..||.+..... -+++|...+...+
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 22 22334577788887777666655 88999999999999999999998876544 3444444443332
Q ss_pred ---CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCc
Q 022444 229 ---TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNL 279 (297)
Q Consensus 229 ---~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~ 279 (297)
...|.++...+.-|-..--.+-|....+-+ .|+--.+..+..-.--++|
T Consensus 247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrq--lFriLfr~ln~~~d~iyDW 298 (341)
T KOG1163|consen 247 VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQ--LFRILFRTLNHQYDYIYDW 298 (341)
T ss_pred HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHH--HHHHHHhhccccCCeEeeH
Confidence 337888888888888877777787765543 3333333444443333444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=181.31 Aligned_cols=166 Identities=22% Similarity=0.250 Sum_probs=127.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCC-CCcEEEEEEeecchh--hhHHHHHHHHHHHHHHHhcCCCCeeE-EEEEEEcCC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTE-TGESVAMKVLDRSAI--IKHKMADQIKREISIMKLVRHPCVVR-LHEVLASRT 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~ 80 (297)
..++|.+.+.||+|+||+||+|+++. +++.++||....... ........+.+|+.+++.+.|+|+++ +++. .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 46789999999999999999999876 677789998653211 12234566899999999999999985 4432 4
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecC-CCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL-KPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di-~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
..|++|||+.|++|.. .. +.. ...++.+++++|.|||+.||+|+|| ||+||+++.++.++|+|||+++....
T Consensus 92 ~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 5799999999998863 21 111 2467889999999999999999999 99999999999999999999876543
Q ss_pred Ccccc--------ccccCCccccCCccccc
Q 022444 160 GVSLL--------RTTCGTPNYVAPEVLSH 181 (297)
Q Consensus 160 ~~~~~--------~~~~~~~~~~aPE~~~~ 181 (297)
..... ....++..|++||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 32111 12345667899998743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-25 Score=198.98 Aligned_cols=242 Identities=34% Similarity=0.614 Sum_probs=206.5
Q ss_pred eccCCceeEEEEEeC---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEEEcccC
Q 022444 15 IGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 15 lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
+|.|++|.|++++.. ..|.-+++|+..+......... ....+-.++..+. |+.+++++-.++.+...+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 689999999987643 4567788887765443333222 3445666667776 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCC
Q 022444 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170 (297)
Q Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 170 (297)
+++|...+.....+.+.....+...++-++.++|+.|++|+|+|++||+++.+|.+++.|||.++....... .+|+
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~cgt 156 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACGT 156 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----cccc
Confidence 999999888888889999999999999999999999999999999999999999999999999876544322 2789
Q ss_pred ccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCC
Q 022444 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETR 250 (297)
Q Consensus 171 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~R 250 (297)
..|+|||++. +.. ...|.||+|+++++|++|..||.. +....|...++.+|..++..+++++.+++..+|..|
T Consensus 157 ~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 157 YEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred hhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence 9999999997 333 899999999999999999999987 778888888899999999999999999999999999
Q ss_pred CCH-----HHHhcCcccccCccc
Q 022444 251 ITI-----EEIRNDEWFRKGYVP 268 (297)
Q Consensus 251 ps~-----~~il~~p~~~~~~~~ 268 (297)
.-. .++.+|+||+.....
T Consensus 230 Lg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 230 LGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred hccCcchhHHHhccchheeeeHh
Confidence 866 799999999987544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=171.65 Aligned_cols=173 Identities=16% Similarity=0.187 Sum_probs=133.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHH------HHHHHHHHHhcCCCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ------IKREISIMKLVRHPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (297)
.++|++++.||.|+||.||++.+ ++..+++|.+.......+..... +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 46899999999999999999766 36679999997655444444333 57899999999999999998876532
Q ss_pred --------CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEccc
Q 022444 80 --------TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (297)
Q Consensus 80 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df 151 (297)
...+++|||++|.+|.+... +++ ....+++.++..+|+.|++|||++|+||+++.+| ++++||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35789999999999977632 222 3456999999999999999999999999999988 999999
Q ss_pred CCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHH
Q 022444 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLI 202 (297)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll 202 (297)
|............ . ......+. .++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~d-------~-----~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD-------R-----IDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH-------H-----HHHHhHhc-ccccccceeEeehHHH
Confidence 9765443221110 0 22334455 7899999999987764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=164.49 Aligned_cols=144 Identities=24% Similarity=0.304 Sum_probs=112.1
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHH-----------------------HHHHHHHHHHHHHhcCCCC
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-----------------------MADQIKREISIMKLVRHPC 68 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~~ 68 (297)
.+.||+|++|.||.|.+. +|++||+|+++........ .......|+..++.+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999999754211100 0123345889999998777
Q ss_pred eeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCEEecCCCCCeeecCCCCEE
Q 022444 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC-HSKGVYHRDLKPENLLLDSQGHLK 147 (297)
Q Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~L-h~~~i~h~di~~~nIli~~~~~~~ 147 (297)
+.....+... ..+++|||++++++.....+..+++...+..++.+++.+|.++ |+.|++|+||||+||+++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6443332222 2389999999877766555557899999999999999999999 799999999999999998 57899
Q ss_pred EcccCCCCCCCC
Q 022444 148 ISDFGLSALPEQ 159 (297)
Q Consensus 148 l~df~~~~~~~~ 159 (297)
|+|||++.....
T Consensus 158 LiDFG~a~~~~~ 169 (190)
T cd05147 158 IIDVSQSVEHDH 169 (190)
T ss_pred EEEccccccCCC
Confidence 999999875443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-24 Score=199.57 Aligned_cols=238 Identities=25% Similarity=0.389 Sum_probs=178.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecch-hhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA-IIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.|..++.||++.|=.|.++++. .|. |+||++-... ....+...+...+++ ....++||.+++.-+-..+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888999999999999999875 455 9999986533 222233344445555 55668999999887766666778888
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCC--CCCCccc-
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL--PEQGVSL- 163 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~--~~~~~~~- 163 (297)
+|+.. +|.+.+....-+..-+.+.++.|++.||...|+.||+|||||.+||+|+.=.=+.|+||...+- ....+..
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 89865 8999888777788889999999999999999999999999999999997655589999986532 2222111
Q ss_pred ----cccccCCccccCCccccccC---------C-CCCchhHHHHHHHHHHHHh-CCCCCCCC-----------CHHHHH
Q 022444 164 ----LRTTCGTPNYVAPEVLSHKG---------Y-NGAAADVWSCGVILYVLIA-GYLPFDEL-----------DLTTLY 217 (297)
Q Consensus 164 ----~~~~~~~~~~~aPE~~~~~~---------~-~~~~~Di~slG~ll~~ll~-g~~pf~~~-----------~~~~~~ 217 (297)
........+|+|||.+.... . -+++-||||+||+++||++ |.+||+-. +++...
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L 259 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL 259 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH
Confidence 11223445899999974311 1 1478899999999999877 78898432 222223
Q ss_pred HHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 218 SKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 218 ~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
++|. +..++++|..|++.||++|.|+++.|+.
T Consensus 260 e~Ie----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 260 EKIE----------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhCc----------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 3222 3467999999999999999999999983
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=169.27 Aligned_cols=241 Identities=19% Similarity=0.323 Sum_probs=191.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++..+..+|.....|..|++++.++ .++.|++..... +......+..|.-.++-+.||||+.+++.|....++.++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 3445667889999999999999754 477777765442 3344566778888899999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeecCCCCEEEc--ccCCCCCCCCC
Q 022444 87 EFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKIS--DFGLSALPEQG 160 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~~~~~~~l~--df~~~~~~~~~ 160 (297)
.|++.++|.+.+..... ....++.+++.+++.+++|||+.. |----++...++||++.+.++. |-.++.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----- 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----- 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----
Confidence 99999999999987654 578899999999999999999975 3344678889999988765443 332221
Q ss_pred ccccccccCCccccCCccccccCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--hhccccCCCCCChhHH
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYN--GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV--EKADFSCPTWFPVGAK 236 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~l~ 236 (297)
+..+..-.+.|++||.+...+-+ -.++|+|||++++|++.|...||....+.+.--++ ...+...|+.++..+.
T Consensus 342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~ 419 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN 419 (448)
T ss_pred --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence 12244557899999998654333 36899999999999999999999998877654444 4445678889999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHh
Q 022444 237 SLIHRILDPNPETRITIEEIR 257 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il 257 (297)
.+++-|++.||.+||.+..|+
T Consensus 420 klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 420 KLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999998773
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-23 Score=175.55 Aligned_cols=190 Identities=25% Similarity=0.418 Sum_probs=143.2
Q ss_pred CCCCeeEEEEEEE---------------------------cCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 022444 65 RHPCVVRLHEVLA---------------------------SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI 117 (297)
Q Consensus 65 ~h~~i~~~~~~~~---------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 117 (297)
+||||+++.++|. ....+|+||...+ .+|+.++..+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 5999999987662 2345899999886 4999988764 456677788899999
Q ss_pred HHHHHHHhCCCEEecCCCCCeeec--CCC--CEEEcccCCCCCCCCC------ccccccccCCccccCCccccccC----
Q 022444 118 DGVDYCHSKGVYHRDLKPENLLLD--SQG--HLKISDFGLSALPEQG------VSLLRTTCGTPNYVAPEVLSHKG---- 183 (297)
Q Consensus 118 ~al~~Lh~~~i~h~di~~~nIli~--~~~--~~~l~df~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~---- 183 (297)
+|+.|||++|+.|+|+|.+||++. +|+ .+.+.|||++-..... .+.....-|+-..+|||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999994 333 4789999986433221 12223344677899999975321
Q ss_pred -CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--hhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHH
Q 022444 184 -YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV--EKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEI 256 (297)
Q Consensus 184 -~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~i 256 (297)
.+-.++|.|+.|.+.|++++...||.+.....+-.+- ...-+.+++.+|+.+++++..+|+.||++|+|++-.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 1136899999999999999999999764322221111 222356788899999999999999999999997643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=189.00 Aligned_cols=235 Identities=21% Similarity=0.305 Sum_probs=180.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
...|.|.+.||.|++|.||.|...+ |+.||+|+-...+.+.-....+++..++ . .--+.|..+...+.-.+.-+++
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~--~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-P--QMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-h--hhhcchHHHHHHHccCCcceee
Confidence 3469999999999999999999876 9999999998887666555555555444 1 1134555555555555667899
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-------CCCEEEcccCCCCCCC
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-------QGHLKISDFGLSALPE 158 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-------~~~~~l~df~~~~~~~ 158 (297)
++|.+.|+|.+++...+.+++..+..++.+++..+..||.++||||||||+|+++.. ..-++|+|||.+..+.
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999999999999998889999999999999999999999999999999999999942 2359999999987543
Q ss_pred --CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-ccCCCCCC---
Q 022444 159 --QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFP--- 232 (297)
Q Consensus 159 --~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~--- 232 (297)
.........+++..+-.+|...|..|+ ++.|.|+|+.+++.|+.|++. + ..++. ......++
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~----------q-~~~g~~~~~~~~~~Ry~ 920 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM----------E-VKNGSSWMVKTNFPRYW 920 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH----------H-hcCCcceeccccchhhh
Confidence 223456678889999999999999998 999999999999999999744 1 22221 11111122
Q ss_pred --hhHHHHHHHhcCCCcCCCCCHHHH
Q 022444 233 --VGAKSLIHRILDPNPETRITIEEI 256 (297)
Q Consensus 233 --~~l~~li~~~L~~~p~~Rps~~~i 256 (297)
+-+..|+..+|+.|-..=|...++
T Consensus 921 ~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 921 KRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred hHHHHHHHHHHHhCcCcccchhHHHH
Confidence 335688999999554444444443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-21 Score=156.76 Aligned_cols=145 Identities=22% Similarity=0.279 Sum_probs=113.7
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh-----------------------HHHHHHHHHHHHHHHhcCCC
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-----------------------HKMADQIKREISIMKLVRHP 67 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~h~ 67 (297)
+.+.||+|++|+||+|.+. +|+.|+||+++...... .........|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987542110 00122346788999999888
Q ss_pred CeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCE
Q 022444 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHL 146 (297)
Q Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~ 146 (297)
++.....+... ..+++|||++|+++........+++......++.+++.++.++|+ .|++|+||||+||+++ ++.+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 87544443322 248999999987654443344678889999999999999999999 9999999999999998 8899
Q ss_pred EEcccCCCCCCCC
Q 022444 147 KISDFGLSALPEQ 159 (297)
Q Consensus 147 ~l~df~~~~~~~~ 159 (297)
+|+|||.+.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=182.58 Aligned_cols=239 Identities=31% Similarity=0.577 Sum_probs=178.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|..++.|..|++|.||+++++.+.+++++| ++..+. +.+. ++....+|.++
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------hhhc--cccccCCccee----------------
Confidence 46899999999999999999999999999994 433221 1111 12222233222
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc----
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---- 162 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~---- 162 (297)
|+-...+++.++++... +.+++|||+.||+|+|++|+|.+|+.=|.+|++|||++........
T Consensus 136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 45556666655655444 7889999999999999999999999999999999999764322111
Q ss_pred -----------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC---
Q 022444 163 -----------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP--- 228 (297)
Q Consensus 163 -----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 228 (297)
....-++++.|+|||++.-.+|. ...|.|+||+++|+++-|+.||.+.+++++...+.......+
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d 281 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED 281 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence 12234789999999999888887 899999999999999999999999999998877766654433
Q ss_pred CCCChhHHHHHHHhcCCCcCCCC---CHHHHhcCcccccCccc---cccccccCCCcccccccc
Q 022444 229 TWFPVGAKSLIHRILDPNPETRI---TIEEIRNDEWFRKGYVP---VKLIEYEDVNLDDVNAAF 286 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rp---s~~~il~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 286 (297)
..++.++++++.++|..+|..|. .+-++-+|+||+.---. +.-.++-+..++..+..+
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsy 345 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSY 345 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchh
Confidence 33789999999999999999985 56678889999976554 333444444444444433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-20 Score=148.32 Aligned_cols=187 Identities=16% Similarity=0.182 Sum_probs=138.5
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHH-HHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEEE
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~-~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.+...|++|+||+|+.+.. .+.+++.+.+.......... ...+.+|+++++++. ++++++++++ ...+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45778999999999997765 67888888776655432222 224789999999996 5889999886 3469999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecC-CCCCeeecCCCCEEEcccCCCCCCCCCccc--
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL-KPENLLLDSQGHLKISDFGLSALPEQGVSL-- 163 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di-~~~nIli~~~~~~~l~df~~~~~~~~~~~~-- 163 (297)
+|+.|.+|.+.... ....++.+++.+|.++|+.|++|+|| +|+||+++.++.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999888654321 12457789999999999999999999 799999999999999999999754433211
Q ss_pred --c---------ccccCCccccCCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 022444 164 --L---------RTTCGTPNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIAGYLPF 208 (297)
Q Consensus 164 --~---------~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf 208 (297)
. .....++.+.+|+...-. ..+-.+.+.++.|+-+|.++|+..+.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 011135566666654322 11126778899999999999998876
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=150.24 Aligned_cols=147 Identities=19% Similarity=0.254 Sum_probs=115.4
Q ss_pred ceEEeEEeccCCceeEEEEE-eCCCCcEEEEEEeecchhh---------------------hHHHHHHHHHHHHHHHhcC
Q 022444 8 KYEVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAII---------------------KHKMADQIKREISIMKLVR 65 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~iK~~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~ 65 (297)
-|++.+.||.|++|.||.|. +..+|++|++|++...... .......+..|+..++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37899999999999999999 6678999999998753210 0011234578999999997
Q ss_pred CC--CeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CEEecCCCCCeeecC
Q 022444 66 HP--CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG-VYHRDLKPENLLLDS 142 (297)
Q Consensus 66 h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~-i~h~di~~~nIli~~ 142 (297)
+. .++++++. ...++|||++.+.+|.........+....+..++.+++.++.+||+.| ++|+||+|+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34455543 234899999999888766544456667778899999999999999999 99999999999998
Q ss_pred CCCEEEcccCCCCCCCC
Q 022444 143 QGHLKISDFGLSALPEQ 159 (297)
Q Consensus 143 ~~~~~l~df~~~~~~~~ 159 (297)
++.++|+|||.+.....
T Consensus 184 ~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCEEEEEChhhhccCC
Confidence 88999999998764443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.9e-19 Score=142.51 Aligned_cols=134 Identities=17% Similarity=0.209 Sum_probs=105.3
Q ss_pred EEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-----CCCCeeEEEEEEEcCC---e
Q 022444 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-----RHPCVVRLHEVLASRT---K 81 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~ 81 (297)
.-.+.||+|+++.||. ++.++.. +||++..... ...+.+.+|+..++.+ .||||++++++++++. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 3457899999999995 7767665 6998865431 1245688999999999 5799999999998764 3
Q ss_pred -EEEEEcc--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCEEecCCCCCeeecCC----CCEEEcccC
Q 022444 82 -IYIILEF--ITGGELFDKIVHHGRLSESEARRYFQQLIDGV-DYCHSKGVYHRDLKPENLLLDSQ----GHLKISDFG 152 (297)
Q Consensus 82 -~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al-~~Lh~~~i~h~di~~~nIli~~~----~~~~l~df~ 152 (297)
+.+|+|| +.+++|.+++++. .+++. ..++.+++.++ .|||+++|+|+||||+||+++.. +.++|+|++
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3378999 5578999999763 56555 35677877777 99999999999999999999743 379999944
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.1e-19 Score=157.22 Aligned_cols=198 Identities=26% Similarity=0.394 Sum_probs=158.6
Q ss_pred HHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC-EEecCCCCCe
Q 022444 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGV-YHRDLKPENL 138 (297)
Q Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i-~h~di~~~nI 138 (297)
++.+.|.|+.++++.+.++...+.|.++|..|+|.+.+.+ ..+++......++++++.+|.|||...| +||.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3567899999999999999999999999999999999987 4568888999999999999999998865 9999999999
Q ss_pred eecCCCCEEEcccCCCCCCCC--CccccccccCCccccCCccccccCC------CCCchhHHHHHHHHHHHHhCCCCCCC
Q 022444 139 LLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVLSHKGY------NGAAADVWSCGVILYVLIAGYLPFDE 210 (297)
Q Consensus 139 li~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Di~slG~ll~~ll~g~~pf~~ 210 (297)
+++....+|++|||+...... .............|.|||.+.+... .+.+.||||+|++++++++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999998776542 1111112224558999999876321 24779999999999999999999966
Q ss_pred C----CHHHHHHHhhh-ccccCCC------CCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 211 L----DLTTLYSKVEK-ADFSCPT------WFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 211 ~----~~~~~~~~i~~-~~~~~~~------~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
. .+.++...+.. +..++-+ ..++++..++..|+..+|.+||+++.+-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 3 23456666665 3222211 24567899999999999999999999854
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.8e-18 Score=139.50 Aligned_cols=138 Identities=25% Similarity=0.326 Sum_probs=113.5
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh-----hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++.||+|++|.||.+.+ .|..+++|........ .......+.+|+..+..+.|+++.....++......+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 5678999986543211 1112345778999999999988877776666677889999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCC
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~ 156 (297)
||++|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998865422 8889999999999999999999999999999998 78899999998765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=135.16 Aligned_cols=140 Identities=20% Similarity=0.307 Sum_probs=108.5
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH-------------------HHHHHHHHHHHHHHhcCCC--
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH-------------------KMADQIKREISIMKLVRHP-- 67 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~h~-- 67 (297)
|.+.+.||+|++|.||.+.+. +|+.++||++........ ........|+..+..+.+.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999875 799999998764321000 0112356788888888776
Q ss_pred CeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEE
Q 022444 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (297)
Q Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~ 147 (297)
.++..++. ...+++|||+++++|.+.... .....++.+++.++.++|+.|++|+||+|.||+++.++.++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 34444432 345899999999888765431 34667889999999999999999999999999999999999
Q ss_pred EcccCCCCCCCC
Q 022444 148 ISDFGLSALPEQ 159 (297)
Q Consensus 148 l~df~~~~~~~~ 159 (297)
|+|||.+.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999998865444
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-17 Score=133.54 Aligned_cols=133 Identities=20% Similarity=0.266 Sum_probs=105.3
Q ss_pred EeccCCceeEEEEEeCCCCcEEEEEEeecchhh-----hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 14 TIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
.||+|++|.||++.. +|..+++|........ .......+.+|++.++.+.++++....-++......+++||+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999985 5678999986543211 112235677899999999887665444444455667899999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCC
Q 022444 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (297)
Q Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~ 156 (297)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887754321 8889999999999999999999999999998 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.1e-17 Score=146.85 Aligned_cols=219 Identities=18% Similarity=0.276 Sum_probs=160.5
Q ss_pred EEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCC
Q 022444 25 FAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRL 104 (297)
Q Consensus 25 ~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 104 (297)
.+..+.++.++.|++....+. .....+.+.++.++.++||||+++++.++...++|+|.|.+. .|..++++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 356677899999999877653 445667889999999999999999999999999999999995 6666776543
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCccccCCccccccC
Q 022444 105 SESEARRYFQQLIDGVDYCH-SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183 (297)
Q Consensus 105 ~~~~~~~~~~~i~~al~~Lh-~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 183 (297)
...+...+.||+.||.+|| +++++|||++-+.|+++.+|.++|++|.++.....-............|..|+.+....
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence 6678888899999999997 67899999999999999999999999998765544333334445555778887654332
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHH-----hc
Q 022444 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEI-----RN 258 (297)
Q Consensus 184 ~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~i-----l~ 258 (297)
...|.|.||+++++++.|..+- .........+|.....+..+-+.-.+..||..... +-
T Consensus 182 ---~s~D~~~Lg~li~el~ng~~~~-------------~~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~ 245 (690)
T KOG1243|consen 182 ---WSIDSWGLGCLIEELFNGSLLT-------------KTDLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRLL 245 (690)
T ss_pred ---cchhhhhHHHHHHHHhCcccCc-------------chhhhccCccchhHHHHHHHHhccccccccchhhHHHHHHhc
Confidence 4679999999999999983321 11122233345444455544444445555553333 34
Q ss_pred CcccccCcc
Q 022444 259 DEWFRKGYV 267 (297)
Q Consensus 259 ~p~~~~~~~ 267 (297)
|+||++...
T Consensus 246 ~gff~n~fv 254 (690)
T KOG1243|consen 246 GGFFRNDFV 254 (690)
T ss_pred cccccchHH
Confidence 777777643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-18 Score=152.93 Aligned_cols=177 Identities=26% Similarity=0.427 Sum_probs=136.7
Q ss_pred CeEEEEEcccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~ 156 (297)
.++|+.|++|...+|.+++.+.. ..+....+.++.|++.++.| .|.+|+|++|.||+...+..++++|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 46899999999999999997543 36778899999999999999 9999999999999999999999999998765
Q ss_pred CCCCc------cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhccccCCC
Q 022444 157 PEQGV------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLYSKVEKADFSCPT 229 (297)
Q Consensus 157 ~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~ 229 (297)
..... .......|+..|++||++.+..+. .+.||||||+++++++.- ...+. .......+..+..+...
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChHH
Confidence 54332 234567899999999999999988 999999999999999871 22221 11222333333333111
Q ss_pred CC-ChhHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 230 WF-PVGAKSLIHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 230 ~~-~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
.. -++-..|+.+||...|.+||++.+.--|+|++
T Consensus 482 ~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 482 LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 11 13345899999999999999888877777753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-19 Score=165.81 Aligned_cols=258 Identities=35% Similarity=0.579 Sum_probs=206.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCC-cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 83 (297)
...|.+.+.||.|+++.|-.+....+. ..++.|.+.... ...........+..+-+.+. |.|++..++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 457999999999999999888875433 344555554333 23333445556777777777 999999999999999999
Q ss_pred EEEcccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCEEecCCCCCeeecCCC-CEEEcccCCCCCCCC
Q 022444 84 IILEFITGGELFDKI-VHHG-RLSESEARRYFQQLIDGVDYCH-SKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQ 159 (297)
Q Consensus 84 lv~e~~~~~~L~~~l-~~~~-~~~~~~~~~~~~~i~~al~~Lh-~~~i~h~di~~~nIli~~~~-~~~l~df~~~~~~~~ 159 (297)
+..++..|+++.+.+ .... ..+......++.++..++.|+| ..++.|+|++|+|.+++.++ .++..|||++.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999888 5554 6788889999999999999999 99999999999999999999 999999999875443
Q ss_pred ---CccccccccC-CccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-hhc----cccCCCC
Q 022444 160 ---GVSLLRTTCG-TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV-EKA----DFSCPTW 230 (297)
Q Consensus 160 ---~~~~~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i-~~~----~~~~~~~ 230 (297)
.........| ++.|.|||...+..+..+..|+||.|+++..+++|..|+......+....- ... .......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 2223445667 899999999988777779999999999999999999999765544322111 111 1333444
Q ss_pred CChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 231 FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 231 ~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
++....+++.+++..+|+.|.+.+++-.+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7788899999999999999999999999999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=9e-17 Score=148.90 Aligned_cols=139 Identities=19% Similarity=0.264 Sum_probs=110.9
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecch-----hhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA-----IIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.|...+.||+|++|.||++..... .+++|+..... .........+.+|++.++.+.|++++....+.......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 345678999999999999987543 34444432211 11122245678999999999999998877777666778
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCC
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~ 157 (297)
+++|||+++++|.+++. ....++.+++.+|.+||+.|++|+|++|+||++ .++.++++|||.+...
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999988775 457789999999999999999999999999999 6788999999988754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=128.35 Aligned_cols=140 Identities=24% Similarity=0.351 Sum_probs=99.0
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHH---------------------HHHHHHHHHHhcCCC--C
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD---------------------QIKREISIMKLVRHP--C 68 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~---------------------~~~~e~~~l~~l~h~--~ 68 (297)
.+.||+|++|+||.+.+. ++++|+||++............ ....+...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999987 8899999998753221111111 113455555555433 3
Q ss_pred eeEEEEEEEcCCeEEEEEcccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCE
Q 022444 69 VVRLHEVLASRTKIYIILEFITGGELFD-KIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHL 146 (297)
Q Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~ 146 (297)
+.++++. ...+++|||++++.+.. .+... .. ......++.+++.++.++|+ .|++|+||+|+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4555543 24589999999844321 11111 11 16788999999999999999 9999999999999999 8899
Q ss_pred EEcccCCCCCCCC
Q 022444 147 KISDFGLSALPEQ 159 (297)
Q Consensus 147 ~l~df~~~~~~~~ 159 (297)
+++|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999998864443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-15 Score=125.34 Aligned_cols=137 Identities=24% Similarity=0.362 Sum_probs=103.8
Q ss_pred EEec-cCCceeEEEEEeCCCCcEEEEEEeecchh----------hhHHHHHHHHHHHHHHHhcCCCCe--eEEEEEEEcC
Q 022444 13 RTIG-EGTFAKVKFAQNTETGESVAMKVLDRSAI----------IKHKMADQIKREISIMKLVRHPCV--VRLHEVLASR 79 (297)
Q Consensus 13 ~~lg-~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 79 (297)
..|| .|+.|+||.+... +..+++|.+..... .+......+.+|+.++..+.|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4676 8899999998874 67899998853221 011223567889999999998775 6666654322
Q ss_pred -C---eEEEEEcccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 80 -T---KIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 80 -~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
. ..++|+|+++| .+|.+++.. .++++.. +.+++.++.+||+.||+|+||+|.||+++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23599999997 688887764 3455443 568999999999999999999999999999899999999987
Q ss_pred CC
Q 022444 155 AL 156 (297)
Q Consensus 155 ~~ 156 (297)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.8e-15 Score=115.38 Aligned_cols=132 Identities=23% Similarity=0.311 Sum_probs=110.3
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCeEEEEEcc
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH--PCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
+++.|++|.++.||.+.... ..+++|....... ...+.+|...++.+.+ ..+++++.+....+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 56889999999999999854 6799998865432 3457788888888876 5888998888777889999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CCEEecCCCCCeeecCCCCEEEcccCCCCC
Q 022444 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK---GVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (297)
Q Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~---~i~h~di~~~nIli~~~~~~~l~df~~~~~ 156 (297)
+.+.++... +......++.++++++..+|.. +++|+|++|+||++++.+.++++||+.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998777543 4567788899999999999985 699999999999999989999999997663
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-16 Score=140.46 Aligned_cols=251 Identities=19% Similarity=0.179 Sum_probs=191.6
Q ss_pred ceEEeEEecc--CCceeEEEEEe--CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeE
Q 022444 8 KYEVGRTIGE--GTFAKVKFAQN--TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKI 82 (297)
Q Consensus 8 ~y~~~~~lg~--g~~~~v~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 82 (297)
+|.+.+.+|. |.+|.||.+.. ..++..+++|.-....... .....-.+++...+.+. |++.++.+..++..+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-LDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc-cccccccchhhcccccCccccccccCcccccCCcc
Confidence 4678888999 99999999998 7889999999854332111 11222335666666664 89999988889999999
Q ss_pred EEEEcccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCCEEecCCCCCeeecCC-CCEEEcccCCCCC
Q 022444 83 YIILEFITGGELFDKIVHHGR-LSESEARRYFQQLID----GVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSAL 156 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~----al~~Lh~~~i~h~di~~~nIli~~~-~~~~l~df~~~~~ 156 (297)
|+-.|.+. .+|.++...... ++...++..+.+..+ |+.++|+.+++|.+++|.||+...+ ...+++||+....
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 99999996 588777765544 899999999999999 9999999999999999999999999 7899999999877
Q ss_pred CCCCccccccc-----cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhhhccccCCC
Q 022444 157 PEQGVSLLRTT-----CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL--DLTTLYSKVEKADFSCPT 229 (297)
Q Consensus 157 ~~~~~~~~~~~-----~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~ 229 (297)
...+....... .+...|++||...+. .+...|+|+||.++.+..++....... +........... ..+-.
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip-~e~~~ 349 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP-LEFCE 349 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc-hhhhc
Confidence 66554332222 677899999998654 348999999999999988876665433 111111111111 11122
Q ss_pred CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 230 WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 230 ~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
..+.++...+..|++.+|..|++++.+++|+++.
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 2455667799999999999999999999999987
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-15 Score=124.13 Aligned_cols=207 Identities=14% Similarity=0.221 Sum_probs=145.9
Q ss_pred HHHHHHHhcCCCCeeEEEEEEEc-----CCeEEEEEcccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022444 56 REISIMKLVRHPCVVRLHEVLAS-----RTKIYIILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSK 126 (297)
Q Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~~ 126 (297)
.-...+-.+.|.|+++++.++.+ .....++.||+..+++.+++++. ..++.....+|+.||+.||+|||++
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 33445556679999999988843 34578999999999999988653 3578888999999999999999999
Q ss_pred C--CEEecCCCCCeeecCCCCEEEcccCCCCCCCC----CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHH
Q 022444 127 G--VYHRDLKPENLLLDSQGHLKISDFGLSALPEQ----GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYV 200 (297)
Q Consensus 127 ~--i~h~di~~~nIli~~~~~~~l~df~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ 200 (297)
. |+||++.-+.|++..+|-++++.-.....-.. .........+.++|.+||.=...+.. -.+|||++|+...+
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~-~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTT-GASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccc-cchhhhhhhHHHHH
Confidence 5 99999999999999888887764332211110 00111233457789999875444444 78999999999999
Q ss_pred HHhCCCCCCCC-CHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 201 LIAGYLPFDEL-DLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 201 ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
|..+..--.+. .....-..+.+...-.. ..--+.++..||+..|..||++++++.||.+=+..
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 98876543222 22222222222211111 12225789999999999999999999999876554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.7e-13 Score=123.37 Aligned_cols=142 Identities=21% Similarity=0.330 Sum_probs=95.9
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH---------------------------H----HHH------HH
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---------------------------K----MAD------QI 54 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---------------------------~----~~~------~~ 54 (297)
.+.||+|++|+||+|+.+ +|+.||||+.+..-...- . ... .+
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999975 789999999864311100 0 000 12
Q ss_pred HHHHHHHHhc----CC-CC--eeEEEEEEEcCCeEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHh
Q 022444 55 KREISIMKLV----RH-PC--VVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLID-GVDYCHS 125 (297)
Q Consensus 55 ~~e~~~l~~l----~h-~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~-al~~Lh~ 125 (297)
.+|...+.++ ++ ++ +++++. ...+..+++|||++|.+|.+..... ... ....++..++. .+..+|.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh
Confidence 2333334433 22 32 223332 2234579999999999998776432 122 23445566655 4678899
Q ss_pred CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 126 ~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
.|++|+|++|.||+++.+++++++|||.+.....
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.8e-13 Score=107.96 Aligned_cols=143 Identities=17% Similarity=0.228 Sum_probs=103.5
Q ss_pred eEEeccCCceeEEEEEeCC------CCcEEEEEEeecchh-----------------------hhHHHHHHHHHHHHHHH
Q 022444 12 GRTIGEGTFAKVKFAQNTE------TGESVAMKVLDRSAI-----------------------IKHKMADQIKREISIMK 62 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~-----------------------~~~~~~~~~~~e~~~l~ 62 (297)
...||.|..+.||.|.... .+..+|||+.+.... ..........+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998653 357899998752110 01111233558999999
Q ss_pred hcCC--CCeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCEEecCCCCCee
Q 022444 63 LVRH--PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC-HSKGVYHRDLKPENLL 139 (297)
Q Consensus 63 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~L-h~~~i~h~di~~~nIl 139 (297)
++.. -.+++++.+ ..-+++||++.+..+.....+...++......+..+++.++..+ |+.|++|||+++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8864 456677764 35689999997644422222233455667778889999999998 8999999999999999
Q ss_pred ecCCCCEEEcccCCCCCCCC
Q 022444 140 LDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 140 i~~~~~~~l~df~~~~~~~~ 159 (297)
++ ++.++++||+.+.....
T Consensus 158 ~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EE-CCcEEEEECCCceeCCC
Confidence 96 57899999998775544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-14 Score=136.42 Aligned_cols=262 Identities=26% Similarity=0.436 Sum_probs=195.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+.+.+.+.+-+.++.++.++.+.-..+|..+..++............+....+-..+-...+|-++...-.+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45678888999999999999998888886666665433221111111111111111111112322222222234456899
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC-----
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ----- 159 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~----- 159 (297)
++++.++++|.+.+.+.+..+.+-.+..+..+..++++||...+.|+|++|.|.++..++...+.+|+.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 999999999999999888888888888889999999999999999999999999999999999999973221100
Q ss_pred -----Cc---------------------cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 022444 160 -----GV---------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (297)
Q Consensus 160 -----~~---------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~ 213 (297)
.. .......+++.|.+||...+.... ..+|.|+.|+++++.++|..||....+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg-s~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG-SAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC-CcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 00 001223578899999999887776 899999999999999999999999999
Q ss_pred HHHHHHhhhccccCC---CCCChhHHHHHHHhcCCCcCCCCCHH---HHhcCcccccCcc
Q 022444 214 TTLYSKVEKADFSCP---TWFPVGAKSLIHRILDPNPETRITIE---EIRNDEWFRKGYV 267 (297)
Q Consensus 214 ~~~~~~i~~~~~~~~---~~~~~~l~~li~~~L~~~p~~Rps~~---~il~~p~~~~~~~ 267 (297)
+...+++.+...+-+ ...+.+.++++.+.|..+|.+|..+. ++-.|+||+...-
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 999999888776543 34788999999999999999999999 8999999998743
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=3e-13 Score=123.43 Aligned_cols=146 Identities=19% Similarity=0.365 Sum_probs=93.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh-------------------------------HHHHHHH
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-------------------------------HKMADQI 54 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------------------------------~~~~~~~ 54 (297)
+..|+. +.||+|++|+||.|+.+.+|+.||||+.++.-... .+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 79999999999999998889999999997432100 0111122
Q ss_pred HH------HHHHHHhc----CCCCeeEEEEEEE-cCCeEEEEEcccCCCChHHH--HHhcC----CCCHHHHHHHHHHHH
Q 022444 55 KR------EISIMKLV----RHPCVVRLHEVLA-SRTKIYIILEFITGGELFDK--IVHHG----RLSESEARRYFQQLI 117 (297)
Q Consensus 55 ~~------e~~~l~~l----~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~--l~~~~----~~~~~~~~~~~~~i~ 117 (297)
.+ |.....++ .+...+.+=.++. -....+++|||+.|+++.+. +.+.+ .+.+..+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 22 22223332 2333333333332 23567899999999999764 22222 1222223333333
Q ss_pred HHHHHHHhCCCEEecCCCCCeeecCCC----CEEEcccCCCCCCCC
Q 022444 118 DGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPEQ 159 (297)
Q Consensus 118 ~al~~Lh~~~i~h~di~~~nIli~~~~----~~~l~df~~~~~~~~ 159 (297)
+...|++|+|++|.||+++.++ +++++|||.......
T Consensus 276 -----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4468999999999999999888 999999998865543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-13 Score=123.64 Aligned_cols=254 Identities=20% Similarity=0.192 Sum_probs=184.9
Q ss_pred ccccceEEeEEeccCCceeEEEEEeC-CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCe
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNT-ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTK 81 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 81 (297)
.++++|..+..||.|.++.|+..... .++..+++|............... ..++.+...+ .|.+.+.....+....+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccccc
Confidence 46789999999999999999987755 567778888775443333322222 3455555555 48888887777777777
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC-CCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~-~~~~l~df~~~~~~~~~ 160 (297)
.|+--|+|.++++...+.-...+.+..++.+..+++.++.++|+..++|.|++|+||++..+ +..+++||+........
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 88999999998886666545568888999999999999999999999999999999999876 67789999987643222
Q ss_pred ccccccccCCccccC-CccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHH
Q 022444 161 VSLLRTTCGTPNYVA-PEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239 (297)
Q Consensus 161 ~~~~~~~~~~~~~~a-PE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li 239 (297)
.. ...+..++.| +|++........+.|+++||.-+.+.+++...-... .....+..+..+.......++..+.
T Consensus 421 ~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~~~p~~~~~~~~~q~~~ 494 (524)
T KOG0601|consen 421 SG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSGDTPNLPGLKLQLQVLL 494 (524)
T ss_pred cc---cccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceeeecccccCCCchHHhhhhhh
Confidence 11 1223334442 455443333348999999999999999887543222 2233444454554455568889999
Q ss_pred HHhcCCCcCCCCCHHHHhcCccccc
Q 022444 240 HRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
..+..+++..||++.++..|+=|..
T Consensus 495 kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 495 KVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhcCCccccchhhhhhcccchhhh
Confidence 9999999999999999988775544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.2e-12 Score=110.34 Aligned_cols=211 Identities=17% Similarity=0.247 Sum_probs=156.1
Q ss_pred CceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE----cCCeEEEEEcccCC-CC
Q 022444 19 TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA----SRTKIYIILEFITG-GE 93 (297)
Q Consensus 19 ~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~ 93 (297)
...+.|++....+|..+++|.++...... ......-++.++++.|+|++++.+++. .+..+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 45779999999999999999994332111 122335688899999999999998875 44578999999875 56
Q ss_pred hHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 94 LFDKIVHH---------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 94 L~~~l~~~---------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
|.++.-.. ...++..+|.++.|+..||.++|+.|+...-+.+.+|+++.+.++++...|......
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 76555322 236789999999999999999999999999999999999999899999888766555
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHH-HHHhhhccccCCCCCChhHH
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTL-YSKVEKADFSCPTWFPVGAK 236 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~-~~~i~~~~~~~~~~~~~~l~ 236 (297)
... . |-+... .+.|.=.||.+++.|.||..--...+ .... ...+ ...++.+++
T Consensus 445 ~d~------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~r 499 (655)
T KOG3741|consen 445 EDP------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDLR 499 (655)
T ss_pred CCC------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHHH
Confidence 432 0 112111 67799999999999999964321111 1111 2222 234778889
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 022444 237 SLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~ 258 (297)
++|.-+.+.++++ .+..+++.
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHH
Confidence 9999999888887 78888876
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.7e-12 Score=97.91 Aligned_cols=136 Identities=21% Similarity=0.258 Sum_probs=102.7
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeec-----chhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDR-----SAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~-----~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
..+++|+.+.++.+... |.++++|.=.+ +.+...-....-.+|..++.++.--++....=+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999998764 45577775433 333333334456788888888876666554444456667789999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
|+.|..|.+.+... ...++..+-..+.-||..||+|||+.++||.++.++ +.++|||++....
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 99998888888764 366778888889999999999999999999996554 9999999987444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=6e-12 Score=97.01 Aligned_cols=145 Identities=22% Similarity=0.275 Sum_probs=112.4
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEe-----ecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVL-----DRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~-----~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
....|.+|+.+.|+.+.+ +|+.++||.- +.+.+...-......+|...+.++.--+|.-..-++.+...-.+.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 788999999999999887 4788888753 344444444566778899999998766776666666677777899
Q ss_pred EcccCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC---CEEEcccCCCCCC
Q 022444 86 LEFITG-GELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALP 157 (297)
Q Consensus 86 ~e~~~~-~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~---~~~l~df~~~~~~ 157 (297)
|||.+| .++.+++.... +...+....+++++-+.+..||.++++|||+..+||++..++ .+.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 46677776532 233344478999999999999999999999999999997655 4699999987644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.9e-12 Score=101.96 Aligned_cols=127 Identities=20% Similarity=0.252 Sum_probs=93.7
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCeEEEEEcccC
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~ 90 (297)
++.|+.|..+.||.++.. +..+++|....... .......|...++.+.+.++ ++++.... ...++|||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 578899999999999865 77899998754321 11234567777777754443 45555432 34579999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----EEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV-----YHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i-----~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
|.++.+. . ......+.+++++|..||+.++ +|||++|.||+++ ++.++++||+.+.
T Consensus 75 G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887543 1 1123456789999999999985 9999999999998 6789999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.8e-11 Score=102.45 Aligned_cols=235 Identities=14% Similarity=0.191 Sum_probs=152.5
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEE------EEEc-CCeE
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHE------VLAS-RTKI 82 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~------~~~~-~~~~ 82 (297)
..+.||+|+.+.+|..-... -.+.|++..+..... .+....|.+. .||-+-.=+. +..+ +...
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 45689999999999765332 245677765442111 1223333333 4654332111 1112 2236
Q ss_pred EEEEcccCCCChHHHH-------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 83 YIILEFITGGELFDKI-------VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l-------~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
.++|..+++..--..+ +......+..+++.++.++.+.+.||..|.+-||++++|+++++++.+.|.|=+...
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 7888888764322222 122236889999999999999999999999999999999999999999999866433
Q ss_pred CCCCCccccccccCCccccCCcccc-----ccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCC-----HHHHHHHhhhc-
Q 022444 156 LPEQGVSLLRTTCGTPNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAG-YLPFDELD-----LTTLYSKVEKA- 223 (297)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~-----~~~~~~~i~~~- 223 (297)
.. .........++...|.|||... +-+. +..+|.|.||+++++++.| ++||.+.. +...-..|..+
T Consensus 166 i~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 IN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ec-cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32 2223445778899999999864 2222 4889999999999998886 99996542 00001111111
Q ss_pred ----------cccCC-----CCCChhHHHHHHHhcCC--CcCCCCCHHHH
Q 022444 224 ----------DFSCP-----TWFPVGAKSLIHRILDP--NPETRITIEEI 256 (297)
Q Consensus 224 ----------~~~~~-----~~~~~~l~~li~~~L~~--~p~~Rps~~~i 256 (297)
..+.| +.+|+.++.++.+|... .+.-|||++.=
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 11111 22789999999999974 46689998754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3e-12 Score=116.33 Aligned_cols=152 Identities=20% Similarity=0.361 Sum_probs=114.7
Q ss_pred HHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc---------cccccCCccccCCccccccCC
Q 022444 115 QLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL---------LRTTCGTPNYVAPEVLSHKGY 184 (297)
Q Consensus 115 ~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~ 184 (297)
+++.|+.++|.. ++||++|.|++|+++..+.+|+++|+++.....+... ......+..|.+||.+.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 444999999976 8999999999999999999999999987654432111 111123558999999987444
Q ss_pred CCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHH----HhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 185 NGAAADVWSCGVILYVLI-AGYLPFDELDLTTLYS----KVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 185 ~~~~~Di~slG~ll~~ll-~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
+.++|+||||+++|.+. .|+..+........+. ............+|.++++=+.+++..++.-||++-.++..
T Consensus 187 -~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 -TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred -cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 49999999999999998 5666654432221111 11222344556799999999999999999999999999999
Q ss_pred cccccCcc
Q 022444 260 EWFRKGYV 267 (297)
Q Consensus 260 p~~~~~~~ 267 (297)
|||+....
T Consensus 266 ~ff~D~~~ 273 (700)
T KOG2137|consen 266 PFFSDPGL 273 (700)
T ss_pred cccCCchh
Confidence 99988743
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-10 Score=95.21 Aligned_cols=141 Identities=20% Similarity=0.282 Sum_probs=105.1
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeec-------------------chhhhHHHHHHHHHHHHHHHhcCCC--
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR-------------------SAIIKHKMADQIKREISIMKLVRHP-- 67 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~-------------------~~~~~~~~~~~~~~e~~~l~~l~h~-- 67 (297)
+.+..+||-|..|.||.+.+. +|.++++|.-+. ...+..-......+|.+.|+.+...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999976 788999997531 0111111234578899999999654
Q ss_pred CeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEE
Q 022444 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (297)
Q Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~ 147 (297)
.+++.+++ +.-.++||+.+|..|...- ++.+....++..|++-+..+-..|++|||+++-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67777664 4567999999997775432 23455566666777777777799999999999999999999999
Q ss_pred EcccCCCCCCCC
Q 022444 148 ISDFGLSALPEQ 159 (297)
Q Consensus 148 l~df~~~~~~~~ 159 (297)
++||-.+.....
T Consensus 243 vIDwPQ~v~~~h 254 (304)
T COG0478 243 VIDWPQAVPISH 254 (304)
T ss_pred EEeCcccccCCC
Confidence 999987664443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-10 Score=95.34 Aligned_cols=141 Identities=20% Similarity=0.318 Sum_probs=102.5
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCC--CeeEEEEEEEcC---CeEEEEE
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP--CVVRLHEVLASR---TKIYIIL 86 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~lv~ 86 (297)
.+.|+.|..+.+|++... +|+.+++|........ .....+..|...++.+.+. .+++++.+.... +..+++|
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 367899999999999875 3678999987543311 1234577888888888753 457777776543 2568999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS----------------------------------------- 125 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~----------------------------------------- 125 (297)
|+++|.++.+.+.. ..++......++.+++++|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999877665432 345666666667777777777663
Q ss_pred ---------------CCCEEecCCCCCeeecC--CCCEEEcccCCCCC
Q 022444 126 ---------------KGVYHRDLKPENLLLDS--QGHLKISDFGLSAL 156 (297)
Q Consensus 126 ---------------~~i~h~di~~~nIli~~--~~~~~l~df~~~~~ 156 (297)
..++|||++|.||+++. ++.+.++||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999988 56689999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.8e-10 Score=88.64 Aligned_cols=129 Identities=24% Similarity=0.328 Sum_probs=84.1
Q ss_pred eEEEEEeCCCCcEEEEEEeecc-----------------------hhhhHHHHHHHHHHHHHHHhcCCC--CeeEEEEEE
Q 022444 22 KVKFAQNTETGESVAMKVLDRS-----------------------AIIKHKMADQIKREISIMKLVRHP--CVVRLHEVL 76 (297)
Q Consensus 22 ~v~~~~~~~~~~~~~iK~~~~~-----------------------~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~ 76 (297)
.||.|... +|.++|+|+.... ............+|...|+++..- ++++++.+.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888864 6779999987421 111222345678899999999865 466777653
Q ss_pred EcCCeEEEEEcccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 77 ASRTKIYIILEFIT--GGELFDKIVHHGRLSESEARRYFQQLIDGVDY-CHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 77 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~-Lh~~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
.-.+||||+. |..+..+... .++......++.+++..+.. +|+.|++|||+++.||+++++ .+.++||+.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3369999998 6555443332 12245567777788885555 589999999999999999877 899999997
Q ss_pred CCCCC
Q 022444 154 SALPE 158 (297)
Q Consensus 154 ~~~~~ 158 (297)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 76443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-09 Score=90.47 Aligned_cols=133 Identities=17% Similarity=0.082 Sum_probs=94.6
Q ss_pred eeEEEEEeCCCCcEEEEEEeecchhhhH--------HHHHHHHHHHHHHHhcCCCCe--eEEEEEEEc-----CCeEEEE
Q 022444 21 AKVKFAQNTETGESVAMKVLDRSAIIKH--------KMADQIKREISIMKLVRHPCV--VRLHEVLAS-----RTKIYII 85 (297)
Q Consensus 21 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv 85 (297)
..|..+.. .|+.+.||.......... .....+.+|+..+..+...+| +.++.+++. ...-++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 33555544 467899997754332110 001136688888888854444 344545432 2346899
Q ss_pred EcccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-------CCCEEEcccCCCC
Q 022444 86 LEFITGG-ELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-------QGHLKISDFGLSA 155 (297)
Q Consensus 86 ~e~~~~~-~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-------~~~~~l~df~~~~ 155 (297)
+|++++. +|.+++.. ..+.+......++.+++..+..||..|++|+|++++||+++. +..+.++||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999875 78888753 345667788899999999999999999999999999999975 4579999999765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.3e-08 Score=82.82 Aligned_cols=106 Identities=25% Similarity=0.385 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhcCCCC--eeEEEEEEEcC----CeEEEEEcccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 022444 52 DQIKREISIMKLVRHPC--VVRLHEVLASR----TKIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124 (297)
Q Consensus 52 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~----~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh 124 (297)
....+|+..+..+...+ .++++.+.+.. ...++|+|.+++ .+|.+++......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 34667777777775433 45566655432 245899999987 478888887555778888999999999999999
Q ss_pred hCCCEEecCCCCCeeecCCC---CEEEcccCCCCCC
Q 022444 125 SKGVYHRDLKPENLLLDSQG---HLKISDFGLSALP 157 (297)
Q Consensus 125 ~~~i~h~di~~~nIli~~~~---~~~l~df~~~~~~ 157 (297)
..|++|+|+++.||+++.++ .+.++||+.+...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999998887 8999999976643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.2e-08 Score=80.61 Aligned_cols=139 Identities=18% Similarity=0.255 Sum_probs=91.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHH------HHHHHHHHHHhcC---CCCeeEEEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD------QIKREISIMKLVR---HPCVVRLHEVL 76 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~------~~~~e~~~l~~l~---h~~i~~~~~~~ 76 (297)
.++|.+.+.+......-|.+..- +|+.+++|.........+.... ...+.+....++. -..+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 45789999999988888877765 4788999988654433222221 1223333333332 23333333222
Q ss_pred -----EcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEccc
Q 022444 77 -----ASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (297)
Q Consensus 77 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df 151 (297)
.-....+++|||++|..|.+... +++ .+...+.+++..||+.|++|||.+|.|+++++++ ++++|+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 22245678999999988865432 222 2445677889999999999999999999998555 999999
Q ss_pred CCCC
Q 022444 152 GLSA 155 (297)
Q Consensus 152 ~~~~ 155 (297)
+...
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 7543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.1e-08 Score=79.40 Aligned_cols=138 Identities=14% Similarity=0.156 Sum_probs=99.0
Q ss_pred ccCCceeEEEEEeCCCCcEEEEEEeecchhhh---HHHHHHHHHHHHHHHhcCCCC--eeEEEEEEE---cC--CeEEEE
Q 022444 16 GEGTFAKVKFAQNTETGESVAMKVLDRSAIIK---HKMADQIKREISIMKLVRHPC--VVRLHEVLA---SR--TKIYII 85 (297)
Q Consensus 16 g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~---~~--~~~~lv 85 (297)
|+||.|.|+..... |+.+-+|......... +.-...+.+|+..++.+...+ ++++. ++. .. -.-++|
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46899999998764 4468888764111111 223456788888888886433 44444 221 11 235788
Q ss_pred EcccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC--EEEcccCCCCC
Q 022444 86 LEFITG-GELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH--LKISDFGLSAL 156 (297)
Q Consensus 86 ~e~~~~-~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~--~~l~df~~~~~ 156 (297)
+|-+.+ .+|.+++... .+.+......++.+++.++..||+.|+.|+|+.+.||+++.++. +.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 886653 6888887653 35678888899999999999999999999999999999987777 99999986653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.6e-08 Score=78.75 Aligned_cols=143 Identities=20% Similarity=0.225 Sum_probs=100.1
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh---------------------hHHHHHHHHHHHHHHHhcC--CC
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII---------------------KHKMADQIKREISIMKLVR--HP 67 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~--h~ 67 (297)
+...|+.|..+.||.|.. .++..+++|++...... ......+..+|+..|+++. +-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 445888999999999985 56889999998633222 1112345677888888875 34
Q ss_pred CeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCE
Q 022444 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHL 146 (297)
Q Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~ 146 (297)
.+++.+.+. .-.++||++.......-..+.-++...+...+..++++.+.-|-. .|+||||++.-||++. ++.+
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 555666654 346999998643111111111233444677788888888888755 8999999999999998 8899
Q ss_pred EEcccCCCCCCCC
Q 022444 147 KISDFGLSALPEQ 159 (297)
Q Consensus 147 ~l~df~~~~~~~~ 159 (297)
.++|++.+.....
T Consensus 206 ~iID~~QaV~~~h 218 (268)
T COG1718 206 YIIDVSQAVTIDH 218 (268)
T ss_pred EEEECccccccCC
Confidence 9999998876554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2e-07 Score=89.97 Aligned_cols=211 Identities=18% Similarity=0.163 Sum_probs=148.4
Q ss_pred HHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE----EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 022444 50 MADQIKREISIMKLVRHPCVVRLHEVLASRTKI----YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125 (297)
Q Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~ 125 (297)
.......|+..+.+..|+|++.++.+....... .+..++++..++.+.+..-+..+....+.+..++.+++.++|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 355667788888899999999998887544332 3456788888999999988899999999999999999999999
Q ss_pred CCCEEecCCCC---CeeecCCCCEEEc--ccCCCCCCCCCccccccccCCccccCCccccccCCC-CCchhHHHHHHHHH
Q 022444 126 KGVYHRDLKPE---NLLLDSQGHLKIS--DFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILY 199 (297)
Q Consensus 126 ~~i~h~di~~~---nIli~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~Di~slG~ll~ 199 (297)
....|.-+..+ +--++..+.+..+ +|+.+......... ........+.+||........ ....|+|++|.+..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 97666655555 3334455555555 78776655443222 233345566777776555443 23479999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 200 VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 200 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
.+..|..+-...-.. .. -.+........+++.+|+..++++|+++.+++.|+|++-......
T Consensus 384 ~~~~~~~i~~~~~~~---~~------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~ 445 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVP---VS------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES 445 (1351)
T ss_pred hhhhcCcccccccch---hh------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence 998876553211000 00 001112226789999999999999999999999999987655444
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.8e-07 Score=83.24 Aligned_cols=142 Identities=22% Similarity=0.350 Sum_probs=90.3
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh-------------------------------HHHHHH------HH
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-------------------------------HKMADQ------IK 55 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------------------------------~~~~~~------~~ 55 (297)
+.|++++-|+||.|+.+ +|+.||||+.++.--.. .+..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 68899999999999987 59999999975321000 001111 22
Q ss_pred HHHHHHHhc----C-CCCe--eEEEEEEEcCCeEEEEEcccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022444 56 REISIMKLV----R-HPCV--VRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKG 127 (297)
Q Consensus 56 ~e~~~l~~l----~-h~~i--~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~ 127 (297)
+|...+.++ . .+++ ++++ .+-.+...++|||+.|..+.+... +....+...+...+.++. +..+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 233333332 2 2222 2222 223456789999999988877742 224565444444333321 23333489
Q ss_pred CEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 128 i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
++|+|.+|.||+++.+|++.+.|||.......
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999998776554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.68 E-value=5e-07 Score=74.43 Aligned_cols=133 Identities=17% Similarity=0.208 Sum_probs=82.3
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC--eeEEEEEEEcCCeEEEEEcccC
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
..||+|..+.||+. .+..+++|...... ....+.+|.+.++.+...+ +++++.+....+...++|++++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 24568899886432 1234577888888876443 4678888877777889999999
Q ss_pred CCC-hHHHH--------------Hh-----c----CCCCHHHHHHHH-H----------HHHH-HHHHHH----hCCCEE
Q 022444 91 GGE-LFDKI--------------VH-----H----GRLSESEARRYF-Q----------QLID-GVDYCH----SKGVYH 130 (297)
Q Consensus 91 ~~~-L~~~l--------------~~-----~----~~~~~~~~~~~~-~----------~i~~-al~~Lh----~~~i~h 130 (297)
|.+ +...+ .. + ...+......-. . .+.+ ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11111 00 0 011111111100 0 0011 112222 124789
Q ss_pred ecCCCCCeeecCCCCEEEcccCCCC
Q 022444 131 RDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 131 ~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
||++|.||++++++ +.++||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.5e-06 Score=79.20 Aligned_cols=143 Identities=20% Similarity=0.255 Sum_probs=90.6
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh--------------------------------------hHHHHHH
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--------------------------------------KHKMADQ 53 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------------------------------------~~~~~~~ 53 (297)
-+.|+..+.++|++|+.+. |+.|+||+.++.-.. +-+...+
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3689999999999999875 999999996521100 0111122
Q ss_pred HHHHHHHHHhcCCCC------eeEEEEEEEcCCeEEEEEcccCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 022444 54 IKREISIMKLVRHPC------VVRLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHS 125 (297)
Q Consensus 54 ~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~--~l~~~~~~~~~~~~~~~~~i~~al~~Lh~ 125 (297)
..+.-+..+.+.|-+ |++++-- -.....++||||+|..+.+ .+.+ ..++...+..-+.+... +-+=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--EQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--HHHHh
Confidence 333333333444444 4444432 2346789999999977644 3443 34555544444333322 22345
Q ss_pred CCCEEecCCCCCeeecC----CCCEEEcccCCCCCCCCC
Q 022444 126 KGVYHRDLKPENLLLDS----QGHLKISDFGLSALPEQG 160 (297)
Q Consensus 126 ~~i~h~di~~~nIli~~----~~~~~l~df~~~~~~~~~ 160 (297)
.|++|+|-+|.||++++ ++.+.+.|||+.......
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 68999999999999984 568999999987765543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.7e-06 Score=68.74 Aligned_cols=78 Identities=19% Similarity=0.292 Sum_probs=53.5
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCC--CeeEEEEEEE---cCCeEEEEE
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP--CVVRLHEVLA---SRTKIYIIL 86 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~---~~~~~~lv~ 86 (297)
++.|+.|..+.||.+.... ..+++|..... .....+.+|...++.+... -+++++.... .....+.+|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999865 48999987654 2234556677777766433 3456666432 233578999
Q ss_pred cccCCCChHH
Q 022444 87 EFITGGELFD 96 (297)
Q Consensus 87 e~~~~~~L~~ 96 (297)
++++|.++..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999877765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.31 E-value=1e-05 Score=67.55 Aligned_cols=75 Identities=12% Similarity=0.166 Sum_probs=51.1
Q ss_pred EeccCCc-eeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 14 TIGEGTF-AKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 14 ~lg~g~~-~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
.|..|.. +.||.+... +..+++|...... ...+.+|+..++.+. +--+++++.+....+..+++|++++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4455555 778988753 4678899876542 223556777777663 34466788877766678999999998
Q ss_pred CChHH
Q 022444 92 GELFD 96 (297)
Q Consensus 92 ~~L~~ 96 (297)
.++..
T Consensus 77 ~~l~~ 81 (244)
T cd05150 77 VPAAA 81 (244)
T ss_pred ccHhH
Confidence 77653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.5e-05 Score=61.73 Aligned_cols=131 Identities=21% Similarity=0.301 Sum_probs=94.8
Q ss_pred EEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCeEEEEEcc
Q 022444 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~ 88 (297)
++.+.|+.|..|.||++.+. |..+++|+-.... ....+..|.+++..+.-.++ .+++.+..+ ++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 45678999999999999986 5589999876543 25668889998888876555 456666432 355999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCC-CCCeeecCCCCEEEcccCCCCCCC
Q 022444 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK-PENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~-~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
..|.+|.+.-... -.+.+..++++-.-|-..||-|+.|+ |...++-.++.+.++||..++...
T Consensus 94 i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 94 IDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 9998886654321 23445566777777888999999886 444555566699999999887443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.1e-05 Score=75.86 Aligned_cols=81 Identities=14% Similarity=0.269 Sum_probs=56.3
Q ss_pred EeEEeccCCceeEEEEEeCCCC--cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCe--eEEEEEEEcC---CeE
Q 022444 11 VGRTIGEGTFAKVKFAQNTETG--ESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCV--VRLHEVLASR---TKI 82 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~ 82 (297)
-++.++.|....+|++.....+ ..+++|+.+...... ....+.+|+.+++.+. |.++ ++++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677889999999998865432 468888765432111 1235778999998885 5655 7778877654 357
Q ss_pred EEEEcccCCCC
Q 022444 83 YIILEFITGGE 93 (297)
Q Consensus 83 ~lv~e~~~~~~ 93 (297)
|+|||+++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.7e-07 Score=85.35 Aligned_cols=248 Identities=19% Similarity=0.160 Sum_probs=163.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCeEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRTKIYI 84 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~l 84 (297)
..-+...+-++.++.+.+++.+...+.... .+++... ....-++++|.+++||| .+..++-++.+...++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 334555666778888888877765544433 5555332 23446789999999999 5555565566678899
Q ss_pred EEcccCCC-ChH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGG-ELF-DKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~-~L~-~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
.++++.++ +.. ..-...-.+-..+.....+.-++.++++|+.--+|+| ||+.+ ++..++++|+.........
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccc-
Confidence 99999876 221 1111111234445566677778899999988767776 66653 4678999999876554432
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-CCCCC------ChhH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CPTWF------PVGA 235 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~------~~~l 235 (297)
......+++.+.|||......+. ...|.|++|.=..++.-|.+|-...... ....+..+ .+... +..-
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~----~~~~g~~p~s~~L~~~~aw~~~~~ 460 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV----LPMIGNGPNSPMLTDKSAWSPVFH 460 (829)
T ss_pred ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc----cCCCCCCCCccccchhhhcCcccc
Confidence 34456788999999988877776 8899999998767777776665331100 00000000 01111 1111
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccccc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~ 273 (297)
.++...|+...|..|+..-..+.|.+|...+.+..+.+
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~aa 498 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHCAA 498 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhccCcccceecc
Confidence 24778899999999999999999999999887766544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.5e-05 Score=60.91 Aligned_cols=98 Identities=16% Similarity=0.276 Sum_probs=77.3
Q ss_pred HHHHHHHHhcCC-CCeeEEEEEEEcCCeEEEEEcccCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 022444 55 KREISIMKLVRH-PCVVRLHEVLASRTKIYIILEFITGGELFD---KIVHHGRLSESEARRYFQQLIDGVDYCHS---KG 127 (297)
Q Consensus 55 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~~~~~i~~al~~Lh~---~~ 127 (297)
.+|.-+++.+++ +++++++|+| ..+++.|+...+++.. .+......++..+.+++.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357788888876 6999999998 3367889887665532 11222346899999999999999999987 34
Q ss_pred CEEecCCCCCeeecCCCCEEEcccCCCCC
Q 022444 128 VYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (297)
Q Consensus 128 i~h~di~~~nIli~~~~~~~l~df~~~~~ 156 (297)
+.-.|++++|+-++.+++++++|.+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 67789999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.16 E-value=7.6e-05 Score=59.96 Aligned_cols=134 Identities=21% Similarity=0.273 Sum_probs=90.9
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchh-------------hhHHHHHHHHHHHHHHHhcC------CCCeeEE
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-------------IKHKMADQIKREISIMKLVR------HPCVVRL 72 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~------h~~i~~~ 72 (297)
...||+|+.-.||.- . .....+||+...... ......+...+|+.....+. +..|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999988843 3 334578998876540 00111334445555555444 7899999
Q ss_pred EEEEEcCCeEEEEEcccC------CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC--
Q 022444 73 HEVLASRTKIYIILEFIT------GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-- 144 (297)
Q Consensus 73 ~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-- 144 (297)
+|+.+.+....+|+|.+. +.+|.+++.+ +.++. . +...+-+...+|-+++|+.+|++|.||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999999999999998753 3567777754 35555 3 334445666788899999999999999996432
Q ss_pred --CEEEcc-cCC
Q 022444 145 --HLKISD-FGL 153 (297)
Q Consensus 145 --~~~l~d-f~~ 153 (297)
.+.++| ||.
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 477776 553
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.2e-06 Score=72.56 Aligned_cols=140 Identities=15% Similarity=0.219 Sum_probs=98.2
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeec-----------------chhhhHHHH--HHHHHHHHHHHhcCC--C
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR-----------------SAIIKHKMA--DQIKREISIMKLVRH--P 67 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~-----------------~~~~~~~~~--~~~~~e~~~l~~l~h--~ 67 (297)
+.+.+.||-|..|.+|.+.+. .|.+.++|.-+. ......-+. -...+|...++.+.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567889999999999999875 688898886421 000011111 224567777777753 2
Q ss_pred CeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEE
Q 022444 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (297)
Q Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~ 147 (297)
-+++.+++ +.-++||+.+.|-+|.+... ......+...+...+--|..+|+||||++--||++++++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 34455544 45689999999988865432 123344555666777788999999999999999999999999
Q ss_pred EcccCCCCCCCC
Q 022444 148 ISDFGLSALPEQ 159 (297)
Q Consensus 148 l~df~~~~~~~~ 159 (297)
++||-.......
T Consensus 243 vIDFPQmvS~sh 254 (465)
T KOG2268|consen 243 VIDFPQMVSTSH 254 (465)
T ss_pred EeechHhhccCC
Confidence 999987654443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.13 E-value=9.8e-05 Score=63.87 Aligned_cols=145 Identities=23% Similarity=0.283 Sum_probs=100.0
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeec---------------------chhh-hHHH-HHHHHHHHHHHHhcCCC
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDR---------------------SAII-KHKM-ADQIKREISIMKLVRHP 67 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~---------------------~~~~-~~~~-~~~~~~e~~~l~~l~h~ 67 (297)
+-..|.-|..+.||-|... +|..+|||++.- -+.. ...+ .-++..|+..|+++...
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 5568889999999998854 778899998741 0000 1112 23467888888888776
Q ss_pred CeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCEEecCCCCCeeecCCCCE
Q 022444 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC-HSKGVYHRDLKPENLLLDSQGHL 146 (297)
Q Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~L-h~~~i~h~di~~~nIli~~~~~~ 146 (297)
+|+..--+.. ..-.|||+++....-..-..+...++...+..+-.+++..+.-| +.+++||.||+--|+++ .+|.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 6654322221 12368999985422222223344677888888888888888777 78899999999999999 67889
Q ss_pred EEcccCCCCCCCC
Q 022444 147 KISDFGLSALPEQ 159 (297)
Q Consensus 147 ~l~df~~~~~~~~ 159 (297)
+++|.+.+.....
T Consensus 304 yiIDVSQSVE~DH 316 (520)
T KOG2270|consen 304 YIIDVSQSVEHDH 316 (520)
T ss_pred EEEEccccccCCC
Confidence 9999887654443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.8e-05 Score=63.14 Aligned_cols=74 Identities=8% Similarity=0.058 Sum_probs=45.3
Q ss_pred eEEeccCCce-eEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCC---CeeEEEEEEEcC---CeEEE
Q 022444 12 GRTIGEGTFA-KVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP---CVVRLHEVLASR---TKIYI 84 (297)
Q Consensus 12 ~~~lg~g~~~-~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~l 84 (297)
++.|+.|+.+ .||.+. ..+++|...... ....+.+|...++.+... -+.++++..... ...++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 4567777776 488762 347788754321 134577888888777532 344555544322 23488
Q ss_pred EEcccCCCChH
Q 022444 85 ILEFITGGELF 95 (297)
Q Consensus 85 v~e~~~~~~L~ 95 (297)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999886663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00037 Score=62.06 Aligned_cols=80 Identities=20% Similarity=0.196 Sum_probs=52.1
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchh--hh--HHHHHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCeEEE
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--IK--HKMADQIKREISIMKLVR---HPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 84 (297)
.+.||.|....||++.....++.++||.-..... .. .-..+....|.+.|+.+. ...+++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999999864446899997532110 00 012344555666666653 3467778776 3455789
Q ss_pred EEcccCCCC
Q 022444 85 ILEFITGGE 93 (297)
Q Consensus 85 v~e~~~~~~ 93 (297)
+||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999987643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00011 Score=60.81 Aligned_cols=75 Identities=24% Similarity=0.294 Sum_probs=46.5
Q ss_pred eEEeccCCceeEEEEEeCC-CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCeEEEEEccc
Q 022444 12 GRTIGEGTFAKVKFAQNTE-TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRTKIYIILEFI 89 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~ 89 (297)
++.|..|-...+|++.... +++.+++|....... ..-...+|...++.+...+ .++++.... ..+++||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEee
Confidence 5677778888999987543 356798997654321 1112335777777775333 345554432 13799999
Q ss_pred CCCCh
Q 022444 90 TGGEL 94 (297)
Q Consensus 90 ~~~~L 94 (297)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.90 E-value=8.9e-05 Score=63.75 Aligned_cols=136 Identities=18% Similarity=0.220 Sum_probs=79.5
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC--eeEEEEE------EEcCCeEE
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEV------LASRTKIY 83 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~ 83 (297)
++.|..|....+|.+... +..+++|+..... ...+..|+.+++.+.+.+ +++++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKVS------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCCCC------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 667777888899998653 3468999876421 233455666666664322 4444431 12345678
Q ss_pred EEEcccCCCChHH-----------HH----HhcCCCC--------HHHHH------------HHHHHHHHHHHHHHh---
Q 022444 84 IILEFITGGELFD-----------KI----VHHGRLS--------ESEAR------------RYFQQLIDGVDYCHS--- 125 (297)
Q Consensus 84 lv~e~~~~~~L~~-----------~l----~~~~~~~--------~~~~~------------~~~~~i~~al~~Lh~--- 125 (297)
.++++++|.++.. .+ .....+. ..... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998865421 00 0000000 00000 011122334444443
Q ss_pred ----CCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 126 ----KGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 126 ----~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
.+++|||++|.||+++.++.+.++||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999887777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.88 E-value=7.7e-05 Score=62.76 Aligned_cols=135 Identities=18% Similarity=0.225 Sum_probs=75.6
Q ss_pred EeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCeEEEEEcccCCC
Q 022444 14 TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILEFITGG 92 (297)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~ 92 (297)
.+..|-.+.+|++. .+++.+++|...... ....-...+|..+++.+...++ ++++.... .++|++|++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45667778899887 356678898754322 1100123567777777764333 44444432 36899999886
Q ss_pred ChHHH--------------HH---hc----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCEEecC
Q 022444 93 ELFDK--------------IV---HH----GRLSES-EARRYFQQL---------IDGVDYCHS--------KGVYHRDL 133 (297)
Q Consensus 93 ~L~~~--------------l~---~~----~~~~~~-~~~~~~~~i---------~~al~~Lh~--------~~i~h~di 133 (297)
.+... +. .. .+++.. .+..+..++ ...+..+.. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 54311 10 00 011111 111211111 111222221 24899999
Q ss_pred CCCCeeecCCCCEEEcccCCCCCCC
Q 022444 134 KPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 134 ~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
.|.||++++++ +.++||+.+....
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCcCC
Confidence 99999998877 7899999776433
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00061 Score=58.63 Aligned_cols=78 Identities=12% Similarity=0.093 Sum_probs=53.9
Q ss_pred EEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC---CCeeEEEEEEEc---CCeEE
Q 022444 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH---PCVVRLHEVLAS---RTKIY 83 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~ 83 (297)
.-.+.||.|..+.||..... ++ .+++|..+... ....+..|...++.+.. ..++++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34668999999999998753 23 47777753310 12356678888877743 357888887753 35689
Q ss_pred EEEcccCCCCh
Q 022444 84 IILEFITGGEL 94 (297)
Q Consensus 84 lv~e~~~~~~L 94 (297)
+|||++++.++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999988654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00058 Score=54.64 Aligned_cols=128 Identities=23% Similarity=0.292 Sum_probs=85.2
Q ss_pred cceEEeEEeccCCc-eeEEEEEeCCCCcEEEEEEeec---chh-------h-hH-------HHHHHHHHHHHHHHhcC--
Q 022444 7 GKYEVGRTIGEGTF-AKVKFAQNTETGESVAMKVLDR---SAI-------I-KH-------KMADQIKREISIMKLVR-- 65 (297)
Q Consensus 7 ~~y~~~~~lg~g~~-~~v~~~~~~~~~~~~~iK~~~~---~~~-------~-~~-------~~~~~~~~e~~~l~~l~-- 65 (297)
..++.++.||.|.. |.||+++.. |+.+|+|++.. ... . .. .....+..|....-+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57899999999999 999999874 77999999321 100 0 00 12334556666555553
Q ss_pred -CCCe--eEEEEEEEcC------------------CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 022444 66 -HPCV--VRLHEVLASR------------------TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124 (297)
Q Consensus 66 -h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh 124 (297)
+.++ ++++++..-. ....||.|+++... .++ ..-+.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 5566 8898887211 12356667665432 222 233456666678899
Q ss_pred hCCCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 125 ~~~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
+.||+-+|+++.|.. + -+|+||+.+
T Consensus 182 k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---C--CEEEecccC
Confidence 999999999999986 2 488898854
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00098 Score=57.96 Aligned_cols=30 Identities=30% Similarity=0.496 Sum_probs=25.6
Q ss_pred CCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 126 ~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
.|+||||++|.||+++.+...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999866556899999765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00068 Score=58.34 Aligned_cols=142 Identities=20% Similarity=0.247 Sum_probs=88.1
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCC--eEEE
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH--PCVVRLHEVLASRT--KIYI 84 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~l 84 (297)
..+++.+..|-...+|..... ++.++++ .+. ............+|+..++.+.- .-....++.+.++. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 345666656666667777665 7889998 332 11122224556677777777743 22344556665444 6699
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHH-HHHHHHHHHHHh--------------------------------------
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYF-QQLIDGVDYCHS-------------------------------------- 125 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~-~~i~~al~~Lh~-------------------------------------- 125 (297)
+|+|+.|..+.+.... .....+.+ ..+.+.|.-||+
T Consensus 103 v~~~veGe~~~~~~~~-----~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 103 VMEWVEGEVVWSALPP-----ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEEEecceeccCcCCc-----ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 9999988544322211 00001222 255555555554
Q ss_pred --------------------CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 126 --------------------KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 126 --------------------~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
..++|||+++.|+++++++.+-++||+.+.....
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 2489999999999999988899999998776554
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0012 Score=57.21 Aligned_cols=138 Identities=20% Similarity=0.281 Sum_probs=76.9
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC--eeEEEEE------EEcCCeE
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEV------LASRTKI 82 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~ 82 (297)
.++.++.|....+|.+... +| .+++|...... . .+.+..+..++..+...+ +++++.. ....+..
T Consensus 26 ~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eccccCCccccceEEEEeC-CC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 3567777777899988743 44 58889875421 1 122334455555553222 3444332 1224567
Q ss_pred EEEEcccCCCChH-----------HHH----HhcCCCCH-------HHHH----------------HHHHHHHHHHHHHH
Q 022444 83 YIILEFITGGELF-----------DKI----VHHGRLSE-------SEAR----------------RYFQQLIDGVDYCH 124 (297)
Q Consensus 83 ~lv~e~~~~~~L~-----------~~l----~~~~~~~~-------~~~~----------------~~~~~i~~al~~Lh 124 (297)
+++++|++|.++. ..+ .....++. ...+ .....+..++.++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999874431 001 00011100 0000 01112333455553
Q ss_pred h-------CCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 125 S-------KGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 125 ~-------~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
. .+++|||+++.||+++.++...++||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 579999999999999988777899999754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00038 Score=62.77 Aligned_cols=162 Identities=21% Similarity=0.239 Sum_probs=104.3
Q ss_pred HHHHHHHHHHHhcCCCCeeEEEEEEEcC-CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEE
Q 022444 52 DQIKREISIMKLVRHPCVVRLHEVLASR-TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130 (297)
Q Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h 130 (297)
.++.-...+++.+.|++...++++.... ....+|+|+++ .+|.+.+..+. +...... .|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~------------------~~ 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL------------------AH 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc------------------cc
Confidence 3456778899999999999999887543 45789999995 58888776543 2111111 22
Q ss_pred ecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022444 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (297)
Q Consensus 131 ~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~ 210 (297)
+ +.+-|++. .+| .... . + | .. ..+++|||++|.++.++.-|...+..
T Consensus 87 ~-~~~~~~~~-------~td-~~~t---~-------------~--~-----~~-~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 87 G-VLHLNIIY-------ITD-HFLT---K-------------Y--P-----SP-IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred c-cceehhhh-------ccc-cccc---c-------------C--C-----CC-CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 2 11222222 111 0000 0 0 1 00 12699999999999999999888766
Q ss_pred CCHHHHHHHhhhccc------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 211 LDLTTLYSKVEKADF------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 211 ~~~~~~~~~i~~~~~------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
....+....+..-.. .+...++.....+...|+...|+.||...++..++-|..++
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY 201 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence 554444433322211 11112566778899999999999999999999999998773
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0016 Score=56.09 Aligned_cols=75 Identities=19% Similarity=0.213 Sum_probs=46.1
Q ss_pred eEEeccCCceeEEEEEeCC------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCeEEE
Q 022444 12 GRTIGEGTFAKVKFAQNTE------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYI 84 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~l 84 (297)
++.|..|--..+|++.... .++.+++|+..... .......+|..+++.+...++ ++++..+.. ..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4566667777899987643 25789999875432 112234567777777653333 455655532 35
Q ss_pred EEcccCCCCh
Q 022444 85 ILEFITGGEL 94 (297)
Q Consensus 85 v~e~~~~~~L 94 (297)
|++|++|.++
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 7888887655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0028 Score=56.49 Aligned_cols=77 Identities=12% Similarity=0.056 Sum_probs=48.7
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh-H---HHHHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCeEE
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-H---KMADQIKREISIMKLVR---HPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 83 (297)
..+.||.|....||++.+. +..++||.-....... . ....+...|...|+... ...+++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678899999999999874 4569998765211100 0 01233334455555543 357888888875 3457
Q ss_pred EEEcccCC
Q 022444 84 IILEFITG 91 (297)
Q Consensus 84 lv~e~~~~ 91 (297)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0061 Score=53.37 Aligned_cols=76 Identities=16% Similarity=0.131 Sum_probs=45.2
Q ss_pred EeccCCceeEEEEEeCCCCcEEEEEEeecchh--h-h-HHHHHHHHHHHHHHHhcC--CC-CeeEEEEEEEcCCeEEEEE
Q 022444 14 TIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--I-K-HKMADQIKREISIMKLVR--HP-CVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~-~-~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~ 86 (297)
.||.|....||++.+...++.++||--....- . + +-...+..-|...|+... -| .+++++.+ +.+...++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999864446799985421110 0 0 111233445566666553 23 55666654 445566889
Q ss_pred cccCC
Q 022444 87 EFITG 91 (297)
Q Consensus 87 e~~~~ 91 (297)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.25 E-value=3.7e-05 Score=76.91 Aligned_cols=209 Identities=16% Similarity=0.098 Sum_probs=144.2
Q ss_pred HHHHHHHHhcCCCCeeEEEEEEEc--CCeEEEEEcccCCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC-C
Q 022444 55 KREISIMKLVRHPCVVRLHEVLAS--RTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVDYCHSK-G 127 (297)
Q Consensus 55 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~al~~Lh~~-~ 127 (297)
..+.+.++...|+++.....-... ....+..++++.+|.+.+.+.++.. ....-+.........+..-.|+. +
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344445556678888776655433 3356889999999999999876432 32233333333324444444433 2
Q ss_pred ----CEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh
Q 022444 128 ----VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA 203 (297)
Q Consensus 128 ----i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~ 203 (297)
-+|.++++-|.+|..+-+++++++|+.+.........+...+++.|+.|++...-.++ .++|+|.+|+-+|....
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhc
Confidence 6788999999999999999999999988666666666677788889999988766665 67999999999999988
Q ss_pred CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 204 GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 204 g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
|..+|.......+...+.+.. ...+...|.+.......+|-+.-..||.-...+.-+.+--
T Consensus 1436 ~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1436 GNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred ccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 887774322222222222222 2444556788888888888888889999998888666543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0027 Score=55.89 Aligned_cols=138 Identities=18% Similarity=0.225 Sum_probs=78.3
Q ss_pred EeEEeccCCceeEEEEEeCC----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCeEEEE
Q 022444 11 VGRTIGEGTFAKVKFAQNTE----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYII 85 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv 85 (297)
-++.|..|--..+|++.... .++.+++|...... ....+ ..+|..+++.+...++ +++++.+..+ .+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 44566567778899987532 34679999875432 12222 2567777777764444 4566665332 46
Q ss_pred EcccCCCChHHH----------H----H---hcC------CCCHHHHHHHHHH-----------------HHHHHHHH--
Q 022444 86 LEFITGGELFDK----------I----V---HHG------RLSESEARRYFQQ-----------------LIDGVDYC-- 123 (297)
Q Consensus 86 ~e~~~~~~L~~~----------l----~---~~~------~~~~~~~~~~~~~-----------------i~~al~~L-- 123 (297)
.+|+++.++... + . +.. ......+..+..+ +...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 888776554211 0 0 000 0111222222211 11112222
Q ss_pred --H----hCCCEEecCCCCCeeecC-CCCEEEcccCCCCC
Q 022444 124 --H----SKGVYHRDLKPENLLLDS-QGHLKISDFGLSAL 156 (297)
Q Consensus 124 --h----~~~i~h~di~~~nIli~~-~~~~~l~df~~~~~ 156 (297)
. ...++|+|+++.||++++ ++.+.++||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999986 46799999997663
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0056 Score=52.08 Aligned_cols=30 Identities=23% Similarity=0.464 Sum_probs=24.6
Q ss_pred CCEEecCCCCCeeecCCCC-EEEcccCCCCC
Q 022444 127 GVYHRDLKPENLLLDSQGH-LKISDFGLSAL 156 (297)
Q Consensus 127 ~i~h~di~~~nIli~~~~~-~~l~df~~~~~ 156 (297)
.++|||++|.||+++++++ .-++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987565 46999997553
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0038 Score=54.63 Aligned_cols=139 Identities=20% Similarity=0.252 Sum_probs=76.2
Q ss_pred eEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCeEEEEEc
Q 022444 12 GRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILE 87 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e 87 (297)
++.|..|--..+|++..... +..+++|+..... ... -...+|..+++.+...++ ++++.++.. . ++.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYV-IDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeE-echHHHHHHHHHHHhcCCCCceeEEeCC-c---Eeeh
Confidence 44555566677898875432 3478999875432 111 123467777777765455 456665532 2 4788
Q ss_pred ccCCCChHH----------HH----H---hcC-C----C-CHHHHHHHHHH----------------------HHHHHHH
Q 022444 88 FITGGELFD----------KI----V---HHG-R----L-SESEARRYFQQ----------------------LIDGVDY 122 (297)
Q Consensus 88 ~~~~~~L~~----------~l----~---~~~-~----~-~~~~~~~~~~~----------------------i~~al~~ 122 (297)
|+++.++.. .+ . ... + + ....+..+..+ +...+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 887655421 01 0 000 0 1 11222222211 1111222
Q ss_pred HH----hC----CCEEecCCCCCeeecC-CCCEEEcccCCCCCCC
Q 022444 123 CH----SK----GVYHRDLKPENLLLDS-QGHLKISDFGLSALPE 158 (297)
Q Consensus 123 Lh----~~----~i~h~di~~~nIli~~-~~~~~l~df~~~~~~~ 158 (297)
+. +. -++|+|+.+.||++++ ++.++++||+++....
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 21 11 2899999999999975 4689999999876443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0068 Score=51.75 Aligned_cols=76 Identities=18% Similarity=0.188 Sum_probs=46.0
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc---CCCCeeEEEEEEEcCCeEEEE
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv 85 (297)
.+-.+.++.|..+.+|.+. .+++.+.+|+-.... ...+..|...|+.+ .-..+++++.+....+.-+++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3456788889999999987 567889999876322 23355666666666 345678899988777777999
Q ss_pred EcccCCC
Q 022444 86 LEFITGG 92 (297)
Q Consensus 86 ~e~~~~~ 92 (297)
+||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9998754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.014 Score=51.93 Aligned_cols=78 Identities=18% Similarity=0.210 Sum_probs=47.4
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh--h-HHHHHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCeEEEE
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--K-HKMADQIKREISIMKLVR---HPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv 85 (297)
.+.||.|....||++.+...++.++||--....-. + +-..++..-|...|+... -..+++++.+ +.+...++
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 67899999999999998544567888843210000 0 111344455666666553 2356667664 44556788
Q ss_pred EcccCC
Q 022444 86 LEFITG 91 (297)
Q Consensus 86 ~e~~~~ 91 (297)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888754
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.038 Score=47.86 Aligned_cols=30 Identities=17% Similarity=0.200 Sum_probs=27.2
Q ss_pred CCEEecCCCCCeeecCCCCEEEcccCCCCC
Q 022444 127 GVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (297)
Q Consensus 127 ~i~h~di~~~nIli~~~~~~~l~df~~~~~ 156 (297)
+++|||+.+.|+++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999987653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.011 Score=51.56 Aligned_cols=105 Identities=20% Similarity=0.275 Sum_probs=71.8
Q ss_pred CCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCC
Q 022444 79 RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~ 157 (297)
..+.|++|++. |+++. .+. .-..+++..++.+.+..+.-+.+. ..=|+|+.-.||+|+ .|++.|+||.+++..
T Consensus 298 ~~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 34667888876 33442 222 235678899999999988888765 688999999999998 999999999999854
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHH
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGV 196 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 196 (297)
..+...... ..-.|-.+.|. ++.+.+||-+=.
T Consensus 372 ~~q~~isy~-----rldhp~lF~G~--dd~QFeIYrlMr 403 (488)
T COG5072 372 YSQGIISYN-----RLDHPDLFNGV--DDYQFEIYRLMR 403 (488)
T ss_pred cCCceeecc-----ccCchhhhcCc--cceeeeHHHHHH
Confidence 443222222 23334444433 358888887533
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0063 Score=49.53 Aligned_cols=29 Identities=34% Similarity=0.701 Sum_probs=20.9
Q ss_pred CCEEecCCCCCeee-cCCCCEEEcccCCCC
Q 022444 127 GVYHRDLKPENLLL-DSQGHLKISDFGLSA 155 (297)
Q Consensus 127 ~i~h~di~~~nIli-~~~~~~~l~df~~~~ 155 (297)
.++|+|+.+.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 888999999999765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.05 Score=48.53 Aligned_cols=76 Identities=14% Similarity=0.181 Sum_probs=43.8
Q ss_pred EeEEeccCCceeEEEEEeCCC-CcE-----EEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCeEE
Q 022444 11 VGRTIGEGTFAKVKFAQNTET-GES-----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIY 83 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~-~~~-----~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~ 83 (297)
.++.|..|--..+|++..... +.. |.++.... . ... .-...+|+.+++.+...++ +++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~--~~l-~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-Y--NSL-VIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-C--Cce-EeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 455666688888999875432 222 33333211 1 111 1123467888888865544 566776632 5
Q ss_pred EEEcccCCCCh
Q 022444 84 IILEFITGGEL 94 (297)
Q Consensus 84 lv~e~~~~~~L 94 (297)
++.||++|.+|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 88899887554
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.22 Score=40.92 Aligned_cols=77 Identities=19% Similarity=0.286 Sum_probs=54.0
Q ss_pred EEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc---CCCCeeEEEEEEEcCCeEEEEE
Q 022444 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+-.+.+.-|.....|.+.+. ..++.+|.-.. +....+..|+.-|..+ +-..+.+++.+..+..+.|+|+
T Consensus 19 ~er~~v~gG~inea~~v~dg--~~~~FvK~n~~------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVl 90 (286)
T COG3001 19 KEREEVSGGDINEAWRLRDG--TDPFFVKCNQR------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVL 90 (286)
T ss_pred hcccccCCccccceeEeecC--CcceEEEecch------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEE
Confidence 34556777777888887763 56788886432 2344455666655555 3466788999988999999999
Q ss_pred cccCCCCh
Q 022444 87 EFITGGEL 94 (297)
Q Consensus 87 e~~~~~~L 94 (297)
+|.+.+.+
T Consensus 91 e~L~~~~~ 98 (286)
T COG3001 91 EYLPTGPL 98 (286)
T ss_pred eeccCCCC
Confidence 99986554
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.085 Score=48.00 Aligned_cols=75 Identities=13% Similarity=0.111 Sum_probs=43.9
Q ss_pred EeEEeccCCceeEEEEEeCCC--------CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCe
Q 022444 11 VGRTIGEGTFAKVKFAQNTET--------GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTK 81 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~--------~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~ 81 (297)
-++.|..|---.+|++..... ++.|++++..... .... ....|..+++.+...++ .++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 556676677777888875421 4678888875432 1212 23456666666654444 35666552
Q ss_pred EEEEEcccCCCC
Q 022444 82 IYIILEFITGGE 93 (297)
Q Consensus 82 ~~lv~e~~~~~~ 93 (297)
.+.+.+|++|.+
T Consensus 181 gg~I~efi~g~~ 192 (442)
T PTZ00296 181 GGRIEEWLYGDP 192 (442)
T ss_pred CCEEEEeeCCcc
Confidence 245678887653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.33 Score=49.09 Aligned_cols=31 Identities=29% Similarity=0.493 Sum_probs=26.2
Q ss_pred CCCEEecCCCCCeeecCCC--CEE-EcccCCCCC
Q 022444 126 KGVYHRDLKPENLLLDSQG--HLK-ISDFGLSAL 156 (297)
Q Consensus 126 ~~i~h~di~~~nIli~~~~--~~~-l~df~~~~~ 156 (297)
.++||+|+++.||+++.++ ++. ++|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998875 565 999998764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.066 Score=47.56 Aligned_cols=62 Identities=13% Similarity=0.207 Sum_probs=44.2
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCEEecCCCCCeeecCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC-HSKGVYHRDLKPENLLLDSQ 143 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~L-h~~~i~h~di~~~nIli~~~ 143 (297)
...++-+|..|.++..+++.. ..+++....++.-...|+-.+ --.+++|.|++|.||++...
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 345667788888888877653 344556666776666666554 45689999999999999543
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.041 Score=46.59 Aligned_cols=50 Identities=28% Similarity=0.461 Sum_probs=37.4
Q ss_pred HHHHHHHHHHHHHHHHhC--CCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 109 ARRYFQQLIDGVDYCHSK--GVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 109 ~~~~~~~i~~al~~Lh~~--~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
+...+..+-.++.-++.. -++|+|+.|+|++.++.+.++|+||..+....
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~D 185 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLND 185 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCcc
Confidence 334445555555555544 59999999999999999999999999876433
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.17 Score=41.35 Aligned_cols=101 Identities=19% Similarity=0.212 Sum_probs=63.3
Q ss_pred cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHH
Q 022444 33 ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRY 112 (297)
Q Consensus 33 ~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 112 (297)
-+..+|+++..+..-. ...+.++++++.++ -+|+++.. .+.-.+.++.|+|..... ....+
T Consensus 86 G~L~lKKi~slp~~~~--~~~y~nky~v~Arm--hGilrL~N--Dn~~~yGvIlE~Cy~~~i-------------~~~N~ 146 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCIN--DALYFNKYRVFARM--HGILRLKN--DNNYKYGVILERCYKIKI-------------NFSNF 146 (308)
T ss_pred chhhhhhccCCCcccc--hhhhhhhhhHHHHh--hheeEeec--CCCceeEEEEeeccCccc-------------chhHH
Confidence 3466777765443311 23346667777664 35666652 233356788898854321 01111
Q ss_pred HHHHHHHHHHHHhC--CCEEecCCCCCeeecCCCCEEEcccC
Q 022444 113 FQQLIDGVDYCHSK--GVYHRDLKPENLLLDSQGHLKISDFG 152 (297)
Q Consensus 113 ~~~i~~al~~Lh~~--~i~h~di~~~nIli~~~~~~~l~df~ 152 (297)
+..=+.+|.-.|+. +.+|||-.|+||+-|..|.+||.|=+
T Consensus 147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 22224567778854 69999999999999999999999855
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.068 Score=46.17 Aligned_cols=29 Identities=28% Similarity=0.551 Sum_probs=25.1
Q ss_pred CCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 126 ~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
.+++|||+++.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999998644
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 297 | ||||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-72 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-72 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-72 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-72 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-71 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-70 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-70 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-69 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-63 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-62 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-62 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-62 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-61 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-61 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-61 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-61 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-59 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-59 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-58 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-55 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-54 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-54 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-53 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-53 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-51 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-49 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-49 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-49 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-49 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-49 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-49 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-49 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-49 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-49 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-49 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-49 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-49 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-49 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-49 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-49 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-49 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-49 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-49 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-49 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-48 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-48 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-48 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-48 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-48 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-47 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-47 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-46 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-46 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-46 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-45 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-45 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-45 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-45 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-45 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-45 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-45 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-45 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-45 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-45 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-45 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-45 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-45 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-45 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-45 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-45 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-45 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-45 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-45 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-45 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-45 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-45 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-45 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-45 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-45 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-45 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-45 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-45 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-45 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-45 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-45 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-45 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-45 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-45 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-45 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-44 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-44 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-44 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-44 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-44 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-44 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-44 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-44 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-44 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-44 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-44 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-44 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-44 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-44 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-44 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-44 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-44 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-44 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-44 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-44 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-44 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-44 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-44 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-44 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-44 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-44 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-44 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-44 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-44 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-44 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-44 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-44 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-44 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-44 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-44 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-44 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-44 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-44 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-44 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-44 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-44 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-44 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-44 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-44 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-44 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-44 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-44 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-44 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-44 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-44 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-44 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-44 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-44 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-44 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-44 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-44 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-44 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-44 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-44 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-44 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-44 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-44 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-44 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-43 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-43 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-43 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-43 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-43 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-43 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-43 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-43 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-43 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-43 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-43 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-43 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-43 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-43 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-43 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-43 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-43 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-43 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-43 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-43 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-43 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-43 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-43 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-43 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-43 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-43 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-43 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-43 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-42 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-41 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-41 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-41 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-41 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-41 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-41 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-41 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-41 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-41 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-41 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-40 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-40 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-40 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-40 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-40 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-40 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-40 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-40 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-39 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-39 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-39 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-39 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-39 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-39 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-39 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-39 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-39 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-39 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-39 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-39 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-39 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-39 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-39 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-39 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-39 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-39 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-39 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-39 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-38 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-38 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-38 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-38 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-38 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-38 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-38 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-38 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-38 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-38 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-38 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-38 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-38 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-38 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-38 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-38 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-38 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-38 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-38 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-38 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-38 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-38 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-38 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-38 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-38 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-38 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-38 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-38 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-38 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-38 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-38 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-37 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-37 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-37 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-37 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-37 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-37 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-36 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-36 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-36 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-36 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-36 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-35 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-35 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-35 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-34 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-34 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-34 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-34 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-34 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-34 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-34 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-34 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-34 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-34 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-33 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-33 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-33 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-33 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-32 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-30 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-30 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-30 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-30 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-30 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-29 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-29 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-29 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-29 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-29 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-29 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-29 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-29 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-29 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-29 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-29 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-28 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-28 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-28 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-28 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-28 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-28 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-28 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-28 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-28 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-28 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-27 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-27 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-27 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-27 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-27 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-27 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-27 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-26 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-26 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-26 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-26 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-26 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-26 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-26 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-26 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-26 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-26 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-26 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-26 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-26 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-26 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-26 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-26 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-26 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-26 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-26 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-26 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-26 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-25 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-25 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-25 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-25 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-25 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-25 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-25 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-25 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-25 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-25 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-25 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-25 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-25 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-25 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-25 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-25 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-25 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-25 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-25 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-25 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-25 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-25 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-25 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-25 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-25 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-25 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-25 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-25 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-25 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-25 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-25 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-25 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-25 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-25 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-25 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-25 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-25 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-25 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-25 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-25 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-25 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-25 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-25 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-25 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-25 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-25 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-25 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-25 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-25 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-25 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-25 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-25 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-24 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-24 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-24 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-24 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-24 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-24 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-24 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-24 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-23 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-23 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-22 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-22 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-22 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-22 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-22 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-21 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-21 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-21 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-21 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-21 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-20 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-20 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-18 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-18 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-18 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-18 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-18 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-18 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-18 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-18 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-18 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-18 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-18 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-18 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-18 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-18 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-18 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-18 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-18 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-18 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-18 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-18 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-18 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-18 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-18 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-18 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-18 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-18 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-18 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-18 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-18 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-18 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-18 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-18 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-18 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-18 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-18 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-18 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-18 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-18 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-18 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-18 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-18 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-18 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-17 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-17 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-17 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-17 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-17 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-15 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-13 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-12 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-12 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-12 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-10 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 6e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-09 |
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 481 bits (1241), Expect = e-174
Identities = 123/268 (45%), Positives = 176/268 (65%), Gaps = 1/268 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
K+G Y +G T+G GTF KVK ++ TG VA+K+L+R I + +IKREI +KL
Sbjct: 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
RHP +++L++V+++ T ++++E+++GGELFD I HGR+ E EARR FQQ++ VDYC
Sbjct: 68 FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H V HRDLKPEN+LLD+ + KI+DFGLS + G LRT+CG+PNY APEV+S +
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRL 186
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
Y G D+WSCGVILY L+ G LPFD+ + TL+ K+ F P + +L+ +L
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHML 246
Query: 244 DPNPETRITIEEIRNDEWFRKGYVPVKL 271
+P R TI++IR EWF++
Sbjct: 247 QVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 480 bits (1238), Expect = e-174
Identities = 106/271 (39%), Positives = 158/271 (58%), Gaps = 7/271 (2%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
M V V +++ +T+GEG + +V+ A N T E+VA+K++D + + IK+EI I
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICI 58
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
K++ H VV+ + Y+ LE+ +GGELFD+I + E +A+R+F QL+ GV
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VSLLRTTCGTPNYVAPEV 178
Y H G+ HRD+KPENLLLD + +LKISDFGL+ + LL CGT YVAPE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLYSKVEKADFSCPTW--FPVGA 235
L + ++ DVWSCG++L ++AG LP+D+ D YS ++ W
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGY 266
+L+H+IL NP RITI +I+ D W+ K
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPL 269
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 481 bits (1239), Expect = e-173
Identities = 106/296 (35%), Positives = 161/296 (54%), Gaps = 7/296 (2%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
M V V +++ +T+GEG + +V+ A N T E+VA+K++D + + IK+EI I
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICI 58
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
K++ H VV+ + Y+ LE+ +GGELFD+I + E +A+R+F QL+ GV
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VSLLRTTCGTPNYVAPEV 178
Y H G+ HRD+KPENLLLD + +LKISDFGL+ + LL CGT YVAPE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLYSKVEKADFSCPTW--FPVGA 235
L + ++ DVWSCG++L ++AG LP+D+ D YS ++ W
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEV 291
+L+H+IL NP RITI +I+ D W+ K + + +
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHI 294
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 485 bits (1249), Expect = e-172
Identities = 123/280 (43%), Positives = 181/280 (64%), Gaps = 1/280 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
K+G Y +G T+G GTF KVK ++ TG VA+K+L+R I + +I+REI +KL
Sbjct: 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL 72
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
RHP +++L++V+++ + I++++E+++GGELFD I +GRL E E+RR FQQ++ GVDYC
Sbjct: 73 FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H V HRDLKPEN+LLD+ + KI+DFGLS + G LRT+CG+PNY APEV+S +
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRL 191
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
Y G D+WS GVILY L+ G LPFD+ + TL+ K+ F P + SL+ +L
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHML 251
Query: 244 DPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVN 283
+P R TI++IR EWF++ E + ++
Sbjct: 252 QVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMID 291
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 474 bits (1221), Expect = e-170
Identities = 126/280 (45%), Positives = 185/280 (66%), Gaps = 3/280 (1%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
R +G Y + T+GEG+F KVK A + +T + VA+K + R + K M +++REIS +KL
Sbjct: 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL 65
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+RHP +++L++V+ + T I +++E+ GGELFD IV R++E E RR+FQQ+I ++YC
Sbjct: 66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H + HRDLKPENLLLD ++KI+DFGLS + G + L+T+CG+PNY APEV++ K
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKL 183
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
Y G DVWSCG++LYV++ G LPFD+ + L+ KV + P + GA+SLI R++
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243
Query: 244 DPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVN 283
+P RITI+EIR D WF P L E+V +
Sbjct: 244 VADPMQRITIQEIRRDPWFNVNL-PDYLRPMEEVQGSYAD 282
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 471 bits (1214), Expect = e-170
Identities = 100/268 (37%), Positives = 145/268 (54%), Gaps = 1/268 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
R +Y GR +G+G FAK + +T E A K++ +S ++K +++ EISI +
Sbjct: 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 71
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+ H VV H ++++LE L + L+E EAR Y +Q++ G Y
Sbjct: 72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H V HRDLK NL L+ +KI DFGL+ E + CGTPNY+APEVLS KG
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
+ DVWS G I+Y L+ G PF+ L Y +++K ++S P A SLI ++L
Sbjct: 192 H-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250
Query: 244 DPNPETRITIEEIRNDEWFRKGYVPVKL 271
+P R TI E+ NDE+F GY+P +L
Sbjct: 251 QTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 472 bits (1216), Expect = e-169
Identities = 100/268 (37%), Positives = 145/268 (54%), Gaps = 1/268 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
R +Y GR +G+G FAK + +T E A K++ +S ++K +++ EISI +
Sbjct: 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+ H VV H ++++LE L + L+E EAR Y +Q++ G Y
Sbjct: 98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H V HRDLK NL L+ +KI DFGL+ E + CGTPNY+APEVLS KG
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
+ DVWS G I+Y L+ G PF+ L Y +++K ++S P A SLI ++L
Sbjct: 218 H-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 276
Query: 244 DPNPETRITIEEIRNDEWFRKGYVPVKL 271
+P R TI E+ NDE+F GY+P +L
Sbjct: 277 QTDPTARPTINELLNDEFFTSGYIPARL 304
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 465 bits (1200), Expect = e-167
Identities = 90/288 (31%), Positives = 155/288 (53%), Gaps = 9/288 (3%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-MADQIKREISIMK 62
+ +GKY +G +GEG++ KVK ++ET A+K+L + + + +K+EI +++
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 63 LVRHPCVVRLHEVL--ASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLID 118
+RH V++L +VL + K+Y+++E+ G E+ D + R +A YF QLID
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLID 120
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV--SLLRTTCGTPNYVAP 176
G++Y HS+G+ H+D+KP NLLL + G LKIS G++ RT+ G+P + P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 177 EVLS-HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGA 235
E+ + ++G D+WS GV LY + G PF+ ++ L+ + K ++ P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240
Query: 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVN 283
L+ +L+ P R +I +IR WFRK + P + + D +
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 464 bits (1197), Expect = e-166
Identities = 113/299 (37%), Positives = 162/299 (54%), Gaps = 16/299 (5%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
++ +Y+ + IG G F + ++ T E VA+K ++R A I + ++REI
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINH 70
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
+ +RHP +VR EV+ + T + II+E+ +GGEL+++I + GR SE EAR +FQQL+ GV
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 122 YCHSKGVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
YCHS + HRDLK EN LLD LKI DFG S S ++T GTP Y+APEVL
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVL 189
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSK----VEKADFSCP--TWFPV 233
+ Y+G ADVWSCGV LYV++ G PF++ + Y K + +S P
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249
Query: 234 GAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYED--VNLDDVNAAFDDSE 290
LI RI +P TRI+I EI+ WF K P L+ + + +
Sbjct: 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNL-PADLMNESNTGSQFQEPEQPMQSLD 307
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 458 bits (1182), Expect = e-165
Identities = 89/266 (33%), Positives = 150/266 (56%), Gaps = 2/266 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
K+ ++VG +G+G+FA V A++ TG VA+K++D+ A+ K M +++ E+ I
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDY 122
++HP ++ L+ +Y++LE GE+ + + SE+EAR + Q+I G+ Y
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
HS G+ HRDL NLLL ++KI+DFGL+ + T CGTPNY++PE+ +
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
+ G +DVWS G + Y L+ G PFD + +KV AD+ P++ + AK LIH++
Sbjct: 188 AH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246
Query: 243 LDPNPETRITIEEIRNDEWFRKGYVP 268
L NP R+++ + + + +
Sbjct: 247 LRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 449 bits (1158), Expect = e-161
Identities = 101/290 (34%), Positives = 155/290 (53%), Gaps = 30/290 (10%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-------------- 49
++ +Y + IG+G++ VK A N AMKVL + +I+
Sbjct: 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 50 ---------MADQIKREISIMKLVRHPCVVRLHEVL--ASRTKIYIILEFITGGELFDKI 98
+Q+ +EI+I+K + HP VV+L EVL + +Y++ E + G + + +
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-V 128
Query: 99 VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158
LSE +AR YFQ LI G++Y H + + HRD+KP NLL+ GH+KI+DFG+S +
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 159 QGVSLLRTTCGTPNYVAPEVLS--HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
+LL T GTP ++APE LS K ++G A DVW+ GV LY + G PF + + L
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 217 YSKVEKADFSCPTWFPV--GAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
+SK++ P + K LI R+LD NPE+RI + EI+ W +
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 442 bits (1140), Expect = e-159
Identities = 88/266 (33%), Positives = 145/266 (54%), Gaps = 3/266 (1%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ +++GR +G+G F V A+ + +A+KVL +S + K + Q++REI I +
Sbjct: 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
RHP ++R++ R +IY++LEF GEL+ ++ HGR E + + ++L D + YCH
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ V HRD+KPENLL+ +G LKI+DFG S RT CGT +Y+ PE++ K +
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEGKTH 189
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244
D+W GV+ Y + G PFD T + ++ D P + G+K LI ++L
Sbjct: 190 -DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLR 248
Query: 245 PNPETRITIEEIRNDEWFRKGYVPVK 270
+P R+ ++ + W + V
Sbjct: 249 YHPPQRLPLKGVMEHPWVKANSRRVL 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 442 bits (1138), Expect = e-158
Identities = 116/285 (40%), Positives = 172/285 (60%), Gaps = 2/285 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+G Y + +TIG+G FAKVK A++ TG VA+K++D++ + ++ RE+ IMK+
Sbjct: 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKI 70
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+ HP +V+L EV+ + +Y+I+E+ +GGE+FD +V HGR+ E EAR F+Q++ V YC
Sbjct: 71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H K + HRDLK ENLLLD+ ++KI+DFG S G L CG P Y APE+ K
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKK 189
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
Y+G DVWS GVILY L++G LPFD +L L +V + + P + ++L+ R L
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 249
Query: 244 DPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDD 288
NP R T+E+I D W G+ +L + + LD + D
Sbjct: 250 VLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRID 294
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 436 bits (1123), Expect = e-156
Identities = 86/272 (31%), Positives = 144/272 (52%), Gaps = 3/272 (1%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ +E+GR +G+G F V A+ ++ +A+KVL ++ + K + Q++RE+ I +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
RHP ++RL+ T++Y+ILE+ G ++ ++ + E Y +L + + YCH
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
SK V HRD+KPENLLL S G LKI+DFG S S CGT +Y+ PE++ + +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGRMH 184
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244
D+WS GV+ Y + G PF+ Y ++ + +F+ P + GA+ LI R+L
Sbjct: 185 -DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 243
Query: 245 PNPETRITIEEIRNDEWFRKGYVPVKLIEYED 276
NP R + E+ W + ++
Sbjct: 244 HNPSQRPMLREVLEHPWITANSSKPSNCQNKE 275
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 427 bits (1100), Expect = e-152
Identities = 82/292 (28%), Positives = 136/292 (46%), Gaps = 13/292 (4%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD-----QIKREISI 60
KY +G G F V A + E + V +K + + +++ + ++ EI+I
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEF-ITGGELFDKIVHHGRLSESEARRYFQQLIDG 119
+ V H ++++ ++ ++ +++E +G +LF I H RL E A F+QL+
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
V Y K + HRD+K EN+++ +K+ DFG +A E+G L T CGT Y APEVL
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVL 201
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
Y G ++WS GV LY L+ PF EL+ + +A P SL+
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMSLV 255
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEV 291
+L P PE R T+E++ D W + E ++ + +
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAAS 307
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 415 bits (1070), Expect = e-148
Identities = 83/281 (29%), Positives = 134/281 (47%), Gaps = 17/281 (6%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ---IKREISI 60
+Y +G +G+G F V VA+KV+ R+ ++ E+++
Sbjct: 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVAL 87
Query: 61 MKLVR----HPCVVRLHEVLASRTKIYIILEF-ITGGELFDKIVHHGRLSESEARRYFQQ 115
+ V HP V+RL + ++ ++LE + +LFD I G L E +R +F Q
Sbjct: 88 LWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ 147
Query: 116 LIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
++ + +CHS+GV HRD+K EN+L+D + G K+ DFG AL GT Y
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYS 205
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVG 234
PE +S Y+ A VWS G++LY ++ G +PF+ ++ +A+ P
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSPD 259
Query: 235 AKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYE 275
+LI R L P P +R ++EEI D W + V L +
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSK 300
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 412 bits (1061), Expect = e-146
Identities = 83/285 (29%), Positives = 132/285 (46%), Gaps = 15/285 (5%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD---QIKREISI 60
+Y+VG +G G F V VA+K +++ I ++ E+ +
Sbjct: 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 99
Query: 61 MKLVRH--PCVVRLHEVLASRTKIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLI 117
+K V V+RL + +ILE +LFD I G L E AR +F Q++
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 159
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+ V +CH+ GV HRD+K EN+L+D +G LK+ DFG AL + + GT Y P
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPP 217
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAK 236
E + + Y+G +A VWS G++LY ++ G +PF+ + ++ + +
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 271
Query: 237 SLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDD 281
LI L P R T EEI+N W + +P + E +L
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 399 bits (1028), Expect = e-141
Identities = 69/317 (21%), Positives = 131/317 (41%), Gaps = 49/317 (15%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-------------- 49
+ + Y + RT+ +G F K+ + + + A+K ++S + K +
Sbjct: 28 KYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85
Query: 50 MADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRL----- 104
D K E+ I+ +++ + ++ + ++YII E++ + + L
Sbjct: 86 KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 105 ---SESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160
+ + +++ Y H+ K + HRD+KP N+L+D G +K+SDFG S
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 161 VSLLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPF-DELDLTTLYS 218
++ + GT ++ PE S++ YNGA D+WS G+ LYV+ +PF ++ L L++
Sbjct: 206 --KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 219 KVEKADFSCPT-------------------WFPVGAKSLIHRILDPNPETRITIEEIRND 259
+ + P + + L NP RIT E+
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323
Query: 260 EWFRKGYVPVKLIEYED 276
EW L E+
Sbjct: 324 EWLAD-TNIEDLREFSK 339
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 335 bits (860), Expect = e-115
Identities = 100/281 (35%), Positives = 154/281 (54%), Gaps = 17/281 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMK 62
+Y + +T+G G +VK A +T + VA+K++ + + A ++ EI I+K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+ HPC++++ + YI+LE + GGELFDK+V + RL E+ + YF Q++ V Y
Sbjct: 71 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 123 CHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
H G+ HRDLKPEN+LL SQ +KI+DFG S + + SL+RT CGTP Y+APEVL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL 188
Query: 180 SHKGYN--GAAADVWSCGVILYVLIAGYLPF-DELDLTTLYSKVEKA--DFSCPTWFPV- 233
G A D WS GVIL++ ++GY PF + +L ++ +F W V
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 234 -GAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273
A L+ ++L +P+ R T EE W + + K +
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-110
Identities = 100/280 (35%), Positives = 154/280 (55%), Gaps = 19/280 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMK 62
+Y + +T+G G +VK A +T + VA++++ + + A ++ EI I+K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+ HPC++++ + YI+LE + GGELFDK+V + RL E+ + YF Q++ V Y
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 123 CHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
H G+ HRDLKPEN+LL SQ +KI+DFG S + + SL+RT CGTP Y+APEVL
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL 313
Query: 180 S---HKGYNGAAADVWSCGVILYVLIAGYLPF-DELDLTTLYSKVEKA--DFSCPTWFPV 233
GY A D WS GVIL++ ++GY PF + +L ++ +F W V
Sbjct: 314 VSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372
Query: 234 --GAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKL 271
A L+ ++L +P+ R T EE W + + K
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 412
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-109
Identities = 70/298 (23%), Positives = 124/298 (41%), Gaps = 38/298 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+E +G+G F +V A+N A+K + + + I E+ ++ + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQ 62
Query: 68 CVVRLHEV-------------LASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYF 113
VVR + + ++ ++I +E+ G L+D I E R F
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV------------ 161
+Q+++ + Y HS+G+ HRDLKP N+ +D ++KI DFGL+ + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 162 --SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSK 219
L + GT YVA EVL G+ D++S G+I + +I Y ++ + K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKK 240
Query: 220 VEKADFSCPTWFPVG----AKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273
+ P F K +I ++D +P R + N W + + E
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 314 bits (808), Expect = e-108
Identities = 97/276 (35%), Positives = 153/276 (55%), Gaps = 10/276 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y+V +G+G F+ V+ + TG A K+++ + + +++RE I + ++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHP 65
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+VRLH+ + + Y++ + +TGGELF+ IV SE++A QQ+++ + YCHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HR+LKPENLLL S+ +K++DFGL+ GTP Y++PEVL Y
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPY 184
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
D+W+CGVILY+L+ GY PF + D LY++++ D+ P W V AKSLI
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYED 276
+L NP+ RIT ++ W I +D
Sbjct: 244 SMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 279
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-107
Identities = 103/265 (38%), Positives = 147/265 (55%), Gaps = 13/265 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y + TIG G++ +VK A T A K + + + + D+ K+EI IMK + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHP 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++RL+E T IY+++E TGGELF+++VH ES+A R + ++ V YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 128 VYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
V HRDLKPEN L + LK+ DFGL+A + G ++RT GTP YV+P+VL Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVL-EGLY 184
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
G D WS GV++YVL+ GY PF + + K+ + F W V A+SLI
Sbjct: 185 -GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR 243
Query: 241 RILDPNPETRITIEEIRNDEWFRKG 265
R+L +P+ RIT + EWF K
Sbjct: 244 RLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = e-107
Identities = 65/280 (23%), Positives = 128/280 (45%), Gaps = 21/280 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y + + IG G +KV N E + A+K ++ + D + EI+ + ++
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRNEIAYLNKLQQH 86
Query: 68 C--VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
++RL++ + IY+++E +L + + E + Y++ +++ V H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTT-CGTPNYVAPEVLSHKG 183
G+ H DLKP N L+ G LK+ DFG++ + S+++ + GT NY+ PE +
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 184 YN----------GAAADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVE-KADFSCPTW 230
+ +DVWS G ILY + G PF ++ ++ L++ ++ + P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 231 FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270
+ ++ L +P+ RI+I E+ + + PV
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-107
Identities = 83/274 (30%), Positives = 138/274 (50%), Gaps = 19/274 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK------HKMADQIKREISIM 61
YE +G G + V+ + T + A+K++D + ++ + +E+ I+
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 62 K-LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
+ + HP +++L + + T +++ + + GELFD + LSE E R+ + L++ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL- 179
H + HRDLKPEN+LLD ++K++DFG S + G LR CGTP+Y+APE++
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 196
Query: 180 -----SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFP 232
+H GY G D+WS GVI+Y L+AG PF + + F P W
Sbjct: 197 CSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 233 V--GAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
K L+ R L P+ R T EE +F++
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-107
Identities = 91/273 (33%), Positives = 144/273 (52%), Gaps = 18/273 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-----IKHKMADQIKREISIMK 62
KY+ IG G + V+ + TG A+K+++ +A ++ + +RE I++
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 63 -LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
+ HP ++ L + S + ++++ + + GELFD + LSE E R + L++ V
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL-- 179
+ H+ + HRDLKPEN+LLD +++SDFG S E G LR CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKC 273
Query: 180 ----SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV 233
+H GY G D+W+CGVIL+ L+AG PF + + + FS P W
Sbjct: 274 SMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 234 --GAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
K LI R+L +PE R+T E+ +F +
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-106
Identities = 94/272 (34%), Positives = 150/272 (55%), Gaps = 13/272 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G G F++V + TG+ A+K + +S + ++ EI+++K ++H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHE 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V L ++ S T Y++++ ++GGELFD+I+ G +E +A QQ++ V Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPENLL + + I+DFGLS + + G+ + T CGTP YVAPEVL+ K Y
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPEVLAQKPY 184
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
A D WS GVI Y+L+ GY PF E + L+ K+++ +F P W + AK I
Sbjct: 185 -SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFIC 243
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLI 272
+L+ +P R T E+ + W + I
Sbjct: 244 HLLEKDPNERYTCEKALSHPWIDGNTALHRDI 275
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-106
Identities = 97/277 (35%), Positives = 151/277 (54%), Gaps = 10/277 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y+V +G+G F+ V+ + TG A K+++ + ++RE I + ++HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHP 88
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+VRLH+ + + Y++ + +TGGELF+ IV SE++A QQ+++ + YCHS G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HR+LKPENLLL S+ +K++DFGL+ GTP Y++PEVL Y
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPY 207
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
D+W+CGVILY+L+ GY PF + D LY++++ D+ P W V AKSLI
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDV 277
+L NP+ RIT ++ W I +D
Sbjct: 267 SMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-105
Identities = 75/296 (25%), Positives = 114/296 (38%), Gaps = 40/296 (13%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+ G +E+ +G G F V + +TGE VA+K + K++ ++ EI IMK
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKK 68
Query: 64 VRHPCVVRLHEVLASRTKI------YIILEFITGGELFDKIVHHGR---LSESEARRYFQ 114
+ HP VV EV K+ + +E+ GG+L + L E R
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTP 171
+ + Y H + HRDLKPEN++L KI D G + +QG L GT
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTL 187
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF-DELDLTTLYSKVEKADFSCPTW 230
Y+APE+L K Y D WS G + + I G+ PF + KV +
Sbjct: 188 QYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 231 FPV-------------------GAKSLIHR----ILDPNPETRITIEEIRNDEWFR 263
+ + R +L + R T + N F+
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-105
Identities = 78/268 (29%), Positives = 131/268 (48%), Gaps = 15/268 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ R +G G F V + +G +K +++ +QI+ EI ++K + HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVDYC 123
++++ EV +YI++E GGEL ++IV LSE +Q+++ + Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 124 HSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
HS+ V H+DLKPEN+L +KI DFGL+ L + GT Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVF- 198
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT-WFPV--GAKS 237
+ D+WS GV++Y L+ G LPF L + K + + P+ A
Sbjct: 199 KRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVD 257
Query: 238 LIHRILDPNPETRITIEEIRNDEWFRKG 265
L+ ++L +PE R + ++ + EWF++
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = e-104
Identities = 65/279 (23%), Positives = 128/279 (45%), Gaps = 21/279 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y + + IG G +KV N E + A+K ++ + D + EI+ + ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRNEIAYLNKLQQH 67
Query: 68 C--VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
++RL++ + IY+++E +L + + E + Y++ +++ V H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTT-CGTPNYVAPEVLSHKG 183
G+ H DLKP N L+ G LK+ DFG++ + S+++ + GT NY+ PE +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 184 YN----------GAAADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVE-KADFSCPTW 230
+ +DVWS G ILY + G PF ++ ++ L++ ++ + P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 231 FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269
+ ++ L +P+ RI+I E+ + + PV
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-104
Identities = 96/264 (36%), Positives = 149/264 (56%), Gaps = 11/264 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y + +G+G+F +V ++ T + A+KV+++++ K I RE+ ++K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L E+L + YI+ E TGGELFD+I+ R SE +A R +Q+ G+ Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPEN+LL+S+ +KI DFGLS +Q + ++ GT Y+APEVL Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVL-RGTY 199
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
DVWS GVILY+L++G PF + + +VE F P W + AK LI
Sbjct: 200 -DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 241 RILDPNPETRITIEEIRNDEWFRK 264
++L +P RIT + W +K
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQK 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = e-103
Identities = 65/286 (22%), Positives = 129/286 (45%), Gaps = 21/286 (7%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+ K Y + + IG G +KV N E + A+K ++ + D + EI+ +
Sbjct: 51 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYL 108
Query: 62 KLVRHPC--VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDG 119
++ ++RL++ + IY+++E +L + + E + Y++ +++
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTT-CGTPNYVAPE 177
V H G+ H DLKP N L+ G LK+ DFG++ + S+++ + G NY+ PE
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 178 VLSHKGYN----------GAAADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVE-KAD 224
+ + +DVWS G ILY + G PF ++ ++ L++ ++ +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 225 FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270
P + ++ L +P+ RI+I E+ + + PV
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-103
Identities = 65/319 (20%), Positives = 118/319 (36%), Gaps = 52/319 (16%)
Query: 1 MVVRKVGK--YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI 58
M + + + +G+G A V ++ +TG+ A+KV + + ++ D RE
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58
Query: 59 SIMKLVRHPCVVRLHEVLASRTK--IYIILEFITGGELFDKIVHHGR---LSESEARRYF 113
++K + H +V+L + T +I+EF G L+ + L ESE
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ ++ G+++ G+ HR++KP N++ D Q K++DFG + E + G
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177
Query: 170 TPNYVAPEVLS--------HKGYNGAAADVWSCGVILYVLIAGYLPFDEL----DLTTLY 217
T Y+ P++ K Y GA D+WS GV Y G LPF +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 218 SKVEKADFSC-------------------PTWFPVG------AKSLIHRILDPNPETRIT 252
K+ S P + ++ IL+ + E
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 253 IEEIRNDEWFRKGYVPVKL 271
++ +
Sbjct: 297 FDQFFAETSDILHRGNSHH 315
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-103
Identities = 97/265 (36%), Positives = 147/265 (55%), Gaps = 9/265 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y++ +G+G F+ V+ G+ A +++ + ++RE I +L++HP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHP 70
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+VRLH+ ++ Y+I + +TGGELF+ IV SE++A QQ+++ V +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
V HR+LKPENLLL S+ +K++DFGL+ E GTP Y++PEVL Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
G D+W+CGVILY+L+ GY PF + D LY +++ DF P W V AK LI+
Sbjct: 191 -GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249
Query: 241 RILDPNPETRITIEEIRNDEWFRKG 265
++L NP RIT E W
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHR 274
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-102
Identities = 93/274 (33%), Positives = 146/274 (53%), Gaps = 15/274 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+EV +G G + V + T + A+KV + K ++ EI ++ + HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKV-----LKKTVDKKIVRTEIGVLLRLSHP 108
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L E+ + T+I ++LE +TGGELFD+IV G SE +A +Q+++ V Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPENLL + LKI+DFGLS + E L++T CGTP Y APE+L Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAY 227
Query: 185 NGAAADVWSCGVILYVLIAGYLPF-DELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLI 239
G D+WS G+I Y+L+ G+ PF DE ++ ++ F P W V AK L+
Sbjct: 228 -GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273
+++ +P+ R+T + W ++
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMD 320
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = e-100
Identities = 89/268 (33%), Positives = 152/268 (56%), Gaps = 13/268 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA---DQIKREISIMKLV 64
YE+G +G G FA V+ + TG+ A K + + + + ++I+RE++I++ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
RHP ++ LH++ ++T + +ILE ++GGELFD + L+E EA ++ +Q++DGV Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 125 SKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
SK + H DLKPEN++L + +K+ DFG++ E G + + GTP +VAPE+++
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVN 184
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAK 236
++ G AD+WS GVI Y+L++G PF + + DF + AK
Sbjct: 185 YEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 243
Query: 237 SLIHRILDPNPETRITIEEIRNDEWFRK 264
I R+L +P+ R+TI + W +
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKA 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = e-100
Identities = 65/309 (21%), Positives = 117/309 (37%), Gaps = 52/309 (16%)
Query: 1 MVVRKVGK--YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI 58
M + + + +G+G A V ++ +TG+ A+KV + + ++ D RE
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58
Query: 59 SIMKLVRHPCVVRLHEVLASRTK--IYIILEFITGGELFDKIVHHGR---LSESEARRYF 113
++K + H +V+L + T +I+EF G L+ + L ESE
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ ++ G+++ G+ HR++KP N++ D Q K++DFG + E + G
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177
Query: 170 TPNYVAPEVLS--------HKGYNGAAADVWSCGVILYVLIAGYLPFDEL----DLTTLY 217
T Y+ P++ K Y GA D+WS GV Y G LPF +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 218 SKVEKADFS-------------------------CPTWFPVGAKSLIHRILDPNPETRIT 252
K+ S V ++ IL+ + E
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 253 IEEIRNDEW 261
++ +
Sbjct: 297 FDQFFAETS 305
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 1e-99
Identities = 88/270 (32%), Positives = 132/270 (48%), Gaps = 20/270 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRH 66
YEV IG G+++ K + T A+K++D+S EI I+ + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQH 75
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P ++ L +V +Y++ E + GGEL DKI+ SE EA + V+Y H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 127 GVYHRDLKPENLLLDSQGH----LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
GV HRDLKP N+L + ++I DFG + LL T C T N+VAPEVL +
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTT---LYSKVEKA--DFSCPTWFPV--GA 235
GY AA D+WS GV+LY ++ GY PF T + +++ S W V A
Sbjct: 196 GY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 236 KSLIHRILDPNPETRITIEEIRNDEWFRKG 265
K L+ ++L +P R+T + W
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 1e-99
Identities = 88/271 (32%), Positives = 145/271 (53%), Gaps = 15/271 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ--IKREISIMKLVR 65
YE+ IG+G F+ V+ N ETG+ A+K++D + +KRE SI +++
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVD 121
HP +V L E +S +Y++ EF+ G +L +IV SE+ A Y +Q+++ +
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 122 YCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
YCH + HRD+KP +LL S+ + +K+ FG++ + + GTP+++APEV
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--G 234
+ + Y G DVW CGVIL++L++G LPF L+ + K + W +
Sbjct: 205 VKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISES 262
Query: 235 AKSLIHRILDPNPETRITIEEIRNDEWFRKG 265
AK L+ R+L +P RIT+ E N W ++
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 3e-99
Identities = 95/281 (33%), Positives = 149/281 (53%), Gaps = 13/281 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA---DQIKREISIMKLV 64
Y++G +G G FA VK + TG A K + + + ++I+RE+SI++ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
H V+ LH+V +RT + +ILE ++GGELFD + LSE EA + +Q++DGV+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 125 SKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
+K + H DLKPEN++L + H+K+ DFGL+ E G + GTP +VAPE+++
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVN 191
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAK 236
++ G AD+WS GVI Y+L++G PF + + DF + AK
Sbjct: 192 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 237 SLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDV 277
I ++L R+TI+E W ++ E V
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 3e-99
Identities = 92/269 (34%), Positives = 146/269 (54%), Gaps = 13/269 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA---DQIKREISIMKLV 64
Y+ G +G G FA VK + TG A K + + + + I+RE+SI+K +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+HP V+ LHEV ++T + +ILE + GGELFD + L+E EA + +Q+++GV Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 125 SKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
S + H DLKPEN++L + +KI DFGL+ + G + + GTP +VAPE+++
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVN 190
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAK 236
++ G AD+WS GVI Y+L++G PF + V +F + AK
Sbjct: 191 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 237 SLIHRILDPNPETRITIEEIRNDEWFRKG 265
I R+L +P+ R+TI++ W +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 1e-98
Identities = 81/310 (26%), Positives = 133/310 (42%), Gaps = 53/310 (17%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ--IKREISIMKLVR 65
KY + IG+G++ V+ A +T A+K+++++ I + D IK E+ +MK +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR---------------------- 103
HP + RL+EV I +++E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 104 ------------------LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG- 144
E +Q+ + Y H++G+ HRD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 145 -HLKISDFGLS----ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVIL 198
+K+ DFGLS L + T GTP +VAPEVL+ + G D WS GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 199 YVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIHRILDPNPETRITIE 254
++L+ G +PF ++ S+V F P + + A+ L+ +L+ N + R
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326
Query: 255 EIRNDEWFRK 264
W +
Sbjct: 327 RALQHPWISQ 336
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 1e-98
Identities = 97/292 (33%), Positives = 152/292 (52%), Gaps = 17/292 (5%)
Query: 1 MVVRKVG----KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA---DQ 53
M K Y++G +G G FA VK + TG A K + + + ++
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 54 IKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYF 113
I+RE+SI++ V HP ++ LH+V +RT + +ILE ++GGELFD + LSE EA +
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGVSLLRTTCG 169
+Q++DGV+Y H+K + H DLKPEN++L + H+K+ DFGL+ E G + G
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFG 180
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSC 227
TP +VAPE+++++ G AD+WS GVI Y+L++G PF + + DF
Sbjct: 181 TPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239
Query: 228 PTWFPV--GAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDV 277
+ AK I ++L R+TI+E W ++ E V
Sbjct: 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 2e-97
Identities = 97/264 (36%), Positives = 151/264 (57%), Gaps = 11/264 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y + +G+G+F +V ++ T + A+KV+++++ K+K I RE+ ++K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHP 81
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L E+L + YI+ E TGGELFD+I+ R SE +A R +Q+ G+ Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPEN+LL+S+ +KI DFGLS +Q + ++ GT Y+APEVL Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVL-RGTY 199
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
DVWS GVILY+L++G PF + + +VE F P W + AK LI
Sbjct: 200 -DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 241 RILDPNPETRITIEEIRNDEWFRK 264
++L +P RIT + W +K
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQK 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 3e-97
Identities = 97/264 (36%), Positives = 152/264 (57%), Gaps = 10/264 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ R +G+G+F +V ++ TG+ A+KV+ + + + + + RE+ ++K + HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L+E + Y++ E TGGELFD+I+ R SE +A R +Q++ G+ Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPENLLL+S+ +++I DFGLS E ++ GT Y+APEVL H Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVL-HGTY 204
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
DVWS GVILY+L++G PF+ + + KVEK F P W V AK LI
Sbjct: 205 -DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263
Query: 241 RILDPNPETRITIEEIRNDEWFRK 264
++L P RI+ + + EW +
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQT 287
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 3e-97
Identities = 91/276 (32%), Positives = 148/276 (53%), Gaps = 25/276 (9%)
Query: 8 KYEVG---RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
Y++ + +GEG+F+ + + ++ ++ A+K+ I K A+ ++EI+ +KL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKI-----ISKRMEAN-TQKEITALKLC 62
Query: 65 R-HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
HP +V+LHEV + ++++E + GGELF++I SE+EA ++L+ V +
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 124 HSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
H GV HRDLKPENLL + +KI DFG + L L+T C T +Y APE+L+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFD-------ELDLTTLYSKVEKA--DFSCPTWF 231
GY + D+WS GVILY +++G +PF + K++K F W
Sbjct: 183 QNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241
Query: 232 PV--GAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265
V AK LI +L +P R+ + +R +EW + G
Sbjct: 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 5e-96
Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 13/264 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + +G G F V T + ++ K + + +K+EISI+ + RH
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSK 126
++ LHE S ++ +I EFI+G ++F++I L+E E Y Q+ + + + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 127 GVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ H D++PEN++ ++ +KI +FG + + G R P Y APEV H
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV 180
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
A D+WS G ++YVL++G PF + + A F + + A +
Sbjct: 181 -STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 241 RILDPNPETRITIEEIRNDEWFRK 264
R+L ++R+T E W ++
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQ 263
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 5e-96
Identities = 89/269 (33%), Positives = 140/269 (52%), Gaps = 14/269 (5%)
Query: 8 KYEV-GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
Y + + +G G FA V+ + TG+ A K L + + A+ I EI++++L +
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKS 87
Query: 67 -PCVVRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYC 123
P V+ LHEV + ++I +ILE+ GGE+F + +SE++ R +Q+++GV Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 124 HSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
H + H DLKP+N+LL S G +KI DFG+S LR GTP Y+APE+L+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILN 206
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAK 236
+ A D+W+ G+I Y+L+ PF D Y + + D+S T+ V A
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT 265
Query: 237 SLIHRILDPNPETRITIEEIRNDEWFRKG 265
I +L NPE R T E + W ++
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 7e-96
Identities = 92/265 (34%), Positives = 151/265 (56%), Gaps = 11/265 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y+ + +G G + +V ++ T A+K++ ++++ + + E++++KL+ HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHP 96
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L++ + Y+++E GGELFD+I+H + +E +A +Q++ GV Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPENLLL+S+ +KI DFGLSA+ E ++ GT Y+APEVL K Y
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVL-RKKY 214
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
DVWS GVIL++L+AGY PF + KVEK F P W V GAK LI
Sbjct: 215 -DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 241 RILDPNPETRITIEEIRNDEWFRKG 265
++L + + RI+ ++ W ++
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEM 298
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 2e-95
Identities = 94/275 (34%), Positives = 145/275 (52%), Gaps = 20/275 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA----------DQIKRE 57
Y R +G G + +V + A+KV+ +S K + + ++I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 58 ISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI 117
IS++K + HP +++L +V + Y++ EF GGELF++I++ + E +A +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
G+ Y H + HRD+KPEN+LL+++ ++KI DFGLS+ + LR GT Y+
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYI 215
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFP 232
APEVL K Y DVWSCGVI+Y+L+ GY PF + + KVEK F W
Sbjct: 216 APEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN 273
Query: 233 V--GAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265
+ AK LI +L + R T EE N W +K
Sbjct: 274 ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 9e-95
Identities = 76/264 (28%), Positives = 131/264 (49%), Gaps = 12/264 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y++ +G G F V TG K ++ + +K EISIM + HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHP 108
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSK 126
++ LH+ + ++ +ILEF++GGELFD+I ++SE+E Y +Q +G+ + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 127 GVYHRDLKPENLLLDSQG--HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ H D+KPEN++ +++ +KI DFGL+ +++ T T + APE++ +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPV 227
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSLIH 240
G D+W+ GV+ YVL++G PF D V++ +F + V AK I
Sbjct: 228 -GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286
Query: 241 RILDPNPETRITIEEIRNDEWFRK 264
+L P R+T+ + W +
Sbjct: 287 NLLQKEPRKRLTVHDALEHPWLKG 310
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 1e-93
Identities = 79/268 (29%), Positives = 135/268 (50%), Gaps = 18/268 (6%)
Query: 8 KYEVGRT--IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ--IKREISIMKL 63
Y V +T +G G F +V + T TG +A K+ I M D+ +K EIS+M
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI-----IKTRGMKDKEEVKNEISVMNQ 142
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDY 122
+ H +++L++ S+ I +++E++ GGELFD+I+ L+E + + +Q+ +G+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRH 202
Query: 123 CHSKGVYHRDLKPENLLLDSQG--HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
H + H DLKPEN+L ++ +KI DFGL+ + L+ GTP ++APEV++
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVN 261
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAK 236
+ D+WS GVI Y+L++G PF + + + D + + AK
Sbjct: 262 YDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 237 SLIHRILDPNPETRITIEEIRNDEWFRK 264
I ++L RI+ E W
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSD 348
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 3e-92
Identities = 84/277 (30%), Positives = 133/277 (48%), Gaps = 30/277 (10%)
Query: 8 KYEVGR-TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVR 65
Y++ + +G G KV + TG+ A+K+L S + ++E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 66 HPCVVRLHEV----LASRTKIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDG 119
P +V + +V + + II+E + GGELF +I +E EA + +
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+ + HS + HRD+KPENLL S+ LK++DFG + Q L+T C TP YVAP
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAP 198
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPF----DELDLTTLYSKVEKA--DFSCPTW 230
EVL + Y + D+WS GVI+Y+L+ G+ PF + + ++ F P W
Sbjct: 199 EVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257
Query: 231 FPV--GAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265
V AK LI +L +P R+TI + N W +
Sbjct: 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 4e-92
Identities = 82/272 (30%), Positives = 136/272 (50%), Gaps = 16/272 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ--IKREISIMKLVR 65
Y++ +G G F V TG + A K ++ +D+ +++EI M ++R
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKF-----VMTPHESDKETVRKEIQTMSVLR 212
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCH 124
HP +V LH+ ++ +I EF++GGELF+K+ H ++SE EA Y +Q+ G+ + H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 125 SKGVYHRDLKPENLLLDSQG--HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
H DLKPEN++ ++ LK+ DFGL+A + ++ T GT + APEV K
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGK 331
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPV--GAKSL 238
G D+WS GV+ Y+L++G PF + V+ + + + K
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 239 IHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270
I ++L +P TR+TI + W G P +
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 9e-92
Identities = 90/275 (32%), Positives = 132/275 (48%), Gaps = 28/275 (10%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRHP 67
+ +G G KV N T E A+K+L + +RE+ + + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCP 115
Query: 68 CVVRLHEV----LASRTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVD 121
+VR+ +V A R + I++E + GGELF +I G +E EA + + + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 122 YCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
Y HS + HRD+KPENLL S+ LK++DFG + S L T C TP YVAPEV
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEV 234
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPF-DELDLTT---LYSKVEKA--DFSCPTWFP 232
L + Y + D+WS GVI+Y+L+ GY PF L + +++ +F P W
Sbjct: 235 LGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 233 V--GAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265
V K LI +L P R+TI E N W +
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 5e-91
Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 40/294 (13%)
Query: 8 KYEVGR-TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
Y++ +GEG A+V+ N T + A+K++++ + ++ RE+ ++ +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQG 69
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
H V+ L E + Y++ E + GG + I +E EA Q + +D+ H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 126 KGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVS-------LLRTTCGTPNYVA 175
KG+ HRDLKPEN+L + +KI DF L + + L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 176 PEVL-----SHKGYNGAAADVWSCGVILYVLIAGYLPFD---------------ELDLTT 215
PEV+ Y D+WS GVILY+L++GY PF
Sbjct: 190 PEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 216 LYSKVEKA--DFSCPTWFPV--GAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265
L+ +++ +F W + AK LI ++L + + R++ ++ W +
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 1e-89
Identities = 44/304 (14%), Positives = 93/304 (30%), Gaps = 51/304 (16%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+ G +G+ A + ETGES + V + Q+K E+ ++L
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 64 VR-------------------------HPCVVRLHEVLASRTKIYIILEF--------IT 90
+R ++R+ + +
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150
G L H L + Q+I + H G+ H L+P +++LD +G + ++
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 151 FGLSALPEQGVSLLRTTCGTPNYVAPEVLS----------HKGYNGAAADVWSCGVILYV 200
F + + + PE+ + + + D W+ G+++Y
Sbjct: 250 FEHLVRD----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 201 LIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDE 260
+ LP + + F P ++L+ L E R+ +
Sbjct: 306 IWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 361
Query: 261 WFRK 264
+ +
Sbjct: 362 EYEQ 365
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 1e-88
Identities = 79/264 (29%), Positives = 135/264 (51%), Gaps = 9/264 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++ G+ +GEG+F+ V A+ T A+K+L++ IIK + RE +M + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
V+L+ K+Y L + GEL I G E+ R Y +++ ++Y H KG+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGTPNYVAPEVLSHKGYNG 186
HRDLKPEN+LL+ H++I+DFG + + R GT YV+PE+L+ K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-C 210
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246
++D+W+ G I+Y L+AG PF + ++ K+ K ++ P F A+ L+ ++L +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 247 PETRITI------EEIRNDEWFRK 264
R+ ++ +F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFFES 294
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 5e-85
Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 14/272 (5%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ YEV TIG G++ + + + G+ + K LD ++ + E+++++ +
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL 62
Query: 65 RHPCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLID 118
+HP +VR ++ + RT +YI++E+ GG+L I + L E R QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 119 GVDYCHSKG-----VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY 173
+ CH + V HRDLKP N+ LD + ++K+ DFGL+ + S +T GTP Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC-PTWFP 232
++PE ++ YN +D+WS G +LY L A PF L K+ + F P +
Sbjct: 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 233 VGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
+I R+L+ R ++EEI + +
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 6e-83
Identities = 70/260 (26%), Positives = 131/260 (50%), Gaps = 5/260 (1%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + IGEG+F K ++TE G +K ++ S + K ++ +RE++++ ++HP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHP 83
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHS 125
+V+ E +YI++++ GG+LF +I E + +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ + HRD+K +N+ L G +++ DFG++ + V L R GTP Y++PE+ +K YN
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC-PTWFPVGAKSLIHRILD 244
+D+W+ G +LY L F+ + L K+ F + +SL+ ++
Sbjct: 204 -NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFK 262
Query: 245 PNPETRITIEEIRNDEWFRK 264
NP R ++ I + K
Sbjct: 263 RNPRDRPSVNSILEKGFIAK 282
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 1e-82
Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 29/287 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD--QIKREISIMKLVR 65
Y + +GEG F+ V + G A+K I+ H+ D + +RE + +L
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR-----ILCHEQQDREEAQREADMHRLFN 84
Query: 66 HPCVVRLHEVLASRT----KIYIILEFITGGELFDKI----VHHGRLSESEARRYFQQLI 117
HP ++RL + +++L F G L+++I L+E + +
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR---------TTC 168
G++ H+KG HRDLKP N+LL +G + D G V R
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 169 GTPNYVAPEVLSHKGYN--GAAADVWSCGVILYVLIAGYLPFDELDLTT-LYSKVEKADF 225
T +Y APE+ S + + DVWS G +LY ++ G P+D + + +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
Query: 226 SCPTW--FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270
S P L++ ++ +P R I + + + P +
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 3e-82
Identities = 77/283 (27%), Positives = 119/283 (42%), Gaps = 36/283 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRH 66
+ V R + EG FA V AQ+ +G A+K L + + + I +E+ MK L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGH 85
Query: 67 PCVVRLH-------EVLASRTKIYIILEFITGGELFDKIV---HHGRLSESEARRYFQQL 116
P +V+ E + +++L + G+L + + G LS + F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 117 IDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR--------- 165
V + H + + HRDLK ENLLL +QG +K+ DFG +
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 166 ---TTCGTPNYVAPEV--LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV 220
T TP Y PE+ L G D+W+ G ILY+L PF++ ++
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRI 261
Query: 221 EKADFSCPTW--FPVGAKSLIHRILDPNPETRITIEEIRNDEW 261
+S P SLI +L NPE R++I E+ +
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 2e-81
Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 45/294 (15%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRH 66
+ +G G+ V F + G VA+K + D EI ++ + H
Sbjct: 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLI------DFCDIALMEIKLLTESDDH 68
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-------RLSESEARRYFQQLIDG 119
P V+R + + +YI LE L D + E +Q+ G
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGH-------------LKISDFGLSALPEQGVS---- 162
V + HS + HRDLKP+N+L+ + + ISDFGL + G S
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 163 LLRTTCGTPNYVAPEVLSHKGYN------GAAADVWSCGVILYVLI-AGYLPFD---ELD 212
L GT + APE+L + D++S G + Y ++ G PF +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 213 LTTLYSKVEKADFSCPTWFPV--GAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
+ + C + A LI +++D +P R T ++ F
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 2e-80
Identities = 86/260 (33%), Positives = 143/260 (55%), Gaps = 9/260 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++ +T+G G+F +V ++ E+G AMK+LD+ ++K K + E I++ V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V+L + +Y+++E++ GGE+F + GR SE AR Y Q++ +Y HS +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPENLL+D QG+++++DFG + + T CGTP +APE++ KGY A
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---TLCGTPEALAPEIILSKGY-NKA 218
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248
D W+ GV++Y + AGY PF +Y K+ P+ F K L+ +L +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 249 TRI-----TIEEIRNDEWFR 263
R + +I+N +WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWFA 298
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 4e-80
Identities = 86/260 (33%), Positives = 148/260 (56%), Gaps = 9/260 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+++ RT+G G+F +V ++ G AMKVL + +++ K + E ++ +V HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++R+ +I++I+++I GGELF + R A+ Y ++ ++Y HSK +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPEN+LLD GH+KI+DFG + + + T CGTP+Y+APEV+S K Y +
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVSTKPY-NKS 183
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248
D WS G+++Y ++AGY PF + + Y K+ A+ P +F K L+ R++ +
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 243
Query: 249 TRI-----TIEEIRNDEWFR 263
R+ E+++N WF+
Sbjct: 244 QRLGNLQNGTEDVKNHPWFK 263
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 1e-79
Identities = 45/303 (14%), Positives = 83/303 (27%), Gaps = 45/303 (14%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+ K ++ + G + V ++ E E A+KV A +++
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 64 VRHPCVVRLHEVL--------------------------ASRTKIYIILEFITG-----G 92
+ + + +++ +
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 93 ELFDKIVHHGRLSESEARRYF-QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151
D + A QLI SKG+ H P+NL + G L + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIAGYLPFDE 210
+ + Y E L+ A + W G+ +Y + +LPF
Sbjct: 239 SALWKVG---TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 211 LDLTT---------LYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEW 261
+ + F T P K+LI R L+ + R+ E
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355
Query: 262 FRK 264
F +
Sbjct: 356 FLQ 358
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 6e-79
Identities = 78/275 (28%), Positives = 120/275 (43%), Gaps = 49/275 (17%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHP 67
+ +G G KV N T E A+K+L + +RE+ + + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCP 71
Query: 68 CVVRLHEV----LASRTKIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVD 121
+VR+ +V A R + I++E + GGELF +I +E EA + + + +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 122 YCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
Y HS + HRD+KPENLL S+ LK++DFG A E
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKET 170
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPF-DELDLTT---LYSKVEKA--DFSCPTWFP 232
+ Y + D+WS GVI+Y+L+ GY PF L + +++ +F P W
Sbjct: 171 T-GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 228
Query: 233 V--GAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265
V K LI +L P R+TI E N W +
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 1e-77
Identities = 64/281 (22%), Positives = 103/281 (36%), Gaps = 28/281 (9%)
Query: 3 VRKVGK--YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
V VGK + +G G + + VA+K + RE+ +
Sbjct: 18 VVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQL 70
Query: 61 MK-LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLID 118
++ HP V+R R YI +E L + + E QQ
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS 129
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGH-----LKISDFGLSALPEQGVS---LLRTTCGT 170
G+ + HS + HRDLKP N+L+ ISDFGL G GT
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 171 PNYVAPEVLS---HKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFS 226
++APE+LS + D++S G + Y V+ G PF + +
Sbjct: 190 EGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD 248
Query: 227 CPTWFP---VGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
C V A+ LI +++ +P+ R + + + +F
Sbjct: 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 1e-77
Identities = 74/283 (26%), Positives = 135/283 (47%), Gaps = 9/283 (3%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
M + + + + IG G F++V A G VA+K + ++ K +EI +
Sbjct: 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDL 85
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQL 116
+K + HP V++ + ++ I+LE G+L I H + + E +YF QL
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+++ HS+ V HRD+KP N+ + + G +K+ D GL + + GTP Y++P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPF--DELDLTTLYSKVEKADFSC--PTWFP 232
E + GYN +D+WS G +LY + A PF D+++L +L K+E+ D+ +
Sbjct: 206 ERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264
Query: 233 VGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYE 275
+ L++ ++P+PE R + + + L +
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 2e-77
Identities = 70/257 (27%), Positives = 133/257 (51%), Gaps = 7/257 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R IG+G+F KV Q +T + AMK +++ ++ + +E+ IM+ + HP +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
++++++ + GG+L + + E + + +L+ +DY ++ + HRD
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG--AAAD 190
+KP+N+LLD GH+ I+DF ++A+ + + + T GT Y+APE+ S + G A D
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199
Query: 191 VWSCGVILYVLIAGYLPF---DELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247
WS GV Y L+ G P+ + E + P+ + SL+ ++L+PNP
Sbjct: 200 WWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNP 259
Query: 248 ETRI-TIEEIRNDEWFR 263
+ R + +++N +
Sbjct: 260 DQRFSQLSDVQNFPYMN 276
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-76
Identities = 66/274 (24%), Positives = 114/274 (41%), Gaps = 31/274 (11%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++ IG G F +V A++ G++ +K +K+ ++ +RE+ + + H
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIK------RVKYN-NEKAEREVKALAKLDHVN 65
Query: 69 VVRLHE----------------VLASRTKIYIILEFITGGELFDKIV--HHGRLSESEAR 110
+V + + ++I +EF G L I +L + A
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 111 RYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170
F+Q+ GVDY HSK + +RDLKP N+ L +KI DFGL + + GT
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKGT 184
Query: 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW 230
Y++PE +S + Y D+++ G+IL L+ E ++ +
Sbjct: 185 LRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGII--SDI 239
Query: 231 FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
F K+L+ ++L PE R EI K
Sbjct: 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 3e-76
Identities = 65/259 (25%), Positives = 109/259 (42%), Gaps = 8/259 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ +G G++ +V ++ E G A+K A ++ S K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSK 126
C VRL + +Y+ E G L G L E++ Y + + + + HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
G+ H D+KP N+ L +G K+ DFGL G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELL-QGSYG- 233
Query: 187 AAADVWSCGVILYVLIAGY-LPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDP 245
AADV+S G+ + + LP L +F +S++ +L+P
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMMLEP 291
Query: 246 NPETRITIEEIRNDEWFRK 264
+P+ R T E + R+
Sbjct: 292 DPKLRATAEALLALPVLRQ 310
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-74
Identities = 84/256 (32%), Positives = 132/256 (51%), Gaps = 6/256 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + TG AMK+L + II E +++ RHP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ ++ ++E+ GGELF + +E AR Y +++ ++Y HS+ V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
+K ENL+LD GH+KI+DFGL + ++T CGTP Y+APEVL Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 193 SCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI- 251
GV++Y ++ G LPF D L+ + + P AKSL+ +L +P+ R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
Query: 252 ----TIEEIRNDEWFR 263
+E+ +F
Sbjct: 250 GGPSDAKEVMEHRFFL 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-74
Identities = 50/294 (17%), Positives = 95/294 (32%), Gaps = 42/294 (14%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL----- 63
G +G+ A + ETGES + V + Q+K E+ ++L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 64 -----------------VRHPCVVRLHEVLASRTKIYIILEFIT-----------GGELF 95
V+ P ++ V ++++ F G L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 96 DKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155
H L + Q+I + H G+ H L+P +++LD +G + ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 156 LP-EQGVSLLRTTCGTPNYVAPEVLSHKGYN----GAAADVWSCGVILYVLIAGYLPFDE 210
VS + P A +L ++ A D W+ G+ +Y + LP +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 211 LDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
+ F P ++L+ L E R+ + + +
Sbjct: 320 DAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-73
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 33/297 (11%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
R + +E + +G G F V A+N + A+K + + +++ RE+ +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAK 59
Query: 64 VRHPCVVRLHEV------------LASRTKIYIILEFITGGELFDKIVHHGRLSESE--- 108
+ HP +VR + + +YI ++ L D + + E E
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 109 ARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL------------ 156
F Q+ + V++ HSKG+ HRDLKP N+ +K+ DFGL
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
P + GT Y++PE + Y+ D++S G+IL+ L+ Y +++
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMERVRT 236
Query: 217 YSKVEKADFS-CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLI 272
+ V F T ++ +L P+P R I + F P K +
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 3e-73
Identities = 85/261 (32%), Positives = 140/261 (53%), Gaps = 10/261 (3%)
Query: 13 RTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVRHPC 68
R +G+G + KV + TG+ AMKVL ++ I+ K K E +I++ V+HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V L + K+Y+ILE+++GGELF ++ G E A Y ++ + + H KG+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPEN++L+ QGH+K++DFGL ++ T CGT Y+APE+L G+ A
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRA 201
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248
D WS G ++Y ++ G PF + K+ K + P + A+ L+ ++L N
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAA 261
Query: 249 TRI-----TIEEIRNDEWFRK 264
+R+ E++ +FR
Sbjct: 262 SRLGAGPGDAGEVQAHPFFRH 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-73
Identities = 87/256 (33%), Positives = 132/256 (51%), Gaps = 6/256 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
+ IG+G+F KV A++ A+KVL + AI+K K I E +++ K V+HP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + K+Y +L++I GGELF + E AR Y ++ + Y HS + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKPEN+LLDSQGH+ ++DFGL + S T CGTP Y+APEVL + Y D
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDW 222
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W G +LY ++ G PF + +Y + A+ L+ +L + R+
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 282
Query: 252 ----TIEEIRNDEWFR 263
EI++ +F
Sbjct: 283 GAKDDFMEIKSHVFFS 298
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 7e-73
Identities = 79/253 (31%), Positives = 133/253 (52%), Gaps = 3/253 (1%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+ +G+G+F KV A+ +T + A+K L + ++ + E ++ L HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
+ ++ ++ ++E++ GG+L I + S A Y ++I G+ + HSKG+ +R
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD GH+KI+DFG+ G + T CGTP+Y+APE+L + Y + D
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDW 201
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
WS GV+LY ++ G PF D L+ + + P W AK L+ ++ PE R+
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 261
Query: 252 -TIEEIRNDEWFR 263
+IR FR
Sbjct: 262 GVRGDIRQHPLFR 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-72
Identities = 44/286 (15%), Positives = 101/286 (35%), Gaps = 36/286 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFA-----QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
V +GEG FA+V A + + + +KV + + + + + +K
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI---GTQLMERLK 122
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-----LSESEARRYFQQLI 117
++ + + ++ E + G L + I + + + + +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 118 DGVDYCHSKGVYHRDLKPENLLL-----------DSQGHLKISDFGLSALPE--QGVSLL 164
++ H + H D+KP+N +L D L + D G S + ++
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLYSKVEKA 223
C T + E+LS+K +N D + +Y ++ G Y+ + +
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 224 DFSCPTWFPVGAKSLIHRILDPNPETRIT-IEEIRN--DEWFRKGY 266
W H +L+ + ++ +R + F++ Y
Sbjct: 302 LPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-72
Identities = 87/260 (33%), Positives = 143/260 (55%), Gaps = 10/260 (3%)
Query: 13 RTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G+G+F KV K ++ + AMKVL ++ + K E I+ V HP +
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFI 88
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
V+LH + K+Y+IL+F+ GG+LF ++ +E + + Y +L +D+ HS G+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAA 189
+RDLKPEN+LLD +GH+K++DFGLS + CGT Y+APEV++ +G+ +A
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSA 207
Query: 190 DVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPET 249
D WS GV+++ ++ G LPF D + + KA P + A+SL+ + NP
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPAN 267
Query: 250 RI-----TIEEIRNDEWFRK 264
R+ +EEI+ +F
Sbjct: 268 RLGAGPDGVEEIKRHSFFST 287
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 2e-72
Identities = 76/257 (29%), Positives = 141/257 (54%), Gaps = 7/257 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+G+G+F KV ++ T E A+K+L + +I+ + E ++ L + P + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++Y ++E++ GG+L I GR E A Y ++ G+ + SKG+ +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N++LDS+GH+KI+DFG+ +T CGTP+Y+APE+++++ Y G + D
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 204
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W+ GV+LY ++AG PF+ D L+ + + + + P A ++ ++ +P R+
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 264
Query: 252 -----TIEEIRNDEWFR 263
+I+ +FR
Sbjct: 265 GCGPEGERDIKEHAFFR 281
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-72
Identities = 90/266 (33%), Positives = 142/266 (53%), Gaps = 13/266 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
YEV + IG G F +V+ ++ T + AMK+L + +IK + E IM P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV+L +Y+++E++ GG+L ++ + + E AR Y +++ +D HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-- 185
HRD+KP+N+LLD GHLK++DFG + ++G+ T GTP+Y++PEVL +G +
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 186 -GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV--EKADFSCPTWFPVG--AKSLIH 240
G D WS GV LY ++ G PF L YSK+ K + P + AK+LI
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
Query: 241 RILDPNPETRIT---IEEIRNDEWFR 263
L + E R+ +EEI+ +F+
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFK 334
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-72
Identities = 82/258 (31%), Positives = 135/258 (52%), Gaps = 8/258 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
R +G+G+F KV A+ ETG+ A+KVL + I++ + E I+ L HP + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L + +++ ++EF+ GG+L I R E+ AR Y ++I + + H KG+ +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD +GH K++DFG+ T CGTP+Y+APE+L Y G A D
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDW 207
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W+ GV+LY ++ G+ PF+ + L+ + + PTW A ++ + NP R+
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRL 267
Query: 252 ------TIEEIRNDEWFR 263
I +F+
Sbjct: 268 GSLTQGGEHAILRHPFFK 285
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 2e-71
Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 17/271 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG G F++V + +TG+ AMK++++ ++K + E ++
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKG 127
+ +LH +Y+++E+ GG+L + G R+ AR Y +++ +D H G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN- 185
HRD+KP+N+LLD GH++++DFG L G GTP+Y++PE+L G
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 186 -----GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV--EKADFSCPT---WFPVGA 235
G D W+ GV Y + G PF Y K+ K S P P A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 236 KSLIHRILDPNPETRIT---IEEIRNDEWFR 263
+ I R+L PETR+ + R +F
Sbjct: 303 RDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-71
Identities = 88/257 (34%), Positives = 133/257 (51%), Gaps = 7/257 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + TG AMK+L + I+ E +++ RHP + L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHR 131
+ ++ ++E+ GGELF + SE AR Y +++ +DY HS K V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK ENL+LD GH+KI+DFGL + + ++T CGTP Y+APEVL Y G A D
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 332
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W GV++Y ++ G LPF D L+ + + P AKSL+ +L +P+ R+
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 392
Query: 252 -----TIEEIRNDEWFR 263
+EI +F
Sbjct: 393 GGGSEDAKEIMQHRFFA 409
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 9e-71
Identities = 78/267 (29%), Positives = 142/267 (53%), Gaps = 17/267 (6%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
R IG G++AKV + +T AMKV+ + + + D ++ E + + HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++++ ++E++ GG+L + +L E AR Y ++ ++Y H +G+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLDS+GH+K++D+G+ + T CGTPNY+APE+L + Y G + D
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 193
Query: 192 WSCGVILYVLIAGYLPFDEL---------DLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
W+ GV+++ ++AG PFD + L+ + + P V A S++
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 253
Query: 243 LDPNPETRI------TIEEIRNDEWFR 263
L+ +P+ R+ +I+ +FR
Sbjct: 254 LNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-70
Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 17/270 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG G F +V + + AMK+L++ ++K + E ++
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ LH +Y+++++ GG+L + RL E AR Y +++ +D H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVL-----SH 181
HRD+KP+N+L+D GH++++DFG L E G GTP+Y++PE+L
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV--EKADFSCPTWFPVG---AK 236
Y G D WS GV +Y ++ G PF L Y K+ K F PT AK
Sbjct: 256 GRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 237 SLIHRILDPNPETRIT---IEEIRNDEWFR 263
LI R++ + E R+ IE+ + +F
Sbjct: 315 DLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 5e-70
Identities = 77/267 (28%), Positives = 142/267 (53%), Gaps = 17/267 (6%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
R IG G++AKV + +T AM+V+ + + + D ++ E + + HP +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++++ ++E++ GG+L + +L E AR Y ++ ++Y H +G+ +R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLDS+GH+K++D+G+ + T CGTPNY+APE+L + Y G + D
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 236
Query: 192 WSCGVILYVLIAGYLPFDEL---------DLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
W+ GV+++ ++AG PFD + L+ + + P V A S++
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 296
Query: 243 LDPNPETRI------TIEEIRNDEWFR 263
L+ +P+ R+ +I+ +FR
Sbjct: 297 LNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-69
Identities = 75/275 (27%), Positives = 135/275 (49%), Gaps = 16/275 (5%)
Query: 4 RKVGK--YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+ +G+ + R +G G F +V Q TG+ A K L++ + K K E I+
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLI 117
V +V L ++T + +++ + GG++ I + + E A Y Q++
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177
G+++ H + + +RDLKPEN+LLD G+++ISD GL+ + G + + GTP ++APE
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 178 VLSHKGYNGAAADVWSCGVILYVLIAGYLPFD----ELDLTTLYSKVEKADFSCPTWFPV 233
+L + Y + D ++ GV LY +IA PF +++ L +V + + P F
Sbjct: 360 LLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418
Query: 234 GAKSLIHRILDPNPETRI-----TIEEIRNDEWFR 263
+K +L +PE R+ + + +R FR
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-69
Identities = 76/257 (29%), Positives = 141/257 (54%), Gaps = 7/257 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+G+G+F KV ++ T E A+K+L + +I+ + E ++ L + P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++Y ++E++ GG+L I GR E A Y ++ G+ + SKG+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N++LDS+GH+KI+DFG+ +T CGTP+Y+APE+++++ Y G + D
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 525
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRI 251
W+ GV+LY ++AG PF+ D L+ + + + + P A ++ ++ +P R+
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 585
Query: 252 -----TIEEIRNDEWFR 263
+I+ +FR
Sbjct: 586 GCGPEGERDIKEHAFFR 602
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-68
Identities = 84/270 (31%), Positives = 148/270 (54%), Gaps = 20/270 (7%)
Query: 13 RTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVRH-P 67
+ +G G + KV + +TG+ AMKVL ++ I+ K K + + E +++ +R P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V LH + TK+++IL++I GGELF + R +E E + Y +++ +++ H G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTPNYVAPEVL--SHKG 183
+ +RD+K EN+LLDS GH+ ++DFGLS + ++ CGT Y+AP+++ G
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 184 YNGAAADVWSCGVILYVLIAGYLPF----DELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
+ A D WS GV++Y L+ G PF ++ + ++ K++ P AK LI
Sbjct: 239 H-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 297
Query: 240 HRILDPNPETRI-----TIEEIRNDEWFRK 264
R+L +P+ R+ +EI+ +F+K
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-68
Identities = 78/263 (29%), Positives = 128/263 (48%), Gaps = 13/263 (4%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCV 69
R IG G F +V + +TG+ AMK LD+ I + E ++ LV P +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
V + + K+ IL+ + GG+L + HG SE++ R Y ++I G+++ H++ V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAA 189
+RDLKP N+LLD GH++ISD GL+ + + GT Y+APEVL ++A
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 190 DVWSCGVILYVLIAGYLPF---DELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPN 246
D +S G +L+ L+ G+ PF D + P F +SL+ +L +
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 432
Query: 247 PETRI-----TIEEIRNDEWFRK 264
R+ +E++ +FR
Sbjct: 433 VNRRLGCLGRGAQEVKESPFFRS 455
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 1e-67
Identities = 81/273 (29%), Positives = 135/273 (49%), Gaps = 15/273 (5%)
Query: 4 RKVGK--YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+ V K + R +G+G F +V Q TG+ A K L++ I K K E I+
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDG 119
+ V VV L ++ + ++L + GG+L I H G+ E+ A Y ++ G
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
++ H + + +RDLKPEN+LLD GH++ISD GL+ +G + ++ GT Y+APEV+
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRVGTVGYMAPEVV 357
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA----DFSCPTWFPVGA 235
++ Y + D W+ G +LY +IAG PF + +VE+ F A
Sbjct: 358 KNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416
Query: 236 KSLIHRILDPNPETRI-----TIEEIRNDEWFR 263
+SL ++L +P R+ + E++ F+
Sbjct: 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-60
Identities = 53/281 (18%), Positives = 93/281 (33%), Gaps = 31/281 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ IG G F V G A+K + + ++ + L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVDYC 123
VVR A + I E+ GG L D I + R E+E + Q+ G+ Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 124 HSKGVYHRDLKPENLLLDSQGHL-------------------KISDFGLSALPEQGVSLL 164
HS + H D+KP N+ + KI D G +S
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR----ISSP 187
Query: 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD 224
+ G ++A EVL + AD+++ + + D + ++ +
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGR 244
Query: 225 FS-CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
P L+ ++ P+PE R + +
Sbjct: 245 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-57
Identities = 63/328 (19%), Positives = 109/328 (33%), Gaps = 74/328 (22%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKV----------------------LDRSAI 45
+E + +G G F V A+N + A+K L+ I
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 46 IKH---------------------------------KMADQIKREISIMKLVRHPCVVRL 72
+++ D +I M V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESE---ARRYFQQLIDGVDYCHSKGVY 129
+ + + +YI ++ L D + L + E F Q+ + V++ HSKG+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT------------CGTPNYVAPE 177
HRDLKP N+ +K+ DFGL +Q GT Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 178 VLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAK 236
+ Y+ D++S G+IL+ L+ + E + + V F T
Sbjct: 247 QIHGNNYS-HKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKFPLLFTQKYPQEH 303
Query: 237 SLIHRILDPNPETRITIEEIRNDEWFRK 264
++ +L P+P R +I + F
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-55
Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 15/263 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+G+GT+ V ++ +A+K + + + + EI++ K ++H +V+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 72 LHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEA--RRYFQQLIDGVDYCHSKGV 128
+ I I +E + GG L + G L ++E Y +Q+++G+ Y H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 129 YHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYN 185
HRD+K +N+L+++ G LKISDFG S T GT Y+APE++ +GY
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY- 202
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVEKADFS--CPTWFPVGAKSLIHR 241
G AAD+WS G + + G PF EL ++ KV P AK+ I +
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSAEAKAFILK 261
Query: 242 ILDPNPETRITIEEIRNDEWFRK 264
+P+P+ R ++ DE+ +
Sbjct: 262 CFEPDPDKRACANDLLVDEFLKV 284
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-55
Identities = 61/262 (23%), Positives = 104/262 (39%), Gaps = 18/262 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+G G+F +V ++ +TG A+K + + E+ + P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPR 111
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V L+ + + I +E + GG L I G L E A Y Q ++G++Y H++ +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 129 YHRDLKPENLLLDSQG-HLKISDFGLSA-LPEQGVSLLRTTC----GTPNYVAPEVLSHK 182
H D+K +N+LL S G + DFG + L G+ T GT ++APEV+ K
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLY--SKVEKADFSCPTWFPVGAKSLI 239
A D+WS ++ ++ G P+ + + P I
Sbjct: 232 PC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 240 HRILDPNPETRITIEEIRNDEW 261
L P R + E+R
Sbjct: 291 QEGLRKEPVHRASAMELRRKVG 312
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 7e-53
Identities = 71/254 (27%), Positives = 117/254 (46%), Gaps = 11/254 (4%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ IG G+F V A G VA+K+L + ++ RE++IMK +RHP +
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNI 96
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID---GVDYCHSK 126
V + + I+ E+++ G L+ + G + + RR D G++Y H++
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 127 G--VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HR+LK NLL+D + +K+ DFGLS L ++ GTP ++APEVL +
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF--SCPTWFPVGAKSLIHRI 242
N +DV+S GVIL+ L P+ L+ + + V P ++I
Sbjct: 217 N-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGC 275
Query: 243 LDPNPETRITIEEI 256
P R + I
Sbjct: 276 WTNEPWKRPSFATI 289
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-52
Identities = 66/271 (24%), Positives = 124/271 (45%), Gaps = 20/271 (7%)
Query: 7 GKYE-VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
G++ IG G+F V +TET VA L + K + K E ++K ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 83
Query: 66 HPCVVRLH----EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
HP +VR + + + I ++ E +T G L + + R + +Q++ G+
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 122 YCHSKG--VYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
+ H++ + HRDLK +N+ + G +KI D GL+ L S + GTP ++APE+
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEM 201
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEKADFSCPTWFPVG--- 234
+ Y+ + DV++ G+ + + P+ E +Y +V P F
Sbjct: 202 YE-EKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPASFDKVAIP 257
Query: 235 -AKSLIHRILDPNPETRITIEEIRNDEWFRK 264
K +I + N + R +I+++ N +F++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-52
Identities = 74/259 (28%), Positives = 116/259 (44%), Gaps = 27/259 (10%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
EV +G G F V A + VA+K ++ + K E+ + V HP +
Sbjct: 11 EVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERK-----AFIVELRQLSRVNHPNI 63
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID---GVDYCHS- 125
V+L A + +++E+ GG L++ + L A + GV Y HS
Sbjct: 64 VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 126 --KGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
K + HRDLKP NLLL + G LKI DFG + + ++ G+ ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT---NNKGSAAWMAPEVFEGS 178
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC-----PTWFPVGAKS 237
Y+ DV+S G+IL+ +I PFDE+ ++ A + P +S
Sbjct: 179 NYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTRPPLIKNLPKPIES 235
Query: 238 LIHRILDPNPETRITIEEI 256
L+ R +P R ++EEI
Sbjct: 236 LMTRCWSKDPSQRPSMEEI 254
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-52
Identities = 72/308 (23%), Positives = 123/308 (39%), Gaps = 74/308 (24%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-------REISI 60
KYE IGEG++ V +N +TG+ VA+K K ++ REI +
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIRM 55
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQLID 118
+K ++HP +V L EV + +++++ E+ D+ + + E + Q +
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQ 113
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-----NY 173
V++CH HRD+KPEN+L+ +K+ DFG + R P +
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA----------R-LLTGPSDYYDDE 162
Query: 174 V------APEVL-SHKGYNGAAADVWSCGVILYVLIAG--YLP----FDELD-----LTT 215
V +PE+L Y G DVW+ G + L++G P D+L L
Sbjct: 163 VATRWYRSPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD 221
Query: 216 LYSKV--------EKADFSCPTWFPVG------------AKSLIHRILDPNPETRITIEE 255
L + + P + A L+ L +P R+T E+
Sbjct: 222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281
Query: 256 IRNDEWFR 263
+ + +F
Sbjct: 282 LLHHPYFE 289
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-52
Identities = 78/312 (25%), Positives = 126/312 (40%), Gaps = 70/312 (22%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK------ 55
V + +YE +GEG FA V A++ T + VA+K IK + K
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKK------IKLGHRSEAKDGINRT 58
Query: 56 --REISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARR 111
REI +++ + HP ++ L + ++ I ++ +F+ + + L+ S +
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKA 116
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
Y + G++Y H + HRDLKP NLLLD G LK++DFGL+ + G+P
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-----------KSFGSP 165
Query: 172 N-----------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG--YLP----FDELDL 213
N Y APE+L + Y G D+W+ G IL L+ +LP D+L
Sbjct: 166 NRAYTHQVVTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 224
Query: 214 ----------------TTL-----YSKVEKADFSCP-TWFPVGAKSLIHRILDPNPETRI 251
+L + + LI + NP RI
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284
Query: 252 TIEEIRNDEWFR 263
T + ++F
Sbjct: 285 TATQALKMKYFS 296
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-51
Identities = 77/319 (24%), Positives = 129/319 (40%), Gaps = 68/319 (21%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-------R 56
+ + KYE +GEG++ V +N +TG VA+K K +D K R
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK--------KFLESDDDKMVKKIAMR 73
Query: 57 EISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQ 114
EI ++K +RH +V L EV + + Y++ EF+ + + L ++Y
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLF 131
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSLLRTTCGTP 171
Q+I+G+ +CHS + HRD+KPEN+L+ G +K+ DFG + A P +
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD--------- 182
Query: 172 NYV------APEVLSHKGYNGAAADVWSCGVILYVLIAG--YLP----FDELD-----LT 214
+ V APE+L G A DVW+ G ++ + G P D+L L
Sbjct: 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG 242
Query: 215 TLYSKV--------EKADFSCPTWFPV------------GAKSLIHRILDPNPETRITIE 254
L + A P L + L +P+ R
Sbjct: 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA 302
Query: 255 EIRNDEWFRKGYVPVKLIE 273
E+ + ++F+ + +
Sbjct: 303 ELLHHDFFQMDGFAERFSQ 321
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-51
Identities = 80/320 (25%), Positives = 135/320 (42%), Gaps = 81/320 (25%)
Query: 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL--------DRSAIIKHKMADQI 54
+ +++ +G GT+A V N TG VA+K + +AI
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI--------- 51
Query: 55 KREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG-----ELFDKIVHHGRLSESEA 109
REIS+MK ++H +VRL++V+ + K+ ++ EF+ + L +
Sbjct: 52 -REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 110 RRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ + QL+ G+ +CH + HRDLKP+NLL++ +G LK+ DFGL+ R G
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA----------R-AFG 159
Query: 170 TPN-----------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG--YLP----FDEL 211
P Y AP+VL + Y + D+WSCG IL +I G P ++L
Sbjct: 160 IPVNTFSSEVVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218
Query: 212 DLT--TL----------YSKVEKADFSCPTWFPVG----------------AKSLIHRIL 243
L + +K+ K + + P +H +L
Sbjct: 219 KLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLL 278
Query: 244 DPNPETRITIEEIRNDEWFR 263
NP+ R++ ++ + WF
Sbjct: 279 QLNPDMRLSAKQALHHPWFA 298
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-51
Identities = 74/316 (23%), Positives = 124/316 (39%), Gaps = 79/316 (25%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL---------DRSAIIKHKMADQI 54
+ +Y +GEGT+ +V A +T T E+VA+K + +AI
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI--------- 81
Query: 55 KREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQ 114
RE+S++K ++H ++ L V+ ++++I E+ +L + + +S + +
Sbjct: 82 -REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLY 139
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDS-----QGHLKISDFGLSALPEQGVSLLRTTCG 169
QLI+GV++CHS+ HRDLKP+NLLL LKI DFGL+ R G
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------RAF-G 188
Query: 170 TPN-----------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG--YLP----FDEL 211
P Y PE+L + Y + D+WS I ++ P D+L
Sbjct: 189 IPIRQFTHEIITLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247
Query: 212 ----------------------DLTTLYSKVEKADFS--CPTWFPVGAKSLIHRILDPNP 247
D + K L+ +L+ +P
Sbjct: 248 FKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307
Query: 248 ETRITIEEIRNDEWFR 263
RI+ + +F
Sbjct: 308 VKRISAKNALEHPYFS 323
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-50
Identities = 88/308 (28%), Positives = 127/308 (41%), Gaps = 75/308 (24%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL---------DRSAIIKHKMADQIKREI 58
KYE IGEGT+ V A+N ET E VA+K + SA+ REI
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----------REI 52
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQL 116
++K ++H +VRLH+VL S K+ ++ EF + FD +G L + + QL
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQL 110
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN---- 172
+ G+ +CHS+ V HRDLKP+NLL++ G LK+++FGL+ R G P
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA----------R-AFGIPVRCYS 159
Query: 173 -------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF----DELD--------- 212
Y P+VL + D+WS G I L P D D
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
Query: 213 ----------LTTL--YSKVEKADFSCP-----TWFPVGAKSLIHRILDPNPETRITIEE 255
+T L Y + + L+ +L NP RI+ EE
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 256 IRNDEWFR 263
+F
Sbjct: 280 ALQHPYFS 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 4e-50
Identities = 82/315 (26%), Positives = 133/315 (42%), Gaps = 82/315 (26%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL---------DRSAIIKHKMADQI 54
+ KY+ +GEGT+ V A+++ G VA+K + +AI
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAI--------- 67
Query: 55 KREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRY 112
REIS++K + HP +V L +V+ S + ++ EF+ ++ D+ + L +S+ + Y
Sbjct: 68 -REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIY 124
Query: 113 FQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172
QL+ GV +CH + HRDLKP+NLL++S G LK++DFGL+ R G P
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA----------R-AFGIPV 173
Query: 173 -----------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG--YLP----FDELDLT 214
Y AP+VL K Y + D+WS G I +I G P D+L
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKY-STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232
Query: 215 ---------------TLYSKVEKADFSCPTWFPVG-----------AKSLIHRILDPNPE 248
++ F + L+ +L +P
Sbjct: 233 FSILGTPNPREWPQVQELPLWKQRTF--QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290
Query: 249 TRITIEEIRNDEWFR 263
RI+ + N +F+
Sbjct: 291 KRISARDAMNHPYFK 305
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-50
Identities = 65/265 (24%), Positives = 114/265 (43%), Gaps = 22/265 (8%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
G +G+G F + + ETGE + MK L R + +E+ +M+ + HP V
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++ VL ++ I E+I GG L I + S+ + + + G+ Y HS +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR--------------TTCGTPNYV 174
HRDL N L+ ++ ++DFGL+ L + T G P ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---SCPTWF 231
APE+++ + Y+ DV+S G++L +I + T+ + F CP
Sbjct: 190 APEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248
Query: 232 PVGAKSLIHRILDPNPETRITIEEI 256
P + R D +PE R + ++
Sbjct: 249 PPSFFPITVRCCDLDPEKRPSFVKL 273
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-49
Identities = 62/267 (23%), Positives = 113/267 (42%), Gaps = 28/267 (10%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVL----DRSAIIKHKMADQIKREISIMKLVR 65
E + IG+G F V + + VA+K L + + +RE+ IM +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID---GVDY 122
HP +V+L +++EF+ G+L+ ++ + + + ++D G++Y
Sbjct: 82 HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 123 CHSKG--VYHRDLKPENLLLDSQG-----HLKISDFGLSALPEQGVSLLRTTCGTPNYVA 175
++ + HRDL+ N+ L S K++DFGLS VS G ++A
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS---GLLGNFQWMA 194
Query: 176 PEVLS--HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT--TLYSKVEKADF--SCPT 229
PE + + Y AD +S +ILY ++ G PFDE + + + + P
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 230 WFPVGAKSLIHRILDPNPETRITIEEI 256
P +++I +P+ R I
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYI 280
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-49
Identities = 65/307 (21%), Positives = 118/307 (38%), Gaps = 74/307 (24%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL--------DRSAIIKHKMADQIKREIS 59
Y +GEGT+A V ++ T VA+K + +AI RE+S
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----------REVS 52
Query: 60 IMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQLI 117
++K ++H +V LH+++ + + ++ E++ + D ++ + + QL+
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLL 110
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN----- 172
G+ YCH + V HRDLKP+NLL++ +G LK++DFGL+ R P
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA----------RAK-SIPTKTYDN 159
Query: 173 ------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAG--YLP----FDELDLT------ 214
Y P++L D+W G I Y + G P ++L
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219
Query: 215 ---------TLYSKVEKADFSCP---------TWFPVGAKSLIHRILDPNPETRITIEEI 256
+ + ++ L+ ++L RI+ E+
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279
Query: 257 RNDEWFR 263
+F
Sbjct: 280 MKHPFFL 286
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-49
Identities = 86/308 (27%), Positives = 138/308 (44%), Gaps = 77/308 (25%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL---------DRSAIIKHKMADQIKREI 58
KY IGEGT+ V AQN GE+ A+K + + I REI
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTI----------REI 51
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQL 116
SI+K ++H +V+L++V+ ++ ++ ++ E + +L D G L A+ + QL
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQL 109
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN---- 172
++G+ YCH + V HRDLKP+NLL++ +G LKI+DFGL+ R G P
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA----------R-AFGIPVRKYT 158
Query: 173 -------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG--YLP----FDELDLT--TL 216
Y AP+VL K Y D+WS G I ++ G P D+L L
Sbjct: 159 HEIVTLWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
Query: 217 ----------YSKVEKADFSCPTWFPVG-----------AKSLIHRILDPNPETRITIEE 255
+++ K D + + P+ L+ ++L +P RIT ++
Sbjct: 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277
Query: 256 IRNDEWFR 263
+F+
Sbjct: 278 ALEHAYFK 285
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-48
Identities = 72/312 (23%), Positives = 114/312 (36%), Gaps = 66/312 (21%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKV--LDRSAIIKHKMADQIKREISIM 61
+YE IG G + V A++ +G VA+K + + RE++++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 62 K---LVRHPCVVRLHEVLASR-----TKIYIILEFITG--GELFDKIVHHGRLSESEARR 111
+ HP VVRL +V A+ K+ ++ E + DK G L +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKD 124
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
+Q + G+D+ H+ + HRDLKPEN+L+ S G +K++DFGL+ R
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA----------R-IYSYQ 173
Query: 172 N----------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAG--YLP----FDELDL-- 213
Y APEVL Y D+WS G I + D+L
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232
Query: 214 TTL----------YSKVEKADFSCPTWFPV-----------GAKSLIHRILDPNPETRIT 252
+ + + F P P L+ +L NP RI+
Sbjct: 233 DLIGLPPEDDWPRDVSLPRGAF--PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 253 IEEIRNDEWFRK 264
+ K
Sbjct: 291 AFRALQHSYLHK 302
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-48
Identities = 61/268 (22%), Positives = 107/268 (39%), Gaps = 31/268 (11%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
E+G IG+G F +V + + E VA++++D + KRE+ + RH
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNE-DQLKAFKREVMAYRQTRHEN 90
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKG 127
VV S + II G L+ + L ++ R+ Q+++ G+ Y H+KG
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLS-----ALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
+ H+DLK +N+ D G + I+DFGL + LR G ++APE++
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 183 GYNGA--------AADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK------ADFSCP 228
+ +DV++ G I Y L A PF + ++ +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269
Query: 229 TWFPVGAKSLIHRILDPNPETRITIEEI 256
++ E R T ++
Sbjct: 270 KEI----SDILLFCWAFEQEERPTFTKL 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-48
Identities = 65/261 (24%), Positives = 117/261 (44%), Gaps = 20/261 (7%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA-DQIKREISIMKLVRHPC 68
+ IG G F KV A G+ VA+K + +++E + +++HP
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++ L V + +++EF GG L ++ R+ + Q+ G++Y H + +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 129 Y---HRDLKPENLLLDSQGH--------LKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177
HRDLK N+L+ + LKI+DFGL+ + + + G ++APE
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWMAPE 184
Query: 178 VLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF--SCPTWFPVGA 235
V+ ++ +DVWS GV+L+ L+ G +PF +D + V P+ P
Sbjct: 185 VIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF 243
Query: 236 KSLIHRILDPNPETRITIEEI 256
L+ +P+P +R + I
Sbjct: 244 AKLMEDCWNPDPHSRPSFTNI 264
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-48
Identities = 61/259 (23%), Positives = 117/259 (45%), Gaps = 18/259 (6%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
VG+ IG G+F V + + + VA+K+L+ +A ++ K E+ +++ RH
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVN 81
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++ ++ ++ I+ ++ G L+ + + + +Q G+DY H+K
Sbjct: 82 ILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ HRDLK N+ L +KI DFGL+ + G G+ ++APEV+ + N
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 186 --GAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEK-----ADFSCPTWFPVGAKS 237
+DV++ G++LY L+ G LP+ ++ + V + + P K
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260
Query: 238 LIHRILDPNPETRITIEEI 256
L+ L + R + I
Sbjct: 261 LMAECLKKKRDERPSFPRI 279
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-47
Identities = 80/318 (25%), Positives = 131/318 (41%), Gaps = 73/318 (22%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-------- 55
+V KYE IG+GTF +V A++ +TG+ VA+K K M + K
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--------KVLM-ENEKEGFPITAL 64
Query: 56 REISIMKLVRHPCVVRLHEVLASR--------TKIYIILEFI----TGGELFDKIVHHGR 103
REI I++L++H VV L E+ ++ IY++ +F G L +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSN--VLVK 120
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQG 160
+ SE +R Q L++G+ Y H + HRD+K N+L+ G LK++DFGL+ +L +
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 161 VSLLRTTC-GTPNYVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG-------------- 204
T T Y PE+L + Y G D+W G I+ +
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239
Query: 205 ------------------YLP-FDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDP 245
+++L+L + K A LI ++L
Sbjct: 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLIDKLLVL 298
Query: 246 NPETRITIEEIRNDEWFR 263
+P RI ++ N ++F
Sbjct: 299 DPAQRIDSDDALNHDFFW 316
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-47
Identities = 72/271 (26%), Positives = 131/271 (48%), Gaps = 17/271 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ IG+G+F +V + T + VA+K++D + I++EI+++ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPY 81
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
V + + TK++II+E++ GG D ++ G L E++ ++++ G+DY HS+
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRD+K N+LL G +K++DFG++ T GTP ++APEV+ Y+ +
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SK 199
Query: 189 ADVWSCGVILYVLIAGYLPFDELD-LTTLY--SKVE----KADFSCPTWFPVGAKSLIHR 241
AD+WS G+ L G P EL + L+ K + ++S P K +
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP--L----KEFVEA 253
Query: 242 ILDPNPETRITIEEIRNDEWFRKGYVPVKLI 272
L+ P R T +E+ ++ + +
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILRNAKKTSYL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-46
Identities = 48/260 (18%), Positives = 97/260 (37%), Gaps = 24/260 (9%)
Query: 10 EVGRTIGEGTFAKVKFA--QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ E ++ Q + + +KVL K D E +++ HP
Sbjct: 13 NFLTKLNENHSGELWKGRWQGND----IVVKVLKVRDWSTRKSRD-FNEECPRLRIFSHP 67
Query: 68 CVVRLHEVLAS--RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID---GVDY 122
V+ + S +I ++ G L++ ++H G + + + +D G+ +
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 123 CHSKG--VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
H+ + L ++++D +IS + + P +VAPE L
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEALQ 181
Query: 181 HKGYNGA--AADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF--SCPTWFPVGAK 236
K + +AD+WS V+L+ L+ +PF +L + KV + P
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241
Query: 237 SLIHRILDPNPETRITIEEI 256
L+ ++ +P R + I
Sbjct: 242 KLMKICMNEDPAKRPKFDMI 261
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-46
Identities = 77/319 (24%), Positives = 119/319 (37%), Gaps = 84/319 (26%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNT-ETGESVAMKV--LDR-------SAIIKHKMADQ 53
R +YE IGEG + KV A++ G VA+K + S I
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-------- 59
Query: 54 IKREISIMK---LVRHPCVVRLHEVLASR-----TKIYIILEFITG--GELFDKIVHHGR 103
RE+++++ HP VVRL +V TK+ ++ E + DK+ G
Sbjct: 60 --REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG- 116
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
+ + QL+ G+D+ HS V HRDLKP+N+L+ S G +K++DFGL+
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA--------- 167
Query: 164 LRTTCGTPN----------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAG--YLP---- 207
R Y APEVL Y D+WS G I +
Sbjct: 168 -R-IYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSD 224
Query: 208 FDELDL--TTL----------YSKVEKADFSCPTW--------FPV---GAKSLIHRILD 244
D+L + + + F + K L+ + L
Sbjct: 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAF--HSKSAQPIEKFVTDIDELGKDLLLKCLT 282
Query: 245 PNPETRITIEEIRNDEWFR 263
NP RI+ + +F+
Sbjct: 283 FNPAKRISAYSALSHPYFQ 301
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-46
Identities = 71/269 (26%), Positives = 136/269 (50%), Gaps = 8/269 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ IGEG+ V A+ +G VA+K++D + K + + + E+ IM+ +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHF 102
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
VV +++ ++++++EF+ GG L D IV RL+E + + ++ + Y H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V HRD+K +++LL G +K+SDFG A + V ++ GTP ++APEV+S Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY-AT 220
Query: 188 AADVWSCGVILYVLIAGYLP-FDELDLTTLY--SKVEKADFSCPTWFPVGAKSLIHRILD 244
D+WS G+++ ++ G P F + + + + + R+L
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280
Query: 245 PNPETRITIEEIRNDEWFRKGYVPVKLIE 273
+P+ R T +E+ + + + +P L+
Sbjct: 281 RDPQERATAQELLDHPFLLQTGLPECLVP 309
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 4e-46
Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 6/243 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E +G G V + +G +A K++ IK + +QI RE+ ++ P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG- 127
+V + S +I I +E + GG L + GR+ E + +I G+ Y K
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ HRD+KP N+L++S+G +K+ DFG+S + S+ + GT +Y++PE L Y+
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 209
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247
+D+WS G+ L + G P D L P ++ +
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269
Query: 248 ETR 250
++R
Sbjct: 270 DSR 272
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-46
Identities = 70/269 (26%), Positives = 131/269 (48%), Gaps = 8/269 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY IG+G V A + TG+ VA++ ++ + + + I EI +M+ ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNP 77
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V + ++++++E++ GG L D +V + E + ++ + +++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V HRD+K +N+LL G +K++DFG A S T GTP ++APEV++ K Y G
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 195
Query: 188 AADVWSCGVILYVLIAGYLP-FDELDLTTLY--SKVEKADFSCPTWFPVGAKSLIHRILD 244
D+WS G++ +I G P +E L LY + + P + ++R L+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255
Query: 245 PNPETRITIEEIRNDEWFRKGYVPVKLIE 273
+ E R + +E+ ++ + L
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-44
Identities = 74/270 (27%), Positives = 134/270 (49%), Gaps = 10/270 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++V +GEG++ V A + ETG+ VA+K + ++ + + I +EISIM+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQE-IIKEISIMQQCDSP 84
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSK 126
VV+ + T ++I++E+ G + D I + + L+E E Q + G++Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
HRD+K N+LL+++GH K++DFG++ ++ T GTP ++APEV+ GYN
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204
Query: 187 AAADVWSCGVILYVLIAGYLPFDELD-LTTLY--SKVEKADFSCPTWFPVGAKSLIHRIL 243
AD+WS G+ + G P+ ++ + ++ F P + + + L
Sbjct: 205 -VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCL 263
Query: 244 DPNPETRITIEEIRNDEWFRKGYVPVKLIE 273
+PE R T ++ + R L +
Sbjct: 264 VKSPEQRATATQLLQHPFVRSAKGVSILRD 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-44
Identities = 60/267 (22%), Positives = 107/267 (40%), Gaps = 15/267 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHP 67
E +G GT +V + +TG +A+K + RS + +I ++ + +K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK- 126
+V+ + T ++I +E + K G + E + ++ + Y K
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHKGYN 185
GV HRD+KP N+LLD +G +K+ DFG+S + G Y+APE +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 186 GAA----ADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVEKA--DFSCPTWFPVGAKS 237
ADVWS G+ L L G P+ L +++ F +S
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQS 262
Query: 238 LIHRILDPNPETRITIEEIRNDEWFRK 264
+ L + R ++ + ++
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-43
Identities = 76/275 (27%), Positives = 136/275 (49%), Gaps = 13/275 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+E+ +G+G F KV A+N ETG A KV++ + + EI I+ HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHP 76
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSK 126
+V+L K++I++EF GG + ++ L+E + + +Q+++ +++ HSK
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH----- 181
+ HRDLK N+L+ +G ++++DFG+SA + + + GTP ++APEV+
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLY--SKVEKADFSCPTWFPVGAKSL 238
Y+ AD+WS G+ L + P EL+ + L +K + P+ + V +
Sbjct: 197 TPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255
Query: 239 IHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273
+ LD NPETR + ++ + L E
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-42
Identities = 79/308 (25%), Positives = 121/308 (39%), Gaps = 75/308 (24%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLV 64
Y + IG G+F V A+ ++GE VA+K K+ + RE+ IM+ +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKL 104
Query: 65 RHPCVVRLHEVLASRT------KIYIILEFITGGELFDKIVHHGR----LSESEARRYFQ 114
H +VRL S + ++L+++ ++ H+ R L + Y
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQGVSLLRTTC-GTPN 172
QL + Y HS G+ HRD+KP+NLLLD LK+ DFG + + G PN
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA----------KQLVRGEPN 213
Query: 173 --YV------APEV-LSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDLTTLYSKV 220
Y+ APE+ Y ++ DVWS G +L L+ G F +D KV
Sbjct: 214 VSYICSRYYRAPELIFGATDYT-SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 221 --------------EKADFSCPTWFPVG------------AKSLIHRILDPNPETRITIE 254
+F P A +L R+L+ P R+T
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 255 EIRNDEWF 262
E +F
Sbjct: 333 EACAHSFF 340
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 80/307 (26%), Positives = 121/307 (39%), Gaps = 74/307 (24%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMK--VLDRSAIIKHKMADQIKREISIMKLVR 65
Y + IG G+F V A+ E+ E VA+K + D RE+ IM++V+
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD---------KRFKNRELQIMRIVK 90
Query: 66 HPCVVRLHEVLASRT------KIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQ 115
HP VV L S + ++LE++ ++ H+ + + + Y Q
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 116 LIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQGVSLLRTTC-GTPN- 172
L+ + Y HS G+ HRD+KP+NLLLD G LK+ DFG + + G PN
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA----------KILIAGEPNV 199
Query: 173 -YV------APEV-LSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDLTTLYSKV- 220
Y+ APE+ Y D+WS G ++ L+ G F +D KV
Sbjct: 200 SYICSRYYRAPELIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258
Query: 221 -------------EKADFSCPTWFPVG------------AKSLIHRILDPNPETRITIEE 255
+ P P A LI R+L+ P R+T E
Sbjct: 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE 318
Query: 256 IRNDEWF 262
+F
Sbjct: 319 ALCHPFF 325
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 50/219 (22%), Positives = 96/219 (43%), Gaps = 15/219 (6%)
Query: 7 GKYEVGRTIGEG--TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
G YE+ IG+G V A+ TGE V ++ ++ A +M ++ E+ + KL
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDY 122
HP +V + +++++ F+ G D ++E Q ++ +DY
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC-------GTPNYVA 175
H G HR +K ++L+ G + +S + R +++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 176 PEVL--SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
PEVL + +GY+ A +D++S G+ L G++PF ++
Sbjct: 204 PEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMP 241
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-42
Identities = 77/280 (27%), Positives = 131/280 (46%), Gaps = 27/280 (9%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
YE+ IG G A V+ A E VA+K ++ D++ +EI M HP
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM--DELLKEIQAMSQCHHPN 74
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVH--------HGRLSESEARRYFQQLIDGV 120
+V + + +++++++ ++GG + D I H G L ES +++++G+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR-----TTCGTPNYVA 175
+Y H G HRD+K N+LL G ++I+DFG+SA G + R T GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 176 PEVLS-HKGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYS---------KVEKAD 224
PEV+ +GY+ AD+WS G+ L G P+ + + L + D
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 225 FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
+ + +I L +PE R T E+ ++F+K
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRH 66
Y++ R +G G +++V A N E V +K I+K +IKREI I++ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGG 90
Query: 67 PCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
P ++ L +++ ++ E + + ++ L++ + R Y +++ +DYCH
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQ--TLTDYDIRFYMYEILKALDYCH 147
Query: 125 SKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTC--GTPNYVAPEVL-S 180
S G+ HRD+KP N+++D L++ D+GL+ E + + PE+L
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPF----DELD 212
++ Y+ + D+WS G +L +I PF D D
Sbjct: 205 YQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-41
Identities = 67/273 (24%), Positives = 119/273 (43%), Gaps = 14/273 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ R IG G+F V FA++ E VA+K + S ++ I +E+ ++ +RHP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++ ++++E+ G VH L E E + G+ Y HS
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSH---KG 183
+ HRD+K N+LL G +K+ DFG +++ + GTP ++APEV+
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQ 229
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLY--SKVEKADFSCPTWFPVGAKSLIH 240
Y+G DVWS G+ L P ++ ++ LY ++ E W ++ +
Sbjct: 230 YDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY-FRNFVD 287
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273
L P+ R T E + + + P +++
Sbjct: 288 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-41
Identities = 71/260 (27%), Positives = 129/260 (49%), Gaps = 8/260 (3%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+Y++ +G G + V A++T VA+K + K + + +RE+ + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+V + +V Y+++E+I G L + I HG LS A + Q++DG+ + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ HRD+KP+N+L+DS LKI DFG++ AL E ++ GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EAT 189
Query: 186 GAAADVWSCGVILYVLIAGYLPFD-ELDLTTLYSKVEKADFSCPTWF----PVGAKSLIH 240
D++S G++LY ++ G PF+ E ++ ++ + + T P ++I
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVIL 249
Query: 241 RILDPNPETR-ITIEEIRND 259
R + + R TI+E+++D
Sbjct: 250 RATEKDKANRYKTIQEMKDD 269
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-41
Identities = 59/276 (21%), Positives = 113/276 (40%), Gaps = 28/276 (10%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHP 67
+ IG G + V + +G+ +A+K + + + K Q+ ++ + M+ P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCP 81
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV------HHGRLSESEARRYFQQLIDGVD 121
+V+ + L +I +E ++ FDK + E + + ++
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 122 YCHSKG-VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL--RTTCGTPNYVAPEV 178
+ + HRD+KP N+LLD G++K+ DFG+S Q V + G Y+APE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPER 196
Query: 179 L----SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD------LTTLYSKVEKADFSCP 228
+ S +GY+ +DVWS G+ LY L G P+ + + + + S
Sbjct: 197 IDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 229 TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
F + ++ L + R +E+ +
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-40
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 12/212 (5%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQI-----KREI 58
+ G Y + R +G G V A++T VA+K++ +D + +RE
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE-----TLSSDPVFRTRMQREA 85
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID 118
++ P VV +H+ ++Y+ + I G +L + G L+ A +Q+
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL-SALPEQGVSLLRTTCGTPNYVAPE 177
+D H+ G HRD+KPEN+L+ + + DFG+ SA ++ ++ L T GT Y+APE
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 178 VLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
S + AD+++ +LY + G P+
Sbjct: 206 RFSE-SHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-40
Identities = 83/300 (27%), Positives = 130/300 (43%), Gaps = 61/300 (20%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
+++ +GEG + V A + TGE VA+K ++ + A + REI I+K +H
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKH 68
Query: 67 PCVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGRLSESEARRYFQ-QLIDGV 120
++ + + + +YII E + +L +++ LS+ + +YF Q + V
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSD-DHIQYFIYQTLRAV 125
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN----YV-- 174
H V HRDLKP NLL++S LK+ DFGL+ + ++ + G + +V
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 175 ----APEV-LSHKGYNGAAADVWSCGVIL--------------YV----LIAGYL--PFD 209
APEV L+ Y+ A DVWSCG IL Y LI G + P
Sbjct: 186 RWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 210 ELDLTTLYS-----------KVEKADFSCPTWFP---VGAKSLIHRILDPNPETRITIEE 255
+ DL + S A FP L+ R+L +P RIT +E
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLE--KMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-40
Identities = 73/334 (21%), Positives = 127/334 (38%), Gaps = 84/334 (25%)
Query: 3 VRKVGKYEV-GRTIGEGTFAKVKFAQN--TETGESVAMK-----VLDRSAIIKHKMADQI 54
R +E G +G GT+ V A+ + + A+K + SA
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC--------- 66
Query: 55 KREISIMKLVRHPCVVRLHEVLASRT--KIYIILEF--------ITGGELFDKIVHHGRL 104
REI++++ ++HP V+ L +V S K++++ ++ I +L
Sbjct: 67 -REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 125
Query: 105 SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS----QGHLKISDFGLS---ALP 157
+ Q++DG+ Y H+ V HRDLKP N+L+ +G +KI+D G + P
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 158 EQGVSLLRTTCGTPNYVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG------------ 204
+ ++ L T Y APE+L + Y A D+W+ G I L+
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244
Query: 205 ---YLPFDELDL----------------------TTLYSKVEKADFSCPTWFPVGAKS-- 237
D+LD +TL + ++ + K
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304
Query: 238 --------LIHRILDPNPETRITIEEIRNDEWFR 263
L+ ++L +P RIT E+ D +F
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-40
Identities = 62/271 (22%), Positives = 115/271 (42%), Gaps = 22/271 (8%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHP 67
E +G G + V+ ++ +G+ +A+K + + + + ++ ++ I M+ V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV-----HHGRLSESEARRYFQQLIDGVDY 122
V + L ++I +E + DK + E + ++ +++
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 123 CHSKG-VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEV-- 178
HSK V HRD+KP N+L+++ G +K+ DFG+S + + G Y+APE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERIN 182
Query: 179 --LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD--LTTLYSKVEKADFSCPT-WFPV 233
L+ KGY+ +D+WS G+ + L P+D L VE+ P F
Sbjct: 183 PELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241
Query: 234 GAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
+ L N + R T E+ +F
Sbjct: 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-40
Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 19/220 (8%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVR 65
G +E+ +G GT+ +V ++ +TG+ A+KV+D + ++IK+EI+++K
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 66 HPCVVRLHE------VLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLI 117
H + + ++++++EF G + D K L E ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177
G+ + H V HRD+K +N+LL +K+ DFG+SA ++ V T GTP ++APE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199
Query: 178 VLSHK-----GYNGAAADVWSCGVILYVLIAGYLPFDELD 212
V++ Y+ +D+WS G+ + G P ++
Sbjct: 200 VIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMH 238
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-39
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQI-----KREISIM 61
+YE+G +G G ++V A++ VA+KVL D +RE
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA-----DLARDPSFYLRFRREAQNA 66
Query: 62 KLVRHPCVVRLHEV----LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI 117
+ HP +V +++ + YI++E++ G L D + G ++ A
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTC--GTPNYV 174
+++ H G+ HRD+KP N+++ + +K+ DFG++ A+ + G S+ +T GT Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
+PE A +DV+S G +LY ++ G PF
Sbjct: 187 SPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-39
Identities = 84/296 (28%), Positives = 128/296 (43%), Gaps = 61/296 (20%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y IGEG + V A + VA+K + S + REI I+ RH
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHE 85
Query: 68 CVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
++ +++++ + T +YI+ + + +L K++ LS + Q++ G+ Y
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTTCGTPNYV------ 174
HS V HRDLKP NLLL++ LKI DFGL A P+ + T YV
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 198
Query: 175 APEV-LSHKGYNGAAADVWSCGVIL--------------YV----LIAGYL--PFDELDL 213
APE+ L+ KGY + D+WS G IL Y+ I G L P E DL
Sbjct: 199 APEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE-DL 256
Query: 214 TTLYS-----------KVEKADFSCPTWFP---VGAKSLIHRILDPNPETRITIEE 255
+ + K ++ FP A L+ ++L NP RI +E+
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWN--RLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-38
Identities = 57/290 (19%), Positives = 111/290 (38%), Gaps = 50/290 (17%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G+G + +V + GE+VA+K+ + + + + E+ ++RH +
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64
Query: 70 VRL----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+ S T++++I + G L+D + L R + G+ + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 126 K--------GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT----CGTPNY 173
+ + HRDLK +N+L+ G I+D GL+ + Q + L GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 174 VAPEVLSHKGYNGAA-----ADVWSCGVILYVLIAGYLPFDELDLTTL-YSKVEKADFSC 227
+APEVL D+W+ G++L+ + + ++ + V D S
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 228 -----------------PTWFPVGAKSLIHRIL----DPNPETRITIEEI 256
WF + + +++ NP R+T I
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-38
Identities = 82/329 (24%), Positives = 135/329 (41%), Gaps = 72/329 (21%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ +G G + V A +T+TG VA+K L R A + RE+ ++K ++H
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHE 88
Query: 68 CVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
V+ L +V +Y++ + G +L + IV +L++ + Q++ G+
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT-PNYV------ 174
Y HS + HRDLKP NL ++ LKI DFGL+ R T YV
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----------RHTADEMTGYVATRWYR 196
Query: 175 APEV-LSHKGYNGAAADVWSCGVILYVLIAGYLPF-------------------DELDLT 214
APE+ L+ YN D+WS G I+ L+ G F L
Sbjct: 197 APEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 215 TLYS-----------KVEKADFSCPTWFP---VGAKSLIHRILDPNPETRITIEEIRNDE 260
+ S ++ K +F+ F A L+ ++L + + RIT +
Sbjct: 256 KISSESARNYIQSLTQMPKMNFA--NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 261 WFRKGYVPVKLIEYEDVNLDDVNAAFDDS 289
+F +Y D + + V +D S
Sbjct: 314 YFA---------QYHDPDDEPVADPYDQS 333
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 65/296 (21%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
Y + +G G + V A + TG VA+K L R + ++ A + RE+ ++K +RH
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELRLLKHMRH 83
Query: 67 PCVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
V+ L +V Y+++ F+ G +L K++ H +L E + Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT-PNYV----- 174
Y H+ G+ HRDLKP NL ++ LKI DFGL+ R YV
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----------RQADSEMTGYVVTRWY 191
Query: 175 -APEV-LSHKGYNGAAADVWSCGVILYVLIAGYLPF-------------------DELDL 213
APEV L+ Y D+WS G I+ +I G F +
Sbjct: 192 RAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 214 TTLYS-----------KVEKADFSCPTWFP---VGAKSLIHRILDPNPETRITIEE 255
L S ++EK DF+ + A +L+ ++L + E R+T E
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGE 304
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 73/303 (24%), Positives = 119/303 (39%), Gaps = 67/303 (22%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y + +G G V A + + + VA+K + + + REI I++ + H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 68 CVVRLHEVLASRTK--------------IYIILEFITGGELFDKIVHHGRLSESEARRYF 113
+V++ E+L +YI+ E++ +L ++ G L E AR +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARLFM 126
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGL--SALPEQGVSLLRTTCGT 170
QL+ G+ Y HS V HRDLKP NL ++++ LKI DFGL P +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS---- 182
Query: 171 PNYV------APEV-LSHKGYNGAAADVWSCGVIL--------------YV----LIAGY 205
+ +P + LS Y A D+W+ G I + LI
Sbjct: 183 -EGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
Query: 206 L--PFDELDLTTLYSKVEKADFSCPTW--------FP---VGAKSLIHRILDPNPETRIT 252
+ +E D L S + + T P A + +IL +P R+T
Sbjct: 241 IPVVHEE-DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299
Query: 253 IEE 255
EE
Sbjct: 300 AEE 302
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 73/328 (22%), Positives = 122/328 (37%), Gaps = 83/328 (25%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY +G+T+G G+F V + E+G+ A+K + + K RE+ IMK++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLDHV 60
Query: 68 CVVRLHEVLASRTK--------------------------------------IYIILEFI 89
+++L + + + +I+E++
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 90 TGGELFDKIVHHGR----LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-G 144
L + R + + Y QL V + HS G+ HRD+KP+NLL++S+
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 145 HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV-LSHKGYNGAAADVWSCGVILYVLIA 203
LK+ DFG + + C + Y APE+ L Y + D+WS G + LI
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVFGELIL 237
Query: 204 GYLPF---DELDLTTLYSKV--------------EKADFSCPTW--------F----PVG 234
G F +D ++ + PT P
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSL 297
Query: 235 AKSLIHRILDPNPETRITIEEIRNDEWF 262
A L+ +IL P+ RI E +F
Sbjct: 298 AIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 66/296 (22%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
Y +G G + V A + +GE VA+K L R + ++ A + RE+ ++K ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQSEIFAKRAYRELLLLKHMQH 82
Query: 67 PCVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
V+ L +V + Y+++ F+ +L KI+ + SE + + Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGL-KFSEEKIQYLVYQMLKGL 139
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT-PNYV----- 174
Y HS GV HRDLKP NL ++ LKI DFGL+ R YV
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----------RHADAEMTGYVVTRWY 189
Query: 175 -APEV-LSHKGYNGAAADVWSCGVILYVLIAGYLPF-------------------DELDL 213
APEV LS YN D+WS G I+ ++ G F +
Sbjct: 190 RAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 214 TTLYS-----------KVEKADFSCPTWFP---VGAKSLIHRILDPNPETRITIEE 255
L + + DF+ FP A L+ ++L+ + + R+T +
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFT--QLFPRASPQAADLLEKMLELDVDKRLTAAQ 302
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
+YE+ IG G++ V A + VA+K + R + + + +I REI+I+ + H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLNH 111
Query: 67 PCVVRLHEVLASRT-----KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
VV++ +++ + ++Y++LE + L+E + L+ GV
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSLLRTTCGTPN------ 172
Y HS G+ HRDLKP N L++ +K+ DFGL+ PE G S L + +
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 173 ------------YV------APEV-LSHKGYNGAAADVWSCGVIL 198
+V APE+ L + Y A DVWS G I
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIF 274
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 62/255 (24%), Positives = 99/255 (38%), Gaps = 33/255 (12%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTE-TGESVAMKVL----DRSAIIKHKMADQIKREISIM 61
G+YEV I G + A + G V +K L D A E +
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ------AMAMAERQFL 133
Query: 62 KLVRHPCVVRLHEV-----LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQL 116
V HP +V++ YI++E++ G L +L +EA Y ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEI 191
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL-SALPEQGVSLLRTTCGTPNYVA 175
+ + Y HS G+ + DLKPEN++L + LK+ D G S + G GTP + A
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGYLY-----GTPGFQA 245
Query: 176 PEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGA 235
PE++ + A D+++ G L L + + L
Sbjct: 246 PEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK------TYDSY 297
Query: 236 KSLIHRILDPNPETR 250
L+ R +DP+P R
Sbjct: 298 GRLLRRAIDPDPRQR 312
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 62/292 (21%), Positives = 115/292 (39%), Gaps = 52/292 (17%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++ + IG+G + +V GE VA+KV + + + + EI L+RH +
Sbjct: 40 QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENI 93
Query: 70 VRL----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+ + S T++Y+I ++ G L+D + L + + G+ + H+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 126 K--------GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL----RTTCGTPNY 173
+ + HRDLK +N+L+ G I+D GL+ + + T GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 174 VAPEVL------SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL-YSKVEKADFS 226
+ PEVL +H AD++S G+IL+ + + ++ L Y + +D S
Sbjct: 213 MPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 227 C-----------------PTWFPVGA----KSLIHRILDPNPETRITIEEIR 257
W L+ NP +R+T ++
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-36
Identities = 69/308 (22%), Positives = 117/308 (37%), Gaps = 66/308 (21%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMK-VLDRSAIIKHKMADQI--KREISIMKL- 63
+++V R G+GTF V+ + TG SVA+K V+ D RE+ IM+
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ----------DPRFRNRELQIMQDL 73
Query: 64 --VRHPCVVRLHEVLASRTK-------IYIILEFITGGELFDKIVHHGR----LSESEAR 110
+ HP +V+L + + + +++E++ L ++ R +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIK 132
Query: 111 RYFQQLIDGVDYCH--SKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLLRTT 167
+ QLI + H S V HRD+KP N+L++ + G LK+ DFG + +
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 168 CGTPNYVAPEV-LSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDLTTLYSKV--- 220
C + Y APE+ ++ Y A D+WS G I ++ G F + +V
Sbjct: 193 C-SRYYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250
Query: 221 -----------EKADFSCPTWFPV---------------GAKSLIHRILDPNPETRITIE 254
D + A L+ +L PE R+
Sbjct: 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 255 EIRNDEWF 262
E +F
Sbjct: 311 EALCHPYF 318
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 42/251 (16%), Positives = 78/251 (31%), Gaps = 37/251 (14%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
G+Y + G + A +T VA+ +D ++ + + + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P V R+ +V+ +R ++ E+I GG L + V S A R Q L D H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
GV P + + G + ++ +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA--------N 180
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT-------WFPVGAKSLI 239
D+ G LY L+ P E + + + E+ P P ++
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240
Query: 240 HRILDPNPETR 250
R + + R
Sbjct: 241 ARSVQGDGGIR 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 55/295 (18%), Positives = 111/295 (37%), Gaps = 56/295 (18%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +IG+G F +V GE VA+K+ + + + EI ++RH +
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI 98
Query: 70 VRL----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+ ++ + T+++++ ++ G LFD ++ ++ + G+ + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 126 K--------GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL----RTTCGTPNY 173
+ + HRDLK +N+L+ G I+D GL+ + + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 174 VAPEVL------SHKGYNGAAADVWSCGVILYVLIAGY----------LPFDEL-----D 212
+APEVL H AD+++ G++ + + LP+ +L
Sbjct: 218 MAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 213 LTTLYSKV---------EKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258
+ + V SC + ++ N R+T I+
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVM--AKIMRECWYANGAARLTALRIKK 329
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 69/308 (22%), Positives = 119/308 (38%), Gaps = 77/308 (25%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM--------ADQIKREIS 59
Y V R I G++ V ++ G VA+K + + + ++ REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 60 IMKLVRHPCVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGRLSESEAR-RYF 113
++ HP ++ L ++ + +Y++ E + +L +++H R+ S +YF
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDL-AQVIHDQRIVISPQHIQYF 139
Query: 114 Q-QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172
++ G+ H GV HRDL P N+LL + I DF L+ R N
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA----------REDTADAN 189
Query: 173 ---YV------APEV-LSHKGYNGAAADVWSCGVIL--------------YV----LIAG 204
YV APE+ + KG+ D+WS G ++ + I
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 205 YL--PFDELDLTTLYS------------KVEKADFSCPTWFP---VGAKSLIHRILDPNP 247
+ P E D+ S V ++ P A LI ++L+ NP
Sbjct: 249 VVGTPKIE-DVVMFSSPSARDYLRNSLSNVPARAWT--AVVPTADPVALDLIAKMLEFNP 305
Query: 248 ETRITIEE 255
+ RI+ E+
Sbjct: 306 QRRISTEQ 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-35
Identities = 56/292 (19%), Positives = 104/292 (35%), Gaps = 50/292 (17%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ G F V A E VA+K+ K + Q + E+ + ++H
Sbjct: 25 PLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHE 78
Query: 68 CVVRL----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+++ + +++I F G L D + +S +E + + G+ Y
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD-FLKANVVSWNELCHIAETMARGLAYL 137
Query: 124 HSKGVY----------HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGTP 171
H HRD+K +N+LL + I+DFGL+ E G S T GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 172 NYVAPEVLSHKGYNGA----AADVWSCGVILYVLIAGYLPFDEL--DLTTLYSKVEKADF 225
Y+APEVL D+++ G++L+ L + D + + +
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 226 SC-----------------PTWFPVGAKSLIHRIL----DPNPETRITIEEI 256
S W +++ + D + E R++ +
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 77/336 (22%), Positives = 123/336 (36%), Gaps = 61/336 (18%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ + IG G V A + +VA+K L R A + RE+ +MK V H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 84
Query: 68 CVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
++ L V + +YI++E + L +++ L Q++ G+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGIK 141
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGTPNYVAPEVL 179
+ HS G+ HRDLKP N+++ S LKI DFGL+ + T T Y APEV+
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVI 198
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPF-------------------DELDLTTLYSKV 220
GY D+WS G I+ +I G + F + L V
Sbjct: 199 LGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 221 ----------EKADFS--CPTWFPVG-----------AKSLIHRILDPNPETRITIEEIR 257
F P A+ L+ ++L + RI+++E
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317
Query: 258 NDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVGK 293
+ Y P + D D+ E
Sbjct: 318 QHPYINVWYDPSEAEAPPPKIPDK---QLDEREHTI 350
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 76/340 (22%), Positives = 128/340 (37%), Gaps = 69/340 (20%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ + IG G V A + +VA+K L R A + RE+ +MK V H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 121
Query: 68 CVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
++ L V + +Y+++E + L +++ L Q++ G+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQME-LDHERMSYLLYQMLCGIK 178
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV------A 175
+ HS G+ HRDLKP N+++ S LKI DFGL+ + TP YV A
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TP-YVVTRYYRA 231
Query: 176 PEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF-------------------DELDLTTL 216
PEV+ GY D+WS G I+ ++ + F + L
Sbjct: 232 PEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 217 YSKVEKADFSCPTW--------FPVG---------------AKSLIHRILDPNPETRITI 253
V + P + FP A+ L+ ++L +P RI++
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 254 EEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAFDDSEVGK 293
++ + Y P ++ D D+ E
Sbjct: 351 DDALQHPYINVWYDPAEVEAPPPQIYDK---QLDEREHTI 387
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 33/226 (14%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
Y + IG G++ V A + T ++VA+K ++R + + + +I REI+I+ ++
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--MFEDLIDCKRILREITILNRLKS 84
Query: 67 PCVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
++RL++++ +YI+LE +L L+E + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTTCGTP-------- 171
+ H G+ HRDLKP N LL+ +K+ DFGL + E+ +++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 172 ------NYV------APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
++V APE+ L + Y + D+WS G I L+
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 72/261 (27%), Positives = 104/261 (39%), Gaps = 22/261 (8%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLVRH 66
+G IG G F +V + VA+K + D +E I+K H
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-----PPDLKAKFLQEARILKQYSH 171
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHS 125
P +VRL V + IYI++E + GG+ + G L + G++Y S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG------TPNYVAPEVL 179
K HRDL N L+ + LKISDFG+S GV T APE L
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEAL 287
Query: 180 SHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKS 237
++ Y+ + +DVWS G++L+ G P+ L VEK CP P
Sbjct: 288 NYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 238 LIHRILDPNPETRITIEEIRN 258
L+ + P R + I
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQ 367
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 76/335 (22%), Positives = 129/335 (38%), Gaps = 80/335 (23%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMK-LVR 65
KYE+ + +G+G + V + + TGE VA+K + ++ A + REI I+ L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--AFQNSTDAQRTFREIMILTELSG 67
Query: 66 HPCVVRLHEVLA--SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQ-QLIDGVDY 122
H +V L VL + +Y++ +++ +L ++ L ++Y QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEP-VHKQYVVYQLIKVIKY 124
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN---------- 172
HS G+ HRD+KP N+LL+++ H+K++DFGLS + + N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 173 -----YV------APEV-LSHKGYNGAAADVWSCGVIL--------------YV----LI 202
YV APE+ L Y D+WS G IL + I
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 203 AGYL--PFDE----------------------LDLTTLYSKVEKADFSCPTWFPVGAKS- 237
G + P +E + + K P +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 238 ----LIHRILDPNPETRITIEEIRNDEWFRKGYVP 268
L+ ++L NP RI+ + + + P
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 68/259 (26%), Positives = 115/259 (44%), Gaps = 16/259 (6%)
Query: 12 GRTIGEGTFAKVKFAQ-NTETGES--VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+G+G+F V+ + + +G++ VA+K L + + + D RE++ M + H
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKG 127
++RL+ V + ++ E G L D++ H G RY Q+ +G+ Y SK
Sbjct: 83 LIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHKGY 184
HRDL NLLL ++ +KI DFGL Q APE L + +
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243
+ A+D W GV L+ + G P+ L+ + + K++K P P I+ ++
Sbjct: 202 S-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQDIYNVM 258
Query: 244 ----DPNPETRITIEEIRN 258
PE R T +R+
Sbjct: 259 VQCWAHKPEDRPTFVALRD 277
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 57/262 (21%), Positives = 114/262 (43%), Gaps = 12/262 (4%)
Query: 11 VGRTIGEGTFAKVKFAQ-NTETGE-SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F VK + +VA+K+L ++ + D++ E ++M+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+VR+ + +++E G L + + + + Q+ G+ Y
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT--P-NYVAPEVLSHKGYN 185
HRDL N+LL +Q + KISDFGLS + + P + APE +++ ++
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 186 GAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRIL 243
+ +DVWS GV+++ G P+ + + + + +EK + CP P L++
Sbjct: 199 -SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 257
Query: 244 DPNPETRITIEEIRN--DEWFR 263
+ E R + ++
Sbjct: 258 TYDVENRPGFAAVELRLRNYYY 279
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 10/255 (3%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G G + +V + +VA+K L + + +E ++MK ++HP +
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNL 278
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKG 127
V+L V YII EF+T G L D + R +S Q+ ++Y K
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN-YVAPEVLSHKGYNG 186
HR+L N L+ +K++DFGLS L P + APE L++ ++
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS- 397
Query: 187 AAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILD 244
+DVW+ GV+L+ + G P+ +DL+ +Y +EK P P L+
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 457
Query: 245 PNPETRITIEEIRND 259
NP R + EI
Sbjct: 458 WNPSDRPSFAEIHQA 472
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ + IG G +V + + VA+K L + E SIM
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDV--PVAIKALKAGYT--ERQRRDFLSEASIMGQF 107
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYC 123
HP ++RL V+ I+ E++ G L + H G+ + + + + G+ Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLS 180
G HRDL N+L+DS K+SDFGLS + E TT G + APE ++
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 181 HKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
+ ++ +A+DVWS GV+++ VL G P+ + + S VE+ + P P+G +
Sbjct: 228 FRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-GYRLPA--PMGCPHAL 283
Query: 240 HRIL----DPNPETRITIEEIRN--DEWFR 263
H+++ + R +I + D R
Sbjct: 284 HQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 65/267 (24%), Positives = 122/267 (45%), Gaps = 20/267 (7%)
Query: 11 VGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ + +G G F +V + ++ SVA+K L K E SIM HP
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSK 126
++RL V+ + I+ E++ G L + H + + + + + G+ Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHKG 183
G HRDL N+L++S K+SDFGL + E TT G + +PE ++++
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 184 YNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
+ +A+DVWS G++L+ V+ G P+ E+ + V++ + P P+ + ++++
Sbjct: 227 FT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPP--PMDCPAALYQL 282
Query: 243 L----DPNPETRITIEEIRN--DEWFR 263
+ + R E+I + D+ R
Sbjct: 283 MLDCWQKDRNNRPKFEQIVSILDKLIR 309
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 70/268 (26%), Positives = 116/268 (43%), Gaps = 21/268 (7%)
Query: 11 VGRTIGEGTFAKV---KFAQNTETGE-SVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+ IG G F +V ++ E VA+K L K E IM H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSH 105
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHS 125
++RL V++ + II E++ G L + G S + + + G+ Y +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHK 182
HRDL N+L++S K+SDFGLS + E TT G + APE +S++
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 183 GYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHR 241
+ +A+DVWS G++++ V+ G P+ EL + + F PT P+ S I++
Sbjct: 226 KFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPT--PMDCPSAIYQ 281
Query: 242 IL----DPNPETRITIEEIRN--DEWFR 263
++ R +I + D+ R
Sbjct: 282 LMMQCWQQERARRPKFADIVSILDKLIR 309
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
+Y + R +G G F+ V A++ VAMK++ R + + EI +++ V
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RG---DKVYTEAAEDEIKLLQRVND 74
Query: 66 ----------HPCVVRLHE--VLASRTKIYIILEF-ITGGELFD--KIVHHGRLSESEAR 110
+++L + +++++ F + G L K H + +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 111 RYFQQLIDGVDYCHSK-GVYHRDLKPENLLLD------SQGHLKISDFGLSALPEQGVSL 163
+ +QL+ G+DY H + G+ H D+KPEN+L++ + +KI+D G + ++ +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT- 193
Query: 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
+ T Y +PEVL + G AD+WS +++ LI G F+
Sbjct: 194 --NSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE 236
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 12 GRTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +GEG F KV+ + TGE VA+K L + H +K+EI I++ + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHE 83
Query: 68 CVVRLHEV--LASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCH 124
+V+ + I +I+EF+ G L + + + +++ + +Y Q+ G+DY
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSH 181
S+ HRDL N+L++S+ +KI DFGL+ E + V APE L
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 182 KGYNGAAADVWSCGVILY 199
+ A+DVWS GV L+
Sbjct: 204 SKFY-IASDVWSFGVTLH 220
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+YEV + IG+G+F +V A + + + VA+K++ R+ + + Q EI I++ +R
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RN---EKRFHRQAAEEIRILEHLRK 152
Query: 67 ------PCVVRLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLID 118
V+ + E R I + E + L++ K S R++ ++
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGH--LKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+D H + H DLKPEN+LL QG +K+ DFG S Q V T + Y AP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY---TYIQSRFYRAP 268
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDL 213
EV+ Y G D+WS G IL L+ GY DE D
Sbjct: 269 EVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-29
Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 53/286 (18%)
Query: 12 GRTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLV 64
+ +G+G F V+ TGE VA+K L +H + ++ REI I+K +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILKSL 68
Query: 65 RHPCVVRLHEVLASRTK--IYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVD 121
+H +V+ V S + + +I+E++ G L D + H R+ + +Y Q+ G++
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEV 178
Y +K HRDL N+L++++ +KI DFGL+ + Q + + + APE
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 179 LSHKGYNGAAADVWSCGVILY----------------VLIAGYLPFDELDLTTLYSKVEK 222
L+ ++ A+DVWS GV+LY + + G ++ + L ++
Sbjct: 189 LTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247
Query: 223 -----ADFSCPTWFPVGAKSLIHRIL----DPNPETRITIEEIRND 259
CP I+ I+ + N R + ++
Sbjct: 248 NGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALR 285
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 16/262 (6%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G+G F +V N T VA+K L + +E +MK +RH
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEK 240
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSK 126
+V+L+ V S IYI+ E+++ G L D + L + Q+ G+ Y
Sbjct: 241 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYN 185
HRDL+ N+L+ K++DFGL+ L E R P + APE + +
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 186 GAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRIL 243
+DVWS G++L + G +P+ + + +VE+ CP P L+ +
Sbjct: 360 -IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 418
Query: 244 DPNPETRITIEEIRN--DEWFR 263
PE R T E ++ +++F
Sbjct: 419 RKEPEERPTFEYLQAFLEDYFT 440
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 16/262 (6%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G+G F +V N T VA+K L + +E +MK +RH
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEK 323
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSK 126
+V+L+ V S IYI+ E+++ G L D + L + Q+ G+ Y
Sbjct: 324 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYN 185
HRDL+ N+L+ K++DFGL+ L E R P + APE + +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 186 GAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRIL 243
+DVWS G++L + G +P+ + + +VE+ CP P L+ +
Sbjct: 443 -IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 501
Query: 244 DPNPETRITIEEIRN--DEWFR 263
PE R T E ++ +++F
Sbjct: 502 RKEPEERPTFEYLQAFLEDYFT 523
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 12 GRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +GEG F KV N TGE VA+K L A +H+ K+EI I++ + H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHE 93
Query: 68 CVVRLHEVLASRTK--IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+++ + +++E++ G L D + H + ++ + QQ+ +G+ Y H+
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA 152
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHK 182
+ HRDL N+LLD+ +KI DFGL+ +G R + V APE L
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 183 GYNGAAADVWSCGVILY 199
+ A+DVWS GV LY
Sbjct: 213 KFY-YASDVWSFGVTLY 228
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 20/201 (9%)
Query: 12 GRTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLV 64
+ +G+G F V+ TGE VA+K L +H + ++ REI I+K +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILKSL 99
Query: 65 RHPCVVRLHEVLASRTK--IYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVD 121
+H +V+ V S + + +I+E++ G L D + H R+ + +Y Q+ G++
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEV 178
Y +K HRDL N+L++++ +KI DFGL+ + Q + + + APE
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 179 LSHKGYNGAAADVWSCGVILY 199
L+ ++ A+DVWS GV+LY
Sbjct: 220 LTESKFS-VASDVWSFGVVLY 239
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 45/218 (20%), Positives = 80/218 (36%), Gaps = 35/218 (16%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++ IG G + V + VA+KV + ++ ++ I + L+ H +
Sbjct: 16 KLLELIGRGRYGAVYKG--SLDERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNI 69
Query: 70 VRL-----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
R R + +++E+ G L + + R + G+ Y H
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 125 S---------KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR--------TT 167
+ + HRDL N+L+ + G ISDFGLS + +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 168 CGTPNYVAPEVL------SHKGYNGAAADVWSCGVILY 199
GT Y+APEVL D+++ G+I +
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 12/219 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G G F V GE VA+K L + K +I E +M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNP 77
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSK 126
V RL + + + +I + + G L D + H + + Q+ G++Y +
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGY 184
+ HRDL N+L+ + H+KI+DFGL+ L G P ++A E + H+ Y
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK 222
+DVWS GV ++ ++ G P+D + + + S +EK
Sbjct: 197 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 62/267 (23%), Positives = 108/267 (40%), Gaps = 30/267 (11%)
Query: 15 IGEGTFAKVKFAQ-NTETGE-SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+G G F V+ + VA+KVL + +++ RE IM + +P +VRL
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
V + +++E GG L +V + S Q+ G+ Y K HR
Sbjct: 76 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT--P-NYVAPEVLSHKGYNGAA 188
DL N+LL ++ + KISDFGLS S P + APE ++ + ++ +
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 193
Query: 189 ADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK-----ADFSCPTWFPVGAKSLIHRI 242
+DVWS GV ++ L G P+ ++ + + +E+ CP ++ +
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP--------PELYAL 245
Query: 243 L----DPNPETRITIEEIRN--DEWFR 263
+ E R + +
Sbjct: 246 MSDCWIYKWEDRPDFLTVEQRMRACYY 272
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 66/277 (23%), Positives = 124/277 (44%), Gaps = 27/277 (9%)
Query: 7 GKYEV-------GRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREI 58
G E+ + +G G F VK + + VA+K++ ++ + + +E
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSEDEFF----QEA 54
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLI 117
M + HP +V+ + V + IYI+ E+I+ G L + + HG+ L S+ +
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC 114
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAP 176
+G+ + S HRDL N L+D +K+SDFG++ + P + AP
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAP 174
Query: 177 EVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGA 235
EV + Y+ + +DVW+ G++++ V G +P+D + + KV + P A
Sbjct: 175 EVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRLYR--PHLA 230
Query: 236 KSLIHRIL----DPNPETRITIEEIRN--DEWFRKGY 266
I++I+ PE R T +++ + + K
Sbjct: 231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 27/276 (9%)
Query: 7 GKYEV-------GRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREI 58
GK+ + + IG G F V + VA+K + A+ + E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTIREGAMSEED----FIEEA 54
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLI 117
+M + HP +V+L+ V + I ++ EF+ G L D + G + +
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAP 176
+G+ Y V HRDL N L+ +K+SDFG++ T P + +P
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 174
Query: 177 EVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGA 235
EV S Y+ + +DVWS GV+++ V G +P++ + + + F P A
Sbjct: 175 EVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYK--PRLA 230
Query: 236 KSLIHRIL----DPNPETRITIEEIRN--DEWFRKG 265
+ +++I+ PE R + E G
Sbjct: 231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 12 GRTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLV 64
+G+G F V+ TG VA+K L +H DQ + REI I+K +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL------QHSGPDQQRDFQREIQILKAL 81
Query: 65 RHPCVVRLHEVLASRTK--IYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVD 121
+V+ V + + +++E++ G L D + H RL S Y Q+ G++
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEV 178
Y S+ HRDL N+L++S+ H+KI+DFGL+ L + + APE
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 179 LSHKGYNGAAADVWSCGVILY 199
LS ++ +DVWS GV+LY
Sbjct: 202 LSDNIFS-RQSDVWSFGVVLY 221
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 56/291 (19%)
Query: 7 GKYEVGRT-------IGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKR 56
+Y + R +GEG F +V + + +VA+K + + +K ++
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMS 62
Query: 57 EISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQ 115
E IMK + HP +V+L ++ +II+E GEL + + L Y Q
Sbjct: 63 EAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 116 LIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV- 174
+ + Y S HRD+ N+L+ S +K+ DFGLS R Y
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS----------RYIEDEDYYKA 171
Query: 175 ----------APEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKA 223
+PE ++ + + A+DVW V ++ +L G PF L+ + +EK
Sbjct: 172 SVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
Query: 224 D-----FSCPTWFPVGAKSLIHRIL----DPNPETRITIEEIRN--DEWFR 263
D CP +++ ++ D +P R E+ + ++
Sbjct: 231 DRLPKPDLCP--------PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 18/265 (6%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G G + +V + +VA+K L + ++ +E ++MK ++HP +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNL 71
Query: 70 VRLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
V+L V YII EF+T G L D + + +S Q+ ++Y K
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNG 186
HRDL N L+ +K++DFGLS L P + APE L++ ++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS- 190
Query: 187 AAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL-- 243
+DVW+ GV+L+ + G P+ +DL+ +Y +EK D+ P G ++ ++
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRMER--PEGCPEKVYELMRA 247
Query: 244 --DPNPETRITIEEIRN--DEWFRK 264
NP R + EI + F++
Sbjct: 248 CWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 43/278 (15%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
E+GR IGEG F V +N +VA+K + +E M+
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVREK--FLQEALTMRQF 73
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYC 123
HP +V+L V+ + ++II+E T GEL + L + Y QL + Y
Sbjct: 74 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV--------- 174
SK HRD+ N+L+ S +K+ DFGLS R + Y
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS----------RYMEDSTYYKASKGKLPIK 182
Query: 175 --APEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWF 231
APE ++ + + +A+DVW GV ++ +L+ G PF + + ++E P
Sbjct: 183 WMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPM-- 238
Query: 232 PVGAKSLIHRIL----DPNPETRITIEEIRN--DEWFR 263
P ++ ++ +P R E++
Sbjct: 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 12/219 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G G F V GE VA+K L + K +I E +M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNP 77
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSK 126
V RL + + + +I + + G L D + H + + Q+ G++Y +
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGY 184
+ HRDL N+L+ + H+KI+DFGL+ L G P ++A E + H+ Y
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK 222
+DVWS GV ++ ++ G P+D + + + S +EK
Sbjct: 197 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+YE+ IG+G+F +V A + E VA+K++ ++ K +Q + E+ +++L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNK 109
Query: 67 P------CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLID 118
+V L R + ++ E + L+D + + +S + R++ QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 119 GVDYCHSK--GVYHRDLKPENLLLDSQGH--LKISDFGLSALPEQGVSLLRTTCGTPNYV 174
+ + + + H DLKPEN+LL + +KI DFG S Q + + Y
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY---QYIQSRFYR 225
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDL 213
+PEVL Y A D+WS G IL + G F +E+D
Sbjct: 226 SPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 11/215 (5%)
Query: 15 IGEGTFAKVKFAQ-NTETGE-SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+G G F V+ + VA+KVL + +++ RE IM + +P +VRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
V + +++E GG L +V + S Q+ G+ Y K HR
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHKGYNGAA 188
+L N+LL ++ + KISDFGLS S + APE ++ + ++ +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 519
Query: 189 ADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK 222
+DVWS GV ++ L G P+ ++ + + +E+
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 23/221 (10%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++ +TIG+G F V G VA+K + A A E S+M +RH +
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNL 248
Query: 70 VRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSK 126
V+L V + + +YI+ E++ G L D + GR L ++ + + ++Y
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSL-LRTTCGTPNYVAPEVLSHK 182
HRDL N+L+ K+SDFGL+ + + L ++ T APE L K
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT-------APEALREK 361
Query: 183 GYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK 222
++ +DVWS G++L+ + G +P+ + L + +VEK
Sbjct: 362 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 52/219 (23%), Positives = 100/219 (45%), Gaps = 12/219 (5%)
Query: 12 GRTIGEGTFAKV---KFAQNTETGE-SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G G F V + E+ + V +KV++ + + A + + + + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA--VTDHMLAIGSLDHA 75
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSK 126
+VRL + + + ++ +++ G L D + H G L + Q+ G+ Y
Sbjct: 76 HIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGY 184
G+ HR+L N+LL S ++++DFG++ L L + TP ++A E + Y
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK 222
+DVWS GV ++ ++ G P+ L L + +EK
Sbjct: 195 T-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-27
Identities = 55/265 (20%), Positives = 115/265 (43%), Gaps = 20/265 (7%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F VK+ + + VA+K++ ++ + + E +M + H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQY--DVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEK 80
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L+ V + I+II E++ G L + + R + + + + ++Y SK
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNG 186
HRDL N L++ QG +K+SDFGLS P + PEVL + ++
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS- 199
Query: 187 AAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL-- 243
+ +D+W+ GV+++ + G +P++ + + + P A ++ I+
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYR--PHLASEKVYTIMYS 256
Query: 244 --DPNPETRITIEEIRN--DEWFRK 264
+ R T + + + + +
Sbjct: 257 CWHEKADERPTFKILLSNILDVMDE 281
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 23/221 (10%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++ +TIG+G F V G VA+K + A A E S+M +RH +
Sbjct: 24 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNL 76
Query: 70 VRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSK 126
V+L V + + +YI+ E++ G L D + GR L ++ + + ++Y
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSL-LRTTCGTPNYVAPEVLSHK 182
HRDL N+L+ K+SDFGL+ + + L ++ T APE L K
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT-------APEALREK 189
Query: 183 GYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK 222
++ +DVWS G++L+ + G +P+ + L + +VEK
Sbjct: 190 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 12 GRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
GR IGEG F V +N +VA+K + ++ +E M+ H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHS 125
P +V+L V+ + ++II+E T GEL + L + Y QL + Y S
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGY 184
K HRD+ N+L+ S +K+ DFGLS E + P ++APE ++ + +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK 222
+A+DVW GV ++ +L+ G PF + + ++E
Sbjct: 570 T-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 65/265 (24%), Positives = 125/265 (47%), Gaps = 22/265 (8%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++ +G G F +V N T VA+K L + ++ E ++MK ++H
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFL----AEANLMKQLQHQR 69
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+VRL+ V ++ IYII E++ G L D K +L+ ++ Q+ +G+ + +
Sbjct: 70 LVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYN 185
HRDL+ N+L+ KI+DFGL+ L E R P + APE +++ +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 186 GAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL- 243
+DVWS G++L ++ G +P+ + + +E+ + P +++++
Sbjct: 189 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVR--PDNCPEELYQLMR 244
Query: 244 ---DPNPETRITIEEIRN--DEWFR 263
PE R T + +R+ +++F
Sbjct: 245 LCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 53/274 (19%), Positives = 95/274 (34%), Gaps = 39/274 (14%)
Query: 10 EVGRTIGEGTFAKV-------KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
++G+GTF K+ V +KVLD++ ++ S+M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMS 67
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVD 121
+ H +V + V + ++ EF+ G L + + ++ +QL +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHL--------KISDFGLSALPEQGVSLLRTTCGTPNY 173
+ + H ++ +N+LL + K+SD G+S T
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS----------ITVLPKDIL 177
Query: 174 ------VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-F 225
V PE + + A D WS G L+ + G P LD E
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237
Query: 226 SCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259
P + +LI+ +D P+ R + I D
Sbjct: 238 PAPKAAELA--NLINNCMDYEPDHRPSFRAIIRD 269
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 65/334 (19%), Positives = 123/334 (36%), Gaps = 87/334 (26%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+ V R +G+GTF +V Q+ + + A+KV+ R+ K K E I+K +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN---IKKYTRSAKIEADILKKIQN 90
Query: 67 -----PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDG 119
+V+ H + +I E + G L++ I + + + Y +++
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGH-------------------------LKISDFGLS 154
++Y + H DLKPEN+LLD +K+ DFG +
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DEL 211
+ T Y APEV+ + G+ ++D+WS G +L L G L F + +
Sbjct: 210 TFKSDYHG---SIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 212 DLTTLYSKV---------EKADFSCPTWF----------PVGAKS--------------- 237
+ + + +A + + + P A S
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 238 ---------LIHRILDPNPETRITIEEIRNDEWF 262
++ IL +P R + E+ ++
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 68/295 (23%), Positives = 117/295 (39%), Gaps = 36/295 (12%)
Query: 10 EVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
IG G F V N A+K L+R I Q E IMK H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDFSH 149
Query: 67 PCVVRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
P V+ L + L S ++L ++ G+L + I + + + + Q+ G+ +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGT--PNYV---APEV 178
SK HRDL N +LD + +K++DFGL+ + ++ + G P V A E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP--VKWMALES 267
Query: 179 LSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK-----ADFSCPTWFP 232
L + + +DVWS GV+L+ ++ G P+ +++ + + + CP
Sbjct: 268 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP---- 322
Query: 233 VGAKSLIHRIL----DPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVN 283
++ ++ P E R + E+ + + Y VN VN
Sbjct: 323 ----DPLYEVMLKCWHPKAEMRPSFSELVSR--ISAIFSTFIGEHYVHVNATYVN 371
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 11/217 (5%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++ + +G G F +V A + + VA+K + ++ E ++MK ++H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFL----AEANVMKTLQHDKL 245
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKG 127
V+LH V ++ IYII EF+ G L D + + + Q+ +G+ + +
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNG 186
HRDL+ N+L+ + KI+DFGL+ + E R P + APE ++ +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT- 363
Query: 187 AAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK 222
+DVWS G++L ++ G +P+ + + +E+
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 64/333 (19%), Positives = 118/333 (35%), Gaps = 83/333 (24%)
Query: 7 GKYEVGRTIGEGTFAKV-KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV- 64
+YE+ +GEGTF KV + + VA+K++ R+ K + + EI+++K +
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN---VGKYREAARLEINVLKKIK 74
Query: 65 ------RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQL 116
+ CV + + + I E + G F+ + + R QL
Sbjct: 75 EKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGH-------------------LKISDFGLSALP 157
+ + H + H DLKPEN+L + ++++DFG +
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDL- 213
+ + T T +Y PEV+ G+ DVWS G IL+ G+ F + +
Sbjct: 193 HEHHT---TIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 214 -----------TTLYSKVEKAD--FSCPTWFPVGAKS----------------------- 237
+ + + K + + +
Sbjct: 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308
Query: 238 ----LIHRILDPNPETRITIEEIRNDEWFRKGY 266
L+ R+L+ +P RIT+ E +F
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 72/336 (21%), Positives = 121/336 (36%), Gaps = 83/336 (24%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+YE+ T+GEG F KV + + G VA+K++ ++ + + + EI +++ +
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN---VDRYCEAARSEIQVLEHLN 69
Query: 66 -------HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQL 116
CV ++ E I I+ E + G +D I +G R+ Q+
Sbjct: 70 TTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGH-------------------LKISDFGLSALP 157
V++ HS + H DLKPEN+L + +K+ DFG +
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDL- 213
++ S T T +Y APEV+ G+ DVWS G IL G+ F D +
Sbjct: 188 DEHHS---TLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 214 -----------TTLYSKVEKADF-----------------------------SCPTWFPV 233
+ K K +
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303
Query: 234 GAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269
LI ++L+ +P RIT+ E +F +
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 63/276 (22%), Positives = 109/276 (39%), Gaps = 44/276 (15%)
Query: 10 EVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
IG G F V N A+K L+R I Q E IMK H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDFSH 85
Query: 67 PCVVRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
P V+ L + L S ++L ++ G+L + I + + + + Q+ G+ Y
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS----------ALPEQGVSL-LRTTCGTPNY 173
SK HRDL N +LD + +K++DFGL+ + G L ++
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM------ 199
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK-----ADFSC 227
A E L + + +DVWS GV+L+ ++ G P+ +++ + + + C
Sbjct: 200 -ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257
Query: 228 PTWFPVGAKSLIHRIL----DPNPETRITIEEIRND 259
P ++ ++ P E R + E+ +
Sbjct: 258 PD--------PLYEVMLKCWHPKAEMRPSFSELVSR 285
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 61/263 (23%), Positives = 113/263 (42%), Gaps = 18/263 (6%)
Query: 10 EVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
R IG+G F V ++ + A+K L R ++ A RE +M+ + H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA--FLREGLLMRGLNH 81
Query: 67 PCVVRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
P V+ L + L +++L ++ G+L I R + + + Q+ G++Y
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGT--PNYV---APEV 178
+ HRDL N +LD +K++DFGL+ + ++ ++ P V A E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP--VKWTALES 199
Query: 179 LSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAK 236
L + +DVWS GV+L+ +L G P+ +D L + + P + P
Sbjct: 200 LQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258
Query: 237 SLIHRILDPNPETRITIEEIRND 259
++ + + +P R T + +
Sbjct: 259 QVMQQCWEADPAVRPTFRVLVGE 281
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 61/284 (21%), Positives = 110/284 (38%), Gaps = 51/284 (17%)
Query: 10 EVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+GR +G+G F V + Q + VA+K+L I + + RE + MK H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFDH 84
Query: 67 PCVVRL------HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI--- 117
P V +L +IL F+ G+L ++ R+ E+ Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143
Query: 118 ----DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY 173
G++Y S+ HRDL N +L + ++DFGLS R Y
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS----------RKIYSGDYY 193
Query: 174 V------------APEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKV 220
A E L+ Y +DVW+ GV ++ ++ G P+ ++ +Y+ +
Sbjct: 194 RQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
Query: 221 EKAD-FSCPTWFPVGAKSLIHRIL----DPNPETRITIEEIRND 259
+ P ++ ++ +P+ R + +R +
Sbjct: 253 IGGNRLKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-21
Identities = 56/226 (24%), Positives = 86/226 (38%), Gaps = 49/226 (21%)
Query: 10 EVGRTIGEGTFAKVKFA-----QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-L 63
G+T+G G F KV A ++ +VA+K+L SA + + A + E+ ++ L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSELKVLSYL 83
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGEL-----------FDKIVHHGRLSESEARRY 112
H +V L +I E+ G+L + + E
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 113 FQQLID-------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165
+ L+ G+ + SK HRDL N+LL KI DFGL+ R
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA----------R 193
Query: 166 TTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
NYV APE + + Y +DVWS G+ L+
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-21
Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 37/238 (15%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+ VG+ IG G F +++ +N T E VA+K+ + + Q+ E K +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RA---PQLHLEYRFYKQLGS 63
Query: 67 -PCVVRLHEVLASRTKIYIILEFITGG----ELFDKIVHHGRLSESEARRYFQQLIDGVD 121
+ +++ ++LE + G +LFD S QLI ++
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAIQLISRME 119
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLK-----ISDFGLS-----------ALPEQGVSLLR 165
Y HSK + +RD+KPEN L+ G+ I DF L+ + SL
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL-- 177
Query: 166 TTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK 222
GT Y++ + +H G D+ + G + + G LP+ L TL + +K
Sbjct: 178 --TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK 231
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-21
Identities = 62/287 (21%), Positives = 111/287 (38%), Gaps = 58/287 (20%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ R +G+G+F V K E VA+K ++ +A ++ ++ + E S+MK
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRY---FQQLI---- 117
VVRL V++ +I+E +T G+L + + ++I
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 118 ---DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
DG+ Y ++ HRDL N ++ +KI DFG++ R T Y
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT----------RDIYETDYYR 195
Query: 175 ------------APEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVE 221
+PE L + +DVWS GV+L+ + P+ L + V
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 222 K-----ADFSCPTWFPVGAKSLIHRIL----DPNPETRITIEEIRND 259
+ +CP ++ ++ NP+ R + EI +
Sbjct: 255 EGGLLDKPDNCP--------DMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 12 GRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVR 65
G+T+G G F KV A + VA+K+L +A K A + E+ IM L +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA--LMSELKIMSHLGQ 108
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFD-------KIVHHGRLSESEARRYFQQLID 118
H +V L + +I E+ G+L + + + + + + L+
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 119 -------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
G+ + SK HRD+ N+LL + KI DFGL+ R
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDS 218
Query: 172 NYV------------APEVLSHKGYNGAAADVWSCGVILY 199
NY+ APE + Y +DVWS G++L+
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 59/284 (20%), Positives = 95/284 (33%), Gaps = 52/284 (18%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ R +G G F +V N + VA+K L + ++ E I+
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FLMEALIISKF 131
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI------- 117
H +VR V +I+LE + GG+L + + L+
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLS-ALPE------QGVSLL--R 165
G Y HRD+ N LL G KI DFG++ + G ++L +
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK-- 222
PE + + D WS GV+L+ + GY+P+ + V
Sbjct: 252 WM-------PPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303
Query: 223 ---ADFSCPTWFPVGAKSLIHRIL----DPNPETRITIEEIRND 259
+CP ++RI+ PE R I
Sbjct: 304 RMDPPKNCP--------GPVYRIMTQCWQHQPEDRPNFAIILER 339
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 58/284 (20%), Positives = 95/284 (33%), Gaps = 52/284 (18%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ R +G G F +V N + VA+K L + ++ E I+
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI------- 117
H +VR V +I++E + GG+L + + L+
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLS-ALPE------QGVSLL--R 165
G Y HRD+ N LL G KI DFG++ + G ++L +
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEK-- 222
PE + + D WS GV+L+ + GY+P+ + V
Sbjct: 211 WM-------PPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262
Query: 223 ---ADFSCPTWFPVGAKSLIHRIL----DPNPETRITIEEIRND 259
+CP ++RI+ PE R I
Sbjct: 263 RMDPPKNCP--------GPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 7e-20
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
K+ +GR IG G+F ++ N +T E VA+K+ + KH Q+ E I ++++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHP---QLLYESKIYRILQG 61
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
+ + ++++ + G L D R LS Q+I+ V++ H
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 125 SKGVYHRDLKPENLLLDSQGH---LKISDFGLSAL-----------PEQGVSLLRTTCGT 170
SK HRD+KP+N L+ + I DFGL+ + +L GT
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL----TGT 176
Query: 171 PNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK 222
Y + V +H G D+ S G +L + G LP+ L T K EK
Sbjct: 177 ARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-20
Identities = 71/325 (21%), Positives = 118/325 (36%), Gaps = 75/325 (23%)
Query: 12 GRTIGEGTFAKVKFAQ--NTETGESVAMKVLDRSAIIKHKMADQIK---REISIMK-LVR 65
IGEG F +V A+ A+K + A D + E+ ++ L
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-----SKDDHRDFAGELEVLCKLGH 84
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRYFQQL 116
HP ++ L R +Y+ +E+ G L D + + + QQL
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 117 ID-------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ G+DY K HRDL N+L+ KI+DFGLS R G
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----------R---G 191
Query: 170 TPNYV------------APEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTL 216
YV A E L++ Y +DVWS GV+L+ ++ G P+ + L
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250
Query: 217 YSKV------EKADFSCPTWFPVGAKSLIHRIL----DPNPETRITIEEIRN--DEWFRK 264
Y K+ EK P+ ++ ++ P R + +I + +
Sbjct: 251 YEKLPQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301
Query: 265 GYVPVKLIEYEDVNLDDVNAAFDDS 289
V YE ++ + +++
Sbjct: 302 RKTYVNTTLYEKFTYAGIDCSAEEA 326
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 9e-20
Identities = 61/289 (21%), Positives = 108/289 (37%), Gaps = 58/289 (20%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+GE F KV E ++VA+K L A + + E + +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE--FRHEAMLRARL 69
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRY---------FQQ 115
+HP VV L V+ + +I + + G+L + +V S+ +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 116 LI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE-------QGV 161
+ G++Y S V H+DL N+L+ + ++KISD GL G
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 162 SLL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYS 218
SLL R APE + + ++ +D+WS GV+L+ V G P+ +
Sbjct: 190 SLLPIRWM-------APEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 219 KVEK-----ADFSCPTWFPVGAKSLIHRIL----DPNPETRITIEEIRN 258
+ CP W ++ ++ + P R ++I +
Sbjct: 242 MIRNRQVLPCPDDCPAW--------VYALMIECWNEFPSRRPRFKDIHS 282
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 2e-19
Identities = 63/290 (21%), Positives = 100/290 (34%), Gaps = 101/290 (34%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
G+Y V R +G G F+ V + + + + VAMKV+ +SA + EI ++K VR
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSA---EHYTETALDEIRLLKSVRN 92
Query: 66 --------------------------HPCVVRLHEVLASRTKIYIILEFITGGELFDKIV 99
H C+V EVL +L++I
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMV--FEVLGHH-----LLKWI-------IKS 138
Query: 100 HHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLL------------------ 140
++ L ++ QQ++ G+DY H+K + H D+KPEN+LL
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 141 -------------------------------DSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ +KI+D G + + T
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDI 254
Query: 170 TPN-YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
Y + EVL GYN AD+WS + + L G F+
Sbjct: 255 QTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTR 303
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 41/241 (17%)
Query: 10 EVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+G+ +GEG F V Q T VA+K + + + ++ E + MK H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 67 PCVVRL-----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI---- 117
P V+RL K +IL F+ G+L +++ RL Q L+
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154
Query: 118 ---DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
G++Y ++ HRDL N +L + ++DFGLS + Y
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS----------KKIYSGDYYR 204
Query: 175 ------------APEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVE 221
A E L+ + Y + +DVW+ GV ++ + G P+ + +Y +
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 222 K 222
Sbjct: 264 H 264
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-19
Identities = 63/299 (21%), Positives = 114/299 (38%), Gaps = 71/299 (23%)
Query: 12 GRTIGEGTFAKV--KFAQNTETGES---VAMKVLDRSAIIKHKMADQIK--REISIMKLV 64
R +GEG F KV N + VA+K L +A + RE ++ +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-----LAARKDFQREAELLTNL 74
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRYFQQ 115
+H +V+ + V + ++ E++ G+L I+ G+ +++ Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 116 LI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC 168
++ G+ Y S+ HRDL N L+ + +KI DFG+S R
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS----------RDVY 184
Query: 169 GTPNYV------------APEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTT 215
T Y PE + ++ + +DVWS GVIL+ + G P+ +L T
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 216 LYSKVEK-----ADFSCPTWFPVGAKSLIHRIL----DPNPETRITIEEIRN--DEWFR 263
+ + + CP ++ ++ P+ R+ I+EI +
Sbjct: 244 VIECITQGRVLERPRVCPKE--------VYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 61/296 (20%), Positives = 113/296 (38%), Gaps = 60/296 (20%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ +GEG F KV + VA+K L + A + +RE ++ ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTML 100
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRY--------FQQL 116
+H +VR V + ++ E++ G+L + HG ++ A QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 117 I-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPE------QGVS 162
+ G+ Y HRDL N L+ +KI DFG+S + G +
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 163 LL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSK 219
+L R PE + ++ + +DVWS GV+L+ + G P+ +L T
Sbjct: 221 MLPIRWM-------PPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272
Query: 220 VEK-----ADFSCPTWFPVGAKSLIHRIL----DPNPETRITIEEIRN--DEWFRK 264
+ + +CP ++ I+ P+ R +I+++ +
Sbjct: 273 ITQGRELERPRACPPE--------VYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-18
Identities = 50/237 (21%), Positives = 91/237 (38%), Gaps = 35/237 (14%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
Y+VGR IGEG+F + N + VA+K R + Q++ E KL+
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAP---QLRDEYRTYKLLAG 64
Query: 67 -PCVVRLHEVLASRTKIYIILEFITG---GELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+ ++ ++++ + G +L D + S +Q++ V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQS 121
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLK-----ISDFGLS-----------ALPEQGVSLLRT 166
H K + +RD+KP+N L+ + DFG+ + +L
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL--- 178
Query: 167 TCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK 222
GT Y++ + +H G D+ + G + + G LP+ L T K E+
Sbjct: 179 -SGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 49/224 (21%)
Query: 12 GRTIGEGTFAKVKFA-------QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-L 63
G+ +GEG F +V A VA+K+L A K + E+ +MK +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD--LISEMEMMKMI 131
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRYFQ 114
+H ++ L +Y+I+E+ + G L + + E + +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 115 QLID-------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167
L+ G++Y SK HRDL N+L+ +KI+DFGL+ R
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA----------RDI 241
Query: 168 CGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
Y APE L + Y +DVWS GV+L+
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 49/226 (21%)
Query: 10 EVGRTIGEGTFAKVKFA-------QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+G+ +GEG F +V A + +VA+K+L A K + E+ +MK
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMK 95
Query: 63 -LVRHPCVVRLHEVLASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRY 112
+ +H ++ L +Y+I+E+ + G L + + E +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 113 FQQLI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165
F+ L+ G++Y S+ HRDL N+L+ +KI+DFGL+ R
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA----------R 205
Query: 166 TTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
Y APE L + Y +DVWS GV+++
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-18
Identities = 59/235 (25%), Positives = 96/235 (40%), Gaps = 33/235 (14%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+Y +GR IG G+F + + GE VA+K+ KH Q+ E I K+++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHP---QLHIESKIYKMMQG 63
Query: 67 -PCVVRLHEVLASRTKIYIILEFITG---GELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+ + A +++E + G +LF+ + S Q+I ++Y
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEY 120
Query: 123 CHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSAL-----------PEQGVSLLRTTC 168
HSK HRD+KP+N L+ + I DFGL+ + +L
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL----T 176
Query: 169 GTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEK 222
GT Y + + +H G D+ S G +L G LP+ L T K E+
Sbjct: 177 GTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-18
Identities = 66/273 (24%), Positives = 106/273 (38%), Gaps = 66/273 (24%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL-- 72
IG G F KV + G VA+K + + + + EI + RHP +V L
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102
Query: 73 ------HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESE--------------ARRY 112
+L IY +++ G L + +G + AR
Sbjct: 103 FCDERNEMIL-----IY---KYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAAR-- 150
Query: 113 FQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL-PEQGVSLLRTTC-GT 170
G+ Y H++ + HRD+K N+LLD KI+DFG+S E + L T GT
Sbjct: 151 ------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 171 PNYVAPE-----VLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF 225
Y+ PE L+ K +DV+S GV+L+ ++ + +
Sbjct: 205 LGYIDPEYFIKGRLTEK------SDVYSFGVVLFEVLCARSAIV--------QSLPREMV 250
Query: 226 SCPTW-FPVGAKSLIHRILDPNPETRITIEEIR 257
+ W + +I+DPN +I E +R
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLADKIRPESLR 283
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-18
Identities = 56/229 (24%), Positives = 84/229 (36%), Gaps = 54/229 (23%)
Query: 12 GRTIGEGTF-----AKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
G+T+GEG F A + +VA+K+L +A + E +++K V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD--LLSEFNVLKQVNH 85
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGEL-----------------FDKIVHHGRLSESEA 109
P V++L+ + + +I+E+ G L E
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 110 RRYFQQLI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162
LI G+ Y + HRDL N+L+ +KISDFGLS
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-------- 197
Query: 163 LLRTTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
R +YV A E L Y +DVWS GV+L+
Sbjct: 198 --RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-18
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 49/226 (21%)
Query: 10 EVGRTIGEGTFAKVKFA-------QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+G+ +GEG F +V A + +VA+K+L A K + E+ +MK
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMK 141
Query: 63 -LVRHPCVVRLHEVLASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRY 112
+ +H ++ L +Y+I+E+ + G L + + E +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 113 FQQLID-------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165
F+ L+ G++Y S+ HRDL N+L+ +KI+DFGL+ R
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA----------R 251
Query: 166 TTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
Y APE L + Y +DVWS GV+++
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-18
Identities = 57/223 (25%), Positives = 86/223 (38%), Gaps = 48/223 (21%)
Query: 12 GRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVR 65
G+ +G G F +V A T T +VA+K+L A A + E+ I+ +
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGH 89
Query: 66 HPCVVRLHEV-LASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRYFQQ 115
H VV L + +I+EF G L + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 116 LID-------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC 168
LI G+++ S+ HRDL N+LL + +KI DFGL+ R
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA----------RDIY 199
Query: 169 GTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
P+YV APE + + Y +DVWS GV+L+
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 57/231 (24%), Positives = 83/231 (35%), Gaps = 54/231 (23%)
Query: 10 EVGRTIGEGTF-----AKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-L 63
E G+ +G G F A T VA+K+L A + A + E+ +M L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA--LMSELKMMTQL 105
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGEL----------------FDKIVHHGRLSES 107
H +V L IY+I E+ G+L + E
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 108 EARRYFQQLI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160
F+ L+ G+++ K HRDL N+L+ +KI DFGL+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219
Query: 161 VSLLRTTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
R NYV APE L Y +DVWS G++L+
Sbjct: 220 ----RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-17
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G G F KV + G VA+K L ++ Q + E+ ++ + H ++RL
Sbjct: 38 LGRGGFGKV-YKGRLADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 94
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEA----RRYFQQLIDGV--------DY 122
+ T+ ++ ++ G + + R +R ++ G D+
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQ--RIALGSARGLAYLHDH 150
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSH 181
C K + HRD+K N+LLD + + DFGL+ L + + + T GT ++APE LS
Sbjct: 151 CDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 209
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFD 209
G + DV+ GV+L LI G FD
Sbjct: 210 -GKSSEKTDVFGYGVMLLELITGQRAFD 236
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 53/231 (22%), Positives = 82/231 (35%), Gaps = 54/231 (23%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
E R IGEG F +V E VA+K+L A + +RE ++M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREAALMAEF 107
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGEL-----------------FDKIVHHGRLSES 107
+P +V+L V A + ++ E++ G+L D S
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 108 EARRYFQQLI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160
+ + G+ Y + HRDL N L+ +KI+DFGLS
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 221
Query: 161 VSLLRTTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
R Y PE + + Y +DVW+ GV+L+
Sbjct: 222 ----RNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLW 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 8e-17
Identities = 45/254 (17%), Positives = 94/254 (37%), Gaps = 48/254 (18%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
++ +G+ IG G F + A T E A V+ ++++ + E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSELKFYQRVAK 92
Query: 67 PCVVRLHEVLASRTKI-------------------YIILEFITGGELFDKIVHHGRLSES 107
++ + ++++E + G +L +G +S
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 108 EARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD--SQGHLKISDFGLS----------A 155
+ +++D ++Y H H D+K NLLL + + ++D+GLS
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLI---AGYLPFDEL 211
E GT + + + +HKG +DV G Y ++ G LP+++
Sbjct: 212 YQENPRKGHN---GTIEFTS--LDAHKGVALSRRSDVEILG---YCMLRWLCGKLPWEQN 263
Query: 212 DLTTLYSKVEKADF 225
+ + K +
Sbjct: 264 LKDPVAVQTAKTNL 277
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.1 bits (186), Expect = 5e-16
Identities = 38/192 (19%), Positives = 61/192 (31%), Gaps = 48/192 (25%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL-----DRSAIIKHKMADQIKREISIMK 62
K + IGEG F +V VA+K++ D K ++I EI I K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 63 LV---------RHPCVVRLHEV------------------------------LASRTKIY 83
+ R + L+ V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDS 142
I+LEF GG +++ S + A+ QL + + HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQM-RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 143 QGHLKISDFGLS 154
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-15
Identities = 60/233 (25%), Positives = 90/233 (38%), Gaps = 50/233 (21%)
Query: 4 RKVGKYEVGRTIGEGTFAKV-KFAQNTETGESVAMKVLDRSAIIK-HKMADQIKREISIM 61
+ G +GEG F V K N +VA+K L I ++ Q +EI +M
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 62 KLVRHPCVVRL--------HEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESE---- 108
+H +V L L +Y ++ G L D
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCL-----VY---VYMPNGSLLD---RLSCLDGTPPLSWH 133
Query: 109 ---------ARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL-PE 158
A G+++ H HRD+K N+LLD KISDFGL+ +
Sbjct: 134 MRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 159 QGVSLLRT-TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
+++ + GT Y+APE L G +D++S GV+L +I G DE
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDE 236
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 42/254 (16%), Positives = 89/254 (35%), Gaps = 51/254 (20%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-IKHKMADQIKREISIMKLVR 65
++VG IG+G F + + + + ESV + ++ + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCI-YLADMNSSESVGSD--APCVVKVEPSDNGPLFTELKFYQRAA 91
Query: 66 HPCVVRLHEVLASRTKI-------------------YIILEFITGGELFDKIVHHGR-LS 105
P ++ + ++I++ G +L + + S
Sbjct: 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFS 150
Query: 106 ESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD--SQGHLKISDFGLS--------- 154
+ +++D ++Y H H D+K NLLL+ + + + D+GL+
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 155 -ALPE-QGVSLLRTTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLI---AGYLPF 208
A GT + + + +H G D+ G Y +I G+LP+
Sbjct: 211 KAYAADPKRCH----DGTIEFTS--IDAHNGVAPSRRGDLEILG---YCMIQWLTGHLPW 261
Query: 209 DELDLTTLYSKVEK 222
++ Y + K
Sbjct: 262 EDNLKDPKYVRDSK 275
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 35/256 (13%), Positives = 83/256 (32%), Gaps = 55/256 (21%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETG--------ESVAMKVLDRSAIIKHKM-------- 50
++++ + A T T + ++K+ + + ++
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 51 ADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII--------LEFITGGELFDKIVHHG 102
Q+ + + + + K + L+ D
Sbjct: 102 PLQVNKWKKLYST-PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQ-----SALDV-SPKH 154
Query: 103 RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL--DSQGHLKISDFGLS------ 154
LSE + +L+D +++ H H ++ EN+ + + Q + ++ +G +
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 155 ----ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA-AADVWSCGVILYVLI---AGYL 206
A E S G +++ + HKG + +D+ S G Y ++ G+L
Sbjct: 215 GKHVAYVEGSRSPHE---GDLEFIS--MDLHKGCGPSRRSDLQSLG---YCMLKWLYGFL 266
Query: 207 PFDELDLTTLYSKVEK 222
P+ T +K
Sbjct: 267 PWTNCLPNTEDIMKQK 282
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 33/117 (28%), Positives = 52/117 (44%), Gaps = 23/117 (19%)
Query: 95 FDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154
+ ++ L+ Y Q+ G+++ S+ HRDL N+LL + +KI DFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 155 ALPEQGVSLLRTTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
R P+YV APE + + Y +DVWS GV+L+
Sbjct: 241 ----------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 4e-06
Identities = 36/152 (23%), Positives = 55/152 (36%), Gaps = 13/152 (8%)
Query: 10 EVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-L 63
++G+ +G G F +V A T T +VA+K+L A A + E+ I+ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHI 82
Query: 64 VRHPCVVRLH-EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
H VV L + +I+EF G L + R + + G DY
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST-YLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154
G DLK + S S F
Sbjct: 142 ---VGAIPVDLKRRLDSITSSQSSASSGFVEE 170
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 25/155 (16%), Positives = 56/155 (36%), Gaps = 20/155 (12%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD-QIKREISIMKLVR-- 65
+G+ +GEG + V F +E +K K+ + + ++ L
Sbjct: 92 DAIGKLMGEGKESAV-FNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 66 ----HPCVVRLHEVLASRTKIY----IILEFITGGELFDKIVHHGRLSESEARRYFQQLI 117
+ +L + + + +++E I EL+ + ++
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR-------VRVENPDEVLDMIL 203
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152
+ V + +G+ H DL N+L+ + + I DF
Sbjct: 204 EEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 32/168 (19%), Positives = 57/168 (33%), Gaps = 26/168 (15%)
Query: 9 YEVGRTIGEGTFAKVKFAQN--TETGESVAMKV-------LDRSAIIKHKMADQIKREIS 59
+G I G A V +A ++A+K+ D+ + R IS
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 60 IMKLVR------HPCVVRLHEVLASRTKIY------IILEFITGGELFDKIVHH--GRLS 105
+ V + R E S + Y +++EFI EL + L
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 106 ESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFG 152
E + F +++ V + + + H DL N++ + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI--DKVYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.8 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.63 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.29 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.22 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.0 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.83 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.69 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.46 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.26 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.09 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.93 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.88 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.78 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.44 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.93 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.79 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.73 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.72 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-64 Score=423.90 Aligned_cols=260 Identities=47% Similarity=0.914 Sum_probs=223.0
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
+.+++|++.+.||+|+||+||+|+++.+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 35789999999999999999999999999999999998766556666778999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||+ +|+|.+++.+.+++++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++..... ..
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~ 167 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NF 167 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-Cc
Confidence 999999 6799999999899999999999999999999999999999999999999999999999999999765543 23
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....|++.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+...+.+.+.....+++..+|+++.+||.+||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 247 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRML 247 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHS
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 34568999999999999888777899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccC
Q 022444 244 DPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~ 265 (297)
++||++|||++|+++||||+..
T Consensus 248 ~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 248 IVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp CSSGGGSCCHHHHHHCHHHHTT
T ss_pred cCChhHCcCHHHHHcCcccccC
Confidence 9999999999999999999753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-64 Score=427.27 Aligned_cols=260 Identities=31% Similarity=0.591 Sum_probs=241.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+.++|++.+.||+|+||+||+|+++.+|+.||+|++...........+.+.+|+++++.++||||+++++++++.+++|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45679999999999999999999999999999999987766666667889999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC--cc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~--~~ 162 (297)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++..... ..
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999865432 22
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHh
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~ 242 (297)
.....+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++.+++......++..+++++.+||.+|
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l 268 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL 268 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence 34566899999999999988876 99999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCHHH------HhcCcccccC
Q 022444 243 LDPNPETRITIEE------IRNDEWFRKG 265 (297)
Q Consensus 243 L~~~p~~Rps~~~------il~~p~~~~~ 265 (297)
|.+||++|||++| |++||||++.
T Consensus 269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 269 LVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 9999999999988 5899999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-63 Score=428.96 Aligned_cols=261 Identities=27% Similarity=0.557 Sum_probs=230.7
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
+++++|++++.||+|+||+||+|+++.+|+.||||++....... ...+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 46789999999999999999999999999999999997654333 34677899999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 84 IILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||+++......
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999999997543 57899999999999999999999999999999999999999999999999998776554
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIH 240 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~ 240 (297)
......+|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++..++..... +.+..+|+++.+||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 444566799999999999988887 999999999999999999999999999999888887765 456679999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+||++||++|||++|+|+||||++..
T Consensus 259 ~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHccCChhHCcCHHHHhcCHHhhcCC
Confidence 99999999999999999999998653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-62 Score=421.10 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=232.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|++.++||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 469999999999999999999999999999999975432 22345789999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|||+||+|.+++.+ .++++..+..++.||+.||.|||++||+|+||||+|||++.+|.+||+|||+++...........
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 99999999998876 57999999999999999999999999999999999999999999999999999877665555667
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc---cCCCCCChhHHHHHHHhc
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---SCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~l~~li~~~L 243 (297)
.+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+..... +.+..+++++.+||.+||
T Consensus 230 ~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L 308 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL 308 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHc
Confidence 7899999999999888886 999999999999999999999999998888888876533 233458999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCcccc
Q 022444 244 DPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
..||++|||++|+|+||||++...+.
T Consensus 309 ~~dP~~R~ta~e~l~Hp~~~~~~~p~ 334 (346)
T 4fih_A 309 VRDPAQRATAAELLKHPFLAKAGPPA 334 (346)
T ss_dssp CSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred CCChhHCcCHHHHhcCHhhcCCCCCc
Confidence 99999999999999999999875443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-62 Score=416.72 Aligned_cols=257 Identities=34% Similarity=0.639 Sum_probs=227.2
Q ss_pred cceEEeEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
++|++++.||+|+||+||+|++. .+++.||+|++......... ...+.+|+.++++++||||+++++++.+.+.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 47999999999999999999974 46889999999764432222 235778999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+|+||||+||+++.+|.+||+|||+++........
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876555455
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
....+|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++..++.....++|..+|+++.+||.+||
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 261 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 261 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence 5567899999999999988887 999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCC-----HHHHhcCcccccC
Q 022444 244 DPNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
++||++||| ++|+++||||+..
T Consensus 262 ~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 262 KRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp CSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 999999999 4799999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-60 Score=421.73 Aligned_cols=258 Identities=26% Similarity=0.444 Sum_probs=232.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
..|++.++||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 469999999999999999999999999999999975432 22345789999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
|||+||+|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++............
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 99999999998865 57999999999999999999999999999999999999999999999999999877665555667
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---ccCCCCCChhHHHHHHHhc
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~l~~li~~~L 243 (297)
.+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.... ...+..+++++.+||.+||
T Consensus 307 ~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L 385 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL 385 (423)
T ss_dssp CEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHc
Confidence 7899999999999888886 99999999999999999999999999888888887653 3344568999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCcccc
Q 022444 244 DPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
..||++|||++|+|+||||++...+.
T Consensus 386 ~~dP~~R~ta~ell~Hp~~~~~~~p~ 411 (423)
T 4fie_A 386 VRDPAQRATAAELLKHPFLAKAGPPA 411 (423)
T ss_dssp CSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred CCChhHCcCHHHHhcCHHhcCCCCCc
Confidence 99999999999999999999875443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=399.56 Aligned_cols=254 Identities=26% Similarity=0.485 Sum_probs=219.4
Q ss_pred cce-EEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc----CCe
Q 022444 7 GKY-EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----RTK 81 (297)
Q Consensus 7 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 81 (297)
+|| ++.++||+|+||+||+|.++.++..||+|++....... ...+.+.+|+.++++++||||+++++++.+ ...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 565 78889999999999999999999999999997654333 335778999999999999999999999864 356
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeecC-CCCEEEcccCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDS-QGHLKISDFGLSALPE 158 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~~-~~~~~l~df~~~~~~~ 158 (297)
+|+|||||++|+|.+++.+.+.+++..+..++.||+.||.|||++| |+|+||||+|||++. ++.+||+|||+++...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 8999999999999999999999999999999999999999999998 999999999999974 7899999999997544
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhhhccc--cCCCCCChhH
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLYSKVEKADF--SCPTWFPVGA 235 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~~~~~i~~~~~--~~~~~~~~~l 235 (297)
.. .....+|++.|+|||++.+ .++ .++|||||||++|+|+||+.||.+. +...+...+..+.. ..+..+++++
T Consensus 184 ~~--~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (290)
T 3fpq_A 184 AS--FAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp TT--SBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred CC--ccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence 32 3345689999999999865 455 9999999999999999999999764 45566666665543 3455688999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+||.+||++||++|||++|+|+||||++.
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=404.02 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=224.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..+.|++.++||+|+||.||+|+++.+|+.||||+++.... ..+|+.+++.++||||+++++++.+.+.+|+
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34579999999999999999999999999999999975431 2368999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccCCCCCCCCCcc-
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~~~~~~~~~~~- 162 (297)
|||||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+|+||||+|||++.+| .+||+|||+++.......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999989999999999999999999999999999999999999999987 699999999976543221
Q ss_pred ----ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc---cCCCCCChhH
Q 022444 163 ----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---SCPTWFPVGA 235 (297)
Q Consensus 163 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~l 235 (297)
.....+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+..++..... ..+..+|+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 12234699999999999988887 999999999999999999999988777777777766554 3567799999
Q ss_pred HHHHHHhcCCCcCCCCCHHHH-------------hcCcccccCcccc
Q 022444 236 KSLIHRILDPNPETRITIEEI-------------RNDEWFRKGYVPV 269 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~i-------------l~~p~~~~~~~~~ 269 (297)
.+||.+||++||++|||+.|+ |+|||+.+...++
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 999999999999999999998 5799998876554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-57 Score=400.04 Aligned_cols=262 Identities=27% Similarity=0.382 Sum_probs=224.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc------CC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------RT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 80 (297)
++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 479999999999999999999999999999999975432 22335667899999999999999999998753 35
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.+|+|||||. |+|.+++.+.+++++..++.++.||+.||.|||++||+|+||||+||+++.++.+|++|||+++.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7899999996 589999999899999999999999999999999999999999999999999999999999999765432
Q ss_pred ----ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccC---------
Q 022444 161 ----VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC--------- 227 (297)
Q Consensus 161 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------- 227 (297)
.......+|++.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+..+..+.+.......
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 2234456899999999998877665699999999999999999999999988888777764332111
Q ss_pred ----------------------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 228 ----------------------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 228 ----------------------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
...+++++.+||.+||.+||++|||++|+|+||||++...+..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~ 356 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD 356 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence 1236789999999999999999999999999999998866544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=407.37 Aligned_cols=258 Identities=30% Similarity=0.512 Sum_probs=227.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHH---HHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQI---KREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
++++|++++.||+|+||.||+|+++.+|+.||+|++.............. ..++.+++.++||||++++++|.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 57899999999999999999999999999999999986554433333333 344666777889999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+|+||||+||+++.+|.+||+|||++......
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~- 345 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999765443
Q ss_pred cccccccCCccccCCccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHhhhccccCCCCCChhHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSH-KGYNGAAADVWSCGVILYVLIAGYLPFDEL---DLTTLYSKVEKADFSCPTWFPVGAKS 237 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~l~~ 237 (297)
.....+|++.|+|||++.. ..++ .++|+|||||++|+|++|..||.+. +...+...+......++..+++++.+
T Consensus 346 -~~~t~~GTp~YmAPEvl~~~~~y~-~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~d 423 (689)
T 3v5w_A 346 -KPHASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 423 (689)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCC-THHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred -CCCCccCCcCccCHHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHH
Confidence 2345689999999999964 4555 9999999999999999999999653 44566777778888889999999999
Q ss_pred HHHHhcCCCcCCCCC-----HHHHhcCcccccC
Q 022444 238 LIHRILDPNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 238 li~~~L~~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
||.+||++||++|++ ++||++||||+..
T Consensus 424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 999999999999998 7999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=383.64 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=201.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (297)
.+++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 3567999999999999999999999999999999997544 2334567889999999999999999999886433
Q ss_pred --------eEEEEEcccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEc
Q 022444 81 --------KIYIILEFITGGELFDKIVHHGRL---SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKIS 149 (297)
Q Consensus 81 --------~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~ 149 (297)
.+|++||||++++|.+++.....+ +...++.++.|+++||.|||++||+|+||||+||+++.++.+||+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence 479999999999999999876543 456688999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcc------------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHH
Q 022444 150 DFGLSALPEQGVS------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTL 216 (297)
Q Consensus 150 df~~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~ 216 (297)
|||+++....... .....+|++.|+|||++.+..++ .++|||||||++|+|++ ||.... ....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 9999976543321 12345799999999999988877 99999999999999995 775432 2223
Q ss_pred HHHhhhcccc-CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 217 YSKVEKADFS-CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 217 ~~~i~~~~~~-~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
...+.....+ .....++.+.+||.+||++||++|||+.|+|+||||++.
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 3333333321 112245677899999999999999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-56 Score=381.16 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=220.3
Q ss_pred cceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
++|.+.+.||+|+||.||+|++. .++..||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 56999999999999999999875 367889999997543 3345678999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEE
Q 022444 82 IYIILEFITGGELFDKIVHH-------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKI 148 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l 148 (297)
.++|||||++|+|.+++.+. ..+++..++.++.|++.||.|||+++|+|+||||+||+++.++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999999764 36899999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-
Q 022444 149 SDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD- 224 (297)
Q Consensus 149 ~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~- 224 (297)
+|||+++....... ......|++.|+|||++.+..++ .++||||||+++|+|+| |+.||.+.+..++...+..+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999975443222 22234588999999999988877 99999999999999998 899999999999988887765
Q ss_pred ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 225 FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 225 ~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+.|..+|+++.+|+.+||+.||++|||++++. +||++.
T Consensus 249 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~ 287 (299)
T 4asz_A 249 LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL 287 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence 467788999999999999999999999999994 587754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=375.94 Aligned_cols=267 Identities=42% Similarity=0.791 Sum_probs=243.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++......|+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 56899999999999999999999999999999999976543 23345678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||+++++|.+++...+++++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~ 170 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKL 170 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGG
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-Ccc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998755443 233
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....+++.|+|||.+.+..+++.++||||||+++|+|++|..||.+.+.....+.+..+....|..+++++.+++.+||+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLV 250 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCC
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCC
Confidence 45678999999999988887778999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCcccccccc
Q 022444 245 PNPETRITIEEIRNDEWFRKGYVPVKLIE 273 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~~~~~~~~ 273 (297)
.||++|||++++++||||+.......+..
T Consensus 251 ~dP~~R~t~~eil~h~~~~~~~~~~~~~~ 279 (328)
T 3fe3_A 251 LNPIKRGTLEQIMKDRWINAGHEEDELKP 279 (328)
T ss_dssp SSTTTSCCHHHHTTCTTTTTTCTTCCCCC
T ss_pred CChhHCcCHHHHhcCHhhcCCCcccccCc
Confidence 99999999999999999998876554433
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=375.60 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=219.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.+++++.++||+|+||+||+|+.. .+++.||||++.... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 467899999999999999999864 467899999987543 2334577899999999999999999999999989
Q ss_pred eEEEEEcccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC
Q 022444 81 KIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG 144 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~ 144 (297)
..++|||||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 999999999999999999643 3589999999999999999999999999999999999999999
Q ss_pred CEEEcccCCCCCCCCCc--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhh
Q 022444 145 HLKISDFGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVE 221 (297)
Q Consensus 145 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~ 221 (297)
.+||+|||+++...... .......|++.|+|||++.+..++ .++||||||+++|+|+| |..||.+.+..++.+.+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999997654322 223445788999999999888876 99999999999999998 899999999999888887
Q ss_pred hcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 222 KAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 222 ~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.+. .+.|..+|+++.+++.+||+.||++|||+.+|+++
T Consensus 262 ~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 764 46778899999999999999999999999999873
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=376.08 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=212.9
Q ss_pred cceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
.+|.+.++||+|+||.||+|+++ .++..||||++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 46889999999999999999865 368899999997543 3345778999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCE
Q 022444 82 IYIILEFITGGELFDKIVHH---------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHL 146 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~ 146 (297)
.|+|||||++|+|.+++.+. .++++.+++.++.|++.||.|||+.+|+|+||||+||+++.++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 99999999999999998753 358999999999999999999999999999999999999999999
Q ss_pred EEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc
Q 022444 147 KISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA 223 (297)
Q Consensus 147 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~ 223 (297)
||+|||+++....... ......|++.|+|||++.+..++ .++||||||+++|+|+| |+.||...+..+....+..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999986543322 23345689999999999988876 99999999999999999 89999999998888888776
Q ss_pred -cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 224 -DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 224 -~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
..+.|..+|+++.+|+.+||+.||++|||+.||++
T Consensus 277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 277 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 45677889999999999999999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=400.56 Aligned_cols=259 Identities=31% Similarity=0.602 Sum_probs=232.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++.+.||+|+||.||+|+++.+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999976542 2245688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC--CCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~--~~~~l~df~~~~~~~~~~~ 162 (297)
||||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||+++..... .
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~ 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q 311 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-S
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-C
Confidence 999999999999864 4579999999999999999999999999999999999999854 79999999999876544 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~l 238 (297)
.....+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+......++ ..+++++.+|
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred ceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 33456799999999999988876 999999999999999999999999999999999888765544 4589999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
|++||..||++|||+.|+|+||||+...-+.
T Consensus 391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred HHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 9999999999999999999999999876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=378.96 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=208.1
Q ss_pred cccccceEEeEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS 78 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 78 (297)
++..++|++.+.||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+++++.+ .||||+++++++.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 455678999999999999999999875 467899999886532 234567899999988 59999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC-CCEEEcccCCCCCC
Q 022444 79 RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALP 157 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~-~~~~l~df~~~~~~ 157 (297)
.+++|+||||+++++|.+++. .+++.+++.++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||+++..
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 999999999999999999884 68999999999999999999999999999999999999876 79999999998643
Q ss_pred CCCc----------------------------cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022444 158 EQGV----------------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209 (297)
Q Consensus 158 ~~~~----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~ 209 (297)
.... ......+|++.|+|||++.+....+.++||||+||++|+|++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 3211 112345799999999999876544599999999999999999999995
Q ss_pred CC-CHHHHHHHhhh--------------------------------------cc----------------ccCCCCCChh
Q 022444 210 EL-DLTTLYSKVEK--------------------------------------AD----------------FSCPTWFPVG 234 (297)
Q Consensus 210 ~~-~~~~~~~~i~~--------------------------------------~~----------------~~~~~~~~~~ 234 (297)
.. +..+....+.. .. ......+|++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 43 33333222211 00 0112347889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+.+||++||.+||++|+|++|+|+||||++.
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=368.54 Aligned_cols=260 Identities=32% Similarity=0.603 Sum_probs=239.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++++|++++.||+|+||.||+++++.+|+.||+|++.............+.+|..+++.++||||+++++++...+..|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 46799999999999999999999999999999999987655455556778899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||+++++|.+++.+...+++..++.++.+++.||.|||+.||+|+||||+||+++.++.++|+|||++..........
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999988654444445
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....|++.|+|||++.+..++ .++|+||||+++|+|++|..||...+.....+.+......++..+++++.++|.+||+
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~ 241 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 566789999999999887776 9999999999999999999999999999999999888888889999999999999999
Q ss_pred CCcCCCC-----CHHHHhcCcccccC
Q 022444 245 PNPETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 245 ~~p~~Rp-----s~~~il~~p~~~~~ 265 (297)
.||++|| +++++++||||+..
T Consensus 242 ~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 242 KDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred cCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 9999999 99999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=372.35 Aligned_cols=260 Identities=32% Similarity=0.615 Sum_probs=234.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 83 (297)
.+++|++++.||+|+||.||+++++.+++.||+|++.............+.+|..+++.+ .||||+++++++.+....|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 457899999999999999999999999999999999876655555667788899999988 6999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||+++++|.+++.+...+++..++.++.+++.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence 99999999999999999889999999999999999999999999999999999999999999999999998865544445
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....|++.|+|||++.+..++ .++||||||+++|+|++|..||...+..++.+.+......++..+++++.+++.+||
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL 259 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFM 259 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 5566799999999999887776 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCH------HHHhcCcccccC
Q 022444 244 DPNPETRITI------EEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps~------~~il~~p~~~~~ 265 (297)
++||.+||++ +++++||||+..
T Consensus 260 ~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 260 TKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp CSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred hhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999999 899999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=366.38 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=203.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.+++++.++||+|+||+||+|+++. .+|||+++.... +.+..+.+.+|+.++++++||||+++++++.+ +.+++|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 3578899999999999999998753 599999875432 23446789999999999999999999998754 568999
Q ss_pred EcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC--cc
Q 022444 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~--~~ 162 (297)
||||++|+|.+++... .++++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||+++..... ..
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999999754 57999999999999999999999999999999999999999999999999999765432 22
Q ss_pred ccccccCCccccCCccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhhhccc-----cCCCCCChh
Q 022444 163 LLRTTCGTPNYVAPEVLSHKG--YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY-SKVEKADF-----SCPTWFPVG 234 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~-~~i~~~~~-----~~~~~~~~~ 234 (297)
......|++.|+|||++.+.. ..+.++|||||||++|+|+||+.||.+.+..... ..+..... ..+..+|++
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 344567999999999986432 2248999999999999999999999886654433 33333221 234568999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 235 AKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
+.+|+.+||+.||++|||+.+++++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999998664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=371.78 Aligned_cols=263 Identities=46% Similarity=0.884 Sum_probs=236.9
Q ss_pred ccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..+..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+..++.++||||+++++++.....
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 45778999999999999999999999999999999999987655555555678899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
.++||||+ +++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....+
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 99999999 6799999988889999999999999999999999999999999999999999999999999998766543
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~ 241 (297)
.......|++.|+|||.+.+..+.+.++||||||+++|+|++|..||.........+.+.......+..+|+++.+|+.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 23345678999999999988776568999999999999999999999887766666677777777888899999999999
Q ss_pred hcCCCcCCCCCHHHHhcCcccccCc
Q 022444 242 ILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
||+.||.+|||++++++||||+...
T Consensus 242 ~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 242 MIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HcCCChhHCcCHHHHHhChhhccCC
Confidence 9999999999999999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=367.36 Aligned_cols=260 Identities=31% Similarity=0.613 Sum_probs=237.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 83 (297)
+.++|++.+.||+|+||.||+|+++.+|+.||+|++.............+..|..+++.+ .||||+++++++.+....|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 567999999999999999999999999999999999876544444556677888888876 8999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||+++++|.+++.+...+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998765444444
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....|++.|+|||++.+..++ .++|+||||+++|+|++|..||...+...+.+.+......++..+++++.++|.+||
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 253 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 253 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred ccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHh
Confidence 5566789999999999887776 999999999999999999999999999999999998888888899999999999999
Q ss_pred CCCcCCCCCHH-HHhcCcccccC
Q 022444 244 DPNPETRITIE-EIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps~~-~il~~p~~~~~ 265 (297)
..||++||++. ++++||||+..
T Consensus 254 ~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 254 VREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp CSSGGGSBTTBSCGGGSGGGTTC
T ss_pred cCCHhHcCCChHHHHcCccccCC
Confidence 99999999998 99999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=360.94 Aligned_cols=257 Identities=34% Similarity=0.710 Sum_probs=236.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
.+++|++.+.||+|+||.||+++++.+|+.||+|++...........+.+.+|..+++.+.||||+++++++.+....|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 46889999999999999999999999999999999987655444556778899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+|||+++++|.+++.+...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---~ 160 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T 160 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---B
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---c
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998765432 2
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....|++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+......++......++..+++++.+++++||+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 239 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 345789999999999887776 9999999999999999999999999999999999988888889999999999999999
Q ss_pred CCcCCCC-----CHHHHhcCcccccC
Q 022444 245 PNPETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 245 ~~p~~Rp-----s~~~il~~p~~~~~ 265 (297)
.||++|| +++++++||||++.
T Consensus 240 ~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 240 RDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred cCHHHcCCCcCCCHHHHhcCccccCC
Confidence 9999999 99999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=362.20 Aligned_cols=263 Identities=29% Similarity=0.578 Sum_probs=235.1
Q ss_pred ccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 022444 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (297)
Q Consensus 2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (297)
-.-..++|++.+.||+|+||.||+++++.+++.+|+|++...........+.+.+|..+++.+ +||||+++++++.+..
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 345678999999999999999999999999999999999876555555567788999999887 7999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..|+||||+++++|.+++.+...+++..++.++.+++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998865444
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHhhhccccCCCCC
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE---------LDLTTLYSKVEKADFSCPTWF 231 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~ 231 (297)
........|++.|+|||.+.+..++ .++|+||||+++|+|++|..||.. .......+.+......++..+
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 4445566899999999999887776 999999999999999999999965 234456677777778888889
Q ss_pred ChhHHHHHHHhcCCCcCCCCCH------HHHhcCcccccC
Q 022444 232 PVGAKSLIHRILDPNPETRITI------EEIRNDEWFRKG 265 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~------~~il~~p~~~~~ 265 (297)
+.++.++|.+||+.||++||++ +++++||||++.
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 9999999999999999999995 899999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=363.89 Aligned_cols=260 Identities=29% Similarity=0.582 Sum_probs=237.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 83 (297)
+.++|++.+.||+|+||.||+++++.+++.||+|++.............+..|..+++.+ .||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 467999999999999999999999999999999999876554555567788899999887 7999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||+++++|.+++.+.+.+++..++.++.+++.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998865444444
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....|++.|+|||++.+..++ .++|+||||+++|+|++|..||...+...+.+.+......++..+++++.+|+.+||
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 256 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 256 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 5566799999999999887776 999999999999999999999999999999999999988899999999999999999
Q ss_pred CCCcCCCCC-----HHHHhcCcccccC
Q 022444 244 DPNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
+.||.+||+ ++++++||||+..
T Consensus 257 ~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 257 TKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp CSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred hcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 999999995 6999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=362.76 Aligned_cols=258 Identities=34% Similarity=0.674 Sum_probs=237.9
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
..+++|++++.||+|+||.||+++++.+|+.|++|++.............+.+|+.+++.+.||||+++++++.+....|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 35689999999999999999999999999999999998765555555677889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||+++++|.+++.+.+.+++..++.++.+++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....|++.|+|||++.+..++ .++||||||+++|+|++|..||...+.....+.+......++..+++++.++|.+||
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL 273 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHS
T ss_pred cccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 2345688999999999887776 999999999999999999999999999999999999988889999999999999999
Q ss_pred CCCcCCCCC-----HHHHhcCcccccC
Q 022444 244 DPNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
+.||.+||+ ++++++||||+..
T Consensus 274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 274 QVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred hcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 999999999 9999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=351.61 Aligned_cols=262 Identities=32% Similarity=0.653 Sum_probs=236.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
.+++|++.+.||+|++|.||++.+..++..+++|++.............+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 57899999999999999999999999999999999977665555556778999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+|||+++++|.+.+.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--~~ 164 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RR 164 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--cc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999987654432 22
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+.......+..+++++.+|+.+||+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 243 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 243 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCC
T ss_pred cccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhc
Confidence 345688999999999877665 8999999999999999999999999999999999888888889999999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCcccc
Q 022444 245 PNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
.||++|||++++++||||+......
T Consensus 244 ~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 244 HNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp SSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred cChhhCCCHHHHhhCccccCCccCc
Confidence 9999999999999999999875443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=367.70 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=214.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCC-----CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEEc-
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTET-----GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLAS- 78 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~- 78 (297)
.++|++.+.||+|+||.||+|.+... ++.||||.+..... ....+.+.+|+.+++++.| |||++++++|..
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 36899999999999999999997643 46799999875442 2335678899999999976 899999999865
Q ss_pred CCeEEEEEcccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC
Q 022444 79 RTKIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS 142 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~ 142 (297)
+..+++|||||++|+|.+++.+. ..+++..+..++.|++.||.|||+++|+|+||||+||+++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 45789999999999999999753 24799999999999999999999999999999999999999
Q ss_pred CCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHH
Q 022444 143 QGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL-TTLYS 218 (297)
Q Consensus 143 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~-~~~~~ 218 (297)
++.+||+|||+++....... ......+++.|+|||++.+..++ .++|||||||++|+|+| |..||.+.+. ..+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986544322 23345688899999999988876 99999999999999998 9999988654 44555
Q ss_pred Hhhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 219 KVEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 219 ~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.+..+ +++.|..+|+++.+++.+||+.||++|||+.+|++|
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 55554 467788899999999999999999999999999997
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=367.50 Aligned_cols=260 Identities=29% Similarity=0.599 Sum_probs=231.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 83 (297)
.+++|++++.||+|+||.||+++++.+++.+|+|++...........+.+.+|..+++++ +||||+++++++.+....|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 356899999999999999999999999999999999876554444456677888888877 7999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||+++++|..++.+...+++..++.++.+|+.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999865444445
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHhhhccccCCCCCChh
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL---------DLTTLYSKVEKADFSCPTWFPVG 234 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~ 234 (297)
.....|++.|+|||++.+..++ .++|+||||+++|+|++|..||... ....+.+.+......+|..++.+
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~ 288 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 288 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHH
Confidence 5567899999999999888776 9999999999999999999999532 33456777788888889999999
Q ss_pred HHHHHHHhcCCCcCCCCCH------HHHhcCcccccC
Q 022444 235 AKSLIHRILDPNPETRITI------EEIRNDEWFRKG 265 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~------~~il~~p~~~~~ 265 (297)
+.+||++||+.||++||++ +++++||||++.
T Consensus 289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999999995 899999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=369.92 Aligned_cols=261 Identities=35% Similarity=0.667 Sum_probs=233.5
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.+..++|++.+.||+|+||.||++.++.+|+.+++|++....... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 345578999999999999999999999999999999997655333 3356788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec---CCCCEEEcccCCCCCCCC
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~---~~~~~~l~df~~~~~~~~ 159 (297)
++||||+.+++|.+.+.....+++..+..++.|++.||.|||+.||+|+||||+||+++ .++.++|+|||++.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999999999888999999999999999999999999999999999999998 457899999999987766
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC----CCChhH
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT----WFPVGA 235 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~l 235 (297)
.........|++.|+|||++.+..++ .++||||||+++|+|++|..||...+.....+.+..+...++. .+++++
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 55555567899999999999877776 9999999999999999999999999999999988888765543 579999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+|+.+||+.||++|||+.++|+||||+..
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=373.95 Aligned_cols=261 Identities=47% Similarity=0.885 Sum_probs=239.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|.+.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++......++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 57899999999999999999999999999999999987655555556788999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~ 172 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFL 172 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCB
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-ccc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998765443 223
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....|++.|+|||.+.+..+.+.++||||||+++|+|++|..||...+......++..+....+..+++++.+|+.+||+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 252 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQ 252 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTC
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcC
Confidence 45678999999999988776668999999999999999999999999888899999888888888899999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCc
Q 022444 245 PNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~ 266 (297)
.||++|||++++++||||++..
T Consensus 253 ~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 253 VDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp SSTTTSCCHHHHHTCHHHHTTC
T ss_pred CCchhCcCHHHHHhCHHhhhcC
Confidence 9999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=373.54 Aligned_cols=261 Identities=34% Similarity=0.605 Sum_probs=228.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||++.++.+|+.||+|++.............+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 35789999999999999999999999999999999986554444555677889999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
||||+++++|.+++.+...+++..++.++.+++.||.|||+ .||+|+||||+||+++.++.++|+|||++.........
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 305 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence 99999999999999988899999999999999999999998 99999999999999999999999999999865554445
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....|++.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+......++..+++++.+||.+||
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 384 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 384 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 5567899999999999887776 999999999999999999999999999999999998888899999999999999999
Q ss_pred CCCcCCCC-----CHHHHhcCcccccCc
Q 022444 244 DPNPETRI-----TIEEIRNDEWFRKGY 266 (297)
Q Consensus 244 ~~~p~~Rp-----s~~~il~~p~~~~~~ 266 (297)
+.||++|| |++++++||||+...
T Consensus 385 ~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 385 KKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 99999999 999999999999763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=360.19 Aligned_cols=260 Identities=35% Similarity=0.608 Sum_probs=231.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..++|++.+.||+|+||.||+++++.+|+.+|+|++........ ...+.+.+|+.+++.+.||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 34679999999999999999999999999999999976543221 134678899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC----CEEEcccCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALP 157 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~----~~~l~df~~~~~~ 157 (297)
.++||||+++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999999888999999999999999999999999999999999999998776 7999999998765
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCCh
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPV 233 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 233 (297)
... .......|++.|+|||++.+..++ .++||||||+++|+|++|..||.+.+..+....+......++ ..+++
T Consensus 170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 170 EDG-VEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp CTT-CCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred CCC-CccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 543 223456789999999999877776 999999999999999999999999999988888887766554 45899
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
++.+||.+||..||++|||+.++|+||||+...
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 999999999999999999999999999998643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=351.06 Aligned_cols=258 Identities=24% Similarity=0.451 Sum_probs=227.8
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
...++|++.+.||+|+||+||++.+..+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence 345789999999999999999999999999999999875432 22456788999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||+.+++|.+++.+. .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 999999999999988764 7999999999999999999999999999999999999999999999999998766655555
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc---cccCCCCCChhHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~l~~li~ 240 (297)
.....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+... ....+..+++.+.+|+.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 5567799999999999887776 9999999999999999999999988877665554433 23345568999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+||+.||++|||++++++||||+...
T Consensus 252 ~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHccCChhHCcCHHHHhhChhhcccC
Confidence 99999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=355.09 Aligned_cols=261 Identities=33% Similarity=0.602 Sum_probs=223.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
..++|++.+.||+|+||.||++++. .+++.+++|++...... .......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 3568999999999999999999985 68999999999765322 2233456788999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..|+||||+++++|.+++...+.+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998765444
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHH
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~ 240 (297)
........|++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+.......+..++.++.+++.
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 253 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 3444456789999999999877776 999999999999999999999999999988899888888888899999999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcCcccccCc
Q 022444 241 RILDPNPETRI-----TIEEIRNDEWFRKGY 266 (297)
Q Consensus 241 ~~L~~~p~~Rp-----s~~~il~~p~~~~~~ 266 (297)
+||+.||++|| +++++++||||+...
T Consensus 254 ~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 99999999999 899999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=348.89 Aligned_cols=262 Identities=34% Similarity=0.638 Sum_probs=208.6
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
.++++|++.+.||+|++|.||++++..+|+.|++|++...........+.+.+|+.+++.++||||+++++++.+....+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 56789999999999999999999999999999999997665545555677899999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 84 IILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
++||++++++|.+++... .++++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999999865 5799999999999999999999999999999999999999999999999999876654433
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHh
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~ 242 (297)
......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+.......+..++.++.+++.+|
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 33455688999999999877665 89999999999999999999998877666666666666677778999999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccCc
Q 022444 243 LDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
|+.||++|||++++++||||++..
T Consensus 247 l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTTTC---
T ss_pred cccCHhhCCCHHHHhcCccccCCC
Confidence 999999999999999999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=347.93 Aligned_cols=266 Identities=37% Similarity=0.633 Sum_probs=241.0
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
...++|++.+.||+|++|.||++.+..+++.+++|++...........+.+.+|+.+++.+.|+||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 35578999999999999999999999999999999997665444555677889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
++||++++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998766544444
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....+++.|+|||.+.+..++ .++||||||+++|+|++|..||......+....+.......+..+++.+.+++.+||
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHc
Confidence 4556788999999999877665 899999999999999999999999988888888888888888889999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCccccc
Q 022444 244 DPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
+.||++|||++++++||||++...+..
T Consensus 251 ~~~p~~Rps~~~ll~~~~~~~~~~~~~ 277 (294)
T 2rku_A 251 QTDPTARPTINELLNDEFFTSGYIPAR 277 (294)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred ccChhhCcCHHHHhhChheecCCcCCC
Confidence 999999999999999999998866543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=345.82 Aligned_cols=261 Identities=47% Similarity=0.897 Sum_probs=229.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||.+.++.+|+.|++|++.............+.+|+..++.++|+||+++++++......++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 46799999999999999999999999999999999987655555556788999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+||++.+++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~ 167 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFL 167 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-cce
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998765443 222
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....+++.|+|||.+.+..+.+.++||||||+++|+|++|..||...+.....+.+.......+..++.++.+++.+||+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 247 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQ 247 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHcc
Confidence 34567889999999987766558999999999999999999999999888888888888888888899999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCc
Q 022444 245 PNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~ 266 (297)
.||++|||++++++||||++..
T Consensus 248 ~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 248 VDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp SSGGGSCCHHHHHHSHHHHTTC
T ss_pred CChhhCCCHHHHHhChhhccCc
Confidence 9999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=358.73 Aligned_cols=259 Identities=28% Similarity=0.581 Sum_probs=232.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||+++++.+++.||+|++.............+.+|+.+++.++||||+++++++.+....|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46789999999999999999999999999999999987665555667788899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||+.+++|.+++.....+++..++.++.+++.||.|||+.||+|+||||+||+++.++.++|+|||++...... ...
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~ 171 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQI 171 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-CCB
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-Cce
Confidence 9999999999999998889999999999999999999999999999999999999999999999999999765433 333
Q ss_pred ccccCCccccCCcccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHhhhccccCCCCCChhHHHH
Q 022444 165 RTTCGTPNYVAPEVLSHK---GYNGAAADVWSCGVILYVLIAGYLPFDE---LDLTTLYSKVEKADFSCPTWFPVGAKSL 238 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~ll~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~l~~l 238 (297)
....|++.|+|||++.+. .++ .++||||||+++|+|++|..||.. .........+.......+..++.++.+|
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~l 250 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred eccCCCccccCCeeeccCCCCCCC-ccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHH
Confidence 456789999999998642 344 899999999999999999999964 3455667777777788888899999999
Q ss_pred HHHhcCCCcCCCCC-HHHHhcCcccccC
Q 022444 239 IHRILDPNPETRIT-IEEIRNDEWFRKG 265 (297)
Q Consensus 239 i~~~L~~~p~~Rps-~~~il~~p~~~~~ 265 (297)
|.+||+.||.+||+ ++++++||||+..
T Consensus 251 i~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 99999999999999 9999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-51 Score=354.44 Aligned_cols=266 Identities=37% Similarity=0.633 Sum_probs=241.6
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
...++|++.+.||+|+||.||++.+..+++.+++|++...........+.+.+|+.+++.+.|+||+++++++.+....+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34678999999999999999999999999999999997665444555677889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
++|||+.+++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998766544444
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....++..|+|||.+.+..++ .++||||||+++|+|++|..||......+....+.......+..+++.+.+++.+||
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 276 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHc
Confidence 4556788999999999877765 899999999999999999999999888888888888888888889999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCccccc
Q 022444 244 DPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
+.||++|||++++++||||+.++.+..
T Consensus 277 ~~dp~~Rps~~ell~~~~~~~~~~~~~ 303 (335)
T 2owb_A 277 QTDPTARPTINELLNDEFFTSGYIPAR 303 (335)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred cCChhHCcCHHHHhcCccccCCCcccc
Confidence 999999999999999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=348.66 Aligned_cols=258 Identities=31% Similarity=0.486 Sum_probs=219.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++.+.||+|++|+||+|.++.+++.||+|++..... .......+.+|+.+++.++|+||+++++++.+....++|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4789999999999999999999999999999999976542 233356678999999999999999999999999999999
Q ss_pred EcccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|||+.+ ++.+.+. ..+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+..........
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 999986 5555554 46789999999999999999999999999999999999999999999999999998766554555
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHhhhcc-------------------
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLP-FDELDLTTLYSKVEKAD------------------- 224 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~p-f~~~~~~~~~~~i~~~~------------------- 224 (297)
....+++.|+|||.+.+....+.++||||||+++|+|++|..| |...+..+....+....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 5667899999999998766445999999999999999988777 56666666555543211
Q ss_pred ----------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 225 ----------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 225 ----------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
......+++++.+|+.+||+.||++|||++|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01122467899999999999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=361.52 Aligned_cols=260 Identities=34% Similarity=0.587 Sum_probs=227.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHH-HHhcCCCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
+.++|++++.||+|+||.||+++++.+++.+|+|++.............+..|... ++.+.||||+++++++......|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 46789999999999999999999999999999999987654444444555566665 56789999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||+++++|.+++.+...+++..++.++.+++.||.|||++||+|+||||+||+++.++.++|+|||++.........
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998764444444
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....|++.|+|||++.+..++ .++|+||||+++|+|++|..||...+..+..+++......++..++.++.++|.+||
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL 274 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 274 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHT
T ss_pred cccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHc
Confidence 5566799999999999887776 999999999999999999999999999999999988888888889999999999999
Q ss_pred CCCcCCCCCH----HHHhcCcccccC
Q 022444 244 DPNPETRITI----EEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps~----~~il~~p~~~~~ 265 (297)
+.||.+||++ +++++||||+..
T Consensus 275 ~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 275 QKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp CSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred ccCHHhCCCCCCCHHHHhCCccccCC
Confidence 9999999997 699999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=346.03 Aligned_cols=261 Identities=33% Similarity=0.684 Sum_probs=236.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++.+..+++.+++|++.............+.+|+.+++.++|+||+++++++......++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 46789999999999999999999999999999999977654444456778899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+||++++++|.+++...+.+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 169 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RR 169 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--CB
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--cc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999988654432 22
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+.......+..++.++.+++.+||+
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 248 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLR 248 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSC
T ss_pred ccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhh
Confidence 345688999999999877765 8999999999999999999999999888888888888888888899999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCccc
Q 022444 245 PNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.||.+|||++++++||||+....+
T Consensus 249 ~~p~~Rps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 249 YHPPQRLPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp SSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred cCHhhCCCHHHHhhCHHHHhhccc
Confidence 999999999999999999976543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=350.07 Aligned_cols=268 Identities=25% Similarity=0.377 Sum_probs=217.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++++.||+|++|.||++.+..+|+.+++|++..... .....+.+.+|+.+++.++|+||+++++++......+++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 5789999999999999999999999999999999865432 333456678999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|||+++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 99999999999888888899999999999999999999999999999999999999999999999999976665444445
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------------
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--------------------- 224 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--------------------- 224 (297)
...+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+....
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 66788999999999764444599999999999999999999999887766554443210
Q ss_pred ccC----------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccc
Q 022444 225 FSC----------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEY 274 (297)
Q Consensus 225 ~~~----------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~ 274 (297)
.+. ...++.++.+|+.+||++||++|||++++|+||||++..........
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 300 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKE 300 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--------
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHHHHHh
Confidence 000 13478889999999999999999999999999999987665554443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=353.09 Aligned_cols=258 Identities=27% Similarity=0.515 Sum_probs=229.7
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
+..++|++.+.||+|+||.||++.++.+++.+++|.+.... .....+.+|+.+++.++||||+++++++.+....+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 34679999999999999999999999999999999987543 22355789999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC--CCCEEEcccCCCCCCCCC
Q 022444 84 IILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS--QGHLKISDFGLSALPEQG 160 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~--~~~~~l~df~~~~~~~~~ 160 (297)
++|||+++++|.+.+.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999999997654 6999999999999999999999999999999999999987 789999999998766543
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHH
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAK 236 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~ 236 (297)
.......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+......++ ..+|+++.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred -CccccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 223455688999999999876655 899999999999999999999999998888888887776554 35899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 237 SLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
+|+.+||..||.+|||+.++|+||||++...
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 9999999999999999999999999998644
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=347.87 Aligned_cols=259 Identities=39% Similarity=0.682 Sum_probs=220.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh-----------------------HHHHHHHHHHHHHH
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-----------------------HKMADQIKREISIM 61 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----------------------~~~~~~~~~e~~~l 61 (297)
..++|++.+.||+|+||.||+|++..+++.||+|++....... ....+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4679999999999999999999999999999999997543221 11235688999999
Q ss_pred HhcCCCCeeEEEEEEEc--CCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCee
Q 022444 62 KLVRHPCVVRLHEVLAS--RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLL 139 (297)
Q Consensus 62 ~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIl 139 (297)
+.++||||+++++++.. ....+++|||+++++|.+++. ..++++..++.++.+++.||.|||+.|++|+||+|+||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999976 568999999999999987654 457999999999999999999999999999999999999
Q ss_pred ecCCCCEEEcccCCCCCCCCCccccccccCCccccCCccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022444 140 LDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY--NGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (297)
Q Consensus 140 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~ 217 (297)
++.++.++|+|||++..............+++.|+|||.+.+... .+.++||||||+++|+|++|..||...+.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999998766554444455678999999999976543 247899999999999999999999988888777
Q ss_pred HHhhhccccCC--CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 218 SKVEKADFSCP--TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 218 ~~i~~~~~~~~--~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
..+.......+ ..+++++.+++.+||+.||++|||+.++++||||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 77776655443 468999999999999999999999999999999964
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=341.09 Aligned_cols=266 Identities=35% Similarity=0.671 Sum_probs=234.5
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.+..++|++.+.||+|++|.||++.++.+++.+++|++...... ....+.+.+|+.+++.++|+||+++++++......
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 45678999999999999999999999999999999999765432 33356788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC---EEEcccCCCCCCCC
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQ 159 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~---~~l~df~~~~~~~~ 159 (297)
+++||++.+++|.+.+.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999999998889999999999999999999999999999999999999986655 99999999866554
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhH
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGA 235 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l 235 (297)
.. ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+.......+ ..+++++
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 161 SE-AWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp SC-BCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred Cc-cccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 32 22345688999999999887766 999999999999999999999999998888888877765444 3579999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKL 271 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~ 271 (297)
.+++.+||++||++|||++++|+||||++..+....
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred HHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 999999999999999999999999999987554443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=350.86 Aligned_cols=260 Identities=35% Similarity=0.605 Sum_probs=229.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.++|++.+.||+|+||.||++.++.+|+.+++|++........ ...+.+.+|+.+++.++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4579999999999999999999999999999999976432211 1356788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC----CEEEcccCCCCCCC
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPE 158 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~----~~~l~df~~~~~~~ 158 (297)
++||||+++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888899999999999999999999999999999999999998877 79999999987654
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChh
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVG 234 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~ 234 (297)
... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+.......+ ..++..
T Consensus 170 ~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 170 FGN-EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247 (326)
T ss_dssp TTS-CCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCC-ccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHH
Confidence 332 23345689999999999877766 999999999999999999999998888888777776655443 457899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
+.+|+.+||+.||++|||+.++|+||||+....
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 999999999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=354.16 Aligned_cols=265 Identities=39% Similarity=0.685 Sum_probs=223.8
Q ss_pred CccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
|.+..+++|++.+.||+|+||.||+++++.+++.|++|++...... ...+.+.+|+.+++.++|+||+++++++....
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 7788899999999999999999999999999999999998754422 22356789999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..+++|||+++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred c--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhhccc--cCCCCCChhH
Q 022444 161 V--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEKADF--SCPTWFPVGA 235 (297)
Q Consensus 161 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~~~~--~~~~~~~~~l 235 (297)
. .......+++.|+|||.+.+..+.+.++||||||+++|+|++|..||...... ........... .....+++++
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence 2 22335578999999999987776558899999999999999999999776543 22222222222 2224589999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
.+|+.+||+.||++|||++|+++||||++...
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=354.51 Aligned_cols=257 Identities=36% Similarity=0.707 Sum_probs=229.5
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||++.++.+|+.|++|++...... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999999765432 23356788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC---CEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~---~~~l~df~~~~~~~~~~~ 162 (297)
|||+.+++|.+.+.....+++..++.++.+++.||.|||+.||+|+||+|+||+++.++ .++|+|||++...... .
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~ 185 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E 185 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-C
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-c
Confidence 99999999999998888899999999999999999999999999999999999997654 5999999998766543 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC----CCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT----WFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~l~~l 238 (297)
......+++.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+..+...++. .+|+++.+|
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred ccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 23356789999999999887776 8999999999999999999999999888888888887665543 478999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
|.+||+.||++|||+.++|+||||.+.
T Consensus 265 i~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=350.29 Aligned_cols=262 Identities=28% Similarity=0.464 Sum_probs=208.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++++.||+|+||.||+|.++.+|+.|++|.+.... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 4678999999999999999999999999999999997544 22234567789999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 85 ILEFITGGELFDKIVHH------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
||||+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9999985 999888654 358999999999999999999999999999999999999999999999999987665
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--------------
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-------------- 224 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-------------- 224 (297)
..........+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 444444556789999999999765444599999999999999999999999888776665553210
Q ss_pred --------------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 225 --------------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 225 --------------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
......++.++.+|+.+||+.||++|||++++|+||||++.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 011234788999999999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=348.05 Aligned_cols=258 Identities=30% Similarity=0.450 Sum_probs=214.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++++.||+|+||+||++++. +|+.+|+|++..... .......+.+|+.+++.++||||+++++++.+....++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 4578999999999999999999986 589999999975432 23345678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
||||+.+ +|.+.+... ..+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||.+.........
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9999986 787777654 45999999999999999999999999999999999999999999999999999876555444
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc------------------
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------------------ 225 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------------------ 225 (297)
.....+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+.....
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 55667899999999987654445999999999999999999999987766555544432100
Q ss_pred ------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 226 ------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 226 ------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.....+++++.+|+.+||++||++|||++++|+||||++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0122367889999999999999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=352.40 Aligned_cols=258 Identities=33% Similarity=0.644 Sum_probs=222.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH--HHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH--KMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
.++|++.+.||+|+||.||++.++.+++.||+|++........ ...+.+.+|+.+++.++||||+++++++......|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3579999999999999999999999999999999975432211 13567889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC---EEEcccCCCCC
Q 022444 84 IILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSAL 156 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~---~~l~df~~~~~ 156 (297)
+||||+++++|.+.+... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++. ++|+|||.+..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998877543 25899999999999999999999999999999999999986654 99999999977
Q ss_pred CCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCC
Q 022444 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFP 232 (297)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~ 232 (297)
............+++.|+|||++.+..++ .++||||||+++|+|++|..||... .......+.......+ ..++
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s 260 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHIS 260 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCC
Confidence 66554444566799999999999877776 9999999999999999999999874 4455666665554443 4589
Q ss_pred hhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 233 VGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 233 ~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+++.+|+.+||+.||++|||+.++|+||||++.
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 999999999999999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=354.01 Aligned_cols=257 Identities=42% Similarity=0.755 Sum_probs=212.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++++.||+|+||.||+++++.+++.||+|++...... ...+.+|+..++.++||||+++++++......++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 457899999999999999999999999999999999754322 2457789999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC--EEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH--LKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~--~~l~df~~~~~~~~~~~ 162 (297)
||||+.+++|.+++.+.+++++..++.++.+++.||.|||+.|++|+||||+||+++.++. ++|+|||++...... .
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~ 172 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 172 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-C
Confidence 9999999999999988889999999999999999999999999999999999999987765 999999998743332 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhhhccccCCC--CCChhHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL----TTLYSKVEKADFSCPT--WFPVGAK 236 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~l~ 236 (297)
......+++.|+|||++.+..+++.++||||||+++|+|++|..||..... ....+.+.......+. .+++++.
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence 233456899999999998887775569999999999999999999976433 3444555555444443 5899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 237 SLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+|+.+||+.||++|||++++++||||.+..
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 253 HLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred HHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 999999999999999999999999997653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=358.10 Aligned_cols=260 Identities=33% Similarity=0.557 Sum_probs=227.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||+++++.+++.+|+|++.............+.+|..+++.++||||+++++++.+....|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 46789999999999999999999999999999999976544444344557789999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-c
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~ 163 (297)
||||+++++|.+++.+ ..+++..++.++.+++.||.|||+.||+|+||||+||+++.++.++|+|||++........ .
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 9999999999998875 5799999999999999999999999999999999999999999999999999876544322 3
Q ss_pred cccccCCccccCCccccccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--ccC--CCCCChhHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGY---NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSC--PTWFPVGAK 236 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~--~~~~~~~l~ 236 (297)
.....|++.|+|||++.+... .+.++||||||+++|+|++|..||...+......++.... ..+ ...+++++.
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 305 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHH
Confidence 345679999999999976541 2389999999999999999999999999888888886643 333 346899999
Q ss_pred HHHHHhcCCCcCC--CCCHHHHhcCcccccC
Q 022444 237 SLIHRILDPNPET--RITIEEIRNDEWFRKG 265 (297)
Q Consensus 237 ~li~~~L~~~p~~--Rps~~~il~~p~~~~~ 265 (297)
+||.+||+.+|.+ ||++++|++||||++.
T Consensus 306 ~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 306 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 9999999999998 9999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=344.28 Aligned_cols=257 Identities=30% Similarity=0.485 Sum_probs=213.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++++.||+|+||.||++++ .+|+.+++|++..... .......+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999998 6789999999975542 222345677999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||++.+ +|.+++... +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 999986 898888764 679999999999999999999999999999999999999999999999999987554433334
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--------------------
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-------------------- 224 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-------------------- 224 (297)
....+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 455788999999999765544599999999999999999999999887766655543210
Q ss_pred ---------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 225 ---------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 225 ---------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
......+++++.+|+.+||+.||++|||++++|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01123478899999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=348.38 Aligned_cols=255 Identities=35% Similarity=0.703 Sum_probs=204.8
Q ss_pred ccceEEe---EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCe
Q 022444 6 VGKYEVG---RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTK 81 (297)
Q Consensus 6 ~~~y~~~---~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 81 (297)
..+|++. +.||+|+||.||++.++.+++.||+|++.... .....+|+..++.+. ||||+++++++.+...
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence 4578876 78999999999999999999999999996532 355678999999997 9999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC---CEEEcccCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPE 158 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~---~~~l~df~~~~~~~ 158 (297)
.|+||||+++++|.+++.+...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999999999999988999999999999999999999999999999999999998765 79999999998666
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHhhhccccCCC--
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD-------LTTLYSKVEKADFSCPT-- 229 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~-- 229 (297)
..........+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+ ..+....+..+....+.
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 161 PDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp C----------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 555555566789999999999887776 99999999999999999999997643 34667777776665543
Q ss_pred --CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 230 --WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 230 --~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
.+++++.+|+.+||+.||++|||++++++||||++...
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 47999999999999999999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=337.75 Aligned_cols=257 Identities=40% Similarity=0.701 Sum_probs=229.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++.++.++..+++|++..... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 34689999999999999999999999999999999876432 224668899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee---cCCCCEEEcccCCCCCCCCCc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli---~~~~~~~l~df~~~~~~~~~~ 161 (297)
+|||+++++|.+.+.....+++..++.++.+++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 99999999999999988899999999999999999999999999999999999999 77889999999998765433
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC----CCChhHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT----WFPVGAKS 237 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~l~~ 237 (297)
.......+++.|+|||.+.+. + +.++||||||+++|+|++|..||...+..+....+.......+. .+++++.+
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred cchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 233455688999999998654 4 48999999999999999999999999988888888887766654 58999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
++.+||+.||++|||+.++|+||||++...
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 999999999999999999999999987533
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=349.55 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=212.4
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
...++|++.+.||+|++|+||++++..+++.|++|++..... .......+.+|+.+++.++|+||+++++++......+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 456799999999999999999999999999999999975542 2233456778999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec-----CCCCEEEcccCCCCCCC
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-----SQGHLKISDFGLSALPE 158 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~-----~~~~~~l~df~~~~~~~ 158 (297)
+||||+.+ +|.+++.....+++..++.++.+++.||.|||+.|++|+||||+||+++ .++.++|+|||.+....
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999985 9999999888999999999999999999999999999999999999994 44559999999987655
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cC----------
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SC---------- 227 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~---------- 227 (297)
..........+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+..... +.
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 4444445567789999999998755445999999999999999999999998887766655533210 00
Q ss_pred -------------------CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 228 -------------------PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 228 -------------------~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+..+++++.+|+.+||++||++|||++++|+||||++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 01167899999999999999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=337.45 Aligned_cols=255 Identities=30% Similarity=0.592 Sum_probs=217.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||++.++.++..+++|++.... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 467999999999999999999999999999999997654 222356788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee---cCCCCEEEcccCCCCCCC
Q 022444 86 LEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSALPE 158 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli---~~~~~~~l~df~~~~~~~ 158 (297)
||++++++|.+.+... ..+++..++.++.+++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999999888543 679999999999999999999999999999999999999 445789999999987654
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC---CCCChhH
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP---TWFPVGA 235 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~~l 235 (297)
.. .......+++.|+|||.+.+ .++ .++||||||+++|+|++|..||...+.......+........ ..+++++
T Consensus 179 ~~-~~~~~~~~t~~y~aPE~~~~-~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 179 SD-EHSTNAAGTALYMAPEVFKR-DVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred Cc-ccCcCcccccCcCChHHhcc-CCC-cccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence 43 22335568899999999863 444 899999999999999999999999888887777665554333 3378999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+++.+||+.||++|||++++|+||||+++
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 999999999999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=363.99 Aligned_cols=260 Identities=28% Similarity=0.460 Sum_probs=233.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||+++++.+|+.||+|++.............+.+|..+++.++||||+++++++.....+|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 45789999999999999999999999999999999987665555556778899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 85 ILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
||||++|++|.+++... ..+++..++.++.+|+.||.|||+.||+|+||||+||+++.+|.++|+|||++......
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999999999998764 36999999999999999999999999999999999999999999999999999866554
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHhhhccccCCCCCChhHH
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL----DLTTLYSKVEKADFSCPTWFPVGAK 236 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~l~ 236 (297)
........|++.|+|||++.+..++ .++|+||||+++|+|++|..||... ....+.+.+......++..+|+++.
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 421 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHH
Confidence 4444456899999999999887776 9999999999999999999999765 4567777888888888889999999
Q ss_pred HHHHHhcCCCcCCCCC-----HHHHhcCcccccC
Q 022444 237 SLIHRILDPNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
+||.+||+.||.+||+ ++++++||||+..
T Consensus 422 ~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 9999999999999996 5899999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=349.27 Aligned_cols=261 Identities=24% Similarity=0.401 Sum_probs=213.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++++.||+|++|.||++.++.+++.||+|++...... .....+.+|+.+++.++|+||+++++++......++|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 47899999999999999999999999999999998654311 1112345789999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|||+.+ +|.+++...+ .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 999985 8888887654 58999999999999999999999999999999999999999999999999987666554555
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-------------------
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------------------- 225 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------------------- 225 (297)
....+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+.....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 5667899999999987754445999999999999999999999999887776665533210
Q ss_pred -----------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 226 -----------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 226 -----------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
.....+++++.+|+.+||++||++|||++|+|+||||.+...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 11224678899999999999999999999999999999875543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=357.88 Aligned_cols=260 Identities=27% Similarity=0.534 Sum_probs=226.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.++||+|+||.||+++++.+++.||+|++.............+.+|..+++.+.|+||+++++++.+....|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 35789999999999999999999999999999999976544444334457889999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
||||+++++|.+++.+ ...+++..++.++.+++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 9999999999999987 56899999999999999999999999999999999999999999999999999865543322
Q ss_pred ccccccCCccccCCcccc-----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cccCCC---CCC
Q 022444 163 LLRTTCGTPNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPT---WFP 232 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~---~~~ 232 (297)
......|++.|+|||++. ...+ +.++||||||+++|+|++|..||...+..+...++... ...+|. .++
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 310 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred ccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence 333467999999999986 2334 48999999999999999999999999988888887653 234443 489
Q ss_pred hhHHHHHHHhcCCCcCC--CCCHHHHhcCcccccC
Q 022444 233 VGAKSLIHRILDPNPET--RITIEEIRNDEWFRKG 265 (297)
Q Consensus 233 ~~l~~li~~~L~~~p~~--Rps~~~il~~p~~~~~ 265 (297)
+++.+||++||..+|++ |++++++++||||+..
T Consensus 311 ~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 99999999999999988 9999999999999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=352.77 Aligned_cols=263 Identities=22% Similarity=0.411 Sum_probs=218.0
Q ss_pred ccccceEEeEEeccC--CceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 4 RKVGKYEVGRTIGEG--TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
...++|++.+.||+| ++|.||+++++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456799999999999 9999999999999999999999765432 3456778899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
.++||||+.+++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999875 6799999999999999999999999999999999999999999999999998754322
Q ss_pred Cc-------cccccccCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc------
Q 022444 160 GV-------SLLRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD------ 224 (297)
Q Consensus 160 ~~-------~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~------ 224 (297)
.. .......++..|+|||.+.+ ..++ .++|||||||++|+|++|..||...+.......+....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 11 11223467888999999976 3444 89999999999999999999998765444433322211
Q ss_pred ----------------------------------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 225 ----------------------------------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 225 ----------------------------------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
.+.+..+++++.+||.+||++||++|||++++|+||||++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 1234457889999999999999999999999999999998
Q ss_pred Cccc
Q 022444 265 GYVP 268 (297)
Q Consensus 265 ~~~~ 268 (297)
....
T Consensus 340 ~~~~ 343 (389)
T 3gni_B 340 IKRR 343 (389)
T ss_dssp C---
T ss_pred Hhhc
Confidence 7553
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=374.96 Aligned_cols=260 Identities=29% Similarity=0.584 Sum_probs=238.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 83 (297)
++++|++++.||+|+||.||+++++.+++.||||++.............+..|..++..+ .|++|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 467899999999999999999999999999999999876554555566778888888887 6999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||||+++++|.+++...+.+++..++.++.+|+.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998765444444
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhc
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L 243 (297)
.....|++.|+|||++.+..++ .++||||||+++|+|++|..||...+..++.+.+......++..+++++.+||.+||
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 577 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 577 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHS
T ss_pred cccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 5567899999999999888776 999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCH-----HHHhcCcccccC
Q 022444 244 DPNPETRITI-----EEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps~-----~~il~~p~~~~~ 265 (297)
+.||++||++ ++|++||||+..
T Consensus 578 ~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 578 TKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp CSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred cCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999998 999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=344.06 Aligned_cols=261 Identities=35% Similarity=0.602 Sum_probs=229.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.++|++.+.||+|++|.||+++++.+|+.+++|++........ ...+.+.+|+.+++.+.||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4579999999999999999999999999999999976432211 1356788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC----CEEEcccCCCCCCC
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPE 158 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~----~~~l~df~~~~~~~ 158 (297)
+++||++++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999999888899999999999999999999999999999999999999887 79999999987654
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChh
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVG 234 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~ 234 (297)
... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+.......+ ..+|+.
T Consensus 171 ~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 171 DGV-EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp TTC-CCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccc-cccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 432 22345688999999999877766 999999999999999999999999888888888777655443 458899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
+.+++.+||+.||++|||++++++||||+.....
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~ 282 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence 9999999999999999999999999999876433
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=347.06 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=219.7
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.+.+++|++.+.||+|++|.||++++..+|+.|++|++..... .....+.+.+|+.+++.++|+||+++++++......
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 3568899999999999999999999999999999999865432 233356678999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+++|||+.+++|.++......+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999989988888778899999999999999999999999999999999999999999999999999987665545
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc------------------
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD------------------ 224 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~------------------ 224 (297)
......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+....
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 55566789999999999776444599999999999999999999998887665544432110
Q ss_pred -cc------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 225 -FS------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 225 -~~------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
.. ....+++.+.+|+.+||+.||++|||++++|+||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 00 1124789999999999999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=336.90 Aligned_cols=266 Identities=39% Similarity=0.676 Sum_probs=225.9
Q ss_pred CccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
|.....++|++.+.||+|++|.||++.++.+++.|++|++..... ....+.+.+|+..++.++|+||+++++++....
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 677788999999999999999999999999999999999875442 233567889999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..++++|++++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999999999999988778999999999999999999999999999999999999999999999999998754332
Q ss_pred c--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhhccc--cCCCCCChhH
Q 022444 161 V--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEKADF--SCPTWFPVGA 235 (297)
Q Consensus 161 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~~~~--~~~~~~~~~l 235 (297)
. .......+++.|+|||.+.+..+.+.++||||||+++|+|++|..||...... .....+..... .....+++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHH
Confidence 1 22334568889999999987766558899999999999999999999776543 22222222222 2224589999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+++.+||+.||++|||++++++||||++....
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred HHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence 999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=340.86 Aligned_cols=258 Identities=26% Similarity=0.466 Sum_probs=226.2
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
.|+..+.||+|++|.||+|+++.+|+.||||++.... ....+.+.+|+..++.++|+||+++++++...+..+++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888999999999999999999999999999987543 2234567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
|+++++|.+++.+ ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.............
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 9999999998765 579999999999999999999999999999999999999999999999999987665544444566
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc---CCCCCChhHHHHHHHhcC
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS---CPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~l~~li~~~L~ 244 (297)
.+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+.....+ ....+++.+.+++.+||+
T Consensus 202 ~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 280 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280 (321)
T ss_dssp CSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred cCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHcc
Confidence 789999999999877766 8999999999999999999999988887777776655332 233478999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccCccccc
Q 022444 245 PNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
.||++|||++++++||||.+...+..
T Consensus 281 ~dp~~Rps~~ell~hp~~~~~~~~~~ 306 (321)
T 2c30_A 281 RDPQERATAQELLDHPFLLQTGLPEC 306 (321)
T ss_dssp SSTTTSCCHHHHHTSGGGGGCCCGGG
T ss_pred CChhhCcCHHHHhcChhhccCCCccc
Confidence 99999999999999999998755443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=353.89 Aligned_cols=259 Identities=29% Similarity=0.546 Sum_probs=225.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||+++++.+|+.||+|++.............+.+|..++..+.|+||+++++++.+....|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 45789999999999999999999999999999999976554444445567889999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
||||+++++|.+++.+.+ .+++..++.++.+++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 999999999999998754 799999999999999999999999999999999999999999999999999876544322
Q ss_pred ccccccCCccccCCccccc-------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--ccCC---CC
Q 022444 163 LLRTTCGTPNYVAPEVLSH-------KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSCP---TW 230 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~---~~ 230 (297)
......|++.|+|||++.. ..+ +.++|+||||+++|+|++|..||...+..+...++.... ...+ ..
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 297 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----C
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccC
Confidence 2334579999999999863 234 489999999999999999999999998888888776532 2333 56
Q ss_pred CChhHHHHHHHhcCCCcCCC---CCHHHHhcCcccccC
Q 022444 231 FPVGAKSLIHRILDPNPETR---ITIEEIRNDEWFRKG 265 (297)
Q Consensus 231 ~~~~l~~li~~~L~~~p~~R---ps~~~il~~p~~~~~ 265 (297)
+|+++.+||++||. +|.+| |+++++++||||+..
T Consensus 298 ~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 89999999999999 99998 599999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=361.15 Aligned_cols=260 Identities=36% Similarity=0.651 Sum_probs=227.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH----------HHHHHHHHHHHHHHhcCCCCeeEEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH----------KMADQIKREISIMKLVRHPCVVRLHEV 75 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (297)
.++|++++.||+|+||+||+|.++.+++.+|+|++........ ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4689999999999999999999999999999999976543321 335678899999999999999999999
Q ss_pred EEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC---CEEEcccC
Q 022444 76 LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFG 152 (297)
Q Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~---~~~l~df~ 152 (297)
+.+....++||||+++++|.+.+.+...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 999999999999999999999999888999999999999999999999999999999999999998776 69999999
Q ss_pred CCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----
Q 022444 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP---- 228 (297)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 228 (297)
++...... .......+++.|+|||.+.+ .++ .++||||||+++|+|++|..||...+..+....+..+...++
T Consensus 195 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 195 LSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYN-EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp TCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCEEcCCC-CccccccCCcCCCCHHHhcc-CCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 98765443 23345678999999999874 444 899999999999999999999999999999999988876554
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
..+|+++.+||.+||++||++|||++++|+||||++....
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 5689999999999999999999999999999999987544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=349.34 Aligned_cols=253 Identities=34% Similarity=0.621 Sum_probs=221.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 83 (297)
..++|++.+.||+|+||.||++.++.+++.||+|++..... ...+|+..+.++ .||||+++++++.+....|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 35689999999999999999999999999999999975431 123567777777 7999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC-C---CEEEcccCCCCCCCC
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-G---HLKISDFGLSALPEQ 159 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~-~---~~~l~df~~~~~~~~ 159 (297)
+||||+.+++|.+.+.+.+.+++..+..++.+++.||.|||+.|++|+||||+||++..+ + .++|+|||.+.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999988899999999999999999999999999999999999998543 3 599999999986655
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHhhhccccCC----CCCC
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE---LDLTTLYSKVEKADFSCP----TWFP 232 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~---~~~~~~~~~i~~~~~~~~----~~~~ 232 (297)
.........+++.|+|||++.+..++ .++||||||+++|+|++|..||.. .+..++...+..+....+ ..++
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 44445566789999999999876665 899999999999999999999975 456677788777766554 4589
Q ss_pred hhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 233 VGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 233 ~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+++.+||.+||..||++|||+.++++||||.+.
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 999999999999999999999999999999765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=349.44 Aligned_cols=258 Identities=29% Similarity=0.560 Sum_probs=226.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||+|.++.+|+.+++|++...... ....+.+|+.+++.++|+||+++++++.+....++
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 356899999999999999999999999999999999765422 23567899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC--CCCEEEcccCCCCCCCCCc
Q 022444 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS--QGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~--~~~~~l~df~~~~~~~~~~ 161 (297)
||||+.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999999999999987654 6999999999999999999999999999999999999974 4679999999987654432
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKS 237 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~ 237 (297)
......+++.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+.......+ ..+++++.+
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred -ceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 22345689999999999877766 899999999999999999999999888888888777654433 357999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
||.+||+.||++|||+.++|+||||+....
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 999999999999999999999999987643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=365.96 Aligned_cols=259 Identities=35% Similarity=0.658 Sum_probs=230.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||+++++.+|+.||+|++.............+.+|+.+++.++||||+++++++......++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999765544444567788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee---cCCCCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli---~~~~~~~l~df~~~~~~~~~~~ 162 (297)
||++.+++|.+.+.....+++..++.++.+++.||.|||+.|++|+||||+||++ +.++.++|+|||.+...... .
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~ 183 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-K 183 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-C
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-c
Confidence 9999999999999988899999999999999999999999999999999999999 46789999999988755433 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~l 238 (297)
......+++.|+|||++.+ .++ .++||||||+++|+|++|..||...+..+....+......++ ..+|+++.+|
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 261 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHH
T ss_pred ccccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHH
Confidence 2334568999999999876 454 899999999999999999999999999999888888765443 3488999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
|++||+++|++|||++++|+||||++...
T Consensus 262 i~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 262 IRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 99999999999999999999999987643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=363.72 Aligned_cols=259 Identities=31% Similarity=0.505 Sum_probs=230.8
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||+++++.+|+.||+|++.............+.+|+.+++.++||||+++++++.+....|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 35679999999999999999999999999999999987655555556678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
||||+++++|.+++...+. +++..++.++.+|+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~- 340 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 340 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc-
Confidence 9999999999999986543 9999999999999999999999999999999999999999999999999987654432
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHhhhccccCCCCCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL----DLTTLYSKVEKADFSCPTWFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~l~~l 238 (297)
......|++.|+|||++.+..++ .++||||||+++|+|++|..||... ....+...+......++..+++++.+|
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL 419 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 23345799999999999877766 9999999999999999999999775 345666777777777788899999999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhcCcccccC
Q 022444 239 IHRILDPNPETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 239 i~~~L~~~p~~Rp-----s~~~il~~p~~~~~ 265 (297)
|.+||+.||.+|| +++++++||||++.
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 9999999999999 89999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=359.70 Aligned_cols=259 Identities=36% Similarity=0.641 Sum_probs=227.5
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||+||++.++.+++.||+|++....... .....+.+|+.+++.++||||+++++++......++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 458999999999999999999999999999999997544222 2356788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec---CCCCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~---~~~~~~l~df~~~~~~~~~~~ 162 (297)
||++.+++|.+.+.....+++..++.++.+++.||.|||+.||+|+||||+||+++ .++.++|+|||++...... .
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~ 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-T 178 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-C
Confidence 99999999999998888999999999999999999999999999999999999995 4567999999998765443 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~l 238 (297)
......+++.|+|||++.+. ++ .++||||||+++|+|++|..||.+.+..+....+.......+ ..+|+++.+|
T Consensus 179 ~~~~~~gt~~y~aPE~~~~~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ---CCTTGGGGCCGGGGGSC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred ccCCCcCCCCCCCHHHhCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 33456789999999999753 44 899999999999999999999999999998888887765443 3478999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
|.+||+.||++|||+.++|+||||++....
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence 999999999999999999999999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=344.35 Aligned_cols=255 Identities=34% Similarity=0.650 Sum_probs=208.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||+++++.+++.|++|++.... ..+.+.+|+.+++.++|+||+++++++......+++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 467999999999999999999999999999999997543 235577899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---CCCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~~~~~l~df~~~~~~~~~~~ 162 (297)
|||+++++|.+++...+.+++..++.++.+++.||.|||+.|++|+||+|+||+++. ++.++|+|||++...... .
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~ 205 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-V 205 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-c
Confidence 999999999999998888999999999999999999999999999999999999975 789999999998765433 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhhhccccCC----CCCChhHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT-LYSKVEKADFSCP----TWFPVGAKS 237 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~----~~~~~~l~~ 237 (297)
......+++.|+|||.+.+..++ .++||||||+++|+|++|..||....... ....+.......+ ..++.++.+
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 284 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284 (349)
T ss_dssp -------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred ccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence 22345688999999999887766 99999999999999999999997665443 5556655544332 458899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
|+.+||+.||++|||+.++|+||||++...
T Consensus 285 li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 285 LVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 999999999999999999999999987643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=335.88 Aligned_cols=255 Identities=35% Similarity=0.689 Sum_probs=224.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|++|.||+++++.+|+.+++|.+..... .....+.+|+..++.++||||+++++++......+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4589999999999999999999999999999999976432 1235578999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee---cCCCCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli---~~~~~~~l~df~~~~~~~~~~~ 162 (297)
||++++++|.+.+...+.+++..++.++.+++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999999999888899999999999999999999999999999999999999 67889999999998755432
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~l 238 (297)
......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+.......+ ..+|+++.++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred ccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 22344688999999999877766 999999999999999999999999888888888877754433 4578999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+.+||+.||++|||++++|+||||+...
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 242 ICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=343.34 Aligned_cols=257 Identities=34% Similarity=0.644 Sum_probs=225.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecch-----hhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA-----IIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 79 (297)
.++|++.+.||+|++|.||+|+++.+|+.|+||++.... .......+.+.+|+.+++.+ .||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 357999999999999999999999999999999986532 12233456688999999999 799999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
...++||||+.+++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999998876554
Q ss_pred CccccccccCCccccCCcccccc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----C
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHK------GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----T 229 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~ 229 (297)
. .......+++.|+|||.+.+. .+ +.++||||||+++|+|++|..||...+.......+.......+ .
T Consensus 253 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 253 G-EKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp T-CCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred C-cccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 3 223456789999999998632 23 4899999999999999999999998888887777776655443 3
Q ss_pred CCChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 230 WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 230 ~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
.++..+.+++.+||+.||++|||++++|+||||++
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 57889999999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=338.50 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=209.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh--HHHHHHHHHHHHHHHhc---CCCCeeEEEEEEEcC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK--HKMADQIKREISIMKLV---RHPCVVRLHEVLASR 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~ 79 (297)
..++|++.+.||+|++|+||++++..+++.||+|++....... ........+|+..++.+ .||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3578999999999999999999999999999999987432111 11112344555555554 599999999998765
Q ss_pred C-----eEEEEEcccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccC
Q 022444 80 T-----KIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (297)
Q Consensus 80 ~-----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~ 152 (297)
. ..+++||++.+ +|.+++..... +++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4 58999999975 99999987654 9999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc------
Q 022444 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS------ 226 (297)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~------ 226 (297)
.+...... .......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+......
T Consensus 166 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 166 LARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp CTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccCCC-cccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 98765443 223456789999999999887776 9999999999999999999999988887776665432110
Q ss_pred ---------------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 227 ---------------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 227 ---------------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
....+++++.+|+.+||++||++|||+.++|+||||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1134678999999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=333.73 Aligned_cols=260 Identities=33% Similarity=0.634 Sum_probs=225.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
++|++.+.||+|++|.||++.++.+++.+++|++........ ...+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999876432221 13567889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC----CEEEcccCCCCCCCC
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPEQ 159 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~----~~~l~df~~~~~~~~ 159 (297)
++||++++++|.+++.+...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888999999999999999999999999999999999999998877 799999999876544
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhH
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGA 235 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l 235 (297)
.. ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+.......+ ..+++.+
T Consensus 165 ~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3bhy_A 165 GN-EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred CC-cccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence 32 22345688899999999877765 899999999999999999999999888888777766654433 4588999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+++.+||+.||++|||+.++++||||++..++
T Consensus 243 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 999999999999999999999999999986444
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=347.94 Aligned_cols=256 Identities=32% Similarity=0.536 Sum_probs=221.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH-----HHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH-----KMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (297)
..++|++.+.||+|+||.||+++++.+++.|++|++........ .....+.+|+.+++.++|+||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 35689999999999999999999999999999999976432211 1233466799999999999999999999999
Q ss_pred CeEEEEEcccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 80 TKIYIILEFITGG-ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 80 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
...+++||++.++ +|.+++.....+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999998766 999999988899999999999999999999999999999999999999999999999999987655
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHH
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSL 238 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~l 238 (297)
... ......+++.|+|||.+.+..+.+.++||||||+++|+|++|..||.... .........+..+++++.+|
T Consensus 182 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~l 254 (335)
T 3dls_A 182 RGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMSL 254 (335)
T ss_dssp TTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHHH
T ss_pred CCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHHH
Confidence 432 22345689999999999887775689999999999999999999997532 22333445566789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
+.+||++||++|||++++++||||++...
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~~~~~~~ 283 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTDPWVTQPVN 283 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred HHHHccCChhhCcCHHHHhcCccccCCcc
Confidence 99999999999999999999999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=347.81 Aligned_cols=263 Identities=27% Similarity=0.381 Sum_probs=209.7
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC--
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRT-- 80 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-- 80 (297)
...++|++++.||+|+||.||+|.++.+|+.||+|++.... ..........+|+..++.+. |+||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 34679999999999999999999999999999999986432 22334566779999999997 999999999997543
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..|+||||+.+ +|.+++.. ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 78999999974 89888876 58999999999999999999999999999999999999999999999999998654321
Q ss_pred ---------------------ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022444 161 ---------------------VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSK 219 (297)
Q Consensus 161 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~ 219 (297)
........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 11223457899999999997744445999999999999999999999998887766665
Q ss_pred hhhccc-----------------------------------------------cCCCCCChhHHHHHHHhcCCCcCCCCC
Q 022444 220 VEKADF-----------------------------------------------SCPTWFPVGAKSLIHRILDPNPETRIT 252 (297)
Q Consensus 220 i~~~~~-----------------------------------------------~~~~~~~~~l~~li~~~L~~~p~~Rps 252 (297)
+..... .....+++++.+|+.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 532100 112257889999999999999999999
Q ss_pred HHHHhcCcccccCcccc
Q 022444 253 IEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 253 ~~~il~~p~~~~~~~~~ 269 (297)
++++|+||||+......
T Consensus 323 ~~e~l~Hp~~~~~~~~~ 339 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNPN 339 (388)
T ss_dssp HHHHTTSTTTTTTCCGG
T ss_pred HHHHhCCHHHHHhcCCc
Confidence 99999999998765443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=344.39 Aligned_cols=268 Identities=27% Similarity=0.390 Sum_probs=221.4
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-----
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----- 78 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 78 (297)
..+++|++++.||+|++|.||+|+++.+|+.||+|++....... .....+.+|+.+++.++|+||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 35789999999999999999999999999999999986544222 223456789999999999999999999876
Q ss_pred ---CCeEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 79 ---RTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 79 ---~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
....++||||+.+ +|.+.+... ..+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||.+
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4468999999986 777766653 57999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCC----ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCC
Q 022444 155 ALPEQG----VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW 230 (297)
Q Consensus 155 ~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 230 (297)
...... ........+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+.......+.......+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 654321 1223345678999999998765544599999999999999999999999988877766665432222111
Q ss_pred --------------------------------CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccccc
Q 022444 231 --------------------------------FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273 (297)
Q Consensus 231 --------------------------------~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~ 273 (297)
.++.+.+|+.+||+.||++|||++++|+||||+....+.....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~ 326 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSHH
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccccc
Confidence 2567899999999999999999999999999998876665443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=332.46 Aligned_cols=260 Identities=31% Similarity=0.572 Sum_probs=227.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecch------hhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA------IIKHKMADQIKREISIMKLVR-HPCVVRLHEVLA 77 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 77 (297)
..++|++.+.||+|++|.||++.++.+|+.|++|++.... .......+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4678999999999999999999999999999999997542 112334566789999999996 999999999999
Q ss_pred cCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCC
Q 022444 78 SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~ 157 (297)
.....+++||++++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999998765
Q ss_pred CCCccccccccCCccccCCccccc------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC---
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSH------KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP--- 228 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 228 (297)
... .......+++.|+|||.+.+ ..+ +.++||||||+++|+|++|..||...+.......+.......+
T Consensus 175 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 1phk_A 175 DPG-EKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252 (298)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred CCC-cccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence 433 22334568889999999852 233 4899999999999999999999999888888777777655443
Q ss_pred -CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 229 -TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 229 -~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
..+|+.+.+++.+||+.||++|||+.++++||||++..
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 24789999999999999999999999999999999764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=332.38 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=215.1
Q ss_pred CccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 022444 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (297)
Q Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 79 (297)
|..+..++|++.+.||+|++|.||++.+..+++.|++|.+........ ....+.+|+..+..+ .||||+++++++.+.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 445667899999999999999999999999999999999976433222 345677888899998 899999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC------------
Q 022444 80 TKIYIILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ------------ 143 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~------------ 143 (297)
+..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999999999765 679999999999999999999999999999999999999844
Q ss_pred -------CCEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022444 144 -------GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (297)
Q Consensus 144 -------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~ 216 (297)
..++++|||.+....... ...+++.|+|||.+.+....+.++||||||+++|+|++|..++.....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 479999999887655432 345888999999997664444799999999999999999987754432
Q ss_pred HHHhhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 217 YSKVEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 217 ~~~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
...+... ....+..+++++.+++.+||+.||++|||+.++++||||++..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288 (289)
T ss_dssp HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence 2333333 33556679999999999999999999999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=358.34 Aligned_cols=255 Identities=34% Similarity=0.665 Sum_probs=221.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++++.||+|+||+||+|+++.++..+|+|++........ ....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 479999999999999999999999999999999976543222 2466889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC---CCEEEcccCCCCCCCCCccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~---~~~~l~df~~~~~~~~~~~~ 163 (297)
||+.+++|.+.+....++++..++.++.+++.||.|||+.|++|+||||+||+++.. +.++|+|||++...... ..
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~ 194 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KK 194 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-BC
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-cc
Confidence 999999999999988899999999999999999999999999999999999999764 45999999998765543 23
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSLI 239 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~li 239 (297)
.....+++.|+|||++.+ .++ .++||||||+++|+|++|..||...+..+....+......++ ..+|+++.+||
T Consensus 195 ~~~~~gt~~y~aPE~l~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 272 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRK-KYD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272 (494)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHH
T ss_pred ccccCCCcCeeCHHHHcc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHH
Confidence 345678999999999864 444 899999999999999999999999999999998888766544 34899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 240 HRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+||+.||++|||+.++|+||||++.
T Consensus 273 ~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 273 KQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHCCCChhhCccHHHHhcCcccccC
Confidence 99999999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=343.63 Aligned_cols=266 Identities=26% Similarity=0.361 Sum_probs=217.9
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh--HHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK--HKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
...++|++.+.||+|++|.||++.+..+|+.|++|++....... ......+.+|+.+++.++|+||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 45678999999999999999999999999999999987543221 1123457789999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.+++||++.+ +|.+.+... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999986 888888754 36899999999999999999999999999999999999999999999999999876655
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-c-------------
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-S------------- 226 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~------------- 226 (297)
........+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+..... +
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 44555667899999999997655445899999999999999999999998887776665543210 0
Q ss_pred --------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 227 --------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 227 --------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
....+++++.+||.+||+.||++|||+.|+|+||||++...+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 01345789999999999999999999999999999998765544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=335.74 Aligned_cols=265 Identities=33% Similarity=0.625 Sum_probs=226.0
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh-HHHHHHHHHHHHHHHhcCCCCeeEEEEEE--EcCC
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-HKMADQIKREISIMKLVRHPCVVRLHEVL--ASRT 80 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 80 (297)
+..++|++.+.||+|++|.||.+.+..+++.+++|++....... ......+.+|+..++.++|+||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 45789999999999999999999999999999999997654332 23456788999999999999999999998 4456
Q ss_pred eEEEEEcccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
..+++|||+.++ |.+.+.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 889999999875 7677765 3569999999999999999999999999999999999999999999999999987554
Q ss_pred CC--ccccccccCCccccCCccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhH
Q 022444 159 QG--VSLLRTTCGTPNYVAPEVLSHKGY-NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGA 235 (297)
Q Consensus 159 ~~--~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l 235 (297)
.. ........+++.|+|||.+.+... .+.++||||||+++|+|++|..||...+.....+.+.......+..+++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 21 222334568899999999876433 247999999999999999999999999999999998888888888899999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
.+++.+||+.||++|||++++++||||++.....
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 9999999999999999999999999999875543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=338.27 Aligned_cols=259 Identities=29% Similarity=0.569 Sum_probs=214.7
Q ss_pred ccccceEEe-EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCe
Q 022444 4 RKVGKYEVG-RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTK 81 (297)
Q Consensus 4 ~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 81 (297)
+..++|++. +.||+|++|.||++.+..+++.||+|++.... ......+.+|+..++++ .||||+++++++.+.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 455689995 78999999999999999999999999997543 22346678899999885 79999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC---EEEcccCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPE 158 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~---~~l~df~~~~~~~ 158 (297)
.++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999999999998889999999999999999999999999999999999999988775 9999999987543
Q ss_pred CCc-------cccccccCCccccCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------------
Q 022444 159 QGV-------SLLRTTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELD-------------- 212 (297)
Q Consensus 159 ~~~-------~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-------------- 212 (297)
... .......+++.|+|||.+.+ ..++ .++||||||+++|+|++|..||....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHT-TTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCC-cccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 221 11223458899999999864 3344 89999999999999999999997654
Q ss_pred -HHHHHHHhhhccccCC----CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 213 -LTTLYSKVEKADFSCP----TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 213 -~~~~~~~i~~~~~~~~----~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
...+.+.+.......+ ..+++++.+|+.+||+.||++|||++++|+||||++..
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 2345566666655554 35889999999999999999999999999999998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=344.48 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=211.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----- 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 80 (297)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+++.++|+||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 468999999999999999999999999999999986543 23344567889999999999999999999986553
Q ss_pred -eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 81 -KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
..|++||++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 7799988876 5799999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--------------- 224 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--------------- 224 (297)
. .....++..|+|||.+.+....+.++|||||||++++|++|+.||.+.+..+....+....
T Consensus 181 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 181 E---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp S---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred c---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 2 2345678999999998773334499999999999999999999999887766655543211
Q ss_pred ----------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccc
Q 022444 225 ----------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKL 271 (297)
Q Consensus 225 ----------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~ 271 (297)
......+++++.+|+.+||..||++|||++++|+||||++......-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 320 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 320 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccC
Confidence 01224468999999999999999999999999999999987655543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=333.49 Aligned_cols=260 Identities=27% Similarity=0.469 Sum_probs=229.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++.+..+++.|++|++..... ....+.+.+|+..++.+.|+||+++++++......++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 45679999999999999999999999999999999976542 2335778899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
+|||+++++|.+++.. .++++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 9999999999998865 579999999999999999999999999999999999999999999999999987665544444
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHHHhc
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~L 243 (297)
....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...........+..... ..+..++..+.+++.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHc
Confidence 556788999999999877766 899999999999999999999998888777666655443 445668999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCccc
Q 022444 244 DPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
+.||++|||+.++++||||.+....
T Consensus 256 ~~dp~~Rps~~~ll~~~~~~~~~~~ 280 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKFILRNAKK 280 (303)
T ss_dssp CSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred CCChhhCcCHHHHhhChhhhcCCCc
Confidence 9999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=343.72 Aligned_cols=264 Identities=30% Similarity=0.512 Sum_probs=221.0
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh--hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
+..++|++.+.||+|++|.||++.++.+++.+++|++...... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3456899999999999999999999999999999999765432 23446778899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 022444 82 IYIILEFITGGELFDKIVHH----------------------------------------GRLSESEARRYFQQLIDGVD 121 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~----------------------------------------~~~~~~~~~~~~~~i~~al~ 121 (297)
.++||||+++++|.+++... ..+++..++.++.+++.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999988521 12367788999999999999
Q ss_pred HHHhCCCEEecCCCCCeeecCCC--CEEEcccCCCCCCCCCc----cccccccCCccccCCccccc--cCCCCCchhHHH
Q 022444 122 YCHSKGVYHRDLKPENLLLDSQG--HLKISDFGLSALPEQGV----SLLRTTCGTPNYVAPEVLSH--KGYNGAAADVWS 193 (297)
Q Consensus 122 ~Lh~~~i~h~di~~~nIli~~~~--~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~s 193 (297)
|||+.|++|+||+|+||+++.++ .++|+|||.+....... .......+++.|+|||.+.+ ..+ +.++||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~Diws 261 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWS 261 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC-CTHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC-CcHHHHHH
Confidence 99999999999999999998776 89999999987543211 12345568899999999865 344 48999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC----CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 194 CGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT----WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 194 lG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
||+++|+|++|..||...+..+....+.......+. .+++++.+++.+||+.||++|||+.++|+||||++....
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence 999999999999999999888887777766554332 378999999999999999999999999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=339.19 Aligned_cols=245 Identities=20% Similarity=0.293 Sum_probs=191.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----eE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----KI 82 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 82 (297)
.+|.+.++||+|+||+||+|++ +|+.||||++..... .......|+..+..++||||+++++++...+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999987 488999999865431 1122345677777889999999999986543 68
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK--------GVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~--------~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
|+|||||++|+|.+++.+ .+++++.+..++.+++.||.|||++ +|+||||||+|||++.++++||+|||++
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999976 4789999999999999999999987 8999999999999999999999999998
Q ss_pred CCCCCCcc----ccccccCCccccCCccccccCC-----CCCchhHHHHHHHHHHHHhCCCCCCCC--------------
Q 022444 155 ALPEQGVS----LLRTTCGTPNYVAPEVLSHKGY-----NGAAADVWSCGVILYVLIAGYLPFDEL-------------- 211 (297)
Q Consensus 155 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~ll~g~~pf~~~-------------- 211 (297)
+....... ......|++.|+|||++.+... .+.++|||||||++|+|+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 76543322 1234579999999999875421 136899999999999999997765321
Q ss_pred -CHHHHHHHhhhccc--cCCCC-----CChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 212 -DLTTLYSKVEKADF--SCPTW-----FPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 212 -~~~~~~~~i~~~~~--~~~~~-----~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
....+...+..... ..|.. .++.+.+|+.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22334443333322 22222 2346889999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=334.36 Aligned_cols=261 Identities=30% Similarity=0.546 Sum_probs=226.0
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE--cCC
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA--SRT 80 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~ 80 (297)
+.+.++|++.+.||+|++|.||++.++.+++.+++|.+...... ....+.+.+|+..++.++||||+++++++. ...
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 45678999999999999999999999999999999999765432 234567889999999999999999999874 456
Q ss_pred eEEEEEcccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----CEEecCCCCCeeecCCCCEEEccc
Q 022444 81 KIYIILEFITGGELFDKIVHHG----RLSESEARRYFQQLIDGVDYCHSKG-----VYHRDLKPENLLLDSQGHLKISDF 151 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~al~~Lh~~~-----i~h~di~~~nIli~~~~~~~l~df 151 (297)
..+++|||+++++|.+++.... .+++..++.++.+++.||.|||+.| ++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 8999999999999999987532 4999999999999999999999999 999999999999999999999999
Q ss_pred CCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCC
Q 022444 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTW 230 (297)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~ 230 (297)
|.+..............++..|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+..... ..+..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred chheeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 9987655443333445688899999999877766 999999999999999999999999988888888777655 55667
Q ss_pred CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 231 FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 231 ~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+|+++.+++.+||+.||.+|||+.++++|+|+...
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 89999999999999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=340.71 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=213.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-----CCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-----HPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~ 80 (297)
.++|++++.||+|+||.||++++..+++.||+|++.... ........|+.+++.+. |+||+++++++....
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 468999999999999999999999999999999997533 22345667888888886 999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC----------------
Q 022444 81 KIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---------------- 142 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---------------- 142 (297)
..++|||++ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999999 889999998654 5999999999999999999999999999999999999975
Q ss_pred ---------CCCEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 022444 143 ---------QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (297)
Q Consensus 143 ---------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~ 213 (297)
++.++|+|||.+...... .....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 788999999998754432 2345688999999999888776 999999999999999999999988877
Q ss_pred HHHHHHhhhccccCCC----------------------------------------------CCChhHHHHHHHhcCCCc
Q 022444 214 TTLYSKVEKADFSCPT----------------------------------------------WFPVGAKSLIHRILDPNP 247 (297)
Q Consensus 214 ~~~~~~i~~~~~~~~~----------------------------------------------~~~~~l~~li~~~L~~~p 247 (297)
.+....+.....+.+. ..++.+.+|+.+||++||
T Consensus 265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 7666555433222111 123667899999999999
Q ss_pred CCCCCHHHHhcCcccc
Q 022444 248 ETRITIEEIRNDEWFR 263 (297)
Q Consensus 248 ~~Rps~~~il~~p~~~ 263 (297)
++|||++++|+||||+
T Consensus 345 ~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 345 TLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGSCCHHHHTTSGGGC
T ss_pred hhCCCHHHHhcCcccC
Confidence 9999999999999996
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=336.22 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=203.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.++||+|+||+||+|+++.+++.||||++.............+.......+...|+||+++++++.+....+++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999986543333333333433334444448999999999999999999999
Q ss_pred cccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
|++ +++|.+.+...+ .+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||.+...... ....
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~ 214 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGE 214 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCCc
Confidence 999 568888887644 6999999999999999999999999999999999999999999999999998765433 2233
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc--cCCCCCChhHHHHHHHhc
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF--SCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~l~~li~~~L 243 (297)
...|++.|+|||++.+ .++ .++||||||+++|+|++|..|+..... ...+..... ..+..+++++.+++.+||
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L 289 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYG-TAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMML 289 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCS-THHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHS
T ss_pred ccCCCccccCHhHhcC-CCC-chhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHc
Confidence 4568999999999876 454 899999999999999999776644322 233333222 234568999999999999
Q ss_pred CCCcCCCCCHHHHhcCccccc
Q 022444 244 DPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~ 264 (297)
++||++|||++++|+||||++
T Consensus 290 ~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 290 EPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CSSTTTSCCHHHHHTSGGGSC
T ss_pred CCChhhCcCHHHHHhCccccC
Confidence 999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=352.08 Aligned_cols=263 Identities=27% Similarity=0.361 Sum_probs=199.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE-----cCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-----SRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 80 (297)
.++|++.+.||+|+||.||+|+++.+++.||||++.... ......+.+.+|+.+++.++|+||+++++++. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 468999999999999999999999999999999986543 23334567889999999999999999999983 335
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..|+|||++. ++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++.....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 7999999985 599999998888999999999999999999999999999999999999999999999999999765432
Q ss_pred c---------------------------cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh----------
Q 022444 161 V---------------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA---------- 203 (297)
Q Consensus 161 ~---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~---------- 203 (297)
. .......+++.|+|||++......+.++|||||||++|+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 1 122345678999999987444333499999999999999998
Q ss_pred -CCCCCCCCCH--------------------HHHHHHhhhc----------------------c---------ccCCCCC
Q 022444 204 -GYLPFDELDL--------------------TTLYSKVEKA----------------------D---------FSCPTWF 231 (297)
Q Consensus 204 -g~~pf~~~~~--------------------~~~~~~i~~~----------------------~---------~~~~~~~ 231 (297)
|..+|.+.+. .+....+... . ......+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 6777755431 1111111100 0 0111336
Q ss_pred ChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 232 PVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 232 ~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
++++.+||.+||.+||++|||++|+|+||||++......
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~ 408 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence 889999999999999999999999999999998755443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=338.83 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=222.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|+||.||+|++..+++.|+||++...........+.+.+|+.+++.++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999997654444555677889999999999999999999999999999999
Q ss_pred cccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
||+. ++|.+.+. ...++++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~ 208 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----N 208 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----C
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----C
Confidence 9997 47877775 4567999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccCCccccCCcccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc--CCCCCChhHHHHHH
Q 022444 166 TTCGTPNYVAPEVLS---HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS--CPTWFPVGAKSLIH 240 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~l~~li~ 240 (297)
...+++.|+|||.+. ...+ +.++||||||+++|+|++|..||...+.......+.....+ .+..+|+.+.+|+.
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 287 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred cccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 456889999999985 3344 48999999999999999999999888877666665554432 23458999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
+||+.||++|||++++++||||.+...+.
T Consensus 288 ~~l~~dP~~Rps~~~ll~h~~~~~~~~~~ 316 (348)
T 1u5q_A 288 SCLQKIPQDRPTSEVLLKHRFVLRERPPT 316 (348)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred HHcccChhhCcCHHHHhhChhhhccCCcc
Confidence 99999999999999999999998765443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=344.80 Aligned_cols=259 Identities=29% Similarity=0.524 Sum_probs=219.5
Q ss_pred ceEE--eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 8 KYEV--GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 8 ~y~~--~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.|.+ .+.||+|+||.||++.+..+|+.|++|++..... ...+.+.+|+.+++.++|+||+++++++......++|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3554 6789999999999999999999999999976542 2346688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee--cCCCCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL--DSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli--~~~~~~~l~df~~~~~~~~~~~ 162 (297)
|||+++++|.+.+... ..+++..++.++.+++.||.|||+.|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 9999999999888654 469999999999999999999999999999999999999 567789999999987654432
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~l 238 (297)
......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+.......+ ..+++++.+|
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 322 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence 23345689999999999876665 899999999999999999999999988888888777655443 4589999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCcccccc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYVPVKL 271 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~ 271 (297)
|.+||+.||++|||+.++|+||||++......+
T Consensus 323 i~~~L~~dp~~Rps~~e~l~hp~~~~~~~~~~~ 355 (373)
T 2x4f_A 323 ISKLLIKEKSWRISASEALKHPWLSDHKLHSRL 355 (373)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHCHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHhcCcCcCCCchhhhh
Confidence 999999999999999999999999987544333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=327.32 Aligned_cols=254 Identities=26% Similarity=0.464 Sum_probs=216.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc----CCeE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----RTKI 82 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 82 (297)
..|++.+.||+|++|.||+|.+..++..|++|.+....... ...+.+.+|+.+++.++||||+++++++.. ....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 35899999999999999999999999999999997654333 336778899999999999999999998864 4568
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeec-CCCCEEEcccCCCCCCCC
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLD-SQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~-~~~~~~l~df~~~~~~~~ 159 (297)
++||||+++++|.+++.+...+++..++.++.+++.||.|||+.| ++|+||+|+||+++ .++.++|+|||.+.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999999999998889999999999999999999999999 99999999999998 788999999999865443
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhhccc--cCCCCCChhHH
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEKADF--SCPTWFPVGAK 236 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~i~~~~~--~~~~~~~~~l~ 236 (297)
. ......+++.|+|||.+.+. ++ .++||||||+++|+|++|..||.... .......+..... ..+...++++.
T Consensus 185 ~--~~~~~~~t~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 260 (290)
T 1t4h_A 185 S--FAKAVIGTPEFMAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp T--SBEESCSSCCCCCGGGGGTC-CC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred c--ccccccCCcCcCCHHHHhcc-CC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence 3 22345688999999988643 44 99999999999999999999998744 4444554444322 33455788999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 237 SLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+++.+||+.||++|||++++++||||++.
T Consensus 261 ~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 99999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=346.84 Aligned_cols=263 Identities=24% Similarity=0.375 Sum_probs=210.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----C
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----T 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 80 (297)
.++|++.+.||+|++|.||+|+++.+++.||||++.... ......+.+.+|+.+++.++|+||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 468999999999999999999999999999999997543 2334457788999999999999999999998655 5
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..|+|||++.+ +|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++.....
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 79999999975 99999998888999999999999999999999999999999999999999999999999999765432
Q ss_pred cc----------------------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC-----------CCC
Q 022444 161 VS----------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-----------YLP 207 (297)
Q Consensus 161 ~~----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g-----------~~p 207 (297)
.. ......+++.|+|||.+......+.++|||||||++|+|++| .++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 21 134567899999999874444334999999999999999984 444
Q ss_pred CCCCCH-----------------HHHHHHh------------------------hhccccC-------CCCCChhHHHHH
Q 022444 208 FDELDL-----------------TTLYSKV------------------------EKADFSC-------PTWFPVGAKSLI 239 (297)
Q Consensus 208 f~~~~~-----------------~~~~~~i------------------------~~~~~~~-------~~~~~~~l~~li 239 (297)
|.+.+. .+....+ ....... ...+++++.+||
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 342 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 433220 1111111 1000000 134789999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
.+||.+||++|||++++|+||||++......
T Consensus 343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~ 373 (432)
T 3n9x_A 343 ESMLKFNPNKRITIDQALDHPYLKDVRKKKL 373 (432)
T ss_dssp HHHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred HHHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence 9999999999999999999999998755443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=354.62 Aligned_cols=259 Identities=28% Similarity=0.469 Sum_probs=212.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC------
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR------ 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 79 (297)
.++|++++.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.++|+||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 578999999999999999999999999999999997653 2334466788999999999999999999998543
Q ss_pred CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
...|+||||+.+ +|.+.+.. .+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 467999999976 56666643 589999999999999999999999999999999999999999999999999986654
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-------------
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS------------- 226 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~------------- 226 (297)
. .......+++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 217 ~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 S-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp C-CCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred C-cccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 3 233456789999999999988776 9999999999999999999999998877666555331100
Q ss_pred --------------CCCCC---------------ChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 227 --------------CPTWF---------------PVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 227 --------------~~~~~---------------~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
++... ++++.+||.+||.+||++|||++|+|+||||+....+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~ 367 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAE 367 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHH
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCccc
Confidence 00001 456899999999999999999999999999998765543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=338.86 Aligned_cols=260 Identities=26% Similarity=0.406 Sum_probs=218.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----C
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----T 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 80 (297)
.++|++++.||+|++|.||++.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 458999999999999999999999999999999997533 333456788999999999999999999998654 3
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..++++|++.+ +|.+++.. ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 68999999975 89888865 57999999999999999999999999999999999999999999999999998765433
Q ss_pred ccc---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc------------
Q 022444 161 VSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------------ 225 (297)
Q Consensus 161 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------------ 225 (297)
... .....+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 221 23457899999999876554344999999999999999999999988776665555432100
Q ss_pred -------------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 226 -------------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 226 -------------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
.....+++++.+|+.+||++||++|||++++|+||||++...+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~ 324 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence 01234788999999999999999999999999999999986544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=329.89 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=217.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|++|.||++++..+++.+++|.+...........+.+.+|+..++.++||||+++++++......+++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999999999999999998765544556677889999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-cc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~ 164 (297)
|||+++++|.+++.+.+++++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999876544322 23
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-----cCCCCCChhHHHHH
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-----SCPTWFPVGAKSLI 239 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~l~~li 239 (297)
....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+............. .....+|+.+.+++
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 248 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVI 248 (294)
T ss_dssp -----CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHH
T ss_pred CccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHH
Confidence 345689999999999887765 899999999999999999999998877665444433322 23456899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcccc
Q 022444 240 HRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
.+||++||.+||+..+.+.+.|.+
T Consensus 249 ~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 249 LRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999655555555543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=340.79 Aligned_cols=260 Identities=23% Similarity=0.402 Sum_probs=220.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (297)
..++|++.+.||+|++|.||++++..+++.|++|++.............+.+|+..++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999999999999999998765555666778899999999999999999999886543
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..|+||||+++++|.+++...+++++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 35999999999999999998889999999999999999999999999999999999999999999999999998765433
Q ss_pred cc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccC----CCCCCh
Q 022444 161 VS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC----PTWFPV 233 (297)
Q Consensus 161 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~ 233 (297)
.. ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+............... ...+|+
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCH
Confidence 22 22334689999999999887766 89999999999999999999999888777665555443322 345899
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
++.+++.+||+.||.+||++.+++.|+|++..
T Consensus 249 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 99999999999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=341.94 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=201.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC------
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR------ 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 79 (297)
.++|++++.||+|++|.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++|+||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 468999999999999999999999999999999986543 2233456788999999999999999999998643
Q ss_pred CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
...+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5679999999 6799888865 6799999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc--------------
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-------------- 225 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-------------- 225 (297)
. .....++..|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 185 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred c---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2 23457889999999987744345999999999999999999999998887666555432100
Q ss_pred -----------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 226 -----------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 226 -----------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
.....+++++.+|+.+||..||++|||++++|+||||++...+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence 011236788999999999999999999999999999998766554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=342.95 Aligned_cols=258 Identities=25% Similarity=0.523 Sum_probs=224.8
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHH--------------HHHHHHHHHHHHhcCCCCee
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM--------------ADQIKREISIMKLVRHPCVV 70 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~ 70 (297)
..++|++.+.||+|++|.||++.+ +++.|++|.+.......... .+.+.+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 457999999999999999999998 89999999997654332211 16788999999999999999
Q ss_pred EEEEEEEcCCeEEEEEcccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeec
Q 022444 71 RLHEVLASRTKIYIILEFITGGELFDK------IVH--HGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLD 141 (297)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~ 141 (297)
++++++...+..++||||+++++|.++ +.. ...+++..++.++.+++.||.|||+ .|++|+||+|+||+++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999998 665 5679999999999999999999999 9999999999999999
Q ss_pred CCCCEEEcccCCCCCCCCCccccccccCCccccCCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 022444 142 SQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIAGYLPFDELDL-TTLYSK 219 (297)
Q Consensus 142 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~~~ 219 (297)
.++.++|+|||.+...... ......++..|+|||.+.+. .+++.++||||||+++|+|++|..||...+. ....+.
T Consensus 187 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 9999999999998765443 33456788999999999876 4443499999999999999999999988776 777777
Q ss_pred hhhccccCC-------------------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 220 VEKADFSCP-------------------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 220 i~~~~~~~~-------------------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+.......+ ..+|.++.+|+.+||+.||.+|||++++++||||++..
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 777766655 56899999999999999999999999999999998763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=331.93 Aligned_cols=259 Identities=28% Similarity=0.478 Sum_probs=220.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++.++.+|+.|++|.+.... ..+.+.+|+..++.+.|+||+++++++......++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3467999999999999999999999999999999987532 23567889999999999999999999999999999
Q ss_pred EEcccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+|||+.+++|.+++. ....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 999999999999987 4567999999999999999999999999999999999999999999999999998766554444
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---ccCCCCCChhHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSCPTWFPVGAKSLIH 240 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~l~~li~ 240 (297)
.....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+.... ...+..++.++.+++.
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 4556788999999999877766 89999999999999999999998887766555444332 2334557899999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
+||+.||.+|||+.++++||||++.....
T Consensus 261 ~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp HHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred HHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence 99999999999999999999999875443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=334.18 Aligned_cols=260 Identities=29% Similarity=0.485 Sum_probs=218.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++++.||+|++|.||++.++.+++.+++|++.... ....+.+.+|+..++.++||||+++++++......++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 4568999999999999999999999999999999986543 2335678889999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
+||++++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999999999988875 457999999999999999999999999999999999999999999999999986533222222
Q ss_pred cccccCCccccCCcccc-----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc---CCCCCChhH
Q 022444 164 LRTTCGTPNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS---CPTWFPVGA 235 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~l 235 (297)
.....+++.|+|||.+. +..+ +.++||||||+++|+|++|..||...+.......+.....+ .+..+|.++
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence 33456888999999984 3444 48999999999999999999999998887776666555432 345588999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+++.+||+.||++|||++++++||||++....
T Consensus 253 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 999999999999999999999999999987543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=329.59 Aligned_cols=257 Identities=36% Similarity=0.647 Sum_probs=224.5
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|++|.||+++++.+++.|++|++...... ......+.+|+..+++++|+||+++++++......+++
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 46899999999999999999999999999999998754422 22356788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC---CCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~---~~~~l~df~~~~~~~~~~~ 162 (297)
+|++.+++|.+.+.....+++..++.++.+++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~- 178 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence 9999999999999888899999999999999999999999999999999999999754 469999999887654332
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~l 238 (297)
......+++.|+|||.+.+. + +.++||||||+++|+|++|..||...+..+....+..+....+ ..+|+++.++
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred ccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 22234577899999998754 4 4899999999999999999999999988888888877655433 4589999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+.+||+.||++|||+.++|+||||++..
T Consensus 257 i~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999999999999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=341.12 Aligned_cols=258 Identities=24% Similarity=0.417 Sum_probs=220.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|++|.||++.+..+++.+++|++.... .....+.+.+|+.+++.++|+||+++++++......++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 568999999999999999999999999999999997653 234456788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|||+++++|.+++.....+++..+..++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 187 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA 187 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C-
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence 99999999999999888999999999999999999999995 9999999999999999999999999988644321 22
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------------------
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSK------------------------- 219 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~------------------------- 219 (297)
....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred cCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 345688999999999887776 999999999999999999999987665443222
Q ss_pred -----------------hhhccc-c-CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 220 -----------------VEKADF-S-CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 220 -----------------i~~~~~-~-~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
+..... . ....++.++.+|+.+||++||++|||++++|+||||++....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 111111 1 122378899999999999999999999999999999986543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=334.66 Aligned_cols=261 Identities=32% Similarity=0.546 Sum_probs=222.2
Q ss_pred cccceEEe-EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeE
Q 022444 5 KVGKYEVG-RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKI 82 (297)
Q Consensus 5 ~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 82 (297)
..++|.+. +.||+|+||.||++.++.+++.||+|++....... .....+.+|+..++.+. |+||+++++++......
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 34578888 89999999999999999999999999997654222 23566888999999995 69999999999999999
Q ss_pred EEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---CCCEEEcccCCCCCC
Q 022444 83 YIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGLSALP 157 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~~~~~l~df~~~~~~ 157 (297)
++||||+.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999999998553 57999999999999999999999999999999999999987 789999999998765
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCCh
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPV 233 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 233 (297)
.... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+.......+ ..+++
T Consensus 185 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 262 (327)
T 3lm5_A 185 GHAC-ELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262 (327)
T ss_dssp ----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CCcc-ccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence 4432 22345689999999999877776 999999999999999999999999888887777766544332 45889
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.+.+++.+||+.||.+|||++++|+||||++..-.
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 99999999999999999999999999999886443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=331.32 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=210.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||++++ +|+.+++|++...... ....+.+.+|+.++++++|+||+++++++......++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 356899999999999999999987 4788999998765432 3335678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 85 ILEFITGGELFDKIVHHGR---LSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
||||+.+++|.+++..... +++..++.++.+++.||.|||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999999987653 999999999999999999999999 99999999999999999999999999876655
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhh--hccccCCCCCChhHHH
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVE--KADFSCPTWFPVGAKS 237 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~l~~ 237 (297)
.........+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+. ......+..+++++.+
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred cccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 44444566789999999999887776 99999999999999999999999998888777663 3345667789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 022444 238 LIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+||+.+|.+|||++++++
T Consensus 271 li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999988
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=338.38 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=209.1
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--- 80 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 80 (297)
+..++|++.+.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 45789999999999999999999999999999999997544 2334577899999999999999999999875432
Q ss_pred ------------------------------------------------------eEEEEEcccCCCChHHHHHhcCC---
Q 022444 81 ------------------------------------------------------KIYIILEFITGGELFDKIVHHGR--- 103 (297)
Q Consensus 81 ------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~--- 103 (297)
..+++|||+++++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987554
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc------------cccccccCCc
Q 022444 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV------------SLLRTTCGTP 171 (297)
Q Consensus 104 ~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~------------~~~~~~~~~~ 171 (297)
.+...++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+....... .......+++
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 4566789999999999999999999999999999999999999999999987655432 1223456899
Q ss_pred cccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc-CCCCCChhHHHHHHHhcCCCcCCC
Q 022444 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-CPTWFPVGAKSLIHRILDPNPETR 250 (297)
Q Consensus 172 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~l~~li~~~L~~~p~~R 250 (297)
.|+|||.+.+..++ .++||||||+++|+|++|..|+.. .......+.....+ .....++++.+++.+||+.||++|
T Consensus 241 ~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 99999999887776 999999999999999998776421 22223333332221 112356788999999999999999
Q ss_pred CCHHHHhcCccccc
Q 022444 251 ITIEEIRNDEWFRK 264 (297)
Q Consensus 251 ps~~~il~~p~~~~ 264 (297)
||++++|+||||++
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=332.03 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=214.5
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc----
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS---- 78 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---- 78 (297)
...++|++.+.||+|++|.||++.+..+++.|++|++..... ....+.+|+..++++ .|+||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 456789999999999999999999999999999999875431 235677899999998 79999999999875
Q ss_pred --CCeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 79 --RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 79 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
....+++|||+.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 46899999999999999999764 46999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCccccccccCCccccCCcccc-----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc--C
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS--C 227 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~ 227 (297)
..............+++.|+|||.+. +..+ +.++||||||+++|+|++|..||...+.......+.....+ .
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 255 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCC
Confidence 76654433344557889999999986 3334 48999999999999999999999888777666555444322 2
Q ss_pred CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 228 PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 228 ~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
+..+|..+.+++.+||+.||.+|||++++++||||++...
T Consensus 256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 3458999999999999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=338.84 Aligned_cols=261 Identities=32% Similarity=0.583 Sum_probs=221.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|+||.||++++. .+++.|++|++...... .......+.+|+.+++.+ .|+||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999984 58999999998653211 111233456788889988 6999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..++||||+++++|.+++.....+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998754332
Q ss_pred -ccccccccCCccccCCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHhhhccccCCCCCChh
Q 022444 161 -VSLLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDEL----DLTTLYSKVEKADFSCPTWFPVG 234 (297)
Q Consensus 161 -~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~ 234 (297)
........+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||... ....+...+.....+.+..++..
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 292 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHH
Confidence 22233456899999999997532 2348999999999999999999999643 34556666666677778889999
Q ss_pred HHHHHHHhcCCCcCCCC-----CHHHHhcCcccccCc
Q 022444 235 AKSLIHRILDPNPETRI-----TIEEIRNDEWFRKGY 266 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rp-----s~~~il~~p~~~~~~ 266 (297)
+.+||.+||..||++|| |+.++++||||++..
T Consensus 293 ~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 99999999999999999 999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=333.44 Aligned_cols=270 Identities=28% Similarity=0.386 Sum_probs=219.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (297)
..++|++.+.||+|++|.||++.+..+|+.|+||.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 4578999999999999999999999999999999986433 233456678999999999999999999987643
Q ss_pred CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
...+++||++.+ +|.+++.. ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 87 ~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 678999999974 89888876 5799999999999999999999999999999999999999999999999999875543
Q ss_pred Cccc----------cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-----
Q 022444 160 GVSL----------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD----- 224 (297)
Q Consensus 160 ~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~----- 224 (297)
.... .....+++.|+|||.+.+....+.++||||||+++|+|++|..||...+.......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 2111 1234678899999988654434599999999999999999999998887655444332110
Q ss_pred -------------------c--------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCC
Q 022444 225 -------------------F--------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDV 277 (297)
Q Consensus 225 -------------------~--------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~ 277 (297)
. .....+++++.+|+.+||+.||++|||++++|+||||+....+..-...+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~ 324 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPI 324 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCC
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCC
Confidence 0 0123578999999999999999999999999999999987665544433444
Q ss_pred C
Q 022444 278 N 278 (297)
Q Consensus 278 ~ 278 (297)
+
T Consensus 325 ~ 325 (353)
T 2b9h_A 325 P 325 (353)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=339.74 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=209.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (297)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 35789999999999999999999999999999999975432 2334567889999999999999999999996554
Q ss_pred --eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 81 --KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 81 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
..++|||++.+ +|.+.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 7888875 468999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-------------
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------------- 225 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------------- 225 (297)
.. .......+++.|+|||.+.+..++ .++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 179 ~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 179 TS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp ------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred cc-cccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 33 223345788999999999887776 999999999999999999999998887666555533210
Q ss_pred ---------cC--------------CC------CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 226 ---------SC--------------PT------WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 226 ---------~~--------------~~------~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
.. +. ..+.++.+|+.+||..||++|||++++|+||||+....+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~ 330 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 330 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHH
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccc
Confidence 00 00 01467899999999999999999999999999998765443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=341.71 Aligned_cols=253 Identities=34% Similarity=0.616 Sum_probs=206.1
Q ss_pred cccceEEe-EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHH-HhcCCCCeeEEEEEEEc----
Q 022444 5 KVGKYEVG-RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVRLHEVLAS---- 78 (297)
Q Consensus 5 ~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~---- 78 (297)
..++|.+. +.||.|+||.||++.++.+++.||||++... ....+|+..+ +...|+||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 35678887 7899999999999999999999999998643 2345666666 44579999999998865
Q ss_pred CCeEEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---CCCEEEcccCC
Q 022444 79 RTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGL 153 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~~~~~l~df~~ 153 (297)
..++|+||||+.+++|.+++.... .+++..++.++.+++.||.|||+.||+|+||||+||+++. ++.++|+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 567899999999999999998653 5999999999999999999999999999999999999987 78899999999
Q ss_pred CCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhhhccccCC-
Q 022444 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT----TLYSKVEKADFSCP- 228 (297)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~- 228 (297)
+...... .......+++.|+|||++.+..++ .++||||||+++|+|++|..||...+.. .....+..+....+
T Consensus 211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 211 AKETTSH-NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp CEECC------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccCCC-CccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 8755432 223456788999999999877776 9999999999999999999999765432 13444554444433
Q ss_pred ---CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 229 ---TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 229 ---~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
..+++++.+||.+||+.||++|||+.++++||||.+...
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 458999999999999999999999999999999987643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=341.88 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=210.2
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-----
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----- 78 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 78 (297)
...++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34678999999999999999999999999999999986543 112368999999999999999998833
Q ss_pred ---------------------------------CCeEEEEEcccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 022444 79 ---------------------------------RTKIYIILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVD 121 (297)
Q Consensus 79 ---------------------------------~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~al~ 121 (297)
....++||||+++ +|.+.+. ....+++..++.++.|++.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3358999999985 7666554 4567999999999999999999
Q ss_pred HHHhCCCEEecCCCCCeeec-CCCCEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHH
Q 022444 122 YCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYV 200 (297)
Q Consensus 122 ~Lh~~~i~h~di~~~nIli~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ 200 (297)
|||+.|++|+||||+||+++ .++.++|+|||.+....... ......++..|+|||.+.+....+.++||||||+++|+
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 99999999999999999997 68899999999987654432 23355678899999998775534499999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHhhhc-----------------------------cccCCCCCChhHHHHHHHhcCCCcCCCC
Q 022444 201 LIAGYLPFDELDLTTLYSKVEKA-----------------------------DFSCPTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 201 ll~g~~pf~~~~~~~~~~~i~~~-----------------------------~~~~~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
|++|..||.+.+..+....+... ...++..+|+++.+|+.+||+.||++||
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 99999999988877666555321 0113455789999999999999999999
Q ss_pred CHHHHhcCcccccCc
Q 022444 252 TIEEIRNDEWFRKGY 266 (297)
Q Consensus 252 s~~~il~~p~~~~~~ 266 (297)
|+.|+|+||||++..
T Consensus 315 t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 315 NPYEAMAHPFFDHLR 329 (383)
T ss_dssp CHHHHHTSGGGHHHH
T ss_pred CHHHHhcCHHHHHHH
Confidence 999999999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=331.87 Aligned_cols=253 Identities=24% Similarity=0.453 Sum_probs=209.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEc--CCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLAS--RTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~ 81 (297)
..++|++.+.||+|++|.||++++..+++.|++|++.... .+.+.+|+.+++.+. |+||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3568999999999999999999999999999999987433 356789999999997 9999999999987 667
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~~~~~~~~~ 160 (297)
.+++||++.+++|.+++. .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 899999999999988875 489999999999999999999999999999999999999777 8999999998755443
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHH-------------hhhcccc
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLYSK-------------VEKADFS 226 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~~~~~-------------i~~~~~~ 226 (297)
. ......++..|+|||.+.+....+.++||||||+++|+|++|..||... +..+.... +......
T Consensus 185 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 185 Q-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp C-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred C-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2 2345578889999999977444459999999999999999999999443 22222111 1111111
Q ss_pred ------------------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 227 ------------------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 227 ------------------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
.+..+++++.+||.+||++||++|||++++|+||||++...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 11227899999999999999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=333.34 Aligned_cols=261 Identities=24% Similarity=0.424 Sum_probs=212.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCeEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH--PCVVRLHEVLASRTKIY 83 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 83 (297)
-++|++.+.||+|+||.||++.+. +++.||+|++..... .....+.+.+|+.+++.+.| +||+++++++......+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 457999999999999999999985 688999999976542 23345778899999999986 99999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
++||+ .+++|.+++.....+++..++.++.+++.||.|||+.||+|+||||+||+++ ++.++|+|||++........
T Consensus 86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 99995 5679999999988999999999999999999999999999999999999996 67899999999986654322
Q ss_pred -ccccccCCccccCCccccc-----------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhh--ccccC
Q 022444 163 -LLRTTCGTPNYVAPEVLSH-----------KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEK--ADFSC 227 (297)
Q Consensus 163 -~~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~--~~~~~ 227 (297)
......|++.|+|||.+.+ ..+ +.++||||||+++|+|++|..||...... .....+.. .....
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC
Confidence 2335578999999999864 333 48999999999999999999999764322 22222222 23455
Q ss_pred CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccc
Q 022444 228 PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKL 271 (297)
Q Consensus 228 ~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~ 271 (297)
+...+.++.+|+.+||+.||++|||+.++|+||||+....+.+.
T Consensus 243 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~ 286 (343)
T 3dbq_A 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 286 (343)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC----
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCcccc
Confidence 66678899999999999999999999999999999977655443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=344.31 Aligned_cols=259 Identities=37% Similarity=0.711 Sum_probs=209.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh-----hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|+||.||+|.++.+++.||+|++...... .......+.+|+.++++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 46899999999999999999999999999999999764322 11222347889999999999999999999854 5
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC---CEEEcccCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALP 157 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~---~~~l~df~~~~~~ 157 (297)
..++||||+.+++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||.+...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6899999999999999998888999999999999999999999999999999999999997544 5999999999876
Q ss_pred CCCccccccccCCccccCCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhhhccccCC----C
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSH---KGYNGAAADVWSCGVILYVLIAGYLPFDELDL-TTLYSKVEKADFSCP----T 229 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~----~ 229 (297)
... .......+++.|+|||++.+ ..+ +.++||||||+++|+|++|..||..... ......+........ .
T Consensus 293 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 370 (419)
T 3i6u_A 293 GET-SLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370 (419)
T ss_dssp C------------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred CCC-ccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence 543 22335578999999999854 333 3799999999999999999999976433 233444444443332 4
Q ss_pred CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 230 WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 230 ~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
.+++.+.+|+.+||+.||++|||++++|+||||++...
T Consensus 371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence 58999999999999999999999999999999987643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=326.06 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=202.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++++..+++.||+|++....... .....+.++...++.+.||||+++++++......++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 4678999999999999999999999999999999997653222 223445556666888899999999999999999999
Q ss_pred EEcccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 85 ILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 85 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
+||++++ +|.+++. ....+++..++.++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9999985 8766664 356799999999999999999999998 999999999999999999999999999876544
Q ss_pred CccccccccCCccccCCccc----cccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHH-HHHHhhhccccC-CCCCC
Q 022444 160 GVSLLRTTCGTPNYVAPEVL----SHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTT-LYSKVEKADFSC-PTWFP 232 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~-~~~~i~~~~~~~-~~~~~ 232 (297)
.. ......+++.|+|||.+ .+..+ +.++||||||+++|+|++|..||... .... ..+.+....... +..++
T Consensus 163 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 163 DV-AKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred cc-cccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 32 22344688899999996 33344 48999999999999999999999863 3333 333333333333 24589
Q ss_pred hhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 233 VGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 233 ~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+++.+++.+||+.||++|||+.++++||||+...
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 9999999999999999999999999999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=332.77 Aligned_cols=261 Identities=29% Similarity=0.523 Sum_probs=195.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+.+|+..++.++||||+++++++...+..+++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 4689999999999999999999999999999999865432 23356678899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCC
Q 022444 86 LEFITGGELFDKIVH--------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~ 157 (297)
|||+++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999999874 456899999999999999999999999999999999999999999999999987654
Q ss_pred CCCc-----cccccccCCccccCCccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc------
Q 022444 158 EQGV-----SLLRTTCGTPNYVAPEVLSH-KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------ 225 (297)
Q Consensus 158 ~~~~-----~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------ 225 (297)
.... .......+++.|+|||.+.+ ..++ .++||||||+++|+|++|..||.................
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCC-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCC-chhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 3321 11234468889999999875 3444 999999999999999999999988765554433322221
Q ss_pred ----cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 226 ----SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 226 ----~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
.....+++++.+++.+||+.||.+|||++++++||||++....+
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298 (303)
T ss_dssp ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence 12245788999999999999999999999999999999875543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=342.04 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=209.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc------CCCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV------RHPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 79 (297)
..+|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ .|+||+++++.+...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 357999999999999999999999999999999997643 2234455667766666 577999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC--EEEcccCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH--LKISDFGLSA 155 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~--~~l~df~~~~ 155 (297)
...+++||++. ++|.+++.... .+++..++.++.+++.||.|||+.||+|+||||+||+++.++. ++|+|||++.
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999996 59999887654 4899999999999999999999999999999999999999887 9999999986
Q ss_pred CCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc----------
Q 022444 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---------- 225 (297)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---------- 225 (297)
..... .....+++.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+.....
T Consensus 251 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 251 YEHQR---VYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp ETTCC---CCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred ecCCc---ccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 54432 2345788999999999888776 999999999999999999999988877665544332100
Q ss_pred -------------------------------------------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHH
Q 022444 226 -------------------------------------------------SCPTWFPVGAKSLIHRILDPNPETRITIEEI 256 (297)
Q Consensus 226 -------------------------------------------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~i 256 (297)
..+...++++.+||.+||++||++|||++|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 0011236789999999999999999999999
Q ss_pred hcCcccccCccc
Q 022444 257 RNDEWFRKGYVP 268 (297)
Q Consensus 257 l~~p~~~~~~~~ 268 (297)
|+||||++....
T Consensus 407 L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 407 LRHPWLRRRLPK 418 (429)
T ss_dssp HTSTTTC-----
T ss_pred hCChhhccCCCC
Confidence 999999986443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=336.50 Aligned_cols=267 Identities=23% Similarity=0.365 Sum_probs=213.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchh--------hhHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--------IKHKMADQIKREISIMKLVRHPCVVRLHEVL 76 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (297)
..++|++.+.||+|++|.||++.+.. |+.||+|.+..... ......+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45789999999999999999999865 89999999854321 2233457789999999999999999999988
Q ss_pred E-----cCCeEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcc
Q 022444 77 A-----SRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (297)
Q Consensus 77 ~-----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~d 150 (297)
. .....+++||++.+ +|.+.+... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 4 33468999999984 888877654 3699999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc------
Q 022444 151 FGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD------ 224 (297)
Q Consensus 151 f~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~------ 224 (297)
||.+...... .......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+....
T Consensus 178 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 178 FNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp TTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 9998754433 223345678899999998774434599999999999999999999999887666655543210
Q ss_pred --------------------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccc
Q 022444 225 --------------------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEY 274 (297)
Q Consensus 225 --------------------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~ 274 (297)
......+++.+.+|+.+||+.||++|||+.++|+||||++...+....+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 332 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG 332 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc
Confidence 01123467889999999999999999999999999999998777666554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=349.54 Aligned_cols=250 Identities=16% Similarity=0.191 Sum_probs=204.5
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHH---HHHHhcCCCCeeEEE-------EE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI---SIMKLVRHPCVVRLH-------EV 75 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~ 75 (297)
.++|++.+.||+|+||+||+|+++.+|+.||||++...........+.+.+|+ ..++.+.||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999999999999999999755433444567788999 555556799999987 77
Q ss_pred EEcCC-----------------eEEEEEcccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCEEe
Q 022444 76 LASRT-----------------KIYIILEFITGGELFDKIVHHGRLSE-------SEARRYFQQLIDGVDYCHSKGVYHR 131 (297)
Q Consensus 76 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~i~~al~~Lh~~~i~h~ 131 (297)
+...+ ..|++|||+ +++|.+++...+.+++ ..++.++.|++.||.|||+.||+|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66553 389999999 5699999987665655 7888899999999999999999999
Q ss_pred cCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCccccCCcccccc-----------CCCCCchhHHHHHHHHHH
Q 022444 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK-----------GYNGAAADVWSCGVILYV 200 (297)
Q Consensus 132 di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~Di~slG~ll~~ 200 (297)
||||+||+++.++.++|+|||++..... ......| +.|+|||.+.+. .++ .++||||||+++|+
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHHHH
Confidence 9999999999999999999999875433 2234556 999999999876 565 99999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 201 LIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 201 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
|++|..||...+.......+. .....+|+++.+|+.+||+.||++|||+.++++||||++.
T Consensus 306 lltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 999999997655443333322 2335689999999999999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=333.57 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=213.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE---
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI--- 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--- 82 (297)
.++|++.+.||+|++|.||+|.++.+|+.||+|++..... .......+.+|+.+++.++|+||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4689999999999999999999999999999999976432 334457788999999999999999999999766654
Q ss_pred ---EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 83 ---YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 83 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
+++||++. ++|.+.+. ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999997 48877764 3599999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--------------- 224 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--------------- 224 (297)
. .....+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 197 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 197 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred C---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3 2345678999999998773334499999999999999999999999887666555543210
Q ss_pred ----------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 225 ----------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 225 ----------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
......+++++.+|+.+||+.||++|||++++|+||||+....+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 334 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence 011234689999999999999999999999999999999765443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=330.49 Aligned_cols=259 Identities=38% Similarity=0.711 Sum_probs=212.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh-----hHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|+||.||++.++.+++.|+||++...... .......+.+|+.+++.+.|+||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46899999999999999999999999999999998754321 1222345788999999999999999999987654
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC---EEEcccCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALP 157 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~---~~l~df~~~~~~ 157 (297)
.+++|||+.+++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988889999999999999999999999999999999999999987664 999999998765
Q ss_pred CCCccccccccCCccccCCcccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhhccccC----CC
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLS---HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEKADFSC----PT 229 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~----~~ 229 (297)
... .......+++.|+|||.+. ...+ +.++||||||+++|+|++|..||...... .....+....... ..
T Consensus 168 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 168 GET-SLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp CCC-HHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred ccc-cccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 433 1223446889999999974 2334 48999999999999999999999765432 3334444443332 24
Q ss_pred CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 230 WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 230 ~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
.+++++.+++.+||+.||++|||+.++|+||||++...
T Consensus 246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 57899999999999999999999999999999987643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=335.79 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=203.7
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--- 80 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 80 (297)
+.+++|++.+.||+|+||.||+++++.+|+.||||++..... ......+++..++.++|+||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 467899999999999999999999999999999998865432 1233456777788889999999999985432
Q ss_pred ----eEEEEEcccCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCCEEecCCCCCeeecC-CCCEEEc
Q 022444 81 ----KIYIILEFITGGELFDKI----VHHGRLSESEARRYFQQLIDGVDYCH--SKGVYHRDLKPENLLLDS-QGHLKIS 149 (297)
Q Consensus 81 ----~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~al~~Lh--~~~i~h~di~~~nIli~~-~~~~~l~ 149 (297)
..+++|||+.+ +|.+.+ .....+++..++.++.+++.||.||| +.|++|+||||+||+++. ++.++|+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 38899999987 544433 35567899999999999999999999 999999999999999997 8999999
Q ss_pred ccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-----
Q 022444 150 DFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD----- 224 (297)
Q Consensus 150 df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~----- 224 (297)
|||.+....... ......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+.......+....
T Consensus 175 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 175 DFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 999998665432 22345678899999998766544599999999999999999999999888776666553310
Q ss_pred ---------------------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 225 ---------------------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 225 ---------------------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
......+++++.+|+.+||+.||.+|||+.++|+||||++...+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 0111225678999999999999999999999999999999876554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=325.34 Aligned_cols=258 Identities=26% Similarity=0.375 Sum_probs=209.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE-------
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA------- 77 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------- 77 (297)
..++|++.+.||+|++|.||++.++.+++.|++|.+.... ....+.+.+|+..++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 3578999999999999999999999999999999987543 334567889999999999999999999873
Q ss_pred -------cCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec-CCCCEEEc
Q 022444 78 -------SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKIS 149 (297)
Q Consensus 78 -------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~-~~~~~~l~ 149 (297)
.....+++|||+. ++|.+++.. +++++..++.++.+++.||.|||+.|++|+||+|+||+++ .++.++|+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999998 599988865 5799999999999999999999999999999999999997 56789999
Q ss_pred ccCCCCCCCCCc---cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-
Q 022444 150 DFGLSALPEQGV---SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF- 225 (297)
Q Consensus 150 df~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~- 225 (297)
|||.+....... .......++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999987654321 1223445688899999986644345999999999999999999999998877665555433211
Q ss_pred -----------------------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 226 -----------------------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 226 -----------------------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
.....++.++.+|+.+||+.||++|||++++|+||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 112458999999999999999999999999999999997643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=333.53 Aligned_cols=259 Identities=24% Similarity=0.426 Sum_probs=212.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC--CCCeeEEEEEEEcCCeEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--HPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 84 (297)
.+|++.+.||+|+||.||++.+.. ++.||||++..... .....+.+.+|+.+++.+. |+||+++++++......|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 359999999999999999999875 89999999976543 2344677889999999997 5999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-- 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-- 162 (297)
||| +.+++|.+++.....+++..++.++.+|+.||.|||+.||+|+||||+||+++ ++.++|+|||++........
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 55779999999888999999999999999999999999999999999999995 68899999999986654322
Q ss_pred ccccccCCccccCCcccccc----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhhhc--cccCCC
Q 022444 163 LLRTTCGTPNYVAPEVLSHK----------GYNGAAADVWSCGVILYVLIAGYLPFDELD-LTTLYSKVEKA--DFSCPT 229 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~i~~~--~~~~~~ 229 (297)
......|++.|+|||++.+. ...+.++||||||+++|+|++|..||.... .......+... ....+.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 23355789999999998652 123489999999999999999999997653 22333333333 234566
Q ss_pred CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 230 WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 230 ~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
..+.++.+|+.+||+.||++|||+.++|+||||+....+.
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 331 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC---
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCccc
Confidence 6789999999999999999999999999999999765543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=323.40 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=210.6
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|.....||+|++|.||++.+..++..|++|.+.... ....+.+.+|+..++.++|+||+++++++......+++||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 3444559999999999999999999999999987643 2335668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-CCCEEEcccCCCCCCCCCccc
Q 022444 88 FITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-~~~~~l~df~~~~~~~~~~~~ 163 (297)
++++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+.........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999999999997652 4678999999999999999999999999999999999987 899999999998766544333
Q ss_pred cccccCCccccCCccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HH-H-HhhhccccCCCCCChhHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKG--YNGAAADVWSCGVILYVLIAGYLPFDELDLTT-LY-S-KVEKADFSCPTWFPVGAKSL 238 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-~~-~-~i~~~~~~~~~~~~~~l~~l 238 (297)
.....+++.|+|||.+.+.. + +.++||||||+++|+|++|..||....... .. . .........+..+++++.++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGC-SHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCC-CcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHH
Confidence 44567889999999986543 4 489999999999999999999997643222 11 1 12233345667789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
+.+||+.||++|||++++|+||||+......
T Consensus 259 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 289 (295)
T 2clq_A 259 ILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289 (295)
T ss_dssp HHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred HHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence 9999999999999999999999999775443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=323.86 Aligned_cols=258 Identities=27% Similarity=0.484 Sum_probs=209.3
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-----
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----- 78 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 78 (297)
+..++|++.+.||+|++|.||++++..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 45678999999999999999999999999999999996532 335678899999999999999999998754
Q ss_pred --------CCeEEEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEc
Q 022444 79 --------RTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKIS 149 (297)
Q Consensus 79 --------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~ 149 (297)
....+++|||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence 457899999999999999998544 57889999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCC--------------ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHH
Q 022444 150 DFGLSALPEQG--------------VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE-LDLT 214 (297)
Q Consensus 150 df~~~~~~~~~--------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~-~~~~ 214 (297)
|||.+...... ........+++.|+|||.+.+....+.++||||||+++|+|++ ||.. .+..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99998765422 1122345678899999999765444599999999999999997 5543 2334
Q ss_pred HHHHHhhhccccCC----CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 215 TLYSKVEKADFSCP----TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 215 ~~~~~i~~~~~~~~----~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.....+.......+ ...+..+.+++.+||+.||++|||++++++||||+.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence 45555554444333 3456779999999999999999999999999999876444
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=328.09 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=210.9
Q ss_pred ccceEEeEEeccCCceeEEEEEe-CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCC------CeeEEEEEEEc
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQN-TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP------CVVRLHEVLAS 78 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~ 78 (297)
.++|++.+.||+|++|.||++.+ +.+++.|++|++.... .....+.+|+..++.+.|+ +++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 46899999999999999999998 5688999999997543 2345577888888877654 59999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC--------------
Q 022444 79 RTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-------------- 142 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-------------- 142 (297)
....+++||++ +++|.+++.... ++++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999 789999998765 6899999999999999999999999999999999999987
Q ss_pred -----CCCEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022444 143 -----QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (297)
Q Consensus 143 -----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~ 217 (297)
++.++|+|||.+...... .....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999998754432 2345688999999999887776 9999999999999999999999888766654
Q ss_pred HHhhhccccC--------------------------------------------CCCCChhHHHHHHHhcCCCcCCCCCH
Q 022444 218 SKVEKADFSC--------------------------------------------PTWFPVGAKSLIHRILDPNPETRITI 253 (297)
Q Consensus 218 ~~i~~~~~~~--------------------------------------------~~~~~~~l~~li~~~L~~~p~~Rps~ 253 (297)
..+.....+. +...++++.+|+.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 4432221111 11135678899999999999999999
Q ss_pred HHHhcCcccccCc
Q 022444 254 EEIRNDEWFRKGY 266 (297)
Q Consensus 254 ~~il~~p~~~~~~ 266 (297)
.|+++||||+...
T Consensus 324 ~ell~hp~f~~~~ 336 (339)
T 1z57_A 324 REALKHPFFDLLK 336 (339)
T ss_dssp HHHTTSGGGGGGG
T ss_pred HHHhcCHHHHHHh
Confidence 9999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=324.05 Aligned_cols=263 Identities=29% Similarity=0.393 Sum_probs=215.9
Q ss_pred cccccceEEeEEeccCCceeEEEEEeC-CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc---CCCCeeEEEEEEE-
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNT-ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLA- 77 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~- 77 (297)
.+..++|++.+.||+|++|.||++++. .+++.|++|++........ ....+.+|+..++.+ .||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 345688999999999999999999995 6789999999875432211 112334555555554 8999999999986
Q ss_pred ----cCCeEEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEccc
Q 022444 78 ----SRTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (297)
Q Consensus 78 ----~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df 151 (297)
.....+++||++. ++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 4567899999998 59999987654 4899999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-------
Q 022444 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD------- 224 (297)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~------- 224 (297)
|.+...... .......++..|+|||.+.+..++ .++||||||+++|+|++|..||...+..+....+....
T Consensus 165 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 165 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccccCC-CCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 998765533 223355688999999999877766 89999999999999999999999888776665553210
Q ss_pred --------------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 225 --------------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 225 --------------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
......+++.+.+|+.+||+.||++|||+.++++||||++.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 012345789999999999999999999999999999999876554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=328.96 Aligned_cols=252 Identities=25% Similarity=0.442 Sum_probs=207.5
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--eEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--KIY 83 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 83 (297)
.++|++.+.||+|+||.||++++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 46899999999999999999999999999999999754422 23566779999999999999999999987655 789
Q ss_pred EEEcccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee----cCCCCEEEcccCCCCC
Q 022444 84 IILEFITGGELFDKIVHHGR---LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSAL 156 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli----~~~~~~~l~df~~~~~ 156 (297)
+||||+++++|.+++..... +++..++.++.+++.||.|||+.|++|+||||+||++ +.++.++|+|||.+..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999999986543 9999999999999999999999999999999999999 7777899999999876
Q ss_pred CCCCccccccccCCccccCCcccc--------ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHhhhcc
Q 022444 157 PEQGVSLLRTTCGTPNYVAPEVLS--------HKGYNGAAADVWSCGVILYVLIAGYLPFDELD----LTTLYSKVEKAD 224 (297)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~----~~~~~~~i~~~~ 224 (297)
..... ......+++.|+|||.+. +..+ +.++||||||+++|+|++|..||.... ......++..+.
T Consensus 166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCC-ceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 55432 223456899999999985 2344 489999999999999999999996432 233333333322
Q ss_pred c---------------------c----CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 022444 225 F---------------------S----CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEW 261 (297)
Q Consensus 225 ~---------------------~----~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~ 261 (297)
+ + .+..+++.+.+++.+||++||++|||++|+|+||-
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1 1 11123467889999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=328.79 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=212.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe----
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK---- 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 81 (297)
.++|.+.+.||+|++|.||+|.++.+|+.|+||.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999987543 233345678899999999999999999999976543
Q ss_pred --EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 82 --IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 82 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
.+++||++. ++|.+.+.. .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 499999997 488877643 599999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc----------------
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---------------- 223 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---------------- 223 (297)
. .....+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 2 234567889999999876433459999999999999999999999888766555443221
Q ss_pred ------------c---ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 224 ------------D---FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 224 ------------~---~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
. ......+++++.+|+.+||+.||++|||++++|+||||+....+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence 0 11223578999999999999999999999999999999876544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=326.50 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=215.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.++|++.+.||+|+||.||++.+..+++ .|+||++.... .....+.+.+|+.+++.++|+||+++++++......
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 4689999999999999999999986554 59999997543 233356788999999999999999999999998999
Q ss_pred EEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
++||||+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999999754 579999999999999999999999999999999999999999999999999987654432
Q ss_pred cc---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHH
Q 022444 162 SL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAK 236 (297)
Q Consensus 162 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~ 236 (297)
.. .....++..|+|||.+.+..++ .++||||||+++|+|++ |..||......+....+... ..+.+..+|+++.
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 284 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH 284 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHH
Confidence 21 2233456689999999877666 89999999999999999 99999999988888877665 4566777999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 022444 237 SLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~ 258 (297)
+++.+||+.||++|||+.++++
T Consensus 285 ~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 285 QLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=321.32 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=210.9
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
..+++|++.+.||+|++|.||++.+..+++.|++|++...........+.+.+|+..++.++||||+++++++......+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 45789999999999999999999999999999999998765555556678899999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-c
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-S 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~-~ 162 (297)
+++|++++++|.+++....++++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 999999999999999988899999999999999999999999999999999999999999999999999987654432 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc---cCCCCCChhHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---SCPTWFPVGAKSLI 239 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~l~~li 239 (297)
......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+..... ..+..+|+++.+++
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 269 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269 (309)
T ss_dssp ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred cccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence 23345688899999999877665 899999999999999999999988766655554443322 33566899999999
Q ss_pred HHhcCCCcCCCC-CHHHHhc
Q 022444 240 HRILDPNPETRI-TIEEIRN 258 (297)
Q Consensus 240 ~~~L~~~p~~Rp-s~~~il~ 258 (297)
.+||+.||++|| |++++++
T Consensus 270 ~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 270 ARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHTCSSGGGSCSSHHHHHH
T ss_pred HHhccCCHHHHHHhHHHHHH
Confidence 999999999999 8888876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=323.65 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=213.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||+||++.+..+++.+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 3578999999999999999999999999999999885532 3445778899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
||||+.+++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999999987 567999999999999999999999999999999999999999999999999998755432221
Q ss_pred c--------------ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---Hhhhcccc
Q 022444 164 L--------------RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS---KVEKADFS 226 (297)
Q Consensus 164 ~--------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~---~i~~~~~~ 226 (297)
. ....|++.|+|||.+.+..++ .++||||||+++|+|++|..||.......... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 1 144688999999999887776 99999999999999999999986532211000 00001123
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+..+|+.+.+++.+||+.||++|||+.++++ ++++.
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 45678999999999999999999999999988 66554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=330.93 Aligned_cols=258 Identities=31% Similarity=0.542 Sum_probs=220.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHHhcC--CCCeeEEEEEEEcC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVR--HPCVVRLHEVLASR 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 79 (297)
..++|++.+.||+|+||.||++++..+++.|++|.+........ .....+.+|+.+++.+. |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 35689999999999999999999999999999999976432211 11234567888999986 59999999999999
Q ss_pred CeEEEEEcccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec-CCCCEEEcccCCCCCC
Q 022444 80 TKIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALP 157 (297)
Q Consensus 80 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~-~~~~~~l~df~~~~~~ 157 (297)
+..++++|++.+ ++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+...
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999999976 89999999888999999999999999999999999999999999999999 6789999999998765
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHH
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKS 237 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~ 237 (297)
... ......+++.|+|||.+.+..+.+.++||||||+++|+|++|..||.... .+.......+..+|+++.+
T Consensus 201 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~ 272 (320)
T 3a99_A 201 KDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 272 (320)
T ss_dssp CSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHH
T ss_pred ccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHHHHH
Confidence 432 22345688999999999877665588999999999999999999996532 2333445566779999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
++.+||+.||++|||++++++||||++...+..
T Consensus 273 li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~ 305 (320)
T 3a99_A 273 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 305 (320)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHH
T ss_pred HHHHHccCChhhCcCHHHHhcCHhhcCccCccc
Confidence 999999999999999999999999998765443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=326.48 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=200.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.++|++.+.||+|++|.||+|.+..++. .|++|++....... ...+.+.+|+..++.++|+||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 4689999999999999999999887665 89999987643222 3357788999999999999999999999776554
Q ss_pred ------EEEEcccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcc
Q 022444 83 ------YIILEFITGGELFDKIVHHG------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (297)
Q Consensus 83 ------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~d 150 (297)
++++||+.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 99999999999999986543 589999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-cc
Q 022444 151 FGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FS 226 (297)
Q Consensus 151 f~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~ 226 (297)
||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+.... ..
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 259 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence 999876543322 22234456789999999877766 99999999999999999 999999888877777665553 56
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCC-------HHHHhcCcccccCc
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRIT-------IEEIRNDEWFRKGY 266 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps-------~~~il~~p~~~~~~ 266 (297)
.+..+++++.+++.+||+.||.+||| ++++++|||+....
T Consensus 260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 67779999999999999999999999 88888999998763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=316.11 Aligned_cols=248 Identities=22% Similarity=0.394 Sum_probs=217.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|++|.||++.+. +++.|++|++...... .+.+.+|+.++++++||||+++++++.+....+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999987 5778999999754322 34578999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-c
Q 022444 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~ 163 (297)
|||+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999999999654 4589999999999999999999999999999999999999999999999999875543322 2
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~ 241 (297)
.....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+... ....+..+++++.+++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHH
Confidence 3344556789999999877776 99999999999999999 99999999988888887766 345566689999999999
Q ss_pred hcCCCcCCCCCHHHHhcC
Q 022444 242 ILDPNPETRITIEEIRND 259 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~~ 259 (297)
||+.+|++|||+.+++++
T Consensus 243 ~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 243 CWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCcccCcCHHHHHHH
Confidence 999999999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=329.81 Aligned_cols=250 Identities=24% Similarity=0.424 Sum_probs=216.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-------CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-------ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 77 (297)
.++|++.+.||+|+||.||+|++. .++..|++|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 468999999999999999999974 345679999997543 334467788999999999 8999999999999
Q ss_pred cCCeEEEEEcccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec
Q 022444 78 SRTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~ 141 (297)
.....|+||||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 9999999999999999999998653 478999999999999999999999999999999999999
Q ss_pred CCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022444 142 SQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYS 218 (297)
Q Consensus 142 ~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~ 218 (297)
.++.++|+|||++........ ......+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+..+...
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999875443221 22334566789999999877766 99999999999999999 999999988887777
Q ss_pred Hhhhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 219 KVEKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 219 ~i~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+.... ...+..+++++.+++.+||+.+|.+|||+.++++
T Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 766654 4566779999999999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=337.15 Aligned_cols=256 Identities=18% Similarity=0.197 Sum_probs=195.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc--CCCCeeEEE-------EEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV--RHPCVVRLH-------EVLA 77 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~ 77 (297)
.+|++.+.||+|+||.||++++..+|+.||+|++...........+.+.+|+..++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999876544445566677775444444 699988855 4443
Q ss_pred cC-----------------CeEEEEEcccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCEEecC
Q 022444 78 SR-----------------TKIYIILEFITGGELFDKIVHH-GRLSESEA------RRYFQQLIDGVDYCHSKGVYHRDL 133 (297)
Q Consensus 78 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~------~~~~~~i~~al~~Lh~~~i~h~di 133 (297)
.. ...|+||||+. ++|.+++... ..++...+ +.++.|++.||.|||+.||+|+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 32 34899999998 7999999864 34455555 677899999999999999999999
Q ss_pred CCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022444 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (297)
Q Consensus 134 ~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~ 211 (297)
||+||+++.++.++|+|||++........ ...+++.|+|||.+.+ ..++ .++||||||+++|+|++|..||...
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRGP---ASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEEE---GGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCcc---CccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999886543321 3445599999999976 5555 9999999999999999999999766
Q ss_pred CHHHH--HHH-----hhhcc--ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 212 DLTTL--YSK-----VEKAD--FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 212 ~~~~~--~~~-----i~~~~--~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
..... ... ..... .+....+|+++.+|+.+||+.||++|||+.++|+||||++...
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 33211 000 00111 2223468999999999999999999999999999999987643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=328.79 Aligned_cols=261 Identities=32% Similarity=0.560 Sum_probs=209.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHHhc----CCCCeeEEEEEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLV----RHPCVVRLHEVLA 77 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~~i~~~~~~~~ 77 (297)
..++|++.+.||+|++|.||++.+..+++.|++|++........ .....+.+|+..++++ .|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 35689999999999999999999999999999999975432221 1223355788888888 8999999999998
Q ss_pred cCCeEEEEEcc-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec-CCCCEEEcccCCCC
Q 022444 78 SRTKIYIILEF-ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSA 155 (297)
Q Consensus 78 ~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~-~~~~~~l~df~~~~ 155 (297)
..+..++++|+ +.+++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+.
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 88899999999 78899999999888899999999999999999999999999999999999999 78999999999987
Q ss_pred CCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhH
Q 022444 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGA 235 (297)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l 235 (297)
..... ......++..|+|||.+.+..+.+.++||||||+++|+|++|+.||... ..+.......+..++.++
T Consensus 189 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~~~ 260 (312)
T 2iwi_A 189 LLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDC 260 (312)
T ss_dssp ECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSCHHH
T ss_pred hcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCCHHH
Confidence 65543 2234568889999999987766556899999999999999999999753 223344556677899999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccccc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~ 273 (297)
.+++.+||+.||++|||++++++||||++.........
T Consensus 261 ~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~~~~ 298 (312)
T 2iwi_A 261 CALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNP 298 (312)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSTTTCC---------
T ss_pred HHHHHHHccCChhhCcCHHHHhcChhhcCchhcccccc
Confidence 99999999999999999999999999998766554443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=332.79 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=205.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----- 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 80 (297)
..+|++.+.||+|+||.||+|++..+++ +++|++..... ...+|+.+++.++|+||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 4579999999999999999999987666 88887754321 1236899999999999999999984332
Q ss_pred -eEEEEEcccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec-CCCCEEEcccCCC
Q 022444 81 -KIYIILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLS 154 (297)
Q Consensus 81 -~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~-~~~~~~l~df~~~ 154 (297)
..++||||++++ +.+.+. ....+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+|||.+
T Consensus 111 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 111 VFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 388999999874 433332 356799999999999999999999999999999999999998 7899999999998
Q ss_pred CCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc----------
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---------- 224 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~---------- 224 (297)
....... ......+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 190 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 190 KILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp EECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 7654332 22345678899999998765434599999999999999999999999887766555443210
Q ss_pred -------------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 225 -------------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 225 -------------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
..++..+++++.+|+.+||.+||++|||+.++++||||++....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 01233478899999999999999999999999999999976443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=313.98 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=216.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++.++ ++..+++|++...... .+.+.+|+..++.++||||+++++++......++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 4578999999999999999999876 5677999999764422 3457899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
+||++++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999999997654 599999999999999999999999999999999999999999999999999875544322
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccc-cCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADF-SCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~ 240 (297)
......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+..... ..+..+|+.+.+++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMY 239 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHH
Confidence 22334456679999999877666 89999999999999999 9999999888888777766643 445668999999999
Q ss_pred HhcCCCcCCCCCHHHHhcC
Q 022444 241 RILDPNPETRITIEEIRND 259 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~ 259 (297)
+||+.+|++|||+.+++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 240 SCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999983
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=317.73 Aligned_cols=255 Identities=28% Similarity=0.529 Sum_probs=206.0
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
....++|++.+.||+|++|.||++.+..+|+.+++|++.............+.+|+..++.++|+||+++++++......
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34678999999999999999999999999999999999764433445567788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 83 YIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
+++||++.+++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998864 4568999999999999999999999999999999999999999999999999987665
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhhhccccC--CCCCChh
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL--DLTTLYSKVEKADFSC--PTWFPVG 234 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~--~~~~~~~ 234 (297)
..........++..|+|||.+.+..++ .++||||||+++|+|++|..||... ........+.....+. ...+|++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence 544444455688899999999877766 9999999999999999999999654 3344555555444322 2458999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.+++.+||+.||++|||+.++++
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=332.96 Aligned_cols=250 Identities=28% Similarity=0.460 Sum_probs=204.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC--------CCCeeEEEEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--------HPCVVRLHEVLA 77 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~ 77 (297)
.++|++.+.||+|+||+||++++..+++.||+|++.... .....+.+|+.+++.+. |+||+++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 468999999999999999999999999999999997543 23456778888888885 788999999987
Q ss_pred ----cCCeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCC------
Q 022444 78 ----SRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQG------ 144 (297)
Q Consensus 78 ----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~------ 144 (297)
.....++|||++ ++++.+.+... ..+++..++.++.||+.||.|||+. ||+|+||||+||+++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 556899999999 55776766544 4699999999999999999999998 999999999999998775
Q ss_pred -------------------------------------------CEEEcccCCCCCCCCCccccccccCCccccCCccccc
Q 022444 145 -------------------------------------------HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181 (297)
Q Consensus 145 -------------------------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 181 (297)
.++|+|||.+...... .....+++.|+|||++.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHT
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcC
Confidence 7999999998765432 234568999999999988
Q ss_pred cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHhhhcc-------------------------------
Q 022444 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDL------TTLYSKVEKAD------------------------------- 224 (297)
Q Consensus 182 ~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~------~~~~~~i~~~~------------------------------- 224 (297)
..++ .++||||||+++|+|++|..||...+. .+....+....
T Consensus 268 ~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp SCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 8776 899999999999999999999976541 12221111100
Q ss_pred -----------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 225 -----------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 225 -----------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
...+...+..+.+||.+||+.||++|||++++|+||||++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0111223457889999999999999999999999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=327.45 Aligned_cols=251 Identities=25% Similarity=0.429 Sum_probs=218.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 77 (297)
.++|++.+.||+|+||.||+|++.. ++..|++|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 4689999999999999999999753 34679999987653 233457788999999999 8999999999999
Q ss_pred cCCeEEEEEcccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec
Q 022444 78 SRTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~ 141 (297)
.....++||||+.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||||+||+++
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 9999999999999999999998653 489999999999999999999999999999999999999
Q ss_pred CCCCEEEcccCCCCCCCCCc--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022444 142 SQGHLKISDFGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYS 218 (297)
Q Consensus 142 ~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~ 218 (297)
.++.++|+|||.+....... .......+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+..+..+
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999997654432 222334567789999999877766 99999999999999999 999999999888888
Q ss_pred Hhhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 219 KVEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 219 ~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.+... ....+..+++++.+++.+||+.||++|||+.+++++
T Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 305 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77666 345667799999999999999999999999999983
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=315.51 Aligned_cols=248 Identities=21% Similarity=0.384 Sum_probs=214.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||++.+. ++..|++|++...... .+.+.+|+..++.++|+||+++++++......+++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 468999999999999999999876 6778999999754322 34578999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-c
Q 022444 86 LEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~ 163 (297)
|||+.+++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 999999999999976 56799999999999999999999999999999999999999999999999999875543322 2
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~ 241 (297)
.....+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+.... ...+..+++.+.+++.+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 256 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 256 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHH
Confidence 2334456789999999877766 99999999999999998 999999999888888777664 44566689999999999
Q ss_pred hcCCCcCCCCCHHHHhcC
Q 022444 242 ILDPNPETRITIEEIRND 259 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~~ 259 (297)
||+.+|.+|||+.++++|
T Consensus 257 ~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 257 CWHEKADERPTFKILLSN 274 (283)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCChhHCcCHHHHHHH
Confidence 999999999999999984
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=330.88 Aligned_cols=257 Identities=22% Similarity=0.315 Sum_probs=218.4
Q ss_pred ccceEEeEEeccCCceeEEEEE-----eCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|+||.||+|+ +..++..|++|++.... .......+.+|+.+++.++|+||+++++++....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3679999999999999999999 44577899999986543 2233456788999999999999999999999888
Q ss_pred eEEEEEcccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC---CEEEcc
Q 022444 81 KIYIILEFITGGELFDKIVHHG-------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISD 150 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~---~~~l~d 150 (297)
..++||||+.+++|.+++.... .+++..++.++.+++.||.|||+.||+|+||||+||+++.++ .++|+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999999997653 489999999999999999999999999999999999998555 599999
Q ss_pred cCCCCCCCCC--ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-cc
Q 022444 151 FGLSALPEQG--VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FS 226 (297)
Q Consensus 151 f~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~ 226 (297)
||.+...... ........+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+.... ..
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~ 306 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 306 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998643221 1222344567899999999877776 99999999999999998 999999999888888877664 45
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+..+|+.+.+|+.+||+.+|.+|||+.+++++.+.-..
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 567799999999999999999999999999998876554
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=331.98 Aligned_cols=250 Identities=28% Similarity=0.460 Sum_probs=217.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||+|.++.+++.||+|.+.... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 468999999999999999999999999999999987542 223345678999999999999999999999988899999
Q ss_pred EcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
|||+++++|.+++...+ .++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 99999999999997654 59999999999999999999999999999999999999999999999999987544322211
Q ss_pred --ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 165 --RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 165 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+..+.+..+ ..+.+..+|+++.+++.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 112245679999999876665 89999999999999998 99999998888877766554 45667779999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+||+.||++|||++++++
T Consensus 350 ~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 350 QCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=325.87 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=219.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|+||.||++++. .+++.|++|++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 468999999999999999999987 345899999997543 2334567889999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHH------------------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPE 136 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~ 136 (297)
..+++|||+.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 999999999999999999764 56899999999999999999999999999999999
Q ss_pred CeeecCCCCEEEcccCCCCCCCCCc--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022444 137 NLLLDSQGHLKISDFGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (297)
Q Consensus 137 nIli~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~ 213 (297)
||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+.
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 9999999999999999986543221 122344567889999999877766 99999999999999999 9999999988
Q ss_pred HHHHHHhhhccc-cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 214 TTLYSKVEKADF-SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 214 ~~~~~~i~~~~~-~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+....+..... ..+..+|.++.+++.+||+.||++|||+.++++ .|++.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~--~L~~~ 333 (343)
T 1luf_A 283 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRM 333 (343)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH--HHHHH
Confidence 888877766654 566779999999999999999999999999987 45443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=321.00 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=217.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|+||.||++.+. .++..|++|++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 468999999999999999999983 456899999997543 2344577889999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGR------------------------LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPE 136 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~ 136 (297)
..+++|||+.+++|.+++..... +++..++.++.+++.||.|||+.|++|+||+|+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 99999999999999999986543 899999999999999999999999999999999
Q ss_pred CeeecCCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022444 137 NLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (297)
Q Consensus 137 nIli~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~ 213 (297)
||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+.
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999875543322 22344567789999999876665 99999999999999999 9999998888
Q ss_pred HHHHHHhhhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 214 TTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 214 ~~~~~~i~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
....+.+.... ...+..+|+++.+++.+||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77777766553 45567799999999999999999999999999873
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=316.46 Aligned_cols=267 Identities=21% Similarity=0.297 Sum_probs=222.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 84 (297)
.++|++.+.||+|++|.||++.+..+++.|++|++..... .+.+.+|+..++.+ .|++++++++++......++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 4679999999999999999999999999999999865431 23467889999999 69999999999999999999
Q ss_pred EEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC-----EEEcccCCCCCCC
Q 022444 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH-----LKISDFGLSALPE 158 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~-----~~l~df~~~~~~~ 158 (297)
+||++ +++|.+++...+ ++++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999 889999998654 5999999999999999999999999999999999999987765 9999999987654
Q ss_pred CCcc-------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHhhhccc---
Q 022444 159 QGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL---DLTTLYSKVEKADF--- 225 (297)
Q Consensus 159 ~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~---~~~~~~~~i~~~~~--- 225 (297)
.... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||... ........+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 4322 13345688999999999887776 9999999999999999999999874 33344444433322
Q ss_pred --cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCccc
Q 022444 226 --SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDD 281 (297)
Q Consensus 226 --~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~~ 281 (297)
.....+|+++.+++.+||+.||++|||++++++ .|++...........+++|+.
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~--~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 242 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHHHHHHTTCCSCSCCGGGC
T ss_pred HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH--HHHHHHHhcCCCCCCccccCC
Confidence 223468999999999999999999999999988 677776666666666676653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=332.82 Aligned_cols=252 Identities=28% Similarity=0.401 Sum_probs=206.0
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc------CC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------RT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 80 (297)
.+|++.+.||+|+||.||+++++.+|+.||||++.... ....+|+++++.++|+||+++++++.. ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 36999999999999999999999999999999986532 123368999999999999999998742 22
Q ss_pred eEEEEEcccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC-CCEEEcccCCCC
Q 022444 81 KIYIILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSA 155 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~-~~~~l~df~~~~ 155 (297)
.++++|||+.+ ++.+.+. ....+++..++.++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++.
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 47799999986 6655553 34679999999999999999999999999999999999999965 568999999997
Q ss_pred CCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc------------
Q 022444 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA------------ 223 (297)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~------------ 223 (297)
...... ......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 206 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 206 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp ECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred hcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 654332 2234568899999999876533349999999999999999999999988766555444221
Q ss_pred -----ccc------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 224 -----DFS------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 224 -----~~~------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
... ++..+++++.+||.+||..||.+|||+.++++||||+....
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 011 23346889999999999999999999999999999987643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=328.14 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=208.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CC-----CeeEEEEEEEc
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HP-----CVVRLHEVLAS 78 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~ 78 (297)
..++|++.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.+++.+. |+ +++++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 4678999999999999999999999999999999997543 22445666777777764 44 59999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCEEecCCCCCeeec--CCCCEEEcccC
Q 022444 79 RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCH--SKGVYHRDLKPENLLLD--SQGHLKISDFG 152 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh--~~~i~h~di~~~nIli~--~~~~~~l~df~ 152 (297)
....++|||++.+ +|.+++... ..+++..++.++.+++.||.||| +.||+|+||||+||+++ .++.++|+|||
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999999965 999999765 46899999999999999999999 57999999999999995 46789999999
Q ss_pred CCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----
Q 022444 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP---- 228 (297)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 228 (297)
.+...... .....+++.|+|||++.+..++ .++||||||+++|+|++|..||...+..+....+.......+
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98765432 2345788899999999888776 999999999999999999999998887766655533210000
Q ss_pred --------------C------------------C----------------------------CChhHHHHHHHhcCCCcC
Q 022444 229 --------------T------------------W----------------------------FPVGAKSLIHRILDPNPE 248 (297)
Q Consensus 229 --------------~------------------~----------------------------~~~~l~~li~~~L~~~p~ 248 (297)
. . ..+++.+||.+||++||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 0 0 003688999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q 022444 249 TRITIEEIRNDEWFRKG 265 (297)
Q Consensus 249 ~Rps~~~il~~p~~~~~ 265 (297)
+|||++++|+||||++.
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=311.71 Aligned_cols=251 Identities=26% Similarity=0.467 Sum_probs=205.1
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-HKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
.-..++|++.+.||+|++|.||++.+. ++.+++|++....... ....+.+.+|+..++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 345789999999999999999999985 7899999987544322 2335678899999999999999999999999899
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---CEEecCCCCCeeecC--------CCCEEEcc
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG---VYHRDLKPENLLLDS--------QGHLKISD 150 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~---i~h~di~~~nIli~~--------~~~~~l~d 150 (297)
.+++|||+++++|.+++. ..++++..++.++.+++.||.|||+.| ++|+||+|+||+++. ++.++|+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999988875 458999999999999999999999999 899999999999986 67899999
Q ss_pred cCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--ccCC
Q 022444 151 FGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSCP 228 (297)
Q Consensus 151 f~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~ 228 (297)
||.+........ ....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.......+.... .+.+
T Consensus 160 fg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 160 FGLAREWHRTTK--MSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp CCC---------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred CCcccccccccc--cCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 999876544322 245688999999999877766 99999999999999999999999888777666655543 4556
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
..+|+++.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 7799999999999999999999999999873
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=324.43 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=208.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCC-cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC------eeEEEEEEEc
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC------VVRLHEVLAS 78 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~ 78 (297)
.++|++.+.||+|++|.||++.+..++ ..|++|++.... ...+.+.+|+.+++.+.|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 468999999999999999999998776 689999997543 23455677888888886554 8999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee----------------
Q 022444 79 RTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---------------- 140 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli---------------- 140 (297)
....+++||++ ++++.+.+.... ++++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999999 557777776543 69999999999999999999999999999999999999
Q ss_pred ---cCCCCEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022444 141 ---DSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (297)
Q Consensus 141 ---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~ 217 (297)
+.++.++|+|||.+...... .....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+..
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56788999999998754432 2345688999999999887776 9999999999999999999999887766554
Q ss_pred HHhhhccccCC--------------------------------------------CCCChhHHHHHHHhcCCCcCCCCCH
Q 022444 218 SKVEKADFSCP--------------------------------------------TWFPVGAKSLIHRILDPNPETRITI 253 (297)
Q Consensus 218 ~~i~~~~~~~~--------------------------------------------~~~~~~l~~li~~~L~~~p~~Rps~ 253 (297)
..+.....+.+ ...+.++.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 44332211111 1123578899999999999999999
Q ss_pred HHHhcCcccccCc
Q 022444 254 EEIRNDEWFRKGY 266 (297)
Q Consensus 254 ~~il~~p~~~~~~ 266 (297)
+++|+||||++..
T Consensus 329 ~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 329 AEALLHPFFAGLT 341 (355)
T ss_dssp HHHTTSGGGGGCC
T ss_pred HHHhcChhhcCCC
Confidence 9999999999763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=325.12 Aligned_cols=252 Identities=32% Similarity=0.579 Sum_probs=183.7
Q ss_pred cccceEEeE-EeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc----C
Q 022444 5 KVGKYEVGR-TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----R 79 (297)
Q Consensus 5 ~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (297)
..++|++.+ .||+|++|.||++.++.+++.||+|++..... ...+....++.+.|+||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 357899965 69999999999999999999999999865431 12223344567789999999999865 4
Q ss_pred CeEEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---CCCEEEcccCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGLS 154 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~~~~~l~df~~~ 154 (297)
...++||||+.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56899999999999999998754 6999999999999999999999999999999999999976 445999999998
Q ss_pred CCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHhhhccccCC--
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL----YSKVEKADFSCP-- 228 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~-- 228 (297)
...... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||........ ...+.......+
T Consensus 179 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 179 KETTQN--ALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp EEC------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred eecccc--ccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 755432 22345678899999999766665 899999999999999999999976654433 222222222222
Q ss_pred --CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 229 --TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 229 --~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
..+++++.+|+.+||+.||++|||++++|+||||++..
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 45899999999999999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=316.20 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=219.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++.++.++..+++|.+.... ...+.+.+|+.+++.++|+||+++++++......++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3568999999999999999999999999999999997543 234667899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+||++.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999999864 3489999999999999999999999999999999999999999999999999876654322
Q ss_pred -ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHH
Q 022444 163 -LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLI 239 (297)
Q Consensus 163 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li 239 (297)
......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+.....+.+... ....+..+|+.+.+++
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 245 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 23334456789999999877766 99999999999999999 99999988877777766655 3456677999999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 022444 240 HRILDPNPETRITIEEIRN 258 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~ 258 (297)
.+||+.||.+|||++++++
T Consensus 246 ~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 246 RACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCChhhCcCHHHHHH
Confidence 9999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=321.85 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=214.3
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEE--EEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESV--AMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~--~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 81 (297)
..++|++.+.||+|++|.||+++++.++..+ ++|.+.... .......+.+|+.+++++ .||||+++++++.....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 3578999999999999999999999888765 888886533 233356688999999999 89999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~ 145 (297)
.+++||++++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 999999999999999997654 6999999999999999999999999999999999999999999
Q ss_pred EEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-
Q 022444 146 LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA- 223 (297)
Q Consensus 146 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~- 223 (297)
++|+|||.+...... .......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+.....+.+...
T Consensus 181 ~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEEcccCcCcccccc-ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 999999998744332 122234467789999999776665 89999999999999998 99999999988888877665
Q ss_pred cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 224 DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
....+..+|+++.+++.+||+.+|.+|||+++++++
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 345566789999999999999999999999999984
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=317.08 Aligned_cols=266 Identities=24% Similarity=0.415 Sum_probs=209.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC--CCCeeEEEEEEEcCCeE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--HPCVVRLHEVLASRTKI 82 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 82 (297)
..++|++.+.||+|++|.||++.+. +++.+++|++..... .....+.+.+|+..++++. |+||+++++++......
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3457999999999999999999986 588999999975432 2334577889999999997 59999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+++|| +.+++|.+++.....+++..++.++.++++||.|||+.|++|+||+|+||+++ ++.++|+|||.+........
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 99999 55779999999888999999999999999999999999999999999999995 58999999999876544322
Q ss_pred --ccccccCCccccCCcccccc----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhhc--cccC
Q 022444 163 --LLRTTCGTPNYVAPEVLSHK----------GYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEKA--DFSC 227 (297)
Q Consensus 163 --~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~~--~~~~ 227 (297)
......+++.|+|||.+.+. ...+.++||||||+++|+|++|..||...... .....+... ....
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence 22345688999999998652 12348999999999999999999999765322 222322222 2345
Q ss_pred CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccc
Q 022444 228 PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEY 274 (297)
Q Consensus 228 ~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~ 274 (297)
+...+.++.+++.+||+.||++|||+.++++||||+....+......
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~~~ 308 (313)
T 3cek_A 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308 (313)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---------
T ss_pred cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchhhhhh
Confidence 66678999999999999999999999999999999988766655443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=327.53 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=211.8
Q ss_pred cccceEEeEEeccCCceeEEEEE-----eCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS 78 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 78 (297)
..++|++.+.||+|+||.||+++ +..+++.|+||++.... .....+.+.+|+.+++++ .||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 35789999999999999999999 55677999999997543 223356788999999999 68999999999876
Q ss_pred CC-eEEEEEcccCCCChHHHHHhcCC------------------------------------------------------
Q 022444 79 RT-KIYIILEFITGGELFDKIVHHGR------------------------------------------------------ 103 (297)
Q Consensus 79 ~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 103 (297)
.. ..+++|||+++++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 54 48999999999999999976543
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--ccccccC
Q 022444 104 ------------LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCG 169 (297)
Q Consensus 104 ------------~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~--~~~~~~~ 169 (297)
+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||.+........ ......+
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 89999999999999999999999999999999999999999999999999876543222 2334456
Q ss_pred CccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHhhhc-cccCCCCCChhHHHHHHHhcCCC
Q 022444 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT-LYSKVEKA-DFSCPTWFPVGAKSLIHRILDPN 246 (297)
Q Consensus 170 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~-~~~~i~~~-~~~~~~~~~~~l~~li~~~L~~~ 246 (297)
++.|+|||.+.+..++ .++||||||+++|+|++ |..||....... ....+... ....+..+++++.+++.+||+.|
T Consensus 258 t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 336 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 336 (359)
T ss_dssp CGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 7889999999877776 99999999999999998 999998765433 33333333 44566779999999999999999
Q ss_pred cCCCCCHHHHhcC
Q 022444 247 PETRITIEEIRND 259 (297)
Q Consensus 247 p~~Rps~~~il~~ 259 (297)
|.+|||++++++|
T Consensus 337 P~~Rps~~ell~~ 349 (359)
T 3vhe_A 337 PSQRPTFSELVEH 349 (359)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999984
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=314.58 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=204.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..++|++.+.||+|+||.||++.+..+ +..+++|...... .....+.+.+|+..++.++||||+++++++. .+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 357899999999999999999998653 4569999886543 2344567889999999999999999999984 567
Q ss_pred EEEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.++||||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 899999999999999997654 6999999999999999999999999999999999999999999999999998765443
Q ss_pred cc-ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHH
Q 022444 161 VS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKS 237 (297)
Q Consensus 161 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~ 237 (297)
.. ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+.... .+.+..+|+++.+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 248 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 248 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 22 22234456789999999877766 89999999999999996 999999888777777776553 4567789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 022444 238 LIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+||+.||++|||+.++++
T Consensus 249 li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 249 LMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=316.18 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=198.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++.++.+|+.|++|++....... .....+.++..+++.+.|+||+++++++...+..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 4678999999999999999999999999999999997654222 223445555667888899999999999999999999
Q ss_pred EEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+||++ ++.+..+... ...+++..++.++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 99999 4455555543 46799999999999999999999995 99999999999999999999999999987554332
Q ss_pred ccccccCCccccCCcccc-----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhhhcccc---CCCCCCh
Q 022444 163 LLRTTCGTPNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLYSKVEKADFS---CPTWFPV 233 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~~~~~i~~~~~~---~~~~~~~ 233 (297)
......+++.|+|||.+. ...+ +.++||||||+++|+|++|..||... ........+.....+ ....+|.
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258 (318)
T ss_dssp -------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred cccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence 223456888999999985 2334 48999999999999999999999874 444455555444332 2234899
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
++.+++.+||+.||.+|||++++++||||++..
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 999999999999999999999999999998753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=320.37 Aligned_cols=257 Identities=21% Similarity=0.367 Sum_probs=190.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS-IMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
.++|++.+.||+|+||.||++.++.+|+.|++|++...... .....+..++. +++.+.|+||+++++++...+..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 46899999999999999999999999999999999765321 22333444444 6777899999999999999999999
Q ss_pred EEcccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 85 ILEFITGGELFDKIVH-----HGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
+||++.+ +|.+++.. ...+++..+..++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9999986 88777763 56799999999999999999999999 99999999999999999999999999987654
Q ss_pred CCccccccccCCccccCCcccc----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhhccc-cC----C
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLS----HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEKADF-SC----P 228 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~~~~-~~----~ 228 (297)
.... .....+++.|+|||.+. +..++ .++||||||+++|+|++|..||...... +....+..... .. .
T Consensus 178 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3aln_A 178 DSIA-KTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255 (327)
T ss_dssp -----------------------------CC-SHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSS
T ss_pred cccc-cccCCCCccccCceeeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccc
Confidence 4322 22346888999999983 34444 8999999999999999999999765422 22233222222 11 2
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
..+++++.+|+.+||+.||++|||+.++++||||.+...
T Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 347899999999999999999999999999999987643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=322.97 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=217.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 84 (297)
-++|++.+.||+|+||.||++++..+++.||+|++..... .+.+.+|+.+++.+ .|+||+++++++......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 3679999999999999999999999999999999865421 23477899999999 89999999999999999999
Q ss_pred EEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC-----EEEcccCCCCCCC
Q 022444 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH-----LKISDFGLSALPE 158 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~-----~~l~df~~~~~~~ 158 (297)
+||++ +++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 8899999986 467999999999999999999999999999999999999998887 9999999987544
Q ss_pred CCcc-------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhhhccccCC
Q 022444 159 QGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD---LTTLYSKVEKADFSCP 228 (297)
Q Consensus 159 ~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~ 228 (297)
.... ......|++.|+|||.+.+..++ .++||||||+++|+|++|..||...+ .......+.....+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 3222 12355789999999999887776 99999999999999999999998743 4444455444333322
Q ss_pred -----CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCcc
Q 022444 229 -----TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLD 280 (297)
Q Consensus 229 -----~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~ 280 (297)
..+| ++.+++.+||+.+|.+||++.++++ .|++...+........++|.
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~--~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK--LFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH--HHHHHHHHTTCCCSCCCTTT
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH--HHHHHHHHcCCCCCCCccCC
Confidence 2355 9999999999999999999999987 55554444444444444444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=315.41 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=205.2
Q ss_pred ccceEEeEEeccCCceeEEEEE----eCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--C
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--R 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (297)
.++|++.+.||+|+||.||+++ +..+++.|++|++.... ....+.+.+|+.+++.++|+||+++++++.. .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4689999999999999999998 56789999999987543 3335678899999999999999999999854 3
Q ss_pred CeEEEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
...++||||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 46899999999999999997654 49999999999999999999999999999999999999999999999999987654
Q ss_pred CCcc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Q 022444 159 QGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT----------------TLYSK 219 (297)
Q Consensus 159 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~----------------~~~~~ 219 (297)
.... ......++..|+|||.+.+..++ .++||||||+++|+|++|..|+...... ...+.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 4322 12233456679999999887776 9999999999999999999998643221 11222
Q ss_pred h-hhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 220 V-EKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 220 i-~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+ .....+.+..+|+++.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2 22245667779999999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=329.94 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=193.9
Q ss_pred ccceEEe-EEeccCCceeEEEEEeC--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE--cCC
Q 022444 6 VGKYEVG-RTIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA--SRT 80 (297)
Q Consensus 6 ~~~y~~~-~~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~ 80 (297)
.+.|++. ++||+|+||.||+|+++ .+++.||+|.+..... ...+.+|+.+++.++||||+++++++. ...
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3568874 48999999999999966 5788999999865432 234678999999999999999999984 467
Q ss_pred eEEEEEcccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee----cCCCCEE
Q 022444 81 KIYIILEFITGGELFDKIVHH---------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLK 147 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli----~~~~~~~ 147 (297)
..++||||+.+ +|.+++... ..+++..++.++.+|+.||.|||+.||+|+||||+||++ +.++.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 89999999975 888777532 248999999999999999999999999999999999999 6778999
Q ss_pred EcccCCCCCCCCCc---cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------H
Q 022444 148 ISDFGLSALPEQGV---SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT---------T 215 (297)
Q Consensus 148 l~df~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---------~ 215 (297)
|+|||++....... .......+++.|+|||.+.+....+.++|||||||++|+|++|..||...... +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999998654322 22334578999999999987554459999999999999999999999654431 2
Q ss_pred HHHHhhhc-ccc-------------------------------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHh
Q 022444 216 LYSKVEKA-DFS-------------------------------------CPTWFPVGAKSLIHRILDPNPETRITIEEIR 257 (297)
Q Consensus 216 ~~~~i~~~-~~~-------------------------------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il 257 (297)
....+... ..+ .....++.+.+||.+||++||.+|||++++|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 22222110 000 0112367889999999999999999999999
Q ss_pred cCcccccCcccc
Q 022444 258 NDEWFRKGYVPV 269 (297)
Q Consensus 258 ~~p~~~~~~~~~ 269 (297)
+||||++...+.
T Consensus 333 ~hp~f~~~~~~~ 344 (405)
T 3rgf_A 333 QDPYFLEDPLPT 344 (405)
T ss_dssp TSGGGTSSSCCC
T ss_pred cChhhccCCCCc
Confidence 999999875543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=308.94 Aligned_cols=247 Identities=22% Similarity=0.389 Sum_probs=216.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|++|.||++.+. ++..+++|.+...... .+.+.+|+..++.++||||+++++++......+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 468999999999999999999986 6778999999764422 35678999999999999999999999988899999
Q ss_pred EcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-cc
Q 022444 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SL 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~-~~ 163 (297)
||++++++|.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999999999765 468999999999999999999999999999999999999999999999999987554321 12
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHH
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHR 241 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~ 241 (297)
.....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+.... ...+..++..+.+++.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 240 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred cccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHH
Confidence 2344566789999999877766 99999999999999999 899999988888887776663 34566689999999999
Q ss_pred hcCCCcCCCCCHHHHhc
Q 022444 242 ILDPNPETRITIEEIRN 258 (297)
Q Consensus 242 ~L~~~p~~Rps~~~il~ 258 (297)
||+.+|++|||+.++++
T Consensus 241 ~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 241 CWRERPEDRPAFSRLLR 257 (267)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=315.22 Aligned_cols=246 Identities=21% Similarity=0.293 Sum_probs=208.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCC-------cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETG-------ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA 77 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (297)
..++|++.+.||+|+||.||+++++.++ ..+++|++.... ....+.+.+|+..++.++|+||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 4578999999999999999999998776 479999986543 334567889999999999999999999999
Q ss_pred cCCeEEEEEcccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC--------EEE
Q 022444 78 SRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH--------LKI 148 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~--------~~l 148 (297)
.....+++|||+.+++|.+++..... +++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 88899999999999999999987654 999999999999999999999999999999999999998886 999
Q ss_pred cccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhccccC
Q 022444 149 SDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLYSKVEKADFSC 227 (297)
Q Consensus 149 ~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~ 227 (297)
+|||.+...... ....++..|+|||.+.+....+.++||||||+++|+|++| ..||...+...... ........
T Consensus 163 ~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~~ 237 (289)
T 4fvq_A 163 SDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQL 237 (289)
T ss_dssp CCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCCC
T ss_pred ccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccCCC
Confidence 999998655432 1234677899999998733334999999999999999995 55666555544443 34445666
Q ss_pred CCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 228 PTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 228 ~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+...++++.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 238 PAPKAAELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7778999999999999999999999999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=327.54 Aligned_cols=256 Identities=22% Similarity=0.417 Sum_probs=205.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-----------CCCeeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-----------HPCVVRLHE 74 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~ 74 (297)
.++|++.+.||+|++|.||+|++..+++.||+|++..... ....+.+|+..++.+. |+||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 4689999999999999999999999999999999975432 2345667888888775 789999999
Q ss_pred EEEcCC----eEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCEEecCCCCCeeecC-----
Q 022444 75 VLASRT----KIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDS----- 142 (297)
Q Consensus 75 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~-~i~h~di~~~nIli~~----- 142 (297)
++.... ..+++||++ +++|.+++... ..+++..++.++.+++.||.|||+. |++|+||+|+||+++.
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 886543 789999999 78999999763 4599999999999999999999998 9999999999999953
Q ss_pred -CCCEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------H
Q 022444 143 -QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT------T 215 (297)
Q Consensus 143 -~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~------~ 215 (297)
.+.++|+|||.+...... .....+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.. +
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 347999999998765432 2345688999999999887776 9999999999999999999999765421 1
Q ss_pred HHHHhh------------------------------------------hccccCCCCCChhHHHHHHHhcCCCcCCCCCH
Q 022444 216 LYSKVE------------------------------------------KADFSCPTWFPVGAKSLIHRILDPNPETRITI 253 (297)
Q Consensus 216 ~~~~i~------------------------------------------~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~ 253 (297)
....+. ......+..+++++.+||.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 111111 11112233356788999999999999999999
Q ss_pred HHHhcCcccccCccccc
Q 022444 254 EEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 254 ~~il~~p~~~~~~~~~~ 270 (297)
+++|+||||++......
T Consensus 329 ~ell~hp~f~~~~~~~~ 345 (373)
T 1q8y_A 329 GGLVNHPWLKDTLGMEE 345 (373)
T ss_dssp HHHHTCGGGTTCTTCTT
T ss_pred HHHhhChhhhcccCccc
Confidence 99999999998754443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=318.37 Aligned_cols=250 Identities=24% Similarity=0.425 Sum_probs=215.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-------CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-------ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 77 (297)
.++|++.+.||+|+||.||+|.+. .++..|++|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 468999999999999999999975 457889999997543 233456788999999999 8999999999999
Q ss_pred cCCeEEEEEcccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec
Q 022444 78 SRTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~ 141 (297)
.....++||||+.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 9899999999999999999998654 389999999999999999999999999999999999999
Q ss_pred CCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022444 142 SQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYS 218 (297)
Q Consensus 142 ~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~ 218 (297)
.++.++|+|||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+...
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 999999999999875543321 22234456789999999776665 99999999999999999 999999988888877
Q ss_pred Hhhhcc-ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 219 KVEKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 219 ~i~~~~-~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+.... ...+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 776654 4556779999999999999999999999999988
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=312.37 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=215.7
Q ss_pred ccceEEeE-EeccCCceeEEEEEe--CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGR-TIGEGTFAKVKFAQN--TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~-~lg~g~~~~v~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.++|++.+ .||+|++|.||++.+ ..+++.+++|++.... ......+.+.+|+..++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 46799998 999999999999954 5678899999997653 2333467789999999999999999999998 56678
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+++||++.+++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999875543322
Q ss_pred c---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHH
Q 022444 163 L---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKS 237 (297)
Q Consensus 163 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~ 237 (297)
. .....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+.... ...+..+|+++.+
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 251 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 1223356789999999776665 89999999999999999 999999988888877776654 4566779999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
++.+||+.||++|||+.++++ .|++.
T Consensus 252 li~~~l~~dp~~Rps~~~l~~--~L~~~ 277 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVEL--RLRNY 277 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH--HHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHH--HHHHH
Confidence 999999999999999999987 44443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=313.13 Aligned_cols=273 Identities=22% Similarity=0.296 Sum_probs=220.3
Q ss_pred CccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEE-EEEEcC
Q 022444 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLH-EVLASR 79 (297)
Q Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-~~~~~~ 79 (297)
|-.+..++|++.+.||+|++|.||++++..+++.|++|++..... .+.+.+|+.+++.+.|++++..+ .+....
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 345667899999999999999999999999999999999865431 23477899999999987655544 444677
Q ss_pred CeEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec---CCCCEEEcccCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSA 155 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~---~~~~~~l~df~~~~ 155 (297)
...+++||++ +++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 7889999999 8899999974 45799999999999999999999999999999999999994 78899999999987
Q ss_pred CCCCCcc-------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhhhccc
Q 022444 156 LPEQGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD---LTTLYSKVEKADF 225 (297)
Q Consensus 156 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---~~~~~~~i~~~~~ 225 (297)
....... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||.... .......+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 6544322 12345688999999999887766 99999999999999999999997643 2223333333322
Q ss_pred cC-----CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCcccc
Q 022444 226 SC-----PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDV 282 (297)
Q Consensus 226 ~~-----~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (297)
.. ...+|+++.+++.+||+.||++|||++++++ .|++...........+++|+.+
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHHHHHTTCCSSCCCGGGGC
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH--HHHHHHHhcCCccccccccccc
Confidence 22 3668999999999999999999999999988 7777666666666666777654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=325.21 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=205.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeC---CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.++|++.+.||+|+||.||+++++ .++..|+||.+.... .....+.+.+|+.+++.++||||+++++++......
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 357999999999999999999987 467789999987543 233456788999999999999999999999988999
Q ss_pred EEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
++||||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99999999999999997654 69999999999999999999999999999999999999999999999999987654432
Q ss_pred cc---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHH
Q 022444 162 SL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAK 236 (297)
Q Consensus 162 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~ 236 (297)
.. .....++..|+|||.+.+..++ .++||||||+++|++++ |..||...+..+....+... ..+.+..+|..+.
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 280 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY 280 (373)
T ss_dssp ------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHH
T ss_pred ccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence 21 1222345689999999877776 89999999999999998 99999998888887777655 3455667899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 022444 237 SLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~ 258 (297)
+++.+||+.||++|||++++++
T Consensus 281 ~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 281 QLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=321.41 Aligned_cols=253 Identities=22% Similarity=0.360 Sum_probs=210.7
Q ss_pred ccceEEeEEeccCCceeEEEEEe-----CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQN-----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 79 (297)
.++|++.+.||+|++|.||++.+ ..++..|++|.+.... .....+.+.+|+.+++++ .||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 36899999999999999999997 3467789999997543 223356788999999999 899999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHG-----------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPE 136 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~ 136 (297)
+..+++|||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 99999999999999999997643 2789999999999999999999999999999999
Q ss_pred CeeecCCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022444 137 NLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (297)
Q Consensus 137 nIli~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~ 213 (297)
||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||.....
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999999999876543322 22334467789999999877766 99999999999999998 9999987764
Q ss_pred HHHHH-Hhhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 022444 214 TTLYS-KVEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEW 261 (297)
Q Consensus 214 ~~~~~-~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~ 261 (297)
..... .+... ....+..+|+++.+++.+||+.||.+|||+.+++++..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 281 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 44333 33322 34456678999999999999999999999999998543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=308.28 Aligned_cols=246 Identities=18% Similarity=0.297 Sum_probs=212.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CeE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKI 82 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 82 (297)
..++|++.+.||+|++|.||++++. ++.+++|++...... ....+.+.+|+..++.++||||+++++++... ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 4678999999999999999999985 788999999765422 23356788999999999999999999999876 788
Q ss_pred EEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 83 YIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
+++|||+++++|.+++.... .+++..++.++.+++.||.|||+.| ++|+||+|+||+++.++.++++||+.+....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999999998765 4899999999999999999999999 9999999999999999999999888765433
Q ss_pred CCccccccccCCccccCCccccccCCCC--CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--cccCCCCCChh
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNG--AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTWFPVG 234 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 234 (297)
. ....+++.|+|||.+.+..... .++||||||+++|+|++|..||...+.......+... ....+..+|++
T Consensus 165 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 S-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp C-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred c-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2 2446788999999997654442 3799999999999999999999988887776665544 34566779999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.+++.+||+.||++|||++++++
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=315.90 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=217.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|++|.||+|.++ .+++.|++|.+.... .......+.+|+.+++.+.|+||+++++++....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 468999999999999999999876 357889999987543 2233556889999999999999999999999889
Q ss_pred eEEEEEcccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcc
Q 022444 81 KIYIILEFITGGELFDKIVHH----------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~d 150 (297)
..+++||++.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECc
Confidence 999999999999999998753 3578999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-cc
Q 022444 151 FGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FS 226 (297)
Q Consensus 151 f~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~ 226 (297)
||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+.... ..
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 260 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCC
Confidence 999875543322 12233457789999999877766 99999999999999999 899999988888877776654 35
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.+..+|..+.+++.+||+.||.+|||+.+++++
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 261 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 567799999999999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=321.59 Aligned_cols=250 Identities=23% Similarity=0.406 Sum_probs=211.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcE----EEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
.++|++.+.||+|+||.||+|.+..+++. +++|.+.... .......+.+|+..++.++|+||+++++++. ...
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 46899999999999999999999888776 6777664332 1122345668899999999999999999885 466
Q ss_pred EEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.++|+||+.+++|.+++... +.+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 89999999999999999764 57999999999999999999999999999999999999999999999999999765433
Q ss_pred cc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHH
Q 022444 161 VS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAK 236 (297)
Q Consensus 161 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~ 236 (297)
.. ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...........+... ....+..++.++.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY 247 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTT
T ss_pred cccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHH
Confidence 22 22344567789999999877766 99999999999999999 99999988877777777665 3456677899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcC
Q 022444 237 SLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~ 259 (297)
+++.+||+.||.+|||+.+++++
T Consensus 248 ~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 248 MVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=315.86 Aligned_cols=250 Identities=24% Similarity=0.412 Sum_probs=211.8
Q ss_pred ccceEEeEEeccCCceeEEEEEe-----CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQN-----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 79 (297)
.++|++.+.||+|+||.||++.+ ..+++.|++|.+.... .....+.+.+|+..++.+ +||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 36899999999999999999985 4578899999997543 223356788999999999 899999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec
Q 022444 80 TKIYIILEFITGGELFDKIVHHG------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~ 141 (297)
+..+++||++++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 99999999999999999997654 489999999999999999999999999999999999999
Q ss_pred CCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022444 142 SQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYS 218 (297)
Q Consensus 142 ~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~ 218 (297)
.++.++|+|||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||..........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 999999999999876654322 12234456789999999877766 99999999999999998 999998766443333
Q ss_pred H-hhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 219 K-VEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 219 ~-i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
. +... ....+..+|.++.+++.+||+.||.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3 2222 23445668999999999999999999999999988
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=309.97 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=215.3
Q ss_pred cccceEEeE-EeccCCceeEEEEEeC--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGR-TIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~-~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..++|.+.+ .||+|++|.||++.+. .++..|++|++.... .....+.+.+|+..++.++||||+++++++ ..+.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 456788887 9999999999999864 467889999997643 234467788999999999999999999998 4567
Q ss_pred EEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.+++||++.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 89999999999999998643 46999999999999999999999999999999999999999999999999998765433
Q ss_pred cc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhH
Q 022444 161 VS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGA 235 (297)
Q Consensus 161 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l 235 (297)
.. ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+.... ...+..+|+++
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHH
Confidence 22 12233457889999999776665 89999999999999998 999999888887777776654 45677899999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDE 260 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p 260 (297)
.+++.+||+.+|++|||+.+++++.
T Consensus 243 ~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 243 YALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.05 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=209.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCC----cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETG----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..+|++.+.||+|++|.||+|.++.++ ..|++|.+.... .......+.+|+.+++.++|+||+++++++.....
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 357999999999999999999987543 459999987543 23335568899999999999999999999999899
Q ss_pred EEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.++|||++.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999999764 57999999999999999999999999999999999999999999999999998765433
Q ss_pred ccc---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhH
Q 022444 161 VSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGA 235 (297)
Q Consensus 161 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l 235 (297)
... .....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+..+.+... ..+.+..+|+.+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 279 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred cccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHH
Confidence 221 1223456789999999877766 89999999999999999 99999998888887777665 455667799999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 022444 236 KSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+++.+||+.+|++|||+.++++
T Consensus 280 ~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 280 YQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999988
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=307.69 Aligned_cols=248 Identities=24% Similarity=0.416 Sum_probs=206.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHH----HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM----ADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
.++|++.+.||+|++|.||++++..+++.|++|++.......... .+.+.+|+.+++.++|+||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468999999999999999999999999999999986544322211 267889999999999999999999986655
Q ss_pred EEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeecCCCC-----EEEcccCC
Q 022444 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGH-----LKISDFGL 153 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~~~~~-----~~l~df~~ 153 (297)
+++|||+++++|.+.+... ..+++..++.++.+++.||.|||+.| ++|+||+|+||+++.++. ++|+|||.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 6999999999998888654 46999999999999999999999999 999999999999988776 99999999
Q ss_pred CCCCCCCccccccccCCccccCCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhhhc--cccCC
Q 022444 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELDLTTL--YSKVEKA--DFSCP 228 (297)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~--~~~i~~~--~~~~~ 228 (297)
+...... .....+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||........ ...+... ....+
T Consensus 176 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 4f0f_A 176 SQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252 (287)
T ss_dssp CBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC
T ss_pred ccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC
Confidence 8754432 33456889999999984322 224899999999999999999999977653332 3333332 34566
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
..+|+++.+++.+||+.||.+|||++++++
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 778999999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=318.19 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=207.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEE----EEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESV----AMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~----~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
+.++|++.+.||+|+||.||+|++..+++.+ ++|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3568999999999999999999998777655 677665432 2334567889999999999999999999997654
Q ss_pred eEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
.+++++++.+++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 7889999999999999976 45699999999999999999999999999999999999999999999999999865433
Q ss_pred Ccc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhH
Q 022444 160 GVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGA 235 (297)
Q Consensus 160 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l 235 (297)
... ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+.... .+.+..++.++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred CcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 222 22234457789999999887776 99999999999999999 999999888777777665553 45667789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 236 KSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.+++.+||+.+|++|||+.+++++
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=318.87 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=214.0
Q ss_pred ccceEEeEEeccCCceeEEEEE-----eCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|++|.||+++ +..++..|++|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 4689999999999999999999 55678899999996543 2233456888999999999999999999999888
Q ss_pred eEEEEEcccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---CCCEEEcc
Q 022444 81 KIYIILEFITGGELFDKIVHHG-------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISD 150 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~~~~~l~d 150 (297)
..+++|||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++. +..++|+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999999998653 4899999999999999999999999999999999999984 44699999
Q ss_pred cCCCCCCCCCc--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-cc
Q 022444 151 FGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FS 226 (297)
Q Consensus 151 f~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~ 226 (297)
||.+....... .......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...........+.... ..
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 265 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence 99876432221 122344567899999999877766 99999999999999998 999999888888777776653 45
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+..+|..+.+++.+||+.||.+|||+.++++++|.-..
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 566799999999999999999999999999999886554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=312.48 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=206.1
Q ss_pred cceEEeEEeccCCceeEEEEE----eCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--C
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--T 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (297)
.+|++.+.||+|++|.||+++ +..+++.|++|++.... .....+.+.+|+.+++.++|+||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 469999999999999999999 56789999999997554 233456788999999999999999999999766 6
Q ss_pred eEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
..+++|||+++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 78999999999999999954 45799999999999999999999999999999999999999999999999999876554
Q ss_pred Ccc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHhh
Q 022444 160 GVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL---------------DLTTLYSKVE 221 (297)
Q Consensus 160 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~---------------~~~~~~~~i~ 221 (297)
... ......++..|+|||.+.+..++ .++||||||+++|+|++|..|+... ........+.
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 322 23344567789999999877766 8999999999999999999886322 1112222222
Q ss_pred h-ccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 222 K-ADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 222 ~-~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
. ...+.+..+|+++.+++.+||+.||.+|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2 234566779999999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=311.99 Aligned_cols=272 Identities=22% Similarity=0.303 Sum_probs=213.6
Q ss_pred CccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEE-EEEcC
Q 022444 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE-VLASR 79 (297)
Q Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~ 79 (297)
|-.+..++|++.+.||+|++|.||++++..+++.|++|++..... ...+.+|+.+++.+.|++++..+. ++...
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 344566899999999999999999999999999999998765432 234678899999998876655544 45677
Q ss_pred CeEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee---cCCCCEEEcccCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSA 155 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli---~~~~~~~l~df~~~~ 155 (297)
...+++||++ +++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 8899999999 8899999874 4579999999999999999999999999999999999999 788999999999987
Q ss_pred CCCCCcc-------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhhhccc
Q 022444 156 LPEQGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT---TLYSKVEKADF 225 (297)
Q Consensus 156 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---~~~~~i~~~~~ 225 (297)
....... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.. .....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 5543322 22345688999999999887766 9999999999999999999999764322 22233322222
Q ss_pred cC-----CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCccc
Q 022444 226 SC-----PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDD 281 (297)
Q Consensus 226 ~~-----~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~~ 281 (297)
.. ...+|+++.+++.+||+.||++|||+.++++ .|++........-..+++|+.
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHHHHHHTCCTTCCCGGGG
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH--HHHHHHHHhCCCccCccchhh
Confidence 22 2568999999999999999999999999998 777776666665556666654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=307.55 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=210.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCC---CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTE---TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..++|++.+.||+|++|.||++.+.. ++..|++|.+.... .....+.+.+|+..++.++||||+++++++.+ +.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 35789999999999999999998653 34569999987653 22335678899999999999999999999865 45
Q ss_pred EEEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.+++||++.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 689999999999999997654 5999999999999999999999999999999999999999999999999998765443
Q ss_pred cc-ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHH
Q 022444 161 VS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKS 237 (297)
Q Consensus 161 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~ 237 (297)
.. ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||......+....+... ..+.+..+|+.+.+
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 245 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT 245 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 22 22334567789999999877766 99999999999999998 99999887777766666554 34566779999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcC
Q 022444 238 LIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~ 259 (297)
++.+||+.||++|||+.+++++
T Consensus 246 li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 246 LMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999873
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=315.87 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=207.8
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEE----EEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESV----AMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~----~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
+.++|++++.||+|+||.||++.+..+++.+ ++|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3578999999999999999999998887765 566554322 2234567889999999999999999999997654
Q ss_pred eEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
.+++++++.+++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 7899999999999999976 45699999999999999999999999999999999999999999999999999976543
Q ss_pred Ccc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhH
Q 022444 160 GVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGA 235 (297)
Q Consensus 160 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l 235 (297)
... ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+.... .+.+..++.++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred ccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 322 22234456789999999887776 99999999999999999 999999988887777766554 56667799999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 022444 236 KSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+++.+||+.||.+|||+.++++
T Consensus 249 ~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 249 YMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=326.31 Aligned_cols=243 Identities=27% Similarity=0.500 Sum_probs=211.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-eEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-KIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 83 (297)
..++|++.+.||+|+||.||++.++ ++.||||++.... ..+.+.+|+.++++++||||+++++++.... ..+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 3568999999999999999999985 6799999997543 2456889999999999999999999986654 799
Q ss_pred EEEcccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 84 IILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+||||+++++|.+++...+. +++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999999999987654 7999999999999999999999999999999999999999999999999987543321
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLI 239 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li 239 (297)
....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+..+ ..+.+..+|+++.+++
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 419 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM 419 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ---cCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 223567789999999887776 99999999999999998 99999988877777776655 4566778999999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 022444 240 HRILDPNPETRITIEEIRN 258 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~ 258 (297)
.+||+.||.+|||+.++++
T Consensus 420 ~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 420 KNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 9999999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=312.75 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=204.8
Q ss_pred cccceEEeEEeccCCceeEEEEEeCC---CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTE---TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT- 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 80 (297)
..++|++.+.||+|++|.||+|.+.. ++..|++|.+..... .....+.+.+|+..++.++||||+++++++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34689999999999999999998764 456899999875432 2233567889999999999999999999987654
Q ss_pred ----eEEEEEcccCCCChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcc
Q 022444 81 ----KIYIILEFITGGELFDKIV------HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (297)
Q Consensus 81 ----~~~lv~e~~~~~~L~~~l~------~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~d 150 (297)
..++++|++.+++|.+++. ....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 3599999999999999984 335699999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-ccc
Q 022444 151 FGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFS 226 (297)
Q Consensus 151 f~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~ 226 (297)
||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...........+... ...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 269 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK 269 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence 999876543321 22334567789999999877766 99999999999999999 99999988877777766555 345
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+..+++++.+++.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 270 QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 66779999999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=306.03 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=211.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.-+|++.+.||+|+||.||+|.+..++. .+++|.+.... .....+.+.+|+.+++.++|+||+++++++...+..
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 3467888999999999999999765444 79999986533 333457788999999999999999999999766554
Q ss_pred -EEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 83 -YIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 83 -~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
++++|++.+++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999999986 456899999999999999999999999999999999999999999999999998755432
Q ss_pred c----cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChh
Q 022444 161 V----SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVG 234 (297)
Q Consensus 161 ~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 234 (297)
. .......+++.|+|||.+.+..++ .++||||||+++|+|++ +.+||...+..+....+.... .+.+..+|++
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDS 256 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHH
Confidence 1 222344567899999999877776 99999999999999999 566677777777666665554 4566778999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.+++.+||+.||.+|||++++++
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=331.99 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=219.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
..+|++.+.||+|+||.||++.++.++..|+||.+.... ...+.+.+|+.+++.++||||+++++++......++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 457999999999999999999999889999999997543 1246688999999999999999999999988899999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
|||+.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999999864 3589999999999999999999999999999999999999999999999999876543322
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+..+.+... ....+..+|+++.+|+.
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 453 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 453 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 22334456789999999877666 89999999999999999 99999998887777766554 34567779999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccC
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+||+.||++|||+.++++ .|+..
T Consensus 454 ~cl~~dP~~RPs~~el~~--~L~~~ 476 (495)
T 1opk_A 454 ACWQWNPSDRPSFAEIHQ--AFETM 476 (495)
T ss_dssp HHTCSSGGGSCCHHHHHH--HHHTS
T ss_pred HHcCcChhHCcCHHHHHH--HHHHH
Confidence 999999999999999987 45444
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=321.21 Aligned_cols=274 Identities=15% Similarity=0.181 Sum_probs=211.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCC-----CcEEEEEEeecchhhhHHHH--------HHHHHHHHHHHhcCCCCeeEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTET-----GESVAMKVLDRSAIIKHKMA--------DQIKREISIMKLVRHPCVVRL 72 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~ 72 (297)
.++|++.+.||+|+||.||++.++.+ ++.|++|++........... .....++..++.+.|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34899999999999999999998764 58899999875432111111 123345666778889999999
Q ss_pred EEEEEcC----CeEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec--CCCC
Q 022444 73 HEVLASR----TKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD--SQGH 145 (297)
Q Consensus 73 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~--~~~~ 145 (297)
++++... ...+++|||+ +++|.+++... ..+++..++.++.+++.||.|||+.||+|+||||+||+++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998653 4589999999 88999999875 5799999999999999999999999999999999999999 8899
Q ss_pred EEEcccCCCCCCCCCccc-------cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Q 022444 146 LKISDFGLSALPEQGVSL-------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT-LY 217 (297)
Q Consensus 146 ~~l~df~~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-~~ 217 (297)
++|+|||++......... .....+++.|+|||.+.+..++ .++||||||+++|+|++|..||....... ..
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999999654432111 1234489999999999887776 99999999999999999999997532221 11
Q ss_pred HHhhhc---c-------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCccccc
Q 022444 218 SKVEKA---D-------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVN 283 (297)
Q Consensus 218 ~~i~~~---~-------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (297)
...... . ......+|+++.+++..||+.+|.+|||+.++++ .|++............++|...+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~--~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD--ILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHHHHTTCCCCCCCCC----
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH--HHHHHHHHcCCCcCCccceEecc
Confidence 111100 0 0112568999999999999999999999999988 77777766666666777776544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=305.29 Aligned_cols=246 Identities=25% Similarity=0.433 Sum_probs=212.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|++|.||++.+. ++..+++|.+..... ..+.+.+|+..++.++|+||+++++++. .+..+++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 468999999999999999999976 567899999865431 2456789999999999999999999985 4568999
Q ss_pred EcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 86 LEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
||++.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999999997543 699999999999999999999999999999999999999999999999999876544322
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+..+.+... ....+..+|+++.+++.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 244 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHH
Confidence 22334456789999999766665 89999999999999999 99999998888877777655 34456678999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+||+.||++|||+.++++
T Consensus 245 ~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 245 LCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHhccChhhCCCHHHHHH
Confidence 999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=305.92 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=210.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-------
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------- 78 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 78 (297)
..+|++.+.||+|++|.||++.+..+++.|++|.+.... ..+.+|+..++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 367999999999999999999999999999999997543 235678999999999999999998754
Q ss_pred ---------CCeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEE
Q 022444 79 ---------RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (297)
Q Consensus 79 ---------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~ 147 (297)
....+++|||+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 34589999999999999999754 5799999999999999999999999999999999999999999999
Q ss_pred EcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccC
Q 022444 148 ISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC 227 (297)
Q Consensus 148 l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 227 (297)
|+|||.+....... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..|+.. .......+... ..
T Consensus 163 l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~--~~ 236 (284)
T 2a19_B 163 IGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDG--II 236 (284)
T ss_dssp ECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTT--CC
T ss_pred ECcchhheeccccc-cccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhcc--cc
Confidence 99999987654432 22345688999999999877766 999999999999999999988742 22333333332 34
Q ss_pred CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 228 PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 228 ~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+..+|..+.+++.+||+.||.+|||+.+++++++.-+.
T Consensus 237 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 56689999999999999999999999999998876554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=311.74 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=211.1
Q ss_pred ccceEEeEEeccCCceeEEEEEe-----CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQN-----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 79 (297)
.++|++.+.||+|+||.||++.+ ..+++.|++|++.... .......+.+|+..++.+ .||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 46899999999999999999985 4577899999997643 223356788999999999 689999999998765
Q ss_pred C-eEEEEEcccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC
Q 022444 80 T-KIYIILEFITGGELFDKIVHHGR----------------LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS 142 (297)
Q Consensus 80 ~-~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~ 142 (297)
+ ..+++|||+++++|.+++..... +++..++.++.+++.||.|||+.|++|+||+|+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 4 58999999999999999987554 899999999999999999999999999999999999999
Q ss_pred CCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHH
Q 022444 143 QGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT-TLYS 218 (297)
Q Consensus 143 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~-~~~~ 218 (297)
++.++|+|||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...... ....
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 99999999999876543322 22334567789999999877766 99999999999999998 99999876533 3334
Q ss_pred Hhhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 219 KVEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 219 ~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.+... ....+..+++++.+++.+||+.||.+|||+.++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44333 345567789999999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=314.91 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=210.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCc-----EEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE-----SVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 79 (297)
.++|++.+.||+|+||.||++.+..+++ .+++|.+.... .....+.+.+|+.+++.+ .||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 3579999999999999999999876654 79999987543 223356788999999999 899999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHH--------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~ 145 (297)
...+++|||+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence 9999999999999999998753 35799999999999999999999999999999999999999999
Q ss_pred EEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhh
Q 022444 146 LKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEK 222 (297)
Q Consensus 146 ~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~ 222 (297)
++|+|||.+........ ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...........+..
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 99999999876543222 12233456789999999877766 99999999999999998 9999987654443333322
Q ss_pred c--cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 223 A--DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 223 ~--~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
. ....+..+|+.+.+++.+||+.||.+|||+.++++
T Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 282 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 2 23446668999999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=306.01 Aligned_cols=243 Identities=26% Similarity=0.493 Sum_probs=204.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-CeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-TKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 83 (297)
..++|++.+.||+|++|.||++.++ |+.+++|.+.... ..+.+.+|+..++.++|+||+++++++... ...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 4578999999999999999999875 7899999987543 245688999999999999999999987544 4789
Q ss_pred EEEcccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 84 IILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
++||++++++|.+++..... +++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999999999976543 8999999999999999999999999999999999999999999999999887554322
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLI 239 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li 239 (297)
....++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+... ....+..+|+.+.+++
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred ---cCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence 233567789999999877766 99999999999999998 99999988877777776555 3456677999999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 022444 240 HRILDPNPETRITIEEIRN 258 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~ 258 (297)
.+||+.||++|||+.++++
T Consensus 248 ~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 248 KNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCChhhCCCHHHHHH
Confidence 9999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=311.48 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=203.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE----cCC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA----SRT 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~ 80 (297)
..++|++.+.||+|++|.||++.+..+++.|++|++.... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 4568999999999999999999999999999999986543 234567889999999999999999999886 345
Q ss_pred eEEEEEcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~ 156 (297)
..++++||+.+++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999999999998875 46799999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccc---------cccccCCccccCCccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhh-h
Q 022444 157 PEQGVSL---------LRTTCGTPNYVAPEVLSHKGY--NGAAADVWSCGVILYVLIAGYLPFDELDL--TTLYSKVE-K 222 (297)
Q Consensus 157 ~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~ll~g~~pf~~~~~--~~~~~~i~-~ 222 (297)
....... .....+++.|+|||.+.+... .+.++||||||+++|+|++|..||..... ......+. .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 4321111 123346889999999865432 24899999999999999999999953210 01111111 2
Q ss_pred ccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 223 ADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 223 ~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
...+.+..++.++.+++.+||+.||.+|||+++++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2234445689999999999999999999999999984
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=325.19 Aligned_cols=246 Identities=25% Similarity=0.454 Sum_probs=213.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||++.++ ++..||||++.... ...+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 467999999999999999999986 46789999997543 22567889999999999999999999985 5678999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
|||+.+++|.+++... ..++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999999999754 3689999999999999999999999999999999999999999999999999976543221
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+..+ ..+.+..+|+++.+++.
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 419 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 419 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred ccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 12233456789999999877766 99999999999999999 99999999888887777655 44567779999999999
Q ss_pred HhcCCCcCCCCCHHHHhc
Q 022444 241 RILDPNPETRITIEEIRN 258 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~ 258 (297)
+||+.||++|||++++++
T Consensus 420 ~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 420 RCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHccCChhHCcCHHHHHH
Confidence 999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=308.57 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=206.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCC-CCc--EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTE-TGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~--~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..++|++.+.||+|++|+||++++.. +++ .|++|.+...........+.+.+|+..++.++|+||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 34689999999999999999998643 333 68999987655445556678899999999999999999999987654
Q ss_pred EEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.++++|++.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 88999999999999998764 56999999999999999999999999999999999999999999999999998765433
Q ss_pred cc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc--ccCCCCCChh
Q 022444 161 VS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD--FSCPTWFPVG 234 (297)
Q Consensus 161 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 234 (297)
.. ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+.......+.... .+.+..+|.+
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence 22 12234466789999999876665 89999999999999999 999999998888887776553 3455678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
+.+++.+||+.||.+|||+.++++ +|++
T Consensus 254 l~~li~~~l~~~p~~Rps~~~l~~--~l~~ 281 (291)
T 1u46_A 254 IYNVMVQCWAHKPEDRPTFVALRD--FLLE 281 (291)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHH--HHHH
Confidence 999999999999999999999998 5544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=312.65 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=208.8
Q ss_pred ccceEEeEEeccCCceeEEEEE----eCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE--cC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA--SR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~ 79 (297)
..+|++.+.||+|++|.||+++ +..+++.|++|++.... ....+.+.+|+.+++.++|+||+++++++. ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 3589999999999999999999 56789999999997653 233466889999999999999999999886 45
Q ss_pred CeEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
...++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 678999999999999999976 4569999999999999999999999999999999999999999999999999987654
Q ss_pred CCcc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHh
Q 022444 159 QGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT---------------TLYSKV 220 (297)
Q Consensus 159 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---------------~~~~~i 220 (297)
.... ......++..|+|||.+.+..++ .++||||||+++|+|++|..||...... .....+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 3322 22334567789999999877665 8999999999999999999998544321 222222
Q ss_pred hh-ccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 221 EK-ADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 221 ~~-~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.. ...+.+..+|+++.+++.+||+.||++|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22 234566779999999999999999999999999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=315.41 Aligned_cols=255 Identities=16% Similarity=0.181 Sum_probs=201.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCC---CCcEEEEEEeecchhhhHH--------HHHHHHHHHHHHHhcCCCCeeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE---TGESVAMKVLDRSAIIKHK--------MADQIKREISIMKLVRHPCVVRLHEV 75 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (297)
++|++.+.||+|+||.||+|.+.. ++..+++|+.......... ....+.+++..++.+.|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 7889999998754321111 11235578888999999999999999
Q ss_pred EEc----CCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC--CEEEc
Q 022444 76 LAS----RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG--HLKIS 149 (297)
Q Consensus 76 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~--~~~l~ 149 (297)
+.. ....+++||++ +++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 877 67899999999 889999998877999999999999999999999999999999999999998877 99999
Q ss_pred ccCCCCCCCCCc-------cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHh
Q 022444 150 DFGLSALPEQGV-------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL--DLTTLYSKV 220 (297)
Q Consensus 150 df~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~--~~~~~~~~i 220 (297)
|||.+....... .......++..|+|||.+.+..++ .++||||||+++|+|++|..||... +........
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 274 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence 999996553321 112345788999999999877666 9999999999999999999999542 222222221
Q ss_pred hhccccCC---------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 221 EKADFSCP---------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 221 ~~~~~~~~---------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.......+ ..+|+++.+++.+||+.||++|||++++++ .|++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~~ 326 (345)
T 2v62_A 275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK--ILNPH 326 (345)
T ss_dssp HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHCTT
T ss_pred HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH--HHhcc
Confidence 11111111 268999999999999999999999999988 55554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=306.41 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=208.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEE-EcCC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVL-ASRT 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 80 (297)
...+|++.+.||+|+||.||+|.+..+ ...+++|.+.... .....+.+.+|+.++++++||||+++++++ ....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 345799999999999999999997543 3458888886533 334457788999999999999999999986 4556
Q ss_pred eEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
..+++||++.+++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 78999999999999999976 34589999999999999999999999999999999999999999999999999876543
Q ss_pred Ccc----ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCCh
Q 022444 160 GVS----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPV 233 (297)
Q Consensus 160 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 233 (297)
... ......+++.|+|||.+.+..++ .++||||||+++|+|++ |.+||...+..+....+.... ...+..+|+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence 321 22334566789999999877776 99999999999999999 777887777666666555554 344667899
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+.+++.+||+.+|++|||++++++
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999987
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=323.37 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=210.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||++.++. +..||||++..... ..+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 4579999999999999999999875 46799999875432 13567899999999999999999999865 678999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
|||+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999999743 4699999999999999999999999999999999999999999999999999976543222
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
......++..|+|||.+.+..++ .++||||||+++|+|++ |..||......+....+..+ ..+.+..+|+.+.+++.
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 415 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 415 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 22234456789999999877766 99999999999999999 99999998888887777655 45667789999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccC
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+||+.||++|||++++++ .+++.
T Consensus 416 ~cl~~dP~~Rpt~~~l~~--~L~~~ 438 (452)
T 1fmk_A 416 QCWRKEPEERPTFEYLQA--FLEDY 438 (452)
T ss_dssp HHTCSSGGGSCCHHHHHH--HHHTT
T ss_pred HHccCChhhCcCHHHHHH--HHHHH
Confidence 999999999999999987 44443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=305.26 Aligned_cols=247 Identities=26% Similarity=0.471 Sum_probs=195.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||++++.. .+++|++..... .....+.+.+|+..++.++|+||++++++. .....+++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 4689999999999999999998753 499999875432 233457788999999999999999999965 55678999
Q ss_pred EcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC--Ccc
Q 022444 86 LEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~--~~~ 162 (297)
|||+.+++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..... ...
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 999999999999854 45699999999999999999999999999999999999999999999999999875442 122
Q ss_pred ccccccCCccccCCcccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhhcccc-----CCCCCCh
Q 022444 163 LLRTTCGTPNYVAPEVLS---HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEKADFS-----CPTWFPV 233 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~~~~~-----~~~~~~~ 233 (297)
......+++.|+|||.+. +..++ .++||||||+++|+|++|..||...... ...+.+...... ....+|+
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSC-HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCH
T ss_pred cccccCCCccccCchhhcccCCCCCC-cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCH
Confidence 233456889999999986 33443 7999999999999999999999875543 344444433322 2345889
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+++.+||+.+|++|||+.++++
T Consensus 257 ~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 257 RMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=317.03 Aligned_cols=264 Identities=13% Similarity=0.176 Sum_probs=214.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCC--------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeE------
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTE--------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR------ 71 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~------ 71 (297)
-++|++.+.||+|++|.||++++.. +++.||+|.+... ..+.+|+.+++.++|+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3689999999999999999999987 4889999998653 34668888899999988876
Q ss_pred ---------EEEEEEc-CCeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCee
Q 022444 72 ---------LHEVLAS-RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLL 139 (297)
Q Consensus 72 ---------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIl 139 (297)
+++++.. ....+++|||+ +++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6677765 67899999999 89999999876 68999999999999999999999999999999999999
Q ss_pred ecCCC--CEEEcccCCCCCCCCCcc-------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022444 140 LDSQG--HLKISDFGLSALPEQGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (297)
Q Consensus 140 i~~~~--~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~ 210 (297)
++.++ .++|+|||++........ ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 899999999976543322 12334788999999999887766 999999999999999999999977
Q ss_pred CC--HHHHHHHhh---hccccCC------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCc
Q 022444 211 LD--LTTLYSKVE---KADFSCP------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNL 279 (297)
Q Consensus 211 ~~--~~~~~~~i~---~~~~~~~------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~ 279 (297)
.. ......... ....... ..+|+++.+++.+||+.||++|||++++++ .|++...........+++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~~~~~~~~~~~~~~dw 348 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN--NLEALLQDLRVSPYDPIGL 348 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHHHHTTCCTTSCCCC
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH--HHHHHHHhcCCCcCccccC
Confidence 53 333322222 1112111 246899999999999999999999999988 6777766666666666666
Q ss_pred cc
Q 022444 280 DD 281 (297)
Q Consensus 280 ~~ 281 (297)
..
T Consensus 349 ~~ 350 (352)
T 2jii_A 349 PM 350 (352)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=303.98 Aligned_cols=232 Identities=32% Similarity=0.586 Sum_probs=190.8
Q ss_pred cccceEEe-EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHH-HhcCCCCeeEEEEEEEc----
Q 022444 5 KVGKYEVG-RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVRLHEVLAS---- 78 (297)
Q Consensus 5 ~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~---- 78 (297)
..++|.+. +.||+|++|.||++.++.+++.||+|++... ....+|+..+ +...|+||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 45789988 7899999999999999999999999998643 2344666666 56689999999999876
Q ss_pred CCeEEEEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---CCCEEEcccCC
Q 022444 79 RTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGL 153 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~~~~~l~df~~ 153 (297)
....+++|||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++. ++.++|+|||.
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 677899999999999999998754 6999999999999999999999999999999999999998 78899999998
Q ss_pred CCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh----hhccccCC-
Q 022444 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV----EKADFSCP- 228 (297)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i----~~~~~~~~- 228 (297)
+..... ..+ +.++||||||+++|+|++|..||...+.......+ .......+
T Consensus 167 a~~~~~----------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 167 AKETTG----------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp CEECTT----------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred cccccc----------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 753321 222 38999999999999999999999776554433222 22222233
Q ss_pred ---CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 229 ---TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 229 ---~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
..+++++.+++.+||+.||.+|||++++++||||++...
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 458999999999999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=310.41 Aligned_cols=246 Identities=24% Similarity=0.245 Sum_probs=197.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----e
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----K 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 81 (297)
.++|++.+.||+|+||.||++++. ++.||||++.... ........|+..++.++||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 468999999999999999999886 7899999996543 22334556888899999999999999987633 4
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCEEecCCCCCeeecCCCCEEEccc
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK----------GVYHRDLKPENLLLDSQGHLKISDF 151 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~----------~i~h~di~~~nIli~~~~~~~l~df 151 (297)
+++||||+++++|.+++.. ..+++..++.++.+++.||.|||+. |++|+||||+||+++.++.++|+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 7999999999999999976 4699999999999999999999999 9999999999999999999999999
Q ss_pred CCCCCCCCCcc--ccccccCCccccCCccccccCCC----CCchhHHHHHHHHHHHHhCCCCCCCCC-------------
Q 022444 152 GLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYN----GAAADVWSCGVILYVLIAGYLPFDELD------------- 212 (297)
Q Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~----~~~~Di~slG~ll~~ll~g~~pf~~~~------------- 212 (297)
|.+........ ......+++.|+|||.+.+.... +.++||||||+++|+|++|+.||....
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99865443222 23345789999999998763221 367899999999999999999996532
Q ss_pred ---HHHHHHHhhhcccc--CCC-----CCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 213 ---LTTLYSKVEKADFS--CPT-----WFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 213 ---~~~~~~~i~~~~~~--~~~-----~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.......+...... .+. ..++++.+++.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22333332222211 111 12345999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=316.58 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=205.9
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
+..++|++.+.||+|+||.||++.++ +++.|++|.+.... ....+.+.+|+..++.++||||+++++++......+
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 45678999999999999999999965 68999999886543 233567889999999999999999999999889999
Q ss_pred EEEcccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 84 IILEFITGGELFDKIVHHG----RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
++|||+.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999986543 589999999999999999999999999999999999999999999999999875432
Q ss_pred Cc--cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHhhhcc------
Q 022444 160 GV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY-------SKVEKAD------ 224 (297)
Q Consensus 160 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~-------~~i~~~~------ 224 (297)
.. .......+++.|+|||.+.+..++ .++||||||+++|+|++|+.||......+.. .......
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 21 122334578899999999877766 9999999999999999999999654322111 0111110
Q ss_pred c----cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 022444 225 F----SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDE 260 (297)
Q Consensus 225 ~----~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p 260 (297)
. ..+..++..+.+++.+||+.||++|||+.+++++.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0 11122456789999999999999999999999853
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=309.08 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=206.7
Q ss_pred cce-EEeEEeccCCceeEEEEEe----CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--C
Q 022444 7 GKY-EVGRTIGEGTFAKVKFAQN----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--R 79 (297)
Q Consensus 7 ~~y-~~~~~lg~g~~~~v~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (297)
++| ++++.||+|+||.||++.. ..+++.|++|++.... .....+.+.+|+.+++.++|+||+++++++.. .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 455 9999999999999988753 4578999999997653 23345678899999999999999999999976 4
Q ss_pred CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
...+++|||+++++|.+++.+. ++++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 6789999999999999998764 599999999999999999999999999999999999999999999999999876554
Q ss_pred Ccc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHhh
Q 022444 160 GVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT---------------TLYSKVE 221 (297)
Q Consensus 160 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---------------~~~~~i~ 221 (297)
... ......++..|+|||.+.+..++ .++||||||+++|+|++|..||...... ...+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 322 22344567789999999877666 8999999999999999999999654221 1122222
Q ss_pred h-ccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 222 K-ADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 222 ~-~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
. ...+.+..+|+++.+++.+||+.||++|||+.++++ +|+.
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~ 307 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKT 307 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHH
Confidence 2 234566779999999999999999999999999986 4443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=321.07 Aligned_cols=249 Identities=26% Similarity=0.441 Sum_probs=204.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--eEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--KIY 83 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 83 (297)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 4679999999999999999999999999999999975442 223566778999999999999999999987654 789
Q ss_pred EEEcccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee----cCCCCEEEcccCCCCC
Q 022444 84 IILEFITGGELFDKIVHHGR---LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSAL 156 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli----~~~~~~~l~df~~~~~ 156 (297)
+||||+++++|.+++..... +++..++.++.+++.||.|||+.|++|+||||+||++ +.++.++|+|||.+..
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999999976443 9999999999999999999999999999999999999 6777899999999876
Q ss_pred CCCCccccccccCCccccCCccccc--------cCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHhhhcc
Q 022444 157 PEQGVSLLRTTCGTPNYVAPEVLSH--------KGYNGAAADVWSCGVILYVLIAGYLPFDEL----DLTTLYSKVEKAD 224 (297)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~----~~~~~~~~i~~~~ 224 (297)
..... ......+++.|+|||.+.+ ..+ +.++||||||+++|+|++|..||... ...+...++..+.
T Consensus 166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCCC-ccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 55432 2334568999999999864 233 37899999999999999999999642 2233444443332
Q ss_pred cc---------------------CC----CCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 225 FS---------------------CP----TWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 225 ~~---------------------~~----~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+. .. ..+++.+.+++.+||++||++|||+.++++
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 11 11 123467889999999999999999999866
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=306.16 Aligned_cols=248 Identities=29% Similarity=0.413 Sum_probs=187.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEE--------
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLA-------- 77 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-------- 77 (297)
.+|++.+.||+|+||.||++++..+++.|++|++.... ......+.+|+..++++. |+||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 48999999999999999999999999999999986543 233466788999999996 999999999983
Q ss_pred cCCeEEEEEcccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeecCCCCEEEcccC
Q 022444 78 SRTKIYIILEFITGGELFDKIVH---HGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFG 152 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~~~~~~~l~df~ 152 (297)
.....++++|++. ++|.+++.. .+++++..++.++.+++.||.|||+.| ++|+||+|+||+++.++.++|+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 3446899999997 588888764 456999999999999999999999999 9999999999999999999999999
Q ss_pred CCCCCCCCccc------------cccccCCccccCCccc---cccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022444 153 LSALPEQGVSL------------LRTTCGTPNYVAPEVL---SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (297)
Q Consensus 153 ~~~~~~~~~~~------------~~~~~~~~~~~aPE~~---~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~ 217 (297)
.+......... .....+++.|+|||.+ .+..++ .++||||||+++|+|++|..||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSS-HHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC-hHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 98765543221 1134578899999998 344444 8999999999999999999999765544333
Q ss_pred HHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 022444 218 SKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEW 261 (297)
Q Consensus 218 ~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~ 261 (297)
... ...+.+...+..+.+|+.+||+.||.+|||+.+++++..
T Consensus 263 ~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 263 NGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 221 123445567889999999999999999999999999643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=302.68 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=194.2
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh--cCCCCeeEEEEEEEc--
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL--VRHPCVVRLHEVLAS-- 78 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~-- 78 (297)
....++|++.+.||+|+||.||++++ +++.||+|++.... ......|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567899999999999999999987 58899999986543 2334455555555 789999999998643
Q ss_pred --CCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCEEecCCCCCeeecCCCCEEE
Q 022444 79 --RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH--------SKGVYHRDLKPENLLLDSQGHLKI 148 (297)
Q Consensus 79 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh--------~~~i~h~di~~~nIli~~~~~~~l 148 (297)
....+++|||+++++|.+++.. ..+++..++.++.+++.||.||| +.|++|+||||+||+++.++.++|
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999964 57999999999999999999999 999999999999999999999999
Q ss_pred cccCCCCCCCCCccc----cccccCCccccCCccccccCCC-----CCchhHHHHHHHHHHHHhC----------CCCCC
Q 022444 149 SDFGLSALPEQGVSL----LRTTCGTPNYVAPEVLSHKGYN-----GAAADVWSCGVILYVLIAG----------YLPFD 209 (297)
Q Consensus 149 ~df~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~ll~~ll~g----------~~pf~ 209 (297)
+|||.+......... .....+++.|+|||.+.+.... +.++||||||+++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998654332221 2234789999999999765322 2689999999999999999 88885
Q ss_pred CCC-----HHHHHHHhhhcc--ccCC-----CCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 210 ELD-----LTTLYSKVEKAD--FSCP-----TWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 210 ~~~-----~~~~~~~i~~~~--~~~~-----~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
... .......+.... ...+ ..+++++.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 432 222222222111 1111 114467999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=316.01 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=191.5
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 85 (297)
+.|.+.+.||+|+||+||.+. ..+|+.||||.+.... .+.+.+|+.+++.+ +||||+++++++.+....+++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 356678899999999998654 4579999999986543 34567889999876 899999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC-------------CC
Q 022444 86 LEFITGGELFDKIVHHGRL-------SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-------------GH 145 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~-------------~~ 145 (297)
||+++ ++|.+++...... ++..++.++.|++.||.|||+.||+|+||||+||+++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99996 5999999865433 223457899999999999999999999999999999754 47
Q ss_pred EEEcccCCCCCCCCCccc----cccccCCccccCCcccccc------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022444 146 LKISDFGLSALPEQGVSL----LRTTCGTPNYVAPEVLSHK------GYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (297)
Q Consensus 146 ~~l~df~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~ 214 (297)
++|+|||++......... .....|++.|+|||++.+. ...+.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999998765543221 2345689999999998651 223589999999999999999 99999765443
Q ss_pred HHHHHhhhccccCCC-------CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 215 TLYSKVEKADFSCPT-------WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 215 ~~~~~i~~~~~~~~~-------~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
. ..+.......+. .+++++.+++.+||+.||++|||+.++++||||...
T Consensus 247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 3 222222222111 135789999999999999999999999999999754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=300.37 Aligned_cols=241 Identities=30% Similarity=0.475 Sum_probs=197.8
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|+||.||++++. ++.+++|.+.... ..+.+.+|+..+++++||||+++++++.+ ..++
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 4568999999999999999999885 6889999986432 24567899999999999999999998753 4789
Q ss_pred EEcccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCEEecCCCCCeeecCCCC-EEEcccCCCCCC
Q 022444 85 ILEFITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHS---KGVYHRDLKPENLLLDSQGH-LKISDFGLSALP 157 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~al~~Lh~---~~i~h~di~~~nIli~~~~~-~~l~df~~~~~~ 157 (297)
+|||+++++|.+++.... .++...++.++.++++||.|||+ .|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999999999998655 37899999999999999999999 89999999999999998886 799999998755
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhh-hccccCCCCCChh
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL--TTLYSKVE-KADFSCPTWFPVG 234 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~--~~~~~~i~-~~~~~~~~~~~~~ 234 (297)
... .....+++.|+|||.+.+..++ .++||||||+++|+|++|..||..... ......+. ....+.+..+|+.
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
T 2eva_A 157 QTH---MTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHH
T ss_pred ccc---cccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHH
Confidence 432 1234588999999999877766 999999999999999999999976432 22222222 2334556678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.+++.+||+.||++|||++++++
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999988
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=318.98 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=195.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 85 (297)
.+|.+.+.||+|++|+|+. ....+++.||||++..... ....+|+.+++.+ +||||+++++++.+....|++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3599999999999999764 4456789999999865331 2245789999999 799999999999999999999
Q ss_pred EcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---C--CCEEEcccCCCCCCCC
Q 022444 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---Q--GHLKISDFGLSALPEQ 159 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~--~~~~l~df~~~~~~~~ 159 (297)
||++.+ +|.+++.... ..++..++.++.|++.||.|||+.||+|+||||+||+++. + ..++|+|||++.....
T Consensus 97 ~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 999975 9999987654 4566677899999999999999999999999999999953 2 3588999999876553
Q ss_pred Cc---cccccccCCccccCCccccc---cCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhccccC---CC
Q 022444 160 GV---SLLRTTCGTPNYVAPEVLSH---KGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKADFSC---PT 229 (297)
Q Consensus 160 ~~---~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~---~~ 229 (297)
.. .......|++.|+|||++.+ ..+ +.++|||||||++|+|++ |..||...........+....... +.
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccc
Confidence 32 22344568999999999974 333 479999999999999999 999997655444333332222211 11
Q ss_pred CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 230 WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 230 ~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
..+..+.+|+.+||+.||++|||++++++||||....
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 2345688999999999999999999999999997643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=313.97 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=200.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE-cCCeE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-SRTKI 82 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 82 (297)
.+|++.+.||+|+||.||++.+..+ +..+++|.+.... .....+.+.+|+.+++.++||||+++++++. .....
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4689999999999999999997533 3468889886532 2334677889999999999999999999864 44578
Q ss_pred EEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+++|||+.+++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999999997653 58899999999999999999999999999999999999999999999999987553321
Q ss_pred c----ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhH
Q 022444 162 S----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGA 235 (297)
Q Consensus 162 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l 235 (297)
. ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+..+. ...+..+|+.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 1 12234566789999999877776 99999999999999999 788998776666555555543 34566799999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 022444 236 KSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+++.+||+.||++|||+.++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=336.48 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=207.8
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-----
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----- 78 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 78 (297)
...++|++.+.||+|+||.||++.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 45689999999999999999999999999999999987543 23345678899999999999999999998754
Q ss_pred -CCeEEEEEcccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC---EEEccc
Q 022444 79 -RTKIYIILEFITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDF 151 (297)
Q Consensus 79 -~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~---~~l~df 151 (297)
....++||||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 667899999999999999998754 5899999999999999999999999999999999999987765 899999
Q ss_pred CCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------
Q 022444 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS------------- 218 (297)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~------------- 218 (297)
|.+....... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||..........
T Consensus 169 G~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 169 GYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc-ccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9988665432 23456789999999999887776 99999999999999999999997643221110
Q ss_pred -Hhhhccc------cC----CCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 219 -KVEKADF------SC----PTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 219 -~i~~~~~------~~----~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
....+.. +. ...+++.+.+++.+||.+||++|||++++++||||+....
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 0001111 11 1125678999999999999999999999999999987543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=323.91 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=215.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||++.++. +..|+||++..... ..+.+.+|+.+++.++|+||+++++++.. ...++|
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 4579999999999999999999875 46799999975432 23567899999999999999999999865 678999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
|||+.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999999999743 4699999999999999999999999999999999999999999999999999986653221
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
......++..|+|||.+.+..++ .++||||||+++|+|++ |..||......+..+.+..+ ..+.+..+|+++.+|+.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 498 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 498 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 12234456789999999877766 99999999999999999 99999998888887777655 34567789999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccC
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+||+.||++|||++++++ .|+..
T Consensus 499 ~cl~~dP~~RPt~~~l~~--~L~~~ 521 (535)
T 2h8h_A 499 QCWRKEPEERPTFEYLQA--FLEDY 521 (535)
T ss_dssp HHTCSSGGGSCCHHHHHH--HHHTS
T ss_pred HHcCCChhHCcCHHHHHH--HHHHH
Confidence 999999999999999987 44443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=304.53 Aligned_cols=249 Identities=26% Similarity=0.429 Sum_probs=206.1
Q ss_pred ccceEEeEEeccCCceeEEEEE----eCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT- 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 80 (297)
.++|++++.||+|++|.||+++ +..+++.|++|.+.... ....+.+.+|+..++.++|+||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 3579999999999999999998 46689999999987643 334567889999999999999999999886543
Q ss_pred -eEEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 81 -KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 81 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
..+++||++++++|.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 789999999999999999875 459999999999999999999999999999999999999999999999999987654
Q ss_pred CCccc---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Q 022444 159 QGVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT----------------TLYSK 219 (297)
Q Consensus 159 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~----------------~~~~~ 219 (297)
..... .....++..|+|||.+.+..++ .++||||||+++|+|++|..|+...... .+.+.
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 43221 2233456679999999876665 8999999999999999999988543111 11222
Q ss_pred hhh-ccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 220 VEK-ADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 220 i~~-~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+.. ...+.+..+|+++.+++.+||+.||++|||+.++++
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222 234566779999999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=310.81 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=202.9
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++.+. +++.||+|++........ ...+.+|+.+++.++|+||+++++++......++
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 3568999999999999999999854 688999999876542221 2357889999999999999999999999899999
Q ss_pred EEcccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCEEecCCCCCeeecCCCCEEEcccCCCCCC
Q 022444 85 ILEFITGGELFDKIVHHG----RLSESEARRYFQQLIDGVDYCHSK---GVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~al~~Lh~~---~i~h~di~~~nIli~~~~~~~l~df~~~~~~ 157 (297)
+|||+.+++|.+++.... ++++..++.++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||.+...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 999999999999997643 389999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcc-ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHhhhcc-c--
Q 022444 158 EQGVS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL--------DLTTLYSKVEKAD-F-- 225 (297)
Q Consensus 158 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~--------~~~~~~~~i~~~~-~-- 225 (297)
..... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||... ...+......... .
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred CcccccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence 43322 23344589999999999777665 9999999999999999999999521 1111111111110 0
Q ss_pred --------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 022444 226 --------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEW 261 (297)
Q Consensus 226 --------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~ 261 (297)
..+...+..+.+++.+||+.||++|||+.++++|..
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 011112367899999999999999999999999554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=327.68 Aligned_cols=243 Identities=23% Similarity=0.397 Sum_probs=208.5
Q ss_pred EEeccCCceeEEEEEe--CCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccC
Q 022444 13 RTIGEGTFAKVKFAQN--TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
+.||+|+||.||++.+ +.+++.||||++.... ......+.+.+|+.+++.++|+||+++++++.. +..++||||+.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4899999999999954 4667899999987643 233446778999999999999999999999864 56889999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc---ccccc
Q 022444 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---LLRTT 167 (297)
Q Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~---~~~~~ 167 (297)
+++|.+++.....+++..++.++.+|+.||.|||+.||+|+||||+||+++.++.++|+|||++........ .....
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 999999999888899999999999999999999999999999999999999999999999999875543221 12233
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHHhcCC
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~L~~ 245 (297)
.++..|+|||++.+..++ .++||||||+++|+|++ |..||...+..+..+.+..+. ...+..+|+++.+++.+||+.
T Consensus 533 ~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 611 (635)
T 4fl3_A 533 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 611 (635)
T ss_dssp --CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 456789999999877776 99999999999999998 999999999888888777664 456778999999999999999
Q ss_pred CcCCCCCHHHHhc
Q 022444 246 NPETRITIEEIRN 258 (297)
Q Consensus 246 ~p~~Rps~~~il~ 258 (297)
||++|||++++++
T Consensus 612 dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 612 DVENRPGFAAVEL 624 (635)
T ss_dssp STTTSCCHHHHHH
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=326.38 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=208.7
Q ss_pred cceEEeE-EeccCCceeEEEEEeC--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 7 GKYEVGR-TIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 7 ~~y~~~~-~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
+++.+.+ .||+|+||.||++.++ .++..||||++.... .....+.+.+|+.+++.++|+||+++++++.. +..+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 3456666 8999999999999875 456779999997643 22345678899999999999999999999976 5699
Q ss_pred EEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 84 IILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+||||+.+++|.+++... ..+++..++.++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999998754 4599999999999999999999999999999999999999999999999999986543322
Q ss_pred c---cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHH
Q 022444 163 L---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKS 237 (297)
Q Consensus 163 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~ 237 (297)
. .....++..|+|||++.+..++ .++||||||+++|+|++ |..||...+..+..+.+..+. ...+..+|+++.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1 1223345789999999877776 99999999999999998 999999988888888776664 4667789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 022444 238 LIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~ 258 (297)
++.+||+.+|.+|||++++++
T Consensus 571 li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999865
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=316.83 Aligned_cols=272 Identities=22% Similarity=0.317 Sum_probs=218.7
Q ss_pred CccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEEcC
Q 022444 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASR 79 (297)
Q Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 79 (297)
|-.+..++|++.+.||+|+||.||++++..+++.||||++..... ...+.+|+.+++.+.| +++..+..++...
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 456677899999999999999999999999999999998765432 2336788999999986 6666777777788
Q ss_pred CeEEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeee---cCCCCEEEcccCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSA 155 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli---~~~~~~~l~df~~~~ 155 (297)
...+++||++ +++|.+++.. ...+++..++.++.+|+.||.|||+.||+|+||||+||++ +.++.++|+|||++.
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 8999999999 8899999975 4579999999999999999999999999999999999999 578899999999987
Q ss_pred CCCCCcc-------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhhhccc
Q 022444 156 LPEQGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL---TTLYSKVEKADF 225 (297)
Q Consensus 156 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---~~~~~~i~~~~~ 225 (297)
....... ......++..|+|||.+.+..++ .++||||||+++|+|++|..||..... ...+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence 5543322 12255688999999999888776 999999999999999999999977543 333333322221
Q ss_pred -----cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCccc
Q 022444 226 -----SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDD 281 (297)
Q Consensus 226 -----~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~~ 281 (297)
.....+|+++.+|+..||+.+|.+||++.+|++ .|++........-...++|+.
T Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~--~L~~l~~~~~~~~~~~~dW~~ 292 (483)
T 3sv0_A 234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR--LFRDLFIREGFQFDYVFDWTI 292 (483)
T ss_dssp HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHHHHTTCCCSSCCHHHH
T ss_pred cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHHcCCCccCCcCchh
Confidence 223568999999999999999999999999987 555555544444444455443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=305.79 Aligned_cols=269 Identities=23% Similarity=0.316 Sum_probs=209.1
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++.+.||+|++|.||++.+.. .+++|++..... .....+.+.+|+..++.++|+||+++++++......++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 35789999999999999999999864 499999875432 12223456788999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC---
Q 022444 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--- 160 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~--- 160 (297)
++|++.+++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999999999998754 699999999999999999999999999999999999997 689999999987654321
Q ss_pred --ccccccccCCccccCCccccccC--------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccC--C
Q 022444 161 --VSLLRTTCGTPNYVAPEVLSHKG--------YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSC--P 228 (297)
Q Consensus 161 --~~~~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~ 228 (297)
........+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||...........+.....+. +
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 265 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ 265 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc
Confidence 12223445788999999986521 22489999999999999999999999988888777766654432 2
Q ss_pred CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCcc
Q 022444 229 TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLD 280 (297)
Q Consensus 229 ~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~ 280 (297)
..+|.++.+++.+||+.||.+|||+.++++ .|++...+..-.+.+...|.
T Consensus 266 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 266 IGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp SSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC---------------
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhccCCCCccccc
Confidence 358899999999999999999999999998 77766655555555544443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=323.95 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=211.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.++|++.+.||+|+||.||+|.+..+ +..+++|.+.... .....+.+.+|+..++.++||||+++++++. .+..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 46799999999999999999998643 4678999886543 2334567889999999999999999999984 4568
Q ss_pred EEEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
++||||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 99999999999999998654 68999999999999999999999999999999999999999999999999998664432
Q ss_pred c-ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHH
Q 022444 162 S-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSL 238 (297)
Q Consensus 162 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~l 238 (297)
. ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+.... .+.+..+|+.+.++
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 624 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 624 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHH
Confidence 2 22234456789999999877766 89999999999999997 999999998888887776654 56777899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 022444 239 IHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~ 258 (297)
+.+||+.||++|||+.++++
T Consensus 625 i~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 625 MTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=300.84 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=192.0
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh--cCCCCeeEEEEEEEcC----
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL--VRHPCVVRLHEVLASR---- 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~---- 79 (297)
.++|++.+.||+|+||.||+++++ ++.||+|++.... ......+.+++.. +.|+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 468999999999999999999985 8899999986433 1222334444444 4899999999998776
Q ss_pred CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCEEecCCCCCeeecCCCCEEEccc
Q 022444 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK--------GVYHRDLKPENLLLDSQGHLKISDF 151 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~--------~i~h~di~~~nIli~~~~~~~l~df 151 (297)
...+++|||+++++|.+++.. ..+++..++.++.+++.||.|||+. |++|+||||+||+++.++.++|+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 689999999999999999975 4799999999999999999999999 9999999999999999999999999
Q ss_pred CCCCCCCCCccc----cccccCCccccCCccccccCCCCC-----chhHHHHHHHHHHHHhC----------CCCCCCCC
Q 022444 152 GLSALPEQGVSL----LRTTCGTPNYVAPEVLSHKGYNGA-----AADVWSCGVILYVLIAG----------YLPFDELD 212 (297)
Q Consensus 152 ~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~-----~~Di~slG~ll~~ll~g----------~~pf~~~~ 212 (297)
|.+......... .....+++.|+|||.+.+...... ++||||||+++|+|++| ..||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 998654433222 224568899999999977655522 38999999999999999 67775432
Q ss_pred -----HHHHHHHhhhc--cccCCC-----CCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 213 -----LTTLYSKVEKA--DFSCPT-----WFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 213 -----~~~~~~~i~~~--~~~~~~-----~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
.......+... ....+. .+++++.+++.+||+.||++|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 22222222221 122221 345679999999999999999999999983
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=299.95 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=199.6
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchh-hhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
|...+.||+|++|.||++.+ +++.+++|.+..... ......+.+.+|+..++.++||||+++++++......+++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 33448999999999999986 578999999865331 233446778899999999999999999999999899999999
Q ss_pred ccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--
Q 022444 88 FITGGELFDKIVH---HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-- 162 (297)
Q Consensus 88 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-- 162 (297)
++++++|.+++.. ..++++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999998864 34689999999999999999999999999999999999999999999999999875443222
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhhhcc-----------ccC
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT----LYSKVEKAD-----------FSC 227 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~----~~~~i~~~~-----------~~~ 227 (297)
......+++.|+|||.+.+. + +.++||||||+++|+|++|..||....... ..+.+.... ...
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 22345688999999998754 3 489999999999999999999997654322 222221111 111
Q ss_pred CCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 228 PTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 228 ~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+...++.+.+++.+||+.+|++|||++++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2224577899999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.89 Aligned_cols=241 Identities=16% Similarity=0.211 Sum_probs=194.9
Q ss_pred ccceEEeEEeccCCceeEEEEE-----eCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC---CCCeeEEEEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR---HPCVVRLHEVLA 77 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 77 (297)
.++|++.+.||+|+||.||+|. +..+++.||+|++.... ...+..+...++.+. |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3579999999999999999994 66789999999997543 234556666777666 899999999999
Q ss_pred cCCeEEEEEcccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC----------
Q 022444 78 SRTKIYIILEFITGGELFDKIVH-----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---------- 142 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---------- 142 (297)
..+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+|+||||+||+++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999999974 456999999999999999999999999999999999999988
Q ss_pred -CCCEEEcccCCCCCCC--CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022444 143 -QGHLKISDFGLSALPE--QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSK 219 (297)
Q Consensus 143 -~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~ 219 (297)
++.++|+|||++.... ..........|++.|+|||++.+..++ .++||||||+++|+|++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 8999999999996433 222334556789999999999888776 99999999999999999999995432210
Q ss_pred hhhccccC-CCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 220 VEKADFSC-PTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 220 i~~~~~~~-~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
......+ ....++.+.+++..||+.+|.+|++..+.+.
T Consensus 293 -~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 -CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp -EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred -eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 0000111 1124678999999999999999966554444
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.34 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=190.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE-----cC
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-----SR 79 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (297)
..++|++.+.||+|+||.||++++ +++.||+|++...... ......++..+..++|+||+++++.+. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 468999999999999999999977 5889999999754311 111234444455689999999997553 23
Q ss_pred CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCEEecCCCCCeeecCCCCEEEcc
Q 022444 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK---------GVYHRDLKPENLLLDSQGHLKISD 150 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~---------~i~h~di~~~nIli~~~~~~~l~d 150 (297)
...++||||+++++|.+++... ..++..++.++.+++.||.|||+. |++|+||||+||+++.++.++|+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 3678999999999999999764 558999999999999999999999 999999999999999999999999
Q ss_pred cCCCCCCCCCc--------cccccccCCccccCCcccccc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC---
Q 022444 151 FGLSALPEQGV--------SLLRTTCGTPNYVAPEVLSHK-------GYNGAAADVWSCGVILYVLIAGYLPFDELD--- 212 (297)
Q Consensus 151 f~~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~ll~~ll~g~~pf~~~~--- 212 (297)
||++....... .......+++.|+|||.+.+. .+ +.++||||||+++|+|++|..||....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 99987544321 122244689999999998762 22 368999999999999999977653221
Q ss_pred ---------------HHHHHHHhhh--ccccCCCC------CChhHHHHHHHhcCCCcCCCCCHHHHhc------Ccccc
Q 022444 213 ---------------LTTLYSKVEK--ADFSCPTW------FPVGAKSLIHRILDPNPETRITIEEIRN------DEWFR 263 (297)
Q Consensus 213 ---------------~~~~~~~i~~--~~~~~~~~------~~~~l~~li~~~L~~~p~~Rps~~~il~------~p~~~ 263 (297)
.......+.. ....++.. +++++.+++.+||+.||++|||+.++++ ++|-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 1111111111 12223333 2347999999999999999999999954 66666
Q ss_pred cCc
Q 022444 264 KGY 266 (297)
Q Consensus 264 ~~~ 266 (297)
+..
T Consensus 323 ~~~ 325 (336)
T 3g2f_A 323 NKS 325 (336)
T ss_dssp ---
T ss_pred ccc
Confidence 553
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=314.02 Aligned_cols=251 Identities=18% Similarity=0.179 Sum_probs=194.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC-CCe----------------
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCV---------------- 69 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i---------------- 69 (297)
.+|+..+.||+|+||.||+|++..+|+.||||++...........+.+.+|+..++.+.| ++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 358899999999999999999999999999999874443333445678899999998876 211
Q ss_pred -----eEEEEEEEc-----CCeEEEEEcccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEec
Q 022444 70 -----VRLHEVLAS-----RTKIYIILEFITGGELFDKIVH-------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132 (297)
Q Consensus 70 -----~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~d 132 (297)
..+..++.. ....+++|+.+ +++|.+++.. ...+++..++.++.|++.||.|||+.||+|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 111121211 22467777776 4689888841 22477888999999999999999999999999
Q ss_pred CCCCCeeecCCCCEEEcccCCCCCCCCCccccccccCCccccCCccc----------cccCCCCCchhHHHHHHHHHHHH
Q 022444 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL----------SHKGYNGAAADVWSCGVILYVLI 202 (297)
Q Consensus 133 i~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~~Di~slG~ll~~ll 202 (297)
|||+||+++.++.++|+|||++...... .....| +.|+|||++ .+..++ .++||||||+++|+|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMT-FAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC-HHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCC-chhhHHHHHHHHHHHH
Confidence 9999999999999999999998765443 334566 999999998 333343 7999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 203 AGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 203 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
+|+.||...+.......+. .....+|+++.+|+.+||+.||++|||+.++++||||++...
T Consensus 312 tg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HCCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence 9999998765544333332 223458999999999999999999999999999999987643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=295.50 Aligned_cols=244 Identities=22% Similarity=0.352 Sum_probs=198.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh--cCCCCeeEEEEEEEcCC----
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL--VRHPCVVRLHEVLASRT---- 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~---- 80 (297)
++|++.+.||+|++|.||++++ +++.|++|.+.... ...+.+|.++++. ++|+||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 5899999999999999999998 48899999986432 3445677788877 68999999999997765
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCEEecCCCCCeeecCCCCEEEcccC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH--------SKGVYHRDLKPENLLLDSQGHLKISDFG 152 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh--------~~~i~h~di~~~nIli~~~~~~~l~df~ 152 (297)
..+++|||+++++|.+++.+ .++++..++.++.+++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 79999999999999999976 47999999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCcc----ccccccCCccccCCccccccCCC-----CCchhHHHHHHHHHHHHhC----------CCCCCCC--
Q 022444 153 LSALPEQGVS----LLRTTCGTPNYVAPEVLSHKGYN-----GAAADVWSCGVILYVLIAG----------YLPFDEL-- 211 (297)
Q Consensus 153 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~ll~~ll~g----------~~pf~~~-- 211 (297)
.+........ ......+++.|+|||.+.+.... +.++||||||+++|+|++| ..||...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 9865443322 22345688999999998765322 1589999999999999999 7888654
Q ss_pred ---CHHHHHHHhhhccc--cCCC-----CCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 212 ---DLTTLYSKVEKADF--SCPT-----WFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 212 ---~~~~~~~~i~~~~~--~~~~-----~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
........+..... ..+. .+++.+.+++.+||+.||++|||+.+++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23344444433222 1221 234578999999999999999999999883
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=288.25 Aligned_cols=226 Identities=18% Similarity=0.234 Sum_probs=189.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|+||.||++++..+++.|++|++.............+.+|+..++.+.|+||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 78999999999999999999999999999999998765444555677889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++.+ .....++..++.+++.||.|||+.|++|+||||+||+++.++.++|++++.
T Consensus 111 e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~------------- 175 (286)
T 3uqc_A 111 EWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------------- 175 (286)
T ss_dssp ECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-------------
T ss_pred EecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-------------
Confidence 99999999999864 346677899999999999999999999999999999999999999985432
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---Hhhhccc----cCCCCCChhHHHHH
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS---KVEKADF----SCPTWFPVGAKSLI 239 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~---~i~~~~~----~~~~~~~~~l~~li 239 (297)
++| + +.++||||||+++|+|++|+.||...+...... ....... .....+|+++.+++
T Consensus 176 -------~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (286)
T 3uqc_A 176 -------MPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240 (286)
T ss_dssp -------CTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHH
T ss_pred -------cCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHH
Confidence 222 2 489999999999999999999998755432111 1111111 12356899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 240 HRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+||+.||++| |+.++++ .+++.
T Consensus 241 ~~~l~~dP~~R-s~~el~~--~L~~~ 263 (286)
T 3uqc_A 241 ARSVQGDGGIR-SASTLLN--LMQQA 263 (286)
T ss_dssp HHHHCTTSSCC-CHHHHHH--HHHHH
T ss_pred HHHcccCCccC-CHHHHHH--HHHHH
Confidence 99999999999 9999998 55543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=321.55 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=198.0
Q ss_pred cceEEeEEeccCCceeEEEEEeCC-CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe----
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE-TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK---- 81 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 81 (297)
++|++.+.||+|+||.||++.+.. +|+.|+||++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 789999999999999999999976 78999999986543 23345667899999999999999999999976554
Q ss_pred -EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 -IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.|+||||+++++|.+.+.. .+++..++.++.+++.+|.|||+.||+|+||||+||+++.+ .++|+|||.+......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 7999999999999887765 79999999999999999999999999999999999999875 8999999998765443
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHH
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~ 240 (297)
....|++.|+|||++.+.. +.++||||||+++|+|++|..||........ . ........++.+.++|.
T Consensus 235 ----~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~--~~~~~~~~~~~l~~li~ 302 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P--EDDPVLKTYDSYGRLLR 302 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C--TTCHHHHHCHHHHHHHH
T ss_pred ----CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc----c--ccccccccCHHHHHHHh
Confidence 3456899999999987543 4899999999999999999988864211100 0 00000113578999999
Q ss_pred HhcCCCcCCCCCHHHHhcCccccc
Q 022444 241 RILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
+||++||++||+..+.+.|+|+.-
T Consensus 303 ~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 303 RAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred hhccCChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999998754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=302.06 Aligned_cols=243 Identities=22% Similarity=0.288 Sum_probs=191.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh-----hHHHHHHHHHHHHHHHhcC---------CCCeeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMKLVR---------HPCVVR 71 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~~i~~ 71 (297)
.++|++.+.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ |+||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 6799999999765321 2223456778888887775 888888
Q ss_pred EEEEEE------------------------------cCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 022444 72 LHEVLA------------------------------SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121 (297)
Q Consensus 72 ~~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~ 121 (297)
+.+++. .....|+||||+.++++.+.+.+ ..+++..++.++.|++.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 887642 26789999999999987777654 57899999999999999999
Q ss_pred HHH-hCCCEEecCCCCCeeecCCC--------------------CEEEcccCCCCCCCCCccccccccCCccccCCcccc
Q 022444 122 YCH-SKGVYHRDLKPENLLLDSQG--------------------HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180 (297)
Q Consensus 122 ~Lh-~~~i~h~di~~~nIli~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 180 (297)
||| +.||+|+||||+||+++.++ .++|+|||+++..... ...|++.|+|||++.
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhc
Confidence 999 99999999999999999887 8999999999865532 347889999999998
Q ss_pred ccCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHhhhc-ccc--C----CCCCChhHHHHHHHhcCCCcCCCC
Q 022444 181 HKGYNGAAADVWSCGVI-LYVLIAGYLPFDELDL-TTLYSKVEKA-DFS--C----PTWFPVGAKSLIHRILDPNPETRI 251 (297)
Q Consensus 181 ~~~~~~~~~Di~slG~l-l~~ll~g~~pf~~~~~-~~~~~~i~~~-~~~--~----~~~~~~~l~~li~~~L~~~p~~Rp 251 (297)
+.. +.++||||||++ .++++.|..||..... ....+.+... ... . +..+++++.+||.+||++|
T Consensus 251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp CCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred CCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 765 489999998777 6678889999854211 1122222211 111 1 1136788999999999976
Q ss_pred CHHHHh-cCcccc
Q 022444 252 TIEEIR-NDEWFR 263 (297)
Q Consensus 252 s~~~il-~~p~~~ 263 (297)
|++++| +||||+
T Consensus 324 sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHCGGGC
T ss_pred CHHHHHhcCCCcC
Confidence 999999 999995
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-33 Score=260.72 Aligned_cols=185 Identities=15% Similarity=0.141 Sum_probs=135.4
Q ss_pred eccCCceeEEEEEeCCCCcEEEEEEeecch-------hhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCeEEEEE
Q 022444 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSA-------IIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
.+.|+.+....++....|+.+++|++.... .......+.+.+|+++|+++ .|+||++++++++++...|+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 456666666666666778999999996532 12334456799999999999 6999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||++|++|.+.+.+.+++++. +++.||++||.|+|++||+|+||||+|||++.+|.+||+|||+++...........
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t 398 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTN 398 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHH
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccC
Confidence 999999999999998888765 47889999999999999999999999999999999999999999877665555566
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG 204 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g 204 (297)
.+|++.|+|||++.+.. ..++|+|++|++++.+.++
T Consensus 399 ~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 399 LVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp HHHHHHHHHHHHC-------------------CCCCTT
T ss_pred ceechhhccHHHhCCCC--CCcccccccccchhhhccc
Confidence 78999999999997643 3789999999988766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=213.75 Aligned_cols=186 Identities=20% Similarity=0.210 Sum_probs=141.5
Q ss_pred EEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchh-----hhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-----IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
...+.||+|+||.||++.. .+..+++|....... ......+.+.+|+.++++++|+||+++..++......|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3467899999999999944 577899998644222 222234568999999999999999944444445666799
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc-
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL- 163 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~- 163 (297)
+|||+++++|.+++.. +..++.|++++|.|||++||+|+||||+||+++. .++|+|||+++........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999998875 6789999999999999999999999999999988 9999999999876553221
Q ss_pred ------cccccCCccccCCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022444 164 ------LRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPF 208 (297)
Q Consensus 164 ------~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf 208 (297)
.....+++.|+|||.+.. ..+. ..+|+|+..+-..+-+.++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhcccc
Confidence 124568999999999976 4444 6789999988888877776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-24 Score=179.94 Aligned_cols=136 Identities=18% Similarity=0.245 Sum_probs=108.4
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH---------------HHHHHHHHHHHHHHhcCCCCeeEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---------------KMADQIKREISIMKLVRHPCVVRL 72 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~~~ 72 (297)
.|++.+.||+|++|.||++.+ .+|+.+|+|++........ .....+.+|+.+++.+.| +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 355569999999999999999 7899999999864321111 234568899999999984 444
Q ss_pred EEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccC
Q 022444 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (297)
Q Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~ 152 (297)
.+++.. +..++||||+++++|.+ +. ......++.+++.||.+||+.|++|+||||+||+++ ++.++|+|||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 444433 45699999999999987 42 234557999999999999999999999999999999 9999999999
Q ss_pred CCCC
Q 022444 153 LSAL 156 (297)
Q Consensus 153 ~~~~ 156 (297)
.+..
T Consensus 238 ~a~~ 241 (282)
T 1zar_A 238 QSVE 241 (282)
T ss_dssp TCEE
T ss_pred CCeE
Confidence 8863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2e-20 Score=156.52 Aligned_cols=141 Identities=20% Similarity=0.243 Sum_probs=109.0
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcE--EEEEEeecchhh---------------------hHHHHHHHHHHHHHHHhc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGES--VAMKVLDRSAII---------------------KHKMADQIKREISIMKLV 64 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~--~~iK~~~~~~~~---------------------~~~~~~~~~~e~~~l~~l 64 (297)
.|++.+.||+|++|.||+|.+..+|+. ||||++...... .......+.+|+..++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999999778889 999987543211 011123578899999999
Q ss_pred CCCCe--eEEEEEEEcCCeEEEEEcccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCEEecCCCC
Q 022444 65 RHPCV--VRLHEVLASRTKIYIILEFITG-G----ELFDKIVHHGRLSESEARRYFQQLIDGVDYCH-SKGVYHRDLKPE 136 (297)
Q Consensus 65 ~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh-~~~i~h~di~~~ 136 (297)
.|+++ +.++.. ...++||||+.+ | +|.+.... .++..+..++.+++.+|.+|| +.|++|+||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 87754 445443 256899999942 3 66655432 235578899999999999999 999999999999
Q ss_pred CeeecCCCCEEEcccCCCCCC
Q 022444 137 NLLLDSQGHLKISDFGLSALP 157 (297)
Q Consensus 137 nIli~~~~~~~l~df~~~~~~ 157 (297)
||+++. .++|+|||++...
T Consensus 201 NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS--SEEECCCTTCEET
T ss_pred HEEEcC--cEEEEECcccccC
Confidence 999988 9999999988644
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-17 Score=145.52 Aligned_cols=140 Identities=16% Similarity=0.193 Sum_probs=102.5
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh---------------hHH----HHHHHHHHHHHHHhcCCCC
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII---------------KHK----MADQIKREISIMKLVRHPC 68 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------------~~~----~~~~~~~e~~~l~~l~h~~ 68 (297)
-|++.+.||.|++|.||.|.+. +|+.||||+++..... ... ..-...+|...+.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999985 6999999987532110 000 1112345677777775444
Q ss_pred e--eEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC--
Q 022444 69 V--VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-- 144 (297)
Q Consensus 69 i--~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-- 144 (297)
+ ...++.. ..++||||+.|.+|.++.. .+....++.|++.+|.+||+.|+||+||||.||++++++
T Consensus 175 v~vp~p~~~~----~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQS----RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEEE----TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeecc----CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 4 3333332 2379999999988865432 234567889999999999999999999999999998776
Q ss_pred --------CEEEcccCCCCCCC
Q 022444 145 --------HLKISDFGLSALPE 158 (297)
Q Consensus 145 --------~~~l~df~~~~~~~ 158 (297)
.+.++||+.+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999776443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=3.5e-12 Score=106.43 Aligned_cols=142 Identities=16% Similarity=0.141 Sum_probs=110.6
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKI 82 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 82 (297)
+.++.|++...++.|+.+.||++... +..+++|......... ...+.+|...++.+. +..++++++++...+..
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 35678999999999999999999754 6789999986532111 234677888888884 56788899998888899
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS------------------------------------- 125 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~------------------------------------- 125 (297)
|++||+++|.+|.+... +......++.+++++|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999998876531 123345788899999999998
Q ss_pred ----------------------CCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 126 ----------------------KGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 126 ----------------------~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
.+++|||++|.||++++++.+.++||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999765556799998543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=1.3e-11 Score=102.67 Aligned_cols=136 Identities=14% Similarity=0.156 Sum_probs=97.7
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC--eeEEEEEEEcCCeE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEVLASRTKI 82 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~ 82 (297)
....|.+....+.|..+.||++.. .+|..+++|...... ...+..|...++.+.+.+ +++++.+....+..
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 345677655545666799999965 467789999876431 134567777777775434 56688888877889
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG----------------------------------- 127 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~----------------------------------- 127 (297)
+++||+++|.++. .. ... ...++.+++.+|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999998873 11 111 2356677777788887643
Q ss_pred -----------------------CEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 128 -----------------------VYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 128 -----------------------i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
++|||++|.||++++++.+.++||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999776556799999654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=2.1e-10 Score=100.18 Aligned_cols=141 Identities=20% Similarity=0.319 Sum_probs=104.8
Q ss_pred EEeEEeccCCceeEEEEEeCCCCcEEEEEEee--cchhhhHHHHHHHHHHHHHHHhcCC--CCeeEEEEEEEcC---CeE
Q 022444 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLD--RSAIIKHKMADQIKREISIMKLVRH--PCVVRLHEVLASR---TKI 82 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~--~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~ 82 (297)
.-++.|+.|..+.||++... +..+++|+.. .... ......+.+|+.+++.+.. ..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 35778999999999999864 4678899876 3221 1113456788888888863 4578888888665 358
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS------------------------------------- 125 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~------------------------------------- 125 (297)
|+|||+++|.++.+.. ...++......++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999987774321 1246788889999999999999997
Q ss_pred ---------------------CCCEEecCCCCCeeecCCCC--EEEcccCCCCC
Q 022444 126 ---------------------KGVYHRDLKPENLLLDSQGH--LKISDFGLSAL 156 (297)
Q Consensus 126 ---------------------~~i~h~di~~~nIli~~~~~--~~l~df~~~~~ 156 (297)
.+++|||+++.||+++.++. +.++||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.95 E-value=1e-09 Score=93.54 Aligned_cols=184 Identities=17% Similarity=0.212 Sum_probs=118.9
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCC--eeEEEEEEEcCC---eEEEE
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPC--VVRLHEVLASRT---KIYII 85 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv 85 (297)
++.++.|..+.||++. ..+++|+.... .....+.+|...++.+. +.. +++++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999764 45899986432 22456778888888773 333 445555543333 34889
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS---------------------------------------- 125 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~---------------------------------------- 125 (297)
|++++|.++..... ..++..+...++.+++..+..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865433 256777788888888888888885
Q ss_pred ------------------CCCEEecCCCCCeeecC--CCCEEEcccCCCCCCCCCccccccccCCccccCCccc----cc
Q 022444 126 ------------------KGVYHRDLKPENLLLDS--QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL----SH 181 (297)
Q Consensus 126 ------------------~~i~h~di~~~nIli~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~ 181 (297)
..++|||++|.||+++. +..+.++||+.+................ .-.+|+.. ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHH
Confidence 13799999999999988 4567899999875432211100000000 00122211 11
Q ss_pred cCCC---------CCchhHHHHHHHHHHHHhCCCCC
Q 022444 182 KGYN---------GAAADVWSCGVILYVLIAGYLPF 208 (297)
Q Consensus 182 ~~~~---------~~~~Di~slG~ll~~ll~g~~pf 208 (297)
.+.. ....+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1110 02358999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=1.2e-07 Score=79.03 Aligned_cols=132 Identities=14% Similarity=0.168 Sum_probs=95.6
Q ss_pred EeccCCce-eEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeEEEEEcccCC
Q 022444 14 TIGEGTFA-KVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILEFITG 91 (297)
Q Consensus 14 ~lg~g~~~-~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (297)
.+..|..+ .||+......+..+++|.-.... ...+.+|...++.+. +--+.+++.++.+.+..+++|++++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445444 68998887778889999875432 345667888887774 33467888888888899999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 022444 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS---------------------------------------------- 125 (297)
Q Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~---------------------------------------------- 125 (297)
.++.+..... ......+..++...|..||+
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8877655431 22334556667777777775
Q ss_pred ------------CCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 126 ------------KGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 126 ------------~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
..++|||+++.||+++.++.+-++||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127899999999999877767799998654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=8.9e-07 Score=75.33 Aligned_cols=134 Identities=20% Similarity=0.250 Sum_probs=92.4
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCC---CeeEEEEEEE-cCCeEEEEEc
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP---CVVRLHEVLA-SRTKIYIILE 87 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e 87 (297)
++.++.|....||.+ |..+++|+... ......+..|...++.+.+. .+++++.+.. ..+..+++|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 567888888899988 45688998532 12345688899999988642 3567777664 4456789999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK----------------------------------------- 126 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~----------------------------------------- 126 (297)
+++|.++.+... ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988765321 1234444455555555555555532
Q ss_pred -------------------CCEEecCCCCCeeecC---CCCE-EEcccCCCCCC
Q 022444 127 -------------------GVYHRDLKPENLLLDS---QGHL-KISDFGLSALP 157 (297)
Q Consensus 127 -------------------~i~h~di~~~nIli~~---~~~~-~l~df~~~~~~ 157 (297)
.++|||++|.||+++. ++.+ .++||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 4554 79999976543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=2.5e-06 Score=75.19 Aligned_cols=80 Identities=16% Similarity=0.073 Sum_probs=48.3
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchh--hh--HHHHHHHHHHHHHHHhcCC---CCeeEEEEEEEcCCeEE
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--IK--HKMADQIKREISIMKLVRH---PCVVRLHEVLASRTKIY 83 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~ 83 (297)
-++.||.|..+.||++....++..+++|....... .. .........|...++.+.. ..+++++.+. .+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccE
Confidence 46789999999999998766678899997653211 00 0112334567777776632 2345666542 34468
Q ss_pred EEEcccCCC
Q 022444 84 IILEFITGG 92 (297)
Q Consensus 84 lv~e~~~~~ 92 (297)
++||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.21 E-value=2.1e-05 Score=62.48 Aligned_cols=135 Identities=13% Similarity=0.091 Sum_probs=91.4
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccccC
Q 022444 92 GELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169 (297)
Q Consensus 92 ~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 169 (297)
.+|.+.+.. ..+++++++|.++.|.+.+|..+-. ..-...=+.|..|++..+|++.+.+ +.+. ..
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG 99 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence 478888874 5689999999999999999887621 1222344567899999999988874 1111 11
Q ss_pred CccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCC----
Q 022444 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDP---- 245 (297)
Q Consensus 170 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~---- 245 (297)
...+.|||... .. .+.+.=|||||+++|..+-=..| ...+..+++.+.+||..|.+-
T Consensus 100 ~~~~~~pe~~~-~~-~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~~~d~ 160 (229)
T 2yle_A 100 EPPPVAGKLGY-SQ-CMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANTVEAD 160 (229)
T ss_dssp -------CCSS-SS-SCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTCCC--
T ss_pred ccCCCChhhcc-cc-chHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhccccc
Confidence 22456787753 12 23778899999999998853332 122344899999999999866
Q ss_pred ---------------------CcCCCCCHHHHhc
Q 022444 246 ---------------------NPETRITIEEIRN 258 (297)
Q Consensus 246 ---------------------~p~~Rps~~~il~ 258 (297)
.+..|+|+++|++
T Consensus 161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp ------------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccccccccCcCCHHHHHH
Confidence 2468999999986
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=9.6e-06 Score=70.30 Aligned_cols=86 Identities=9% Similarity=0.166 Sum_probs=52.6
Q ss_pred EEeEEe-ccCCceeEEEEEeC--C----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC---CCCeeEEEEEEEcC
Q 022444 10 EVGRTI-GEGTFAKVKFAQNT--E----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR---HPCVVRLHEVLASR 79 (297)
Q Consensus 10 ~~~~~l-g~g~~~~v~~~~~~--~----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~ 79 (297)
..++.| +.|....+|++... . ++..+++|...............+.+|...++.+. ...+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88889999988753 1 25679999865432000000123445666666553 23467788776554
Q ss_pred ---CeEEEEEcccCCCChH
Q 022444 80 ---TKIYIILEFITGGELF 95 (297)
Q Consensus 80 ---~~~~lv~e~~~~~~L~ 95 (297)
...+++||+++|.++.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999886543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=5e-05 Score=65.09 Aligned_cols=30 Identities=20% Similarity=0.330 Sum_probs=26.8
Q ss_pred CCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 126 ~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
.+++|||+++.||+++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888889999999654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.00 E-value=6.1e-05 Score=64.04 Aligned_cols=76 Identities=14% Similarity=0.193 Sum_probs=57.5
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCeEEEEEc
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR---HPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e 87 (297)
-++.|+.|....+|++.. ++..+++|...... ...+..|...++.+. ...+++++.+....+..+++||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 457889999999999985 46789999876432 344667777777663 3567888888877788999999
Q ss_pred ccCCCCh
Q 022444 88 FITGGEL 94 (297)
Q Consensus 88 ~~~~~~L 94 (297)
++++.++
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9988654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00012 Score=65.00 Aligned_cols=34 Identities=15% Similarity=0.282 Sum_probs=28.5
Q ss_pred HhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 124 h~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
+...++|||++|.||+++.++ +.++||+.+....
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 356799999999999998776 9999999876443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.69 E-value=8e-05 Score=62.92 Aligned_cols=74 Identities=11% Similarity=0.034 Sum_probs=43.8
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCeEEEEEc
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILE 87 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e 87 (297)
+.-++.|+.|....+|++ ..+++|+...... .. -...+|...++.+...++ ++++... .+..+++++
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e 87 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTE---EY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR 87 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC-------C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCcc---ce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence 333788988999999998 4588998764321 10 112345555555542222 4566543 334578999
Q ss_pred cc-CCCCh
Q 022444 88 FI-TGGEL 94 (297)
Q Consensus 88 ~~-~~~~L 94 (297)
|+ +|.++
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0011 Score=55.52 Aligned_cols=78 Identities=10% Similarity=0.032 Sum_probs=52.6
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC---CCeeEEEEEEEcCCeEEE
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH---PCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~l 84 (297)
+..-++.+|.|..+.||+++.. +|+.+++|+........ ...+..|...|+.+.. --+++++... .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 4667889999999999999864 78899999865432111 2235677777777742 2345566543 2368
Q ss_pred EEcccCCCC
Q 022444 85 ILEFITGGE 93 (297)
Q Consensus 85 v~e~~~~~~ 93 (297)
+||+..+..
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 899887644
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0004 Score=61.79 Aligned_cols=74 Identities=15% Similarity=0.165 Sum_probs=47.5
Q ss_pred EeEEeccCCceeEEEEEeCC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCeE
Q 022444 11 VGRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKI 82 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~ 82 (297)
-++.|+.|....+|++.... ++..+++|+..... . ...+.+|...++.+...++ +++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 45678888889999998653 35789999884321 1 1223357777776643333 567776532
Q ss_pred EEEEcccCCCC
Q 022444 83 YIILEFITGGE 93 (297)
Q Consensus 83 ~lv~e~~~~~~ 93 (297)
.++++|++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28899987633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0005 Score=60.02 Aligned_cols=136 Identities=18% Similarity=0.194 Sum_probs=78.5
Q ss_pred eEEeccCCceeEEEEEeCC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCeEE
Q 022444 12 GRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRTKIY 83 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~ 83 (297)
++.|..|--..+|++.... ++..+++|+..... .......+|..+++.+...+ .+++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 4567778888899998642 35789999863311 11234457777777774222 3567776643 2
Q ss_pred EEEcccCCCChHH--------------HHH---hc-----CCCC--HHHHHHHHHHHHH-------------------HH
Q 022444 84 IILEFITGGELFD--------------KIV---HH-----GRLS--ESEARRYFQQLID-------------------GV 120 (297)
Q Consensus 84 lv~e~~~~~~L~~--------------~l~---~~-----~~~~--~~~~~~~~~~i~~-------------------al 120 (297)
+|+||++|.+|.. .+. .. .... ..++..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998754421 000 00 0111 3445555544321 22
Q ss_pred HHH----Hh----CCCEEecCCCCCeeecCC----CCEEEcccCCCC
Q 022444 121 DYC----HS----KGVYHRDLKPENLLLDSQ----GHLKISDFGLSA 155 (297)
Q Consensus 121 ~~L----h~----~~i~h~di~~~nIli~~~----~~~~l~df~~~~ 155 (297)
..| .. ..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 333 22 249999999999999876 689999999765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00053 Score=58.64 Aligned_cols=33 Identities=27% Similarity=0.373 Sum_probs=27.5
Q ss_pred CCCEEecCCCCCeeecCC----CCEEEcccCCCCCCC
Q 022444 126 KGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPE 158 (297)
Q Consensus 126 ~~i~h~di~~~nIli~~~----~~~~l~df~~~~~~~ 158 (297)
..++|||+++.||+++.+ +.+.++||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 469999999999999874 679999999876443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0014 Score=56.97 Aligned_cols=75 Identities=13% Similarity=0.060 Sum_probs=42.3
Q ss_pred EeEEeccCCceeEEEEEeCC--------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCe
Q 022444 11 VGRTIGEGTFAKVKFAQNTE--------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRTK 81 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~ 81 (297)
-++.|+.|....+|++.... .+..+++|+...... . ......|...++.+...+ .++++... .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--N-- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence 35677778888999998653 136788998754321 1 111245666666664333 44666554 2
Q ss_pred EEEEEcccCCCC
Q 022444 82 IYIILEFITGGE 93 (297)
Q Consensus 82 ~~lv~e~~~~~~ 93 (297)
.++++++++|.+
T Consensus 109 ~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 GGRIEEWLYGDP 120 (369)
T ss_dssp TEEEEECCCSEE
T ss_pred CcEEEEEecCCc
Confidence 268999998744
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0026 Score=53.86 Aligned_cols=138 Identities=14% Similarity=0.152 Sum_probs=73.0
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC--eeEEEEE------EEcCCeE
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEV------LASRTKI 82 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~ 82 (297)
-++.|+.|....+|.+... +| .+++|...... . ...+..+...++.+...+ +++++.. ....+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 4567777888899998764 33 68899886521 1 122334455554443112 2233211 1223567
Q ss_pred EEEEcccCCCChH---------------HHHHhcCCC--------CHHHHHH---------------HHHHHHHHHHHHH
Q 022444 83 YIILEFITGGELF---------------DKIVHHGRL--------SESEARR---------------YFQQLIDGVDYCH 124 (297)
Q Consensus 83 ~lv~e~~~~~~L~---------------~~l~~~~~~--------~~~~~~~---------------~~~~i~~al~~Lh 124 (297)
++++++++|..+. .+......+ ....-.. +...+...+..++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999875431 111111111 0000000 0011334455554
Q ss_pred h-------CCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 125 S-------KGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 125 ~-------~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
+ .+++|||+++.||+++.++.+.++||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2 369999999999999877656899998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0028 Score=53.91 Aligned_cols=75 Identities=15% Similarity=0.108 Sum_probs=42.8
Q ss_pred EEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC--eeEEEEE-----EEcCCeEEEE
Q 022444 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEV-----LASRTKIYII 85 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~lv 85 (297)
..++ |....||.+... +|+.+++|....... . ...+..|...++.+...+ +++++.. ....+..+.+
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 778889987643 566799999863211 1 123444555555553212 3333332 1224566889
Q ss_pred EcccCCCC
Q 022444 86 LEFITGGE 93 (297)
Q Consensus 86 ~e~~~~~~ 93 (297)
+++++|.+
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998744
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0037 Score=55.97 Aligned_cols=76 Identities=13% Similarity=0.148 Sum_probs=47.3
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCeEEEEEccc
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILEFI 89 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~ 89 (297)
-++.|+.|--..+|++.....+..+++|+..... .... ...+|..+++.+...++ +++++.+. + ..+++|+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 4567888888999999876545789999874321 1111 12467777887765444 56777763 2 2499999
Q ss_pred CCCCh
Q 022444 90 TGGEL 94 (297)
Q Consensus 90 ~~~~L 94 (297)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.015 Score=49.70 Aligned_cols=31 Identities=23% Similarity=0.373 Sum_probs=27.2
Q ss_pred CCCEEecCCCCCeeecCCCCEEEcccCCCCC
Q 022444 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (297)
Q Consensus 126 ~~i~h~di~~~nIli~~~~~~~l~df~~~~~ 156 (297)
.+++|||+++.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999998888899999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.017 Score=51.06 Aligned_cols=75 Identities=13% Similarity=0.143 Sum_probs=45.7
Q ss_pred EeEEeccCCceeEEEEEeCCC-------CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCeE
Q 022444 11 VGRTIGEGTFAKVKFAQNTET-------GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRTKI 82 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~ 82 (297)
-++.|..|--..+|++..... +..+++|+..... ... -...+|..+++.+...+ .+++++.+. .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKF-YDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 456677788888999987521 5789999865422 111 11235666666664222 355665442 2
Q ss_pred EEEEcccCCCC
Q 022444 83 YIILEFITGGE 93 (297)
Q Consensus 83 ~lv~e~~~~~~ 93 (297)
+.|++|++|.+
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 68999998855
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.79 E-value=0.033 Score=48.87 Aligned_cols=29 Identities=31% Similarity=0.501 Sum_probs=24.7
Q ss_pred CEEecCCCCCeee------cCCCCEEEcccCCCCC
Q 022444 128 VYHRDLKPENLLL------DSQGHLKISDFGLSAL 156 (297)
Q Consensus 128 i~h~di~~~nIli------~~~~~~~l~df~~~~~ 156 (297)
++|+|+.+.||++ +++..+.++||.++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 7899999999999 3456799999998763
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.73 E-value=0.13 Score=40.72 Aligned_cols=115 Identities=18% Similarity=0.246 Sum_probs=78.8
Q ss_pred CCCCeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC
Q 022444 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG 144 (297)
Q Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~ 144 (297)
.||+++.. .+-...+.+.+.++..+.+.-+..+ ..++....++++.+|+....+++ .-+|--++|+|++++.++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCC
Confidence 58889877 5556677777777776532222223 25688999999999988774443 347888999999999999
Q ss_pred CEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022444 145 HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208 (297)
Q Consensus 145 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf 208 (297)
.+++.-.|... -++|..+ + ...=.-..=|++..+++++..|
T Consensus 117 ~p~i~~RGik~-----------------~l~P~~~-----~-ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 117 LPIAKTRGLQN-----------------VVDPLPV-----S-EAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CEEESCCEETT-----------------TBSCCCC-----C-HHHHHHHHHHHHHHHHCTTCCH
T ss_pred CEEEEEccCcc-----------------CCCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCH
Confidence 99999776422 1233211 1 2223345778888999998887
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.72 E-value=0.48 Score=37.51 Aligned_cols=113 Identities=15% Similarity=0.208 Sum_probs=77.0
Q ss_pred CCCCeeEEEEEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCCEEecCCCCCeeecCC
Q 022444 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD-YCHSKGVYHRDLKPENLLLDSQ 143 (297)
Q Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~-~Lh~~~i~h~di~~~nIli~~~ 143 (297)
.||++ -..+-.+.+.+.+.++..++..-+..+ ..++....++++.+|+.... ++ ..-+|--++|+|++++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 57888 334446777777877776443333444 35788999999999877655 33 455788899999999999
Q ss_pred CCEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhH-HHHHHHHHHHHhCCCCC
Q 022444 144 GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV-WSCGVILYVLIAGYLPF 208 (297)
Q Consensus 144 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di-~slG~ll~~ll~g~~pf 208 (297)
+.+++.-.|+-. .+||..+ ...|. -..=|++..++.++..|
T Consensus 121 ~~p~i~hRGi~~-----------------~lpP~e~-------~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 121 LEPFFLHVGVKE-----------------SLPPDEW-------DDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CCEEESCCEETT-----------------TBSSCSC-------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred CcEEEEEcCCcc-----------------cCCCCCC-------CHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999777532 2334221 22333 34777888888887776
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 297 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-91 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-87 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-84 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-83 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-83 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-82 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-81 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-80 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-80 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-79 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-79 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-79 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-77 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-76 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-75 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-75 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-75 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-74 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-73 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-72 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-71 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-71 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-71 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-70 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-66 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-66 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-66 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-65 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-64 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-64 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-62 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-62 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-61 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-60 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-59 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-59 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-56 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-54 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 268 bits (687), Expect = 9e-91
Identities = 87/257 (33%), Positives = 141/257 (54%), Gaps = 3/257 (1%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+E+GR +G+G F V A+ ++ +A+KVL ++ + K + Q++RE+ I +RHP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++RL+ T++Y+ILE+ G ++ ++ + E Y +L + + YCHSK
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V HRD+KPENLLL S G LKI+DFG S S T CGT +Y+ PE++ + +
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEGRMH-DE 183
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247
D+WS GV+ Y + G PF+ Y ++ + +F+ P + GA+ LI R+L NP
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 243
Query: 248 ETRITIEEIRNDEWFRK 264
R + E+ W
Sbjct: 244 SQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (662), Expect = 7e-87
Identities = 104/266 (39%), Positives = 156/266 (58%), Gaps = 7/266 (2%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
V +++ +T+GEG + +V+ A N T E+VA+K++D + + IK+EI I K++
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 61
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
H VV+ + Y+ LE+ +GGELFD+I + E +A+R+F QL+ GV Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSAL--PEQGVSLLRTTCGTPNYVAPEVLSHKG 183
G+ HRD+KPENLLLD + +LKISDFGL+ + LL CGT YVAPE+L +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLYSKVEKADFSCPTW--FPVGAKSLIH 240
++ DVWSCG++L ++AG LP+D+ D YS ++ W +L+H
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 241 RILDPNPETRITIEEIRNDEWFRKGY 266
+IL NP RITI +I+ D W+ K
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (648), Expect = 1e-84
Identities = 80/263 (30%), Positives = 137/263 (52%), Gaps = 3/263 (1%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
++ ++ G+ +GEG+F+ V A+ T A+K+L++ IIK + RE +M
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+ HP V+L+ K+Y L + GEL I G E+ R Y +++ ++Y
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGTPNYVAPEVLSH 181
H KG+ HRDLKPEN+LL+ H++I+DFG + + R GT YV+PE+L+
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHR 241
K ++D+W+ G I+Y L+AG PF + ++ K+ K ++ P F A+ L+ +
Sbjct: 185 KSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243
Query: 242 ILDPNPETRITIEEIRNDEWFRK 264
+L + R+ EE+ +
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 251 bits (642), Expect = 2e-83
Identities = 62/270 (22%), Positives = 115/270 (42%), Gaps = 8/270 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ R IG G+F V FA++ E VA+K + S ++ I +E+ ++ +RHP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++ ++++E+ G VH L E E + G+ Y HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYN 185
+ HRD+K N+LL G +K+ DFG +++ + GTP ++APEV+ +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQY 191
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW--FPVGAKSLIHRIL 243
DVWS G+ L P ++ + + + + + ++ + L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 244 DPNPETRITIEEIRNDEWFRKGYVPVKLIE 273
P+ R T E + + + P +++
Sbjct: 252 QKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (636), Expect = 8e-83
Identities = 75/264 (28%), Positives = 129/264 (48%), Gaps = 11/264 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ +G+G F KV AQN ET A KV+D + + EI I+ HP
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPN 70
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKG 127
+V+L + ++I++EF GG + ++ R L+ES+ + +Q +D ++Y H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL----SHKG 183
+ HRDLK N+L G +K++DFG+SA + + + GTP ++APEV+ S
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD---FSCPTWFPVGAKSLIH 240
ADVWS G+ L + P EL+ + K+ K++ + P+ + K +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250
Query: 241 RILDPNPETRITIEEIRNDEWFRK 264
+ L+ N + R T ++ +
Sbjct: 251 KCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 5e-82
Identities = 66/261 (25%), Positives = 126/261 (48%), Gaps = 8/261 (3%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
KY IG+G V A + TG+ VA++ ++ + + I EI +M+ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKN 76
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P +V + ++++++E++ GG L D +V + E + ++ + +++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
V HRD+K +N+LL G +K++DFG A S T GTP ++APEV++ K Y G
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 194
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---DFSCPTWFPVGAKSLIHRIL 243
D+WS G++ +I G P+ + + + P + ++R L
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 244 DPNPETRITIEEIRNDEWFRK 264
D + E R + +E+ ++ +
Sbjct: 255 DMDVEKRGSAKELLQHQFLKI 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 247 bits (632), Expect = 3e-81
Identities = 84/268 (31%), Positives = 134/268 (50%), Gaps = 12/268 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y++ +G G F V TG + A K + + +++EI M ++RHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHP 83
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSK 126
+V LH+ ++ +I EF++GGELF+K+ H ++SE EA Y +Q+ G+ + H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 127 GVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
H DLKPEN++ ++ LK+ DFGL+A + S ++ T GT + APEV K
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTTGTAEFAAPEVAEGKPV 202
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF----SCPTWFPVGAKSLIH 240
G D+WS GV+ Y+L++G PF + V+ D+ S + K I
Sbjct: 203 -GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVP 268
++L +P TR+TI + W G P
Sbjct: 262 KLLLADPNTRMTIHQALEHPWLTPGNAP 289
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 245 bits (627), Expect = 2e-80
Identities = 75/267 (28%), Positives = 131/267 (49%), Gaps = 12/267 (4%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
Y++ +G G F V TG K ++ + +K EISIM + H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMNQLHH 85
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHS 125
P ++ LH+ + ++ +ILEF++GGELFD+I ++SE+E Y +Q +G+ + H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 126 KGVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
+ H D+KPEN++ +++ +KI DFGL+ +++ T T + APE++ +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP 204
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSLI 239
G D+W+ GV+ YVL++G PF D V++ D+ + AK I
Sbjct: 205 V-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGY 266
+L P R+T+ + W + +
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKGDH 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 5e-80
Identities = 76/266 (28%), Positives = 131/266 (49%), Gaps = 14/266 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
YEV TIG G++ + + + G+ + K LD ++ + + + E+++++ ++HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63
Query: 68 CVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVD 121
+VR ++ + RT +YI++E+ GG+L I + L E R QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 122 YCHSKG-----VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
CH + V HRDLKP N+ LD + ++K+ DFGL+ + S + GTP Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPVGA 235
E ++ Y +D+WS G +LY L A PF L K+ + F P +
Sbjct: 184 EQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242
Query: 236 KSLIHRILDPNPETRITIEEIRNDEW 261
+I R+L+ R ++EEI +
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 1e-79
Identities = 79/258 (30%), Positives = 137/258 (53%), Gaps = 3/258 (1%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHP 67
+ + + +G+G+F KV A+ +T + A+K L + ++ + E ++ L HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ + ++ ++ ++E++ GG+L I + S A Y ++I G+ + HSKG
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ +RDLK +N+LLD GH+KI+DFG+ G + T CGTP+Y+APE+L + Y
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NH 182
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247
+ D WS GV+LY ++ G PF D L+ + + P W AK L+ ++ P
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREP 242
Query: 248 ETRITIE-EIRNDEWFRK 264
E R+ + +IR FR+
Sbjct: 243 EKRLGVRGDIRQHPLFRE 260
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 241 bits (617), Expect = 1e-79
Identities = 103/273 (37%), Positives = 155/273 (56%), Gaps = 11/273 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y+ +G G F++V A++ T + VA+K + + A+ + ++ EI+++ ++HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHP 67
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V L ++ S +Y+I++ ++GGELFD+IV G +E +A R Q++D V Y H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 128 VYHRDLKPENLLL---DSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPENLL D + ISDFGLS + + G S+L T CGTP YVAPEVL+ K Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY 186
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSCPTW--FPVGAKSLIH 240
A D WS GVI Y+L+ GY PF + + L+ ++ KA+ F P W AK I
Sbjct: 187 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245
Query: 241 RILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273
+++ +PE R T E+ W K I
Sbjct: 246 HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIH 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 240 bits (614), Expect = 1e-79
Identities = 83/276 (30%), Positives = 139/276 (50%), Gaps = 18/276 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH------KMADQIKREISIM 61
YE +G G + V+ + T + A+K++D + ++ + +E+ I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 62 KLVR-HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
+ V HP +++L + + T +++ + + GELFD + LSE E R+ + L++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
H + HRDLKPEN+LLD ++K++DFG S + G LR CGTP+Y+APE++
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 182
Query: 181 -----HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--FSCPTW--F 231
+ G D+WS GVI+Y L+AG PF + + + F P W +
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242
Query: 232 PVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267
K L+ R L P+ R T EE +F++ YV
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ-YV 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (603), Expect = 3e-77
Identities = 71/264 (26%), Positives = 126/264 (47%), Gaps = 13/264 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + +G G F V T + ++ K + +K +K+EISI+ + RH
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHR 61
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSK 126
++ LHE S ++ +I EFI+G ++F++I L+E E Y Q+ + + + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 127 GVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ H D++PEN++ ++ +KI +FG + + G R P Y APEV H
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV 180
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSLIH 240
A D+WS G ++YVL++G PF + + A+++ + A +
Sbjct: 181 -STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 241 RILDPNPETRITIEEIRNDEWFRK 264
R+L ++R+T E W ++
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQ 263
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 1e-76
Identities = 66/317 (20%), Positives = 121/317 (38%), Gaps = 57/317 (17%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+E +G G V + +G +A K++ IK + +QI RE+ ++ P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK- 126
+V + S +I I +E + GG L + GR+ E + +I G+ Y K
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
+ HRD+KP N+L++S+G +K+ DFG+S ++ + GT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHY-S 181
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVG------------ 234
+D+WS G+ L + G P D L P
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 235 --------------------------------AKSLIHRILDPNPETRITIEEIRNDEWF 262
+ +++ L NP R ++++ +
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 263 RKGYVPVKLIEYEDVNL 279
++ + E+V+
Sbjct: 302 KR-------SDAEEVDF 311
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 1e-75
Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM---ADQIKREISIMKL 63
+Y+VG +G G F V VA+K +++ I ++ E+ ++K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 64 VR--HPCVVRLHEVLASRTKIYIILEFITGG-ELFDKIVHHGRLSESEARRYFQQLIDGV 120
V V+RL + +ILE +LFD I G L E AR +F Q+++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 121 DYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
+CH+ GV HRD+K EN+L+D ++G LK+ DFG AL + ++ GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWI 181
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLI 239
+ Y+G +A VWS G++LY ++ G +PF+ ++ + + LI
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQVFFRQRVSSECQHLI 235
Query: 240 HRILDPNPETRITIEEIRNDEWFRKGYVPVKLIE 273
L P R T EEI+N W + +P + E
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 231 bits (591), Expect = 1e-75
Identities = 86/261 (32%), Positives = 149/261 (57%), Gaps = 9/261 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+++ RT+G G+F +V ++ G AMKVL + +++ K + E ++ +V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++R+ +I++I+++I GGELF + R A+ Y ++ ++Y HSK +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPEN+LLD GH+KI+DFG + + + T CGTP+Y+APEV+S K Y +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVSTKPY-NKS 181
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNPE 248
D WS G+++Y ++AGY PF + + Y K+ A+ P +F K L+ R++ +
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 241
Query: 249 TRI-----TIEEIRNDEWFRK 264
R+ E+++N WF++
Sbjct: 242 QRLGNLQNGTEDVKNHPWFKE 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 3e-75
Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 16/268 (5%)
Query: 7 GKY-EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
G++ + IG G+F V +TET VA L + K + + K E ++K ++
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 66
Query: 66 HPCVVRLHEVLASRTK----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
HP +VR ++ S K I ++ E +T G L + + R + +Q++ G+
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 122 YCHSKG--VYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
+ H++ + HRDLK +N+ + G +KI D GL+ L S + GTP ++APE+
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEM 184
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLYSKVEKA--DFSCPTWFPVGA 235
K + DV++ G+ + + P+ E + +Y +V S
Sbjct: 185 YEEKY--DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 236 KSLIHRILDPNPETRITIEEIRNDEWFR 263
K +I + N + R +I+++ N +F+
Sbjct: 243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (586), Expect = 1e-74
Identities = 84/261 (32%), Positives = 134/261 (51%), Gaps = 6/261 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ + +G+GTF KV + TG AMK+L + II E +++ RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ L + ++ ++E+ GGELF + +E AR Y +++ ++Y HS+
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V +RD+K ENL+LD GH+KI+DFGL + ++T CGTP Y+APEVL Y G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 184
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247
A D W GV++Y ++ G LPF D L+ + + P AKSL+ +L +P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 248 ETRI-----TIEEIRNDEWFR 263
+ R+ +E+ +F
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL 265
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 227 bits (579), Expect = 3e-73
Identities = 79/266 (29%), Positives = 130/266 (48%), Gaps = 13/266 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--- 65
+ V R IG G F +V + +TG+ AMK LD+ I + E ++ LV
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
P +V + + K+ IL+ + GG+L + HG SE++ R Y ++I G+++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ V +RDLKP N+LLD GH++ISD GL+ + + GT Y+APEVL
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAY 183
Query: 186 GAAADVWSCGVILYVLIAGYLPFD---ELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242
++AD +S G +L+ L+ G+ PF D + P F +SL+ +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243
Query: 243 LDPNPETRIT-----IEEIRNDEWFR 263
L + R+ +E++ +FR
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 1e-72
Identities = 91/268 (33%), Positives = 146/268 (54%), Gaps = 13/268 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK---MADQIKREISIMKLV 64
Y+ G +G G FA VK + TG A K + + + + I+RE+SI+K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+HP V+ LHEV ++T + +ILE + GGELFD + L+E EA + +Q+++GV Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 125 SKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
S + H DLKPEN++L + +KI DFGL+ + G + + GTP +VAPE+++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVN 189
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVG----AK 236
++ G AD+WS GVI Y+L++G PF + V ++ + AK
Sbjct: 190 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 237 SLIHRILDPNPETRITIEEIRNDEWFRK 264
I R+L +P+ R+TI++ W +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-71
Identities = 91/304 (29%), Positives = 144/304 (47%), Gaps = 29/304 (9%)
Query: 6 VGKYEV-GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KL 63
+ Y+V + +G G KV N T E A+K+L + + +RE+ + +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 61
Query: 64 VRHPCVVRLHEVL----ASRTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLI 117
+ P +VR+ +V A R + I++E + GGELF +I G +E EA + +
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
+ + Y HS + HRD+KPENLL S+ LK++DFG + + L T C TP YV
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYV 180
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVE------KADFSCP 228
APEVL + Y + D+WS GVI+Y+L+ GY PF + ++ + +F P
Sbjct: 181 APEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 229 TW--FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLDDVNAAF 286
W K LI +L P R+TI E N W + + + L + +
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 299
Query: 287 DDSE 290
+D +
Sbjct: 300 EDVK 303
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 6e-71
Identities = 61/261 (23%), Positives = 117/261 (44%), Gaps = 16/261 (6%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
G+ VG+ IG G+F V + VA+K+L+ +A ++ K E+ +++ RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRH 63
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHS 125
++ ++ ++ I+ ++ G L+ + + + + +Q G+DY H+
Sbjct: 64 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSAL--PEQGVSLLRTTCGTPNYVAPEVLSHKG 183
K + HRDLK N+ L +KI DFGL+ + G G+ ++APEV+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 184 YN--GAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------SCPTWFPVGA 235
N +DV++ G++LY L+ G LP+ ++ + + + P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 236 KSLIHRILDPNPETRITIEEI 256
K L+ L + R +I
Sbjct: 243 KRLMAECLKKKRDERPLFPQI 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (562), Expect = 7e-71
Identities = 87/262 (33%), Positives = 146/262 (55%), Gaps = 9/262 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+++ +T+G G+F +V ++ E+G AMK+LD+ ++K K + E I++ V P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L + +Y+++E++ GGE+F + GR SE AR Y Q++ +Y HS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ +RDLKPENLL+D QG+++++DFG + ++ T CGTP +APE++ KGYN
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIILSKGYN-K 217
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDPNP 247
A D W+ GV++Y + AGY PF +Y K+ P+ F K L+ +L +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 248 ETRI-----TIEEIRNDEWFRK 264
R + +I+N +WF
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 216 bits (551), Expect = 3e-70
Identities = 65/265 (24%), Positives = 119/265 (44%), Gaps = 13/265 (4%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+YE+G +G G ++V A++ VA+KVL + +RE + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 67 PCVVRLHEVLASRTK----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
P +V +++ + T YI++E++ G L D + G ++ A +++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL---PEQGVSLLRTTCGTPNYVAPEVL 179
H G+ HRD+KP N+++ + +K+ DFG++ V+ GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT----WFPVGA 235
A +DV+S G +LY ++ G PF ++ + + D P+
Sbjct: 187 RGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 236 KSLIHRILDPNPETRI-TIEEIRND 259
+++ + L NPE R T E+R D
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-66
Identities = 64/256 (25%), Positives = 114/256 (44%), Gaps = 16/256 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ ++ +TIG+G F V G VA+K + A E S+M +RH
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK-----NDATAQAFLAEASVMTQLRHS 60
Query: 68 CVVRLHEVLA-SRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCH 124
+V+L V+ + +YI+ E++ G L D + GR L ++ + + ++Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
HRDL N+L+ K+SDFGL+ ++ S T + APE L K +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF 177
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRI 242
+ +DVWS G++L+ + + G +P+ + L + +VEK P P ++
Sbjct: 178 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNC 236
Query: 243 LDPNPETRITIEEIRN 258
+ R + ++R
Sbjct: 237 WHLDAAMRPSFLQLRE 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 4e-66
Identities = 73/300 (24%), Positives = 119/300 (39%), Gaps = 41/300 (13%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+Y IGEG + V A + VA+K + + REI I+ RH
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 67 PCVVRLHEVLASRT----KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
++ +++++ + T K ++ + G +L+ ++ LS + Q++ G+ Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKY 124
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL---PEQGVSLLRTTCGTPNYVAPEVL 179
HS V HRDLKP NLLL++ LKI DFGL+ + L T Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPF--------------------DELDLTTLYSK 219
+ + D+WS G IL +++ F E + K
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 220 VEKADFSCPTWFPVG-----------AKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268
S P V A L+ ++L NP RI +E+ + + Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 9e-66
Identities = 73/314 (23%), Positives = 122/314 (38%), Gaps = 45/314 (14%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+V KYE IG+GTF +V A++ +TG+ VA+K + K REI I+
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKIL 63
Query: 62 KLVRHPCVVRLHEVLASRT--------KIYIILEFITGGELFDKIVHHGRLSESEARRYF 113
+L++H VV L E+ ++ IY++ +F + + SE +R
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS----LLRTTCG 169
Q L++G+ Y H + HRD+K N+L+ G LK++DFGL+ +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT 229
T Y PE+L + G D+W G I+ + + + + S
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 230 WFPVG--------------------------------AKSLIHRILDPNPETRITIEEIR 257
A LI ++L +P RI ++
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 258 NDEWFRKGYVPVKL 271
N ++F +P L
Sbjct: 304 NHDFFWSDPMPSDL 317
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 2e-65
Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 31/292 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ IGEGT+ V A+N TGE VA+K + R + REIS++K + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 61
Query: 68 CVVRLHEVLASRTKIYIILEFI-TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+V+L +V+ + K+Y++ EF+ + F + + Y QL+ G+ +CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
V HRDLKP+NLL++++G +K++DFGL+ V T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA------------------DFSCP 228
A D+WS G I ++ F ++ + S P
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 229 TWFPVG-----------AKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269
W +SL+ ++L +P RI+ + +F+ PV
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-65
Identities = 68/289 (23%), Positives = 112/289 (38%), Gaps = 30/289 (10%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK--MADQIKREISIMKLVRHP 67
E +GEG FA V A++ T + VA+K + + K + REI +++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++ L + ++ I ++ +F+ + L+ S + Y + G++Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ HRDLKP NLLLD G LK++DFGL+ T Y APE+L G
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTW--------------- 230
D+W+ G IL L+ +++ + + W
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 231 -----------FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268
LI + NP RIT + ++F P
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-64
Identities = 58/251 (23%), Positives = 112/251 (44%), Gaps = 10/251 (3%)
Query: 13 RTIGEGTFAKVKFA--QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70
+ +G G F VK Q + ++VA+K+L A + D++ E ++M+ + +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
R+ + +++E G L + + + + Q+ G+ Y H
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGA 187
RDL N+LL +Q + KISDFGLS + + + APE +++ + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 189
Query: 188 AADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDP 245
+DVWS GV+++ + G P+ + + + + +EK + CP P L++
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 246 NPETRITIEEI 256
+ E R +
Sbjct: 250 DVENRPGFAAV 260
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 201 bits (511), Expect = 4e-64
Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 31/286 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY IGEGT+ V AQN GE+ A+K + + REISI+K ++H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHS 60
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L++V+ ++ ++ ++ E + V G L A+ + QL++G+ YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V HRDLKP+NLL++ +G LKI+DFGL+ V T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA--DFSCPTW--------------- 230
D+WS G I ++ G F + ++ + + W
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 231 ------------FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264
L+ ++L +P RIT ++ +F++
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 9e-64
Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 12/260 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQ---NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+ +G+G+F V+ + + SVA+K L + + + D RE++ M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCH 124
H ++RL+ V+ + + ++ E G L D++ H G RY Q+ +G+ Y
Sbjct: 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSH 181
SK HRDL NLLL ++ +KI DFGL Q + APE L
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 182 KGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD--FSCPTWFPVGAKSL 238
+ + A+D W GV L+ + G P+ L+ + + K++K P P ++
Sbjct: 189 RTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 239 IHRILDPNPETRITIEEIRN 258
+ + PE R T +R+
Sbjct: 248 MVQCWAHKPEDRPTFVALRD 267
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-63
Identities = 82/320 (25%), Positives = 133/320 (41%), Gaps = 45/320 (14%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y + +G G + V A + TG VA+K L R A + RE+ ++K +RH
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHE 77
Query: 68 CVVRLHEV------LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
V+ L +V L T Y+++ F+ G K++ H +L E + Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
Y H+ G+ HRDLKP NL ++ LKI DFGL+ + S + T Y APEV+ +
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILN 192
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVG------- 234
D+WS G I+ +I G F D ++ K + P F
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 235 ------------------------AKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270
A +L+ ++L + E R+T E +F +
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312
Query: 271 LIEYE--DVNLDDVNAAFDD 288
+ + D + DDV+ D+
Sbjct: 313 EPQVQKYDDSFDDVDRTLDE 332
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 4e-63
Identities = 53/255 (20%), Positives = 117/255 (45%), Gaps = 10/255 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F VK+ + VA+K++ ++ + D+ E +M + H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L+ V + I+II E++ G L + + R + + + + ++Y SK
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
HRDL N L++ QG +K+SDFGLS + + + + + PEVL + ++
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS- 179
Query: 187 AAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILD 244
+ +D+W+ GV+++ + + G +P++ + + + P ++++
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239
Query: 245 PNPETRITIEEIRND 259
+ R T + + ++
Sbjct: 240 EKADERPTFKILLSN 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 1e-62
Identities = 67/255 (26%), Positives = 110/255 (43%), Gaps = 10/255 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G G + +V + +VA+K L + ++ +E ++MK ++HP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHP 73
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHS 125
+V+L V YII EF+T G L D + R +S Q+ ++Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT-TCGTPNYVAPEVLSHKGY 184
K HRDL N L+ +K++DFGLS L + APE L++ +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 185 NGAAADVWSCGVILYVLI-AGYLPFDELDLTTLYSKVEK-ADFSCPTWFPVGAKSLIHRI 242
+DVW+ GV+L+ + G P+ +DL+ +Y +EK P P L+
Sbjct: 194 -SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252
Query: 243 LDPNPETRITIEEIR 257
NP R + EI
Sbjct: 253 WQWNPSDRPSFAEIH 267
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-62
Identities = 87/279 (31%), Positives = 147/279 (52%), Gaps = 18/279 (6%)
Query: 4 RKVG--KYEVGRTIGEGTFAKVKFAQ---NTETGESVAMKVLDRSAII-KHKMADQIKRE 57
KVG +E+ + +G G + KV + +TG+ AMKVL ++ I+ K K + + E
Sbjct: 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78
Query: 58 ISIMKLVRH-PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQL 116
+++ +R P +V LH + TK+++IL++I GGELF + R +E E + Y ++
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVA 175
+ +++ H G+ +RD+K EN+LLDS GH+ ++DFGLS CGT Y+A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 176 PEVLSHKGYN-GAAADVWSCGVILYVLIAGYLPFDELD----LTTLYSKVEKADFSCPTW 230
P+++ A D WS GV++Y L+ G PF + ++ K++ P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258
Query: 231 FPVGAKSLIHRILDPNPETRI-----TIEEIRNDEWFRK 264
AK LI R+L +P+ R+ +EI+ +F+K
Sbjct: 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 8e-62
Identities = 81/291 (27%), Positives = 122/291 (41%), Gaps = 31/291 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KYE IGEGT+ V A+N ET E VA+K + + REI ++K ++H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHK 61
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+VRLH+VL S K+ ++ EF +G L + + QL+ G+ +CHS+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V HRDLKP+NLL++ G LK+++FGL+ V T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 188 AADVWSCGVILYVLIAGYLP-FDELDLTTLYSKVEKADFS-------------------- 226
+ D+WS G I L P F D+ ++ + +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 227 ---------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268
+ L+ +L NP RI+ EE +F P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-62
Identities = 61/251 (24%), Positives = 109/251 (43%), Gaps = 12/251 (4%)
Query: 15 IGEGTFAKVKFAQN--TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+G G F V+ + VA+KVL + + +++ RE IM + +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 73 HEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
V + +++E GG L +V + S Q+ G+ Y K HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 132 DLKPENLLLDSQGHLKISDFGLSAL---PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
DL N+LL ++ + KISDFGLS + + + APE ++ + ++ +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 192
Query: 189 ADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRILDPN 246
+DVWS GV ++ ++ G P+ ++ + + +E+ CP P +L+
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 247 PETRITIEEIR 257
E R +
Sbjct: 253 WEDRPDFLTVE 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-61
Identities = 65/262 (24%), Positives = 121/262 (46%), Gaps = 14/262 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ +G G F +V VA+K L + ++ D E ++MK ++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHS 125
+VRL+ V+ ++ IYII E++ G L D + +L+ ++ Q+ +G+ +
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHKGY 184
+ HRDL+ N+L+ KI+DFGL+ L E R + APE +++ G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GT 186
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRI 242
+DVWS G++L ++ G +P+ + + +E+ P P L+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 243 LDPNPETRITIEEIRN--DEWF 262
PE R T + +R+ +++F
Sbjct: 247 WKERPEDRPTFDYLRSVLEDFF 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 2e-61
Identities = 65/261 (24%), Positives = 109/261 (41%), Gaps = 14/261 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
++ + IG G F +V G+ VA+K L K E SIM
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFD 85
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFD-KIVHHGRLSESEARRYFQQLIDGVDYCH 124
HP V+ L V+ T + II EF+ G L + G+ + + + + G+ Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-----CGTPNYVAPEVL 179
HRDL N+L++S K+SDFGLS E S T + APE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 180 SHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKS 237
++ + A+DVWS G++++ +++ G P+ ++ + + +E+ P P
Sbjct: 206 QYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 238 LIHRILDPNPETRITIEEIRN 258
L+ + R +I N
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVN 285
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-61
Identities = 67/262 (25%), Positives = 114/262 (43%), Gaps = 14/262 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G+G F +V T VA+K L + + +E +MK +RH
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHS 125
+V+L+ V+ S IYI+ E+++ G L D + L + Q+ G+ Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHKGY 184
HRDL+ N+L+ K++DFGL+ L E R + APE + +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRI 242
+DVWS G++L L G +P+ + + +VE+ CP P L+ +
Sbjct: 192 T-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250
Query: 243 LDPNPETRITIEEIRN--DEWF 262
PE R T E ++ +++F
Sbjct: 251 WRKEPEERPTFEYLQAFLEDYF 272
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-60
Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 39/296 (13%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ +G G + V A +T+TG VA+K L R A + RE+ ++K ++H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHE 77
Query: 68 CVVRLHEVLASRTKI----YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
V+ L +V + + L G + IV +L++ + Q++ G+ Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
HS + HRDLKP NL ++ LKI DFGL+ + ++ T Y APE++ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---GYVATRWYRAPEIMLNWM 194
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVG--------- 234
+ D+WS G I+ L+ G F D + + +
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 235 ----------------------AKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268
A L+ ++L + + RIT + +F + + P
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-60
Identities = 58/285 (20%), Positives = 109/285 (38%), Gaps = 37/285 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGES-----VAMKVLDRSAIIKHKMADQIKREISIM- 61
E G+ +G G F KV A ++ VA+K+L A + + E+ +M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-------------------- 101
+L H +V L IY+I E+ G+L + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 102 ---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL-- 156
L+ + + Q+ G+++ K HRDL N+L+ +KI DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215
+ + ++APE L Y +DVWS G++L+ + + G P+ + +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 216 LYSKVEKADF--SCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258
+ K+ + F P + ++ + R + + +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-60
Identities = 72/299 (24%), Positives = 115/299 (38%), Gaps = 47/299 (15%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
Y + IG G+F V A+ ++GE VA+K + + K RE+ IM+ + H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHCN 74
Query: 69 VVRLHEVLAS------RTKIYIILEFITGG---ELFDKIVHHGRLSESEARRYFQQLIDG 119
+VRL S + ++L+++ L + Y QL
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
+ Y HS G+ HRD+KP+NLLLD LK+ DFG + +G + + Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPEL 193
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW-------- 230
+ ++ DVWS G +L L+ G F ++ K +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 231 ---------------------FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268
P A +L R+L+ P R+T E +F + P
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-60
Identities = 68/259 (26%), Positives = 112/259 (43%), Gaps = 11/259 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ E+GR IGEG F V VA+K + ++ +E M+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFD-KIVHHGRLSESEARRYFQQLIDGVDYC 123
HP +V+L V+ + ++II+E T GEL V L + Y QL + Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHK 182
SK HRD+ N+L+ S +K+ DFGLS E + ++APE ++ +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 183 GYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIH 240
+ A+DVW GV ++ +L+ G PF + + ++E + P P SL+
Sbjct: 185 RFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243
Query: 241 RILDPNPETRITIEEIRND 259
+ +P R E++
Sbjct: 244 KCWAYDPSRRPRFTELKAQ 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-60
Identities = 68/298 (22%), Positives = 112/298 (37%), Gaps = 26/298 (8%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHP 67
+ IGEG F +V A+ + G + + E+ ++ KL HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH----------------GRLSESEARR 111
++ L R +Y+ +E+ G L D + LS +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
+ + G+DY K HRDL N+L+ KI+DFGLS E V
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPV 190
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPT 229
++A E L++ +DVWS GV+L+ +++ G P+ + LY K+ + P
Sbjct: 191 RWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 249
Query: 230 WFPVGAKSLIHRILDPNPETRITIEEIRN--DEWF--RKGYVPVKLIE-YEDVNLDDV 282
L+ + P R + +I + RK YV L E + +D
Sbjct: 250 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 7e-60
Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 7/257 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR--SAIIKHKMADQIKREISIMKLVRH 66
++ + +G G F V GE V + V + K +I E +M V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P V RL + + T I G L H + + Q+ G++Y +
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC--GTPNYVAPEVLSHKGY 184
+ HRDL N+L+ + H+KI+DFGL+ L ++A E + H+ Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRI 242
+DVWS GV ++ L+ G P+D + + + S +EK + P + ++ +
Sbjct: 191 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 243 LDPNPETRITIEEIRND 259
+ ++R E+ +
Sbjct: 250 WMIDADSRPKFRELIIE 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-59
Identities = 55/252 (21%), Positives = 101/252 (40%), Gaps = 10/252 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ IG G F V + VA+K + A+ + + E +M + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFD-KIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L+ V + I ++ EF+ G L D G + + +G+ Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGL-SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
V HRDL N L+ +K+SDFG+ + + + T + +PEV S Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-S 180
Query: 187 AAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILD 244
+ +DVWS GV+++ + + G +P++ + + + P +++
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240
Query: 245 PNPETRITIEEI 256
PE R +
Sbjct: 241 ERPEDRPAFSRL 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 2e-59
Identities = 57/300 (19%), Positives = 107/300 (35%), Gaps = 28/300 (9%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
M +R +Y +GR IG G+F + + GE VA+K+ Q+ E I
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKI 55
Query: 61 MKLVRHP-CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDG 119
K+++ + + A +++E + + S Q+I
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSL-------LRTTCG 169
++Y HSK HRD+KP+N L+ + I DFGL+ + + G
Sbjct: 116 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---- 225
T Y + + D+ S G +L G LP+ L T K E+
Sbjct: 176 TARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
Query: 226 ----SCPTWFPVGAKSLIHRILDPNPETRITIEEIRN---DEWFRKGYVPVKLIEYEDVN 278
+P + ++ + + +R + + R+G+ + ++ +
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-59
Identities = 76/297 (25%), Positives = 120/297 (40%), Gaps = 40/297 (13%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTET-GESVAMKVLDRSAIIKHKMADQIKREISIMK 62
R +YE IGEG + KV A++ + G VA+K + R + M RE+++++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLR 62
Query: 63 L---VRHPCVVRLHEVLAS-----RTKIYIILEFITGGEL-FDKIVHHGRLSESEARRYF 113
HP VVRL +V TK+ ++ E + + V + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY 173
QL+ G+D+ HS V HRDLKP+N+L+ S G +K++DFGL+ + ++L + T Y
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWY 181
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS------- 226
APEVL Y D+WS G I + F K+
Sbjct: 182 RAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 227 --------------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFR 263
T K L+ + L NP RI+ + +F+
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 189 bits (481), Expect = 5e-59
Identities = 65/298 (21%), Positives = 121/298 (40%), Gaps = 52/298 (17%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRH 66
Y++ R +G G +++V A N E V +K I+K +IKREI I++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGG 89
Query: 67 PCVVRLHEVLASRTK--IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
P ++ L +++ ++ E + + + L++ + R Y +++ +DYCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQ---LYQTLTDYDIRFYMYEILKALDYCH 146
Query: 125 SKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
S G+ HRD+KP N+++D + L++ D+GL+ G + + PE+L
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQ 205
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDE--------------LDLTTLYSKVEKADFSCPT 229
+ D+WS G +L +I PF L LY ++K +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 230 WFPVG------------------------AKSLIHRILDPNPETRITIEEIRNDEWFR 263
F A + ++L + ++R+T E +F
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 4e-58
Identities = 64/282 (22%), Positives = 108/282 (38%), Gaps = 36/282 (12%)
Query: 8 KYEVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
E R IGEG F +V E VA+K+L A M +RE ++M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR------------------- 103
+P +V+L V A + ++ E++ G+L + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 104 -----LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158
LS +E +Q+ G+ Y + HRDL N L+ +KI+DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 159 QGVSLLRTT--CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYL-PFDELDLTT 215
++ PE + + Y +DVW+ GV+L+ + + L P+ +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 216 LYSKVEKADF-SCPTWFPVGAKSLIHRILDPNPETRITIEEI 256
+ V + +CP P+ +L+ P R + I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-56
Identities = 62/260 (23%), Positives = 105/260 (40%), Gaps = 13/260 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ IG G F +V + VA+K L K ++ E IM
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQF 66
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYC 123
H ++RL V++ + II E++ G L + G S + + + G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC---GTPNYVAPEVLS 180
+ HRDL N+L++S K+SDFGLS + E TT + APE +S
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 181 HKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSL 238
++ + A+DVWS G++++ ++ G P+ EL + + P P L
Sbjct: 187 YRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 239 IHRILDPNPETRITIEEIRN 258
+ + R +I +
Sbjct: 246 MMQCWQQERARRPKFADIVS 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 9e-56
Identities = 63/278 (22%), Positives = 112/278 (40%), Gaps = 32/278 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIM- 61
+ G+T+G G F KV A ++ +VA+K+L SA + + + + E+ ++
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG------------------R 103
L H +V L +I E+ G+L + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
L + + Q+ G+ + SK HRDL N+LL KI DFGL+ + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 164 LRTT--CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKV 220
+ ++APE + +DVWS G+ L+ L + G P+ + + + + K+
Sbjct: 202 VVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 221 EKADFS--CPTWFPVGAKSLIHRILDPNPETRITIEEI 256
K F P P ++ D +P R T ++I
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 178 bits (453), Expect = 3e-55
Identities = 48/273 (17%), Positives = 96/273 (35%), Gaps = 27/273 (9%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
Y+VGR IGEG+F + N + VA+K + A Q++ E KL+
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAG 59
Query: 67 -PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+ ++ ++++ + + + S +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 126 KGVYHRDLKPENLLLDSQ-----GHLKISDFGLSALPEQGVS-------LLRTTCGTPNY 173
K + +RD+KP+N L+ + + DFG+ V+ + GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW--- 230
++ + D+ + G + + G LP+ L T K E+ +
Sbjct: 180 MSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 231 -----FPVGAKSLIHRILDPNPETRITIEEIRN 258
FP +H + + + ++
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-54
Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 31/280 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGES-------VAMKVLDRSAIIKHKMADQIKREISI 60
+ +G+ +GEG F +V A+ + VA+K+L A K + E+ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 61 MK-LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG----------------R 103
MK + +H ++ L +Y+I+E+ + G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
LS + Q+ G++Y SK HRDL N+L+ +KI+DFGL+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 164 LRT--TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKV 220
+T ++APE L + Y +DVWS GV+L+ + G P+ + + L+ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 221 EKAD-FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259
++ P+ ++ P R T +++ D
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (448), Expect = 7e-54
Identities = 74/313 (23%), Positives = 123/313 (39%), Gaps = 54/313 (17%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+Y+ + IG G V A + +VA+K L R A + RE+ +MK V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNH 75
Query: 67 PCVVRLHEV------LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
++ L V L +Y+++E + V L Q++ G+
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGI 132
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
+ HS G+ HRDLKP N+++ S LKI DFGL+ ++ T Y APEV+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVIL 191
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV-------------------- 220
GY D+WS G I+ ++ + F D ++KV
Sbjct: 192 GMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 221 -------EKADFSCPTWFPVG---------------AKSLIHRILDPNPETRITIEEIRN 258
+ A + P FP A+ L+ ++L +P RI++++
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
Query: 259 DEWFRKGYVPVKL 271
+ Y P ++
Sbjct: 311 HPYINVWYDPAEV 323
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-52
Identities = 62/258 (24%), Positives = 105/258 (40%), Gaps = 14/258 (5%)
Query: 12 GRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
IG G F V N A+K L+R I Q E IMK HP
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 69 VVRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSK 126
V+ L + L S ++L ++ G+L + I + + + + Q+ G+ + SK
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSAL----PEQGVSLLRTTCGTPNYVAPEVLSHK 182
HRDL N +LD + +K++DFGL+ V ++A E L
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT- 208
Query: 183 GYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIH 240
+DVWS GV+L+ L+ G P+ +++ + + + P + P ++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268
Query: 241 RILDPNPETRITIEEIRN 258
+ P E R + E+ +
Sbjct: 269 KCWHPKAEMRPSFSELVS 286
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-52
Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 28/282 (9%)
Query: 8 KYEVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
K + R +G+G+F V K E VA+K ++ +A ++ + + E S+MK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----------LSESEARRY 112
VVRL V++ +I+E +T G+L + S S+ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 113 FQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGT 170
++ DG+ Y ++ HRDL N ++ +KI DFG++ + +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLYSKVEKAD-FSCP 228
+++PE L + +DVWS GV+L+ + P+ L + V + P
Sbjct: 199 VRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 229 TWFPVGAKSLIHRILDPNPETRITIEEIRN------DEWFRK 264
P L+ NP+ R + EI + + FR+
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-50
Identities = 59/278 (21%), Positives = 105/278 (37%), Gaps = 29/278 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+ ++G+ +G G F +V A T T +VA+K+L A + ++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIH 72
Query: 63 LVRHPCVVRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR----------------LS 105
+ H VV L + +I+EF G L + L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 106 ESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165
Y Q+ G+++ S+ HRDL N+LL + +KI DFGL+ + +R
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 166 TT--CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY-LPFDELDLTTLYSKV-- 220
++APE + + Y +DVWS GV+L+ + + P+ + + + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 221 EKADFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258
E P + + P R T E+
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-48
Identities = 51/294 (17%), Positives = 107/294 (36%), Gaps = 50/294 (17%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+ +IG+G F +V GE VA+K+ + + + + EI ++RH
Sbjct: 3 RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 67 PCVVRLHEVL----ASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
++ + T+++++ ++ G LFD + + ++ + G+ +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115
Query: 123 CHS--------KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT----CGT 170
H + HRDLK +N+L+ G I+D GL+ + + GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 171 PNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAGYLPFD---------------E 210
Y+APEVL + AD+++ G++ + + +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 211 LDLTTLYSKV--EKADFSCPTWF-----PVGAKSLIHRILDPNPETRITIEEIR 257
+ + V +K + P + ++ N R+T I+
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (366), Expect = 1e-41
Identities = 59/330 (17%), Positives = 112/330 (33%), Gaps = 79/330 (23%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K +Y + R +G G F+ V A++ VAMK++ + + + EI +++ V
Sbjct: 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRV 66
Query: 65 RHPCVVRL-------------HEVLASRTKIYIILEFITGG---ELFDKIVHHGRLSESE 108
+ H +++++ F G K H +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 109 ARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQG------HLKISDFGLSALPEQGV 161
++ +QL+ G+DY H + G+ H D+KPEN+L++ +KI+D G + ++
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY---- 217
+ T Y +PEVL + G AD+WS +++ LI G F+ + +
Sbjct: 187 ---TNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242
Query: 218 --------------------------------------------SKVEKADFSCPTWFPV 233
V +
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302
Query: 234 GAKSLIHRILDPNPETRITIEEIRNDEWFR 263
+ +L +P R + N W +
Sbjct: 303 EISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 1e-20
Identities = 33/217 (15%), Positives = 66/217 (30%), Gaps = 52/217 (23%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD---------------Q 53
+G+ +GEG + V + E +K K+ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 54 IKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYF 113
+ E ++ ++ V +++ +++E I R+
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAK-------ELYRVRVENPDEVL 109
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY 173
+++ V + +G+ H DL N+L+ +G + I DF S G
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS-----------VEVGEEG- 156
Query: 174 VAPEVLSHKGYN---------GAAADVWSCGVILYVL 201
E+L N D+ S I +L
Sbjct: 157 -WREILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.16 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.14 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.41 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-63 Score=413.08 Aligned_cols=258 Identities=33% Similarity=0.674 Sum_probs=240.2
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++++|++.+.||+|+||+||+|+++.+++.||+|++......+......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 36789999999999999999999999999999999987666566667788999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||+++++|.+++.+.+.+++..+..++.|+++||.|||++||+|+||||+||+++.++.+||+|||++....... .
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--~ 161 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--R 161 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--C
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc--c
Confidence 99999999999999998899999999999999999999999999999999999999999999999999997665432 3
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....|++.|+|||++.+..++ .++|||||||++|+|++|+.||...+..+...++.......|..+|+++.+|+.+||+
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 240 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 240 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence 355789999999999988776 9999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccC
Q 022444 245 PNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 245 ~~p~~Rps~~~il~~p~~~~~ 265 (297)
+||++|||++|+|+||||+..
T Consensus 241 ~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 241 HNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp SSGGGSCCHHHHHTCHHHHHH
T ss_pred CCHhHCcCHHHHHcCcCcCCc
Confidence 999999999999999999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-61 Score=406.19 Aligned_cols=260 Identities=31% Similarity=0.589 Sum_probs=236.0
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+-++|++.+.||+|+||+||+|+++.+|+.||||++...........+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999987665556667789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc--c
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV--S 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~--~ 162 (297)
||||+++++|.+++...+.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999997654322 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHh
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~ 242 (297)
......|++.|+|||++.+..++ .++|||||||++|+|++|..||...+.....+++......++..+++++.+||++|
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTT
T ss_pred ccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 23455799999999999888876 89999999999999999999999999999999999998889999999999999999
Q ss_pred cCCCcCCCCCHHH------HhcCcccccC
Q 022444 243 LDPNPETRITIEE------IRNDEWFRKG 265 (297)
Q Consensus 243 L~~~p~~Rps~~~------il~~p~~~~~ 265 (297)
|+.||++|||++| +++||||+..
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 9999999999998 5889999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-60 Score=408.77 Aligned_cols=260 Identities=32% Similarity=0.601 Sum_probs=244.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++++|++++.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 67899999999999999999999999999999999987665555567788899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||+++|+|.+++.+.+.+++..++.++.|++.||.|||++||+|+||||+||+++.+|.+||+|||+++.........
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998776655566
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
...+|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...+.+.+......+|..+++++.+||++||+
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~ 241 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhcc
Confidence 677899999999999988886 9999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCC-----HHHHhcCcccccC
Q 022444 245 PNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 245 ~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
+||++|++ ++++++||||++.
T Consensus 242 ~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 242 KDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCchhhcccccccHHHHHcCcccccC
Confidence 99999995 8999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-61 Score=403.95 Aligned_cols=259 Identities=39% Similarity=0.694 Sum_probs=221.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
..++|++++.||+|+||+||+|+++.+|+.||||++...... +..+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 367899999999999999999999999999999999765422 234568899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc--c
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV--S 162 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~--~ 162 (297)
||||+++++|.+++.+...+++..++.++.|+++||.|||++||+|+||||+||+++.++.+||+|||++....... .
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998654332 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhhhccc--cCCCCCChhHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT-LYSKVEKADF--SCPTWFPVGAKSLI 239 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-~~~~i~~~~~--~~~~~~~~~l~~li 239 (297)
......|++.|+|||++.+..+++.++|||||||++|+|++|+.||....... .......... .....+++++.+|+
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 23456799999999999888776688999999999999999999997654332 2223222222 22245899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 240 HRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+||+.||++|||++|+|+||||++.
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 99999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-60 Score=402.54 Aligned_cols=254 Identities=25% Similarity=0.466 Sum_probs=227.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 479999999999999999999999999999999875432 22466889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccc
Q 022444 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (297)
Q Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~ 166 (297)
||+++++|.+++.+ ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++............
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 99999999987765 57999999999999999999999999999999999999999999999999999876655555567
Q ss_pred ccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc---cccCCCCCChhHHHHHHHhc
Q 022444 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---DFSCPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 167 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~l~~li~~~L 243 (297)
..|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+... ....+..+|+++.+||.+||
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 254 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHT
T ss_pred cccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHc
Confidence 7899999999999988776 8999999999999999999999988877666555443 23445668999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccC
Q 022444 244 DPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~ 265 (297)
++||++|||+.|+|+||||+..
T Consensus 255 ~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 255 DMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp CSSTTTSCCHHHHTTCGGGGGC
T ss_pred cCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-59 Score=400.47 Aligned_cols=257 Identities=34% Similarity=0.712 Sum_probs=239.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (297)
++++|++++.||+|+||+||+|+++.+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 46789999999999999999999999999999999987665555667889999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||+.|++|...+.....+++..++.++.||+.||.|||++||+|+||||+||+++.+|.+||+|||++.......
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--- 158 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--- 158 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB---
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+...++.......+..+|+++.+++.+||.
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 237 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 237 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 346799999999999888877 8999999999999999999999999999999999999888999999999999999999
Q ss_pred CCcCCCC-----CHHHHhcCcccccC
Q 022444 245 PNPETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 245 ~~p~~Rp-----s~~~il~~p~~~~~ 265 (297)
+||.+|+ |++++++||||++.
T Consensus 238 ~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 238 RDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred hCHHhccccchhhHHHHHcCcccccC
Confidence 9999996 99999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-59 Score=395.58 Aligned_cols=255 Identities=30% Similarity=0.560 Sum_probs=216.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCeEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTKIY 83 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 83 (297)
.++|++++.||+|+||+||+|+++.+|+.||+|.+...... ....+.+.+|++++++++||||+++++++.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 47899999999999999999999999999999999765433 3335778899999999999999999998854 45689
Q ss_pred EEEcccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----CEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 84 IILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKG-----VYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~al~~Lh~~~-----i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
+||||+++|+|.+++.+ ...+++..++.++.|++.||.|||+.| |+|+||||+||+++.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998864 357999999999999999999999976 999999999999999999999999999
Q ss_pred CCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc-cCCCCCCh
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF-SCPTWFPV 233 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~ 233 (297)
..............|++.|+|||++.+..++ .++|||||||++|+|++|..||...+..++..++..... ..+..+|+
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 240 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 8766554555567889999999999888776 999999999999999999999999999999888877765 45677999
Q ss_pred hHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 022444 234 GAKSLIHRILDPNPETRITIEEIRNDEWF 262 (297)
Q Consensus 234 ~l~~li~~~L~~~p~~Rps~~~il~~p~~ 262 (297)
++.+|+.+||+.||++|||++|+|+|||+
T Consensus 241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-59 Score=398.50 Aligned_cols=256 Identities=38% Similarity=0.726 Sum_probs=213.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||+||+|+++.+|+.||||++....... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356999999999999999999999999999999997655332 235678999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec---CCCCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~---~~~~~~l~df~~~~~~~~~~~ 162 (297)
|||++|++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||++. .++.+||+|||++...... .
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~ 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-S 164 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-C
Confidence 99999999999999888999999999999999999999999999999999999995 4789999999999765543 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~l 238 (297)
......|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.......+ ..+|+++.+|
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp --------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred eeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 23456799999999999988876 999999999999999999999999998888888877765443 4588999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+.+||++||++|||++|+|+||||++.
T Consensus 244 i~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=398.46 Aligned_cols=259 Identities=31% Similarity=0.601 Sum_probs=237.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHH-hcCCCCeeEEEEEEEcCCeEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRHPCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 84 (297)
+++|++.+.||+|+||+||+|+++.+|+.||||++.............+..|...+. .++||||+++++++.+++..|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998765444444555666666554 6899999999999999999999
Q ss_pred EEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccc
Q 022444 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (297)
Q Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~ 164 (297)
||||+++|+|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998776655666
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcC
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILD 244 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~ 244 (297)
....|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...+..++....+..|..+|+++.+||++||+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSC
T ss_pred cccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcc
Confidence 667899999999999988887 8999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCHH-HHhcCcccccC
Q 022444 245 PNPETRITIE-EIRNDEWFRKG 265 (297)
Q Consensus 245 ~~p~~Rps~~-~il~~p~~~~~ 265 (297)
+||++|||++ ++++||||++.
T Consensus 240 ~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp SSGGGSBTTBSCGGGSGGGTTC
T ss_pred cCCCCCcCHHHHHHhCchhccC
Confidence 9999999996 89999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-59 Score=397.19 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=225.4
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
+.|++++.||+|+||.||+|+++.+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46999999999999999999999999999999997643 223456789999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
||+++++|.+++.+ .+++++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++...........
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 99999999998765 45799999999999999999999999999999999999999999999999999876654444445
Q ss_pred cccCCccccCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc---cCCCCCChhHHH
Q 022444 166 TTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF---SCPTWFPVGAKS 237 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~l~~ 237 (297)
...|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+...++..... ..+..+|+++.+
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 6779999999999843 333 4899999999999999999999999888888777776643 334568999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 238 LIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
||.+||++||++|||++|+|+||||+..
T Consensus 248 li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999854
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=392.86 Aligned_cols=264 Identities=34% Similarity=0.598 Sum_probs=229.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh---HHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK---HKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
++|++.+.||+|+||.||+|+++.+|+.||||++....... ....+.+.+|+.++++++||||+++++++.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999999999999999997543322 123567889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC----CEEEcccCCCCCCCC
Q 022444 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPEQ 159 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~----~~~l~df~~~~~~~~ 159 (297)
+||||+++++|.+++...+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++ .++++|||++.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 9999999999999999888999999999999999999999999999999999999998776 499999999876654
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhH
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGA 235 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l 235 (297)
.. ......+++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.......+ ..+|+++
T Consensus 170 ~~-~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 247 (293)
T d1jksa_ 170 GN-EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247 (293)
T ss_dssp SC-BCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred Cc-cccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHH
Confidence 42 23355788999999999887776 999999999999999999999999999988888877765543 5689999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccc
Q 022444 236 KSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLI 272 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~ 272 (297)
.+||++||+.||++|||++|+|+||||+.......+.
T Consensus 248 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~l~ 284 (293)
T d1jksa_ 248 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS 284 (293)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTCC--------
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCChhHhhc
Confidence 9999999999999999999999999998765444433
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-58 Score=396.01 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=227.8
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEc
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (297)
+|++++.||+|+||+||+|+++.+|+.||||++...........+.+.+|+.++++++||||+++++++.+....|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999987655555666788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccccc
Q 022444 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (297)
Q Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~ 167 (297)
||.+++|..++....++++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++...... ...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----~~~ 171 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSF 171 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC----Ccc
Confidence 9999999888888889999999999999999999999999999999999999999999999999999865543 345
Q ss_pred cCCccccCCccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc--CCCCCChhHHHHHHHhc
Q 022444 168 CGTPNYVAPEVLSHKG--YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS--CPTWFPVGAKSLIHRIL 243 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~l~~li~~~L 243 (297)
.|++.|+|||++.+.. ..+.++|||||||++|+|++|..||.+.+..+...++.....+ .+..+|+++.+|+.+||
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence 7999999999986432 2248999999999999999999999998888877777665443 23458999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCcc
Q 022444 244 DPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 244 ~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
+.||++|||++++|+||||.+...
T Consensus 252 ~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp CSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred cCChhHCcCHHHHHhCHHhcCCCC
Confidence 999999999999999999987543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-58 Score=400.58 Aligned_cols=256 Identities=34% Similarity=0.678 Sum_probs=238.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++++.||+|+||.||+|+++.+|+.||||++...........+.+.+|+.+++.++||||+++++++......+++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 57899999999999999999999999999999999876655556677889999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
||++.+++|.+.+.+.+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++..... ..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~~ 196 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TW 196 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---BC
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---cc
Confidence 999999999999999899999999999999999999999999999999999999999999999999999866543 23
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHHHHHhcCC
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~L~~ 245 (297)
...|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+......++.......+..+|+++.+||++||.+
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred cccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhh
Confidence 45789999999999988876 99999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCC-----CHHHHhcCcccccC
Q 022444 246 NPETRI-----TIEEIRNDEWFRKG 265 (297)
Q Consensus 246 ~p~~Rp-----s~~~il~~p~~~~~ 265 (297)
||.+|+ |++++++||||++.
T Consensus 276 dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred CHHhccccccccHHHHHcCccccCC
Confidence 999994 99999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-58 Score=399.65 Aligned_cols=258 Identities=31% Similarity=0.604 Sum_probs=230.1
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5689999999999999999999999999999999976542 2346688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC--CCCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS--QGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~--~~~~~l~df~~~~~~~~~~~ 162 (297)
|||+++++|.+++. ..+++++..++.++.||+.||.|||++|++|+||||+||+++. ++.+||+|||++...... .
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~ 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q 180 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-S
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-c
Confidence 99999999999985 4457999999999999999999999999999999999999964 578999999998766543 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC----CCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT----WFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~l~~l 238 (297)
......|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.......+. .+|+++.+|
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred ccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 23456789999999999888776 9999999999999999999999999999988888877655443 488999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
|.+||++||++|||++|+|+||||++...+
T Consensus 260 i~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred HHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 999999999999999999999999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=382.38 Aligned_cols=253 Identities=25% Similarity=0.479 Sum_probs=218.7
Q ss_pred ccce-EEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc----CC
Q 022444 6 VGKY-EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----RT 80 (297)
Q Consensus 6 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 80 (297)
.+|| ++.++||+|+||+||+|+++.++..||+|++...... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 4566 7888999999999999999999999999998765432 2335678899999999999999999999864 45
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CEEecCCCCCeeec-CCCCEEEcccCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLD-SQGHLKISDFGLSALP 157 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~--i~h~di~~~nIli~-~~~~~~l~df~~~~~~ 157 (297)
.+|+||||+++++|.+++.+...+++..++.++.|+++||.|||++| |+|+||||+||+++ +++.+||+|||+++..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 68999999999999999999889999999999999999999999998 99999999999996 4789999999999765
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhhhccc--cCCCCCChh
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLYSKVEKADF--SCPTWFPVG 234 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~~~~~i~~~~~--~~~~~~~~~ 234 (297)
... ......|++.|+|||.+.+ .++ .++|||||||++|+|++|+.||... +...+.+.+..+.. ..+..++++
T Consensus 166 ~~~--~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 166 RAS--FAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp CTT--SBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred cCC--ccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 443 2345679999999999875 455 9999999999999999999999765 45556666665533 344558899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
+.+|+.+||++||++|||++|+|+||||+
T Consensus 242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-57 Score=396.51 Aligned_cols=257 Identities=29% Similarity=0.565 Sum_probs=229.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++++.||+|+||.||+|+++.+|+.||||++...... ....+.+|+.++++++||||+++++++.+...+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999765422 245678999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec--CCCCEEEcccCCCCCCCCCcc
Q 022444 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD--SQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~--~~~~~~l~df~~~~~~~~~~~ 162 (297)
||||++++|.+.+.+.+ ++++.+++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++...... .
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~ 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-E 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-S
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-C
Confidence 99999999998876544 699999999999999999999999999999999999997 5789999999999876543 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCC----CCCChhHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCP----TWFPVGAKSL 238 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~l 238 (297)
......+++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.......+ ..+|+++.+|
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred ceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 33456789999999999888876 999999999999999999999999999998888887765544 4589999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
|.+||++||.+|||++|+|+||||+....
T Consensus 263 i~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 99999999999999999999999987543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.1e-57 Score=381.85 Aligned_cols=259 Identities=30% Similarity=0.548 Sum_probs=229.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh------hHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEc
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII------KHKMADQIKREISIMKLVR-HPCVVRLHEVLAS 78 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 78 (297)
.++|++.+.||+|+||+||+|+++.+|+.+|||++...... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999999999999999998754322 2334456889999999997 9999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 79 RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
+...|+||||+++++|.+++...+++++..++.++.||++||.|||++||+|+||||+||+++.++.+||+|||.+....
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999998765
Q ss_pred CCccccccccCCccccCCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC----
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHK-----GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT---- 229 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 229 (297)
... ......|++.|.|||.+.+. ...+.++||||+|+++|+|++|+.||.+.+.....+.+.......+.
T Consensus 162 ~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (277)
T d1phka_ 162 PGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240 (277)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred CCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 432 33456789999999998542 12258999999999999999999999999998888888777654333
Q ss_pred CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 230 WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 230 ~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.+|+++.+|+.+||++||++|||++|+|+||||++.
T Consensus 241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 589999999999999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=397.61 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=219.3
Q ss_pred cccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.-+.++|++++.||+|+||+||+|+++.+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+..+.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 346789999999999999999999999999999999997543 233456788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
|+||||+++++|.+++.+.+.+++..++.++.|++.||.|||+ +||+|+||||+||+++.++.+||+|||++......
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999999988899999999999999999999997 59999999999999999999999999998754332
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------------------
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL------------------------- 216 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~------------------------- 216 (297)
......|++.|+|||++.+..++ .++||||+||++|+|++|+.||...+....
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 23356899999999999988887 999999999999999999999976543221
Q ss_pred -----------------HHHhhhccc-cCC-CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 217 -----------------YSKVEKADF-SCP-TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 217 -----------------~~~i~~~~~-~~~-~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
...+..... ..+ ..++.++.+|+.+||..||.+|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 111111111 111 1257899999999999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.3e-57 Score=393.90 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=224.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHH---HHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
++++|++.+.||+|+||.||+|+++.+|+.||||++.............+. +++.+++.+.||||+++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 578999999999999999999999999999999999765544333333333 44667777789999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
.|+||||+++++|.+++.+...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999765543
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhhhccccCCCCCChhHHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD---LTTLYSKVEKADFSCPTWFPVGAKSL 238 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~l~~l 238 (297)
......|++.|+|||++......+.++|||||||++|+|++|+.||...+ ...+...+.......+..+|+++.+|
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence 23456799999999999754433499999999999999999999997654 33445555556667778899999999
Q ss_pred HHHhcCCCcCCCCC-----HHHHhcCcccccC
Q 022444 239 IHRILDPNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 239 i~~~L~~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
|.+||++||++||| ++++++||||++.
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999999999 7999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-57 Score=387.96 Aligned_cols=257 Identities=27% Similarity=0.519 Sum_probs=229.8
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
+..++|++.+.||+|+||+||+|+++.+|+.||+|++...... ...+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 4578999999999999999999999999999999999765422 245778999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC--CCEEEcccCCCCCCCCC
Q 022444 84 IILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQG 160 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~--~~~~l~df~~~~~~~~~ 160 (297)
+|||||+|++|.+++...+ ++++.+++.++.||+.||.|||+.||+|+||||+||+++.+ ..++++|||.+......
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999998665 79999999999999999999999999999999999999854 47999999998766543
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCC----CCChhHH
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPT----WFPVGAK 236 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~l~ 236 (297)
.......+++.|+|||.+.+..++ .++|||||||++|+|++|..||...+..+....+......++. .+|+++.
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred -CcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 223456788999999999877776 9999999999999999999999999999999999888766553 5899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 237 SLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
+||.+||.+||++|||+.|+|+||||++..
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 999999999999999999999999998653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-57 Score=385.96 Aligned_cols=267 Identities=24% Similarity=0.312 Sum_probs=224.5
Q ss_pred EeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhh--HHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcc
Q 022444 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK--HKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (297)
Q Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (297)
.++.||+|+||+||+|+++.+|+.||||++....... ....+.+.+|+.+++.++||||+++++++...++.|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999986543221 12235688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcccccccc
Q 022444 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC 168 (297)
Q Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~~~~ 168 (297)
+.++++.........+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+..............
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 99988877777777899999999999999999999999999999999999999999999999999987766655556678
Q ss_pred CCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc----------------------
Q 022444 169 GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS---------------------- 226 (297)
Q Consensus 169 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------------------- 226 (297)
+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+...++......
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence 9999999999876554459999999999999999999999988887776665432100
Q ss_pred ------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCC
Q 022444 227 ------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDV 277 (297)
Q Consensus 227 ------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~ 277 (297)
....+++++.+|+.+||+.||++|||++|+|+||||++.+.+....+.|-+
T Consensus 242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~p 298 (299)
T d1ua2a_ 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298 (299)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCCC
T ss_pred CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCCC
Confidence 012357899999999999999999999999999999988777666555543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-56 Score=378.32 Aligned_cols=263 Identities=29% Similarity=0.464 Sum_probs=222.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
+++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|++++++++||||+++++++.+..+.|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4789999999999999999999999999999999965432 233456788999999999999999999999999999999
Q ss_pred EcccCCCChHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccc
Q 022444 86 LEFITGGELFDKI-V-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (297)
Q Consensus 86 ~e~~~~~~L~~~l-~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~ 163 (297)
||++.++ +.+.+ . ....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++++|||.+.........
T Consensus 80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 9999764 44444 3 3456999999999999999999999999999999999999999999999999999876666566
Q ss_pred cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccc------------------
Q 022444 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADF------------------ 225 (297)
Q Consensus 164 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~------------------ 225 (297)
.....+++.|+|||.+....+.+.++||||||+++|+|++|+.||...+..+...++.....
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 66778999999999988777767999999999999999999999998877766555422100
Q ss_pred c-----------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 226 S-----------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 226 ~-----------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
. ....+++++.+|+++||++||++|||+.|+|+||||++...+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 0 01235688999999999999999999999999999998866643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=377.31 Aligned_cols=254 Identities=31% Similarity=0.535 Sum_probs=219.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhH---HHHHHHHHHHHHHHhcC--CCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVR--HPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 80 (297)
.++|++.+.||+|+||+||+|+++.+|+.||||++........ .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4689999999999999999999999999999999875432211 11233567999999986 899999999999999
Q ss_pred eEEEEEcccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC-CCEEEcccCCCCCCC
Q 022444 81 KIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPE 158 (297)
Q Consensus 81 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~-~~~~l~df~~~~~~~ 158 (297)
..++|||++.+ +++.+++.+...+++..++.++.|+++||.|||++||+|+||||+||+++.+ +.++|+|||.+....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999975 6788888888899999999999999999999999999999999999999854 789999999987654
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCCCChhHHHH
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTWFPVGAKSL 238 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~l~~l 238 (297)
.. ......|++.|+|||.+.+..+.+.++|||||||++|+|++|+.||... +.+......++..+|+++.+|
T Consensus 163 ~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 163 DT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHL 234 (273)
T ss_dssp SS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHH
T ss_pred cc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHH
Confidence 43 2345678999999999987776667899999999999999999999753 244556677788899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 239 IHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
|.+||+.||++|||++|+|+||||++...
T Consensus 235 i~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 99999999999999999999999998644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-55 Score=374.28 Aligned_cols=257 Identities=30% Similarity=0.466 Sum_probs=218.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
++||+++++||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.++++++||||+++++.+.+.+..+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 579999999999999999999986 789999999976543 333457788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
++++.++.+..+....+.+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++++|||.+...........
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 99999877777777778899999999999999999999999999999999999999999999999999876655444455
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------------
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--------------------- 224 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--------------------- 224 (297)
...+++.|+|||.+.+....+.++||||||+++|+|++|+.||...+..+...++....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 66788999999999876665699999999999999999999999887776655543210
Q ss_pred --------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 225 --------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 225 --------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
......+++++.+|+++||++||++|||++|+|+||||++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1123346789999999999999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=375.40 Aligned_cols=251 Identities=34% Similarity=0.601 Sum_probs=211.2
Q ss_pred ccceEEeE-EeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHh-cCCCCeeEEEEEEEc----C
Q 022444 6 VGKYEVGR-TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL-VRHPCVVRLHEVLAS----R 79 (297)
Q Consensus 6 ~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~ 79 (297)
+++|++++ .||+|+||.||+|+++.+++.||||++... ....+|+.++.+ .+||||+++++++.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 67899886 599999999999999999999999998643 335578887654 479999999999865 4
Q ss_pred CeEEEEEcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---CCCEEEcccCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGLS 154 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~~~~~l~df~~~ 154 (297)
..+|+|||||+||+|.+++.+. ..+++.+++.++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||++
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6789999999999999999764 36999999999999999999999999999999999999975 457999999999
Q ss_pred CCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhhhccccCCC-
Q 022444 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT----LYSKVEKADFSCPT- 229 (297)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~- 229 (297)
+...... ......|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+... +...+......++.
T Consensus 162 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 162 KETTSHN-SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp EECCCCC-CCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeccCCC-ccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 7665432 33456799999999999888877 99999999999999999999997655433 33344444444443
Q ss_pred ---CCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCc
Q 022444 230 ---WFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGY 266 (297)
Q Consensus 230 ---~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~ 266 (297)
.+|+++.+||++||++||++|||++|+|+||||++..
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 3789999999999999999999999999999998654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=362.06 Aligned_cols=259 Identities=31% Similarity=0.453 Sum_probs=224.5
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
++||++++.||+|+||+||+|+++.+++.||||+++.... .......+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4799999999999999999999999999999999976542 334567788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCccccc
Q 022444 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~~~~ 165 (297)
++++.++++..++...+.+++..++.++.|++.||+|||++||+|+||||+||+++.++.++++|||.+...........
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 99999999998888888999999999999999999999999999999999999999999999999999987766555555
Q ss_pred cccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHhhhcc--------------------
Q 022444 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF-DELDLTTLYSKVEKAD-------------------- 224 (297)
Q Consensus 166 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf-~~~~~~~~~~~i~~~~-------------------- 224 (297)
...++..|.|||.+.+....+.++|||||||++|+|++|..|| ...+..+...++....
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 6677889999999877665569999999999999999999885 4555555555442211
Q ss_pred ---------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 225 ---------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 225 ---------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
......+++.+.+|+++||.+||++|||++|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 11223357889999999999999999999999999999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.2e-54 Score=362.98 Aligned_cols=257 Identities=23% Similarity=0.414 Sum_probs=215.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----e
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----K 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 81 (297)
.++|++.+.||+|+||.||+|+++.+|+.||||++......+......+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998766666666778999999999999999999999986543 4
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
.|+||||++|++|.+++...+++++.+++.++.|++.||.|||++|++|+||||+||+++.++..+++|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999998999999999999999999999999999999999999999999999999999876443322
Q ss_pred ---cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc----CCCCCChh
Q 022444 162 ---SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS----CPTWFPVG 234 (297)
Q Consensus 162 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~ 234 (297)
.......|++.|+|||++.+..++ .++||||||+++|+|++|..||...+..+...++...... ....+|++
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244 (277)
T ss_dssp -------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred ccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 233455789999999999887776 8999999999999999999999998887776665555432 23558999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
+.++|.+||++||++||+..+.+.|+|++
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999544444566654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=365.73 Aligned_cols=262 Identities=28% Similarity=0.375 Sum_probs=213.3
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCC-CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc---CCCCeeEEEEEEEc-
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTET-GESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLAS- 78 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~- 78 (297)
+..++|++++.||+|+||+||+|++..+ ++.||||++........ ......+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 4568999999999999999999999765 66789999875432221 122344556555544 79999999998842
Q ss_pred ----CCeEEEEEcccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 79 ----RTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 79 ----~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
....++++|++.++++..... ....+++..++.++.|++.||.|||++||+|+||||+||+++.++.++++|||.
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 347899999999876644433 345689999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc----------
Q 022444 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA---------- 223 (297)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~---------- 223 (297)
+...... .......|++.|+|||++.+..++ .++|||||||++|+|++|..||...+..+...++...
T Consensus 163 ~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 163 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhccc-ccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 8765443 334567799999999999888887 9999999999999999999999988877766655321
Q ss_pred -----------------cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccc
Q 022444 224 -----------------DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVP 268 (297)
Q Consensus 224 -----------------~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~ 268 (297)
.......+++.+.+||++||++||++|||++|+|+||||++..++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 012234478899999999999999999999999999999986543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-54 Score=363.76 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=219.5
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||+||+|+++.+++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 357999999999999999999999999999999987543 2245688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
|||+++|+|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++.......
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999998754 4689999999999999999999999999999999999999999999999999987654333
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYL-PFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~-pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
......+++.|+|||.+.+..++ .++||||||+++|+|++|.. ||...+.....+.+... ..+.+..+|+++.+|+.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 250 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence 23344578899999999888876 99999999999999999655 56666777777666554 45667789999999999
Q ss_pred HhcCCCcCCCCCHHHHhcCcccccC
Q 022444 241 RILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
+||+.||++|||++++++ +|+..
T Consensus 251 ~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 251 ACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp HHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred HHcCCCHhHCcCHHHHHH--HHHHH
Confidence 999999999999999976 55544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=366.56 Aligned_cols=266 Identities=27% Similarity=0.358 Sum_probs=216.5
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-----
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----- 78 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 78 (297)
...++|+++++||+|+||+||+|+++.+|+.||||++...... ......+.+|+.++++++|+|++++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 3578999999999999999999999999999999998655422 2334667899999999999999999998744
Q ss_pred ---CCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 79 ---RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 79 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
..+.|++||++.++.+.........+++..++.++.|++.||.|||++||+|+||||+||+++.++.++++|||++.
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 34689999999887766666666789999999999999999999999999999999999999999999999999986
Q ss_pred CCCCC----ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhccccCCCC-
Q 022444 156 LPEQG----VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFSCPTW- 230 (297)
Q Consensus 156 ~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~- 230 (297)
..... ........+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+.......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 54322 1223345689999999998766444599999999999999999999999888777666554432211111
Q ss_pred -------------------------------CChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccc
Q 022444 231 -------------------------------FPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVK 270 (297)
Q Consensus 231 -------------------------------~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~ 270 (297)
.++++.+||.+||++||++|||++|+|+||||+..+.+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence 2456789999999999999999999999999997755443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-53 Score=361.86 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=207.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCc---EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.++|++.+.||+|+||+||+|+++.+++ .++||.+.... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 4679999999999999999999986664 57888876543 233456788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
++||||+++|+|.+++... +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++......
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999988764 468999999999999999999999999999999999999999999999999998654332
Q ss_pred cc-----cccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChh
Q 022444 162 SL-----LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVG 234 (297)
Q Consensus 162 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 234 (297)
.. .....+++.|+|||.+.+..++ .++|||||||++|+|+| |..||.+.+..+....+..+ ..+.+..+|++
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence 21 2234568899999999877776 89999999999999998 89999999998888887665 35667779999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 235 AKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
+.+|+.+||+.||++|||+.+++++
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=368.08 Aligned_cols=259 Identities=29% Similarity=0.413 Sum_probs=211.6
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (297)
..++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 35789999999999999999999999999999999975432 3345677889999999999999999999996544
Q ss_pred --eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCC
Q 022444 81 --KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (297)
Q Consensus 81 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~ 158 (297)
.+|+||||+ +.+|..... ..++++..++.++.|++.||.|||++||+|+||||+||+++.++.++++|||.+....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 556766554 5689999999999999999999999999999999999999999999999999997655
Q ss_pred CCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc--------------
Q 022444 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD-------------- 224 (297)
Q Consensus 159 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~-------------- 224 (297)
.. .....+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 173 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 173 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred Cc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 43 3456789999999999776655699999999999999999999998887665544332211
Q ss_pred -----------------ccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccc
Q 022444 225 -----------------FSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPV 269 (297)
Q Consensus 225 -----------------~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~ 269 (297)
......+++++.+||++||..||++|||++|+|+||||++.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence 112244688999999999999999999999999999999865443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=354.93 Aligned_cols=247 Identities=22% Similarity=0.394 Sum_probs=207.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.+.||+|+||+||+|.++ +++.||||++..... ..+.+.+|++.+++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 57999999999999999999986 567899999875432 2356889999999999999999999999889999999
Q ss_pred cccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-cc
Q 022444 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~ 164 (297)
||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999999988754 4688999999999999999999999999999999999999999999999999976654322 23
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHHHHh
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~ 242 (297)
....+++.|+|||++.+..++ .++||||||+++|+|+| |.+||...+..+..+.+..+. ...|..+|+++.+++.+|
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238 (263)
T ss_dssp -----CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred cceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence 345688999999999888876 99999999999999999 677888888888888877663 455677899999999999
Q ss_pred cCCCcCCCCCHHHHhcC
Q 022444 243 LDPNPETRITIEEIRND 259 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~ 259 (297)
|+.||++|||++++++|
T Consensus 239 l~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 239 WKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=359.74 Aligned_cols=248 Identities=23% Similarity=0.397 Sum_probs=211.8
Q ss_pred EEeccCCceeEEEEEeC--CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEEcccC
Q 022444 13 RTIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (297)
Q Consensus 13 ~~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (297)
++||+|+||+||+|.+. .+++.||||++.... .+....+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 47999999999999864 456789999986543 234446778999999999999999999999865 45789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc---ccccc
Q 022444 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---LLRTT 167 (297)
Q Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~---~~~~~ 167 (297)
+|+|.+++.+..++++..++.++.||+.||.|||++|++|+||||+||+++.++.++++|||+++....... .....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 999999999988999999999999999999999999999999999999999999999999999976543322 22344
Q ss_pred cCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHHhcCC
Q 022444 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRILDP 245 (297)
Q Consensus 168 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~L~~ 245 (297)
.+++.|+|||.+.+..++ .++||||||+++|+|++ |..||.+.+..+....+..+ .++.|..+|+++.+|+.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 678899999999877766 89999999999999998 89999999988888888765 4567788999999999999999
Q ss_pred CcCCCCCHHHH---hcCcccc
Q 022444 246 NPETRITIEEI---RNDEWFR 263 (297)
Q Consensus 246 ~p~~Rps~~~i---l~~p~~~ 263 (297)
||++|||+++| |+|+|++
T Consensus 250 dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHhh
Confidence 99999999998 5666653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=358.02 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=218.3
Q ss_pred ccceEEeEE-eccCCceeEEEEEeCC--CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRT-IGEGTFAKVKFAQNTE--TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~-lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
.++|.+.+. ||+|+||+||+|.++. ++..||||++.... .....+.+.+|++++++++||||+++++++.. +..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 357888885 9999999999998763 45579999987543 23345778899999999999999999999865 568
Q ss_pred EEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
|+||||+++|+|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999998765 4579999999999999999999999999999999999999999999999999997654432
Q ss_pred c---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHH
Q 022444 162 S---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAK 236 (297)
Q Consensus 162 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~ 236 (297)
. ......+++.|+|||.+.+..++ .++||||||+++|+|+| |..||...+..+....+..+. ++.|..+|+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 242 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 2 22344578899999999877766 99999999999999998 999999988888888877664 567788999999
Q ss_pred HHHHHhcCCCcCCCCCHHHH---hcCccccc
Q 022444 237 SLIHRILDPNPETRITIEEI---RNDEWFRK 264 (297)
Q Consensus 237 ~li~~~L~~~p~~Rps~~~i---l~~p~~~~ 264 (297)
+|+.+||+.||++|||+.+| |+|+|+.-
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999998 66777653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=352.99 Aligned_cols=247 Identities=21% Similarity=0.393 Sum_probs=219.6
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (297)
++|++.++||+|+||+||+|+++ ++..||||+++..... .+.+.+|+.++++++||||+++++++.++..+++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 57999999999999999999985 7788999999764422 356789999999999999999999999989999999
Q ss_pred cccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-cc
Q 022444 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (297)
Q Consensus 87 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-~~ 164 (297)
||+.+|+|.+++.. ...+++..+..++.|+++||.|||+.||+|+||+|+||+++.++.+||+|||+++....... ..
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 99999999888654 45789999999999999999999999999999999999999999999999999976544322 33
Q ss_pred ccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHHHh
Q 022444 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIHRI 242 (297)
Q Consensus 165 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~ 242 (297)
....+++.|+|||.+.+..++ .++||||||+++|+|+| |+.||...+..++...+..+ ..+.|..+|+++.+|+++|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred cccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHH
Confidence 346688899999999888876 89999999999999998 89999999999988888776 4566777999999999999
Q ss_pred cCCCcCCCCCHHHHhcC
Q 022444 243 LDPNPETRITIEEIRND 259 (297)
Q Consensus 243 L~~~p~~Rps~~~il~~ 259 (297)
|+.||++|||++++++|
T Consensus 238 l~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSN 254 (258)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=361.36 Aligned_cols=265 Identities=26% Similarity=0.393 Sum_probs=214.8
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (297)
-.+||++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 3468999999999999999999999999999999997543 3344567889999999999999999999986543
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..+++++++.+++|.+++.. .++++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+......
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred ceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 23444455668899999875 47999999999999999999999999999999999999999999999999998755433
Q ss_pred cc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc-------------
Q 022444 161 VS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD------------- 224 (297)
Q Consensus 161 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~------------- 224 (297)
.. ......+++.|+|||.+......+.++||||+|+++|+|++|+.||...+..+.........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 23456789999999998666555689999999999999999999998776554443321110
Q ss_pred ---------c---------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccc
Q 022444 225 ---------F---------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLI 272 (297)
Q Consensus 225 ---------~---------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~ 272 (297)
. .....++.++.+|+.+||+.||++|||+.++|+||||++...+.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~ 308 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 308 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc
Confidence 0 11234678899999999999999999999999999999887765544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=355.64 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=216.8
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||.||+|+++ ++..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 368999999999999999999986 57789999987543 223568899999999999999999998754 567999
Q ss_pred EcccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc-
Q 022444 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~- 162 (297)
|||+++|+|.+++... .++++..++.++.|+++||.|||++||+|+||||+||+++.++.+||+|||+++.......
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999999877543 3699999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
......+++.|+|||.+.+..++ .++||||||+++|+|+| |.+|+...+..+..+.+..+ ....+..+|+++.+|+.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHH
Confidence 33455688899999999877766 99999999999999999 56677777888888887765 45567789999999999
Q ss_pred HhcCCCcCCCCCHHHHhc--Cccccc
Q 022444 241 RILDPNPETRITIEEIRN--DEWFRK 264 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~--~p~~~~ 264 (297)
+||+.||++|||++++++ |+||..
T Consensus 245 ~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 245 LCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999988 777753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=363.90 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=210.7
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCc-----EEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGE-----SVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (297)
++|++.+.||+|+||+||+|++..+++ .|++|.+.... .......+.+|+.+++++ +||||+++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 579999999999999999999875543 68999886543 233346688999999988 8999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHG-----------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPEN 137 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~n 137 (297)
..++||||+++|+|.+++.... .+++..++.++.|++.||.|||++||+|+||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 9999999999999999997542 47999999999999999999999999999999999
Q ss_pred eeecCCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022444 138 LLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (297)
Q Consensus 138 Ili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~ 214 (297)
|+++.++.+||+|||+++....... ......+++.|+|||++.+..++ .++|||||||++|+|+| |..||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999976554322 22345578899999999888776 99999999999999998 89999887655
Q ss_pred HHHHHhhhc--cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 215 TLYSKVEKA--DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 215 ~~~~~i~~~--~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
....++... .++.|..+|+++.+|+.+||+.||++|||++||++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444443333 345677899999999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=364.67 Aligned_cols=269 Identities=25% Similarity=0.344 Sum_probs=217.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----C
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----T 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 80 (297)
.+||++++.||+|+||+||+|+++.+|+.||||++..... +....+.+.+|+.+++.++|+|++++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3689999999999999999999999999999999976542 233356788999999999999999999998532 3
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..+++++++.+++|.+++.. +++++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||.+......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 34566677788999998864 57999999999999999999999999999999999999999999999999998755432
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcccc--------------
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKADFS-------------- 226 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------------- 226 (297)
.....++..|+|||.+.+....+.++||||||+++|+|++|..||.+.+.......+......
T Consensus 175 ---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 175 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp ---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred ---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 335567889999999877766669999999999999999999999888766655554322111
Q ss_pred -----------------CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCc
Q 022444 227 -----------------CPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNL 279 (297)
Q Consensus 227 -----------------~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~ 279 (297)
....+++++.+||++||..||++|||++|+|+||||++.....+-...++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~~~ 321 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQ 321 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCCCC
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCCCC
Confidence 01246889999999999999999999999999999998765444333333333
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=360.42 Aligned_cols=260 Identities=32% Similarity=0.594 Sum_probs=222.6
Q ss_pred ccceEEeEEeccCCceeEEEEEe---CCCCcEEEEEEeecchhh-hHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQN---TETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVRH-PCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~---~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 80 (297)
+++|++++.||+|+||+||+|++ +.+|+.||||.+...... +....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 57899999999999999999997 457899999998654321 22234557789999999977 89999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
..++++||+.+++|.+++...+.+++..++.++.|++.||.|+|+.|++|+||||+||+++.++.++|+|||.+......
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998755433
Q ss_pred -ccccccccCCccccCCccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHhhhccccCCCCCChh
Q 022444 161 -VSLLRTTCGTPNYVAPEVLSHKGY-NGAAADVWSCGVILYVLIAGYLPFDELD----LTTLYSKVEKADFSCPTWFPVG 234 (297)
Q Consensus 161 -~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~ll~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 234 (297)
........+++.|++||.+.+... .+.++|||||||++|+|++|+.||...+ ...+.........+.+..++++
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHH
Confidence 233456678999999999976543 3589999999999999999999997654 3344455555667777889999
Q ss_pred HHHHHHHhcCCCcCCCCC-----HHHHhcCcccccC
Q 022444 235 AKSLIHRILDPNPETRIT-----IEEIRNDEWFRKG 265 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps-----~~~il~~p~~~~~ 265 (297)
+.+|+++||++||.+||| ++|+++||||++.
T Consensus 263 ~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 999999999999999994 8999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-53 Score=354.42 Aligned_cols=249 Identities=24% Similarity=0.419 Sum_probs=204.5
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||+||+|+.+ ..||||++...... ....+.+.+|+.++++++||||+++++++. ....++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 468999999999999999999864 35999998754322 334677889999999999999999999874 4568999
Q ss_pred EcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc--c
Q 022444 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV--S 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~--~ 162 (297)
|||+++++|.+++... .++++..+..++.|+++||.|||++||+|+||||+||+++.++.+||+|||++....... .
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999999754 569999999999999999999999999999999999999999999999999997654322 2
Q ss_pred ccccccCCccccCCccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhhhccc-----cCCCCCChh
Q 022444 163 LLRTTCGTPNYVAPEVLSHKG--YNGAAADVWSCGVILYVLIAGYLPFDELDLTT-LYSKVEKADF-----SCPTWFPVG 234 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-~~~~i~~~~~-----~~~~~~~~~ 234 (297)
......|++.|+|||++.+.. ..+.++||||||+++|+|+||+.||.+.+... ....+..+.. ..+..+|++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 334557899999999986532 22489999999999999999999998876544 3344333321 245568999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 235 AKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
+.+|+.+||+.||++|||+++++++
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=362.17 Aligned_cols=252 Identities=28% Similarity=0.382 Sum_probs=207.9
Q ss_pred ceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc------CCe
Q 022444 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------RTK 81 (297)
Q Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 81 (297)
+|+..++||+|+||+||+|+++.+|+.||||++.... ....+|+.++++++|+||+++++++.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 6999999999999999999999999999999996543 123468999999999999999998843 335
Q ss_pred EEEEEcccCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccCCCCCC
Q 022444 82 IYIILEFITGGELFD---KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALP 157 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~~~~~~ 157 (297)
+|+||||++++.+.. .......+++..++.++.|++.||.|||++||+|+||||+||+++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 899999998753322 223455799999999999999999999999999999999999999775 8999999998765
Q ss_pred CCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhc--------------
Q 022444 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKA-------------- 223 (297)
Q Consensus 158 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~-------------- 223 (297)
... .......++..|+|||.+.+....+.++|||||||++|+|++|+.||...+..+....+...
T Consensus 174 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 174 VRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp CTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred cCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 443 23345678999999999876544459999999999999999999999888776665554321
Q ss_pred ---cc------------cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcc
Q 022444 224 ---DF------------SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYV 267 (297)
Q Consensus 224 ---~~------------~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~ 267 (297)
.. .....+++++.+|+.+||.+||++|||+.|+|+||||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00 012336889999999999999999999999999999988644
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=362.63 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=205.9
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEE------cC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA------SR 79 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~ 79 (297)
+.+|+++++||+|+||+||+|+++.+|+.||||++..... +......+.+|+.+++.++||||+++++++. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3689999999999999999999999999999999976543 3344567889999999999999999999985 34
Q ss_pred CeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCC
Q 022444 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~ 159 (297)
.++|++|||+.+ ++.+.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++++|||.+.....
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 689999999976 4545443 4789999999999999999999999999999999999999999999999998776554
Q ss_pred CccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhhhcc---------------
Q 022444 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKVEKAD--------------- 224 (297)
Q Consensus 160 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i~~~~--------------- 224 (297)
. .......+++.|+|||.+.+..++ .++||||+||++++|++|+.||.+.+.......+....
T Consensus 172 ~-~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 172 S-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred c-cccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 3 233455688999999999888776 89999999999999999999998877666554442110
Q ss_pred -------ccCC--------------------CCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCcccccc
Q 022444 225 -------FSCP--------------------TWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKL 271 (297)
Q Consensus 225 -------~~~~--------------------~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~ 271 (297)
.... ...++++.+||++||..||++|||++|+|+||||+....+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~ 323 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEV 323 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHH
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccc
Confidence 0000 0024678899999999999999999999999999986554443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-52 Score=348.27 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=206.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (297)
++|++.+.||+|+||.||+|++..+ +..|+||.+.... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 6899999999999999999998654 3567888875433 3344677899999999999999999999985 46789
Q ss_pred EEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc
Q 022444 84 IILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~ 162 (297)
+||||+++++|.+++.. ..++++..++.++.|+++||.|||++|++|+||||+||+++.++.+|++|||+++.......
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 99999999999988765 44689999999999999999999999999999999999999999999999999986544322
Q ss_pred -ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHHHH
Q 022444 163 -LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKSLI 239 (297)
Q Consensus 163 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li 239 (297)
......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....+..+. .+.+..+|+++.+|+
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 242 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 23345678899999999887776 89999999999999998 899999998888888877664 567788999999999
Q ss_pred HHhcCCCcCCCCCHHHHhcC
Q 022444 240 HRILDPNPETRITIEEIRND 259 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~~ 259 (297)
.+||+.||++|||+.+|+++
T Consensus 243 ~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 243 TKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.7e-51 Score=353.00 Aligned_cols=251 Identities=24% Similarity=0.448 Sum_probs=207.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEc--CCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLAS--RTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~ 81 (297)
..++|+++++||+|+||+||+|+++.+|+.||||++.... .+.+.+|+.++++++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3568999999999999999999999999999999986543 356788999999996 9999999999974 457
Q ss_pred EEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCC-CEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~-~~~l~df~~~~~~~~~ 160 (297)
.++||||+.+++|.+.. +.+++..++.++.||+.||.|||++||+|+||||+||+++.++ .++++|||.+......
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999987653 4799999999999999999999999999999999999998755 5899999998765543
Q ss_pred ccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhhh-------------c---
Q 022444 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT-TLYSKVEK-------------A--- 223 (297)
Q Consensus 161 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~i~~-------------~--- 223 (297)
.......+++.|+|||.+.+....+.++|||||||+++++++|..||...... +....+.. .
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 23345678899999999877655459999999999999999999999665322 11111100 0
Q ss_pred ---------------------cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccC
Q 022444 224 ---------------------DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKG 265 (297)
Q Consensus 224 ---------------------~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~ 265 (297)
.......+++++.+||++||.+||++|||++|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 000112267889999999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=344.97 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=207.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCC----cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETG----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
-+.|++.+.||+|+||.||+|.++.++ ..||||.+..... ......+.+|+.++++++||||+++++++.+...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 356999999999999999999987554 4799999865432 2334568899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.+++||++.++++.+.+... ..+++..+..++.+++.||.|||+.||+|+||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999998877654 57999999999999999999999999999999999999999999999999999865443
Q ss_pred cc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhc-cccCCCCCChhH
Q 022444 161 VS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLYSKVEKA-DFSCPTWFPVGA 235 (297)
Q Consensus 161 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l 235 (297)
.. ......|++.|+|||.+.+..++ .++||||||+++|+|+++ ..|+...+..+..+.+..+ +.+.+..+|+++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence 22 22344578899999999887776 899999999999999985 5666777777777777665 356677799999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 022444 236 KSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 236 ~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+++.+||+.||++|||+.+|++
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=344.69 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=210.6
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (297)
.++|++.+.||+|+||+||+|+++.+ +.||||++..... ..+.+.+|+.++++++|+||+++++++.+ +..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 46899999999999999999998754 6799999975432 23568899999999999999999999854 567899
Q ss_pred EcccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc-c
Q 022444 86 LEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-S 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~-~ 162 (297)
|||+.+|+|..++.. .+.+++..++.++.+++.||+|||++|++|+||||+||+++.++++||+|||+++....+. .
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999999888754 3569999999999999999999999999999999999999999999999999997654332 2
Q ss_pred ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHHH
Q 022444 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLIH 240 (297)
Q Consensus 163 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~ 240 (297)
......+++.|+|||.+....++ .++||||||+++|+|++| .+|+......+....+... ..+.+..+|+++.+++.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred eeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence 33345688999999999887776 999999999999999995 5566777777777777655 45677889999999999
Q ss_pred HhcCCCcCCCCCHHHHhc--CcccccC
Q 022444 241 RILDPNPETRITIEEIRN--DEWFRKG 265 (297)
Q Consensus 241 ~~L~~~p~~Rps~~~il~--~p~~~~~ 265 (297)
+||+.||++|||+.+|++ ++||...
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999987 6666543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=350.42 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=214.4
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcE--EEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGES--VAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 81 (297)
..++|++.+.||+|+||.||+|+++.+|.. |+||.+.... .....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 457899999999999999999999888765 5667665433 233356788999999998 69999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCC
Q 022444 82 IYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~ 145 (297)
.++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999999999998654 46899999999999999999999999999999999999999999
Q ss_pred EEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhc-
Q 022444 146 LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLYSKVEKA- 223 (297)
Q Consensus 146 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~i~~~- 223 (297)
+||+|||.++....... .....++..|+|||.+.+..++ .++||||||+++|+|++| ..||...+..++.+.+..+
T Consensus 166 ~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred eEEcccccccccccccc-ccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999876544322 2344578899999999887776 899999999999999996 4689999999998888765
Q ss_pred cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 224 DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
+++.+..+|+++.+|+.+||+.||++|||+++++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 456677899999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=344.12 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=207.5
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCC---CcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCe
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (297)
..++|++.+.||+|+||+||+|+...+ ...||||++...........+.+.+|+.++++++||||+++++++.+ ..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 346799999999999999999986532 24689999877665566667789999999999999999999999965 56
Q ss_pred EEEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCC
Q 022444 82 IYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (297)
Q Consensus 82 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~ 160 (297)
.++||||++++++.+.+.. .+.+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 7899999999999887764 456999999999999999999999999999999999999999999999999999865443
Q ss_pred cc---ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc--ccCCCCCChh
Q 022444 161 VS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD--FSCPTWFPVG 234 (297)
Q Consensus 161 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 234 (297)
.. ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+.+..+...++.... ++.+..+|++
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CCcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence 22 22234567799999999877665 89999999999999998 899999999999888886664 3556779999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcCccccc
Q 022444 235 AKSLIHRILDPNPETRITIEEIRNDEWFRK 264 (297)
Q Consensus 235 l~~li~~~L~~~p~~Rps~~~il~~p~~~~ 264 (297)
+.+++.+||+.||++|||+++|++ +|++
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~--~L~~ 271 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRD--FLLE 271 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH--HHHh
Confidence 999999999999999999999975 5543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=349.18 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=210.0
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCc----EEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCeE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (297)
++|++++.||+|+||+||+|.+..+|+ +||+|.+.... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988776 57788775433 334467789999999999999999999999765 56
Q ss_pred EEEEcccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 83 YIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+++++++.+++|.+.+.. ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 778888888999887765 4579999999999999999999999999999999999999999999999999987654332
Q ss_pred c--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhcc-ccCCCCCChhHHH
Q 022444 162 S--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKAD-FSCPTWFPVGAKS 237 (297)
Q Consensus 162 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~ 237 (297)
. ......+++.|+|||.+.+..++ .++||||||+++|+|+| |..||.+.+..++...+..+. ++.+..+|+++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 2 22334578999999999888776 99999999999999998 899999988888877777654 5677789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcCc
Q 022444 238 LIHRILDPNPETRITIEEIRNDE 260 (297)
Q Consensus 238 li~~~L~~~p~~Rps~~~il~~p 260 (297)
++.+||+.||++|||+.++++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=340.22 Aligned_cols=243 Identities=26% Similarity=0.487 Sum_probs=206.8
Q ss_pred cccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-CCeEE
Q 022444 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-RTKIY 83 (297)
Q Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 83 (297)
..++|++++.||+|+||.||+|+++ |..||||+++... ..+.+.+|++++++++||||+++++++.+ .+.++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 4678999999999999999999985 6789999996543 24568899999999999999999998854 45689
Q ss_pred EEEcccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCc
Q 022444 84 IILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (297)
Q Consensus 84 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~ 161 (297)
+||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999999999986543 58999999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhhhc-cccCCCCCChhHHHHH
Q 022444 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSKVEKA-DFSCPTWFPVGAKSLI 239 (297)
Q Consensus 162 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li 239 (297)
....++..|+|||.+.+..++ .++||||||+++|+|+| |+.||...+..+....+..+ +++.+..+|+++.+|+
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 233 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred ---ccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 234567899999999887776 99999999999999998 79999998888888888764 4567788999999999
Q ss_pred HHhcCCCcCCCCCHHHHhc
Q 022444 240 HRILDPNPETRITIEEIRN 258 (297)
Q Consensus 240 ~~~L~~~p~~Rps~~~il~ 258 (297)
.+||+.||++|||+.++++
T Consensus 234 ~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 234 KNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcccCHhHCcCHHHHHH
Confidence 9999999999999999988
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-50 Score=342.25 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=217.7
Q ss_pred ccceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
.++|++++.||+|+||+||+|+++ .+++.||||++.... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 357999999999999999999975 356789999987544 2334567899999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCC
Q 022444 81 KIYIILEFITGGELFDKIVHHG------------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPE 136 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~ 136 (297)
..++++|++.+++|.+++.... .++...++.++.+++.||+|||+.|++|+||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999986432 3789999999999999999999999999999999
Q ss_pred CeeecCCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCH
Q 022444 137 NLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY-LPFDELDL 213 (297)
Q Consensus 137 nIli~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~ 213 (297)
||+++.++.+||+|||++........ ......+++.|+|||.+.+..++ .++||||||+++|+|++|. .||...+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999875433222 22345678899999999988877 9999999999999999985 68999999
Q ss_pred HHHHHHhhhccc-cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 022444 214 TTLYSKVEKADF-SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFR 263 (297)
Q Consensus 214 ~~~~~~i~~~~~-~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~ 263 (297)
.+....+..+.. +.+..+|+++.+|+.+||+.+|++|||+.+|++ +|+
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~ 297 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQ 297 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHH
Confidence 998888877754 457779999999999999999999999999965 444
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=339.44 Aligned_cols=250 Identities=24% Similarity=0.425 Sum_probs=212.2
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCC-------cEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-------ESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 77 (297)
.++|++.+.||+|+||.||+|++..++ ..||||++.... .......+.+|...++++ +||||+++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 378999999999999999999976543 479999987654 223356677888888888 7999999999999
Q ss_pred cCCeEEEEEcccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeec
Q 022444 78 SRTKIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (297)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~ 141 (297)
++...++||||+.+|+|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 999999999999999999999654 2489999999999999999999999999999999999999
Q ss_pred CCCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022444 142 SQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYS 218 (297)
Q Consensus 142 ~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~ 218 (297)
.++.+||+|||.+........ ......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+..+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 999999999999886654322 23345678899999999888776 99999999999999998 799999999888888
Q ss_pred Hhhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 219 KVEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 219 ~i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+..+ .++.+..+|+++.+|+.+||+.||++|||+.|+++
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 87665 45667789999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=338.12 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=217.3
Q ss_pred ccceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (297)
-++|++.+.||+|+||+||+|.++. ++..||||++.... .......+.+|+.+++++.||||+++++++...+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 3789999999999999999998753 35789999997543 2233466889999999999999999999999889
Q ss_pred eEEEEEcccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcc
Q 022444 81 KIYIILEFITGGELFDKIVHH----------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~d 150 (297)
..++||||+.+|+|.+++... ..++...+..++.++++||.|||+.+|+|+||||+||+++.++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 999999999999999988643 2468899999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhhhcc-cc
Q 022444 151 FGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLYSKVEKAD-FS 226 (297)
Q Consensus 151 f~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~i~~~~-~~ 226 (297)
||+++....... ......+++.|+|||.+.+..++ .++||||||+++|+|+|| ..||...+..+..+.+..+. .+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 999976544322 22334678999999999888776 899999999999999998 58999999988888877654 45
Q ss_pred CCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 227 CPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 227 ~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
.+..+|+.+.+++.+||+.+|++|||++++++
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66789999999999999999999999999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=337.46 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=199.0
Q ss_pred cceEEeEEeccCCceeEEEEEeCC-----CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEc-C
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS-R 79 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~ 79 (297)
++|++.+.||+|+||.||+|.+.. +++.||||++..... ....+.+.++...+.++ .|+||+.+++++.. .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 679999999999999999999753 457899999865432 22245566777777776 58899999998754 4
Q ss_pred CeEEEEEcccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCC
Q 022444 80 TKIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~ 143 (297)
..++++|||+++|+|.+++... ..+++..++.++.|+++||.|||++||+|+||||+||+++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 5689999999999999998653 248899999999999999999999999999999999999999
Q ss_pred CCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHH-HHHHH
Q 022444 144 GHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLT-TLYSK 219 (297)
Q Consensus 144 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~-~~~~~ 219 (297)
+.+||+|||+++....... ......|++.|+|||.+.+..++ .++||||||+++|+|++| ..||...+.. .+...
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543322 23345688999999999887776 999999999999999986 5688776543 34444
Q ss_pred hhhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcC
Q 022444 220 VEKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 220 i~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~ 259 (297)
+..+ .++.+..+|+++.+++.+||+.||++|||++++++|
T Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4443 456677799999999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=332.74 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=211.5
Q ss_pred cceEEeEEeccCCceeEEEEEeC-----CCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (297)
++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+++++ +||||+++++++.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 68999999999999999999863 567899999997544 233356788999999999 6999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC
Q 022444 81 KIYIILEFITGGELFDKIVHHG------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS 142 (297)
Q Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~ 142 (297)
..+++|||+++++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 9999999999999999986543 5899999999999999999999999999999999999999
Q ss_pred CCCEEEcccCCCCCCCCCcc--ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022444 143 QGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYSK 219 (297)
Q Consensus 143 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~ 219 (297)
++.++++|||.++....... ......+++.|+|||.+.+..++ .++||||||+++|+|+| |.+||...+......+
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987654322 23345678999999999877776 99999999999999998 6777777665444433
Q ss_pred h-hhc-cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 220 V-EKA-DFSCPTWFPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 220 i-~~~-~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
+ ..+ ....+..+|+++.+|+.+||+.||++|||+++|++
T Consensus 260 ~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3 333 34555678999999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=329.16 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=202.6
Q ss_pred EEeEEeccCCceeEEEEEeCCCC---cEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEc-CCeEEEE
Q 022444 10 EVGRTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-RTKIYII 85 (297)
Q Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 85 (297)
...++||+|+||+||+|++..++ ..||||.++... .....+.+.+|++++++++||||+++++++.. +...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999986543 368999986432 34446779999999999999999999998764 5689999
Q ss_pred EcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCCCCCCCCCcc--
Q 022444 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-- 162 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~~~~~~~~~~-- 162 (297)
|||+++++|.+++.... .++...++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999999887543 577889999999999999999999999999999999999999999999999986543322
Q ss_pred --ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhhhc-cccCCCCCChhHHHH
Q 022444 163 --LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE-LDLTTLYSKVEKA-DFSCPTWFPVGAKSL 238 (297)
Q Consensus 163 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~-~~~~~~~~~i~~~-~~~~~~~~~~~l~~l 238 (297)
......+++.|+|||.+.+..++ .++||||||+++|+|++|..||.. .+..+....+..+ .+..|..+|+++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 22334678899999999877776 999999999999999997776643 4444555555544 445667789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcC
Q 022444 239 IHRILDPNPETRITIEEIRND 259 (297)
Q Consensus 239 i~~~L~~~p~~Rps~~~il~~ 259 (297)
+.+||+.||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999997
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-47 Score=325.95 Aligned_cols=258 Identities=22% Similarity=0.292 Sum_probs=203.4
Q ss_pred CccccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEEcC
Q 022444 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASR 79 (297)
Q Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~ 79 (297)
|-.|-=++|++.+.||+|+||.||+|++..+|+.||||++..... ...+..|+++++.+.|++ |+.+..++...
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 344444689999999999999999999999999999999875431 234678999999998665 56666777888
Q ss_pred CeEEEEEcccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC---CCCEEEcccCCCC
Q 022444 80 TKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGLSA 155 (297)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~---~~~~~l~df~~~~ 155 (297)
...++|||++.+ ++.+.+. ....+++..+..++.|++.||+|||++||+|+||||+||+++. +..++++|||+++
T Consensus 76 ~~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 76 DYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred CEEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 899999999955 6655554 4567999999999999999999999999999999999999853 4579999999997
Q ss_pred CCCCCcc-------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh---hhc--
Q 022444 156 LPEQGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYSKV---EKA-- 223 (297)
Q Consensus 156 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~i---~~~-- 223 (297)
....... ......|++.|+|||++.+..++ .++||||||+++|+|++|..||...........+ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 6543221 22345689999999999988876 9999999999999999999999776544332222 111
Q ss_pred ---cccCCCCCChhHHHHHHHhcCCCcCCCCCHHHH---hcCcccccC
Q 022444 224 ---DFSCPTWFPVGAKSLIHRILDPNPETRITIEEI---RNDEWFRKG 265 (297)
Q Consensus 224 ---~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~~i---l~~p~~~~~ 265 (297)
.......+|+++.+|+.+||+.+|++||+++++ |+|+|.+++
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 112345689999999999999999999999755 667665544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-46 Score=320.36 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=216.9
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCeEEEE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASRTKIYII 85 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 85 (297)
++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.+.| +|++.+++++......++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 589999999999999999999999999999998865431 2335678888888875 8999999999999999999
Q ss_pred EcccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecC-----CCCEEEcccCCCCCCCC
Q 022444 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-----QGHLKISDFGLSALPEQ 159 (297)
Q Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~-----~~~~~l~df~~~~~~~~ 159 (297)
||++ +++|.+++...+ .++...+..++.+++.+|.|||+.||+|+||||+||+++. ++.++++|||+++....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 579988887654 6999999999999999999999999999999999999964 56799999999976543
Q ss_pred Ccc-------ccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhhhccc----
Q 022444 160 GVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD---LTTLYSKVEKADF---- 225 (297)
Q Consensus 160 ~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---~~~~~~~i~~~~~---- 225 (297)
... ......|++.|+|||++.+..++ .++||||||+++|+|++|..||.+.. .......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 211 22345689999999999988776 99999999999999999999997543 3333333332221
Q ss_pred -cCCCCCChhHHHHHHHhcCCCcCCCCCHHHHhcCcccccCccccccccccCCCcc
Q 022444 226 -SCPTWFPVGAKSLIHRILDPNPETRITIEEIRNDEWFRKGYVPVKLIEYEDVNLD 280 (297)
Q Consensus 226 -~~~~~~~~~l~~li~~~L~~~p~~Rps~~~il~~p~~~~~~~~~~~~~~~~~~~~ 280 (297)
.....+|+++.+++..|++.+|++||+++.+.+ .|++..++.+.....+++|+
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~--~l~~~~~~~~~~~~~~~Dw~ 291 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLERLNTTEDENFDWN 291 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHHHHHHTTCCSCSCCGGG
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH--HHHHHHHHcCCCCCCCCCCC
Confidence 223568999999999999999999999998865 66666566666666677765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=312.96 Aligned_cols=245 Identities=20% Similarity=0.289 Sum_probs=191.2
Q ss_pred cceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----eE
Q 022444 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----KI 82 (297)
Q Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 82 (297)
.+|.+.+.||+|+||+||+|+. +|+.||||++..... .......|+..+..++||||+++++++...+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4689999999999999999986 588999999865431 1122335666667789999999999986433 68
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCEEecCCCCCeeecCCCCEEEcccCCC
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS--------KGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~--------~~i~h~di~~~nIli~~~~~~~l~df~~~ 154 (297)
|+||||+++++|.+++.+. ++++..++.++.+++.+|.|||+ .||+|+||||+||+++.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999764 78999999999999999999997 58999999999999999999999999998
Q ss_pred CCCCCCcc----ccccccCCccccCCccccccCCC-----CCchhHHHHHHHHHHHHhCCCCCCCC--------------
Q 022444 155 ALPEQGVS----LLRTTCGTPNYVAPEVLSHKGYN-----GAAADVWSCGVILYVLIAGYLPFDEL-------------- 211 (297)
Q Consensus 155 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~ll~~ll~g~~pf~~~-------------- 211 (297)
........ ......|++.|+|||.+.+.... +.++||||||+++|+|+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 75543322 23346789999999998754321 36899999999999999998876321
Q ss_pred -CHHHHHHHhhhccc--cCCCC-----CChhHHHHHHHhcCCCcCCCCCHHHHhc
Q 022444 212 -DLTTLYSKVEKADF--SCPTW-----FPVGAKSLIHRILDPNPETRITIEEIRN 258 (297)
Q Consensus 212 -~~~~~~~~i~~~~~--~~~~~-----~~~~l~~li~~~L~~~p~~Rps~~~il~ 258 (297)
......+.+..... ..+.. .+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 23333333333222 22221 2245889999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-44 Score=316.36 Aligned_cols=253 Identities=23% Similarity=0.423 Sum_probs=191.4
Q ss_pred ccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-----------CCCeeEEEE
Q 022444 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-----------HPCVVRLHE 74 (297)
Q Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~ 74 (297)
.+||+++++||+|+||+||+|+++.+|+.||||+++..... .+...+|+.+++.+. |+||+++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 36899999999999999999999999999999999865422 244567777777664 578999988
Q ss_pred EEE--cCCeEEEEEcccCCCCh-HHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCEEecCCCCCeeecCCC----
Q 022444 75 VLA--SRTKIYIILEFITGGEL-FDKI--VHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQG---- 144 (297)
Q Consensus 75 ~~~--~~~~~~lv~e~~~~~~L-~~~l--~~~~~~~~~~~~~~~~~i~~al~~Lh~-~~i~h~di~~~nIli~~~~---- 144 (297)
++. .....+.++.++..... .... .....+++..++.++.+++.||.|||+ .||+|+||||+||+++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 774 33456666666544332 2222 234568999999999999999999998 8999999999999998665
Q ss_pred --CEEEcccCCCCCCCCCccccccccCCccccCCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------H
Q 022444 145 --HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT------L 216 (297)
Q Consensus 145 --~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~------~ 216 (297)
.++++|||.+...... .....+++.|+|||++.+..++ .++||||+|+++++|++|+.||....... .
T Consensus 168 ~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeecccccccccc---cccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 3899999998754432 2356789999999999888876 89999999999999999999996543210 0
Q ss_pred -HHHhh-----------------------------------------hccccCCCCCChhHHHHHHHhcCCCcCCCCCHH
Q 022444 217 -YSKVE-----------------------------------------KADFSCPTWFPVGAKSLIHRILDPNPETRITIE 254 (297)
Q Consensus 217 -~~~i~-----------------------------------------~~~~~~~~~~~~~l~~li~~~L~~~p~~Rps~~ 254 (297)
...+. ..........++++.+||.+||.+||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 00000 000111112356789999999999999999999
Q ss_pred HHhcCcccccCc
Q 022444 255 EIRNDEWFRKGY 266 (297)
Q Consensus 255 ~il~~p~~~~~~ 266 (297)
|+|+||||++..
T Consensus 324 e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 324 GLVNHPWLKDTL 335 (362)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhcCcccCCCC
Confidence 999999999553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.6e-22 Score=159.88 Aligned_cols=138 Identities=17% Similarity=0.242 Sum_probs=108.0
Q ss_pred eEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhh---------------hHHHHHHHHHHHHHHHhcCCCCeeEEE
Q 022444 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII---------------KHKMADQIKREISIMKLVRHPCVVRLH 73 (297)
Q Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (297)
+.+.++||+|+||+||+|++. +|+.||||+++..... .........+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468899999999999999985 7899999987532111 111123455688889999999999988
Q ss_pred EEEEcCCeEEEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCEEecCCCCCeeecCCCCEEEcccCC
Q 022444 74 EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (297)
Q Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~~~i~h~di~~~nIli~~~~~~~l~df~~ 153 (297)
++.. .+++||++++..+.+ ++......++.+++.++.+||++|++|+||||+||++++++ ++|+|||.
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 7642 379999998765532 44566778999999999999999999999999999998654 89999998
Q ss_pred CCCCCC
Q 022444 154 SALPEQ 159 (297)
Q Consensus 154 ~~~~~~ 159 (297)
+.....
T Consensus 149 a~~~~~ 154 (191)
T d1zara2 149 SVEVGE 154 (191)
T ss_dssp CEETTS
T ss_pred cccCCC
Confidence 865543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.73 E-value=2.7e-08 Score=80.58 Aligned_cols=142 Identities=16% Similarity=0.141 Sum_probs=95.4
Q ss_pred ccccceEEeEEeccCCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCeE
Q 022444 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKI 82 (297)
Q Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 82 (297)
+.+..|+.++..+.++.+.||++.. ++..+++|......... ...+.+|...+..+. +--+.+++.+...++..
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4567888888766566678998863 45668888876443221 223456676666654 33467788888888899
Q ss_pred EEEEcccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 022444 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS------------------------------------- 125 (297)
Q Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~al~~Lh~------------------------------------- 125 (297)
++||++.+|.++.+.... ......++.++...+..||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998777554321 11223344455555555553
Q ss_pred ----------------------CCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 126 ----------------------KGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 126 ----------------------~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
..++|||++|.||++++++...++||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127899999999999876666799998654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.27 E-value=1.6e-06 Score=69.48 Aligned_cols=81 Identities=14% Similarity=0.137 Sum_probs=51.9
Q ss_pred ccceEEeEEeccCC-ceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCeE
Q 022444 6 VGKYEVGRTIGEGT-FAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH--PCVVRLHEVLASRTKI 82 (297)
Q Consensus 6 ~~~y~~~~~lg~g~-~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~ 82 (297)
+..++.. .+..|. .+.||++... ++..+++|....... ..+..|...++.+.. --+++++.+..+.+..
T Consensus 10 l~g~~~~-~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~ 81 (255)
T d1nd4a_ 10 LFGYDWA-QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 81 (255)
T ss_dssp TTTCEEE-ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred ccCCceE-EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccce
Confidence 3444443 344444 3678988754 566688998755431 224455555555532 3356788888888889
Q ss_pred EEEEcccCCCCh
Q 022444 83 YIILEFITGGEL 94 (297)
Q Consensus 83 ~lv~e~~~~~~L 94 (297)
+++|++++|.++
T Consensus 82 ~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 82 WLLLGEVPGQDL 93 (255)
T ss_dssp EEEEECCSSEET
T ss_pred EEEEEeeecccc
Confidence 999999988665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.16 E-value=4e-06 Score=71.71 Aligned_cols=81 Identities=17% Similarity=0.133 Sum_probs=47.6
Q ss_pred eEEeccCCceeEEEEEeCCCCcEEEEEEeecch--hhh--HHHHHHHHHHHHHHHhcC-C--CCeeEEEEEEEcCCeEEE
Q 022444 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA--IIK--HKMADQIKREISIMKLVR-H--PCVVRLHEVLASRTKIYI 84 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~--~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~l 84 (297)
.+.||.|....||++.+..+++.+++|--.... ..+ .....+...|...++.+. + ..+++++.+. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 567899999999999988778899999643211 000 001223445666666552 2 3466676653 345578
Q ss_pred EEcccCCCCh
Q 022444 85 ILEFITGGEL 94 (297)
Q Consensus 85 v~e~~~~~~L 94 (297)
+||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.21 E-value=0.00099 Score=56.40 Aligned_cols=74 Identities=16% Similarity=0.169 Sum_probs=47.5
Q ss_pred eEEeccCCceeEEEEEeCC-------CCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCeEE
Q 022444 12 GRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRTKIY 83 (297)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~ 83 (297)
++.|+.|---.+|++.... ..+.+++++..... . .-...+|..+++.+.-.+ .++++.++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678778888899998653 34567787765322 1 122446777777775333 3578887743 5
Q ss_pred EEEcccCCCCh
Q 022444 84 IILEFITGGEL 94 (297)
Q Consensus 84 lv~e~~~~~~L 94 (297)
.|++|++|.++
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999876443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.14 E-value=0.00052 Score=56.56 Aligned_cols=131 Identities=16% Similarity=0.110 Sum_probs=71.8
Q ss_pred CCceeEEEEEeCCCCcEEEEEEeecchhhhHHHHHHHHHHHHHHHhcCCCCee--EEE-----EEEEcCCeEEEEEcccC
Q 022444 18 GTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV--RLH-----EVLASRTKIYIILEFIT 90 (297)
Q Consensus 18 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~--~~~-----~~~~~~~~~~lv~e~~~ 90 (297)
+-...||++.. .+|..+++|+.+..-. ..+.+..|...+..+...++. ... ..+......+.+++++.
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 33468999986 4788899999865321 123455566666655422221 111 12234567788899887
Q ss_pred CCChH-----------HHH----H---h------------------------cCCCCHH---HHHHHHHHHHHHHHHHH-
Q 022444 91 GGELF-----------DKI----V---H------------------------HGRLSES---EARRYFQQLIDGVDYCH- 124 (297)
Q Consensus 91 ~~~L~-----------~~l----~---~------------------------~~~~~~~---~~~~~~~~i~~al~~Lh- 124 (297)
|..+. ..+ . . ...++.. .....+..+...+.-.-
T Consensus 108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 63321 000 0 0 0011111 22233333333333321
Q ss_pred ---hCCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 125 ---SKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 125 ---~~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
..+++|||+++.||++++ + ..++||+.+.
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred ccCCceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 136899999999999964 3 4589999776
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.41 E-value=0.02 Score=46.18 Aligned_cols=30 Identities=27% Similarity=0.396 Sum_probs=26.5
Q ss_pred CCCEEecCCCCCeeecCCCCEEEcccCCCC
Q 022444 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (297)
Q Consensus 126 ~~i~h~di~~~nIli~~~~~~~l~df~~~~ 155 (297)
.|+||||+.++||+++.+...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999765
|